CLAS )
epoetin alfa
5 and
an autologous blood
section 4.4 ) .
see section 4.4 )
It can be
effect was maintained
der Patienten ,
(
treatment ,
ABBREVIATIONS
or other
Protamine sulphate Water
intermediate-acting combined with
disposal and
of
other
medicinal
.
analogues for injection
packed cell volume
Upon discontinuation
such as
difficulty
( human )
arrhythmias , sudden
and post-marketing experience
during pregnancy
leaflet
mmol/ l )
with
mg/ m2 ;
has been
patients with
The
of
-
over 6
insulin sensitivity
2C9 (
The therapeutic margin
The
( FINLAND ) AB
cerebrovascular adverse events in
untreated
(
g/ dl
, anorexia
from light
14 g/ dl
not been established
units
of
The active substance is
the risk of
with or
30
food and drink
produce effects that
trial in healthy
hyperglycaemia
or more
57
of
2
before
mg/ m ) .
section 4.4 ) .
In clinical
is
mmol/ l )
you
, or
pioglitazone
your doctor
with
the
SQUIBB
pioglitazone
to 12 g/ dl
( MTP )
OF THE
Kingdom BRISTOL-MYERS
-
with
and 4.9 )
increased risk
geometric means of
growth hormone
Aclasta
treatment in this
a
moisture
patients
is 50 International
side effects
ketoconazole
.
trials
above baseline
the
alfa
of cleavage (
(
in children and
,
growth hormone and
cardiovascular
you
, read
dose , i. e.
reproductive toxicity
aripiprazole s efficacy
100
haemoglobin of
of diabetes is
is 15 mg
clinical trials aripiprazole has
.
9.5 and 11
epoetin
days 21
increased to the level
Centre ( Europe )
M-III
see
,
of patients
thyroid hormones
adults
)
maintain haemoglobin values
pharmacist .
of
treated
and
Black
to 75.6
measures
doctor
g/ dl ( 0.62
Vascular
or
dihydrogen phosphate
In
and 70 %
de pointes , bradycardia
in clinical trials
EPS
Slovenská
hours
mortality ( p=0.01 )
)
RH12
defined
vitro
no fatalities .
- increased risk
BE STORED OUT OF
Limited
8°C )
%
of Abseamed between 17
not
)
1HU - United
be followed
in subjects with
possibility
month )
.
20 ACTRAPHANE
section 5.1 ) .
haemoglobin
vial contains
.
1 )
.
the reach and sight
insulin requirement
with
or
kidney have
All special warnings and
Tel
use in
3116 8000
negative impact on
IU/ kg epoetin alfa
considered not known (
or lithium concentrations
Therapy- Anaemia
( type 1 )
While on
3.0 %
paediatric
daily dose
common
scheduled
is
mg
(
androgen suppression
(
your doctor
of 0.3
: the
.
If
%
the nearest
00 10
with
ASL/ ALT > 10
of cancer cells to
CYP3A4
ml solution for injection
As for
possibility of
efficacy
)
0.5 to
and what it is
aripiprazole concentrations
can
haemoglobin
RESPONSIBLE FOR BATCH
that primarily
Similarly ,
more ABILIFY
,
mmol/ l
, the
may be injected by
and
OUT OF THE
and symptoms
dose adjustment is necessary
studies
listed below .
Actos 30mg tablets
Deutschland Novartis
less
Following
.
even several
days following
insulin requirement may be
%
, Oxford Road Uxbridge
FACT-An fatigue scale
% of the
hepatic metabolism
In
% )
be
( see section
section 6.1
55 53
should be
acute
contains
,
de pointes , bradycardia
aripiprazole
to sudden
,
epoetin
aripiprazole in
daily dose of
used
treatment
see section
thiazides , glucocorticoids ,
haemolysis , and
no medically
compared with those
: +
tablets
RESTRICTIONS
,
the blood pressure is
patients with normal
frequency
ml contains
The
) prior to
section 5.1 ) .
coma
relative
The
Healthcare A/ S Tlf
& D Centre
prior to
of
,
your
The needle should be
Aripiprazole also demonstrated
the placebo group
anaemia
Norge
potentially medically serious
every
be harmful for
+
heart failure
ml contains 100
in
see section
and sight
) .
please see section 4.4
dehydro-aripiprazole ,
as measured
solution contains 10
starting dose for
bottle
) 74 18 84
, anorexia
OncoEurope Tel
combination therapy (
treatment
adequate and well-controlled
placebo-treated patients
When the CYP3A4
month
Ísland VISTOR HF
solid tumours (
THE
doses
inform your doctor
, rDNA (
2-78 units
in patients with
( 1
few minutes
haloperidol-controlled trial
g/ dl ( 6.2
very
aripiprazole
Takeda Pharma
Cytotoxic actions of epoetin
should be
( Europe ) ,
some of your ABILIFY
transfer protein (
section 5.2
the medicinal product has
from hypoglycaemia
see
Actraphane
bone marrow fibrosis of
to drive and
only
the
Tardive Dyskinesia
once every
hepatitis ,
the
has been studied
: + 31
in type 1 diabetes
described
( 0800 )
addition
see section
with this condition may
and
in CHO
All special warnings and
) .
The
Treatment
5.1 ) .
5.3 )
BRISTOL-MYERS SQUIBB
32
vitro genotoxicity assays
.
patients with severe
, RH12 5AB
dose
, treatment
of the pharmacological effects
effect
D-58638
( 6.2 mmol/ l
IU/ kg
Treatment with a
per se
.
this condition
,
may require discontinuation
10
the
calibrated dropper
of experiencing
two
mg sodium per dose
or CYP2D6 inhibitor
Omission of a meal
concomitant administration
If
ml
In clinical trials and
.
Sími : +
, the
observed ( see sections
mmol/ l ) to
( for pH-adjustment
of greater than
three
in
episodes or
98
days immediately
effect
, use of
.
scheduled for major
When the
at least 211
presents
Tours Cedex 2
+ 44 ( 0)20
in
The
two other
blood sugar (
BRISTOL-MYERS SQUIBB SARL Tél
improvement in
%
strenuous physical exercise may
blood pressure or
24 hours after the
260 lung
than 30
biological efficacy of
of 50 IU/ kg
- If
enzymes
in adult patients
of children .
of 1
pharmacist if you are
be
blood loss and haemolysis
300
insulin and 90 %
efficacy .
.
in
)
existing
74 18
you have
Ltd
(
for pH-adjustment
major
,
food
possibility of multiple medicinal
Before use :
manufacture ( recombinant
.
of
group : oral blood
10
in patients
) .
24-hour period
ABILIFY
.
cancer patients
to other
the intravenous
(
of Aclasta
( 7.5 mmol/
g/ dl (
) gene
times
g/ dl
contains
211
to
( 172 breast ,
or
injection
Octreotide/ lanreotide may
your doctor or
In type
given
.
indigo carmine
In
in
7.5 mmol/ l )
Erythropoietin receptors
Uncommon
controlled studies
30 % dissolved insulin
hypothermia
with
dosage of
.
Cmax and AUC
should be
and
daily dose
between 9.5
Following oral administration
%
.
( anencephaly
Common : fatigue Psychiatric
-
vitro
frequency
1 diabetes
epoetin alfa
supervision and monitoring should
ABILIFY
or
impaired renal function
and
Hunton House Highbridge Business
potent inhibitors of
or even death
)
its application for the
91.6 ± 14.1
in
of this
of adult
)
.
clinical trials
with
and 11
study
358 ( 0)9
,
(
mitratapide
retinopathy
between 9.5
to 30
15 mg
by at least 30
children and adolescents under
mellitus ,
Each tablet contains 15
( all formulations )
isolated cases of angioedema
use of
dose
, brand ( manufacturer
Cmax of
( 7.5 mmol/
production .
If
Cmax
.
side effects (
4 to 6 weeks
of
sections 4.8
of the value )
.
1
you have any
of 50
In patients
see
should be
should
drowsy or
trials and
.
% isophane insulin
, 14 and 7
and 12
considered not known
mmol/ l )
administered
see
.
children
of
digoxin ,
see section 4.8
products and
haemodialysis
410 500
the pharmacokinetics of
)
reactions
discard any
SQUIBB (
the
P450 2C8 although
8954
g/ dl ( 7.5
,
.
75 and
administration
14 30
with aripiprazole ,
1
, hives
forms of
diabetic retinopathy
.
in a
patients with or without
with
by the intravenous route
)
patients ,
,
and 8167 patients )
ABILIFY
blood cell production
of anaemic
with an apparent volume
hypoglycaemia
.
Highbridge
Most reactions are
a
GmbH
(
or more weeks
Starting dose
0)1 46 25 16
injection ,
> 99 %
6.1 .
feelings
AND ROUTE(S
play
patients
programme
days
drive
in vitro studies
Development Centre (
and
aminoglycosides or diuretics
increased
epoetin
presents
subcutaneous route and
evidence
>
In
of
below 30°C ) .
9000 IU/ 0.9 ml
your pharmacist
Patienten
x
Linear Analogue Scale
a manic
that epoetin
% )
from
similar
between 9.5 and
)
by
01
: + 353 (
symptoms
inform your
weeks
patients
infusion , becoming
The
treated patients
,
An
) , 2C9 (
is unclear and
diabetes mellitus
There is an increased
hyperglycaemia
74 18 84
, anxious or
or pharmacist .
an
repeated oral
60 %
a potent inhibitor
GmbH & Co KG
Europe ) ,
most of
30
a
When
.
adult
( 8.1 mmol/ l
patients who
observation
Epoetin alfa
50 %
pyrexia
reproductive toxicity studies
,
should
was comparable
to sudden stabbing migraine-like
)
Thrombotic events can be
Aclasta-treated group
BRISTOL-MYERS SQUIBB
of aripiprazole
4.8
) and
In
Arzneimittel Pütter GmbH
lithium concentrations .
valproate or
or pharmacist .
was
Section 4.2 ) .
is
up to a 31
increase 40,000/ µl or
.
354
of the elimination
days
medicinal products
,
trials of aripiprazole
- if
injection
the pharmacokinetics
very rapid
10 000
may
cerebrovascular adverse
the administration of
be
alfa may
are
zum Einnehmen
epoetin alfa
.
663
.
of NMS
In clinical trials and
dextromethorphan/ 3-methoxymorphinan ratio )
0)20 3116 8951
After
fructose
what it is used
daily
45 93 05
pharmacokinetic characteristics of
with
ventricular arrhythmias , sudden
the
data available
with chronic
see section 4.4
your doctor immediately
You will
of aripiprazole
.
a stroke or
carbohydrate chains
If
, hydroxylation ,
and should
At equivalent doses
Alcohol may
blisters
administration of
%
44 ( 0800
patients
the
the
aggravation of existing hypertension
mg
45 45 93 05
was detected .
mellitus
patients with
in children
When a
A number of
0)810 410 500
to patients with moderate
renal impairment :
aripiprazole .
cartridge
your doctor :
(
, IF
a glass ball to
trials have
occurs ,
you
1 % of
be
x
of administration )
(
aripiprazole has not been
e.
of aripiprazole AUC
- if the
in patients
Hypertensive crisis
glycaemic
caudate
15 mg
the risk
.
follows
GmbH
and
.
dalton .
protect the environment
insulin
may be necessary
,
of 30 minutes ,
,
in
: fatigue Psychiatric disorders
Centre ( Europe
.
rare -
150
is
products to affect
Epoetin alfa
epoetin
, or were
see
IU/ kg 2
versus
for
Bipolar I Disorder
, insulin ( human
patients
alfa
7.5 mmol/ l )
models of dopaminergic
of the
administration
Tel : + 44
of greater than
of
& Co KG
13 g/ dl
or combination therapy
or hepatic impairment may
the use
used with caution
.
+ 46 8 704
and
Actraphane is
13 g/ dl ,
,
anaemia ( e.
in combination therapy with
,
per dose ,
patients treated
than 2 g/ dl
please see section
After injection
SARL Tél :
DISPOSAL
with
, nausea , constipation
for signs and symptoms
For a full list
weight
, even several
produce effects that
11
or waste material should
for cerebrovascular adverse
per month
Please tell
6
receptors on muscle
and carcinogenicity
ABILIFY is 15 mg
controlled clinical studies
patients with a
100
which are
diabetes
kg and adults .
epoetin
(
,
alfa
products
increased Gamma Glutamyl Transferase
( see section 4.8
should be
and
(
, inform
effects of Abraxane
MUST
is difficult
dose
be
and adolescents has not
, accidental or intentional
be presented .
and danazol
3 times per
solution for injection in
Weight gain :
:
episcleritis ,
of
-
In schizophrenia patients
temperature regulation disorder (
g/ dl ( 7.5
or
rather
pregnancy , lactation
therapy .
11.6 63.8 31.0
ALT levels
2 In
95
adverse reactions in
was last updated
side effects
the
is unchanged
OF
additional
.
you
Sverige BRISTOL-MYERS
patients
with
, especially when
(
two
The potentially medically
agitation ,
occurs ,
5.1 )
-
greater than 12
severe manic episodes
Less
with
Elevations
studies
, arterial
days
margin of
It
4.4 ) .
necessary .
and
and behaviour and
should
CI
or
contains 10
and other antipsychotic drugs
weeks
)
or pharmacist
OF THE MEDICINAL PRODUCT
your haemoglobin-levels
precautions for
and
dose adjustment
,
is
hydrolysis ) sites on
insulin resistance .
, antibodies
you
tachycardia
rhabdomyolysis ) , and
headache Eye disorders Common
Gastrointestinal dyspepsia
Pioglitazone is also indicated
your
placebo-controlled trials
no
on overall survival
risk for
has not been established
complications .
colourless solution for injection
a
patients
- 150
8.1 mmol/ l
7.5
in healthy
cell production .
is available
or
These reports are based
hydroxylation
subcutaneous
90
for
vomiting and
when
in
Following initiation
Aripiprazole
by
you are pregnant
as assessed
for ABILIFY
of which were
and
.
of the
maximum daily dose
with
in cancer
between
in this
or
or previous
read
monkeys
Octreotide/ lanreotide may
dose
7.5 mmol/ l )
,
increased
cell volume
olanzapine-treated patients .
aripiprazole has not been
33 -
predonation
07/ 412/ 018
and isophane ( NPH
study
was
the
( 7.5
Treatment of
2 g/ dl (
40
4.7
( see
pharmacist
aripiprazole
no
3 times per week
stroke
60 25 800
necessary
or less
patients participating in
g/ dl
deep vein thrombosis
that
If
Italia Takeda Italia Farmaceutici
week
combination
: anaemia
section 4.6
OR WASTE MATERIALS
no
6.1 .
risk
clinical
Aclasta is available here
, followed by a
hyperglycaemia
.
a replacement insulin which
Distribution No
of the
increased
pharmacokinetics of insulin products
as
Uncommon - Peripheral neuropathy
insulin and
1
,
,
OF UNUSED MEDICINAL
determined ,
treated
18 , or 13
osteonecrosis
+
bottle
CI ]
30
and dehydro-aripiprazole , but
in
Actos 30mg
please see
patients with renal
can
tablet at the
be assured
(
alfa and
and
.
use
use
face. .
extensive extravascular distribution
(
.
,
insulin
doctor or
with renal impairment
Insulins and analogues for
56 tablets 84
9 % of the
Marketing Authorisation Holder
those receiving placebo
order
sealed in
sensory neuropathy , additional
France
clinical
receiving chemotherapy
ABILIFY
controlled
) .
the intravenous route ,
you are pregnant
you
(
is
of the
observed when
concentrations ,
39.0 , 55.3 ]
well-controlled trials of
diabetes
an autologous blood
)
In patients with
or combination therapy
over
insulin in
or waste material should
IS
,
In
D Centre (
animals ,
most of these patients
angina pectoris , increased
of 10
enzyme (
paediatric
effects
)
rare hereditary problems of
carprofen
)
Sími
on the
, diabetes mellitus
Aripiprazole
,
for
and
pharmacist
dextromethorphan/ 3-methoxymorphinan ratio
of akathisia in
IU )
possibility of
or
times per week .
) prior to
solution for injection in
AUC and Cmax
efficacy of epoetin alfa
patients
with or without
.
substances
section 6.1
epoetin
in vivo and in
General
The local safety
in
This effect
is
,
to become
and the Montgomery-Asberg
Centre (
1 800
be
( n= 938 ;
is
In
were reported
is
infusion ,
100
should be
section
AND ROUTE(S
open-label
30 kg and
A number
in this age group
in
diabetic ketoacidosis ,
has
or
active substance in Abilify
for
) .
therapy
Almost all subjects
Erythropoietins are growth factors
aspartame (
gemfibrozil
paediatric patients
a
30 consists of 30
in patients over
Steady State
% with placebo
AB Tel :
or mixed episode
not
Sími
and other antipsychotic drugs
AUC
2°C - 8°C )
the patient
about this medicinal product
( see section
Haemoglobin variability
pioglitazone dose may need
is very
insulin and 70
aggravation of existing
and in clinical
absorption
Keep out of
is
( 30
absolute oral
, D-58638
your
Aripiprazole
between 17 and
The syringes contain 0.7
products .
ABBREVIATIONS FOR
in
loss of efficacy
patients
9.75 mg in 1.3
98 TABLETS ONLY
should be
5
)
significant effect
is a
The
pioglitazone (
- 7.5
analogues for injection
(
Maintenance dose
you
is
x
you
clinical
(
young subjects .
Centre
for
: + 43-(0)800 29
weight gain
The potentially
a mild
30 kg require higher
mechanism of action
other
260
)
animal models of
side effects (
use machines .
31 ( 0 )
.
over " 643 "
15 mg
( 30
and precautions
and
( NPH ) insulin
in
,
)
the patient
treatment
of
+ 45
section
you or
AND
on
10 and
and isophane
delay recovery
.
352 74
uptake into bone
receiving chemotherapy
)
of epoetin
4.4 ) .
cases
, muscle pain
hyponatremia
section
rDNA
symptomatic anaemia in
fibrosis of
in the
dosage or
increased
clinically
be performed in
and controls .
Actraphane 30 consists of
of this population
erythropoietin is 32,000 to
flu-like symptoms
and
cells/ µl
is required
usual dose
a vial
of Product Characteristics
)
especially
-
not
rimonabant 20
.
pre-filled syringes
of
the
period .
to
Hb between 10
symptoms
mg )
have also occurred in
and
mmol/ l
between 10 and 12
(
, insulin ( human
and
or unplanned
see
section 5.3
, and
, especially
1 , 49
or
ABILIFY
section
or
is necessary
)
be
and protein intake
a
disorder .
incidence
trials
is necessary
ml contains 8000 international
of the pancreas
and 3.0
+
section
mg
side effects
Adult surgery patients in
of 80 to
)
in vitro (
orodispersible
GGT ) ,
, especially
less
Uncommon :
the
dose
.
in combination
Middlesex UB8
and
+
Wingates
mmol/ l )
medicinal products
( below 30°C
an autologous blood predonation
first injection .
It
,
stroke in
If blood pressure
patients with a
the
, growth hormone
treated
the frequency
Bagsværd Denmark
and 12 g/ dl
hypoglycaemia
symptoms of
multipack
of
Try to take the
( 1.25 mmol/ l
ml :
-
product at 52-weeks was
administration of epoetin
of CPK (
mixed episode of
of
87 %
0.035 mg of anhydrous
particularly overweight patients
well-controlled
and
%
is
Global R
) Sodium hydroxide
the dose
( this should be
Yarvitan 5 mg/ ml
estimated volume
pioglitazone
in vitro (
and dehydro-aripiprazole , but
) .
with epoetin alfa
site
2C9 ( warfarin )
or
)
or were
combination
.
or
Novartis Ireland
also be used .
Portugal
Aclasta
week by
for
mg once a day
if the
peripheral oedema
discontinuation of treatment
ON BLISTERS
United Kingdom
half-life
%
.
.
effect
other CNS medicinal products
: + 31
solution for injection is
after
the skin
potent
solution for injection
,
patients with
by the liver primarily
- 8°C )
( 6
frequency grouping , undesirable
15
peak is always well
oral aripiprazole
dose is injected .
If
growth hormone
see section
A single-dose study
In the long-term
glucocorticoids ,
Following concomitant
44
of this
toxicity ( reported in
D-58638 Iserlohn , Germany
fast-acting
retinopathy
Patients
cell
Changes in strength
)
with a
isolated patients
, constipation ,
in CHO
and anaphylactic reaction .
and
hypoaesthesia ,
in
0.4 ml
and
A
the
and
2.47 in favour
cardiovascular outcome study of
Sexually active
A
Alcohol
of
the
, ventricular arrhythmias ,
glycine ,
( metformin ,
, and
, vomiting ,
pack with
in
and 60 %
and efficacy .
% dissolved insulin and
the
weeks
This
or pharmacist .
to patients with
> 3 X the
:
ABILIFY is 15
anhydrous
and
The frequency
reached
differentiating hormone , the
12 g/ dl (
feeling
for injections
( haematocrit of
Kingdom Takeda UK
may
the incidence
000
and
infusion
12
Interaction with receptors
l
patients with
of
on one side .
and sight of children
Europe
30 kg and
should be
the
dose-proportional .
cloudy after resuspension .
60
times per week
doctor or
.
ng Ethinylestradiol/Levonorgestrel-Kombination
,
when
, glucose-galactose malabsorption or
&
D Centre (
should
therapeutic margin of epoetin
events (
manic
the incidence of
reduction of manic
emission tomography
schizophrenia
tense
30 %
Aripiprazole is thought
effects may
and AUC
BOX
4.4 ) .
with
with chronic renal failure
the patients
% CI
ABILIFY
two large
may vary with
Hypersensitivity to
WITH BLUE
20 mg
vomiting
, glucocorticoids ,
Abraxane is not recommended
) in
is necessary .
3
patients with
, 30 mg
transitory and
Tél/ Tel : +
the
the levels remain the
see section 4.8
ABILIFY may increase the
,
.
iron deficiency ,
with chronic renal failure
a
15 l/ hr/ m2
, nausea ,
vitro .
.
.
)
in
0)20
orthopaedic surgery
In patients
If you
260 lung ,
special warnings and
Uxbridge - Middlesex
:
in children
pioglitazone
see section 5.2
sleepiness , shaking
epoetin alfa
patients
)
NMS
risk factors
( for pH-adjustment )
of greater than
be followed .
section 6.1
and
olanzapine-treated patients
.
the anterior abdominal wall
toxicity
THE
or
or
monitored
.
Following oral administration
(
during the course
84.0
1 diabetes ,
In a prospective
patients
with
100 IU of insulin
OR BY UNIT
of pioglitazone
erythrocytes
If the disease
)
may
insulin
section
haemoglobin of
orthopaedic surgery
after the
follows :
your doctor
dose
should be
somnolence ,
clinical
in mild (
the medicinal product has
.
lithium concentrations .
your
monotherapy
AUC
clinically significant
5.2 ) .
14 and 7
epoetin
,
: + 46 8
for
events
and Cancer
with
a
cases
increased incidence of
37 (
with renal
month )
in cancer
, anorexia
Global R & D
see section 4.4 )
your shunt and
cartridge
The maximum daily dose
is usually
(
exhibited
4.4
therapeutic
) of
SQUIBB GESMBH
dysmotility and
SAFE
population ,
solution for injection
Aclasta tend to
ACE ) inhibitors ,
Insulin human ,
( 6.2 - 7.5
contains 2000 international
four
cancer patients
epoetin
insufficiency .
If any of these
symptoms
of the nursing
and
reaction
administration
reduced with
IU/ kg
that aripiprazole
one vial of
Pioglitazone
%
under
, these
of
trials , uncommon cases
( 6.2
ml solution for injection
Eye disorders Very
The absolute oral
and
section 5.2 ) .
no significant effect on
how long
study
by the liver primarily
of
, chest pain
, infection
10 and
This
.
IU/ kg/ day
trial in healthy
(
(
or
or
some cases
patients with
type 2 diabetes or
to sudden
dehydro-aripiprazole
(
( Europe )
g/ dl
in
especially
0)20
.
reduce insulin requirement .
12 g/ dl
Adult surgery patients
or discontinuation of treatment
, ketoacidosis
( 7.5
had
you
Slovenija Eli Lilly
of
(
In
The
) .
London
or if
insulin and
( see section
.
well-controlled
is
SMALL IMMEDIATE PACKAGING
35 trials
1
should
to the baby
units ( IU )
patients
the warning signs of
should be
of Abilify and placebo
in
(
32
not
, but it
or
Park
)
the treatment of post-menopausal
with or without
1.25 mmol/ l
sealed
( 91
Although there is
+44 ( 0)20
, pulmonary
: + 33 (
clinical trials
section
.
modifications in patients with
Sími : +
, but
and
patients
.
t½ of
Actraphane is
the
,
insufficiency not yet
0.5 ml contains 1000
+ 43 1
( BSAP ) ,
GmbH & Co
values
The potentially
week
: blurred vision
events
:
infection
Cancer
251 21
signs and symptoms
intravenous route
Meta-analysis of overall
controlled studies
aripiprazole
.
(
ABILIFY
combined with
on the total dose
Upon discontinuation
nerve cells
pharmacist
see section 4.4
other medicinal products :
contains
The
mean age
and
95
a
)
recovery in all
contains
is therefore recommended .
: + 44
, sleepiness , shaking
( 2.1 % )
METHOD OF ADMINISTRATION
will advise you
aripiprazole
majority
, vomiting
of
severe
reduced BSAP
CHILDREN
products
30
0)20
been
their previous insulin .
In
Vantas
to the foetus
individual
danazol
in bisphosphonate-naïve
Try to take
ABILIFY 10 mg tablets
in subjects
and
and
ml
.
patients with
with normal
8°C )
ml
Haemoglobin variability
of Aclasta
10 000
other
-
cases of
of
:
, dysphagia
.
with epoetin
BRISTOL-MYERS SQUIBB NORWAY LTD
section
.
all formulations )
intestinal calcium malabsorption )
or if
methylene groups .
to
The injections are given
feelings
in which
Do not
lithium or
in
4.2 Method
has been accidentally frozen
Maternal toxicity
the intravenous route .
Norge
,
the intravenous route
pharmacokinetic characteristics of aripiprazole
used
has Actraphane
injection
)
g. insulin dosage ,
.
not
Absorption The absorption
four carbohydrate chains
, for
32 2 352
adults
7.5 mmol/ l )
encephalopathy-like symptoms (
.
, the haemoglobin
All women received
.
76 Elimination The
patients ( mean age
Erythropoietin receptors
and 3.2 %
events
in
treatment
67
.
be reduced
closely
per week
75 - 150 60
4AE
, with or
( 1 800
56-99
aripiprazole and 3.2 %
.
section 4.5 ) .
, especially in
could damage the tablet
, 30 or 45
IU )
300 IU .
7.5 mmol/ l )
( subcutaneously )
.
usual dose is 15
patients with a manic
Detailed information on
( 4 or
section 6.1
(
days to
)
of
Very
blood perfusion of the
should be
in type 1 diabetes
increased incidence of
0.99 , 1,18 ;
pharmacokinetics or
.
an interaction
, in
Europharm Limited
tablets 30 tablets
pioglitazone in patients
the
of standard
39 06
Any
.
.
.
, but not
In paediatric
SARL Tél
- 150
isophane insulin .
a clinical
Intravenous injection : over
aripiprazole and dehydro-aripiprazole ,
been carried out
be reduced
.
in patients with
What Aclasta is
headaches as a
chloride Glycerol
with normal
than children over 30
should be done in
Correction for
4.9 ) .
adequate
fibrosis of any origin
NMS are
in
oral
the dosage of
(
Smoking status :
,
dehydro-aripiprazole
and
Immune system disorders
next appointment
biological efficacy
require higher
of a
.
one year or
or
patients
any
rat
effect
diabetes was 9.5
in favour
Pre-existing hypocalcaemia
occurs .
The frequency of these
to maintain urea ,
no influence on the
ml
oedema , difficulties in
pharmacist
duration
a clinical trial
(
Ltd 61 Aldwych London
and
hour
of approximately 6 hours
with
or breathlessness .
be
of 33 -
g/ dl ( 8.1
12 -
pioglitazone .
contain 0.5 ml (
the known
contributing
.
802 with
no
07/ 412/ 018
.
a similar decrease in
Inadequate
a
keratoconjunctivitis sicca
The
in
medically important
( 7.5
month
not
2°C
tell
are pregnant
the
Additionally , aripiprazole
x 1 tablets
ba Latvij Tel :
In a clinical
, take
epoetin
disease
haemodialysis and
aripiprazole or any
you know how
see section
.
injections are given in
hepatocellular dysfunction
possible
731
A
or hyperosmolar coma
Patients
.
( 1.25 mmol/ l
.
been conducted
haloperidol
carton contains one single-use
)
bile
12
,
Nervous
mean age
hours
are
the incidence of
mg
Cytotoxic actions of
+ 36(0 ) 20
diabetic
of efficacy
410 500
moisture .
be
of the
.
When weak inhibitors of
If ALT levels
.
day
as packaged for sale
the medicinal product
Common :
5 and 10
.
active substance or
.
mg of
standard genotoxicity tests
produce enough insulin
The usual dose
1.25 mmol/ l
renal impairment :
ABILIFY in
and you
at the end
syringes contain 1
0.62
11
e. g.
If you
Black patients
by the intravenous
a corresponding unit scale
30 " on
( Madrid )
Abseamed 7000 IU/ 0.7
4.8 - General
their previous insulin .
( 1.25 mmol/ l
0.5 %
g/ dl ( 6.2
pharmacist .
see
is
solution for
in type
t½
cancer patients
) , contact
scheduled for major elective
the
or blood pressure ,
and anaemic rats ,
benefits
the bile
epoetin alfa
once a day
other
mmol/ l )
) in
mg
anorexia
pioglitazone ( as hydrochloride
4000 international units (
more
Horsham West
GmbH Tel : +43
In a prospective ,
of
cooling element .
,
and protracted absorption respectively
156
see section
,
the pooled atrial
and sight of children
5 % ansteigt .
in the treatment of
The recommended
g/ dl
lung ,
plasma concentration of
and
800
60 % in
your doctor
.
per se of insulin
other
trials
-
.
mmol/ l
1
metabolised by multiple
number
below
.
the deltoid region may
Actos and
Ltd
aripiprazole
1
.
compromise or
Seizure : in clinical
orodispersible tablet contains 15
- Peripheral
other
of
monitoring of
if they
353 ( 1 800
(
count has increased
Park , Oxford
other handling
take this
vision Gastrointestinal disorders
containing the active
+ 43 ( 1
IU/ kg
; the average
with a
increased risk for thromboembolic
)
14
of sugar
,
to 12 g/ dl
g/ dl ( 7.5
no experience
section 4.2 ) .
Occlusion of
was last approved on
,
Aldwych
,
and
(
bone marrow
:
If
)
Your doctor
mmol/ l )
in
neutropenia
.
) .
manic
metabolism
5HT2a receptors
minimum
models of dopaminergic
women
and
: orthostatic hypotension*
,
-
for haloperidol-treated
n =
Hunton House Highbridge Business
oral
of
,
and
and
red blood cell count
human )
, sudden unexplained
usual
less than 1
dose
Die
Lietuva
serotonin 5HT1a
( SBECD
be
4.5 Interaction
.
Therabel
patient
haemoglobin target range
West Sussex ,
patients
The frequency
sedation
manic
did not
open-label studies
it
40
Uncommon -
have
effect of
as compared
47 67
24 hours .
In some
injections are given
d
a full
hepatic impairment on the
The syringes
studies ,
4.4 Special
In three
( see section 4.4
and potassium in
IV
for
more
used
effects
g/ dl (
other clinical effects
such
of rimonabant was
has no
insulin .
in
Abseamed can be
human , rDNA
glycine ,
erythropoietin
( metformin ,
3 ml
Water for injections
in
.
risk
and Cmax of
other antipsychotics
,
and 3.0 %
favour of controls
or
As with
000 IU
Takeda UK Ltd Tel
or
and N-dealkylation
Blister ( PVC/ aluminium
g/ dl (
; 95
half-life was due to
" on
IU/ kg
or
Oxford Road
( see section 4.5
clinical trials , rare
taking or
In type 1
6 %
planning to become pregnant
medicinal product contains
for placebo
daily insulin requirement
of excipients , see
+3726441100
especially
have
& D Centre (
or pharmacist .
If
for
535 7000
two
unused product
In a
pregnancy , lactation
or Hb increase 1
tablet formulation is
morphometric vertebral fractures
(
0.6
.
more
patients
50 IU/ kg
, orchidectomy
150
,
ACE ) inhibitors
mmol/ l
dosing
trials of
be presented .
Oral
pioglitazone
weeks
of anaemia and
important signs and
and
doctor
London WC2B 4AE
normal and
ABILIFY is effective
Europe )
100
encephalopathy-like symptoms
if
mg pioglitazone ( as
between 10 and
other potent CYP3A4 inhibitors
or
56 x
g/ dl
.
rats
dogs
47 67
300 IU/ kg given
subcutaneous administration .
In
10 ml
of
the
more
tablets
In
The biological efficacy
for aripiprazole
to maintain haemoglobin values
Special precautions
an increased risk
hours after the
should
more units
34 % ,
without a rapid-cycling course
trial
CYP2D6 and CYP3A4
.
intensify and prolong the
mmol/ l
ml contains
of
The recommended
( see section 4.5
data reveal no
The
trial
unchanged pioglitazone
difference in
in children
is
to
should be restricted
4.4
,
increase 40,000/ µl or
GESMBH Tel :
should be
is
NMS
untreated
Neuroleptic
below 15
aripiprazole
Particular attention should
1 bottle
dizziness , headache ,
flatness
human
and isophane ( NPH
Actraphane
)
was
forms of interaction
see section 6.6 .
10
the
If you
take
the tablet formulation is
was
.
Potential for other medicinal
Aripiprazole
(
Arzneimittel Pütter
haloperidol
digoxin , warfarin ,
unused product
.
take it with
these patients
polymer )
and
or
trials with
the
London
higher dose to
tablets are
per month ,
taxanes
If the
rare
) 731
hours after
The potentially
, increased Aspartate Aminotransferase
loss of consciousness and
an increased risk
please
No other erythropoietic therapy
or hyperosmolar coma or
section
35 trials and
young subjects
looked
headaches as a
you are breast-feeding .
(
and
was 9.5 years
, stomatitis
( n= 938 ;
.
aripiprazole has not been
all cancer patients
Based on
occur in men .
see section 4.4 )
patients ,
overweight or obesity
.
most
and a
4.5 Interaction with
in pregnant
not
contains
: dyspepsia , vomiting
well-controlled trials of
contain
Abseamed
reported
, recovered label was
see section 5.2 )
episode in patients
no adequate and well-controlled
cardiovascular
from moisture
analogues for injection ,
events
( see section
)
with the product
after
observed in
particularly overweight patients )
6.2 mmol/ l
+33 ( 0)1
.
In elderly patients
angioedema
condition may also
( 6 % )
12
.
epoetin
Business Park ,
haematological malignancies
.
for 3
tremor , syncope
forefinger .
studies
a few
the
,
from
If an elevated (
all
of EPS was
, nausea
few
patients
of CYP3A4 ,
, uncommon cases
should be
and 5HT2a receptors and
very
clinical studies
corresponding to 5.330
, ventricular arrhythmias
61
MATERIALS
contraeptives ,
adverse reactions related to
aripiprazole in
recommended in these patients
Actraphane .
iron stores should
5.2 ) .
cerebrovascular adverse events in
reduce the epoetin alfa
Lucien
renal failure
haematocrit
For
.
valproate
you
laboratory parameters
with
adolescents under
- 14
.
and
therapy .
is therefore recommended
bioavailability
injected
Subcutaneous injection :
mmol/ l ) .
Cancer
.
and
MTP )
Limited Eesti filiaal Tel
or if you
should be administered intravenously
.
or
schizophrenia
)
see section
is
mg aspartame (
(
when
medicines used to
is between
section 5.1 ) .
g/ dl ( 0.62
with associated
Patienten mit einer
should not
)
: + 32
- Do not use
Therefore ,
their previous insulin
in the
epoetin alfa has been
see section
.
ml :
patients with
see section 5.1
the
for dose reflected differences
to the insulin requirement
week
: +
In the
declined
.
the haemoglobin target range
MAOI
Abraxane should
47 67 55
:
.
epoetin
(
healthy elderly and younger
+ 44
in paediatric patients
haemoglobin level
Centre (
can be found here
constipation
60
your condition
501 76
( see section 4.8
of
by
carton in order
.
and
, glycine
cartridge
g/ dl
see section 5.2
im Nervensystem zu finden
)
and
and well-controlled studies
with encephalopathy-like symptoms (
route
LTD Tel
chronic renal failure
Takeda Global
and anaphylactic reaction
patients
The terminal half-life (
observed ( see
doctor or pharmacist .
of
and
had
be avoided
( see section
clinically
] ( weeks
It
the incidence
Storbritannia
anaemia the medicinal product
Germany
observed
of 0.6 ml contains
of cardiac events .
If you
patients
%
or the
if you
risk
effects were
of greater than 12
.
section 4.4
and 50
not
used in humans
section 6.1 .
When looking only
% with placebo .
13 g/ dl
tolbutamide
the use of
75 and
.
pectoris ,
Aclasta and risedronate
section
sedation ,
tremor , dizziness ,
40 ( 0)21
episodes or
and 15.7 % for
anaemia
waren ,
oral solution
3 ml ) .
overdose with aripiprazole ,
only in patients who
of
once a
mg/ day
&
5.1
the
R & D
14 and 7 )
or
monitored
treatment
, open-label studies ,
1 to
diabetic
and 3.2 %
occur .
60 -
no
serum testosterone reduction
these trials
five large
international units (
unexplained
dose
recommended
: a
equivalent to 300
with
and a sulphonylurea
( and ,
74 60
that
, IF APPROPRIATE
Sími : + 354
increased risk
incidence of
)
headaches as a
, hyperglycaemia and diabetes
g. insulin dosage
,
see section 4.4 )
A
yearly PSURs unless
Lactose : patients with
If
receptors
Cmax and AUC
not
post-menopausal women in the
) AND
or
kilogram bodyweight
aluminium intoxication
+ 31
should be
blood tests
fibrosis of
50 , 56 ,
the risk of
not
In clinical trials with
30 -
and
(
of
your doctor
IU/ kg once weekly
epoetin
risk of pregnancy .
Aldwych ,
, the incidence of
Oxford Road Uxbridge
rats , but not
As with other
drive
,
risk
minutes ) .
in vitro
Adult cancer
paediatric patients
Actraphane 30
haemoglobin target range
: + 46
hypertension
patients
: + 44 (
House Highbridge Business Park
treated with pioglitazone
,
410 500
in clinical trials
contain 15 , 30
the incidence
Sanofi Winthrop Industrie
ABILIFY
,
& Co KG
x 1
and
Pre-filled syringes ( glass
15 and 5
you
Changes
Be sure to tell
taken
bone marrow cells
.
leaflet
and
Uxbridge -
period
or pharmacist .
PARTICULARS TO APPEAR
see section 5.1 )
you
enzymes
that seen
( also part of
day .
Usual maintenance dose
risk of cross-reaction
.
) .
( 4 or
patients
iron deficiency
disorders and
- 14
or 450
to 200
arrhythmias ,
in
clinical trial
should
Frequencies
survival
of NMS
.
below 30°C ) .
but had no
the
pioglitazone
)
.
of
also occur in
profound myelosuppression
) .
than
medical prescription
(
If convenient
46
(
clinical trials ,
pyrexia ) ,
IU/ kg given subcutaneously
and/ or dark urine
.
mmol/ l )
dose of
( see section 5.3
Treatment should only be
in these patients
pioglitazone
Abseamed
recommended starting dose for
and sight of children
( GGT ) ,
,
blood donation procedure
in patients (
section
+ 353 ( 1
those receiving placebo
should
may
98 x 1 tablets
increased risk
healthy
unregelmäßiger Puls oder
Following subcutaneous injection ,
CYP3A4
: +
some
fructose
alfa ,
In
sections
to years of treatment
epoetin alfa
usually
.
.
No other erythropoietic therapy
with solid tumours (
risk of
the treatment of
with gemfibrozil
considered not known (
seriousness
diabetes mellitus ,
in this patient group
shown significant benefits
10
a
.
10
,
Hunton House Highbridge
entire dose is injected
( Europe )
CYP3A4 ,
of CYP3A4
the
individual
survival
monoamine oxidase inhibitors
and 802
and dehydro-aripiprazole ,
subcutaneous administration
Peripheral neuropathy
( 1.25 mmol/ l
.
What ABILIFY is
in
84.0
minutes ) .
cannot be excluded
unconsciousness and/ or
,
be cautioned
diabetes
observed
aripiprazole and dehydro-aripiprazole
50
reached
to
+ 44 (
)
of pioglitazone as
21 412
aripiprazole concentrations
do not
result of hypoglycaemia
)
with pioglitazone there was
you are pregnant ,
white and
and
trials that
or
diabetic retinopathy
than
.
well-controlled trials of aripiprazole
properties in animal
on overall survival
If you develop PRCA
D Centre (
,
1
44 ( 0800 )
, the incidence of
.
14
,
a potent inhibitor of
dose
controlled
with hepatic impairment
Long-term improved glycaemic
)
the placebo group
of ABILIFY
12 g/ dl (
see section
PRODUCTS
dose
must be discontinued .
the
Research and Development Centre
Tel
see
trials , uncommon cases
when haemoglobin values exceeding
the effect
is 32,000 to
with chronic renal failure
IU/ kg 3
,
you
pharmacokinetics
or
)
tablets
ABILIFY
dyskinesia ,
, aripiprazole
local requirements .
water for
of
moisture .
in paediatric
terminal half-life
: +
Beta-blocking agents may
Before use : store
you need
34 %
all
The dose is
antithrombotic prophylaxis
2C8/ 9 and
should
should
,
( 6.2 -
is
women .
treated for
insulin
ml
daily dose
IS USED FOR
) and/
nausea , constipation ,
SPECIAL WARNING
blurred
tablets 84 tablets
the
: orthostatic hypotension*
has no influence
dose
pioglitazone and
> 99 % )
of heart failure ,
is
When a
cases
was
has no influence
osteoporosis in
insulin 30
Produtos Farmacêuticos , Lda
in
Thrombocytosis
Special populations ( see
Insulin suspensions are
not
injection
of
hyperglycaemia ,
for haloperidol
3 days.
and
Danmark Takeda Global
s efficacy
electrolytes
)
, weight decreased ,
and
has been observed
use machines have
placebo-controlled
few minutes .
a manic or
2°C - 8°C )
, gender , and
may
tablet
5.1 ) .
after the first
g/ dl
( particularly
pruritus
encephalopathy-like
treatment with
Always take ABILIFY
hyperosmolar coma or death
dose ,
, the incidence of
relevant effect on
urticaria )
the incidence of
pharmacokinetics
of patients with the
This is
.
compartment .
or
in paediatric and
CYP3A4 ,
.
( 7.5 mmol/
elderly
times the mean steady-state
substitution of
subcutaneous erythropoietin
atypical antipsychotic agents
. europa . eu/
the intravenous route .
not
elevated liver enzymes and
-
type 1 )
with chronic
intensify and prolong the
or
with
( IU ) per
oral
The AUC
in the
effect
,
proportion
tablet contains
.
only
Treatment of anaemia
units
this medicinal product must
pharmacist .
Subcutaneous injection :
.
units ( IU
crisis with
kg and adults
Actos
.
injection
of death when administered
11 g/ dl (
presented
)
RH12 5AB United Kingdom
Puh/ Tel
alfa in
a dose adjustment
Centre
patients
is 5
absolute change in
as with other
patients ( particularly overweight
and
pregnant
are
schizophrenia and
1
>
one of these trials
or waste material should
and
or tense .
occurs .
g/ dl (
The syringes
+ 43-(0)800 29 5193
dosage or
There are no
but had
your
be
FACT-An
were
126 MINIMUM PARTICULARS TO
see section 4.2 Treatment
cancer
most frequently
section 4.4 )
The
) and
Cmax
)
preventing recurrence of manic
Water for injections
of
see
,
mg of aripiprazole .
units (
:
majority
with
to be
In three
soluble insulin 20 %
(
risk for thromboembolic events
higher than the
could be
the
aripiprazole in the bile
round
Aclasta and 0.8 %
for signs and symptoms
events
1 pre-filled syringe
SARL Tél : +
obesity
The terminal
was
and increased
If
Activated charcoal
frequency
recombinant human
, especially
impact on
injected by
section
g/ dl
and
,
33 IU/ kg
t½ 1.87
mg
x 3 ml .
patient
, increased alkaline
Vascular
,
and
, a
must be
you
section
usually
family history of diabetes
than
Keep out of
thyroid hormones and beta-sympathomimetics
of
PRODUCTS OR WASTE
to protect from
+44 ( 0)20
increased
but with
vomiting
the dose should
95 % CI
Adjustment
30 mg
did not
is
(
type or brand of
)
37 , D-58638
epoetin alfa
Tél/ Tel :
,
Intensified control in
ABILIFY
%
R & D Centre
tremor
The pharmacokinetics of
.
SQUIBB ( FINLAND
General
80
.
Dosage adjustment
of heart failure
placebo
rising by more than
of
investigated
see section
events
Produtos Farmacêuticos ,
,
between
ml 1.8 mg
pioglitazone as hydrochloride .
)
symptoms
and beta-sympathomimetics ,
4000 IU/ 0.4 ml
in
see section
(
and 8167 patients )
therapy
It
mortality : in
.
you
pressure
3 mg aspartame (
6 months after treatment
in
was
increasing
Your doctor may
(
for 2.
diarrhoea
.
.
.
and blurred
ketoacidosis (
The
:
efficacy
use
5.9
receiving chemotherapy ,
of the
diminished parathyroid reserve ,
.
In schizophrenia
SQUIBB NORWAY LTD Tlf
bottle
undergoing dialysis
12 - 14
or
4.2
months
mg
BRISTOL-MYERS
injections
4.4 )
% isophane insulin
insulin
placebo-controlled
In patients with
tablets
, especially
6
IU/ kg
of aripiprazole .
which is potentially lethal
pioglitazone with gemfibrozil
with encephalopathy-like
anaemia
Close monitoring of
special warnings
23 Adjustment of dosage
,
epoetin alfa
the
the
metabolites
and
Distribution
the thighs
the first
of the
AB Tel : +
of
.
in
In a
of
reported
,
, vomiting
not
.
11 g/ dl
.
, the dose should
and inter-individual variation .
injection sites .
Polysorbate 80 Water
- Refraction disorders
three
: + 32 2
It
4.5 ) .
extrapyramidal symptoms
120 ml :
the
oder
caudate
patients
until
%
)
not
REGARD TO THE SAFE
in
the
4.8
, are shown below
should
.
Upon discontinuation of
663 50
during continued treatment
: a
blurred vision
of
(
those receiving placebo
,
a few
clinical trials
- 39 %
18
) of
,
mitotic cellular functions
recommended (
observed
Global R
2,127
disease progression
dose
tablets
subcutaneous tissue .
and N-dealkylation
reactions may
-
802
DISPOSAL
with
parkinsonism
specifically investigated .
is
, abdominal discomfort ,
, and 3A4
of 12 g/ dl
allergic rhinitis ,
and
Limited Wimblehurst Road Horsham
and
14 tablets
on
1.5-2.5
)
occurs .
,
Tlf : + 45
solution .
anorexia
Renal or
be used .
of thrombotic
that
For preventing recurrence of
.
compared
,
CYP3A4
recommended total weekly dose
.
children
of the
on in
particularly
pioglitazone vs. gliclazide
, pyrexia ) ,
occurs
2°C -
ABILIFY
, arterial
into 2 equal
16 to 23 hours
is
(
solid tumours
suitable
of the
mellitus and heart disease
Hb between 10 and
pioglitazone in patients
mg ( i. e.
Cmax of dehydro-aripiprazole ,
weight gain
for
8167
with solid tumours (
physical activity , non-
with
away within
It
blood glucose
Phlebotomy may be performed
the intravenous
,
has
TABLETS ONLY )
)
phosphate dihydrate ,
forms of
entire dose
1 tablets 49 x
Patients who have
a
mmol/ l )
and sight of children
the following
;
epoetin alfa is a
of Abraxane
of the
dyskinesia
and 5 on
contains 10 000
Saccharomyces cerevisiae )
, eating disorder
possible warning signal
in
,
with Actos are
used to treat
is
g/ dl
tablets 28
.
a reduction of
Try to take
infusion was
therapy
l ) .
three weeks
total dose
therefore be applied
%
aripiprazole
local requirements .
SARL Tél : +
in a pre-filled pen
the
by the intravenous route
24 and 36
and protracted absorption respectively
a
patients with these
) .
of the other clinical
(
at risk of
biological efficacy of epoetin
One IU ( International
6.8 mmol/ l )
post-menopausal women
significantly impact
Hunton House Highbridge
low-trauma hip fracture
%
reduced
bodyweight
4
metabolites ,
the intravenous route ,
BRISTOL-MYERS SQUIBB (
Holder :
in adult and paediatric
be advised accordingly .
may
mean age :
symptomatic anaemia in
should not
If you
paediatric and
frequency
300 mg
Cmax corrected for
34.05 ]
must be
For a full list
Norge AS Tlf
hepatic ) pathways in
section 5.2 )
mmol/ l
trials of
Global R
is
hepatic impairment
hyperglycaemia and diabetes
ml solution for injection
of
therefore
respected .
) and/
difficulty
IU/ kg 3
below baseline levels at
to
Creatine Phosphokinase ,
,
make sure
than 1
epoetin
in vitro
450
not
of anhydrous
pre-filled syringe
is
received
weight decreased
with pioglitazone
Road
baseline .
( 30
in bipolar patients
- In pregnant or
tablets
4.2 Treatment
.
can be
efficacy
aripiprazole (
,
( 0)21
patients
Nederland BRISTOL-MYERS SQUIBB
be used
also prevents
(
contains
pharmacist .
and
a
angiotensin converting enzyme (
section 4.4 )
rare cases
Alcohol should
CYP2C8 .
were
,
standard
and inter-individual
United
potent CYP3A4 inhibitors
1
contains
(
to
is
4.8 - General
thyroid hormones and beta-sympathomimetics
or any
with
0.6
Abseamed can be
of ketoconazole or
incidence of clinical fractures
are
a few weeks
, anxious or tense
see
clinical trials and
LTD Tel :
see section 4.4 )
of 33
44 ( 0800 )
als bei
international units ( IU
glucose-galactose
Metacresol Phenol
liver microsomes and tissue
.
the risk of
increased
pregnancy
beliefs
( see
28 x
anaemia with epoetin alfa
5 and 10
trials
354 535 7000
.
hyperglycaemia ,
.
2 units .
or
need
,
mmol/ l )
in
.
should
epoetin
- After
effect
taking ABILIFY
hypersensitivity reactions
clinically
.
6.6
bisphosphonates
Following initiation of
of digoxin
as
, the
anaemia
Any
physician must therefore
intervals
3
patients
insulin and
Male patients should seek
The
suicidal ideation , and
be
) is
be monitored closely
as compared
reduce insulin requirement
less than
if you
,
Treatment of patients
patients
usually
)
of controls
ABILIFY
SQUIBB NORWAY LTD Tlf
lapp lactase deficiency or
of
tablets 98
and sulphonamides
tiredness , nausea
aripiprazole
ESAs are not indicated
24 hours .
should
(
hyporeflexia , neuralgia
local requirements
27 % of the
Abseamed 6000 IU/
Treatment of
is
.
dose may be
obesity )
3.2 % with
.
.
and cardiovascular therapy ,
medicines called antipsychotics
those receiving placebo
MINIMUM PARTICULARS TO APPEAR
,
or
the
.
10
or hyperosmolar coma
Hyperglycaemia
section
2
for
be advised accordingly .
and
than
sudden unexplained
no evidence
of
260
Tel : + 39
.
of
ALT levels remain
These measures
These measures will help
weakness
in
Abraxis BioScience Limited
alfa in
chronic renal failure patients
.
per
731
of the bone
Eye disorders
recombinant human erythropoietin
placebo , or were
of 50 IU/ kg
, pioglitazone
oedema , difficulties in
.
including parkinsonism ,
, Germany
contains 3
recommendations .
Tardive Dyskinesia
11.9 47.3 11.6
(
.
a
NovoLet
raloxifene
for three weeks
anaemia
the patient
)
in women
events
vomiting and
hypersensitivity reactions
and inter-individual
> 3 X the
neuropathy , hypoaesthesia ,
% with
including parkinsonism
g/ dl :
Although
ready-to-infuse
( see section
two
and should
Weight gain
with
or
five large controlled
of hyperglycaemia (
with
+ 45 45
of
more
- 6.8
unit scale .
.
oral
A vial
or pharmacist
: + 44
pharmacokinetics
of
the
IU of epoetin alfa*
tablets :
23 05
adverse events
insulin
is necessary
and sometimes
section 5.2
blood levels of cyclosporin
oral
epoetin alfa
, 90 and
,
doctor or pharmacist .
:
)
and
, the incidence of
stimulates red
In
6 -hydroxypaclitaxel ; and
When seen , it
Ireland BRISTOL-MYERS
should be given
%
When the
and AUC after
please
the refrigerated
be
reactions are transitory
, glycine
of CPK
10 g/ dl (
be effectively treated (
In
e. g.
, Nevirapin und Johanniskraut
pharmacokinetic
during continued treatment
to maintain haemoglobin
glucose control
This
trials and 8167
.
Dosage Dosage
the
also be necessary
trials , uncommon
)
may be
dose of Abraxane
to
Moreover , in patients
events which
is a
Hunton
( IU
(
7.5 mmol/ l
Alcohol may
whether
glass
(
to protect from light
monitored .
the insulin requirement
important
( Europe ) ,
no fatalities
1,000 , less
in vitro solubility .
human insulin
children
clinical
) of EPS
is
(
and " 5
symptoms have been
women
aripiprazole
other
including
tablets
) per
tongue
of epoetin alfa
g/ dl ( 7.5
10
you are breast-feeding .
terminal half-life (
between 17 and 33
emea
of
thrombotic
occurs
patients
(
store in a refrigerator
you
and +0.1 on placebo
rash
g/ dl
in
with
of the
diabetic
a similar pattern of
clinically significant
: +44 (
mg has
Tél/ Tel : +
should be avoided .
been carried out
,
Iserlohn
( 0)810 410 500
of 0.8 ml 6
insulin
a comprehensive battery of
of Aclasta
irregular
cell line by
Dosage adjustment may
0.62
completed suicide
15mg tablets
A sustained haemoglobin level
.
trial , the
encephalopathy-like
on
- if
the treatment of
hypoglycaemia ) ,
influence
,
Rare
should generally
+
)
If you
orodispersible tablet is fragile
MANUFACTURER
)
g/ dl
ml solution for injection
to maintain urea ,
in
Very rare
.
, it may
.
- 12 g/ dl
it
.
United
source
episodes of
The local safety of
)
- 8°C
protein .
to
nitrates , diuretics
)
16
and approximately 18
included
dose regimens
the human insulin molecule
aripiprazole
should be
+49 911 273
and
aripiprazole
After administration of epoetin
,
x 1
)
g/ dl
progression
mg/
Aclasta
angiotensin converting enzyme (
or any
necessary
by 32
administration
)
subcutaneous use of Abseamed
In clinical trials
.
Epoetin
It is
mg
of CYP3A4
women in the HORIZON-PFT
pioglitazone
than 15 minutes
mean age
mm
,
Oxford
( 1.25 mmol/ l
.
concomitant
endogenous human erythropoietin that
(
In
increased
large
-
hours after
study
syringes contain 0.9
A number of
United Kingdom Takeda
When
experiencing potentially clinically significant
are breast-feeding .
genotoxicity ,
of aripiprazole alone was
if you
anorexia , severe
Treatment of adult
, aripiprazole and
.
(
.
16 to 81 times
PRODUCTS
.
experienced the development
by approximately 25
reduction
may be followed
few minutes
approximately
.
this
erythropoiesis stimulating agents (
been carried out .
Erythropoietin is a
linearly
1
which also
sweating
day
products and
medically serious signs and
(
well below
. europa . eu/
and/ or
(
use
ist
at the desired level
+
significant benefits
% )
24
SQUIBB ( FINLAND
a dose adjustment
which produces three active
aripiprazole
a similar pattern of
dietary control .
- Treatment of
D
and a negative
.
This
to dispose
of the Marketing
revealed no
( for pH-adjustment
%
,
see section 5.2 )
in
Do not
was
children and adolescents under
4.4 )
to reproduction
and water for injections
are
or
mmol/ l ) should
An
patients
section 4.4
products
isophane insulin 60 %
.
( MTP )
should not be
intravenous infusion of
(
)
this patient population .
.
orodispersible tablet at the
and
orthostatic hypotension*
dose is 600
placebo
or
the
1HU -
a mixture of dissolved
, the
stroke
.
:
section 4.8
carton contains one single-use
:
or Hb increase 1
Del Ceraso I-03012 Anagni-Frosinone
with
or
) presumably
approximately every
pharmacokinetics of aripiprazole
therapeutic response
in patients with
mixed episode of
49
( 6.2 mmol/ l
is
alfa and other erythropoiesis-stimulating
of dissolved insulin and
United Kingdom
( human ) .
see section 4.4
Continuous rotation of the
period
that epoetin alfa
3.2
benefits
trials of aripiprazole
arrhythmias .
the safety of pioglitazone
House Highbridge Business
In the four placebo-controlled
Iron supplementation
Abseamed
during treatment with
and sight of children
with Abseamed may be
patients
symptoms
the
than 1
)
undesirable effects occurred
and female
alfa
EFFECTIVE USE OF THE
increased
of the
- Middlesex UB8 1HU
( CLAS
(
32 % and
IU of insulin
including
administered intramuscularly
and adult patients
is there any detectable
-
eye pain , abnormal
from light .
doctor or
inhibitors of CYP3A4 ,
with
on
Store and transport refrigerated
and/ or
Neuroleptic
usual
to affect
if they
.
aripiprazole and dehydro-aripiprazole
leaflet was
doctor or pharmacist
g/ dl (
patients
other CNS
not
60 25
are
dose adjustment
)
and
+
( 6 %
haemodialysis and
reports
section 4.4 )
not
, hepatitis
e. g.
bei allen
when starting Actos
haemoglobin of greater than
15 4.5
worsening
haemoglobin ( 1
corresponding to
epoetin alfa
United Kingdom
,
) .
, especially infections and
clinical trials
the face
with
Treatment
site conditions Uncommon
be monitored closely
the effect
reported
Limited Wimblehurst Road Horsham
the pharmacokinetics
In
45 % )
reactions
% of
should be
( 6.2 - 7.5
61 Aldwych ,
Owing to the
EPS including parkinsonism ,
other indications
history of cardiac failure
during
GmbH &
CHILDREN
2000 IU/ 1 ml
BRISTOL-MYERS SQUIBB
for all
the dosage of
80
and water for
placebo
+
see also section 5.2
(
and/
akathisia
between 25
.
( two studies
.
mmol/ l )
%
other medicinal products
9 251 21
that
and symptoms of
The improved
contraindicated
section 5.1 )
myocardial ischaemia , myocardial
354 535 7000
3 times
contains
than
hyperosmolar coma or
per month ) with
- 150 60
,
e. g.
isophane insulin .
; therefore
90
in two studies
stomatitis ( inflammation of
agitation before
pathways involving the
.
not be added to
the
Interaction with receptors other
)
diabetes ,
of fatal
must
Medice Arzneimittel Pütter GmbH
insulin human
tell
concentrations ,
dizziness ,
dosage adjustment
also
In
times per week
)
3 times
)
forms of
potassium and
)
remains unknown .
All
Continuous rotation of the
carbamazepine
oral
or without food
.
( see section
Tel : +353
( for pH-adjustment )
of
mg/ day
Each bottle with 100
10
not receive
and
epoetin alfa alters
chemotherapy
cases of NMS
( human )
and dose regimens
whether
The other ingredients are
both
or very rapid or
in children
patients
adults
dosage of ABILIFY
24 hours after
section 4.8 )
x 1 tablets in
new vertebral fracture
( 141
ABILIFY is used
increased Creatine Phosphokinase ,
( human )
aripiprazole
four weeks
patients
CYP3A4 ( ketoconazole )
to patients with moderate
between the
the metabolism of other
Centre (
with or
33 (
with Abraxane
Cedex 2
.
.
(
between 9.5 and 11
g/ dl ( 7.5
cleavage
dry eye
90 tablets 98 tablets
to sudden stabbing migraine-like
use of
) and
45
It is especially
greater sensitivity
SQUIBB PHARMACEUTICALS LTD
an increased risk
Aclasta is contraindicated
strenuous physical exercise may
chest pain ,
epoetin alfa ,
any 24-hour period
PRODUCTS OR WASTE MATERIALS
elderly women ,
and the
not
of the warning
chemotherapy
patients
has been proposed
.
.
per month
laboratory parameters revealed
elderly patients
Ireland BRISTOL-MYERS
insulin and isophane
for disposal and
less than
( such as
patients
but prescribers
not
to
a benefit-risk assessment with
administered after the completion
following
contains 1000 international units
.
) .
a
taking
.
60
of
recombinant DNA technology in
be marketed .
4.8 )
nausea , vomiting
generally not
worsening
studies
adults .
mellitus ,
all growth factors
an increased risk
infusion lasts for a
The
, 28
in
human insulin
in
)
If epoetin alfa
( see
since bioavailability
,
Park
see section 5.3 )
ml 6
or 5 or more
ABILIFY
sedation
with chronic renal failure
.
vision Gastrointestinal disorders
treatments
Co KG , Kuhloweg
,
.
, warfarin
the intravenous
cases of seizure
patients
patients with
There
4.5 Interaction with
discontinuation of treatment .
.
renal function
-
including
Hunton House Highbridge Business
Aclasta
section 4.2
in a cartridge .
1 g/ dl
In these
contains 5
(
Cardiac
If
g/ dl ( 1.25
hives , swelling
and
are
while you are using
(
vitro studies have
,
) corresponding to 50.4
or
half-life
, muscle rigidity ,
other medicinal products
( 6.2 mmol/ l
yellow
Insulin
, respectively ,
months when stored between
most clinical trials
water
and
use ,
vitro
contents of the pack
of patients with
a
contains
Omission of
No other erythropoietic therapy
For preventing recurrence of
ABBREVIATIONS
increased
22
reached
packed cell volume
unit dose
of
be marketed .
and
an increased risk
failed
is not recommended
.
(
MUST
even several weeks
of epoetin alfa
: hyperglycaemia , in
treatment
including isolated cases of
47 % .
increase 40,000/ µl
with hepatic impairment
cerevisiae
: the levels
in adult patients
is 15 mg
treatment
)
anaemia the medicinal product
and
medicines may
of effect of
product
84 ,
22
Before
a negative
Farmacêuticos , Lda
between
clinical
, postural dizziness ,
each day .
Insulin
, the incidence of
: the
immediately if
from returning .
( Europe ) ,
Authorisation Holder
IU
, were
in
with epoetin
Kuhloweg
36(0 ) 20 501
another (
dissolved
.
prophylaxis
)
with
feeling anxious ,
,
from
after
the exposure of
trials , rare cases
alfa
had sections
6.1
1 ml
and
injections are given in
and with or without
of CPK
than
haemoglobin ( 1 to
vials are
patients
) Acesulfame potassium
to protect from moisture
to
active substance is aripiprazole
without treatment in
12
other ingredients
pyrexia ) ,
dextromethorphan/ 3-methoxymorphinan ratio
000 IU/ 1
and
tablets .
of epoetin alfa may
rising by more
mmol/ l
of aripiprazole
a pre-filled pen .
are not sufficient
between 1.25 and
the
if
important differences .
6 The
during
should
encephalopathy-like symptoms
, patients receiving
see Table 2
)
may be necessary
including hallucinations ,
was
rare
the intravenous route
( 1.25 mmol/ l
reported
dose of
with
4.4
DISPOSAL OF UNUSED MEDICINAL
see also
of greater than
of which were
haemodialysis and adult patients
potentially medically serious signs
The dose of ABILIFY
Actos
,
or
Hunton House Highbridge
manic
of aripiprazole ,
Uxbridge - Middlesex
also
male
dosage of
the medicinal product
should be monitored closely
53
D2 and D3 ,
of in accordance with
.
( anhydrous )
45 93 05
or
the
, Kuhloweg
Hypersensitivity to
by the liver
approximately 25
an
even
no relevant
TO APPEAR
) Ltd 61 Aldwych
in section 4.2 .
you
1
be considered
is
7.5 mmol/ l )
%
% )
Suomi/ Finland OY BRISTOL-MYERS
Tel :
and
or if you
30 kg and adults
300 IU/ kg 3
You
rare cases fatal
It
of EPS was
Uxbridge
lung ,
EU/ 1/ 00/
of seizure
Be sure to
.
no evidence
of pioglitazone ( as
than
placebo .
PHARMACEUTICALS LTD Tel
men and
one year
cardiovascular
type
H1 receptors
risk
month , or if
) ,
d
.
.
a
of dehydro-aripiprazole ,
The peak is always
Some patients may
except
versus animal source insulin
,
vomiting
no
10
gynaecological
( for pH-adjustment
, serotonin
of anaemia
Abseamed 5000 IU/
Persistent pain and/ or
(
in humans
for advice before
Erythropoietins
It is
differentiating hormone , the
no fatalities .
trials
( FINLAND )
to years of
.
the
and controls .
target haemoglobin concentration
74 60
in haemoglobin
a few
of pioglitazone
,
injection site within a
dalton
your doctor or
) ,
of
.
, especially
per month , or
iron stores should
pharmacist
dehydro-aripiprazole
Aclasta
pharmacist
and dehydro-aripiprazole , but
+
- 39
or
Aripiprazole orodispersible tablets may
and swelling
has
not there
clinical trial
.
should
:
patients
products and
obesity ) and
your dose
effect on
The following
patients
in cancer patients
monkeys
antipsychotic drugs should be
(
(
development
> 99
essentially sodium- free
( dextromethorphan ) .
epoetin alfa
should be
:
blurred vision
5HT1a
the treatment of osteoporosis
in
and
see section 4.8
98
.
1 tablets in
1.25
in
in
)
10
a
) ,
ml
sections 4.3 and
Epoetin
An increased 3H-thymidine incorporation
chronic
It
see section 5.2 )
of administration
, headache
(
in
well
patient group .
dose to
% )
your dose of
mg
: +
( 0)20
g/ dl (
%
In
-
contraeptives , thiazides ,
, marked with
aripiprazole ,
well-controlled studies
-
) .
in two main studies
.
Way Wingates Industrial Park
In placebo-controlled
in
should be
APPROPRIATE
see Table 2
used
Cmax
tablets
yellow
is fever
SQUIBB PHARMACEUTICALS LTD
, and the majority
and 47
pregnancy
the doctor
food
DERIVED FROM SUCH MEDICINAL
month before your
The decision
glucocorticoids ,
)
therefore
3 ml .
other indications
% of
human ) .
, particularly
conducted in 375 anaemic
a stable level
3 patients
to
potent
pioglitazone .
doctor
of excipients ,
higher dose
What ABILIFY contains The
Danmark Takeda Global
,
reported
neutropenia occurred
a multiphasic manner .
1
and diabetes
clinical factors warrant
upper respiratory tract infection
2.47 in favour
progression
fat
BRISTOL-MYERS SQUIBB AB
aripiprazole (
THE
.
clinical
30
Overall , in the
)
alfa
pioglitazone
)
to protect from moisture
in bottles
%
paracetamol
, no information will
the intravenous route ,
trial
anaemia and
contribution
should
30 mg
to aripiprazole
for all
patients
) gene
% ) .
IU )
, sudden unexplained
is a
18
your
)
with a cartridge (
,
( haematocrit of 33
mating
.
for major elective
( 172 breast ,
25
THE DISPOSAL OF
use in
,
medically important differences
section 4.4 ) .
AND SULPHONYLUREA
greater sensitivity of this
4.4 ) .
dysgeusia , oesophagitis
patients
subcutaneous administration
.
at the desired level
cellulose Aspartame ( E951
of 12 g/ dl
, Kuhloweg 37
.
section 4.4 )
( warfarin
4AE
Norge BRISTOL-MYERS SQUIBB
% with aripiprazole
migraine-like
The
Non-clinical
pioglitazone ( as hydrochloride
)
the haemoglobin target range
clinical
absorption
or if
first
used in humans
Read all of
ml : 22 kg
( 0)1628 537
Tell
Tel
of aripiprazole
- 300
tablet contains 15
g/ dl ( 1.25
Ireland Limited Tel :
, vomiting , constipation
3.5 % of
In clinical trials
including malformations
( FINLAND )
times per week .
.
ist eine
5.3 ) .
a negative impact on
immediately if
an
Abseamed
is
filiaal Tel
doses of 5.25
749
glucocorticoids
, myalgia
terminal
transient loss
pharmacokinetics
and
your doctor immediately
consider clinical monitoring
4.5
if
Aldwych
included only 3 patients
" A
contains 100
Following subcutaneous injection
an approximate 3
this leaflet carefully
alpha-1
of children
Suomi/ Finland Oy
resulting suspension .
defined by a decrease
NORWAY LTD Tlf :
) sealed in
quinidine
Maintenance dose
complications .
x 1
( or
whether or not there
dogs and rats ,
placebo group
a blister
is
at the maximum recommended
adequate and
2
see
pre-filled syringe of 0.5
SQUIBB AB Tel
4.4
30
.
the
ALT )
14 g/ dl (
phosphokinase and rhabdomyolysis
, diabetic
trials with oral
Aclasta and 0.8
women treated with pioglitazone
24.9
and aspiration have been
incidence of
.
Intravenous injection : over
&
6-month comparative
+ 358
Additional supportive
the
.
margin of epoetin alfa
.
of patients with
of controls
72 ( 31
trial of
the aripiprazole dose
you are pregnant ,
ABILIFY
adult patients
% for
IU per kilogram ,
sugar lumps
,
and Manufacturer
with encephalopathy-like symptoms (
mg/ m2 ;
( see section 4.8
(
1.25 and 2.47 in
8 704 71
14 g/ dl
1 diabetes
increased
12
been reported
with
of anhydrous
,
aripiprazole or any
, the pharmacokinetic characteristics
of an overdose
in patients with a
Centre
the pre-menopausal range
your doctor
epoetin
of diabetes
mmol/ l
Not all pack
fracture , including
starting dose is
,
contains
section
.
6
years .
metabolites
for disposal and
section 5.1
of 10
911 273 0
randomised , controlled ,
In schizophrenia patients
%
the HORIZON-PFT
with placebo .
Glycaemic control should
the patients
type 1
% )
the aripiprazole dose
alfa is
Hb 10 - 13
haloperidol
( ALT )
patients with
In
34 857
251 21 230
mitosis
not
%
you
.
for dehydro-aripiprazole
epoetin
,
with haematological malignancies .
blood loss and haemolysis
Sími : +
on ABILIFY
insulin
Cmax
this leaflet carefully
The following adverse
Patients should be
-
see section 5.1 )
been receiving
6.1 )
3 times per week
% of the patients
Omission of
(
they
20
: + 40 (
dopaminergic hyperactivity and agonist
in
anaemia
alfa is a
clinical
in schizophrenia
of
caution should be exercised
, polycythaemic mice
CI ] ( weeks
, sodium chloride
men
n= 938 ;
NMS is
)
Patients
has been observed
pooled data* )
as a mitosis-stimulating
human .
30 kg and adults
should
food
incidence of
the HORIZON
medically
thrombotic vascular
aripiprazole has
.
per month or the
, 9 %
may increase the
,
2°C - 8°C )
symptoms of heart failure
revealed no medically important
following
may
standard genotoxicity tests
higher dose
In
e. g.
and
phenprocoumon and metformin
fatigue Psychiatric disorders
should
) prior to
with
Osteoporosis The
of hypoglycaemia
%
.
dogs and
>
%
included
take it
.
1 pre-filled pen contains
section
.
.
is
an increased risk
12
10
diabetic
trials , rare
clinically
per
with
evaluated .
paediatric patients
clinical factors warrant
to
( see section
A sustained haemoglobin level
please contact
per
.
hours
with
blurred
wastewater or
started as soon as
, oral
with
with epoetin
0)20 3116 8000
It
subsets ranging from 517
recommended
,
in
have
sufficiently investigated and
use in
, colourless ,
aripiprazole
its metabolites are
which is potentially lethal
alfa
of pregnancy
,
deep venous thrombosis )
) .
conducted in 375 anaemic
stabbing migraine-
placebo-controlled
100 ,
with
6.2 mmol/ l
PHARMACEUTICALS LTD Tel
of
of
should only be
for pH-adjustment
with the
of
: dyspepsia ,
21
for
therapy .
of
patients
200 mg
that seen
doses
of 600 IU/ kg
HOLDER
with
(
one of
,
( see section
in
that
than 2 g/ dl
Centre (
weeks
AUC
This is
6
1/ 04/ 276/
section 5.3
.
half-life of approximately
pioglitazone and
toxicity ( reported in
8000 international
ABILIFY
CYP2D6
This is
37 D-58638 Iserlohn Germany
4.4 Special warnings
93 05 06
see section 6.1
.
MANUFACTURER OF
re-suspension .
is effective in
to maintain urea ,
( see
to
" on
reduced
dosage of
( See section 4.4
two large
6.2 -
the
71
in some
administered after the completion
In addition ,
and
epoetin alfa
BRISTOL-MYERS SQUIBB
IU/ kg ,
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LTD
medicinal
type
(
of these patients
5.1 )
Method
.
on results of
,
or mixed
Treatment
EU/ 1/ 06/ 344/
recommended dose of Abraxane
these
+44
mg pioglitazone (
the
:
Bipolar I Disorder
pioglitazone .
BioScience Limited West Forest
see section 4.4 -
. They include thirst
is
clinical trials of
pre-filled syringe The
in children and
46 8
France
in haemoglobin
dextromethorphan/ 3-methoxymorphinan ratio )
75
90 or
(
Royaume-Uni Tél/ Tel :
In another
warning symptoms of hypoglycaemia
2697
approximately
is between 75 and
section
FACT-An ) general scale
Global R
severe manic
In clinical
4.4 ) .
or 450 IU/ kg
insulin
-
less than
and for
of the
This may constitute
Iron supplementation should be
and
highest nontumorigenic exposure in
- 8°C ) .
mmol/ l
Be sure to tell
Ísland VISTOR
patient
g/ dl
(
and
a
In clinical trials of
with
0)20
alfa in cancer patients
chemotherapy induced anaemia
Sverige Takeda Global
and should not exceed
+ 33 (
studies
)
manic or
differentiating hormone
4.8 -
aripiprazole
PRODUCTS OR WASTE MATERIALS
of
5.3
ml
trials with
and ,
between 17
more
3 ml )
your doctor immediately
and danazol .
dizziness , somnolence
well
were 39.5 %
Tel : +
study (
transient loss of consciousness
Similar changes in
)
hypoglycaemia whilst driving
802 with haematological malignancies
Weight gain :
ml and
these
,
Potential for other medicinal
2
g/ dl
orthopaedic surgery
increased primary
of diabetes is
Committee
use machines have
predonation
SPECIAL WARNING
OF
London WC2B 4AE United
mean age
ketoacidosis
in
ABILIFY
water for injections .
clinical trials
WITH BLUE BOX )
)
some
BRISTOL-MYERS SQUIBB SARL Tél
reduced
close medical
no experience in
on
outer
ketoacidosis
or
see
E951 ) Acesulfame potassium
,
4.4 -
reported
The cartridge contains
of epoetin alfa
haemoglobin is rising by
,
.
did not
Tél :
(
diabetes
had visceral
The recommended starting dose
:
, insulin requirements
.
)
be
4.4
with epoetin
Maintenance dose
products to affect ABILIFY
Treatment
you
)
( see section 5.1
was last approved on
The therapeutic
for pH-adjustment ) ,
the gluteal region or
starting dose for
rapid or
in children
lithium or
with epoetin
ml
( 0.62 mmol/ l
)
ist
mmol/
if
and 60 %
- If
or lithium concentrations .
Uncommon : orthostatic
PHARMACEUTICALS LTD Tel
.
Gastrointestinal
( type 1
to 30
chronic
safety
insulin and
4AE
or more units of
IU )
recombinant DNA technology
( 0)20 3116 8000
GGT ) ,
the
,
to ensure optimum response
or additional
.
28
Diabetic retinopathy
with
treatment
( DVTs )
GmbH Tel : +49
moderate binding affinity for
alfa
13 % of the
In several
37 ,
impact
such as ketoconazole
( for pH-adjustment
hypoglycaemia , hyponatraemia Common
patients )
side effects
.
and
a
,
)
are for
unlikely
preventing
a meal
The absolute oral
.
, ataxia , sensory
this medicinal product must
a cartridge (
and/ or dark urine
0.99
than
should be
g/ dl
.
with
patients received
should not be diluted
be
, the incidence
ketoconazole
the
.
cartridges x 3
(
If
renal impairment :
MAOI ) ,
Actos
half-life (
after
no
Erythropoietin is
only 3
in
64 gynaecological ,
nervousness
vitro studies
corrected .
Denmark
was
Like all medicines
and
g/ dl
patients
Metacresol Phenol
to ensure
) 74 18 84
carefully weighed
UB8
daily dose should
What
, serotonin 5HT1a
placebo .
thrombotic
included
be disposed
Abseamed
, 2C9 (
anaemia
delivery system
at
should
toxicity
THE OUTER PACKAGING
30 60
tablets 56
per month )
section 4.5
Owing to
The
culture mutagenicity tests and
When a dose adjustment
;
of the
in
( e.
when
of
( E951
)
) ,
PRODUCTS , IF
:
human insulin .
) .
in
Saccharomyces cerevisiae ) .
IU/ kg once weekly
8950
OF
listed below is
pregnancy
and lactation
from
of CPK (
)
is catalysed by CYP3A4
.
or
adult patients on
with ABILIFY
and 7
or pharmacist .
ml contains 100
in
the intravenous
) than
between 17
is
or 450 IU/ kg
see section 4.6 )
, inadequately treated
OUT OF
children and
headache Eye disorders
In the
75 -
the first injection .
clinical
hours has been
for pH-adjustment
for the
an autologous predonation programme
were
Cmax
Highbridge Business Park ,
IU/ kg/ day .
749
alpha-1
It stops the
section 5.3 ) .
353 ( 1
a
Iserlohn
( 0)20
dose of 600
studies ,
with solid
a
its own
see
be presented .
of aripiprazole
rats
(
, anxious or
of the hormone .
150/ 004-006
IU/ kg
blood
,
(
of
and
study )
,
with placebo
.
,
subcutaneous tissue
of
Epoetin alfa
see sections 4.8
g/ dl
section 5.3 ) .
and
not been carried out
.
of the art .
57
; Thiazolidinediones
the
and 8167 patients )
side effects (
SPECIAL PRECAUTIONS FOR
KEEP OUT OF
pre-filled syringes
and
683 breast
of patients
in strength ,
In
or
.
without
,
in post-menopausal women
this patient group
with ABILIFY
Patients should
, somnolence
observed ( see sections
g/ dl
and well-controlled trials
3.2 % ]
please tell
been
)
sick
administration
5-hydroxytryptamine
.
precautions for
micro-ophthalmia
hypovolemia
.
hip fracture ,
oral
been determined .
)
malformations and
use
insulin products
The recommended
headache , tiredness
and
whether pioglitazone
from 2 60 mg
to affect ABILIFY
( 0800
Tél
As for other
are
in
of the pharmacological effects
BLUE BOX ) AND
treatment with epoetin
frequency
,
, hyponatremia
to the existing
The
and G-CSF or GM-CSF
therefore
which
150 30
patients with
recommendations .
or
.
and inter-individual variation .
(
84 , 90 and
if the
rapid initial effect together
Sussex ,
to 23 hours .
was administered concomitantly with
:
diabetes
)
which were
Mitratapide
unknown .
water
, dry eye
The decision to administer
weight decreased ,
cartridge
monoamine oxidase inhibitors
deterioration
disorder ,
14 x 1
42 22
may result
the
or stored at
increase peripheral
weeks
insulin requirement
,
a meal
with
The syringes
( days 21
equivalent to 300
, akathisia
(
for
placebo
subcutaneous tissue
as triple
(
When a
paclitaxel
30 kg
loss of consciousness and
ABILIFY is and
and N-dealkylation .
43
prophylaxis by
avoid
Oxford Road
Before
( as hydrochloride )
use
or
and 4.9
, long-acting
Tel
)
in
of the
,
mg tablets may
.
in plasma
ABILIFY is effective
dose is 15 mg
patients
alfa Abseamed 4000 IU/
speech disorder , Neuroleptic
is necessary
use
47
treated
.
of epoetin alfa may
efficacy or
including
These
between
,
anaemic rats
chronic renal failure ,
1 tablets
medicinal
,
or intentional acute
NMS
- United Kingdom
risedronate once a
negative
aripiprazole (
Abseamed
standard
times per week
and protein intake .
.
Common : extrapyramidal
headache Eye disorders Common
on mg/ m2 )
the
haemoglobin is rising by
was 7 times
with
healthy elderly
occur
100 ng/ ml
in vivo and in
time
: + 44
and
the
IU of epoetin alfa*
the
132 The recommended
aripiprazole
(
patients with
) .
( NPH
maximum recommended
scheduled for major
pre-filled syringe
Tardive Dyskinesia
and
pregnant women .
not
( particularly overweight patients
the intravenous route .
g/ dl (
well-controlled studies in
of
in
This medicinal product contains
1
) and
NMS
21 Fasting
human
( dextromethorphan )
.
hypoglycaemia
with
Finland OY
R
small minority
pioglitazone or
of insulin suspensions
patients scheduled
and diabetes mellitus
( see section
recommended dosing regimen
(
, constipation ,
.
no fatalities .
should not be
section 6.1 .
from particles and
The recommended
immediately
-
, dysphagia
.
.
, the incidence of
section 4.4 )
Before use : store
D-58638
347 patients
trial
) .
13 g/ dl
2 diabetes mellitus
pectoris
( 30 mg )
MINIMUM PARTICULARS TO APPEAR
g/ dl (
possible ,
The
59
,
West Sussex
not
cardiovascular
the infusion
Actos 45mg tablets
adult
and for
defined by a decrease
pharmacokinetics of aripiprazole
Actos is and
information on the
.
4AE , United Kingdom
( possibly
be a
see section 4.4
section 4.4 ) .
There
you
and
in
from light .
hypertension ,
: blurred vision
neuropathy , ataxia
If you
signs
ABILIFY
Hunton House
potentially medically serious
the active substance
elimination per se
patients
ABILIFY
humans
2C19 (
4.4
children
use machines
patients with
types of paclitaxel contain
contains 2000
was
was 12.1 % with
weight decreased
red blood cell
The
brand ( manufacturer )
12 g/ dl (
other antipsychotic drugs
Use should be
x 1 tablets in
(
: + 354 535
The initial dose
scheduled
one side
heart beat .
(
clinical trials and
been carried out .
more than 30 %
site within a
2000 international units (
epoetin alfa
6000 IU/ 0.6
+ 354
the thighs
with
hypoactivity .
.
daily insulin requirement
33
The
.
.
, µ : +44
oral solution
re-suspension
haemolysis , blood loss
clinical trials that
sustained haemoglobin level
and
in a
evidence of clinically
( 34 [
, alpha-1
.
1
injection : a
D Centre (
( 4 or more
If
and diabetes mellitus (
.
clinically evident ischaemic heart
administered after the completion
ABILIFY
of the EPAR )
and
insulin
the
the metabolism of other
sections
or
Authorisation Holder
tablets in
for orthopaedic surgery
is individual and determined
monkeys after repeated
obesity
section 4.4 )
has told you
below
oral solution contains
is a
,
-
with renal anaemia ,
( normal and
% ) than
Hypertension
(
KG Kuhloweg
in
or pharmacist
98 TABLETS ONLY )
, the dose should
2007
Omission of
adult patients scheduled
and/
SPECIAL PRECAUTIONS FOR
effect
controls
If the
vision ,
Uncommon - Peripheral
and 4.4
on
in
6.1 ) .
last day of
be
six identified
pathways involving the
in
-
x 1 tablets in
desired haemoglobin level may
was
you
should not be
very
) increased
solution .
( 1.3
45 93
.
are
terminal half-life
11 g/ dl
Amounts
that
human
Weight gain
)
In a
in
epoetin alfa is
see section 4.4
CHMP recommendations
D Centre (
SQUIBB BV Tel
women ,
.
is a single intravenous
)
IT IS USED FOR
of
+ 44 (
should
:
white and
trials involving 1,228 schizophrenic
A-008 and
of aripiprazole alone was
salivary hypersecretion
count has increased
3 patients
is 150
also looked
g/ dl ( 6.2
.
1 g/ dl (
and
Name
In clinical
and
incidence of EPS was
with renal anaemia ,
the incidence of
,
slowing of tumour progression
reported
weeks
of solution
symptomatic
260 lung
10 kg BW
for smokers
Ask your pharmacist
common
.
30
.
IU
with
to a similar
production .
such as sedation
IU )
vs. gliclazide
than children over 30
Consequently ,
) 241
is limited .
.
cartridges x 3
a
local requirements
this
Adjustments of daily dosage
very rare cases
solution
stroke or
with fast-acting
increased incidence of
with gemfibrozil (
cerebrovascular adverse events
for advice before
trials
Each
study included only 3
In cases where there
take it with
other antipsychotics
ability
IS
with
,
or waste material should
the
x 3
ALT ) ,
,
,
leaflet
four carbohydrate chains are
( 6.2
)
2°C -
of
> 3 X
Caution
administration
,
effectively .
ml
, hypoglycaemia ,
most
method
all
IU/ kg
Therapy- Anaemia
and symptoms
, long-acting
with haloperidol
the metabolism of
and patients with
30 or 45
section 4.8 ) .
levels
mmol/ l
The
or
,
,
Ltd 61 Aldwych
epoetin alfa .
Medice Arzneimittel Pütter GmbH
, 23
the
ml
administered
adequate and well-controlled
study
the gluteal region
physician must therefore
60
response
be applied
a
Uncommon
) .
,
Saccharomyces
8.1 mmol/ l )
administration
of
Mitratapide is
, a
( FINLAND )
1 %
aripiprazole and dehydro-aripiprazole ,
year after
and
Based on results
blurred vision
sustained haemoglobin exceeds
not been determined .
injection route
with
= 91.6 ± 14.1
1
( 1.25
and possible
with
be used in patients
50 IU/ kg
of
.
Actos 15 mg
and
( 4 or
The
manic symptoms
overall survival between
a
effect
to resolution
your dose of
.
This medicinal
1 g/ dl (
)
symptomatic anaemia
for four days
2.47 in
infusion of
ACTIVE SUBSTANCE(S ) AND
children
the menopause
: in clinical
5
the
the
insulin therapy
16.1 [
Other potent
epoetin alfa
five large
. europa . eu/
When
, or to other
rhabdomyolysis ,
of
patients may
of 1 ml
00
effect
ABILIFY
to maintain haemoglobin
with gemfibrozil
studies
SPECIAL PRECAUTIONS FOR DISPOSAL
pregnant
Three of the six
- Peripheral neuropathy
of the elimination
aripiprazole tablets ,
, weight decreased ,
should
increased alkaline
monitored
as a mitosis-stimulating factor
vomiting
and adult patients
9.5 and
revealed no medically
absolute oral bioavailability of
of adult patients
not using effective
(
or
The maximum
(
e. g. during
The frequency of these
be avoided .
300 gastro-intestinal
a
intravenous
, the
Novartis Ireland
.
& D
as a mitosis-stimulating
except in paediatric patients
a recent
dosage
by the intravenous
and women
Global
chest pain
haloperidol-treated
, thiazides , glucocorticoids
in the
section 5.3
patients )
administration of ketoconazole
units ( IU )
concomitant administration
International Units ( IU
1 and 5 vials
on the pharmacokinetics
usual dose is 15
international
( GGT
exclude potential
.
known as
you have
of
3116
,
(
and 33
, Neuroleptic Malignant Syndrome
or 24 hours
following
0.62 mmol/ l
6.2 - 7.5
CYP3A4
of dosage may
,
to avoid
& Co
thigh or
done in
31 34
less
precautions to
medically serious signs
Centre
the levels remain the
.
of erythrocytes from precursors
,
molecule
reduction of manic symptoms
or
recommended treatment schedule
4.7
Europharm
Part of the treatment
are ready to use
revealed no medically
39 % )
increased risk
)
, tremor
The daily insulin requirement
with
ABILIFY
may vary with
Tel :
.
effect on
patients with
( 30 % )
, pruritus , erythema
g/ dl (
snack containing carbohydrates .
less
stops the
Highbridge Business
be avoided when taking
be applied
in the
and
section
In
, aripiprazole failed
) , Te .
of these
with high fever
postural dizziness ,
the
changes in routine
ml )
your doctor or pharmacist
and
of Vantas is
44 ( 0)1628
will help
aripiprazole or
in a
see
.
in
men (
1.25
to protect from
in CHO
or
the aripiprazole dose should
or
dosage
diabetes
, a
and
,
.
Sodium hydroxide (
has
should not be
.
carton
peak is always
of the limited
usual starting dose is
and
Abilify
Intravenous injection : over
the
- 150
The maximum
did
THAT THE MEDICINAL PRODUCT
dosage of ABILIFY
erythrocytes
or if
of the Marketing Authorisation
, increased
.
with
very wide
: extrapyramidal
31 34 857 42
from light .
% and isophane insulin
sections
on
There is
an increased risk
.
(
with
see section
is
reported with epoetin alfa
this leaflet carefully
of death when administered
to off-white
( 30
effect
, somnolence , sedation
dosing should
Europharm Limited
aripiprazole and
Fe2+/ day is
The individual
Attention should be paid
(
MAOI )
FACT-An ) general scale
ketoconazole )
.
The recommended
anaemia ,
from light .
,
aripiprazole
in PVC-aluminium perforated
effective
baseline
ESAs ) have shown
4.2
medically important differences .
listed below is
low-trauma hip fracture
%
Treatment of adult
concomitant administration
Do not
mixed episode of
4.7
-
information is
(
patients
of
anaphylactic reaction
several
The
appreciable affinity for
than 1 % of
( 2.5 %
rash and
to affect ABILIFY :
tablet at the
of
geometric means of
and Paget s disease
epoetin
sections 4.3 and 4.4
100
, diabetic hyperosmolar
.
controlled clinical studies
and
six weeks
syringes contain
and
a
consists of 40
to the foetus .
tablets are rectangular and
NAME OF THE
of patients with the
For
small amount of
:
type 2
body weight
2 g/ dl (
)
with
DISPOSAL
aluminium intoxication
constipation ,
Analogue Scale ( CLAS
peak plasma
month )
erythrocytes from precursors
, this
hyperglycaemia , in
a
events in
and
all formulations ) should
To
alfa
, thiazides
Abseamed treatment
anaemic
a vial .
therapeutic margin
Road Uxbridge - Middlesex
,
.
injection
.
re-suspension .
section 5.3 )
; ATC code :
Based
must be followed .
dose
year after
( 0)810 410 500
during treatment with
greater than 14
aripiprazole
and
in
the CYP3A4
)
Patienten
129 MINIMUM PARTICULARS TO
risk
(
1
.
.
the
be used
, malaise
infusion
dose
Aripiprazole
Ask your
specifically and
.
4.4
risk
- 150
having excessive
treated with
(
are transitory and
Europe ) ,
anxious or
with
as being secondary to
or during lactation
Since
as compared
patients reported concurrent peripheral
in
13.2 [ 7.54
and
other ingredients
with or without
skin
Global R
Oxford Road Uxbridge -
restricted
have polycystic ovary
anaemic rats
clinical
the pharmacokinetics of
route ,
90 % isophane insulin
Sodium hydroxide (
studies
are round
in the
done
GmbH & Co KG
49
(
patients
of angioedema
: + 44
Takeda Global R
( 1/ 100
Detailed information on
the geometric means of
listed below
studies
inter-individual variation .
increased with increasing
controlled
and 802
.
Hunton House Highbridge Business
( ebenfalls
per dose
) to
Der
calcium
use of
two species , both
data from 360 dogs
proportion to
Tel :
Do not use Aclasta
tablets
aripiprazole during
8.1
Abseamed has not
47 67
SQUIBB BV
Due to
Sodium hydroxide
dosing ,
included insulin
of EPS was
existing
must also
.
+ 32
been
or
acute
increased risk of thrombotic
signs
in
duration of diabetes
(
of continued therapy .
after
Close supervision
be
France BRISTOL-MYERS SQUIBB SARL
.
patients
inform
human
with
human
use of
tablet at the
vitro (
, but
minutes
The
prior to
Hypersensitivity :
" 15 " on
see section
ABILIFY
A sustained haemoglobin level
.
10 000 international
be monitored and the
( 7.5
( NMS
.
)
the insulin requirement .
-
is 50 International Units
% of
When weak
including
this product is available
vomiting and diarrhoea .
potent CYP3A4 inhibitors with
to
PHARMACEUTICALS LTD Tel
was 15
,
it is
and
These
or
,
risk
and sulphonamides
clinically significant changes
usual
the
brain function
with or
, including ABILIFY
,
this
insulin ( human )
the
ABILIFY contains
all
in section 4.2 .
anxious or tense
more often
forms of
healthy elderly
initial treatment response .
or pharmacist
IU
unit dose
, or
weeks
and sight
cloudy after resuspension .
be marketed .
PRODUCTS OR WASTE MATERIALS
0.62 mmol/ l )
of the hormone
Novo Nordisk A/ S
cancer patients
vascular events
to 125,000
.
Latvij Tel
disorders Common
PROHIBITION OF SALE ,
Abseamed should
the perisurgical setting
and
no clinically
than 2
contains
necessary
( 9 weeks
is effective
4.8 ) .
IU ) of
dogs and
If
.
Tel :
corrected .
vitamin B12
( 1.25 mmol/ l
( e. g. increased
g/ dl (
( 6.2 -
of the Marketing
CYP2D6 (
( see section
risk
a small
, vomiting
.
the perisurgical setting
nausea ,
272
This
The daily insulin requirement
without food
a
)
4.4 ) .
a glass
hip fracture ,
%
and should
expected to
epoetin
.
ABILIFY
aripiprazole .
vomiting and diarrhoea
in
15 mg
contains
and Manufacturer
(
( 9
your doctor or pharmacist
Centre ( Europe )
in a refrigerator (
Close
result
Patients with
When
.
Die
doctor
In clinical
or
bipolar
, polycythaemic mice
cancer patients receiving chemotherapy
or
including
epoetin alfa on
to protect from light
severe
of
(
dose
treated patients
must be discontinued .
highest nontumorigenic exposure in
chemotherapy )
a
sudden
maximum recommended
7.5 mmol/ l )
events
pruritus
United
is 15 mg
dehydro-aripiprazole
+44 ( 0)20 3116
no
pre-filled pens x
.
( two studies
.
a
IU )
Tél/ Tel :
indication
300
in a
The
SQUIBB SARL Tél
4.5
4
the insulin requirement
Leaflet .
3 ml
In clinical trials
Like all medicines
2
is between 75
see
hydrochloride )
and sight
Treatment should consist of
administration
( for pH-adjustment
who
.
and 10 on
the
.
the
or
OUT OF
impact
side
Uncommon
(
rare (
genotoxicity tests
section 4.4 and section
for
therapy
, sedation , headache
Tel : +
5 mg/ ml
, diabetic ketoacidosis ,
your doctor or pharmacist
associated
There is an increased
of
the
in
In PROactive ,
Treatment of symptomatic anaemia
patients with severe
g/ dl
, sodium chloride
kg and adults .
the
of manufacture ( recombinant
.
)
of death and
Changes in HDL-C
was
as a mitosis-stimulating factor
diet
and
or CYP2D6
(
352 74
rats , dogs ,
, placebo-controlled
in
of
epoetin
In clinical
Assessment of
.
initial treatment response .
speech disorder , Neuroleptic
4.4 )
statins
placebo-controlled trial
hours in
medicine
or
)
If
use
If
2
reached
.
Aripiprazole is
4AE United
) .
reaction
both fast-acting
The initial dose
patients with normal
3A4
patients
to 67.2
insulin human
tablets 30 tablets 50
variation .
the risk of cross-reaction
MUST
stroke in
The syringes
(
- 150 30
proportion
.
,
( hydrolysis ) sites
Actraphane contains
blisters
, hypoaesthesia , paraesthesia
is
tumours (
a
KG
hyperglycaemia , in some
solution
of
10
after
pyrexia
clinical trials of
myocardial infarction
as hydrochloride )
to any
to 2
161 Detailed information on
dissolved insulin and
941-0
If
mellitus ( see section
2
has been observed
absorption rather than
( see
.
resorption
( e. g.
tablets
TO APPEAR ON BLISTERS
.
fructose intolerance ,
and anaphylactic reaction
hepatic metabolism
controls
Tell
section 4.5
a
medicines
anaemia in
in both
, D-58638
trials ,
of ABILIFY
SPECIAL PRECAUTIONS FOR
interaction
and
examining the combination of
at least 15
an
adult
human )
" 15 " on
( 1.25 mmol/ l
(
which is potentially lethal
, and 3A4
section
( or
medically
complications
, the dosage of
pharmacist .
with the
52 As with
5HT2a receptors
the average duration
( produced by
in increments of 2
In clinical
epoetin alfa has been
mean age :
infiltration were observed
that
if
BRISTOL-MYERS SQUIBB BV
e. g.
nicht alle
the
,
the
and/ or
alfa is given concomitantly
)
and dehydro-aripiprazole ,
with
( 0.62
( 7.5 mmol/ l
more ABILIFY
more than 2
The daily insulin requirement
been established .
patients treated with aripiprazole
retinopathy
can
(
epoetin alfa
(
14 g/ dl
( 55 %
section 5.1 ) .
ng/ ml
.
vomiting ,
, is an
, the dosage
)
is similar
is 15
a type
.
potentially
40 % in the
Beta-blocking agents may
been receiving aripiprazole
aripiprazole
the reach
was
30
( see section 4.4
) .
of 0.4 ml
.
insulin and isophane
contraeptives
study population had
( two studies
the incidence
during treatment
absolute bioavailability of
trial , the incidence
chest pain
.
. if
the intravenous route
doctor or
clinical studies ,
use machines have
Assessment of
9000 IU/ 0.9
following 30-
, in patients with
The
should be
trials and
"
a finding
and
decrease
of the
of the
immediately if you
Sverige BRISTOL-MYERS SQUIBB AB
a dose
mellitus ,
(
see
Safety
the
distribute
hours
and
1 800
aripiprazole treated
UK Ltd Tel :
peak is always
half-life of
elective
of epoetin alfa
(
stools
Europe
by the intravenous route
15 mg has not
significant
symptomatic
:
LTD Tel
5 mg/ ml
Haemoglobin variability
know how ABILIFY
not
not
of akathisia was
ABILIFY
in exposures
and 802
population
the
Kilruddery , County
encephalopathy-like symptoms (
- 150 60 -
epoetin alfa
patients
As with
isophane
anorexia , hyponatremia
pre-filled syringe
pharmacist
mmol/ l
Tél/ Tel : +
no significant effect
transient ischaemic attacks
receiving non-platinum
products and
,
when administering paclitaxel
occurs ,
Clinical efficacy
anaemia
see section 4.4
) is
,
or
,
.
, aripiprazole
these
are
doctor
(
vomiting and diarrhoea
CYP3A4 or CYP2D6 inhibitor
of children .
AUC and Cmax of
haemoglobin
dose of
tablets
5
ability
+
other antipsychotics
solution contains 10 000
may
A gastric
de pointes
)
.
GmbH & Co
to starting Abseamed therapy
the following
The syringes contain 0.3
a haloperidol-controlled trial
schizophrenia
100
dissolved insulin and
10
this medicinal product must
%
administration of ketoconazole or
use
mg
)
OR WASTE
2.5 % ;
.
Erythropoietin receptors
) .
the
with a
is
haloperidol .
S. A.
and 47
of ketoconazole or
recommended
3x/ week
SMALL IMMEDIATE PACKAGING UNITS
.
agents Certain medicines
but
safety of Vantas
PRODUCTS
g/ dl
90 % Actraphane 20
per
x 1 orodispersible tablets
OUT OF THE REACH
Centre (
, thiazides
IU/ kg 2 times
erythropoietin
epoetin alfa is
in a refrigerator
Similar changes in
renal
21
, gender , and
mg reduced the risk
8.4
(
This medicinal product contains
raloxifene
COMBINATION THERAPY WITH
CYP3A4 (
At two years ,
)
the
you
98 TABLETS ONLY
.
PRODUCTS OR WASTE
.
mmol/ l )
you are breast-feeding .
ABILIFY
)
wide .
two years
must be discontinued
contain substances ( solvents
)
( ALT
)
The
most of these patients
N-dealkylation
Storbritannien Tel
the granting of
you
Actraphane
rising by more than
anxious or
you
OUT OF
dogs
(
) .
with epoetin
anaemia associated with chronic
and dose regimens
mg
in
in
in
GESMBH Tel
epoetin alfa alters
CPK (
effect
during
1 )
.
.
of CYP3A4
times per
(
It may
If convenient
dosage may
% )
,
Suicidal thoughts and
clinical
1 diabetes ,
) .
or very
( omeprazole )
in Aclasta
every
Abseamed
pulse or blood pressure
treated
( dextromethorphan/ 3-methoxymorphinan ratio
hypoglycaemia
tablets
dextromethorphan )
haemolysis , blood loss
insulin
hypothermia , pyrexia
between 1.25
lactose monohydrate
precautions to avoid
controlled studies
reported after months to
in a refrigerator (
carton
-
.
of the value
potentially medically serious signs
with 100 ml
Hb
and
clinical effects of
to
45mg tablets
GESMBH Tel : +
Very rare
the thighs or the
if
3800
The
)
)
but not
most common
following
Patients with
days 21 ,
5.1 )
deep vein thrombosis ,
hypoglycaemia .
In
and completed suicide
to pioglitazone
thromboembolic events in
patients ( particularly
A
the
you to
EMEA
of 10
micrograms
)
should be avoided .
epoetin
Centre ( Europe
93 05 06
hypotension*
prior
be
Carton of 49
insulin
bone marrow cells
especially
are breast-feeding
or 98 tablets
patients
chronic renal failure and
, less than 1
is
of patients with
It is
,
alfa ,
ABILIFY is 10 or
or 13
alfa
mmol/ l ) in
( rhabdomyolysis ) ,
safety .
in
should be
THAT THE MEDICINAL PRODUCT
your doctor or
and rats ,
severe manic
efficacy and
WC2B 4AE ,
.
of CYP3A4 ( ketoconazole
loss
.
in vivo
( with
in
150 60
beta-sympathomimetics ,
of the hormone .
men
followed by a
cardiovascular
27
.
Uncommon
may be observed .
Novo Nordisk A/ S
cleavage
allergic reaction (
Activated charcoal
2ºC -
There are no
during treatment with
your doctor
and
E216 )
12
used with caution
10
or
g/ dl (
15 and 5
primary
( 0 1 year
, respectively
section 6.1
solution for injection
if
hypoglycaemia whilst driving
trials
10
ml
this
.
of dogs
Increased
Bipolar I Disorder ,
administration of Aclasta
either
of
of the
CYP2D6 or 3A4 inhibitor
to be administered intravenously
.
, dizziness ,
from
by
45 93 05 06
effects
patients
Eli Lilly
of cleavage
mellitus , diabetic
two
& D Centre (
oedema
use of Epoetin
satisfactorily controlled
SQUIBB BV Tel
Since insulin and
50 tablets 56
of potent CYP3A4
Aldwych London WC2B 4AE
1 ,
58 Adjustment
not
tablets
pneumonia
concern
+ 47 67
potentially
with
.
pharmacokinetics are
or stroke in
not
,
,
, Wielka
with lithium
by the intravenous
contain 0.6
aripiprazole
Business Park , Oxford
Abseamed 5000 IU/ 0.5
50 International Units
(
2°C -
especially
also prevents
( AST
medical prescription
with chronic renal failure
patients
.
clinical trials , uncommon
,
sleepiness , shaking
or
trials with
and sulphonamides
DK-2880 Bagsværd
per month )
group
6.8 mmol/ l
.
Global
of unchanged
In a
, infection
for
95 %
in 1.3
, 3
administration
FACT-An fatigue scale
after repeated oral
D Centre ( Europe
fractures over
5.1
%
Marketing
and polyps ) :
5000 IU/ 0.5 ml
(
food
The
.
aripiprazole in pregnant
medicinal products
All
Limited
placebo .
may
antipsychotic drugs
, vitamin B12
) Sodium hydroxide
growth factors
)
(
epoetin alfa
events
with
Interactions with
not show potential for
, sudden unexplained
SQUIBB
-
Cmax
3 Elevated
1
16 00
44 ( 0)20
of
Carton of 28
- 8°C ) .
you
the
of your
172 Danmark
glycaemic control despite
for thromboembolic events
section
more
children under 30
they
doses
In
, 64 gynaecological
.
BRISTOL-MYERS
and
37 ,
increased
below 12
section 4.8 )
Abseamed is a
to increase the
be exceeded
the
diabetes
are
soluble insulin
make sure the
on
)
a
with
in vivo
a
all patients receiving
thrombosis ( DVTs )
.
significant
Name
aripiprazole
not
Vantas
Common : extrapyramidal
(
fatigue Psychiatric disorders Common
1 pre-filled syringe
each
worsening
starting dose for
and
BW 120 ml
.
g/ dl
angioedema and anaphylactic reaction
When concomitant
EPS was
both decrease and increase
The AUC
Microcrystalline
l )
Very common
they
hip fracture
House Highbridge Business Park
adverse
of
increased
ABILIFY tablets (
If you
, 90 and
alle Packungsgrößen in
(
6
order
and
,
225 )
body weight
pathways involving the
a
blood pressure
products
less than
month ,
overweight
was
Eye disorders Common
of the
rats
Patients
of greater than 12
insulin requirement may be
that primarily
Like
)
, Neuroleptic Malignant Syndrome
, as
, less than
days immediately
40
with epoetin
days to
is therefore
of
Denmark
physical
between 25
as
ml
is
Die Schmelztabletten
prevention of a new
should
CYP2D6 and CYP3A4
based on conventional studies
In
is
Es liegen
[
pre-filled syringe
of erythrocytes
2.47 in favour
Water for injections
26-week ,
76 The
Laboratoires Takeda Tél :
* :
after
704 71 00
sulphonylureas or insulin
,
or
,
98 tablets .
to affect ABILIFY :
human , rDNA (
in a pre-filled syringe
) or CYP2D6
of fatal
tablets 90
may be observed .
and
as compared to
Actraphane contains
when
and
aripiprazole dose
In
) or coma ,
a
, 17
to maintain haemoglobin values
than
When
Actraphane is a mixture
paediatric haemodialysis patients
What ABILIFY is and
Hb between
serious adverse events When
evident ischaemic heart
Activated charcoal ( 50
predonation
,
Italia Farmaceutici
( 1 800 )
insufficiency .
30 mg of aripiprazole
hours
, especially
.
than 1
,
(
attention should be paid
3 times per week
g/ dl
Administer
( Europe ) ,
only
g/ dl
is dietary
Lactose monohydrate Maize
.
to performing the
- Middlesex
Taking
vascular
.
patients with bipolar disorder
For
of in accordance with
EPS including parkinsonism ,
findings
was
Each ml of ABILIFY
an
Erythropoietins are growth factors
and placebo ( 2.1
at one injection site
epoetin alfa
4AE
.
sections 4.3 and
3A4
of adult
placebo-controlled
Middlesex
WC2B
in
Uncommon -
see section
reaction
Your
, redness
osteoporosis therapy
(
headache Eye disorders
.
g/ dl :
not
in 10-2007
contains 4000 international
recommended
four placebo-controlled studies
PRODUCT AND ROUTE(S )
7.5 mmol/
: +
) .
time
(
are
0)20
.
and rhabdomyolysis ,
forms of
9
% of
the active substance
150 IU/ kg
Tlf : +
be disposed
Centre (
epoetin alfa
of the
.
The treatment
)
Tél/ Tel : +
or
Eye disorders
; suicide attempt
vitro findings
mg of
, the formation
primary
Holder
both
cartridge contains a
AUC and
in adult and paediatric
the
AND EFFECTIVE USE OF
Abseamed
risk
the
BRISTOL-MYERS SQUIBB SARL
you
is
ml of
with solid tumours (
Eye irritation
by the intravenous route
is
143 Even if
once a
glass of water
.
ABILIFY
you
in bipolar
patients )
see section 4.4
,
alcohol
experience
12 g/ dl
section 5.3 ) .
.
) .
or stroke
( for pH-adjustment
use in
sedation
tablets
or
significantly impact renal function
for signs
hydroxide ,
range of
The
benefits
g/ dl (
no appreciable
The frequency
of
its
,
of
ABILIFY ,
In elderly patients with
syringes
1800 ml
no
is
tablets can be
aripiprazole concentrations
.
use
g/ dl
to
this
rhabdomyolysis ) ,
( weeks )
in
insulin
(
THE WEEK (
effect
ketoacidosis
between 17 and 33
increased alkaline
maximum daily dose should
anaemia
treatment with
= 229 )
and
table
Tel . +
blood loss and haemolysis
observed for orthostatic hypotension
.
mg Fe2+/ day
4AE ,
10 % (
RH12 5AB United
given
and 3.0
of 1 ml
6.2 - 7.5
.
by the intravenous
arrhythmias , sudden
)
with encephalopathy-like symptoms
and
ABILIFY solution for injection
of reported cases
and
alkaline
(
or very
other antidiabetic medicines
mg/ m2 ;
A half-life
-
local requirements
in the Package Leaflet
Similarly ,
is taken once daily
Tel : +371 7364000
development
Uncommon -
and
e. g. heart
and
+ 33 ( 0)810
.
experience
administration of
Actos
.
and protracted absorption respectively
.
anaemic patients .
fluids before
recommended dosing regimen
.
Lilly Holdings Limited Eesti
not
month , or if
Tél : +
dietary
.
Aripiprazole
increased risk
)
your doctor or
" A
inflammation
ml ) for the
.
Novartis
use
If
,
.
elective orthopaedic surgery
and
) pioglitazone
experiencing potentially clinically significant
- Middlesex UB8
)
" A-009 " and
Tlf : +
to
.
the tablet formulation is
PRODUCTS
neuropathic pain , tremor
oral
mmol/ l
be used (
active substance is
the dosage of ABILIFY
contacts
risk
greater than
or of no
see section 4.8
see
after
see
per month or the
interaction
.
pharmacokinetics of aripiprazole .
of
and isophane ( NPH
There is an
354 535
second trial utilised
: + 47
to ensure
- Treatment
condition may also
mmol/
see
increased risk
3
15 mg has not
.
injection site within a
should
increased risk
1 g/ dl
Abseamed in patients at
dehydro-aripiprazole
other medicinal products .
As with
- 100 ml
with
) is
years .
adequate and well-controlled
tell
a large
section
can be
1 or
bottle contains
treatment with
suppress
inhibitors of
is necessary .
, BP 27166 ,
, there were
have also occurred
change in their usual
Aripiprazole
administration of
g/ dl (
blurred vision
patients with these
for advice
When considering concomitant
In clinical trials
7.5 mmol/ l )
aripiprazole tablets
treatment
50
over 24
fall
0)20
or worsening
may vary with
as a mitosis-stimulating factor
United Kingdom
or
they
Tel : +
(
Do not
(
, treatment
.
Penfill 100
10
not affect your
or
to the
chest pain ,
: soluble insulin 40
Uxbridge - Middlesex
Each ml of solution
,
The initial dose
or
in these patients
the CYP3A4 or
All patients being
insulin and 60
Patients
aripiprazole and
diabetes
24 hours after the
frequency grouping , undesirable
considered
In
treatment
thromboembolic events in
unpreserved product and
In
significant
10
24
This medicinal product
is given concomitantly
( see
patients
maximum
should not be
severe
favour of controls .
APPROPRIATE
of age
patients
ABILIFY
section 6.1
prophylaxis by
.
10 g/ dl
Cancer Therapy- Anaemia (
intestinal calcium malabsorption
20 501 76 03
the
with solid tumours
should be
symptoms is less
haemoglobin
or unplanned ,
medicinal products
change in
with aripiprazole
until
elderly
.
serotonin
patients
applied
(
) ,
mg/ kg daily
SMALL IMMEDIATE PACKAGING UNITS
,
based on conventional studies
731
the
15 on
Cmax
glucose
female and male
g/ dl ( 7.5
receiving chemotherapy
free from particles and
dopamine
and
with
Actos 45mg
Other potent inhibitors
during treatment
to reproduction
mellitus
the
anaemia may
g/ dl (
( E216 )
to reproduction
pregnant
kg and adults .
products
Penfill 100
0.5 to
of
syringes contain 0.7
.
pregnant women .
, 22 prostate
a clinical
rimonabant 20 mg
tumours (
5.1 )
section 4.4 )
,
per week
for
, the dosage of
in women
of ACOMPLIA
you
, especially
PARTICULARS TO
the intravenous route .
SQUIBB BV
mmol/ l
The possibility
stroke
If any of the
GmbH & Co
orodispersible tablets
non-selective beta- blocking agents
alfa is given concomitantly
should generally
4.4 )
50 IU/ kg
(
especially
OR WASTE
of cardiac events .
1 800
without treatment
( see section
)
renal insufficiency not yet
the patient
251 21 230
Puh/ Tel :
Children and adolescents Aclasta
the
.
not affect your ability
( human ) .
GmbH
, tremor , dizziness
with pioglitazone .
with alcohol
.
and what it is
.
any information
ABILIFY solution for injection
2000 IU/ 1 ml
clinically significant changes
active substance is aripiprazole
IU
for haloperidol (
tumour proliferators
, the
of
placebo , or
Abseamed
and completed suicide
84
56
alcohol or
.
section 4.5 )
of
and
the
intermediate-acting
.
The
In two
18
and Cmax of
werden mit
CONDITIONS OR RESTRICTIONS WITH
psychotic features
III )
Development Centre
50
recombinant DNA technology
, discard
time
solution contains 2000
, or
, such as ketoconazole
.
be followed
swelling
7.5 kg over 2
.
and
"
ml
in patients
aripiprazole
should
The usual dose is
specific
Distribution
patients
whose first treatment
when stored between
normal
or coma
pharmacist
a
.
Serum
sensitive to
was
,
5.8
and
of potent CYP3A4
crisis with encephalopathy-like symptoms
with or
creatinine
corresponding to 42.0
please tell
( 7.5
to the insulin requirement
BRISTOL-MYERS SQUIBB SARL
the intravenous route
sodium citrate and
at one injection site
the
hours after
30mg tablets
:
rare
(
or mixed episode
rare cases of NMS
trials , uncommon
10
times per week
amino acids
,
4.4 ) .
,
recommended dose
2
Centre (
,
heart failure was
contains
mmol/ l
more
.
There are no
please tell your
.
treatment
be
45 mg
and
is
) .
West Sussex , RH12
the intravenous route ,
dextromethorphan
pharmacokinetics of aripiprazole
pioglitazone
)
, the gluteal region
section 4.8 )
with
epoetin alfa
.
animal models of
not been
Abseamed or
haemoglobin target range of
938 ;
please see section 4.4
60
Actraphane 30
.
of ABILIFY
) Ltd
may do regular
7.5
that primarily
0)1628 537
or breathlessness
.
Intravenous injection : over
The
of the
occur .
tablets 84
What ABILIFY is
3 times per
5.8 for placebo
not
and 12 g/ dl
.
, aripiprazole and
in humans
6.1
and rhabdomyolysis
oral
4.6 ) .
AB Puh/ Tel
section 4.5
treatment with epoetin alfa
patients
.
vitro studies have shown
and sulphonamides .
lactation or lay
44 ( 0)1628 537
50 %
or
in
pioglitazone
and its metabolites
IU/ kg epoetin
,
or
4.7
cerebrovascular
has not
)
diabetic ketoacidosis ,
t½ ) is therefore
elemental
Diabetes
Glycine
450 IU/ kg
products .
tremor ,
Erythropoietin receptors may
patients with
patients
At therapeutic
heart failure or
thrombosis , arterial
,
)
as soon as
x 1
) should be
21 230
use
in healthy subjects ,
in
a dose
may
pioglitazone (
CYP2C8 .
scheduled for major
Allé DK-2880 Bagsværd Denmark
USED FOR
ml contains
)
insulin 50 %
were
epoetin
14 g/ dl
1
.
, hyporeflexia
occurs frequently
see section 4.2
fatigue Psychiatric
, 84 ,
with lithium
addition
after
Do not take ABILIFY
Population pharmacokinetic evaluation has
THE OUTER PACKAGING
dysphagia
% and
is
05
g/ dl
genetic
OUT OF
mean improvement from
24 hours
efficacy
placebo
, increased Aspartate Aminotransferase
of any powder
4.5 )
with renal
to
patients with
1 g/ dl
three
Eesti
After administration of
1
cartridge contains a
patients
packed cell volume
epoetin
should
These
risedronate (
of
this patient population .
per month or
compared
,
g/ dl
and approximately 18 %
( for pH-adjustment
feel dizzy
included only 3 patients
Paget s disease
quinidine
Thrombotic/
with
disorders
when taking ABILIFY
The blood glucose
:
overlapping undesirable effects
t½ ) is therefore
combined with
Medice Arzneimittel Pütter GmbH
injections .
.
81
of 12
( 30 mg )
(
0.9
out of
of aripiprazole
included patients
In
in vitro studies
aripiprazole in
interaction
.
24
other
been
34 (
: + 358 9
with lithium
who have a
73 % )
( 1.25
of the
well
In two
disposition of
It is especially
in
section 4.4
of erythrocytes from precursors
Medice Arzneimittel Pütter GmbH
except in paediatric
Less than 1 %
them to divide and
between healthy elderly and
patients with type 2
(
stroke in
pioglitazone in
Takeda Europe
( 5.9
0.4 ml ( 4000
.
& Co
severe renal
Cytotoxic actions of epoetin
6 %
of the
5.1 )
the eyes
. if
of Epoetin alfa and
solution
in isolated
with
% for both groups
( 0)1628 537
( this should be
Actraphane
, headache
) should be
patients received
18 84 16
manic
6.1 )
of anaemia
and
agitation and
42 trials
,
bradycardia
have
4.8
is between 75
IU
incidence of
& D
combined with fast-acting
mg of aripiprazole .
scale or
( approximately 1/ 20th
% below
the
.
)
,
1
Pioglitazone
of
pectoris , increased risk
to tablets
IU .
important for the
Method
4.5 ) .
be
your
4.2
for three weeks
( International
( for pH-adjustment
4.2 Treatment
the
peripheral
Additional adverse
achieved
.
GGT
IU/ kg
Ísland VISTOR
,
trials aripiprazole has
abdominal wall
female
The recommended
with water
or
daily
epoetin alfa
manufacture ( recombinant
signs
and precautions
be assured :
children over 30
RESTRICTIONS
approximately
or
angiotensin converting enzyme (
paclitaxel
no difference in
consider clinical monitoring
( see section
In Paget s disease
on the
In
Takeda Global R &
pregnant women
Reticulocyte count
BRISTOL-MYERS SQUIBB BELGIUM
and
Abseamed 2000
.
diabetes
4.2
the intravenous
In two large
is
+353
been observed .
The rate
Tlf
( normal and
long-acting
.
bottle with 100 ml
IU/ kg epoetin alfa
ra
6 %
a
) .
repeated annual dosing .
%
injection route
very rapid or
see section 4.2
or
5 mg/ ml
-
haemoglobin is rising by
.
1.9 %
cartridge
LTD
Functional Assessment of Cancer
mmol/
may
and
.
doctor
no
few minutes .
1
99.9
Bipolar I Disorder ,
Undesirable effects known
below
1HU - United Kingdom
3 times per
( see
in
t½
Special warnings and
its application for
haemoglobin is
immediately if
population ,
:
10 g/ dl
70
years
products and
75 - 150
Nausea occurred in
BV Tel
use
2
associated with antipsychotic
the incidence of
allergic reaction
and
In controlled clinical
30mg of pioglitazone
or
mixed episode
has been
the bile
the first
0.9 ml
was
55 53 50
12
SAFE
neuropathy , neuropathy ,
Weight gain :
10
%
insulin and pioglitazone
contains
(
linked to
g. insulin dosage
) of
probably need
49
+ 354
with epoetin alfa
in HbA1c
or
Nervous system disorders Uncommon
you
doses of Abseamed
haemodialysis
trial
moderate
not
nausea
Hb
( AST ) ,
and 12
events
and
.
see
.
, creatinine and
on
may
.
if you
.
the
The Marketing Authorisation Holder
less than
- United
of
, especially infections
by a decrease
12
medicine
There have been
Almost all subjects
listed below is
anaemia
.
was
)
inhibitors of
and approximately 18
other antipsychotics
contains
long
and
ABILIFY
, respectively , the
concentration is unchanged
7.5
standard genotoxicity tests
a half-life of a
454
of 10 g/ dl
section
Common :
aripiprazole in
Omission of
mmol/ l
cases of stroke
.
,
, 30 mg
6 hours has been
infusion
Diabetic retinopathy Long-term improved
of Bipolar I Disorder
treatment in between
reduction was 51
with epoetin
Aripiprazole is
risk of pregnancy
mean
4.3
whose arteriovenous fistulae
the
AND
well-controlled
2°C -
80 to 375
a
,
Eli Lilly farmacevtska dru
recommended dose is a
& Co KG Kuhloweg
Following
contain 0.4
,
3.2 % with placebo
24 %
retinopathy Long-term improved
contributes about 58 %
than
and anaemic
only
open-label studies
Increased
women
150
tell
( 6 %
tell
avoided
) .
a
12
to become
your doctor
may also
7000 international
patients
tablet
clinical trials
should
immune system
by
, by
4.3
SARL Tél
Authorisation
g/ dl
is 15 mg
and 8.7 for
Ltd , 61
and disappear
see section 4.6 )
levels
proconvulsant activity of rimonabant
not
the most frequently
rDNA
Iron supplementation should be
for
(
tablets
,
haemoglobin values exceeding 12
,
,
A direct
Eli
BRISTOL-MYERS SQUIBB (
56-99
white
on
Cardiac disorders
Medice
Abseamed should be given
ABILIFY
2°C - 8°C
with Actos and insulin
fast-acting
.
: + 46
On this
be marketed
weeks
0 )
in dose should
weeks
following information is
possible , even several
week by the intravenous
,
ABILIFY
such patients .
358 ( 0)9 8545250
4.5 Interaction
contain lactose monohydrate
( ALT
by a decrease in
generally not
ml (
in other
THE OUTER
Hypertension
in
: + 33
Lda Tel : +
observed
.
or
liegen
be advised accordingly .
37 D-58638 Iserlohn
Uncommon -
use of oral
hypertension .
The
mg/ day
including parkinsonism ,
monoamine oxidase inhibitors (
If
than
over 30
see
.
with or without
in 71
683 breast
was observed in
with overlapping undesirable effects
without
33
injection
a
The potentially
section
trials
oder ohne (
, thiazides ,
to treat adults
EPS was
disease
% ) following the
as
trials that
see section
insulin requirements
events
.
should
should be
) .
, diabetes mellitus
, hyperglycaemia
of the
, salivation , anorexia
Although there is
50
during treatment with
section
Physicians
4.3
greater than
.
, constipation ,
oral
heart failure ,
treatment
of
vertebral fracture(s ) .
resulting
important change in valproate
In a prospective ,
from
.
, but
when
( see section
Taking
)
reported
your doctor or pharmacist
unit dose
and Cmax
tachycardia , nausea ,
4.5
patients with or
vitamin B12 or
% ) .
31 ( 0
4.4 ) .
- 150 60
loose stools ,
of
in adult patients with
patients
in both
-
and take
Glycine
CYP2D6
DISPOSAL
%
)
see
( IU
of
doctor or pharmacist
of EPS was
study )
while approximately 86 %
route .
of
terminal half-life
section 4.4
( below 30°C
and 98
, Germany
,
and water
trials
of in accordance with
respectively ,
, headache
section 4.4
avoid
tablets
Aclasta
However , since cyclosporin
based on
%
headaches as a
therapy
consists of
history of
1 ml 6
& D
the
Park
and
a clear and
be assured :
(
kg
21
g/ dl
Meta-analysis of overall
- Aclasta 5
+44 ( 0)20
not
Highbridge
Global R & D
,
2°C - 8°C
with subsequent
surgery and
not exceed 30 mg
sections 4.8
Tel
hyperglycaemia
infusion
heart failure
Undesirable effects known
polycythaemic mice
is
)
in
REACH
)
taking ABILIFY .
of NMS
2
Anaemia symptoms and sequelae
%
therapeutic
recombinant human erythropoietin
GESMBH
( anencephaly
on
studies
Cmax
stiffness
dopamine
and
After
treatment with aripiprazole
Taking
alfa
: in clinical trials
.
)
month or
direct
OR
13 %
Europe ) ,
patients with
This
antihypertensive medications
( see
especially
study
Intensified control in
000 IU/ 1 ml
administration of ketoconazole or
or
men
, sedation , headache
well-controlled trials of aripiprazole
of the other ingredients
isophane ( NPH
with
for
or
with lithium
g/ dl ( 8.1
Therefore ,
kg
7 %
be used if
67.2
and diabetes
on
-
when pioglitazone
12 g/ dl
(
, especially
symptoms
] )
machines , until
( see
OUT OF THE REACH
aripiprazole
Hb between
improvement in
excessive sedation and
rimonabant ;
placebo
: dehydrogenation
how
4.2 Treatment of patients
and
537
GmbH
blood
of
15 mg
observed ( see
the
with renal
In clinical trials ,
the
Abseamed has no
not
)
ge
patients received a
administration
by
.
.
of
rats , polycythaemic mice
tumours (
mmol/ l ) should
Yarvitan
30
of insulin
either sex .
)
elderly
administration of recombinant human
per week
a multipack with
the use
.
forms of interaction
kilograms .
renal function
In clinical trials
carbohydrate chains
of angioedema and
:
this is superfluous
see section 4.5
100
combination therapy
with a quick
chemotherapy
physical
, the dosage
preventing recurrence of
in
or mixed episode of
intensify and prolong the
section
2 g/ dl (
of the
myocardial infarction or
you are
section
Your doctor
aripiprazole
cell-killing
controls
starting dose for ABILIFY
2 , France
liver
anticancer
no
,
A few
of food
or
increased risk of
ml solution for injection
has
to starting Abseamed therapy
not been established .
month or
not
mellitus and heart disease
or
in
to
a
+358 9 61 33
Adult cancer
)
and 53.3 % for
recommended that the
( 8.1
These measures will help
.
alfa on
these trials ,
Use should be restricted
and
are usually
with haematological malignancies
If convenient
treatment with epoetin alfa
of 33
, the formation
dose
than
%
of 30 mg (
in a pre-filled syringe
Abseamed
ist keine
a t½ of a
( 6.2 - 7.5
instruction for use to
and well-controlled studies
administration
3
isolated cases
placebo-treated patients
Business Park ,
medicinal products .
.
arrhythmias ,
Kuhloweg 37
mmol/ l
and
can
Diabetes
or
)
of
Treatment of
) 731 1736
2°C - 8°C .
% with aripiprazole and
with placebo
. ) .
also
instability ( irregular pulse
section 4.4
ABILIFY
pigment ( haemoglobin
per
clinical
a
administered once a day
0.62
with
28 tablets 30 tablets
and symptoms
if you are
epoetin
before your
experience in children and
-
experience
(
the intravenous route .
of excipients , see
aggravation of existing hypertension
by the intravenous
MUST
its total active metabolites
effects
receiving non-platinum chemotherapy
effect
rats after
Authorisation Holder
Co KG
.
most of these patients
haemoglobin
There is no accumulation
can
,
Thrombocytosis has been
Highbridge Business Park
However , since cyclosporin
be
In
water for injections
44 ( 0)20
,
erythropoiesis stimulating agents
trial in healthy
Similarly
mean age
with
and
in the thighs
your
how your
of 10 to 30
of
, brand ( manufacturer
Hypersensitivity to
enough
aripiprazole ( see section
&
not
of 10 g/ dl
.
: + 32
water
from the
the
10
all patients receiving
AUC and Cmax
ACTOS
(
chronic
, may
units
.
transient ischaemic attacks ,
10 or
four carbohydrate chains are
)
was
within a
.
NYHA stages I to
opening the
may feel dizzy
: +
in order to
corresponding to 50.4
yellow , marked with
the anterior abdominal wall
( 6.2 mmol/ l
Approximately one
Treatment
1 g/ dl
The following
, myoglobinuria
and water for injections
1
and for the
is
of the
: a
units of
, headache , akathisia
4.8 and 4.9 )
(
or less duration ,
haemoglobin
of administration
headache
.
,
(
your
95
moisture .
than 1
machines if
blood donation procedure
approximately
4.4 )
Cmax of dehydro-aripiprazole
(
are
epoetin
mmol/ l ) per
in Actos 30mg
or very rapid
The possibility of
medically
32
ABILIFY
cases of
Novo
the
extent
The
Tlf
studies
,
with pioglitazone .
agitation
section 4.5 ) .
usual dose
, vomiting , nausea
CYP3A4
,
in
The local
mg of aripiprazole
Insulin suspensions
Medice Arzneimittel Pütter
.
round and pink
tablet contains 30mg
% .
.
Abseamed
Uxbridge - Middlesex
diabetic ketoacidosis
be presented
is necessary
Denmark
.
)
be monitored
Actos
or Hb increase 1
that primarily stimulate
ABILIFY can
.
in
administered once a year
15mg
the
or
see section 4.8 )
trials
) The
.
aripiprazole
There are
is
Based
the
x 1 ,
( 2°C -
aripiprazole
.
half-life
PRODUCT
see
.
bacterial and mammalian cell
1.8.1
with chronic
ABILIFY
United Kingdom
times
)
Water for
of Abseamed between 17
: + 44
was
there were
,
Tel :
increased risk
% ] )
clinical trials
diabetes
12
91 ) 663 50
( 1
of
five
, RH12
.
your
15.7
increased to the level
incidence
section 4.2
and inter-individual variation
Actraphane
for cerebrovascular adverse events
- United
combined with
women
% ) .
Insulin suspensions should not
range
nausea
should be
potent
ABILIFY is
,
and acute renal failure
per month ) with
6
and disturbed behaviours
10
suicidal ideation ,
The peak is always
and
monitored and
and rhabdomyolysis ,
medically serious signs and
injections
weight
In the
section
in
The usual starting dose
warnings and precautions
be
trials and
.
under
the
dose is 9.75 mg
den
prescribed
subjects ,
compared with placebo
pulse
the incidence
following
In
or urticaria
:
SQUIBB
3 times per week
with pioglitazone
ml
( also part of
N-dealkylation is
in
site conditions Uncommon -
aripiprazole
Therefore ,
patients
read
Elimination
the occurrence of cardiac
was
) .
BRISTOL-MYERS SQUIBB AB Tel
Eesti Eli Lilly Holdings
, followed by a
oedema
patients treated
effective
epoetin alfa .
order to protect from
EPS was
, arterial
are ready to use
been
, in patients
2°C -
important differences
metabolites ,
Recurrent Fracture Trial
your doctor
5.1
therapy .
40,000 dalton .
.
or irregular
may
a meal or unplanned
the geometric means of
a
somnolence ,
surgery and
(
It is important
not
is
Therefore , no
1HU
has been
6.1 .
Yarvitan 5
count has increased
clinically
cases of seizure
effect
or
the insulin requirement .
carbamazepine ,
failed
,
in subjects with
(
.
trials and
and
of
the insulin requirement
( 8.1 mmol/ l
14
at
well-controlled studies in
, pyrexia
: + 44
subcutaneous use
,
, 174 gynaecological
(
of epoetin
brand ( manufacturer
with
patients with
, it is recommended
ml 6
which is potentially lethal
pre-filled syringe
,
Store
Actraphane
with
( 0800 ) 731
5AB
thyroid hormones and
should generally
2°C - 8°C )
, hives , swelling
factor and differentiating hormone
Aclasta
doses
years ;
.
, oral aripiprazole
trials , an increased
In these
with
the reach and sight
harm and suicide .
tablets
store them in
rare -
respiratory
PRODUCTS OR WASTE
accepted
+
,
Park , Oxford Road
of paclitaxel has
section
8 732
1 tablets .
14
Nordisk A/ S
improvement in
OF THE MEDICINAL
( see
and
, long-acting
Global R &
and 70 %
initial treatment response
diabetes mellitus (
1 orodispersible tablets 49
on
or
SQUIBB GESMBH Tel
be avoided .
pre-filled pen .
: fatigue Psychiatric disorders
should be
When
,
is unchanged ,
administered intravenously
ml
The mean
you are
with
mg Fe2+/ day
Always take ABILIFY
than 1
)
contains
e. g.
patients with
) .
352 74
dose
: +
before taking ABILIFY
)
10 g/ dl (
a
therapy
be a moderate
.
Novartis Europharm Limited Wimblehurst
cases of
for use in
defined
.
atypical antipsychotic agents ,
that the
Zinc
favour of controls .
34
rare - Refraction disorders
increased by 77
the reach and sight
per
should
7.5
15mg tablets can be
and
CHILDREN
that epoetin
the
.
Distribution No
extrapyramidal
section 6.1 .
and sight of children
3 weeks
200 mg
effect
Seizure
hypothermia
with
33 ( 0)810
The peak
with consideration for
House
0.5
in
50
.
of the patients
of recombinant human
extensive extravascular distribution
and
may cause allergic reactions
minutes
( Europe )
Erythropoietin is a
other medicinal products :
USE ,
migraine-like
cannot be excluded .
may
BRISTOL-MYERS SQUIBB
glycaemic control despite
with
in
epoetin
)
, monoamine oxidase inhibitors
, placebo-controlled
)
after dosing
( haematocrit
) AB
0.3
ml ( 9000
tablets
and/
, pioglitazone
64
experience somnolence
your
) .
altered mental status
, sodium chloride ,
9000 IU/ 0.9 ml
.
psychosis
and
.
additional
into an
in
multi-pack comprising
.
14
progression of diabetic
8.1 mmol/ l )
greater than 12
patients
In several controlled studies
of Abraxane
groups
D2 and D3 ,
correction of your
diabetes
placebo-controlled trial , the
ml
transient ischaemic attacks ,
is 5 mg
,
with
alfa
any remaining contents .
the studies
IU/ kg/ day
: + 353
of the
)
patients
epoetin alfa
.
and
or discontinuation of treatment
GGT ) , increased
Limited
ideally starting
vomiting , salivation
receive appropriate training
to aripiprazole
,
a
(
that
with
PRODUCT
a
zoledronic acid , is
410 500
12 g/ dl (
THE SAFE AND
anxiety Uncommon : depression*
of aripiprazole
and a
be considered
: extrapyramidal
.
therapeutic
Norge Takeda
with
symptoms of
is
range
.
on
: + 353 (
211 patients in the
light-headedness , trouble sleeping
1
34 857 42
,
contains 1000 international units
: +44 ( 0)20
a reduction of
:
32 2 352 74
if the
( IU )
shown significant benefits
ABILIFY
shown below
sodium citrate and
have been proposed
in some
)
rare cases of NMS
ABILIFY is not
co-administration were
most of these patients
,
may feel dizzy
overall survival and increased
if
dehydro-aripiprazole , but
)
is
any remaining contents .
the CYP3A4
efficacy of
to
dietary control .
,
) .
,
As with all
section 4.4
another
Although there is no
malabsorption
The effect
938 ; mean age
reduced
was 7 times
( e. g. rifampicin
epoetin
, 30
see section
14 x 1
(
site conditions Uncommon
may
section 4.5 )
first trimester
.
.
precautions to avoid
4.8 ) .
Oral
range of standard
syringes contain 0.4 ml
should
QT prolongation ,
are usually mild to
p rst
common
injections
have
knows how
,
treatment
.
snack containing carbohydrates
and post-marketing experience
HF Sími
haloperidol 73 % )
( Europe
13 days
ability
non-selective beta- blocking agents
,
potassium in
12 - 14
patients with or
of solution
Aclasta therapy
infarction , cerebrovascular accidents
THE REACH
take more
ABILIFY
,
58 The
repeated
,
several
other
used to treat
This was
patients with hypocalcaemia
.
Elevations of CPK (
clinical studies
treatment
take the
weight
glass ball to
placebo-controlled trial , the
BRISTOL-MYERS SQUIBB
in
by
or valproate
per
IU/ kg 2
The pharmacokinetic characteristics
medicine
or obesity
33 ( 0)810
Insulin suspensions are
alfa
in maintaining the clinical
recent low-trauma
observed
THE WEEK
53 50
aripiprazole
aripiprazole and
1
) .
transient and asymptomatic ,
should be given
.
a
or
infusion must be
As
in
or glucose-galactose
be
: fatigue Psychiatric disorders
dosage of ABILIFY
( please see
- 8°C
-
Abseamed
.
which also
rhabdomyolysis ,
toxicity The highest
patients with a
itching , hives
30 minutes ,
rats
50
weight gain
12
meal or unplanned
, tremor
kg over 2
Be sure to
neuropathy
for the occurrence of
mean
) Protamine sulphate Water
Gamma Glutamyl Transferase
6.1
in
experience
on
.
the dosage of
healthy subjects
Aripiprazole orodispersible
or
,
% for
, these
of cardiac events
KG Kuhloweg
: + 358
instability ( irregular pulse
bone
.
BOX ) AND
In several controlled studies
, constipation
- United Kingdom
Actos 15
ABILIFY orodispersible tablets
change in aripiprazole concentrations
vascular
of children
,
protein intake .
) or
with less
normal
36(0 ) 20
other antipsychotics ,
section 4.4 )
isophane (
is designed to be
.
by the intravenous
.
2 studies
tablets
atypical antipsychotic agents ,
, elevated creatine
you
intravenous route
reduced the risk of
should
cerebrovascular adverse
of the pharmacological effects
.
The
mg mitratapide/
with
are hypersensitive ( allergic
, anorexia ,
be used
see
30
( t½ ) is
a glycoprotein that stimulates
once a
not
Actos 45mg
the
The
rectangular
by symptoms
after repeated
: store
aripiprazole Intramuscular
, especially
in a
.
was evaluated in
(
in
) .
in
,
and 4.9 ) .
of heart failure
ABILIFY :
therefore
,
- if you have
is necessary
of aripiprazole .
0.8 ml
(
OR WASTE MATERIALS
,
%
section 4.4
13
2C19 ( omeprazole )
closely monitored throughout this
with haloperidol
some of the
values
+ 354 535 7000
sedation , headache
erythropoietin
per month
Middlesex
methyl parahydroxybenzoate ( E218
.
No dose adjustment is
Actraphane contains
Abseamed 7000 IU/
very rapid
orodispersible tablets are round
for
.
with oral aripiprazole
should be
)
Method
and disappear
.
l
)
6.1
treatment with epoetin
The
one of these trials
Glycine Polysorbate 80 Water
)
erythropoietin
must be
listed below .
specific
section 4.8
Middlesex UB8
and
and sight
of CPK (
or pharmacist
disorders Common :
Special precautions
50 IU/ kg
with chronic renal failure
is
5.2
possible warning signal .
daily dose
haemoglobin target range
g/ dl (
with consideration for
, die aus
Europe ) Ltd
pioglitazone
mellitus
Hypoglycaemia may
12 g/ dl (
SQUIBB
UB8 1HU -
, 56
risk
or mixed episode of
pregnant women .
12 g/ dl
paediatric patients
temperature regulation disorder
must be
15mg tablets
.
recommended
type 1
The usual dose is
.
moderate and
,
1 ml contains
+ 44
Tél/ Tel :
BSAP ) ,
contains metacresol , which
for the
tablets 50 tablets
10
mean weight increase with
)
orodispersible tablets ( tablets
a
of the
a
4.4 ) .
50 International Units (
, polycythaemic mice
)
)
The
warfarin
)
) ,
)
clinically evident ischaemic heart
Novo Allé DK-2880
the active substance or
1 60
or
headache ,
3 X
PACKAGING
60 14
Pioglitazone
is
alfa
Ltd 61 Aldwych London
formation of erythrocytes
pre-filled syringes are
(
mg
)
12 months
pharmacokinetic
populations ( see section
Kuhloweg 37
Treatment with
drive
( see section
The
Uxbridge
tiredness
tremor ,
haemoglobin ( 1
mild inhibitory effect
trials with aripiprazole
hours
,
cell production
, tremor , dizziness
these characteristics
74
, pruritus , or
by
serum levels of
Adult surgery patients in
epoetin alfa
in paediatric patients
occurs
for pH-adjustment )
)
is
pancreatitis , dysphagia
very
placebo .
see section
8°C )
of
, this
,
, vomiting
genotoxic agent
minutes
may
with
in Bipolar I Disorder
other clinical effects
Europe ) , µ
infection or
weight
.
an increased
zoledronic acid
aripiprazole and
NAME
22
In a
, salivary hypersecretion
1 ml
overdose with
diabetes
When
you
syringes contain
Less
patient
renal insufficiency not yet
treatment
heparin )
all growth factors
that
during lactation .
was administered concomitantly
other medicines
55 53 50
and
, Neuroleptic
:
000 IU
mg (
epoetin
, somnolence , tachycardia
and
, Kuhloweg 37 ,
no
20
dihydrogen phosphate
and
)
refer to
: + 44
Any unused product
Generally ,
should be closely monitored
to reproduction
: + 31
if
haloperidol-treated patients .
, long-acting
(
insulin human ( rDNA
22 ,
)
, 25.9 ]
or 480 ml
.
use Abseamed
and whose
kg
Iron
33
Each ml of solution
UB8 1HU -
than a daily dose
see section 6.1
TRIPLE ORAL COMBINATION THERAPY
What
CYP2D6 and CYP3A4
.
)
recommended dose
.
included patients
.
or exposure
Aldwych London WC2B 4AE
concomitant
physician must therefore
In
of
Therapy
IU/ kg
mean age
maximum recommended
% and haloperidol
The
the insulin requirement .
Tél/ Tel :
7.5
several controlled studies
Driving and
g/ dl
myoglobinuria
Each orodispersible tablet contains
osteoporosis ( PFT
R &
,
hypotension*
tremor , dizziness ,
49 x
are transitory and
mg
, growth hormone
)
risk should be
injections .
glycine
recommendations ,
dehydro-aripiprazole ,
see
patient
treated
potent inhibitors
indicated
ml equivalent to 1000
of dosage may
If
not be used
to
of
none
starting dose for ABILIFY
or
epoetin alfa
a
to tablets
The syringes
with
or
.
Der Anteil der
47
adult subjects , nor
section 4.4 )
in
ml contains 100
( also called serotonin
sulphonylureas or insulin
and symptoms reported
orthopaedic surgery
g/ dl :
Patients
5.330
1
1 tablets 49
well
, are not
and
.
few
In three
undergoing dialysis :
or
.
fast-acting ,
is 15 mg
76
, diarrhoea ,
medicinal product
be paid to sudden
House Highbridge
following
creatinine and
Special warnings and
in haemoglobin (
human ,
various
( two studies
,
as
or hepatic impairment
, macrogol 3000
0.5 ml (
34
P1NP
the
motor neuropathy ,
,
long time
Usual warning symptoms may
of epoetin alfa
household waste
your doctor
in
conducted in 375 anaemic
15.7 % for
for disposal and
section 5.1 ) .
Non-clinical data reveal no
warning symptoms of hypoglycaemia
% dissolved
Carton of
.
)
, diabetes
been carried out .
consists of 40
SQUIBB NORWAY
tablets
with quinidine
) .
per dose ,
alfa is given concomitantly
injections in
moderate and go away
chemotherapy
your doctor or
other
Interaction with receptors other
have the following causes
and you will
( 6 %
THAT THE
dose
) to
:
and approximately 60 %
6.1
nausea
by
obesity ) and
7.5 kg over 2
,
Belgique/ België/ Belgien
clinical studies
2°C - 8°C )
schizophrenia
placebo-controlled
,
anaemic rats ,
section 4.2 )
from
international units (
6 %
,
REGARD TO THE SAFE
metformin and/ or
in patients over
doctor
mellitus ( see section
In
the gastrointestinal
.
in
6 % )
injection :
45 % )
(
.
10
Water for
or other CNS
France BRISTOL-MYERS
drive and
between
mmol/ l )
reports of
are currently
of the pancreas
angioedema and anaphylactic reaction
:
AB Puh/ Tel
dose
from
recombinant DNA technology
If convenient
increased risk
731 1736
with
,
all instructions given to
greater sensitivity
is given concomitantly
with aripiprazole
after
local requirements .
or
( see
1
or
12 g/ dl
In patients
dose
.
in adult and paediatric
a
1
, intestinal calcium
be followed
of
therefore
In order
see section 4.5 )
but not
g/ dl
especially
hip fracture
BRISTOL-MYERS SQUIBB BELGIUM
and
important signs and
If
+ 40 ( 0)21
, vomiting , constipation
,
of the hormone .
following undesirable effects occurred
Cancer Therapy- Anaemia
of agitation and
products
24
ULN or ASL/
subcutaneous use
contraeptives , thiazides
for at least 2
)
trials
contains 15 mg of
the
-
.
Simultaneous administration of
or
mmol/ l )
solution
pre-filled syringes are
also
Scientific Discussion (
mean age
been observed .
be followed .
mixed episode
face oedema
of anaemia
Sími : +
g/ dl ( 6.2
during the course
bone marrow
of the six identified
or pharmacist .
intentional
limited experience
or
Specific
between 1.25
week by the intravenous
.
pre-filled syringe of
Always take
receive appropriate training for
and 11 g/ dl
:
4000 international units (
physical
n oder
hypoglycaemia
,
Oxford Road Uxbridge -
studies ,
in
over
Iron status
anaemia
800
Abraxane
the
( iron deficiency
by
0)810
monkeys
pioglitazone
,
14 tablets 28
hypoglycaemia
or other CNS
sodium hydroxide ,
is given concomitantly
Elevations of
Hunton House Highbridge
4.2 Posology
SQUIBB BELGIUM
( see
where
16 to 23
Conjunctivitis ,
, teardrop- shaped tablets
& D
or
40 ( 0)21 272
extensive extravascular distribution
and
repeated
international units
of aripiprazole
some
or without
,
rDNA
.
hepatic impairment
aripiprazole Intramuscular
deep vein
standard genotoxicity tests
Development Centre
completed suicide
vomiting ,
.
If you
facilitate the re-suspension
to reduce
.
%
paclitaxel
see section 4.8 )
the geometric means
of distribution in humans
other ingredients
dose
mg
)
,
below 30°C
Hb
period .
with chronic
.
Read all of
5 mg
50
ml 400
influence
,
old
g/ dl
before
Haemoglobin levels
overall survival between
lead to an increase
daily dose should
medicinal products
ACE ) inhibitors
doctor will
and
lithium
alcohol or
Oxford Road Uxbridge
advanced solid
to drive and
) AB
(
pancreas
dose should
Cmax corrected
)
special warnings and
- Oedema Oedema may
18 years of age
oral
The
with solid
section
Erythropoietins are
14 x 1 ,
, there was
mean
pioglitazone
for
as monotherapy or
patients
Due to
and
trials of aripiprazole in
mother
requests the inclusion ,
in section 4.2 .
patient population and
and
( IU )
indicate that
Patienten mit einer
)
anaemia associated with chronic
Like all
Allow the refrigerated
of ABILIFY
effects of aripiprazole
) .
Cardiac
, dizziness
.
Treatment of patients
(
47
polycythaemic mice )
2.5 % ) of
and
Kingdom Takeda UK
µ : +44 (
)
50 , 56
Centre ( Europe )
e. g. ,
in two studies was
4.4
significant
,
in
by the intravenous
or
significant effects were
treatment during the assessment
,
:
with
a sterile syringe
well-controlled
In clinical trials
, diabetic ketoacidosis ,
Patients with renal impairment
The
49
different time zones
you
vial of 100 mg
aripiprazole
rather than
aripiprazole
1 ml
that the
with diabetes
and hyperglycaemia ,
difference in
be
over 30 minutes
Non-specific skin
Takeda
Within each
is based only
or without psychotic
specifically
tablet contains
of 0.9 ml contains
Aripiprazole should be
4.5 Interaction
rapid
or of no
Co- administration
, may
(
, vomiting ,
Mellitus : hyperglycaemia
.
( see section 4.4
This
not exceed 200
of death and
of 1 ml
Uxbridge
ATC code :
patients
after the same
300
cell production
) 20
pharmacokinetics of
or
(
isophane insulin .
, 56 , 84
six identified metabolites are
.
General disorders and administration
Treatment of adult
30 kg require higher
Actraphane .
±
increased
.
tablets
Abseamed
The dosage
-
73 % ) .
However , elevated creatine
sulphonamides .
. emea .
a clinical trial
be adjusted
with
) .
)
be a moderate
not
section 5.3 ) .
patients
infusion was approximately
contains 200
However , as with
Introducing appropriate
857 42 22
should
particularly
please contact
Medice
use
route
61 33 22 11
the
of anhydrous
BRISTOL-MYERS
with osteoporosis
, monoamine oxidase inhibitors
Important information about some
) .
your doctor or
Alcohol
symptoms
portion of
treated with antidepressants ,
dopamine D4
with renal impairment :
? er
should
AND SIGHT OF CHILDREN
7.5 mmol/ l )
should
reported estimated
Tel :
-
patients
solid
has
tactile hyperesthesia were
blood vessels
see section
local requirements .
(
Novo
of insulin
erythropoiesis-stimulating
months
g/ dl (
.
,
+44
women
in man
Lilly Holdings Limited Eesti
25
potentially medically serious
a dose of
blood pressure or
WITH METFORMIN Blood
the
be increased .
also
2.5 % (
combined with
recommended (
injection
and
with
The medicine can
The pharmacokinetic characteristics of
or
50 IU/ kg
are mannitol
:
4 hours in
your doctor or
and
clinical
with
.
prospective ,
3.2
on bone
of
cancer
GmbH & Co KG
.
of
cancer patients .
is
) corresponding to
2°C -
patients
hypoglycaemia
Owing to the
Abseamed in patients at
1736
prospective
150 60 -
reduction of manic
)
pre-filled syringe of
shortened
per
:
( for pH-adjustment
pregnancy and lactation
Therefore ,
last
After
It
a pre-filled syringe
flavour ( including
first three days after
in osteoporosis ,
and/ or
in patients ( particularly
and
a comprehensive
during the course
gemfibrozil
you
Do not
be reduced
.
+
.
ABILIFY
pioglitazone
and mammalian cell
per
OUT OF
, Aclasta was
cytochrome P450
angina pectoris ,
Use
CYP3A4 ,
see 6.1
Uncommon
occurring within the first
diarrhoea .
- United Kingdom
- 39 %
one side .
.
are pregnant
pharmacist
thiazides , glucocorticoids ,
the
7.5 mmol/ l )
see section
is
People
Treatment of adult
Cmax
you
patients with
with encephalopathy-like symptoms can
in increments
67
doctor or pharmacist
metabolism of paclitaxel is
subcutaneous use
drive
alfa
maximum
Pioglitazone and all
risk of death and
: +44 ( 0)20
insulin
ml
and
added to metformin
.
Arzneimittel Pütter
pioglitazone
CYP3A4
patients with
3 weeks
the HORIZON
times per week
swelling of hands ,
7.5
pregnant women
and inter-individual variation .
with
a glass ball to
itching
.
and danazol
Kuhloweg 37 ,
overall survival and increased
speech disorder , Neuroleptic
is always
weight decreased ,
BRISTOL-MYERS SQUIBB
residual
mmol/ l ) .
improvement from baseline
myoglobinuria
Protamine sulphate Water for
to
.
: +371
and 50
n =
greater than
.
The following
D
QT prolongation or
and
IU/ kg 3 times
The reconstituted suspension
contains 5000 international
safety .
Kuhloweg 37
(
)
30mg tablets can be
Limited Wimblehurst
than children
injection
1 month
mellitus ( see section
you
Allé DK-2880 Bagsværd Denmark
patients with
CYP3A4 ,
OF UNUSED MEDICINAL
( haematocrit
findings from
g/ dl
see
and 60 %
same time
shown reproduction toxicity (
and
800
5
: orthostatic hypotension*
maintain haemoglobin
versus 8.7
of epoetin alfa
The four
working ,
or
The full
NMS
is not
ml
more
of patients
dose
the
Abseamed 6000 IU/ 0.6
: soluble
be
patients with
mellitus
and
.
with epoetin alfa
62
or
and
a
pharmacokinetics of
is
( IU ) per
Europe )
contraeptives ,
ABILIFY
the use
.
of this
or tense .
week
Insulin
a pre-filled syringe
and
and
with
within
Paget s disease
The decision to administer
with metformin
or
a
clinical
2 weeks
is
trials of aripiprazole
higher
the patients
patients with severe
,
and
for pH-adjustment )
between
, or
soluble insulin 20
Tel :
x 1 tablets
blisters .
side effects (
and
pneumonia
EU/ 1/ 06/ 344/
e. g. stroke
inter-individual
Name and address
or
anaemia
and controls .
( below 30°C )
The reconstituted
by
you or
and
, mucosal
international
ml
low-density polyethylene dropper
( see section 4.5
hypoglycaemia whilst driving .
of
or if the
adults
insulin
pioglitazone in all
and
and
diminished parathyroid reserve
Treatment with a
( ALT )
see section 4.8
high risk
+ 33 ( 0)1
Eli Lilly
Arzneimittel Pütter
,
Elevations of CPK
seriousness
more
and transport refrigerated
, a
%
ml
during
very
.
12 g/ dl (
epoetin
pregnant or
valproate or lithium
AST ) , increased
week
+ 44 (
dose
of aripiprazole and
ABILIFY
or the
disorder
.
solution .
The recommended
after repeated
first
only
clinical
episodes
and
doctor immediately
insulin resistance .
PRODUCTS , IF
mg
Bipolar I Disorder
Subcutaneous injection
)
site conditions Uncommon :
) to pioglitazone
,
(
symptomatic
of excipients , see
metabolism
vomiting ,
please tell
a colourless
reported estimated
In several controlled
stroke or
hypoglycaemia may
the entire
cartridge
,
, especially
% of
infusion
of
medically
aripiprazole
and water for injections
, 84
mainly via the
,
no relevant effect on
also
with quinidine
House Highbridge Business Park
)
see
with
have been proposed ;
Linear Analogue Scale
Medice
of symptomatic
12
tablet at the
57
) , increased Gamma
the
aripiprazole
to
%
300 gastro-intestinal
:
gliclazide
no
12
.
and
A specific overdose of
in
.
of
should be
: store
-
; suicide attempt
administration of epoetin
severe
.
insulin
.
children and
of daily
given area may
and
.
been treated
:
)
placebo
in
18 years of age
) and
, feeling anxious ,
of 10
three
:
mmol/ l ) in
somnolence , tremor ,
erythropoietin
The injections are given
.
( 7.5 mmol/ l
hormone erythropoietin
.
large
:
mg
, followed by
t½ )
which were
or
and
and
one of these trials
See section 4.4 )
continuing surveillance
The four carbohydrate chains
and
pharmacokinetics of aripiprazole
g/ dl (
with
( normal
usual
per week
When concomitant
difficulty
or
undergo periodic
the dose should
for
Following dosing for a
diabetic hyperosmolar
Takeda Italia Farmaceutici
) , as
: in clinical
dosage
- decreased locoregional control
Tel : +
based
to
- 50 ml
there is
) .
and
Research and
on
, concentrations
3.5 %
, 23
designed to be
evidence of clinically significant
recommended starting dose is
tell
cerebrovascular adverse
use machines
a potent inhibitor
the Montgomery-Asberg
Concomitant administration of
maximum daily dose should
.
Kuhloweg 37 D-58638
two
weight
on
1 g/ dl
patients with a manic
.
4.5
Unit ) corresponds to
181 Tell the
a
than 2 g/ dl
prophylaxis by
The mean
of CYP3A4 ( ketoconazole
Refraction disorders
.
)
cancer patients receiving chemotherapy
Effect on morphometric
The recommended
% CI ] (
7.5 mmol/ l
marked with
such patients .
section 4.8 ) .
.
People
risk for thromboembolic events
and
the intravenous route
akathisia was 6.2
PACKAGE LEAFLET Yarvitan 5
chronic renal failure patients
the
out of
this
been
patients
GmbH & Co
two
0)20 3116 8000
use
half-life
equivalent to
aripiprazole ,
of pioglitazone (
to
in
Irregular
analogues for
West Sussex
Tel : + 34
reduction
Each
Immune system disorders Uncommon
patients
.
.
Cmax of dehydro-aripiprazole
PRODUCTS
recent (
4.5 Interaction with
the indication increasing
, the incidence
an
the
itching ,
( see section
about hurting yourself
should be
THAT THE MEDICINAL PRODUCT
section 4.4 )
your doctor immediately
15 mg has
and
in
9.5 22.5 8.1 41.7
Novartis Europharm
(
a
FACT-An
+ 31 34
clinical
.
prior to
Overdose
( AST )
In several
mmol/ l
mg once a
,
correct dose
%
manic or mixed episode
in these circumstances
of increase in haemoglobin
Erythropoietin
e. g.
SQUIBB
treatment
, vomiting ,
see section
is achieved
.
22
should consider clinical monitoring
be
haemoglobin target range of
mitratapide
address
0)21
aripiprazole
1.0
chronic renal failure ,
clinical fractures
with epoetin alfa
contains 9000 international
% with aripiprazole
valproate or lithium
patients
for four
disease is
.
in these
AND SIGHT OF
epoetin alfa
Abseamed has no
150 60 -
OUT OF
Neuroleptic Malignant Syndrome (
( e. g. stenoses
%
(
aripiprazole and dehydro-aripiprazole
dizziness , somnolence
anaemia
or Hb increase 1
Tel
and
All special warnings
)
angioedema and
,
, nervousness
,
section 4.2
stabbing
alkaline phosphatase
other
section 4.4
This medicinal product contains
( see section 5.1
1
aripiprazole
:
Very rare
respectively
aripiprazole
0.8 ml
The studies
vanillin and ethyl
elderly
or
in
the
changes in bacterial
aripiprazole
or
Kuhloweg 37
( 5 )
lower the blood pressure
and
these trials
section 4.8
of dietary lipids
decreased
patients
,
to protect from light
Abseamed has
% dissolved
aspirin
6.2 months
5 mg
two large
has no influence
" A-008 " and
was
Almost all subjects
patients with residual
and
.
:
with pioglitazone
( 30 % )
should
per month
Highbridge
epoetin
The terminal
of
both decrease and increase
if
been observed .
FACT-An )
receiving non-platinum chemotherapy
( see section 4.2
In patients with
the warning
(
dysmotility and
free from particles
section 4.8 ) .
or
mg tablets
of
.
(
Special precautions
Actos 45mg
General disorders and administration
stiffness
Authorisation
The safety
should be
inhibitors of CYP3A4
any remaining contents .
The usual dose
8000
in paediatric and
is
may
.
(
acute renal failure .
be used
patients
2°C -
Abseamed is presented
, uncommon cases of
necessary amount
D-90429
combination
different time zones
,
and
did
H1 receptors .
dehydro-aripiprazole ,
need to
an anthracycline
medicine
and/ or
the incidence
other
Centre ( Europe )
e.
measured but a
is achieved ( this
the
aripiprazole
use
150
with
and
1
Novartis Pharma
.
generally
ml
medicine can only be
) or the
catalysed by CYP3A4
oedema .
see section 5.1 )
Global R &
+ 32 2
( 6.2 mmol/ l
EPS including parkinsonism ,
Not all pack
mmol/ l
One
adult dogs .
trial
from 2653 to 16736
the pharmacokinetics of
Co KG , Kuhloweg
( see section
blood loss and haemolysis
cardiotoxicity unequivocally
enzymes
causes of deaths were
body weight
of 0.3 ml 6
use machines
Hypertensive crisis
reported
weight decreased , anorexia
has
.
Like all medicines
be used
nausea , vomiting
patients
and
light-headedness , trouble sleeping
:
some
, 84
or
or
The potentially medically
dose .
Eye disorders Common
treatment
mmol/ l
, poor
should
alfa
kidney have
recommended in these patients
sites of metastases
Not all pack
cases of
, vomiting ,
( 30
.
with a
and
, constipation ,
IU
6.2
after the
% and
The
three
stroke or
such veterinary medicinal products
Takeda Ireland
these patients
placebo
treatment in between
, headache Eye disorders
contents of the
, hyponatremia
%
injections
vomiting and diarrhoea .
see
40,000 dalton
fast-acting
the dose
,
for ABILIFY is 15
) is
of pioglitazone
-
no
,
with metformin and /
clearance is therefore
only in
either valproate or lithium
should
based on
reactions
levels of the
) als
other antipsychotics
decreased
use
or
of
increased fatty deposition and
.
is
speech disorder , Neuroleptic
The following side effects
) .
mmol/ l
(
alfa
the faeces .
should be given
The recommended
units (
the insulin requirement (
)
a
significant weight gain
4.2
or
hr/
and
)
.
women .
rimonabant
(
This medicinal
(
Based on in
may
NovoFine needles
compared with those
overall survival
headache in the
.
)
forms of
symptoms
, monoamine oxidase inhibitors
patients with haematological malignancies
patient population and
.
.
SPECIAL WARNING
Europharm Limited Wimblehurst Road
intravenous route
metabolites
revealed no medically
aripiprazole
and 42 %
, intermediate-acting
( see
section 4.5 ) .
of epoetin
with baseline
to protect from moisture
as
pioglitazone and
.
)
administration of
anaemia with epoetin
ml 210
+
ischaemic
minutes
packed cell volume
7
section
AB Tel :
60
within
B-CTx
Tel : + 40
pain
and
ALT
524 40
4.8 -
be
( t½ )
of cleavage
akathisia was 6.2
insulin syringes with
called serotonin )
(
In
CYP2D6 (
with
included only 3
creatinine and
CYP2D6
Centre (
study
was
does not matter
renal impairment
solution contains 10 000
- United
8950
WC2B 4AE
cardiac failure ,
is
anaemia and
tablets
patients
influence on the
seriousness
Actos tablets contain
haematological malignancies
to
be assured :
Studien
mg )
mmol/ l ) to
and a negative impact
, there were
ACOMPLIA is
Horsham
interaction
is
(
Actraphane
fatal
6 %
should
Some
five large
, vomiting
when a
haloperidol
permeability
ABILIFY
in
Neuroleptic
mg has not
or
symptomatic
exhibited
Vascular
14 g/ dl (
this
see
.
routine volume replacement should
)
insulin resistance
)
be administered intravenously
been reported while taking
( MAOI )
% )
two
United
This leaflet
There have been
The
trials
contains
, these patients
47 67 55 53
a
x 1 , 98
.
section 4.4 -
symptoms
see
one
g/ dl (
studies
long-term use of
PARTICULARS TO APPEAR
mmol/ l ) per
87
and/ or
to
therapeutic margin of epoetin
, hypoalbuminaemia
, especially
to
If
A
,
.
6.2 -
g/ dl ( 0.62
to be treated
insulin
358 9 251 21
Centre (
used
extrapyramidal disorder , akathisia
5.9
.
diabetic
mg
, headache
the human insulin molecule
increased risk
)
in patients
( 0.5
Takeda
and
retinopathy .
or
and
the
of anaemia
glucose fluctuation ,
omeprazole
.
alfa
reproductive toxicity studies .
some of the other
) .
per
in patients with a
3000
of greater than
of the
and
Cancer
alfa
are transitory
These
tablets 98
Common
and water for
efficacy of epoetin alfa
.
take more
gliclazide .
nausea , vomiting and
alfa
of
been reported
effect
When either valproate or
with epoetin
and
section 5.3
crisis with encephalopathy-like symptoms
site conditions Uncommon -
and
(
puberty or due to
the
the most
orodispersible tablet
to pioglitazone
concomitant
intensify and prolong the
The maximum
22
to sudden
AB Puh/ Tel
g/ dl
3.5 % of
greater than
see section
see section 5.1 )
and
THAT THE MEDICINAL PRODUCT
.
% and consists of
pancreatitis ,
aripiprazole
l )
of glucose
In
shock-like
or
g/ dl (
, infection or
rare
after
( 221 multiple
(
antipsychotic
IU
D Centre ( Europe
very
(
in healthy subjects ,
addition
for 3
.
this
Takeda Global
14 and
after
of symptomatic
.
taking ABILIFY
and
Aluminium perforated
the number of patients
%
prior to
the serotonin reuptake site
The rate of
and therefore
the levels
3
marked
incidence (
measure
t½ ) is
or
Grade 1 or
of
to store ABILIFY 6.
)
machines , until
patients was 12.1 %
patients
ml (
39.0
2
) of
or lithium
hyperosmolar coma or
per
provided
in patients
7.5 kg over 2
(
3116
significant
inter-individual variation .
If ALT levels
Therabel Lucien Pharma
treated
aripiprazole
see
be discontinued immediately
Therapy- Anaemia (
and hypoaesthesia ( decreased
surgery and
if
Hypersensitivity to
epoetin alfa
The
encephalopathy-like
glucose
thromboembolic
2/
should be
per
result of hypoglycaemia
psychotic
or
2 352 74
14
;
3x/ week
.
and
mg
Abseamed 10
Non-clinical data reveal no
pioglitazone
aripiprazole
controlled studies
- 8°C
an antipsychotic medicine
consists of 165
use
.
when treating your diabetes
Tlf :
features and with or
to co- morbidities
( 1.25 mmol/ l
the entire
with
.
( see section
or
not
.
, tachycardia ,
CYP3A4 ( ketoconazole )
mean
than
patients
) , and
most
or
trials , uncommon
.
3 times per
of
Aclasta
>
, and
alpha-1
nausea , vomiting
.
per 100
of the hormone
.
was
of one year
compared
In schizophrenia
,
rhabdomyolysis
week by
In CYP2D6
( mean age :
This is given
orodispersible tablet is bioequivalent
from the
ABILIFY
between
2C9 ( warfarin
32 %
a few days to
NovoLet
44 (
Upon discontinuation of the
, Germany
.
international units ( IU
flatness .
,
Upon discontinuation
Mellitus : hyperglycaemia
,
( NPH ) insulin
given
fat
advised
mg pioglitazone (
3 ml
SQUIBB AB Tel :
4.8 )
.
Forest Gate
been observed
are
per ml 1.8
( NYHA stages I
cancer patients
and
for haloperidol
your doctor
the dose should
Common : blurred vision
The
pharmacokinetics of aripiprazole
with a cartridge (
SQUIBB
patients with
2°C
: the
( also part of
-
and
isolated cases of
durch
than
epoetin alfa
a
4.4 )
.
was comparable
with
retinopathy
mg aspartame
section
revealed
( mean difference to
is very
, Kuhloweg 37
than 2
Kingdom BRISTOL-MYERS SQUIBB
10
.
large
in exposures
with
,
is
At
half-life
1 bottle contains
ml contains 5000 international
section
45 mg (
Be sure to tell
should be
.
Norge AS Tlf :
LTD Tel : +
%
to sudden stabbing migraine-like
farmacevtska dru
and should
CYP2D6
to
(
associated with antipsychotic
14 and 7
In
300
Dose adjustment
not specifically investigated .
the
.
or CYP2D6 inhibitor
The
controlled
be disposed
syndrome .
on the pharmacokinetics
.
.
see
(
electrolytes
,
with chronic
.
completed suicide (
with your
patients
Subcutaneous injection
margin of epoetin
cardiovascular
akathisia was 6.2 %
in rating scales
generalised hypersensitivity
be
combination
x 3 ml .
not
Takeda Global
growth hormone and danazol
to 6 weeks )
45 mg tablets
machines
and
them .
are
terminal
, pulmonary
TO APPEAR
the month before your
section 4.8
contains The active
speech disorder
1
be advised accordingly .
doctor
patients scheduled
and
your doctor or
taking
H1 receptors
and
treatment with aripiprazole .
fatal
VISTOR HF Sími :
clinical studies ,
38 When either
( AST )
of 12 g/ dl
placebo ,
no clinically
(
isophane (
pre-filled syringe
route .
human
aripiprazole ,
alfa
pharmacist
( 29 [ 2.7
were 2 5 %
or higher dose
.
in urine ,
)
In patients with
Ltd 61 Aldwych
trials
or
administration
and CYP3A4
and sulphonamides .
-
Correction for
.
a dose adjustment
clinical trial of
.
rash
If
0)20 3116 8951
absolute
- 8°C ) .
observed ( see sections
+
by
patients with severe
:
,
,
.
, somnolence ,
,
100 ml of solution
Uxbridge
, 14 and 7
Before stopping
patients with residual
isophane insulin
been established .
an increased risk
to tell
effects
,
.
MINIMUM PARTICULARS
but
to 12
either sex .
if
Peripheral neuropathy
Aripiprazole orodispersible tablets
When
the administration of
brain function
uptake
epoetin
two
epoetin
the perisurgical setting
in a refrigerator (
once a day .
Tel : +
-2.9
section 4.4 )
of
a sulphonylurea ,
blood pressure
epoetin
half-life (
blood cell production
- hypersensitivity
order to protect from
(
should
90 days ) low-
In a clinical
The
of adult patients
for use in
Nederland
should be given
g/ dl
, 90 and
cancer patients .
be
reconstituted
In
3 times per week
fast-acting
see
and
" high "
mmol/ l
(
mouse spleen cell
, this
the
the present state
Zinc
Bei
mmol/ l )
20
use machines
and
no clinically significant
, especially in
A
) .
mother presents no
23 05 20
type or brand of
terminal half-life
chronic renal failure
insulin and isophane (
Tel
not
and
anaemia
in attention
mixed episode of
forms of interaction
.
R &
and take
in the placebo group
of
The following
stroke or
When the
IU/ kg
1 and 5
44 ( 0)1628 537
rate of
see section
cancer patients receiving chemotherapy
drive
(
significant
.
see section
oral
a
in women with
and/ or a sulphonylurea
catalysed by CYP3A4
4.8 ) .
however
800
Europe )
ketoacidosis
subcutaneous
( see
diabetes
generally mild to
in vitro solubility .
.
has complications .
urine
maintain haemoglobin concentration
, 14
Summary
,
with
features
in patients (
of
or irregular heart beat
PHARMACEUTICALS
in strength ,
anaemia
Annex
( 4
the
improvement
.
achieved
the
thrombotic
ml (
food .
whose
)
)
( 6.2 -
( see section
intentional
the plasma concentration of
+44 (
1
solution
trials
alfa is
increased incidence of
only 3 patients
animal model of familial
bisphosphonate-naïve
, serum levels of
)
tell
Abraxane
animal studies with pioglitazone
178 Danmark
the local representative
g/ dl
per
However , elevated creatine
1
patients with
needle top .
A single-dose study in
(
daily dose of
Driving and
minutes
days 21 ,
45mg tablets can be
132 )
Leaflet .
United
House Highbridge Business Park
15
The
, pain in the
APPEAR ON
doctor or pharmacist
or Hb increase
.
a
, in patients with
50
be used
2C19 (
against the
( see sections 4.8
by
avoided
8.1 mmol/ l
( affecting less
increased
variation .
to
be followed
9.75 mg ( 1.3
between
OUT OF
Takeda
patients
Abraxane
cell volume
are pregnant ,
vascular
increased
65 years
is especially
Eli
you
05 06
2C19 ( omeprazole )
Uxbridge -
11 g/ dl (
rats
( e. g. stenoses
and 4.9
.
.
.
and
including those
or of
is always
cases of
Treatment of patients
.
incidence of EPS was
- United Kingdom
enzymes and
consistently apparent
cell production
AUC and Cmax of
4AE , United Kingdom
symptomatic anaemia
25 and 50
the sustained haemoglobin exceeds
aripiprazole ) once a
excluded in the studies
doctor or
the tablet
%
The
, vomiting and
start
white to off-white
insomnia
should
37 , D-58638
Tel
colourless and
with
following
No other erythropoietic therapy
is
or mixed episode of
risk of cross-reaction
of the nursing
not be used
arrhythmias , sudden unexplained
and
in the treatment of
( 34 [
Meta-analysis of overall
with your
vision
episode in patients
between 10 and
dose of ABILIFY
( 3 ml )
section
treated with Aclasta
contains metacresol , which
week
sections 4.3
at increased risk
a maximum volume of
, 56 ,
, reports of
other
.
and
) .
metabolites are active
Be sure to tell
ml contains 7000 international
Holdings Limited Eesti filiaal
and
After injection
100 ml ready-to-infuse solution
4AE
is
human .
Insulin treatment
a negative impact
, compared
of
AST ) ,
with aripiprazole
)
Your
, the incidence of
three
Each bottle with
potent
as
.
must be discontinued .
and approximately
) of
epoetin alfa
significant
.
and
from
After
)
of CYP3A4 (
No
R & D
doctor
must not be
of the
while taking aripiprazole
22 prostate
(
your doctor or
in
The
21
In
7.5 mmol/
that rimonabant is
: + 32 2
or the
with
,
study duration :
see section
30
is a
if you
, an
LTD Tel : +
or even death .
3 times per week
Syringes
Uncommon - Peripheral
with
a
to
is very wide .
your condition
% with placebo
,
, adequate
If patients
veterinary medicinal product
a multipack with
week by the intravenous
) 524
or
for
syncope
and
should be restricted
, 23 lung
clinically
:
fever
ABILIFY is
:
, creatinine
insulin requirement
( e. g. hypothermia
subjects ,
Adult cancer
should
Treatment of adult
considered
.
vitamin
:
in vitro solubility
in
County
Takeda Global R
all
of efficacy or
see section 4.4
a mixture
3 times per
a problem with
-
the
in
may benefit from
cartridge .
Vascular
In clinical
patients
.
trial
epoetin
maintain haemoglobin values
and
BRISTOL-MYERS SQUIBB ( FINLAND
pioglitazone with
dosage or
patients ,
OR
and
(
in the thighs
AB Tel : +
chemotherapy induced anaemia
Treatment of patients
.
Centre ( Europe )
if
with
Adult
from
pre-filled syringe
for ABILIFY
or unplanned ,
diabetes
, a
, Neuroleptic
low-trauma
g. insulin dosage
.
, the
Pharma
or too near
in order
Centre ( Europe )
If you have
are
until
( 2°C -
a manic or
and precautions
However , in
anterior abdominal wall .
your dose
If
monitoring of
.
% isophane insulin
manic symptoms
medicinal products .
and anaemic rats
three weeks
, or if
are
.
in strength
ABILIFY
Abseamed
is 32,000 to 40,000
allergic reaction (
medicinal products .
jaundice , hepatitis ,
from a
( anhydrous ) .
-
aripiprazole
of 12 - 14
by 32 %
less than 1
should
insulin products with fast
( AST )
units ( IU
4.4
,
ml
the entire
with pioglitazone
,
Latvija Eli
Rimonabant ist ein
in four
the
clinical trials with aripiprazole
Treatment
12 -
.
or of
Before use
monkeys
or intentional
epoetin
with
The
Effect
7.5 mmol/ l
with
included
the
tumour proliferators .
.
transient loss of consciousness
tablets
47 67 55
during pregnancy
of anaemia and
Middlesex
+ 44 ( 0800
in
contains 5000 international
is not appropriate
adverse
and
Luxembourg/ Luxemburg BRISTOL-MYERS
Moreover , in patients
: +
)
1 or
dose
- If you
5.1
Renal or
dosage
daily insulin requirement
Oral contraeptives
to
rare (
+47 23 05
for Vantas
9 weeks )
abdominal wall .
compared
(
patients with
Most reactions
172 Danmark BRISTOL-MYERS
In addition , cases
of Actos 30mg
be a moderate
.
when
infusion
g/ dl
and Bipolar I Disorder
,
11 g/ dl (
Glycine
leaflet
see section
t½ ) is therefore
sealed
People with this condition
or
should be avoided .
of
one single-use
aripiprazole
2 352 74
doctor
subjects
in a
recommended starting dose
of aripiprazole
see sections 4.4
Research and
dose of 600
serotonin 5HT2c and 5HT7
by
anxious or
or
.
type
events have been
on mg/ m2 )
Only
,
tablets .
This represents a
dose of
below 100
Some patients may
especially
, including
A
0.99
Tel : + 43
aripiprazole
)
treatment
, restlessness ,
is
,
,
to
occurs
,
used
type
of 45
patients
5.1
starting before the
pre-filled syringe
patients
or
, 2C9 ( warfarin
4.5 ) .
.
or stored at
administration of
and
or diuretics that
by
epoetin alfa
2°C
e. g. stroke
antipsychotics ,
for
In
10
per se
osteoporosis
H1 receptors .
needle should be
maintenance doses
, recovered label
and
.
Store
"
indicated
for pH-adjustment
below the
N-dealkylation .
.
been carried out .
blisters
sleepiness , shaking and
mmol/ l
)
extrapyramidal
whether
.
to target a haemoglobin
Der
you or
trials ,
the incidence of
not
and doses above
Dose adjustment in order
alfa
duration of
the active substance
.
and
is
affinity for muscarinic receptors
AND
+ 32 2 352
.
6
the reach and sight
solid tumours
and approximately
with
( e. g. increased
If epoetin
four weeks .
or
in combination with insulin
Adult surgery patients in
haemoglobin target range
, 50
(
receiving chemotherapy ,
5.1
PARTICULARS TO
that pioglitazone
pre-filled syringe of 0.6
patients
schizophrenia and
,
clinically
elimination
if
:
if
to reproduction
535 7000
body weight 2 times
Your doctor
)
into 2 equal injections
diabetes
treated
.
manic
:
other erythropoiesis-stimulating agents (
ABILIFY orodispersible tablets contain
are
rare cases
( Europe )
lowest effective
+46 8 732
epoetin alfa
aspiration have been
e. g. during
House Highbridge Business Park
cancer patients
symptoms
to patients with moderate
in
skin fold minimises
carefully weighted
30 months
the
0.63 mg mitratapide/
Seizure : in
the
.
or peripheral
the treatment of
aripiprazole
1.1
ABILIFY 15 mg
for smokers
Unit ) corresponds to
,
are
Aripiprazole was
recommended
blisters
these
levels
, nausea , vomiting
and Bipolar I Disorder
1
patients
and completed suicide (
type 2 diabetes
in paediatric
and 300 IU per
and sight
, weight decreased ,
kg and adults
IU ( International
2.5 % ; 0.5
KG ,
)
one month
back
Treatment of
( 0)20
active
risk for
( 0 ) 241
, sodium chloride ,
H1 receptors
clinical
- Middlesex UB8 1HU
section 4.5 ) .
(
highest nontumorigenic exposure in
the mouth is
74-week extension
Tlf
BV
The maximum daily dose
influence
recent low-trauma
days
and heart disease or
children under
molecule contributes about 58
than
had sections of your
be
less than 15
Sverige BRISTOL-MYERS SQUIBB AB
migraine-like
variation .
% )
If
tell your
see section 4.8
in a pre-filled syringe
your doctor or
are
and diabetes mellitus
greater than 2
that
of epoetin alfa
Particular
of excipients ,
lapp lactase deficiency or
for
catalysed by CYP3A4 .
6.2 -
3A4
with
for rimonabant
Patients with
, ketoacidosis
.
OF THE MEDICINAL
patients
fast-acting
4.8
a cartridge .
haemolysis , and
be disposed
,
blood pressure
adults
more
Oral contraeptives ,
Sími :
, rigors , oedema
)
use
about hurting yourself .
22 prostate
There is no accumulation
treated
of thrombotic
placebo
In the
with or
Common
0)21 272 16 00
, the dosage of
stomach discomfort , diarrhoea
dehydrogenation , hydroxylation ,
reach
/ N. V.
The
in patients
SMALL IMMEDIATE PACKAGING UNITS
( 2°C -
transient loss
Actos 30mg
of a
deep vein thrombosis ,
be disposed
much ABILIFY
site conditions Uncommon -
Lilly
increased
maximum
was
(
genotoxicity tests ,
overlapping undesirable effects
and
sulphonylureas or insulin
of deterioration of
without treatment
The other ingredients
MATERIALS
overdose with aripiprazole ,
g/ dl (
.
in vivo
reflected differences in
for dehydro-aripiprazole
In clinical
the dosage of
NAME OF THE MEDICINAL
Syringes
mg once a
month or the
( see
.
A specific overdose of
(
agitation/ behavioural
of
completed suicide (
In patients
Omission of a meal
with
of children .
or
see
pharmacist for advice
450 IU/ kg
) 74 18 84
Paclitaxel at
of greater than
trials of
haemoglobin values exceeding
After
,
well-controlled trials
.
patients
Abseamed
rats , dogs ,
and
:
or
been reported
showed
warnings
is necessary
Park ,
more information about
,
SQUIBB
1 cartridge contains 3
AUC
In clinical trials of
and
prescribers should be alert
eská republika
Actraphane Penfill is
nervousness
If
, vomiting , an
or
alfa
osteonecrosis of
with alcohol
.
1.25
,
gastro-intestinal
(
, hyponatremia
Tlf :
thromboembolic events
greater
in
ketoacidosis ,
not
diabetes mellitus
Lietuva Eli Lilly
)
another
IT
In
solution
.
the gluteal region or
trials
.
specific frequency can
adult
the
( 0)20
Special precautions
elective orthopaedic surgery
in whom
(
if
pharmacokinetic characteristics of
factor
,
cartridge (
angioedema
One IU
mmol/ l ) .
Industrial
is not recommended .
that
Finland OY BRISTOL-MYERS SQUIBB
the
not been established .
fibrosis of any origin
no significant
obesity
PHARMACEUTICALS
and
of
is controlled
transient and asymptomatic
,
month
polydipsia , hyperglycaemia
medicinal product
levels
49
ketoacidosis ,
Aclasta
37
to the
reactions ( * )
vials are for
longer
order to protect from
, 56
doctor or pharmacist .
, there was
of
in
.
extrapyramidal symptoms
contact
syringes contain 0.8
events
study
muscle pain
randomised
be
of consciousness and
aripiprazole
. emea
:
between 25 and
per week
ml solution for injection
This
mg
pioglitazone
AUC
Highbridge
administration
reactions are
epoetin
a
mammalian cell
with
sodium chloride , glycine
-
chemotherapy
contains The
oral doses of iron
ml equivalent to 300
renal insufficiency not yet
, aqueous solution
-
and
you have further
5.8 for
not
route
( 4 or
APPROPRIATE
does not matter
patients with
ABILIFY can
recommended total weekly dose
a
epoetin
.
The
in
no
, insulin (
after
.
on the
unknown .
use
% )
What Aclasta looks like
) Ltd 61
well-controlled studies
over
, insomnia
is
.
itching
of
)
Maintenance dose between 17
elimination per se
, Royaume-Uni
GmbH & Co KG
The therapeutic margin of
been reported while taking
myocardial infarction or stroke
The possibility of
(
Kingdom .
Although in very
your dose
maximum
Tel
Assessment of
ADMINISTRATION
Nederland BRISTOL-MYERS
.
no medically
, Oxford Road Uxbridge
Units (
tablets ,
with water
535 7000
1 orodispersible tablets
)
be monitored
symptomatic
,
% with
blurred vision
,
100
Rimonabant
is necessary
with the
The
clinical fractures
of heart failure .
4.3 and
18 %
and
the pharmacokinetic characteristics
(
: + 358
( reported in 79
see section 6.1
4
CYP2D6 inhibitor
9.5
muscarinic receptors
insulin
32 2 352
a cytotoxic
10
dose 2 mg )
THAT THE MEDICINAL PRODUCT
Protamine sulphate Water
4.8 - General )
(
less duration
United Kingdom BRISTOL-MYERS SQUIBB
If
+
not
cartridge
at least
units
( 7.5
1.25 mmol/ l )
renewal :
either valproate or lithium
in healthy subjects ,
paclitaxel
for
desired haemoglobin level may
when
effect
mg
Febrile neutropenia occurred
Suomi/ Finland OY BRISTOL-MYERS
fracture , including
is
werden mit
) to
except
- Peripheral neuropathy
Aclasta ( see
after
Insulin treatment
1 , 49
pioglitazone ( as hydrochloride
-hydroxypaclitaxel and 3 -p-hydroxypaclitaxel
medically important
insulin requirement .
Erythropoietin is
of consciousness
erythropoietin
before
should be
cancer patients .
.
aripiprazole
Mannitol
stomach discomfort ,
an
see section 4.5
on
Centre (
, injection route
74 60
.
10
see section 4.4
the
x 3
) , Italy
Recurrence prevention of
39
lithium
injections are given
IU )
In clinical trials
In
following
generally not
is a
49
represent rapid
they
anaemia (
those receiving placebo
Aclasta (
the
Concomitant
those mentioned
.
studied
to sudden stabbing migraine-like
,
is
the insulin requirement
The terminal half-life (
, vomiting and diarrhoea
, use of
or lithium
risk
your pharmacist
8.1 mmol/ l )
symptoms ,
aripiprazole
that the
section
haematocrit
The terminal
quickly with racing ideas
episodes of hypoglycaemia
Bagsværd Denmark
treatment with epoetin alfa
- 14 g/ dl
of
to reproduction .
in patients with
No other erythropoietic therapy
paracetamol
.
or
) increased
for
progression ,
can
and protein intake .
than 1 patient
that the
reported
normal
effectiveness
Dosage adjustment may
THAT THE
injection
was approximately six
+44 ( 0)20
with solid tumours (
injections are given
Black .
blood pressure
product must not be
1
small amount
a dose adjustment
patients
healthy elderly
are
ABILIFY is
)
no known effects on
THE REACH
vitro studies have
Generally ,
of
, thyroid hormones and
.
doctor
paediatric
of the
153 MINIMUM
bipolar patients
)
alfa Abseamed 7000
this
(
Uxbridge -
SQUIBB BV Tel :
controlled as necessary
,
.
cell volume .
.
was observed in 90
by the intravenous
+ 43
+ 32 2
patients
and
,
paediatric patients
, whilst the relative
,
Holdings Limited Eesti
haloperidol ,
t½ ) is therefore
.
: + 33 (
patients
of 0.6 ml contains
may
( Cmax
.
important differences .
growth hormone and
Aclasta has been
three days.
have been proposed ;
alfa
Insulin suspensions should
%
patients
increased production of saliva
This
medicinal products with
,
decreased
30
For the
, the suspension
remain at
0.035 mg
and younger
( 7.5
SQUIBB PHARMACEUTICALS
BRISTOL-MYERS SQUIBB
(
.
In
Tel : +
while taking
( warfarin
with
Global R &
increased incidence of
patients
, aripiprazole
below
the bile
.
14 g/ dl .
increased primary
may also
therapy .
15 mg/ day (
, for
+ 44 ( 0)1628
( 3 ml )
Bipolar I Disorder
x 1 orodispersible tablets
NAME
the
The AUC
: + 31 34
use
or any
elderly patients
1.25
subcutaneous
& Co KG
mg/ day
45 mg
may be a moderate
in
signs and symptoms
PRODUCTS , IF
blood levels of cyclosporin
INSULIN Metabolism
QT prolongation ,
No
, intermediate-acting combined
KG Kuhloweg
g/ dl (
, but had
be managed cautiously
these trials , a
of mitratapide ( parent
and differentiating hormone
- Refraction disorders
to have
mmol/ l )
to 375
see sections 4.3 and
(
( 7.5
.
epoetin alfa
for the
products
.
( 0)21
the first
a
a few weeks .
mg )
need to
swelling and inflammation .
.
per
in
,
that
of excipients ,
forms of
Tel : +
or CYP2D6 inhibitor
be paid to sudden
with
10 000
Ísland VISTOR
units ( IU )
require
in
clinical trials
injection
maize starch
AST ) ,
thyroid hormones and
the
see
be necessary
Upon discontinuation of
anaemia may
mmol/ l )
white
,
be
Actos 45mg
and
+
international
versus
Middlesex UB8
week by the intravenous
should be
If you
doses
aggravation of existing hypertension
Actos
Kingdom
and haloperidol
metformin and
of
hepatitis
and
5000 IU/ 0.5
other
solid
are
Tlf :
intravenous
your immune
label
new information is received
compared with those
chemotherapy
should
(
and diarrhoea
aripiprazole
one-half
45mg
mg/ day .
all
of approximately 6
dose is
population
x ULN ) should
predispose patients to hypotension
For a full list
taken
from hypoglycaemia
result of hypoglycaemia .
,
,
.
may
recently
delayed
PVC/ aluminium
in
Proportional increases of the
or
product
higher
, pruritus , or
consists of 165
occurred
is well
SQUIBB Tlf :
acute
, rDNA (
.
12 g/ dl (
with
may
1 ,
for three weeks (
section 5.1 ) :
constipation
( type 1 )
(
favour of controls
should
OF UNUSED MEDICINAL
, headache
faeces .
alfa
FACT-An
epoetin
placebo-treated
and the
and Cmax of
.
6.1 )
be
pharmacokinetics
human
of malformations
Aripiprazole should be
Cmax of dehydro-aripiprazole
with renal
overall burden of disease
experienced with
half-life of approximately
other
controls
or
dysmotility
Following
,
If
%
.
23 Adjustment of dosage
( type 1 )
by 107 % ,
Your
as measured
aripiprazole and
pH adjustment
g/ dl ( 1.25
, akathisia
white
,
in
with solid tumours (
patients should
difficult
45 93
in patients with
reduced
of children .
but prescribers
but not clinically
as compared to
mellitus
in
is contraindicated ,
be disposed
.
%
reports are based
with
solid
The pre-filled syringes
:
from light
dosing
see section
epoetin
of seizure
beta-sympathomimetics
serum levels
unplanned
a prospective
,
may
retinopathy Long-term improved glycaemic
Actraphane contains
)
.
is
abdominal discomfort
)
NAME OF THE MEDICINAL
IU ) of solution
OF
.
you
kg and
doctor
in
84
.
, flatulence
given
34
is
pre-filled syringes of 0.7
(
If
is
insulin
alfa is very
and
pack The ABILIFY
long-acting insulin
applied
STRIPS
( decreased
been carried out .
per
see
administration
lower the blood pressure
.
not be used
use
)
see section
vomiting , nausea
were
for major
the incidence
15 mg tablets are
)
Similar changes in
+ 32 2 352
and dyskinesia
[ 95 % CI
APPEAR ON THE
( mean age
2°C - 8°C
reducing
.
and inter-individual
patients
Pharmacotherapeutic
contraeptives , thiazides ,
for osteoporosis , but
In clinical trials
renal anaemia ,
07/ 412/ 018
36(0
13
(
lesser amount
Takeda Global R &
impact on overall survival
.
It could be
The ABILIFY
as 10
) 241 941-0
LTD Tel
7.5
or 24
Hydrochloric acid ( for
below
This is
ABILIFY
of
by
manic episodes in patients
no
you have the impression
United Kingdom
patients with
4
and were
Aripiprazole
A-009 " and
6.2 mmol/ l )
no adequate and
4.7 Effects on
years Shelf-life
IU/ kg
diabetes mellitus
18 86
.
e. g.
multiphasic
patients
.
,
(
maintain haemoglobin
with 100
temperature regulation disorder
the nearest hospital
,
for use in
undergoes extensive hepatic metabolism
of
- 7.5
not
However , as with
may
a
of dosage may
g/ dl (
,
Patients who
calibrated
e. g. hypothermia
Do not use ABILIFY
of anhydrous human insulin
bioavailability of
fractures , when
with
in vitro permeability
headache , akathisia
;
women
Therapy- Anaemia (
patients
% ) of EPS
Abseamed
is severe
Lilly farmacevtska dru ba
patients on Abraxane
per week by
x 1 tablets 98
urticaria and angioedema
treatment
rimonabant :
men In the
clinical trials aripiprazole has
and
a solvent-based
,
ALT
41 % )
to
be at risk of
between 10 and 12
rare
as a result of
other medicinal products .
Eli Lilly Holdings Limited
, creatinine
pigment ( haemoglobin )
.
is unchanged
observed
men
the incidence
)
studies
( see
95 %
be considered (
haemoglobin
of
require higher
(
disorder , akathisia
(
:
Nordisk
12
not
olanzapine-treated
renal function
trials
, an
) .
after 12
has told you .
( below 30°C
The maximum
800 ) 749 749
and symptoms
1 tablets
D-58638 Iserlohn ,
and anaphylactic reaction .
store in a refrigerator
administration of ketoconazole or
infusion
use
over 3 weeks .
The
hypoglycaemia whilst driving
if
of pioglitazone during
.
those receiving placebo
Hb between 10
KG
, every three weeks
1
6.1
a potent inhibitor
patients with
Your veterinary surgeon will
closely monitored throughout this
your doctor immediately if
Paget s disease
Thrombotic/
4.2
in dose should
see section
, the
of the
oral
company decided
or
been
This summary was
forms of interaction
it
precursors
month )
m² with
active substance is
of
Only
section 4.4 )
anaemia with epoetin
(
insulin requirement may be
Anpassung der Dosis notwendig
three
during continued treatment
( tablets
.
BRISTOL-MYERS SQUIBB AB
effect of ACOMPLIA
,
SQUIBB AB Tel :
clinical
significant effects
In patients with
.
(
.
other ingredients
,
and dehydro-aripiprazole ,
administered
pioglitazone
CLAS ) .
rare cases
be marketed
of the
if the
in
,
chills , pain in
5.1
(
storage conditions .
with
)
hypersensitivity to
Weight gain :
the
approximately
Blister ( PVC/ aluminium
epoetin alfa .
mating
or less duration ,
What benefit has Actraphane
as
is especially important
Smoking status
CZOL446M2308 )
pharmacokinetics or
on
, muscle pain
times per week
Kingdom Takeda UK Ltd
.
epoetin alfa
:
risk
of Abilify
alfa
site
N-dealkylation
, somnolence , sedation
and
discontinuation of treatment
Abseamed in patients at
medicines called antipsychotics
approximately 27
1 tablets .
, take
to it ,
family history of diabetes
pioglitazone ( see section
After
be disposed
of
, 20
injections
AST
for thromboembolic events
patients
hyperglycaemia and diabetes mellitus
blood pressure and
or even death .
.
6.8
and efficacy
1,000
, Lda Tel :
,
ml ( 1000
clinical trials of
should
Actraphane 30
( 30 mg
clinical trials
.
These measures will help
not
.
Road Uxbridge - Middlesex
.
AUC ) increased
,
a
Centre
you
Takeda
anaemia the medicinal product
cleavage (
or
.
( mouse spleen cell
2
PHARMACEUTICALS LTD
product
pH adjustment )
:
see section 4.6 )
disorder
London
including
Hb
GGT ) , increased
one side and
reduction in
.
50
50
infarction , cerebrovascular accidents
Actos 15
12
emergence of such
,
pioglitazone
your doctor or pharmacist
in the treatment of
+47
weight gain ,
patients
alfa
)
your
in adult patients
BRISTOL-MYERS SQUIBB PHARMACEUTICALS
The
other oral
severe neutropenia or severe
is
from baseline on
, peripheral coldness
25
Risk Management
14 g/ dl
the
SQUIBB PHARMACEUTICALS LTD
tablets
dose
with aripiprazole
investigated
.
10 ml
(
- 14 g/ dl
EMEA
,
5
Ltd Tel :
of
Serum electrolytes
mean age :
.
not been established .
metabolised
use
solid tumours (
.
ml
with
patients
therapy with pioglitazone
with
atypical antipsychotic agents ,
symptoms ,
to the product
agitation
in Saccharomyces
(
reaction
. : +
for the
Oxford Road
alfa
lithium
and rats
p
and very
BV Tel :
Rare :
with
Treatment of
and angioedema
aripiprazole
and beta-sympathomimetics
:
room temperature before
, the incidence
was considered non-genotoxic
rapid initial effect together
If
Penfill
epoetin alfa is a
your shunt
,
factor and differentiating hormone
must be followed .
( see
chest pain
may be followed by
1000 international
occur ( see section
patients
, sugar
1
beta-sympathomimetics
type 2 diabetes
1 ml
or
patients ,
is
3.0 %
aripiprazole ( see section
and
your weight
F-37071 Tours Cedex
insulin
haemoglobin of greater than
speech disorder , Neuroleptic
ml ( 10 000
mellitus (
osteoporosis
WHAT
with
, hives
QT prolongation ,
sustained haemoglobin exceeds
.
has
2,127
and anaemic rats
6.2 - 7.5
, vomiting ,
, even several
either valproate or lithium
sleepiness , shaking and
and
SQUIBB AB Tel
ml contains
.
between
ausgeschieden
5.1 ) .
, face oedema
section 4.4
Adjustments of daily dosage
3 ml
gliclazide as monotherapy
make sure
stimulates red cell
.
monitored
of 15 mg has
but it attaches to
x
, somnolence , tachycardia
, a
mg/ kg daily
7.5 mmol/ l )
1 800 ) 749
of 5 mg
chloride Glycerol Metacresol Phenol
and a negative impact
controlled clinical studies
should be rotated
in two species
.
50
not
patients
paracetamol or
R & D
) .
anterior abdominal wall
.
,
Polysorbate 80
treatment with aripiprazole
)
mg ( 1.3
(
with Abseamed
you
insulin requirement
In clinical trials
354
2697
,
5
last
in pregnancy
mechanism of action
controls
molecule contributes about 58
, therefore
- Oedema Oedema may
33
mmol/ l
paclitaxel
0.2
.
Productive cough
4.4 )
for
occurred in 29 %
Wielka Brytania Tel
9000 IU/ 0.9 ml
95
.
solution for injection in
& D
: dyspepsia ,
significantly
treatment
Effects on
not recommended
)
a pre-filled syringe The
overdose
:
pathways involving the CYP2D6
in
(
.
E218
significant
6 %
the administration
2 months
injection site within a
of Abraxane
international units (
take more Actos
of medicines used
.
) of
,
to have
with
recommended (
Abseamed 4000 IU/
of 10 g/ dl
see section
or additional risk factors
be used
( produced by
syringes contain 0.7 ml
, tremor , dizziness
The usual dose is
Actos
on
disappear
mg/ kg
ABILIFY
randomised , double-blind
recommended
) .
% of
approximately 27 %
vitamin D levels
type 1
.
not
stroke
of
)
- Treatment of
another (
)
bioavailability of the
moderate binding affinity for
growth factor
insulin and
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LTD
plasma concentration
Erythropoietins are growth factors
recommended
34
vision
Patients
Hydrochloric acid
inform your
chronic renal failure patients
,
(
1.0
(
2
BRISTOL-MYERS SQUIBB (
may
only 3
( type 1
debossed with
hours
of
x 1 tablets 56
first three days after
Croscarmellose sodium Crospovidone
some
- In
in schizophrenia and
+
Hb
4.3 )
the dosage of
.
a type of
if you
008 , 010 ,
2
to
by the intravenous
, dysphagia
Insulin
and
doctor
data
vomiting
with
& D
g/ dl
from light
in
MINIMUM PARTICULARS TO APPEAR
4.4
corpora
of aripiprazole in
.
adequate and well-controlled trials
section 5.1
in 32
, long-acting insulin
than
Loss of
manic episodes
Be sure to tell
, diabetes mellitus ,
(
of the
year in
-
and
receiving chemotherapy
or mixed episode of
in
, Oxford Road
with haloperidol
ABILIFY
.
.
20
in clinical trials
none
,
be avoided
a bromobutyl/ polyisoprene rubber
2°C - 8°C
Analogue Scale
see section 4.5
with this condition may
x 1 tablets
no
When a
aripiprazole
may increase
in
, nausea ,
13 %
( 30
taking ABILIFY
West Forest Gate
see section 6.1
Digoxin ( ein
45mg of pioglitazone
4.4
usual , talking very
57
40,000
4000 IU ) of
or Hb increase
are
thiazides , glucocorticoids
patients
contains 5000 international units
the rise in
rats ,
Non-clinical
ABILIFY is used
in increments of
information on
significant
or without
aripiprazole or
elderly patients with
with
cartridge .
use of
Elevations of CPK
Geben Sie es nicht
dogs ,
( peripheral
environment .
( N=70
the active substance or
more ABILIFY tablets
has been
range
of transfusion requirements in
g/ dl (
hours after
in two equal
medically important differences
haematocrit of
pre-filled syringe
patients
IT
?
time each day
chronic liver
of adult
All
section 4.5
submit one additional
4.3
, randomised , double-blind
a
g/ dl
section 4.8 ) .
Nederland BRISTOL-MYERS SQUIBB
pharmacist .
the insulin requirement
below 12
anaemic patients .
.
with lithium
weight decreased , anorexia
Creatine Phosphokinase ,
Medice Arzneimittel Pütter GmbH
,
tumour proliferators .
, especially
at inclusion
AUC
once every three
developmental toxicity
3 times per week
PHARMACEUTICALS LTD Tel
in
with
The
3 ml
significant
) to 12
shown reproduction toxicity
, uncommon cases of
glass of water
and
,
diabetes mellitus
benzodiazepine
is a
variation
with
reactions after
2
administration of
( 0 1 year
24-hour
2 g/ dl
-
after
% Actraphane 40 :
per month ) with
alfa is very
, osteonecrosis
following undesirable effects occurred
, 2C8/ 9
.
-
combination with
women
Belgique/ België/ Belgien
the present state
essential
for ABILIFY
Actraphane
Iron
the deltoid region may
speech disorder
.
Cmax and AUC
When considering concomitant
were
and approximately 18 %
to low
for males )
product must not be
, 72 ( 31
.
should be
OR
, 14 and
with
has
aripiprazole
cartridge to function safely
occurs
.
for use
98
of malformations and
if the
medicines
werden
, 56 x
enzyme (
2 352
dose adjustment is necessary
and inter-individual variation .
in children and
in
more units
or 24 hours
(
272
Pharma
each day
)
All special warnings
at the desired level
should be
initiation of
)
a
to drive and
dose
: a maximum volume
.
30
with baseline
insulin cannot be
section 4.4 ) .
) .
or
patients
route
ABILIFY
may vary with
Hypertension
30 mg )
3 times
a measure
KG
2°C - 8°C )
dextromethorphan/ 3-methoxymorphinan ratio )
dose of
Tablet core
in
aripiprazole
)
years
any confirmed or suspected
revealed no medically
the mean
of
patients with a
Usual maintenance dose
paclitaxel
insulin
is a
ml
.
is
to maintain haemoglobin values
in patients with
Aripiprazole
, somnolence
more information
before taking ABILIFY
, diabetic hyperosmolar
375
42
The recommended
Aclasta
with hepatic impairment :
effective in
The tablets
) .
8°C
(
Abseamed 2000 IU/
( for pH-adjustment
( 1.25
similar to
and water for injections
the pack with you
, suicidal ideation ,
% and consists of
rifampicin
all instructions given to
were not evaluated
your
12
After administration
receiving
6.1 .
other clinical
of epoetin alfa is
, especially in
rDNA
insulin
usual
) .
Neuroleptic
controlled
renal anaemia ,
see
administered once a day
tiredness ,
.
are
) .
for four days
Tel :
of these events
nervousness ; suicide attempt
.
for
cannot be excluded .
studies
(
a meal or
alfa
, swelling
see section 5.2
.
mellitus
patients with
of dehydro-aripiprazole
Occlusion of
retinopathy
tablet
once weekly
Novo
mouth )
other CNS medicinal products
When a dose adjustment
rise in haemoglobin of
medicines
Treatment of anaemia and
not
by
draw conclusions regarding
Abseamed
with epoetin
section 4.4
und 5.2 )
,
13
not including braille
17 and
over " 643 "
section
as
most of these patients
improvement in
of epoetin
once a
The potentially
may
in
or without
when
tablets
In clinical trials
consists of
OF UNUSED MEDICINAL PRODUCTS
with
as hydrochloride
overweight and
dosage
.
Storbritannien
AND ROUTE(S )
Some
or
Uncommon -
Analogue Scale (
from
aripiprazole should be
32
and
.
AUTHORISATION HOLDERS
) , Wielka
adults
of the art
The pharmacokinetics of
approximately 60 %
( 0800 )
may occur in
, corresponding to 5.330
" 640 "
and
is necessary .
group .
see
of
0.7
by a decrease
dysphagia
( ketoconazole )
, take the
until
in schizophrenia
, treatment with
) to
Ltd 61
.
Centre (
urticaria and angioedema
15 mg of
1.25 mmol/ l
(
For any information
treatment
+ 46 8
30
( 7.5
hyperglycaemia and
doctor or
should
dosage
mixed
recommended
,
special warnings and
retinopathy
What
the aripiprazole dose
,
( i. e.
Special warnings and
flavour ( including
g/ dl (
before
other medicines
CNS medicinal products with
,
most
7.5 mmol/ l
is dietary
.
hospital
section
, diabetic
In addition
Package Leaflet
Within each
five large controlled
is achieved
reduce insulin requirement .
It
United
, Kuhloweg 37
count has increased
a sulphonylurea
to patients when indicated
PHARMACEUTICALS
the medicinal product
,
ml equivalent to
Anteil der Patienten
declined
60 days
not
disposition phases
The physician must therefore
the
;
, polycythaemic mice )
In most
6.2
seriousness
or
blisters .
reduce insulin requirement .
in women
( 7.5
SQUIBB
Lilly Holdings Limited
The terminal
Tell
The biological efficacy of
What ABILIFY
30 mg of
Potential for other medicinal
,
857 42 22
(
ABILIFY 15 mg
Taking
pharmacist .
other antipsychotic drugs
is
Ab Puh/ Tel
of anaemia with epoetin
There are no
749
are pregnant or
with solid tumours
.
3A4
ABILIFY .
pharmacist
alfa
placebo
Nervous system disorders
and adult patients
18.93
haemoglobin of
are round and
Upon discontinuation
or Hb increase 1
one year
other erythropoiesis-stimulating agents (
- 8°C ) .
based
8954
patient
33 (
% Actraphane 40 :
is
14 and 7 )
as
occurring within the first
and extrapyramidal symptoms .
blood in urine
For preventing
.
or
stimulate
not affect your
The
incidence of
.
or blood pressure ,
the incidence
(
after dosing
therapeutic margin of epoetin
NPH ) insulin
not
of 10
, aspirin , statins
responsible for dehydrogenation
clinical
ABILIFY can
.
6.1
50
10 g/ dl
* Produced in CHO
with a maintenance dose
OUT OF THE
on the pharmacokinetics
adults
combination with insulin
uncommon in the
and sight
thrombotic events
and
manic episodes in patients
, Oxford
10 Penfill
anaemia and reduction
on
not been
, weight decreased ,
( 0800 )
is thought
vitamin B12
isophane insulin
alfa in adult patients
for signs and symptoms
with
vitro studies
ABILIFY may increase
a manic
no
and
akathisia in bipolar patients
- Diabetic retinopathy
large
maximum
reported
301
cancer patients
Business Park
( see section
If
.
1
stops eating
10
no information on
ABILIFY dose
of 0.3 ml
time
5 ) 2649600
Co KG Kuhloweg
brain function
( haematocrit of 33
emea
the
)
of in vitro solubility
( 7.5 mmol/
compared to baseline
Tlf :
(
may be necessary
recurrence of manic
warnings and
, the
and thus
l ) .
, D-58638
diabetes ,
AUC
psychosis .
,
50 00
Uncommon : orthostatic hypotension*
which involved
half-life of
50
Abraxane
the active substance or
APPROPRIATE
.
and
ischaemic
Overdose of
(
Close monitoring of
Aripiprazole
alfa and other erythropoiesis-stimulating
, silicon dioxide ,
the
patients with renal
jaundice , hepatitis
per
mit
of NMS
and
x 1
and isophane ( NPH
( weeks )
, or if
symptomatic therapy should
BRISTOL-MYERS SQUIBB
The cartridges are designed
, aripiprazole
category
(
agitation
section 4.4
1 )
Although in very
the
of 0.3
The biological efficacy
as this will
controlled studies
with or
, ketoacidosis
by the intravenous route
A half-life
epoetin alfa
The individual
studies
or
study included
50
, it is recommended
subjects ,
by
fast-acting
are not
deep venous thrombosis
controlled studies
renal
on in
.
e. g.
: in
.
few minutes
( see
( 57.3
BRISTOL-MYERS SQUIBB (
controlled
of the reconstituted suspension
-
an increased risk for
Aripiprazole
with epoetin alfa
(
Meta-analysis of overall
rats
or to any
Concomitant administration
indications , and
KG , Kuhloweg
%
of which were
Centre ( Europe )
clinical
manic or
starch Microcrystalline cellulose
:
OF THE MEDICINAL PRODUCT
vitro studies have shown
such as
E951
3
activity
and
entire
of therapy with pioglitazone
Patients
with type 2
episodes in
be exceeded
.
.
in
between 1.25
: + 44 (
to affect ABILIFY :
Novo
) ,
whether you
with consideration for
Aripiprazole
( see
sodium citrate and
; leukopenia was reported
monkeys after
As with any
may vary with age
dose
epoetin
.
recombinant human erythropoietin
important
and safety
metformin
unplanned
)
was
be
In addition ,
vary with age
catalysed by CYP3A4
Centre ( Europe )
An increased 3H-thymidine incorporation
the thighs or
severe manic
that
weight gain
medicinal products .
In
or
in a
4.4
metabolite M-III
with
The
10 and 12
especially important
see section 4.4 )
administered
,
KG
be
28 tablets
other medicinal
diabetes mellitus (
, arterial
.
,
ml solution for injection
In addition ,
Europe )
cartridge contains
In
recommended
with
or
In
35 trials and
.
,
mg has not
The
ketoacidosis
Authorisation
260 lung
Injection sites
1 tablets 49 x
month
( see section
should
section
and 12 g/ dl
4.4 -
Tel
adverse events
Some patients
M-IV
For the treatment of
.
administration of
administration of
bisphosphonates
Abraxane
and 12
irregular heart beat .
mg/ m2 )
8.1 mmol/ l )
to 2 g/ dl
Actos
use
In
week
Luxembourg/ Luxemburg
hours after
: +
to detect possible
of CYP3A4 (
Special precautions
% with placebo
, monoamine oxidase inhibitors
, warfarin
will help
monitored
patients scheduled for major
patients
6 weeks
: the levels
in bacterial
, muscle rigidity ,
(
,
,
Co KG
trials
clinical
.
lorazepam solution for injection
than
.
to protect
( 8.1 mmol/ l
+ 32 2
with a glass of
intermediate-acting
BRISTOL-MYERS SQUIBB
The potentially
of insulin resistance
For
Hb between 10 and
5 %
breakdown
.
a single intravenous
see section 4.4 )
chronic renal failure
was administered concomitantly with
.
( 2°C - 8°C
Because of potential serious
receptors
of
half-life of
AND SIGHT OF
or
Hunton House
: a maximum volume
below
section 4.8 )
disorder , akathisia
not greater than
in both
be necessary
the
or
the desired range
24 hours
.
of
( see section
International
in
DK-2880 Bagsværd Denmark
, the dosage
Before use
be administered intravenously .
one
placebo
further
Finland OY BRISTOL-MYERS
These measures will help
4.4
should
effect of
Keep this
evident ischaemic heart
, 23
Patients
3
increased risk for
malformations
.
a
potent inhibitors
studies looked
Some patients
50 %
extrapyramidal symptoms .
no
no specific frequency can
see section 5.1
Distribution No
reports are based
increases
+
In
13 g/ dl
dissolved insulin and 50
in isolated
impact
shortened overall survival
have also occurred in
Aripiprazole
: +
, before breakfast
)
in a
at the desired level
pioglitazone
well absorbed , with
4.4 ) .
,
10
( see
.
1HU
) 731 1736
BRISTOL-MYERS SQUIBB BV
Ireland
experience in
female
( 0)20 3116 8951
and
as hydrochloride .
.
;
administered to target a
+ 44 ( 0800
e. g. during
with epoetin
pharmacist .
45 45 93 05
and 802 with
this
and inter-individual variation .
by the intravenous route
20
MINIMUM PARTICULARS TO APPEAR
episodes
somnolence
not
supervision and monitoring should
To
per
It
in
PARTICULARS TO
, aqueous
In
50 IU/ kg 3
Highbridge Business Park
SQUIBB PHARMACEUTICALS LTD
dehydrogenation
SQUIBB NORWAY LTD Tlf
of
randomised , controlled ,
antipsychotic drugs
( 0)20 3116 8000
should be
.
pioglitazone
g/ dl
half-life of
When the
in schizophrenia
deep vein thrombosis ,
determine the safety of
Not
.
of the Marketing Authorisation
Elderly patients ( 65
medicinal product
any information
or
and
: +45 39
, akathisia
Gastrointestinal disorders
with renal
, increased risk
whom
, ketoacidosis (
rhabdomyolysis ) ,
KG Kuhloweg
found in
should be
no
7000 international units (
( see section 4.5
A half-life
of one year
- 7.5 mmol/ l
in a
with aripiprazole
insulin sensitivity
,
be advised accordingly
male patients (
if
geometric means of
catalysed by CYP3A4 .
the syringe onto
two
A number of cleavage
,
is
,
four weeks
therapeutic
a
,
In the indication
.
7.5 mmol/ l )
increased with increasing
patients with
should
well absorbed , with
use of Aclasta
been reported while taking
.
with or
risk for thromboembolic
apparent in animal studies
trials
ON BLISTERS OR
,
OR STRIPS
of 14
0)20
0.5
of 10
neuropathy
Insulin human , rDNA
insulin requirement
of manufacture ( recombinant
) 749 749
epoetin
should be
starting dose for
administration
moderate
to years of
patients
medicinal products with
of heart failure ,
with
adverse
injection )
and
trials of aripiprazole
of
of patients with the
65 to 200 kg
rare cases
,
always ask his patients
mmol/ l
not recommended
Tartaric acid
plasma elimination half-life
based on
The company
,
with severe agitation
is
In
In controlled clinical
compared
safety of
treatment
and well-controlled trials
100
cardiovascular outcome study of
of which were
In patients
of 100
Hypertensive crisis
,
with
Treatment
with residual
.
hypertension
UB8
with
75 ± 33
hypoglycaemia ,
Following recurrence of severe
patients with
in a blister
rats
in cancer
There are
surgery patients
occurs ,
GmbH & Co KG
( produced by
Based on in
ml ready-to-infuse solution
section 4.5
incidence
Actraphane NovoLet is
or
84
156
OR STRIPS
The absolute oral
4.8
a
Trial [ PFT
study included only
and
what it is used
insulin products
117 150 IU/ kg
t½
or
one month
)
or
little ,
the
ABILIFY
the warning signs of
x ULN
In patients with
10 g/ dl
no adequate
as
After
that
in 68
patients (
renal failure
observed
possible , even several
treatment with aripiprazole
was 9.5
should be closely monitored
41
If
erythropoietin
:
If
in the placebo group
that epoetin
from hypoglycaemia .
treatment with the product
pen cap on
the foetus
, vomiting and diarrhoea
see section dic
aripiprazole in the
if
,
use machines have
in cancer patients
ml ( 7000
aripiprazole
ABILIFY
.
section 4.4
and
of ketoconazole or
may also
is
the incidence of clinical
SMALL IMMEDIATE PACKAGING UNITS
.
.
patients with
are
with
.
patients
factors
rare cases of NMS
and
%
with a similar rate
such as
is
with severe
patients
aripiprazole and 3.2
clinical
is
In
mg/ m2 )
.
decreased
to dispose
regard to meals .
) .
, abnormal
declined
7.5 mmol/ l
g/ dl ,
dyspepsia , vomiting
see section 4.4 )
increase
treatment with
2
14
know
epoetin
packed cell volume .
United Kingdom
, silicon dioxide
speech disorder
(
with or
very
-
, increased risk
medically important differences .
Starting dose of
or chronic liver disease
.
)
( 30 %
with
,
kidney have
.
cerevisiae
7.5 mmol/ l
who
bisphosphonates or
with
and
% ) .
extrapyramidal
between
: +
one syringe from
When the
see section 4.8 )
baseline
section
in
symptomatic
following diseases
bottles
3 times per week
have been receiving
section 4.4 ) .
,
is
be disposed
501 76
.
or
The possibility of
, 30 mg
refrigerator
45 45 93
Tel : +
( 0 2 year
of these patients
administration
in humans is
In these
of stroke
been demonstrated although individual
Europharm Limited
Park Westhoughton
headache in
(
than
or of
181 Tell
with aripiprazole
2C19 ( omeprazole
to epoetin alfa
effective
( see section 4.4
if
another
with atypical antipsychotic agents
long-acting insulin
you
of seizure
Abseamed
experiencing potentially clinically
tablet contains
increased risk of
-
( low blood
(
therapy .
and
republika OncoEurope Tel
to other
4.4 and
response rates in all
for you to
10 mg
a
The decision to administer
brand ( manufacturer
42
insulin .
three years
:
Actraphane 30 NovoLet
( e. g. ,
( 0)20 3116
treatment with
maintenance doses than
administered
of clinically significant
Non-clinical
,
Butylated hydroxyanisole
or hepatic impairment may
aripiprazole
with
approximately
The potentially medically
, close medical
mit
)
half-life of approximately
87 %
flushes ,
mmol/ l )
tell your doctor
.
erythropoietin is 32,000 to
and
6.2 mmol/ l )
zoledronic acid ( anhydrous
target haemoglobin concentration
significantly
of the limited experience
( see section
It may
observed
99 %
before
and should
should
)
( see
20
between
Serum
peripheral
when
( two
in
paediatric
with renal impairment :
.
5000
( 0)20 3116
prescribed by
including
.
in Bipolar I Disorder
formation
international units (
)
AUC
epoetin alfa .
ABILIFY is
As with other antipsychotics
were
the
)
normal or
ml
mg
251
Aripiprazole should be
Therefore ,
is usually reversible
immediately
primarily
patients
The most
of akathisia in bipolar
,
SARL
large
your
approximately 60 %
) after
receiving chemotherapy ,
.
When a dose adjustment
)
75 years of age
ABILIFY
special warnings
.
Insulins
is limited .
mg orodispersible tablets
If
,
RFT
risk factors
Business Park ,
have
in patients
) Ltd
observed (
NovoFine needles .
agitation
( see
4.2 Treatment
dose
units (
times per week )
.
four
concomitantly
and 5-hydroxytryptamine are involved
defined
14
Any unused product
a type of white
per
( warfarin )
or
( e. g.
of consciousness and
938 ;
What ABILIFY looks like
:
and
mg
monotherapy was
manic episodes in patients
tachycardia
improvement
see
tablet at the
)
Danmark
4AE , United
60
of anhydrous
9000 IU/ 0.9
0)20
,
chronic renal failure patients
.
the last
with
.
swelling
patients
, serotonin 5HT1a
vitro studies have
pioglitazone
is not recommended
Actraphane is
or
26-week ,
very rapid or
haematological malignancies
the
.
SPECIAL PRECAUTIONS FOR
, chest pain ,
to
been treated
3 patients with
can be
; ATC code :
( 75
that epoetin alfa
( see
plasma concentrations
Cmax
weeks
and
a full range
a t½ of a
trials and 8167 patients
.
ml
Following oral administration
who
parkinsonism
of patients received
but not
time each day
or
and anaemic
the
Treatment
these
concomitant administration
periodically
of
95 % CI :
.
-
contributes about 58
: in
1.25 mmol/ l
medicinal products
-
When
in clinical trials
recommendations
zoledronic acid
it
12 g/ dl (
(
has not been investigated
consists of 165
)
The data
:
measures
, muscle rigidity ,
since bioavailability
In another
the
blood , Abseamed
% .
% dissolved insulin
a
use of
24
)
observed
) .
.
-0.6 for
Highbridge Business Park ,
30 mg
acknowledged
the incidence
it
section 5.3
be performed in
section 4.5 ) .
ABILIFY
for thromboembolic events in
can
32
ACOMPLIA should not be
treated
erythropoietin
glucose
days after
.
epoetin alfa
% with placebo .
anxiety Uncommon : depression*
of children .
performed
inadequately controlled by diet
In clinical
,
not other bisphosphonates
( particularly overweight
the tablet
may
than
clinical trials with oral
see section 5.2 )
gynaecological
In addition ,
( see section 4.2
including zoledronic acid
and 98
Der Anteil der
alfa
,
+33 (
,
( 1.25
no
to
37 D-58638
combination
1.1
heart beat
at one injection site
) should be investigated
per month
signs
reactions
and
Tél/ Tel : +
0.05 mg
Polysorbate 80 Water for
treatment ,
hyperglycaemia and diabetes mellitus
stroke
in routine laboratory parameters
section 4.4
50
QT prolongation or
adult
Actos 15mg
) is therefore
compared
Gamma Glutamyl Transferase
Hunton House Highbridge Business
PRODUCTS
allergic symptoms , may
.
therefore be applied
Squibb Srl
aripiprazole
insulin sensitivity
human tumour samples
Consequently ,
and
trials ,
unexplained
the insulin requirement
prior to
used
.
an
cancer patients
, rDNA
with aripiprazole
has
of 0.9
, 25.9 ] (
alfa is a
Pharma Tel .
the dosage of ABILIFY
- 8°C
Always take the
contains
If
13 g/ dl
For preventing recurrence of
6 months
Limited Eesti filiaal
0800 ) 731 1736
6.8 mmol/ l
scientific advice
%
%
of 30 mg
with epoetin
of
The safety
-
APPEAR ON
dose-dependent increase in
peak
presented in
A number of cleavage
shown
,
Common : dyspepsia
+
4.5 )
tachycardia ,
5 mg
mg )
, especially infections
seriousness .
of the
solid tumours
but only 0.01
- 14
trials ,
.
Uncommon
NAME OF THE
IU/ kg 3
but
is
Uxbridge -
an increased risk
:
) 74 18 84
.
treatment with aripiprazole
or stroke
535
mg tablets ,
.
of
50
in
AND SIGHT OF
the sustained haemoglobin exceeds
renal function
14
13
Hb increase
Uxbridge -
and
humans and
you
) 731 1736
( iron deficiency ,
"
disease is
together with
of the value
Lilly Portugal
may
SQUIBB GESMBH
overdose with aripiprazole ,
be disposed
Treatment of anaemia and
treated patients
and pale mucosae
(
Holder .
2 times per week
, increased Alanine Aminotransferase
recommended
two main
cases of stroke or
see section 4.4
8°C )
,
31 34
.
of 1
whom it
hypocalcaemia were observed .
1 800 )
( 1
new
for 3
.
pharmacist
(
Starting dose
of the
to years of
,
the reach
of unchanged aripiprazole was
patients with diabetes
mg )
x 1
were
dissolved insulin and
hypersensitivity ( N
your doctor
Belgique/ België/ Belgien BRISTOL-MYERS
of
sodium hydroxide
%
schizophrenia
patients was 12.1 %
WITH METFORMIN AND
placebo
to reproduction .
79 %
patients
hepatic impairment on the
approximately 6
Pharmacovigilance Plan
Abseamed
and
to
.
loss of consciousness
extrapyramidal
(
SONSTIGE BESTANDTEILE Enthält Lactosemonohydrat
and
8.1
,
.
and water for injections
IU/ kg
randomised , double-blind
Some patients
ml ( 2000
thiazides ,
D-58638 Iserlohn
, with or
section 4.2
150 30 -
Aclasta
.
of NMS
should be
with a
sealed in a
mellitus ( see section
may occur
The maximum daily dose
diabetes mellitus
P450 2C8 although
studies , use
weakness
hyperglycaemia
FOR
section 4.4 )
In combination
10 and 12
of one year
A vial contains
Europe ) , Storbritannien
when stored between
8°C .
weeks when used or
Correction for
may
44 (
obesity
hives , swelling and
after
49 x 1 ,
events have been
of
aripiprazole and
recommended dose
solution .
1.3 % )
insulin products
see section
.
evaluations .
and
GGT
and
or Hb increase
should
section 5.3 ) .
refrigerator
CONDITIONS OR RESTRICTIONS
10
route
see
allergic reaction (
PROactive ,
rash
: fatigue Psychiatric disorders
parkinsonism
elderly and younger
25
insulin
without food
34 %
consists of
female rats
may
(
or coma ,
Adult
( see section
pre-filled syringe The syringes
of one year
of stroke
approximately 60 %
of
Wielka Brytania Tel :
,
Analogue Scale ( CLAS
have an
.
haloperidol
height
,
Actos and insulin
a
if the solution
is no accumulation :
aripiprazole
the intravenous route
Recurrent Fracture Trial [
intermediate-acting
IU/ kg 2
based on mg/ m2
week by
Tél/ Tel : +
after
802 with
+ 45 45
14
, colourless
)
clinical situations
,
mmol/ l
.
Epoetin
2649600
on in
.
.
3.5 % of
should
hospital and take
benefit
Inadequate dosage
month
the
regard to meals
via
in
0.5 to
about hurting yourself
BE STORED
vary with
,
.
:
subjects ,
of 0.5 ml
Actraphane
myoglobinuria
the majority of
(
jaundice , hepatitis ,
(
Vascular
0 ) 241 941-0
of in accordance with
g/ dl
by the intravenous
For
not exceed 30 mg
Treatment of
Read all of
clearance
and
People with
taken in combination
and water
your
) .
, 64
131
epoetin
not including braille
trials with
No evidence exists
)
with or
Elimination The
patients
g/ dl (
on
dose of
the
recent low-trauma hip fracture
+ 44
4.4 Special
8000
-
.
the
) .
sure
occurrence of
180 mg
medicinal products
see section 4.5 )
of children
doctor
with hepatic impairment
A number of cleavage
placebo
recommended
,
g/ dl
( 1 800
one side
0)20 3116 8952
14
iliac crest
1 tablets
House Highbridge
use
as
24 hours after the
on
placebo
.
4.6 ) .
IU/ kg
of
by the intravenous route
%
section 5.1
.
( see
Road Uxbridge -
If you
Very rare
( warfarin
film-coated
If blood pressure
aripiprazole
no difference in
of administration )
(
or
e. g. ,
( fever
including
OF THE MEDICINAL
pharmacokinetics of aripiprazole .
of ABILIFY
PROactive
is
in combination
Abraxane should only be
500 mg
to co- morbidities
, ketoacidosis
effectiveness of
8.1 mmol/ l )
and
and pink
3 weeks .
50 tablets 56 tablets
but not in monkeys
and other
patients with
or
) or coma ,
followed by
: + 45
In two
other
dosage or
route .
and a
mmol/ l
, aripiprazole
with diabetes
range of standard
67019 Scoppito
There are no adequate
12 g/ dl
mmol/ l ) .
in healthy
for
quickly
)
of epoetin
g/ dl (
sulphonylureas
carbamazepine ,
( 6.2 - 7.5
with renal
product
studies
during
patients the incidence
166 Danmark BRISTOL-MYERS SQUIBB
or
elevated creatine phosphokinase
of rimonabant
are transitory and
effect
at
aripiprazole
section 4.5 )
cases
interaction
for
each
incidence
patients with
39
4.4 )
In
, tachycardia
+
vascular events
incoherent speech
an
the aripiprazole dose should
with placebo
10
see section
bisphosphonate-naïve patients and
.
Two-year clinical studies
should you
BRISTOL-MYERS
reduction of manic symptoms
4.5 ) .
of the
moisture .
shortened
if
in men
ABILIFY
: orthostatic
due
including osteomyelitis
impair fertility in
,
, arterial
injection )
moderate and
and
death in utero
a
) ,
of CPK ( Creatine
compared
activation
lapp lactase deficiency
g/ dl (
mother presents no
Aclasta
HOLDER
, while the
pre-filled syringe (
not use
starting dose
site conditions Uncommon -
IU/ kg 3
CYP3A4 ( e. g.
in man is 5
patients
treated patients
years
2 hours after
four placebo-controlled
(
1
Ísland VISTOR
40 (
300 gastro-intestinal
clinical trial in healthy
Abseamed
effect
ABILIFY oral solution
on results
your levels of the
more often
the first
gynaecological
IU ) of solution
100 IU of insulin
headache
.
aripiprazole and
after administration of
Adult surgery
solution for injection in
THE SAFE AND
, see
with caution
orodispersible tablet
(
Other potent
schizophrenia
administration of
IU/ kg
, the oral
As for other
you are pregnant
all
was administered concomitantly with
the intravenous bolus
27 %
Restlessness
diabetes is
Highbridge Business
effects of aripiprazole
(
: + 43
of the pancreas
the
) in women with
not
contains
dose , i. e.
Elimination
alfa
: + 32 2
.
Kuhloweg 37 D-58638
is
patients with
ABILIFY
as with
In patients
, hypocalcaemia ,
.
44 ( 0)20
anterior abdominal wall
bradycardia
, 150
Actos looks like
( subcutaneously )
shown
average age of 62
Tlf :
evidence of
.
reported with epoetin alfa
mg of
When the CYP3A4
route .
.
537
sizes may
see
are growth factors
insulin 20 %
pharmacist
% ) of
A-009 and 15
of malformations and
half-life ( t½ )
the
see section
mmol/ l )
and
permitted recovery from the
Ctrough =
are ready to use
concomitant administration
a cardiovascular
alter laboratory test values
of glass
for
is
antipsychotic drug
The
,
5.1 ) .
AUC
clinical
infection
hypoglycaemia whilst driving
to drive and
In
patient
Syringes are
2.47 in
avoid invasive dental procedures
is not a
+
machines .
trials ,
29 Marketing Authorisation Holder
and
7.5
in two equal
53
angioedema
for humans is
bile
and 802
randomised , double-blind
is not recommended
hydroxylation
37 ,
1.35 , 2.06 ,
( 0)20 3116
disturbed
Lilly
in order
( see section
of cytotoxic agents
dose
should be
Even if you
.
, reduced
into account and should
prior to
three
mania
Abseamed 1000 IU/
section 5.2
in subjects
sie
Insulin
ml solution for injection
56 x 1
very rapid or
in addition to aripiprazole
SARL Tél :
(
tablets 98 x
of anaemic patients .
below 12 g/ dl
,
patients with a
doctor or
complications
)
pharmacist
5238
Less than
and
oral formulations
and
, 2C8/ 9
=
SPECIAL PRECAUTIONS FOR DISPOSAL
condition
the
signs and symptoms of
Epoetin
local requirements
applied
myocardial infarction
30 minutes
encephalopathy-like symptoms
important signs and symptoms
tolbutamide
SQUIBB
in humans and may
THE
and danazol .
or hepatic impairment may
)
What ABILIFY looks like
response
to sudden
but
to 6 weeks
immediately
carefully weighed
, diabetic hyperosmolar
.
and
other
(
Oxford Road
with
1 bottle
to
ranging from 517 to
of one year
any of the
section 4.4 )
adequate and well-controlled
; or
,
84
.
or
symptoms of
could
clinical trials
Novo Allé DK-2880
ABILIFY
with
g/ dl ( 1.25
per
- If
12
cancer
to ensure
358 ( 0)9 8545250
Shunt thromboses may occur
, the bioavailability of
longstanding diabetes
mmol/ l ) should
Takeda Global Research and
dizziness , somnolence ,
acute renal failure .
cancer patients
very
aripiprazole
cardiovascular
revealed no medically
site
has told you
than children over 30
subcutaneous administration .
Abseamed
Road Uxbridge
3.0 %
stenoses
you are breast-feeding .
Mildly anaemic patients
years
below
your doctor or pharmacist
intermediate-acting combined
hypoglycaemia )
symptoms
( Europe ) Ltd
, glucocorticoids ,
with Abseamed
observed for
and
women
The
Following
: + 34
complications
There are
change in their usual
The therapeutic margin of
no
are
mg/ day
feel dizzy ,
treated patients
(
efficacy
paediatric and
.
patients , antibodies
1800 ml .
18
( see sections
water
ABILIFY contains
The usual dose
16 to 81 times
is
Global R &
you
, alpha-1
remaining amount of
( IU )
.
D-90429 Nuremberg
American post
( dextromethorphan ) .
, myoglobinuria (
face.
using machines
2
than 2
in
of the
)
use machines have
x 1
R & D Centre
between
section 5.1 ) .
or to
(
tremor , dizziness
BRISTOL-MYERS
the blood sugar
observed in clinical trials
in the pharmacokinetics of
patients
.
highest nontumorigenic exposure in
for injections
in
Patienten ohne Adipositas (
Use should be
mg has
overall survival and increased
of which were
between
haloperidol-treated patients .
In combination with insulin
, or if
,
This may constitute
haemoglobin and blood pressure
UK Tel.
isophane ( NPH
modifications
.
of renal function
been reported .
pharmacist
mmol/ l )
overdose with
All
( 8.1 mmol/ l
Rimonabant
of aripiprazole in
)
blood donation procedure .
4.7
cases of
5 mg
features
Abseamed 3.
6.2
with chronic
section 4.8
g/ dl
)
make you
75 - 150 60
be assured :
see section
In addition ,
and
DISPOSAL OF UNUSED MEDICINAL
BY UNIT
and
in women with
OR RESTRICTIONS
and
from human tumour samples
Common
placebo-treated patients
see section 6.1
Royaume-Uni Tél/ Tel :
cerevisiae
AND SIGHT OF CHILDREN
- if
31 34 857
000
reaction ,
84
In
manic or
In two
" A-007 "
, redness , pain
sedation
: + 47 67
for use
significant risk factors
3 weeks
6.1 .
When the CYP3A4 inducer
preventing
with encephalopathy-like symptoms
were reported (
-
, growth hormone
The
paediatric haemodialysis patients
mmol/ l
+44 ( 0)20
24 hours after the
.
contain 0.8 ml
Aclasta
300 gastro-intestinal
medicines to reduce
source
Particular attention should
because of the
necessary
.
and
week by
rather
- Oedema Oedema may
aripiprazole
and
When the
is used
scientific advice from
parameters
Purified water
no information on the
ABILIFY
route
machines
ABILIFY
can
mg fructose per ml
:
pH adjustment )
in
10 and 12
programme
a
toxicity
is
a growth factor
haloperidol 73
)
recombinant DNA technology in
aripiprazole and dehydro-aripiprazole
in the
in the thighs or
regard to meals .
to
of EPS
PRCA ,
fast-acting ,
rst vniec ba
main measure of effectiveness
25 and
with
will help
and dehydro-aripiprazole ,
the
ALT ) ,
a possible warning signal
estimated volume
occurs with carbamazepine
and mammalian cell
and
mg
) 749 749
after
vomiting
between 17 and
treatment with
or
)
rats ,
, intestinal calcium malabsorption
,
trials
doctor or pharmacist .
Medicines should not be
In
( 2.5
ABILIFY
.
,
with these characteristics
rats , dogs ,
not
the haemoglobin target range
erythropoietin
be discontinued
45
12 g/ dl (
treated
should not exceed 200
is
syringes
other medicinal products :
the
the
other
thrombosis , arterial
therefore
,
10
the
1 and 10
in order
hypocalcaemia
.
.
less
including
the
) and
12 - 14
, rDNA
symptomatic
patients
and
by the intravenous
are treated with Aclasta
Ísland VISTOR HF Sími
with renal
ABILIFY
: anaemia
immediately if you
with encephalopathy-like symptoms
, but not in
g/ dl
are not iron deficient
soluble
conducted
is not appropriate .
acute
lacrimation , blurred vision
: a maximum volume
diarrhoea softened
of unchanged aripiprazole was
following adverse events
.
,
blood pressure or
are
(
(
Common :
anorexia
see
allergic reaction (
51 out of 3,862
)
long-acting
PRODUCTS
a dose of 600
Europe )
serious adverse reactions
+ 31
with encephalopathy-like symptoms
patient population
including
on veterinary prescription
13
encephalopathy-like symptoms can
corresponding to
.
& D Centre
The
were receiving insulin
30 mg orodispersible tablets
In some cases
Intramuscular
available
by
precautions
dosage of
This
not
The maximum
The AUC
other handling
tablets
200 mg
renal anaemia ,
Development Centre ( Europe
704
Te
mit
two
The effect of
Abseamed contains
epoetin alfa
one of these
chronic
than 2
If
administration
.
reactions
: dyspepsia ,
What ABILIFY looks like
and
increased Creatine Phosphokinase ,
with aripiprazole
Hb between 10 and
Insulin human ,
approximately
to
delay recovery
mg
epoetin alfa should
changes in
In
or
and 50
mmol/ l )
or
sulphonamides .
(
or
should
.
clinical
a glycoprotein that stimulates
ml
%
products
corresponding unit scale .
73 % ) .
the
patients
aripiprazole alone was
House Highbridge Business Park
%
be monitored
,
32 2 352 74
cause
antipsychotic
+ 358 9 251
reduce insulin requirement
HF Sími : +
.
the CYP3A4
of
and
controlled as necessary .
% dissolved insulin
to maintain haemoglobin values
trials and
of 12 -
% ]
,
features
Global
CONTENTS
%
not
receiving
generally not
elective
(
SQUIBB
,
half-life is
Eye disorders Very rare
.
PRODUCT
section 5.1 )
erythrocytes
pharmacist or
be mediated by a
for the
, growth hormone
Like
in clinical trials
BE STORED OUT OF
in clinical trials
42 trials and 8167
,
other
.
of ketoconazole or other
alfa
, rigors , oedema
74 18
aripiprazole and dehydro-aripiprazole are
effects
insulin
They include thirst
mmol/ l
4.8
than
.
61
especially
BRISTOL-MYERS SQUIBB GESMBH Tel
Animal studies could
,
( mean difference
normal
ABILIFY ,
aripiprazole and 3.2 %
that
significant benefits
not
. no
tablets contain
severe
When the CYP3A4 inducer
biological efficacy of epoetin
.
g.
Aripiprazole
hypoactivity
and
per dose
.
section 4.2
syndrome .
encephalopathy-like symptoms can occur
oedema
Cmax of dehydro-aripiprazole
, hypoaesthesia , paraesthesia
with reported estimated doses
maximum daily dose should
, in some cases
for
with
90
( see
Actos are visual disturbance
patients
,
, including ABILIFY
.
Uncommon
Nederland BRISTOL-MYERS SQUIBB BV
in humans is
patients with
.
of angioedema
mg ( 0.7
14 30
ABILIFY
.
see section 4.4 )
43
medicinal products with
if
section
populations ( see section
is
bile
per month
(
50
or
with atypical antipsychotic agents
to the possibility
4.8 ) .
aripiprazole and dehydro-aripiprazole ,
14 x 1 tablets
Taking
aripiprazole
1 month
orodispersible tablets
4.8
cerebrovascular adverse events
.
If you are
of
%
.
( 0)21 272
, IF APPROPRIATE
Although there is no
they
per se of insulin
,
,
, ventricular arrhythmias
.
.
aripiprazole
,
mmol/ l )
, M-III , and
with
and
.
red
, Oxford Road
mellitus (
( see
or
ketoconazole or other
treatment of bipolar disorder
as naturally
and rhabdomyolysis
may lead to hyperglycaemia
psychotic
sedation ,
contains 30 mg
human )
haemoglobin
studies ,
with chronic
(
than
wurde
) .
treatment
The
,
of
and
water for
contains 10 000
7000 IU/ 0.7 ml
human )
make sure
and
a cumulative dose
, myoglobinuria
( WITH BLUE BOX
and were
elective orthopaedic surgery
similar to
Non-specific skin
may also
an interaction
and dose-proportional .
treatment schedule .
98
; this is
your doctor
Based
mg
, Kuhloweg 37
, infection
Cytotoxic actions of
(
ml solution for injection
growth hormone and
- Produtos Farmacêuticos
) .
5.1 ) ,
included in
in
,
& Co
:
indication increasing
and behaviour and
oral aripiprazole
in line with the
,
.
SMALL IMMEDIATE PACKAGING UNITS
use of Epoetin
and what it is
Tel : +49
Store and transport refrigerated
in
12
trials
such as
or mixed episode
prior history of TVEs
mmol/ l
of 50 IU/ kg
shown significant benefits
.
30 mg
100
( PVC/ aluminium
4.4 -
in
doctor or pharmacist
( 2°C
:
including PANSS and the
the tablet
insulin
121 PARTICULARS
dosing
28 x 1
on the
, diabetic
:
30
rise in haemoglobin of
more than
whose arteriovenous fistulae
(
see sections
N-dealkylation
In
controlled by systemic chemotherapy
the incidence
between 10 and
the
-
or pharmacist
and cardiovascular therapy ,
angioedema
and
of Abraxane
, use of Epoetin
10
some of the other
32
is an
Tel : +44
forms of interaction
without
.
aripiprazole
to the
in water and
Treatment
but
ketoacidosis or hyperosmolar coma
) .
section
dosage of ABILIFY
100
.
00
:
.
When
Iron status
the
this dose should be
.
are pregnant
injections Hydrochloric acid
Uncommon
approximately 27 %
and
) .
.
Research and Development Centre
0.7 ml
.
Ask your
should be investigated
not greater than 12
2-78 units
) of EPS including
does not matter
fast-acting
monitored and
Sverige BRISTOL-MYERS SQUIBB
in a
factor and
Aripiprazole is well
for patients
keine Anpassung der Dosis
or
with
in Saccharomyces
treatment
be
There are
)
,
dose
.
.
No other erythropoietic therapy
Healthcare A/ S Tlf
) .
Following recurrence of severe
: + 354 535
compared to baseline
,
than
patients with
In
treated
) prior to
) ,
aripiprazole
neuropathy , additional
see section
anaemia
mmol/ l
GGT )
in
221 multiple
of the
or very rapid
elective
to
.
is given concomitantly with
terminal half-life is determined
)
7.5
or
:
% .
on
and
alkaline phosphatase
, less than 1
of insulin
, a
modifications
13 g/ dl
you
could
the
of CYP3A4 ,
hives
in children and
with renal
with ABILIFY
a
Arzneimittel Pütter GmbH
of akathisia was
Carton of 28 x
with
mmol/ l ) .
the
before you
)
)
Use
at one injection site
pioglitazone
normal and anaemic
ise Sanofi
pre-filled syringe
interaction
alcohol
All special warnings and
patients with reported estimated
5-hydroxytryptamine ( also
of in accordance with
Authorisation
in
increased Alanine Aminotransferase
ABILIFY
for mitratapide versus
section
elevated liver enzymes
parathyroid reserve ,
vitamin D supplementation ,
.
take more ABILIFY
g/ dl
pack and
solution
trials ,
in
was considered non-genotoxic
SQUIBB SARL Tél :
and 3A4 .
be monitored
.
metabolism
interaction
of adverse
is 50 International
g/ dl (
and AUC
,
an
a half-life of a
, 1,18 ;
Insulins and
410 500
- 8°C )
doctor or pharmacist
are breast-feeding
of
Following concomitant
Aclasta and 0.8
.
( see section 5.1
( or if
.
,
days 21
+ 354
(
or to any
blisters
ABILIFY
.
% isophane insulin .
therapeutic margin
g/ dl
hypoalbuminaemia , polydipsia
(
1.1
100
colourless
chest pain
sufficiently investigated and
100 , less than
any confirmed or suspected
g/ dl
or unplanned ,
dehydration )
be
be reduced
:
Iserlohn , Germany
stomach discomfort ,
or
Abseamed
patients treated
Oral
) ,
substance in
Bipolar I Disorder
)
sudden
ABILIFY
not been established
.
.
effect of insulin
subjects ,
per
alfa
2
active malignant disease
tumours ( 683 breast
( 0.62
300
: extrapyramidal disorder
.
products to affect ABILIFY
.
Hypocalcaemia In clinical trials
of
should be closely monitored
a cartridge ( 3
been reported
3 times per
PRODUCTS
is
( MTP
and
this
aripiprazole and dehydro-aripiprazole are
to
orodispersible tablets
aripiprazole .
in children
7.5
,
and
and the Montgomery-Asberg
(
any of the
) , where prophylaxis
.
significant
management of overweight and
LTD Tel :
pharmacist
49
with
Treatment of
IU/ kg 3
-
,
People
sedation , headache
.
mg
epoetin
swelling of hands ,
dose adjustment is necessary
per
the missed dose
(
What ABILIFY is
of the
.
of 0.4 ml contains
placebo-controlled studies
maximum
and
of
Tel : +
.
unused product
per
free from particles and
in Saccharomyces
and
over 30 kg
contains a
to 6 weeks )
einer Adipositas
sufficiently investigated and
13 g/ dl
( BSAP
of digoxin , warfarin
Due to
:
apparent in animal studies
not
treated ( e. g.
receiving chemotherapy
the incidence
, myoglobinuria
.
The usual dose is
not been established
Patients should be
.
prescribed by
In
MEDICINAL PRODUCT MUST
The
and 11 g/ dl
, ventricular
Co KG
either CYP2C8
104 The recommended
the
the patient should
and other erythropoiesis-stimulating
to erythropoietins have been
MUST BE STORED
.
, diabetic ketoacidosis
- 8°C
events in
4.4 ) .
0)20 3116 8954
in
to
cartridge
infusion fluids
Try to take the
mixed episode
magnesium stearate , red
,
in
weight
has not been
Cytotoxic actions of epoetin
at least 2
in patients
concomitant systemic disease
of aripiprazole ,
2°C -
decreased appetite
be administered intravenously
clinical trials ,
in
, hydroxylation , and
.
.
dehydro-aripiprazole , but
In particular , no
Non-clinical
% of
In
patients
aripiprazole
have
or
approximately every four weeks
:
store them in
genotoxicity tests
several
aripiprazole
recommended
) to 12
mmol/ l ) .
of
pioglitazone
or if you
ketoacidosis or hyperosmolar
should
BRISTOL-MYERS SQUIBB BV
)
14.2 %
patients ) .
Like all
another ( see
any
per orodispersible tablet
syringes contain
a lesser amount
SAFE AND
e. g. stenoses
, headache ,
post-menopausal osteoporosis (
Centre (
in patients (
non-healing
BRISTOL-MYERS SQUIBB
in favour
of the
Treatment
significant
with
If you
.
corresponding to
reaction
in
hours in
, abnormal
The terminal half-life (
Europe
blurred
with
of paclitaxel has
the medicinal product has
an
only
)
RH12
abdominal discomfort
6.2 % with
shown
growth hormone
occurred in
OR WASTE MATERIALS
MEDICINAL
hours
bone
dextromethorphan/ 3-methoxymorphinan ratio )
)
baseline
the patient
be
,
As with other
,
for injections Hydrochloric acid
Gate Wellington
53
how
increased Creatine Phosphokinase
control group
) , increased
, osteoporosis in
Aripiprazole
and 98
of epoetin alfa is
353
two
Since insulin and
5 mg
IU
between 17 and
( see section 4.4
.
( IU
.
)
10
doses above 45 mg
with
) .
APPEAR
3 ml equivalent to
water for injections
Adipositas
fatal outcome has
(
other
sulphonamides .
medicines called antipsychotics
monotherapy
Metabolism Human
improvement in
,
)
is very rare
the pharmacokinetics
light .
SALE
and
pregnancy .
observed
)
,
30 mg tablets are
per
10 ml
event onset .
less than three
psychotic features
suspension
, suicidal ideation ,
is ready for use
of
be paid to sudden
Cardiovascular
.
Iron supplementation
Insulin
patients
can
of efficacy or
hypothermia , pyrexia
) 749 749
is 32,000 to
used in humans
.
15 4.5 Interaction
Each tablet contains 45
not
your doctor or
E218 ,
7.5 mmol/ l )
70 The
with
Actos
300 IU/ kg given
e. g. during
PRODUCT
hypersensitivity reactions
30 % ) .
without
, injection route
7.2 % ) .
human dose or exposure
mg
of
with
(
including
appearance ,
corresponding to 75.6 micrograms
trials with
given weekly for three
in man is 5
and
.
shown significant benefits
blood , Abseamed should
1
trials
meal on the
Oxford Road Uxbridge -
5.3
( see section
Oral contraeptives ,
- Middlesex UB8
somnolence , tremor ,
elderly patients with
150 30 - 100
9.5 years
If the
Common :
corresponding to 42.0 micrograms
in
If
(
should be
dosage or
of
administration of recombinant human
(
, nervousness
were
Each ml of
and
colourless
animal models of
of
mmol/ l )
precautions for
24 hours
% Actraphane 20
disorder , akathisia
to
( Madrid ) Spain
nursing mother presents no
WITH
patients
,
have
13
between
)
Europe )
63 patients with
of dissolved insulin and
3
use of
and
SQUIBB
is
in post-menopausal women
The
with metformin and /
maintenance doses than
,
jaundice
% for
CLAS ) .
.
in
FACT-An )
mg
Rare
in
aripiprazole
The peak
you
of Epoetin alfa and
aripiprazole
,
the
%
aripiprazole
with
Iron supplementation should be
used
Novo
bone marrow fibrosis of
between 10 and 12
and 12 g/ dl
alfa ,
anaemia
, diarrhoea
.
in
This is
tablets 28
Middlesex UB8
Treatment with Abseamed
redness
in type 1 diabetes
The
, in
, constipation ,
see
( particularly overweight patients
( see
, hyperglycaemia
.
or
3 mg aspartame (
patients
+44
CONTENTS
.
prophylaxis by
of
10
units (
) .
forms of interaction
( 0)810
of erythrocytes from precursors
of
of
dose is 9.75
anaemia with
medicinal product
mmol/ l
,
10 000
NovoLet delivers
hypoglycaemia may
who suffer from a
Holder
agents
with
dysmotility and
patients
, the
OR WASTE
a manic or
mmol/ l ) in
,
(
normal
instability ( irregular
A-007
inform
symptoms ,
IU/ kg
the
outcome study of pioglitazone
.
per
1 ml contains 2000
After injection
D Centre
Actraphane is a mixture
- Middlesex UB8 1HU
intervals
0 )
route
Europharm Limited Wimblehurst
: soluble
KG Kuhloweg 37
is 32,000 to
pre-filled syringe of
migraine-like
concentrations
SARL
.
with your
lithium
12
0.5 ml
hypovolemia
GGT ) ,
, polycythaemic mice )
aripiprazole
Actos
injections Hydrochloric acid
patients
not
Syringes are
30 mg
vomiting
no medically
0.6 ml
(
pregnant women .
8°C .
,
pharmacist
a cartridge (
effect .
.
revealed no medically important
,
with renal impairment
Tel :
the incidence of
.
patients with or
2°C - 8°C
orodispersible tablet
g/ dl
tablets
PHARMACEUTICALS LTD Tel :
In
cartridge
and
)
Kuhloweg 37
and
At therapeutic
) , 2C9
) or the
, vomiting and
Pre-filled pen
The majority
.
Tel
:
has experience
above 45
mmol/ l ) should
or
63 In
of
and water for
or
not lead to
flushes ,
D Centre
in
( injection
,
SBECD )
or 24 hours
off
1,000 , less
and vascular
.
is
vary with
% had >
scale
solution for injection in
akathisia ,
of liver cirrhosis
times per week )
the active substance or
a
10
+
before
exposure to
( 172 breast
Insulin human , rDNA
than 2 g/ dl
5.3 ) .
, headache ,
In
epoetin
REACH
300
4.4 ) .
designed to be
the
and
who
39 06 5026
50
see section 6.1
2C9 ( warfarin )
fatal
7.5 mmol/ l
your pharmacist
patient
% with placebo
dehydro-aripiprazole
household waste
, aripiprazole
cancer patients
2C9
see
with sulphonylureas
advise you
administered once a day
-
and
administration of
%
metabolites
- 6.8 mmol/ l
ABILIFY can
for 2 weeks
used
.
The syringes contain
.
given weekly for three
reported (
should
CYP3A4
( see section 5.1
of CYP3A4
without
be paid to sudden
may be associated with
mediastinal disorders
patients with renal
stroke
the reach
administration
4.4 )
symptomatic
.
properties in animal
renal
the
and
week by
and
In clinical trials
of
260 lung ,
that
the
but
men .
.
mmol/ l
via subcutaneous administration
n= 938 ;
trials and
taking ACOMPLIA
( 0800 ) 731
solution contains 0.05 mg
or
3.0
.
Water
mg mitratapide/
.
0.5 ml contains
GmbH Tel . +
"
and
site
events
cause
8
-
manic or mixed episode
( see section
alfa may
.
or
packed cell volume .
:
with placebo
body weight 2 times
of continued therapy .
present state
in two studies
+
Paget s disease
Special precautions for
doses
The other ingredients
if
2 ) .
vomiting
)
at least 30
Lilly farmacevtska dru ba
quinidine occurs .
the
.
past
3
Centre (
:
12
advise you
g/ dl (
)
: +
trials , uncommon cases
600 International
weekly dose is between
for pH-adjustment ) ,
are pregnant ,
0.7 ml (
, intermediate-acting
or
ketoacidosis
diabetes mellitus
progression of diabetic
United
patients ,
, anorexia
, somnolence , tachycardia
, increased Aspartate Aminotransferase
0.8 ml
30 consists of 30
with or
pharmacist
constipation , salivary hypersecretion
improvement in
a reduction of
% ( 96
of administration )
g/ dl ( 6.2
, somnolence
4.3 ) .
(
g/ dl ( 8.1
well-controlled studies in
Global
100
gliclazide
.
12 g/ dl (
did
Dosage Dosage
the thighs or the
NPH )
For preventing
or
dose to
AB
68
Medicines should not be
: +
, followed by a
past
Fast improvement in blood
After injection of the
trials ,
epoetin alfa
the use of
hypertension
.
as measured
with
100
contains 6000 international units
change in their usual
, reports
)
in patients
are
in a multiphasic manner
4.2
2°C - 8°C )
;
clinical
month , or
alfa
diabetic
of
If epoetin
,
Oral contraeptives , thiazides
.
55 ml
mmol/ l
House Highbridge Business
in
recommended
,
hydroxylation
especially
may
IU
has been
that
this leaflet
alcohol or
most frequent adverse reaction
the most frequently
aripiprazole
the entire dose
( see section
)
or
treatment
section 5.2 )
75
increase the risk
efficacy
of your ABILIFY
900
Actraphane 50 Penfill 100
existing
, swelling
,
and Package Leaflet and
different time zones
cytotoxic
occurring undesirable effect .
risk of cross-reaction .
die Eliminationshalbwertszeit wegen
hypocalcaemia (
The syringes contain 1
should be alerted about
evidence of
5 vials
the insulin requirement
and
lorazepam
a pre-filled syringe
,
with
an
is
What ABILIFY is
(
)
( 5 )
,
thrombosis , arterial
or
or
in
clinically
7.5
on insulin
, treatment
of
12
the limited experience
a sterile syringe ,
tachycardia
( for pH-adjustment )
that epoetin alfa
MATERIALS
or very
international units ( IU
by
dextromethorphan/ 3-methoxymorphinan ratio )
:
pioglitazone
clinical
5.3 ) .
longer .
with
of 50
of the
in some
if
but
Maintenance dose between 25
3 weeks
surgery and
of pioglitazone
,
and
trials and
] ( n =
thrombosis
the metabolism of
) , increased
major
minutes
and 3A4
during
Based
supervision and monitoring should
Neuroleptic Malignant Syndrome (
overweight patients )
ABILIFY
or lithium concentrations .
of EPS including
and
Tel : + 353
in adult patients with
.
45
pharmacovigilance activities
g/ dl ( 0.62
including
on the
humans
followed by a
, Oxford
Use product immediately
9 %
signs and symptoms
solution
account when
)
This medicinal product
incidence
, µ :
studies ,
and 400 mg
, followed by
CI
oedema
The maximum
vary with age
.
.
prior to
ALT )
,
CYP3A4
of 10 g/ dl
( see section 4.4
encephalopathy-like symptoms
with haematological malignancies
the
4.4
the local representative
cartridge to function safely
is
In
five large controlled studies
Each ml of solution
well-controlled trials of
aripiprazole and dehydro-aripiprazole
1 ml (
Europe ) , Storbritannia
30 mg
Table 3.
10 000
in
a
)
your doctor
BE STORED OUT OF
If any of
Abseamed is
( 95 % CI
2 times per
)
( 1
be reduced
nausea , constipation
is
should be closely monitored
after
to
and differentiating hormone
studies
IU .
( 0)20 3116
dehydro-aripiprazole
( E 320 )
controlled
60 % isophane insulin
with consideration for
Sími
alfa
receiving non-platinum
Uncommon -
.
90 % Actraphane 20
)
cell volume
the
( 1 800
by
Any
.
haemoglobin is rising by
trials of
beyond
the freezer section or
these patients
There are
treated with Aclasta
d ise or uth
with
% )
injection sites
doctor
or worsening
paediatric
or
and aspiration have been
PRODUCT
than
been reported ,
manic or mixed episode
10
trials , rare
- Oedema Oedema may
cancer patients
treatment
,
GmbH &
1 ml
tumours (
Hypertensive crisis with
2.5 mm
TO APPEAR
is 50 International Units
adult patients scheduled
4.2
(
family history of
.
.
l
THE OUTER
in the
Abseamed 5000 IU/ 0.5
clinical trials ,
of
by the intravenous
or 15
in clinical trials
tongue .
with aripiprazole ,
is a medicine
glycaemic control
within a
)
Suomi/ Finland OY BRISTOL-MYERS
+ 44 (
see section 4.4 )
suspension
%
for one injection
der nach einem
.
SARL Tél
cartridge
.
food
may cause allergic reactions
white to off-white
,
mmol/ l )
.
route .
aripiprazole
Based on
t½ 0.24 and
1
USE
of
with
10
trials
,
or
aripiprazole
under the
you
MINIMUM PARTICULARS TO APPEAR
) , 2C9
efficacy in men
feel better
.
) as
, thyroid hormones and
of glass (
and magnesium stearate
- if the
in bipolar
The
after
a few days to
orodispersible tablets
epoetin alfa
) .
clinical trials and
in
.
NAME OF THE
300 gastro-intestinal
intermediate-acting
should
low-trauma hip fracture .
clinical
route .
other medicines
incidence of
%
USED FOR
with aripiprazole
to become
,
may vary with age
- If you
-
reproductive toxicity studies
rapid or irregular
.
administration
of Vantas is
,
should not be
while taking
The
43 1
% ,
The following side effects
the risk of
remain at
Medice Arzneimittel Pütter GmbH
-
0.8 ml contains
, 1,18 ;
on day 1
to the possibility
section 4.4 )
Actos 45mg tablets
weight reduction
The following
4000 international units
ABILIFY ,
increased
the effect
an
:
45mg tablets
Novartis Europharm Limited
in
4.8 and 4.9 )
Highbridge Business Park
ml
time each day .
,
UK Ltd Tel :
use
, and
( see section
bei allen außer
400 mg sucrose
ABILIFY
( 1 )
%
awareness
symptomatic anaemia associated with
76
)
studies ?
PRCA
the intravenous route
also had a
, exertional dyspnoea
Bipolar I Disorder
glucocorticoids ,
2 times per
other
transfer from animal
Diese Studien
Please tell
weeks
see Table 2 )
28 tablets
administration of recombinant human
no fatalities
115 PARTICULARS TO
unclear whether or
Your veterinary surgeon should
Close supervision
in
achieved
ml
12 g/ dl
)
attention should be paid
and postprandial
the
Shunt thromboses may occur
g/ dl
Treatment of
factors
see section 4.2
be marketed
proliferation
patients
solution
Overdose
27 % of the
adults
agitation and disturbed behaviours
- Peripheral
on mg/ m2
,
) were
, tiredness , nausea
phosphate dihydrate ,
a
over 30
treatment
the medicinal product
Haemoglobin variability
,
.
and anaemic rats ,
mg
nausea , vomiting and
anaemia (
In clinical trials
( 1 )
Tél/ Tel : +
THAT THE MEDICINAL PRODUCT
.
the administration
the
is necessary
: dehydrogenation
and
dissolved insulin and
: dyspepsia ,
see
of the warning
similar
A half-life
insulin
inhibitors of
rare cases of NMS
, neuropathy ,
contributes about 58
recommended ( or if
4.8 ) .
%
( Europe ) ,
reported after months
should be
by
,
, 90 and
, vomiting and
contain 0.4
than 2
,
: + 47 67
,
bronchoconstriction
than 1
Within each
In
in
month before your
Tel : +46
4.10 Overdose
100
, the
for pH-adjustment )
use of pioglitazone
.
negative
(
should
Actos 15 mg tablets
300
blood , Abseamed
in patients
4.2
)
weight gain is
accidentally
Global
with
) .
Detailed information on
( 1.3 ml
: +44 (
previous stroke who
Abseamed
OR WASTE
programme
is
Abseamed
by significant intra- and
.
of 10
mg of
( e. g.
24
.
.
172 breast , 64
,
)
occurs
in children
screwed back on tightly
addition
Oral contraeptives ,
been
pH adjustment )
and CYP3A4
enterocytes may be followed
due to
Uncommon :
risk of cross-reaction
When
require higher maintenance doses
normal and anaemic rats
behaviour
10
sterile syringe
In patients with
to tell
dose
the
.
when
This medicinal
and precautions
OR BY UNIT
( an antidiabetic medicine
(
, glucose-galactose malabsorption
conventional studies of
D Centre Limited
change in
,
%
( 6.2 - 7.5
by
insomnia ,
and
.
.
55 %
The AUC
pancreas
.
between
trials
Dennoch
of Actos
( hypoglycaemia
from the
24 hours after
THE REACH
six identified metabolites
particularly
: +44 ( 0)20
,
cases of
including PANSS
prescribed dose when concomitant
) .
, IF APPROPRIATE
REGARDING
.
It is available
50
, tremor , dizziness
0.9
, hyporeflexia ,
No evidence exists
scheduled
.
1
24 hours
with or
.
sodium per dose
BRISTOL-MYERS
potential
, in
they
microcrystalline
.
of
( human ) .
International
or
.
treatment
.
dopaminergic hyperactivity and agonist
:
patients
patients with
0.5
g/ dl ( 1.25
over 3 weeks
-
frequency grouping , undesirable
Brytania Tel : +44
These
410
.
differentiating hormone , the
than
cases ,
tablets 98 tablets
blood sugar
( see section
tumours ,
you are considering stopping
been reported ,
are being
intermediate-acting combined
starting dose is 15
haematocrit of 33
insulin human
trials involving 1,228 schizophrenic
few minutes
precautions for
( human ) .
entire orodispersible tablet on
Cmax
no fatalities
360 dogs over the
aripiprazole failed
.
trial ,
D-58638 Iserlohn
headache
of the stem cell
.
France
.
50 : soluble
,
GmbH
below 30°C
mmol/ l )
Park ,
, angiotensin converting
9000 IU/ 0.9 ml
dose regimens .
tachycardia
clinical trial in healthy
Iron status
ABILIFY
, itching ,
the CYP3A4 inducer
new vertebral fracture (
Beta-blocking agents may
is 0.25
aripiprazole and
, nausea
( normal
in
also be necessary
60
) .
4
, diabetes mellitus
hyperglycaemia
The
needle
section 5.2
therapy
pH adjustment )
schizophrenia and manic
in some
effective as metformin and
IU/ 0.7 ml
4.8 )
irregular heart beat
Aclasta infusion
this should be
(
be paid to sudden
g/ dl
The
e. g. anaphylactic
patient population
using an alcohol wipe
58 In
anaemia associated with
large
8.4 micrograms epoetin alfa
blurred vision
mice .
and
lower
.
( 0)20 3116
Co
placebo-controlled trial
For Paget s disease
angioedema and anaphylactic reaction
in whom
* Produced in CHO
is
interaction
is usually reversible
prospective ,
per month
previous stroke
contraeptives , thiazides ,
in
be
the
, close medical
and
and
vials are for
on
of CPK
45 mg
a
to protect
: +44 ( 0)20
incidence of clinical
8°C ) .
than
in
patients over 75
.
182 ABILIFY
83 Tardive
complications
four placebo-controlled
ml
administration
between
4.2 Method
)
% ) and
In placebo-controlled
and extrapyramidal
pharmacokinetics
at the desired level
The daily
TO APPEAR
elemental
: +33 ( 0)1
or
with
)
epoetin alfa
( see
the
) per orodispersible tablet
ideally starting before
vitamin B12 or
vascular
studies ,
and
and blurred
Skin reactions
EPAR for
CPK
units
)
A
MEDICINAL PRODUCT
- United
30 mg
3 ml )
are usually
is
the following side effects
of
is
6 hours has been
, hypoalbuminaemia ,
The
greater than 12
of
and
, 2C9 (
AUC
.
balance ,
Treatment
overdose
The
section 4.4 -
12 g/ dl
1 60
not
patients
peak is always
patients
8.1 mmol/ l
the active metabolite
weight gain ,
aripiprazole and
86
or
have an increased
concentrations , aripiprazole
anaemic patients .
anaemic
moderate binding affinity for
see section 4.8
initial dose is
aripiprazole or any
placebo-controlled
Abilify has not been
over 30
,
corpora
g/ dl (
is
,
minor metabolites ,
the human insulin molecule
The
,
sensory disturbance , somnolence
taken
SPECIAL WARNING THAT THE
section 4.5
SQUIBB
Manufacturer Marketing authorisation holder
to
some cases
an increased risk
diabetes
see section
longstanding diabetes
, the incidence
Uncommon
Co KG
and suicidal ideation in
Sanofi
The initial dose
Abseamed
with
should be discontinued (
epoetin alfa
) .
in the
DISPOSAL OF UNUSED MEDICINAL
family history of diabetes
Patients
in a blister
than
:
blurred vision .
.
87 % .
not be added to
) and 802
Takeda Global
After
and method of
or
) 241 941-0
SQUIBB BV
24 hours
.
obesity
of ABILIFY
tachycardia , nausea ,
the
orthopaedic surgery
7.5 mmol/ l
8.1 mmol/ l
with
once a
assay .
14
1HU -
are pregnant ,
studies
ABILIFY
insulin
, United Kingdom .
prophylaxis by
recommended ( or if
no evidence of clinically
and
Highbridge Business Park ,
, 2C8/ 9
- decreased locoregional control
children over
Eye disorders Very
of efficacy or other
thrombotic events
alfa
trials of aripiprazole in
mmol/ l )
patients
.
occurring undesirable effect .
3
QT prolongation ,
patients with
In
;
the
Common :
erythrocytes from precursors
( IU
and
see
a
is given subcutaneously (
to affect ABILIFY :
subcutaneous route and
extreme and associated with
patients
abrupt improvement in
The maximum
Bipolar I Disorder
Persistent pain and/ or
undergoing dialysis (
administration of CYP3A4 inducers
Nederland BRISTOL-MYERS SQUIBB
34
after
Die
patients
orodispersible tablet
30
or valproate
+
with pioglitazone
interaction
( 7.5
to 2
,
see
doctor
in cancer
is controlled
is the risk
products
Common :
syringe onto a
g/ dl
2°C
ketoacidosis (
Novo Nordisk
take the
food
long-acting insulin
first trimester
67 55
Suicidal thoughts and
programme ,
.
patient
is rapid
36(0
that
( FINLAND
- In pregnant or
younger
ACOMPLIA
possible warning signal .
of akathisia in bipolar
incidence of
controls
The active substance in
three
sweating
fatigue Psychiatric
international
dose is
corrected for
) , chest pain
Uxbridge -
45
+ 31 34 857
see
In the
terminal half-life is determined
( 1.25
, glycine ,
dose is injected
(
Hunton
of your ABILIFY
effect
week by the intravenous
PACKAGING
or
headache
the placebo group
multi-pack comprising
shortened overall survival
OF
of a full
Driving
1
Upon discontinuation of
have
an
In clinical
product
pre-filled syringes are
The potentially
SQUIBB SARL Tél :
dextromethorphan/ 3-methoxymorphinan ratio
Hb
)
, brand ( manufacturer
per week
reported in children
decision to administer
period .
60
medicinal
with
.
,
treatment outcomes
lithium or
alfa
Puh/ Tel
of children .
needle
by a decrease
is achieved ( this
D-58638 Iserlohn ,
( 6.2
per ml
also
compared with those
encephalopathy-like symptoms (
Hypertension
33
the
on laboratory assessment
necessary amount
If
,
and
erythropoietin
precautions for
two equal
recommended
treatment with
Driving and
clinical trials
) ,
cells/ µl
Actraphane
study
or blood pressure ,
and other
MINIMUM PARTICULARS TO
this medicinal product must
overweight patients
32
section 5.1 ) .
rats
efficacy
,
see
, 30
weight decreased
All
take more Actos
dehydro-aripiprazole did
aripiprazole
injections
back
with
of 50 IU/ kg
.
Detailed instruction accompanying the
, RH12 5AB
:
between 25 and 50
contains 9000
where prophylaxis
.
orodispersible
g/ dl (
Europe
- Aclasta 5 mg
see
should be investigated .
.
181 Tell
,
of epoetin
combination with insulin
with
other three
% of
medically serious signs and
compared
patients
,
(
or hepatic impairment
/ N. V.
patients the incidence
your
treatment with
how your
patients
by a decrease in
has
increased
.
) .
( see
prevention of a new
and 33
with
37 D-58638
recombinant human
male patients
increased risk
Wimblehurst Road
of
[ 95 % CI
Therabel Lucien
.
erythropoietin
important differences .
000
cases of stroke
on day
sensitivity to a
IU of insulin human
,
epoetin
bilateral
4.8 ) .
section 6.1
This
has
uptake into bone
The
and
ml oral solution
was last approved on
sodium hydroxide
Abraxane may
1 tablets in
retinopathy .
.
was 12.1 %
when
of
and symptoms reported
It is
Storbritannia Tlf
administration
.
tactile hyperesthesia were
a
should be disposed
BRISTOL-MYERS SQUIBB NORWAY LTD
Brytania Tel
(
rare cases fatal
population ,
Treatment of
per ml 0.2 mg
you
and
7.5
pre-filled syringe
be followed
the
aripiprazole (
in
dose
most clinical trials
in section 4.2
cartridges
RH12 5AB United
-
:
months of
three
that
route
under 30
and post-marketing experience
that the
bipolar mania
Novo Allé DK-2880
( see section 4.4
2007
occurred
3 times
Moreover ,
with
0)20 3116 8950
Consequently ,
for 2
)
Novartis
Inadequate dosage or
be used
to
that aripiprazole
.
4.5 Interaction with
and its metabolites are
randomised
and you
( 0)20 3116
greater than 12
Allergic reactions have
also be used .
haematocrit of 33
the incidence of
trials
your
(
MEDICINAL PRODUCT AND ROUTE(S
QT prolongation
receptors
a
)
manic
.
Tél : + 33
)
medically important
are not
of one year or
antipsychotic drug
types of paclitaxel contain
peripheral oedema
based on conventional studies
months
epoetin
hours in
condition may also
Limited
be avoided
.
but
.
Maintenance dose between 25
to
SQUIBB
vivo
see section 4.4 )
may
a kidney patient
,
placebo .
for major elective
ABILIFY
should
extensively metabolised
and
( see Annex I
, close medical
no influence
undergo periodic
What ABILIFY
mmol/ l )
placebo-controlled
2
and diabetes mellitus
subcutaneous tissue
&
symptoms can occur
pharmacist if you are
of
is well
of CYP3A4 ,
,
.
Welches Risiko ist
.
potassium
mmol/ l
31 34 857
medicinal
treatment with two other
not known
subjects ,
in two main
1 800 )
) ,
the
)
not
diarrhoea
is
of
Cancer
insulin 20 % and
and
with treatment with pioglitazone
]
is
,
risk for
your dentist
.
4.8 - General )
of the bone
section
is
( 65
your dog will
with quinidine occurs
week
pneumonia
in
% of the
injection , intermediate-acting
interaction
172 breast
is a
haemoglobin
tachycardia , nausea ,
.
alfa
hypoglycaemia
pharmacokinetic
OF UNUSED MEDICINAL
A
6
(
1
and
and
7.5 mmol/ l )
x ULN
.
year
other antipsychotics ,
treatment
& Co KG
)
75
trials of aripiprazole
:
Starting dose
of Aclasta (
2 g/ dl
decreased blood sugar (
Maintenance dose between 17
.
healthy
weight gain
mg of
injections
infusion
via the kidney
Subcutaneous
( see sections
( see section
the pooled atrial fibrillation
33 ( 0)810 410
,
- Middlesex
injections
Tlf
Actos
x
.
or 24
not
the medicinal product
10 % dissolved
and disappear
Abseamed has
between
Epoetin
compared to
red blood cell
has
the intravenous route .
7.5
rapid or
ingredients
included
essentially sodium- free
Middlesex UB8
increased risk
chronic renal failure
, 30
.
In most of these
doctor or pharmacist
erythropoietin
( see section
Treatment should only be
( see section
diuretics
( see section
or
or
symptoms
epoetin alfa
mellitus
REGARDING SUPPLY OR
(
you
,
safety of
itching
no
patients with renal anaemia
intravenous infusion
and a
.
Seizure : in
flatness
In a
pre-filled syringe
patients with
international units (
no adequate and
)
in isolated patients with
12 g/ dl
, nausea , vomiting
20.9 [
treatment with two other
compared to
2 352
in animals The safety
RFT ] )
all
erythropoietin
- 7.5
blood pressure
)
Following concomitant administration
women treated
an
improvement
PRODUCTS , IF APPROPRIATE
-
30 kg and
akathisia , tremor ,
.
Global R & D
.
protein binding
50 , 56 ,
.
more
placebo :
should
the reach
dehydration and pale
ml ( 4000
alfa
and magnesium stearate
efficacy
The medicine
Because these events
.
a recent
reactions
( as hydrochloride
Eli
levels remain the
of Cmax and
The maximum daily dose
-
.
1 60
angioedema and
EPS including parkinsonism ,
Oxford Road Uxbridge -
epoetin alfa
Sími : +
2°C - 8°C .
Risk factors
( e. g. aminoglycosides
clinical trials
Patients should be
.
aripiprazole in the
insulin .
of transfusion requirements
active metabolites
osteomyelitis ,
OF THE MEDICINAL PRODUCT
used for 2.
000 IU
135
and its
(
Based on laboratory assessment
through the
11 g/ dl (
or telithromycin or
The recommended dose is
Bei
and transient .
Vantas
been treated
mg
medicinal products :
to 12 g/ dl
,
headache ,
SQUIBB BV Tel
7.5 mmol/ l )
other medicinal products :
or
this condition
PRODUCTS , IF
(
per
The pharmacokinetic characteristics
is therefore
the incidence of
insulin requirement .
from
g/ dl (
subjects
+
as a result
:
the
,
the incidence
15.0 ,
half-life
( this should be
significant benefits
with aripiprazole and 3.2
achieved
patients
.
with this condition may
,
from hypoglycaemia .
Pioglitazone
inhibitor of osteoclast-mediated
occurs .
a cytotoxic
( 0)20 3116 8952
25 800
of 1 ml 6
until
patients
take more
of dehydro-aripiprazole
studies
Aclasta
hypotension*
or without
increased incidence of
nausea , vomiting ,
dehydrogenation , hydroxylation ,
patients with
One
Glycine Polysorbate 80
704
a
both groups
male patients
44 ( 0800 )
37 ,
and
alfa
Novartis Europharm Limited Wimblehurst
(
.
chronic renal failure and
of
patient group .
use in
; suicide attempt
0.5 ml contains
characteristic
( see section
a
and
placebo-treated
the pharmacokinetics or
may occur
trials and
clinical
blood pressure
Latvija Eli Lilly Holdings
and
1
patients with severe
Subcutaneous injection into
( 6.2
rats
initiation of
% ) .
Hydrochloric acid
of
the pharmacokinetics
PHARMACEUTICALS LTD Tel
drive
.
increased
weeks
clinical trials and
effect
increased risk
may
25 and 50
patients with
WC2B 4AE United
(
impact
,
Aclasta-treated group
at increased risk of
regarding
, sudden unexplained
.
cases
events
( See section
muscle pain
.
may
There are no
of in vitro solubility
6.1 .
2
, but not
mg
is
.
pulse or
Adult surgery patients
ketoacidosis
only in
,
tubing
dose is 600
Actos 45 mg
Withdraw the
over 24
significantly
Tardive Dyskinesia
reported estimated
.
or
and mammalian cell
liver problems or
Kingdom BRISTOL-MYERS SQUIBB
aripiprazole
,
women
IU/ kg 3x/ week
.
or
for
, usually in
blood pressure
akathisia , tremor ,
6.2
in
of these
see section 4.4
manic or
ml contains 8000
warnings and
these findings
Paclitaxel has
patient
.
administration of recombinant human
scheduled for major elective
:
or
of the study
in schizophrenic
3 ml .
In
In patients
be
increased
nurse
)
may
(
not
rapid or irregular
days
Erythropoietin is
vomiting and diarrhoea
recommended
protein intake .
GGT
76
usual
,
0.5
:
was
( 2°C -
adult
) .
8°C )
)
been demonstrated although individual
not
a manic or
or
angina
,
.
usual dose is 15
: dehydrogenation
cytochrome
trials
warfarin )
Patients have
(
12 g/ dl (
tablets 56
%
the occurrence of
(
In a prospective
starting dose for
.
a
transfer from animal
56 , 84 ,
to sudden
DK-2880 Bagsværd Denmark
What
, an
or
for pH-adjustment
.
In a
and
efficacy
pioglitazone
BRISTOL-MYERS
orodispersible tablets
% of the
21 % of
%
Hb between
not
with renal impairment
the
.
mixed episode
( ALT
000
.
see section 4.4
MANUFACTURING
Always take
of the
- 300
read the
Common
adverse
placebo
also
are
IU/ kg
osteoporosis in post-menopausal
section 6.1
the
Dose adjustment in order
Abraxane at dose levels
women
swelling of hands ,
of dosage
Severe hypoglycaemia
weight gain
- This
hours
instability ( irregular pulse
injection ,
Tél/ Tel
,
can occur (
between 9.5 and 11
) .
weight decreased
hypoglycaemic effect of
of Aclasta 5 mg
and
was
you are pregnant
) .
% and
over
osteoporosis
entire orodispersible tablet
has been
ABILIFY solution for injection
olanzapine-treated patients .
.
risk
of the hormone .
and
PHARMACEUTICALS LTD Tel
binding is
) , or to
section 4.5
efficacy
32 2 352 74
.
used in humans .
: + 34 (
effects
studies
based
wastewater or household waste
be considered (
for
REACH AND SIGHT OF
of in accordance with
Ltd Tel : +
and
352
contains a
) .
ml
.
5.3
ABILIFY is used
hypothermia
significant
the symptoms of
14
Road
%
1.25 mmol/ l
of weight regain
ON BLISTERS
g/ dl ( 7.5
be
thiazides ,
of
of
by
paclitaxel .
round and
lung
,
hypertension ,
In a
oral
disorders and
IU
the blood pressure is
,
, dizziness
mice
findings from
these
Europharm Limited Wimblehurst
these
to drive and
significant
pre-filled syringes of
PRODUCTS OR WASTE
treatment .
the
be avoided .
correct
entire
is a
anaemia ( e. g.
of the
, including PANSS
Patients have
Patients
of clinically
well
) of
These trials included patients
Wingates
, increase the risk
children
.
omeprazole )
(
or
34 %
Belgique/ België/ Belgien BRISTOL-MYERS
of anaemia
rapid or
administration of epoetin
30
impairment
should
,
BSAP
mother presents no
insulin dose
in
(
12
section
a clinical
decreased sensitivity
1,000
for 2.
this
, Oxford
30
laboratory parameters
, alpha-1
infusion ,
psychosis
have been proposed ;
In several controlled
Close monitoring of
,
Part of the treatment
34
elective
, 84 AND
& D
of pioglitazone
insulin
and
severe manic
dose of Aclasta for
incidence (
patients
or if you
(
akathisia was 6.2
:
dihydrogen phosphate
of 2
and extrapyramidal
see
rash
are
IU/ kg given subcutaneously
&
Actraphane Penfill is
30
chronic renal failure patients
,
revealed
week
section 4.8 )
post-dose symptoms
patients with
of
should be checked
antihypertensive treatment
+
or
480
trials and 8167
of
in patients
, serum levels
Ísland VISTOR HF Sími
Uncommon -
.
However ,
injection
mg )
combined with
known as non
: the levels
EPS was 19 %
you
.
thiazides , glucocorticoids
bone marrow cells
cerevisiae
with
It
,
- Middlesex UB8
:
signs and symptoms
( see section 4.4
0.4 ml ( 4000
be discontinued immediately .
of
4 or more units
Insulin suspensions should
solid tumours (
Insulin suspensions are
see section 4.5
your pharmacist
or
age 18 years due
ketoacidosis , diabetic hyperosmolar
: up to
see sections 4.8
, or
It
and
Limited
in
, and
be marketed
or any
in approximately
has been
patients participating in
hyperosmolar coma
diabetes mellitus
4.4
with
.
may
(
hypertension and/ or dyslipidemia
ACOMPLIA darf bei Patienten
Part of
Patients
(
should
section 5.1 )
and
and
to 16736
from hypoglycaemia
55 % ) and
than in those
) .
active substance is
.
not
medicinal products .
) sealed
the potential risk
.
.
slowing
stabbing
white
ml solution for injection
healing was comparable
the
epoetin
alfa has been
concomitantly .
of glucose
, creatinine and
.
the
the
incidence
, the incidence of
% )
are generally not well
gliclazide as monotherapy was
,
section 6.1
controlled
oral solution 480
tablets 56
pioglitazone ( see section
diabetes
and
other antipsychotics
.
Europe
.
Therefore ,
fast-acting , insulin
of
scheduled
reversible and dose
, Storbritannien
tablet contains
humans . dic
ba Latvij
IU )
improvement from
)
units (
haemoglobin
,
( ketoconazole
.
dyspepsia , vomiting
resulting
in the face
week by
: + 358 9
and Cmax of dehydro-aripiprazole
biological efficacy of epoetin
this with
and Diabetes
closely monitored throughout this
has been observed
USED FOR
duration ,
should
a
) or
of 6-7.5
the other
The majority of these
hyperosmolar
not
Reticulocyte count
Maintenance dose between
Cmax of
hip
No evidence exists
with
) should
solution
and dizziness
trials
therapy .
)
of
the
and
Ongoing major
epoetin alfa
( or
, Wielka Brytania Tel
treatment with metformin
should
APPEAR ON THE
272 16
with oral aripiprazole
In the indication increasing
glucose
800 ) 749
section 6.1
doctor
, or
in patients with
the four
been reported .
a dose
insulin and
and isophane
80
hours has been
France BRISTOL-MYERS
and Cmax of
Common
this leaflet carefully
vascular
In
Insulin human
between 10
in humans is
was 7 times
treatment with epoetin
more
of the
decreased
based
to protect from light
therapeutic margin of epoetin
a manic or
)
of
26-week ,
have also occurred in
The white
(
of epoetin alfa
.
opening .
no
with
Flushing , hot
1.25 mmol/ l )
also
surgery
,
who have a
patient population and
international units
and/ or
Abraxane should
34
(
A sustained haemoglobin level
from
,
with
aripiprazole
in
.
0.99
1.25 mmol/ l
or
akathisia was 6.2 %
the
All
see
.
Attention should
The dose of
ähnliche Wirkungen
NMS
)
fat meal
in favour
diesen Patienten sollte
is 15
may help to
for rimonabant
, postural dizziness
more than 1
and
Uncommon : orthostatic hypotension*
, serotonin 5HT1a
( iron deficiency
emission tomography
to maintain haemoglobin
may
with aripiprazole
main measure of effectiveness
your doctor or
by the intravenous route
in
injection
at doses of
due
not necessarily in association
or
Within
month ) with
included
International
e. g.
with epoetin alfa
4.9 ) .
in patients with
effect of
becoming less common
24 hours after the
As for
close medical
(
to
clinical trials , uncommon
cell line by
less than
Co-administration
a
controls (
machines .
insulin and
as a mitosis-stimulating
Actraphane 40 Penfill
cases
aluminium lake ( E132
data on the use
other medicinal products
, tell your doctor
prior to
administered by intravenous
See section 4.4 )
been reported
contains
Uncommon
.
have also occurred
) and/
4 or more
with epoetin alfa
,
see section
clinical trials of aripiprazole
dose
3A4 (
Treatment of
or insulin .
.
safety of pioglitazone
the food
45 93 05 06
a
aggravation of existing hypertension
)
or valproate
g/ dl
in patients (
Hypoglycaemia
in pregnant women .
benefits
angioedema and anaphylactic reaction
clinically
section 4.4 ) .
see
jaundice , hepatitis ,
, insulin requirements
in
controls
)
anaemia in
sugar lumps
27 %
Europe )
Aclasta
and beta-sympathomimetics
aripiprazole
no
risk
and
listed below .
.
your
clinical trials
300
7000 international units (
having excessive
combined with fast-acting
unchanged aripiprazole was
between 25 and 50
with
higher than
%
minutes )
maximum of
physicians
in CHO
General )
Limited Tel
unchanged aripiprazole was
600 International Units (
Wimblehurst Road
,
the injection
the
serotonin
diabetes
male patients (
renal impairment
patients with
be necessary when
and
of cleavage (
are generally not well
Thrombotic/
%
If
GGT ) ,
Te . : +44
per se of insulin
time to disease progression
e. g. hypothermia
( Europe
units (
your dose
Arzneimittel Pütter
and a negative
g/ dl (
Store
0.62 mmol/ l
.
some cases
contraeptives , thiazides ,
two weeks following
PRCA
Studies in animals have
, µ
effective in
patients
of 10 g/ dl
BRISTOL-MYERS SQUIBB
, less than
358 9 251 21
Abseamed
to protect from moisture
- In
" and
one of these trials
or very
, compared
.
section
of anaemia
(
Aclasta-treated
in cancer patients .
.
anaemia
with
should
result in foaming .
410
mg aripiprazole
.
8167 patients
should be discontinued .
other handling
1 ml
in a
the pancreas
absorption .
of greater than
The usual dose
12 g/ dl (
given by injection
SQUIBB
In
sections 4.3 and
have
interaction
cancer
mellitus
NMS
2.5
in
below
Aluminium perforated
akathisia in bipolar
mg zoledronic acid anhydrous
pulmonary embolism
of
.
, insomnia ,
blisters
men
adult patients
insulin
g/ dl (
, IF APPROPRIATE
173 Detailed information on
In most
should
In
reactions
Actual scores
CYP3A4
a
recombinant human
the
:
) ,
einer
( type 1
: + 351
) , Storbritannien Tel
and AUC
doctor
ml contains
AND
below 30°C ) .
in 24
minutes ) .
1 ml
between 1.25
haemoglobin and blood pressure
: in clinical
.
, constipation
than
with haematological malignancies
2C19 ( omeprazole )
compared
higher plasma concentrations
administration .
l
)
before
and sometimes
12 g/ dl
the patient
of progression of
Epoetin alfa and
should
in maintaining the clinical
and
61 Aldwych London WC2B
with
or
clinical trials , an
non-selective beta- blocking agents
ON THE
( see
In
and
[ RFT ] )
2.47 in favour
of patients
Abraxane
rDNA
of
When weak inhibitors
hypoglycaemia whilst driving
in increments of 2
" A " over
risk
symptoms
of Cmax and
this
zoledronic acid monohydrate .
brand ( manufacturer
before you
of increased insulin sensitivity
in
and
in children and
well
a bromobutyl/ polyisoprene rubber
( injection
facilitate the
of 0.4
of dissolved insulin
Fasting and
inhibitors of CYP3A4
% of patients
the
pioglitazone
,
( hypoglycaemia )
,
zoledronic acid anhydrous
(
,
that
and precautions
,
per month
4.2 Method
pioglitazone
diabetes
Wimblehurst Road Horsham
, administer the product
risk
see
of
.
52
Erythropoietins are
with
in
.
of
with lithium
severe
( 55
13 g/ dl ,
is
unconsciousness
, long-acting
2°C -
with
precautions for
is
controls
56 tablets 84 tablets
90 tablets
signs
1 or 2
the skin
75 - 150 60
is achieved (
- This medicine
+33 (
may impact on
ml ) ,
cyclosporin
analogues for
patients
In a
in
g/ dl
,
haloperidol
no adequate and well-controlled
( human
kidneys .
( see
in this
Abilify has not been
and adolescents under
20 consists of
Many
from the use of
(
.
how
MUST
unused product
before you
In clinical
as
PRODUCTS
both studies ,
patients with
and
IV
see section 6.1
the
, given weekly
with
704 71
administration
not
when
important differences
1 orodispersible tablets
No
a similar
Distribution No
House Highbridge Business Park
ABILIFY
, corresponding to
equivalent to 300
4
the incidence
with
patients
Always take
maintain haemoglobin concentration
increased Aspartate Aminotransferase (
doses
This medicinal product contains
17 , Km 22
)
Keep out of
this
BV Tel :
704 71 00
or hepatic impairment may
84 tablets 90 tablets
4.7 Use during
substitution
may be
for
per
Elevations
West Sussex , RH12
dose of
the
)
) Yarvitan
EPS was 19 %
with
( see
Manic episodes
lung , 22
solution (
( 0)20 3116
fractures
section
France
All
Water for
.
BRISTOL-MYERS SQUIBB AB
dose is injected
cloudy after resuspension .
caution
)
or
which is primarily hepatic
for rimonabant
, 14
,
when
( 6.2 - 7.5
blood , Abseamed
and
6.1 months (
( International
If
severe
Adjustments of daily dosage
The
of the
Cancer Therapy- Anaemia
erythrocytes
9000 IU/ 0.9 ml
after
, the
rare cases fatal
symptoms of
a
3 times per week
aripiprazole
+3726441100
10
of 10 g/ dl
no
150 60 - 150
enzymes and
possibility of multiple medicinal
and 30
( see section 4.5
also be used .
( 95 % CI
patients
oral solution
Nederland BRISTOL-MYERS SQUIBB
)
) .
which were
4.4
( human ) .
( 5
Diabetes Mellitus : hyperglycaemia
haemoglobin and blood pressure
dextromethorphan ) .
potent inhibitors of
concentrations , aripiprazole and
.
section
.
353 (
serious adverse events When
in
in
patients
g/ dl ( 7.5
and
other forms of
Europe ) Ltd
,
day
It
monitor ACOMPLIA
renal
fast-acting ,
treated with aripiprazole
Rimonabant
%
139 out of
MEDICINAL PRODUCT MUST
disorders Common :
-
headaches as a
Alle Patienten unter Abseamed
exactly as your doctor
adequate and well-controlled trials
serious allergic reactions
type
an overseal ( aluminium
greater than
antidiabetic medicine )
or stroke
from
,
,
8°C )
ABILIFY contains The
and inflammation .
ng/ ml ; Ctrough
,
,
well
trial
(
with renal impairment :
hypoactivity .
the
67.2 micrograms epoetin
6.1 .
Novo Nordisk
) Ltd
CYP2D6
.
type
with a
.
mmol/ l ) or
the intravenous route .
per
is very
, in patients
for
diabetic retinopathy
with a
(
syringes contain 0.8
( 7.5
3.0 % with placebo
Abilify
see
Polysorbate 80
Hb 10 - 13
-
peripheral
4
or
delay recovery
contains The
in strength ,
,
: orthostatic
of patients with the
recommended initial dose
9.5 and 11
.
local requirements .
to
in
but
dose
Close
: the levels
administer Aclasta
aripiprazole
epoetin alfa
3 times
with
.
the
of ABILIFY
4.8
be marketed .
over 30
( Europe )
orthopaedic surgery
The
1
can be
1 cartridge contains 3
with renal
administration
effect of medicines used
with
receiving placebo (
7.5
increased
.
you
) , 2C9
+ 34 ( 91
CLAS )
1HU -
of liver cirrhosis
caudate
.
-
4.4 )
elective orthopaedic surgery
two studies
this condition may
, France
but not in
12 g/ dl (
Because
10 g/ dl (
comparisons .
(
( 3
epoetin alfa
diabetic ketoacidosis
05
pharmacokinetics or
.
) .
any of the
.
should be avoided .
to the active substance
of 0.3
with
approximately 5 l/ kg
QT prolongation ,
patients was 12.1
- Treatment
London
maintain haemoglobin values
these
patients
with ketoacidosis
the risk of
Special warnings and precautions
injection : a
)
serious
6000 IU/ 0.6
insulin ( human )
clinical
OUTER PACKAGING
haemoglobin and blood pressure
( 2°C -
The terminal half-life
BV Tel
mmol/ l )
)
six weeks
.
ml
be necessary
.
(
aripiprazole
nach einem Jahr
should
7.5 mmol/ l )
3 ml equivalent to
aripiprazole
Europe )
myocardial infarction and
insufficiency not yet
)
(
pre-filled syringe of
( 8.1
not
Patients with hepatic impairment
bottle
the first
the
contains
OF UNUSED MEDICINAL
(
)
section 4.8
Allé
see
, aripiprazole
clinical
dose of Abseamed
or
patients with diabetes mellitus
4.5 Interaction with
( AST )
7.5
patients with
2
Aclasta
Treatment of
.
a clinical
When a dose adjustment
systemic exposure was
alfa alters
WC2B 4AE United Kingdom
with
other antipsychotic drugs
) , 2C9 (
Zoledronic acid
14 and 7
) The incidence of
with
of Aclasta .
( 1.25
( 0800 )
than in those
physical
-
Erythropoietin is a
Kuhloweg 37 ,
take more ABILIFY
well-controlled
between epoetin
listed below is
of glucose
in one of
Special precautions for
ABILIFY
32 2 352
in
30 mg of
plasma concentration of pioglitazone
should
) .
and a
possibility
with quinidine occurs
lowest effective
or
10
) of
some cases
be discontinued immediately
60
Tél : + 33
of aripiprazole
recommended
The following reactions
signs and
approximately
lapp lactase deficiency
is
Common
.
prostate
, increased alkaline
as hydrochloride )
(
Abseamed
to the foetus .
Actraphane
of
,
injected
ml
The cartridge contains
7.5 mmol/ l )
LTD Tel : +
.
adult
%
recombinant DNA technology
taken in combination with
mg
hospital
, may
12 g/ dl (
.
had
,
the
carbohydrate composition to
Highbridge Business Park
( 8.1
heart failure was
:
.
the active substance or
modifications
in patients with
mg (
0.62 mmol/ l
the skin (
x 1 , 56
Forest Gate Wellington
tissue
-
aripiprazole
is effective in
between 25 and
20 NovoLet 100
4.4 ) .
a few weeks .
(
-
efficacy
221 multiple
)
Committee
CNS medicinal products with
3
information on
A
patients with metastatic
in rating scales
treatment with aripiprazole
in patients
45 93
16736
treatment ,
in
iron oxide ( E172
administration
for signs and
a clinical
Allé DK-2880 Bagsværd Denmark
and
well
cloudy after resuspension .
- Middlesex UB8 1HU
with
Abseamed
ON THE
, round tablets contain
1
The pre-filled syringes
Actos
)
, tiredness
mmol/ l )
and
.
epoetin alfa
of the nursing
.
As with
, less than 1
i. e.
study
your doctor
be assured :
.
clinically
For more information
2
effects of
BRISTOL-MYERS SQUIBB
.
:
you
keine
8167 patients ) .
annually
a
, insulin
times
in Saccharomyces
.
Intensified control in
Omission of a
hands
immediately if you
-
signs
and inflammation .
CYP3A4 ,
165 amino acids .
)
other medicines
years
not
negative impact
in
dextromethorphan )
for males ) .
in cancer
( 57.3
3116
in animals The safety
the
very
and water for injections
study
)
and
vial
animal model of familial
( 6.2
or
of one year or
see section 6.1 )
+ 47 67
, diarrhoea
.
more weeks
with
x
Nervous system disorders
( possibly delayed
260
adjustment
with reported estimated doses
hyperglycaemia , diabetes mellitus
4.7 Effects on
The incidence
Paget s disease
of
and
In
1 )
.
aripiprazole .
with
with aripiprazole
.
and
and protracted absorption respectively
64
g/ dl
: +
patients with a manic
a
Kingdom
see section 4.2 Treatment
in these
Abseamed should be
- metformin
of insulin
IU/ kg
information on the
of M-II
or valproate
lithium concentrations
g/ dl (
of consciousness
( see section
delayed )
Very
The
relate
.
or hyperosmolar
IT IS USED FOR
Alopecia was observed in
of
The frequency
during
special warnings and
rats after
,
hepatic ) pathways in
(
)
doctor
,
7.5 mmol/ l
section
contains 3 ml
after
a
7
the dosage of
7.5 mmol/ l
SQUIBB BELGIUM S. A.
adult patients
14
: +358 9 61
Use
Before
maintenance doses than
(
than 1 % of
increased alkaline phosphatase
x 1
, are not sufficient
.
.
the risk
10 days following
zu Empfehlungen bezüglich der
Medicines should not be
CYP2D6 and CYP3A4
(
has
see section 6.1
Adult surgery patients in
per
undesirable effects occurred
for use in
risk
combined with
Actos
The following adverse
PACKAGING UNITS
.
IT IS
in women
on
a
of epoetin alfa on
in
) sealed in
5 and
should therefore
is minimal .
in
,
the human insulin molecule
prior
Srl
with
incidence
12
Road Uxbridge
of this population ,
injection
0)1 47 56
% of
2
hours after the
( See section
of pioglitazone
corresponding to
8 kg
a bromobutyl/ polyisoprene
,
2C8/ 9 and
0.99 , 1,18 ;
brand ( manufacturer
you
meal or unplanned
ml
produced by
( see section
of the
- 8°C ) .
with
or very rapid
Yarvitan
fluids before and
It
1
not
tiredness , nausea
.
and
trials with aripiprazole
.
see section 5.3 )
most
subcutaneous injection ,
) ,
4.4 and 5.2
between 10 g/ dl
) .
dizziness , neuropathic
Maintenance dose
insulin
( see section 5.1
2°C - 8°C )
vascular
25.2 micrograms
that
no adequate
,
Takeda Global R &
hyporeflexia ,
(
or lithium
.
The pharmacokinetic characteristics of
Kuhloweg 37 D-58638
and
monotherapy
the
Takeda Ireland
:
4.5 Interaction
of
weeks (
.
symptomatic
patients with
tablets are
and Cmax
intravenous route has to
may occur in
the faeces .
.
dose
is 150
when
, Oxford Road
week
Hydrochloric acid
3.2
Subcutaneous injection : a
.
not
of food
if you
It is
42 trials and
When
aripiprazole
AUC
the pharmacokinetics of
a few days to
and
may be
as monotherapy
following
about hurting yourself .
Eli
treatment with placebo
of
. europa . eu/
a clinical
Alopecia
Hydrochloric acid ( for
patients
pharmacist
United Kingdom Takeda
2 hours
the dose
diabetes
to minimise the risk
weight gain
and
, tiredness ,
) or CYP2D6
hours in
vitro
,
and
,
-
.
and
EPS
but
studies
trials aripiprazole has
ml contains 9000
In a
, pyrexia ) ,
observed (
dopamine
)
Using ABILIFY
and
.
30 %
insulin .
features and with
Due to
a
- decreased locoregional control
three
other erythropoiesis-stimulating agents
,
of CYP3A4 (
unchanged aripiprazole was
per week by
- a sulphonylurea ,
the incidence
and extent of absorption
CYP2D6
e.
dose ,
)
for
.
-
(
take possible
Potential for
blurred vision
is 150
12 g/ dl (
, Abraxane contains
with
1.25 mmol/ l
an
or of no
medicines
7.5 mmol/ l )
alfa
the
see section 5.2
fast-acting
and
Treatment of adult
thyroid hormones
, anorexia
There are
should
.
effectively
of Abseamed
( E951
trials have
, the
a
be used
15
( omeprazole
06 5026
Starting dose
is
.
intravenous bolus studies ,
other
( see section 4.4
with
reach and sight
as
fast-acting
.
reports of
Section 4.2
(
with aripiprazole
Common
UB8 1HU
, gender , and
or other
( produced by
Cmax
with
the ABILIFY
relapse
The full
)
pioglitazone was
minutes
in a
272 16 00
The incidence
and
cloudy after resuspension
.
of
(
the haemoglobin target range
and
solution contains 10 000
levels remain the
times per week
patients receiving
and Cmax of
in
antihypertensive medications
well-controlled trials of aripiprazole
.
treatment
86 68
the intravenous route .
Limited Tel :
and
increased
haemoglobin ( 1
- Refraction disorders
of a full
39 06
Epoetin alfa
x 1 tablets
Abseamed is presented
1.5-2.5 hours after
.
and other
see section 6.1
was 3.9 kg
4.7
.
days to
injections
for
haemoglobin
Erythropoietin receptors may
Oxford Road Uxbridge -
human
in
(
This may constitute
may require discontinuation of
, especially
a
Highbridge Business
encephalopathy-like
a
and
( 7.5
is not recommended
:
IU/ kg 2
not
whether you
allergic reaction
and
There
are round and pink
Additionally , aripiprazole
was
g/ dl (
controlled trials
Co KG , Kuhloweg
Iron supplementation
The
for
somnolence
,
)
Lactose monohydrate Maize
and
After
At steady
with or without
observed
Business
and
unit dose
pooled presentation are
glycosylated haemoglobin increased
REACH
TO
(
) , Storbritannien Tel
6
is
patients
patients
renal
dosing .
the
and " 5 "
with Abraxane
CYP3A4 and CYP2D6
than
with
patients experience
possible
clinical trial
is a
the inhibition of the
30 mg of pioglitazone
Uncommon
You
per dose
administration of
Business
nausea
children and
4000 IU/ 0.4
mellitus
hours
)
medical
Allow
4.2 Method
the risk of
4.3 and 4.4
of consciousness and extrapyramidal
blood loss and haemolysis
indicated for
hours after the
LTD Tlf :
by the intravenous
the reference arm
steroid
cerebrovascular
two
or Hb increase
,
take this
of 1
)
EMEA
with metformin
) .
but
tablets is pioglitazone .
1 , 56 x
alfa
- 7.5 mmol/ l
with
)
than 1
of the
occur during treatment .
.
ABILIFY
.
3A4
EMEA
If
is
be marketed
of 12
symptomatic anaemia associated with
and sight of children
( 44-20
,
analogues for
patients
the average duration of
:
effective
a
or very rapid
some of your ABILIFY
the patients
.
% )
Do not use
The
to
and
in children
) ,
* Produced
Farmacêuticos , Lda
ABILIFY
paclitaxel
of Aclasta .
Adult patients with
In addition ,
and anaemic rats ,
between
and blurred
medically important signs
incidence of
Bagsværd
and
consists of
data
Date of
tablets
and
,
The cartridge contains
ACOMPLIA ,
26-week ,
1
see
jaundice , hepatitis ,
and
What benefit has
,
of
and
occur in
section 5.2 ) .
adverse
ON BLISTERS OR STRIPS
International
receiving chemotherapy
aripiprazole
recommendations , read
package leaflet
angina pectoris
should
generally
.
injection
insulin
of 10 g/ dl
of
see section
.
with
contain 0.4 ml (
after the
Tél
, IF APPROPRIATE
or two weeks
pack
experience
to protect
been observed
300 IU/ kg given
risk
Adult cancer
compared
4.5
& Co
Weight gain :
your weight
meal
"
be
18 years of age
doctor or pharmacist
with epoetin alfa
of
oral
if the
48 The
7.5 mmol/ l
SUPPLY
contains methyl parahydroxybenzoate and
The
or unplanned ,
epoetin
Uncommon -
of excipients ,
alfa therapy
2C9 ( warfarin
Die Schmelztabletten werden
pneumonia
dose is between 75
episcleritis , iritis
active substance is
this patient group
of CYP3A4 ,
tachycardia , nausea ,
and approximately 18
household waste .
normal
, pulmonary
, it may
2 weeks
than
dose
weeks
features
The
9
polydipsia , hyperglycaemia ,
use
deemed necessary in
in whom
may
patients
monoamine oxidase inhibitors
mit
fast-acting
should generally not
% ) of
blocks the ability of
4.5 Interaction with
,
time each day .
The decision to administer
( N =
.
.
.
IT IS USED FOR
per month
.
84
and potassium in
)
Road Uxbridge -
rare hereditary problems
,
Your doctor
two studies
+ 46 8 704
epoetin alfa
Due to
:
shown during
% )
including
contains 15 mg
, dizziness ,
more ABILIFY tablets
used for 2.
Studies in animals have
.
a calibrated
1 and 5 vials
.
If convenient ,
your doctor
The
in
be disposed
postural dizziness ,
or more units of
for smokers .
( see
(
section 5.2 )
.
appropriate doses for
of generalised hypersensitivity
is achieved .
caudate
is
.
itching , hives
should
ACOMPLIA
.
chemotherapy
well-controlled trials of
glucose
(
of
15.7 %
important differences .
with
Patients
%
Pioglitazone tablets are
known complication of chronic
rare
( see section
In patients
overall survival
causes of anaemia (
UB8
At therapeutic concentrations ,
monotherapy with metformin
73 % )
placebo-treated patients
one
CYP2D6
dose
aripiprazole .
of the
first trimester
CONDITIONS OR
ketoacidosis or
Table 3.
aripiprazole (
or
body weight 2 times
Adult and
with
aripiprazole in
, or were
effects of
study
aripiprazole in the bile
1 orodispersible tablets 28
visual aid indicating
x 1 tablets 28
5.1 ) .
is
contains 5000
dose of
BSAP ) ,
the
you
.
,
digoxin , warfarin
to be administered intravenously
need
APPEAR ON
is effective in
if
In the indication increasing
this condition may
of
in patients with
i. e.
of the
pens to function safely
, hyporeflexia
either valproate
Road Uxbridge -
1 60 14 30
Abilify
Abseamed
In the indication increasing
Co KG
bone
( 7.5 mmol/ l
members
enzymes
unchanged
HOLDER
- 14
:
, pharmacist or
Important information about some
Leaflet .
swallowing .
treatment ,
in mortality in
see section
weeks following
from
stroke
PACKAGING UNITS
14
12 g/ dl
controlled
reduce insulin requirement .
of
.
IU ( International
long-acting
the
51 Patients scheduled
Italia
elimination were
stopper .
Abseamed 8000 IU/ 0.8
six months of therapy
no
the
this
to 23
13.2
, especially infections and
.
Oral
( e. g.
;
been reported
+44 ( 0)20 3116
well
with Abseamed
included
6.2 -
be
maximum
mmol/ l )
)
use of
The tablets
taking Actos
If you are
or
coma
.
9.5 and
, especially infections and
given
)
47 67
5.1 )
,
Pioglitazone
not treated
activity ,
6.2
your doctor
haemoglobin values exceeding 12
altered mental status
1,000 ,
pioglitazone concentration is unchanged
Consequently ,
section 4.6 )
IU/ kg
:
section 5.1
all
g/ dl (
) sealed
potassium and
4000 international
of
of the
)
- 39 % )
epoetin
with aripiprazole
with
Treatment with Abseamed
are given in the
)
clinical trials ,
Erythropoietin is
or
,
.
of cancer cells to
REGARD TO SAFE AND
substitution
% ) .
Overdose of epoetin
haemoglobin values exceeding
)
the
and 180-minute
M-IV ) .
be marketed .
Actos 15mg tablets
a
)
aripiprazole
rapid
of hands
,
m²
.
and
: patients with
+ 34 ( 91
% ) following
your doctor
of approximately 6 hours
ability
your
tense .
skin fold minimises
: the
pancreatitis ,
( n =
Do not
is difficult
in Saccharomyces cerevisiae
12
3.2 %
, aripiprazole should
.
3.5 % of
,
over the
) should be investigated
Aclasta and risedronate
14 x 1 ,
The following
alfa
.
Medice Arzneimittel Pütter GmbH
.
with high fever
mg zoledronic acid
.
.
immediately if
type 2 diabetes
of
The
, diarrhoea ,
Abseamed has no influence
the dosage of ABILIFY
, IF APPROPRIATE
resulting suspension .
4.4 ) .
.
to protect
injection site
are 3.3-fold higher
Middlesex UB8 1HU
or hepatic impairment
oral administration
whether or not there
or
and placebo ( 2.1
less than 1
14
baseline
or
tablets
the limited
done
in pregnant women .
33 %
.
electrolytes
Upon discontinuation of
pre-filled pen
on
changes in routine
exposures
or waste material should
concentrations ,
included due to the
the nearest hospital
Actos to the
g/ dl ( 5.9
In
in some cases
the insulin requirement
a doctor or
for
10 and 12
cause
Treatment with
insulin
+
aripiprazole
headache Eye disorders Common
Less than 1 %
significant
Cancer Linear
4.4
a
if
clinically significant
most common
.
see
based
ketoacidosis , diabetic hyperosmolar
.
international units
Further studies
172 breast ,
8.1
on
maize starch ,
day .
be monitored and the
cell line by
, there were
.
Any
All patients being
metformin and/ or
and danazol .
10
is always well
prior to
in pregnancy
erythropoietin
OF UNUSED MEDICINAL
of
(
, D-58638 Iserlohn
if
of transfusion requirements in
will ask you
: extrapyramidal
.
see section
Cancer Linear Analogue Scale
to that seen
30 mg
severe
that examined the metabolic
which
SQUIBB PHARMACEUTICALS LTD
and
] (
CYP2D6 inhibitor
12 g/ dl
should
55
these
neuropathy
.
(
dose is injected .
=
Do not
1
, diabetes mellitus
or pharmacist .
regimens
2°C -
treatment with
to drive and
cannot be excluded .
vehicles , until
N-dealkylation .
or mixed
than 1
( 1.25
see
: +49
and
0.02
The other ingredients
Abseamed
lead to an increase
dysphagia
: +
( e. g. hypothermia
administration of Aclasta
most
-
Aclasta is not
manic episodes in patients
open-label
pharmacokinetics
not
immediately if
,
with epoetin alfa
10
Abseamed
- United
Reticulocyte count
5.3
similar
at
between 9.5 and 11
( 1.25
this
,
the incidence
well-controlled studies in
(
, less than
Takeda Global
to be compatible .
to
and
metabolism
concern .
1HU - United
people with phenylketonuria
clinically significant changes
VISTOR
,
45
difference in
vein
recommended dose is 600
medicinal products :
aripiprazole
and for
g/ dl ( 1.25
month ) with
been reported
74 60
of manufacture ( recombinant
antipsychotic medicine )
g/ dl ( 7.5
at the desired level
fatigue Psychiatric disorders
Therefore ,
Patients
Tlf : +45 39
.
In clinical
, or if
with type 2 diabetes
site conditions
34 [ 3.2 %
> 99 % )
ketoacidosis ,
in
and is
of 0.8
, or
)
tablets 28 x
.
have
( NPH )
Frequencies
, use
1.25
44
tablet with water
the incidence
exposures
patients ,
insulin
revealed
.
reduce the epoetin alfa
oral
RESTRICTIONS WITH
: + 44 (
you
your doctor
- shortened overall survival
by
( 7.5
AND 98
the potential risk
contains 1000 international
: extrapyramidal disorder
is
Patients with renal impairment
while taking aripiprazole
)
.
differences
either valproate
overdose
ist
15 mg
adjustment
and mediastinal disorders
with
26.7
effect of Actos
more
rare
and
of greater than 12
demonstrated
Business Park , Oxford
who
and
When
bone marrow
.
)
)
tumours
FACT-An
,
may
with aripiprazole ,
.
cell volume
and
OUT OF THE REACH
In addition ,
of
high
Cmax
with or without
United Kingdom
.
and approximately
similar
MINIMUM PARTICULARS TO APPEAR
cell line by
extrapyramidal
can occur .
When the CYP3A4
especially in patients
4
be assured
The
OF
Uncommon -
, hepatitis ,
7.5
7.5
methylene groups .
t½ ) is
your doctor or pharmacist
should
patients
the
insufficient safety information
,
patients with
revealed
ml solution for injection
be at risk
patient
see section
may vary with
sie
: anaemia in
your pharmacist
APPROPRIATE
interactions
) , sugar
% ) than
mmol/ l )
.
ABILIFY
Nervous system disorders Uncommon
anterior abdominal wall
AND SIGHT OF CHILDREN
)
especially infections and
measuring cup
can be
with
not
has not been established
Weight gain :
10
COMBINATION THERAPY WITH SULPHONYLUREA
is
Use should be restricted
mortality
The
a
, and
2°C
PRODUCTS , IF APPROPRIATE
patients
study
and
with schizophrenia .
) and
taken in combination
Adjustments of daily dosage
manufacture ( recombinant
clinical trials
or lithium
and
) after
,
prescribed for you
chest pain ,
and pink ,
and Package Leaflet and
- if
%
( 0 )
and rats
and
elderly and
& Co KG
cellulose
must be
rather than of the
( once daily )
Depending on
cytochrome P450 .
shortened
a half-life of a
SQUIBB BV
and
is
controlled
please see section 4.4
.
heart rhythm
: + 36(0
and 11
0.62
of aripiprazole
.
with
pregnant women .
events
all growth factors
or
g/ dl (
patients
IU of epoetin alfa*
open-label
the
and
dose
should
of ABILIFY
- in patients (
.
or
IU/ kg 3 times
Aclasta can
61 Aldwych
advised accordingly
(
)
.
: orthostatic
as measured
undesirable effects occurred
In the
patients with hypocalcaemia (
either
Patients
a full range of
the intravenous route .
45
than
sodium hydroxide
OF THE
Sverige BRISTOL-MYERS SQUIBB AB
(
Pioglitazone and all active
angiotensin converting
or joints
,
Takeda Global R
aripiprazole treatment
when
In
insufficiency not yet
( dextromethorphan
occur
Aclasta works
in some cases
.
)
of
In
like headaches as
.
headache
(
chest pain
maximum of
, headache , tiredness
( see sections
swelling of hands ,
50
)
cells/ µl
House Highbridge
models of dopaminergic hypoactivity
, hydroxylation ,
per
Before
In several controlled studies
have
of children .
of the injection site
administered by intravenous
D-58638
of akathisia was 6.2
healthcare professionals in
+ 45 45 93
-
Very
may require discontinuation of
( 2.5
manic
( 0800
route .
) , or
in
patient group
and a
.
dose
Serum electrolytes
This
of digoxin , warfarin
vehicles , until they
.
children
1 tablets .
) .
for
all timepoints (
severe sensory neuropathy
between 10 g/ dl
4.5 Interaction
and 4.9 )
) .
n =
local requirements
.
no
subcutaneously ) .
patients with severe
only 3 patients with
maximum dose should
8.1 mmol/ l
scale or
Actraphane is a mixture
12 g/ dl
to be compatible .
cardiovascular outcome study
( warfarin
for
In clinical trials and
of the other
medically
2
and 3A4 (
shown that pioglitazone has
but
compartment
,
of
makes bones fragile )
.
480 ml
menopause
, the incidence
( see section 4.2
the
2
or nurse if
Medice
blurred
and
pregnancy
KG
potent inhibitors of CYP3A4
trials
g/ dl
the
administration of
also
situations
or 5 or more
aripiprazole
;
corrected
by the
to have
.
alfa
mixed episode
coma ,
cancer patients
patients
thrombosis
not to
BOTTLE
In
another (
to
been established
or
alfa in adult patients
House Highbridge Business Park
For a full list
mitratapide
between
of dissolved insulin and
of
10
in
Long Term
After
especially in patients
( see
) .
of
The daily
entire dose
, salivary hypersecretion
Kingdom
maximum of 30 mg
controlled clinical studies ,
a lesser degree
600 International Units
Co KG Kuhloweg 37
BEFORE
tumours (
hypersensitivity
if
children
dose adjustment is necessary
4
: +43 1 86
common
) were receiving cardiovascular
syringes
patients
trials
liver problems
dental surgeries .
patients participating in
5 % und
Elderly patients
OUT OF THE REACH
- cardiac failure or
programme
When weak inhibitors of
section
) per
.
of women
inhibitors
Immune system disorders Uncommon
not exceed
.
IU/ kg 3 times
aripiprazole
with
investigated
in
highly protein-bound drugs are
150
of
49 x 1
The
the
BV Tel
the following
are
defined .
65 years )
.
crisis
exclude potential
Europe
margin
% in
,
)
these trials ,
insulin
(
contraindicated for patients with
must not be
in patients
difficulty
of digoxin ,
, nitrates , diuretics
section 4.4 -
(
vitro
or
myocardial infarction or stroke
findings
trial ,
(
been available as an
and 4.9 ) .
but not
The
be
30 mg/ day
in clinical
,
HOLDER
Erythropoietin is
.
hydrochloride )
metformin and
Each ml of
, the incidence
REACH AND SIGHT OF
pyrexia
of
.
of anaemia with
20
2 Adjustment of dosage
The
in paediatric patients
are never to
3.2
erythropoietin treatment .
trials
source insulin
ABILIFY
,
mmol/ l )
Otsuka Pharmaceutical Europe
Park , Oxford
Abseamed 7000
should
is contraindicated ,
49 ( 0
.
The
(
and
Usual maintenance dose 75
of
in healthy
unexplained death
the
rhabdomyolysis ,
for 3
5238
Ísland VISTOR
SQUIBB
.
In several
( see section
64 gynaecological ,
by 32 %
of administration ) .
, 56
most common
if you cannot receive
, the
recurrence of manic
) .
contains 9000 international units
Uncommon
or
.
, tremor ,
to be administered intravenously
and its
.
1800 ml
mild ( Clcr
see section
, 30
, 2C9 ( warfarin
15mg
CPK
patients
The
6 hours has been
equivalent to
may
patient population and
- Refraction disorders
pharmacokinetics
Eye disorders
see section
and
200
.
.
see
If
injection
( please see section
ABILIFY is indicated for
should carefully
been carried out
dose of
erythropoietin
use in
of continued therapy
7400
4.9 ) .
family history of diabetes
studies
) , contact
them
The AUC
insulin human .
if
and
( see
should
Pack size
, the
to
significant
or
.
by
not clinically
347
systemic exposure
attention should be paid
4.4 )
with
observed
should be
but
aripiprazole and 3.0
( heparin
and/
Hypersensitivity :
such as
skin
local requirements
Oxford Road Uxbridge
The biological efficacy of
potent CYP3A4 inhibitors
: soluble insulin
.
reported
but not
dosing for a longer
potassium
aripiprazole
measures
1736
with lithium
9000 IU/ 0.9 ml
Very rare
one year
two
antidiabetic medicine )
410
6 hours has been
been reported in patients
Therefore ,
ACOMPLIA has not
thrombosis ,
the
0)810 410
haemoglobin ( 1
MUST BE STORED
All of
, the dosage of
8.1 mmol/ l
.
, blood
Overall survival
in a pre-filled syringe
progression of diabetic retinopathy
174 gynaecological
elevated creatine phosphokinase
erythropoietin
see section 4.8 )
g/ dl ( 8.1
should
can result in
races .
or
a
6.2 -
including PANSS and
in a
g/ dl (
)
mg )
is
of metformin
human
IU
infusion
this with
isophane (
7.5 mmol/ l )
male and female
your
is not known
on
There are
is 15
alfa
( DVTs ) .
was
or pharmacist
1
Epoetin alfa
.
the
.
SQUIBB NORWAY LTD Tlf
epoetin alfa should
( see section
Penfill is
of 1,900 patients
of
.
: + 46
precautions to
the
weeks
with aripiprazole
to
because
12 g/ dl
aripiprazole
also
used with caution
children
or tense .
primarily
titanium dioxide ( E171
the dosage of
type 1 )
retinopathy
the
you
efficacy
jaundice , hepatitis
the insulin requirement (
Luxembourg/ Luxemburg
+ 32 2
:
Novartis Europharm Limited
LTD Tlf : +
BRISTOL-MYERS SQUIBB
orodispersible tablets contain
GESMBH Tel
with
years
,
g/ dl (
12 g/ dl
diabetic ketoacidosis ,
with overlapping undesirable effects
scheduled
the dosage of
in adult patients with
Aripiprazole
5000 IU/
Adverse reactions
the incidence
) .
delivery system
12 g/ dl (
given area may
upper respiratory tract
at doses
before and
use of Abseamed
2
you
to protect the environment
renal
trials included
cardiovascular
ABILIFY is effective
fatigue Psychiatric disorders Common
necessary
maintain haemoglobin values
compared with those
Be sure to
,
is a mixture
a
to protect
alfa may
+ 47 67
patients with
Some patients
in the treatment of
been receiving
treatment of
mg of aripiprazole .
including parkinsonism ,
any 24-hour
,
( siehe Abschnitt 4.4
patient above and
Common : blurred
3116 8952
When
with other
, 84
not be used
Therefore ,
injection
heart disease or
overseal ( aluminium
450 IU/ kg
,
, anaemia
UB8 1HU -
+
Abseamed
reported after months to
insulin and 70 %
mg/ day
: +3726441100
53 In
not be administered
ALT
( FINLAND
in
, aneurysms , etc.
wurden. er
.
KG ,
0)20
-
aripiprazole
] (
Octreotide/ lanreotide may
ml contains 8000 international
no relevant effect
.
5.9 -
of dehydro-aripiprazole
,
2 352 74 60
Common
Abseamed 8000 IU/
)
day
see
one year
patients , antibodies
6.6 Special
treated with aripiprazole
swelling and inflammation .
minutes
THE
Cytotoxic actions of epoetin
% ,
humans
) .
Norge
with
,
alfa Abseamed 3000
31.0 65.1 26.7
moisture .
starting dose for ABILIFY
1 tablets 98
)
- 8°C ) .
contains
230
(
23 lung , 22
Patients should be
30
* Produced in CHO
in the bile
( see section 4.4
Highbridge Business Park ,
in Bipolar I Disorder
dose
BLUE BOX )
( 43 %
61 Aldwych London
swelling and inflammation .
significant change in
data
the
aripiprazole in
)
data reveal no
contain 1 ml (
be reduced
People
with Abseamed
of rimonabant
30 mg orodispersible tablets
1.25
0.62
site conditions Common :
In some , but
, Nevirapin und Johanniskraut
1 ml (
orodispersible tablets contain
monkeys ,
other insulin products
and/
in
Allé
.
the dosage of ABILIFY
deep vein thrombosis
patients ( particularly
potent
18 , or 13
hypertension ,
% with
bioavailability of rimonabant has
the potential risk
infusion
to
The
rare cases of NMS
800
mouth
pioglitazone .
with solid tumours
for Vantas
aripiprazole
N-dealkylation
risk for
significant
or tense
, the incidence
section 4.4
elimination were
.
.
These symptoms can temporally
10 : soluble
day ) .
, the
with
24 and 36 months
,
a
Inadequate dosage or
by 107 %
is severe and
.
insufficient
UB8 1HU -
portion of the food
.
The
, diabetes mellitus ,
reconstitution
with epoetin alfa
3.2 % with placebo
may
use machines
members within
,
In the four placebo-controlled
-
included patients with or
Following subcutaneous injection ,
disorder , akathisia
develop PRCA
and
a
third
from precursors
(
use of
1
PRODUCTS
Italia Takeda Italia
rats
of consciousness and extrapyramidal
Nederland BRISTOL-MYERS SQUIBB
and
pioglitazone
section
highest nontumorigenic exposure in
in paediatric and
in patients
reactions may
hypoglycaemia may
during treatment with
: +44 ( 0)20
of
with aripiprazole
.
ibuprofen shortly following
rapid initial effect together
The
previous stroke who
sulphonylureas
.
-
reduction in
Tlf : + 45
A sustained haemoglobin level
Additionally , aripiprazole and
) of
) :
and heart disease
in the
5 % und 10
only
Treatment of
( 6.2 - 7.5
a
84 , 90
10
the incidence
in type 1 diabetes
particularly
5238 patients with
.
death
to
with
150
injections .
days to
Business Park
Park
and
Adult surgery patients
for males )
stools
.
72 Adjustment of dosage
For any
, thyroid hormones and
OUT OF
type 2 diabetes
60
metabolites are active (
,
pharmacist
products to affect
agitation
medicinal products
know
psychosis
free fatty
CONDITIONS OR RESTRICTIONS WITH
no
as
weeks
tablets contain lactose monohydrate
no
per
high fever
PRODUCTS OR
other insulin products
pyrexia ( fever )
adjusted
of
0.6 ml (
GmbH & Co
of
following adverse events
,
haemoglobin
and 12
between 9.5
40 %
of
.
- Treatment of
0.62 mmol/ l
in order to
arrhythmias
including parkinsonism
pharmacokinetics of aripiprazole .
13 g/ dl ,
given
take it
administered by intravenous
of children
%
in bipolar
Please tell
during pregnancy
30
in exposures
and 10 cartridges
7.5 mmol/ l )
household waste .
dosage of ABILIFY
were
& Co KG
thromboembolic events
a single intravenous
.
TO APPEAR ON
with
See section
section
Frequencies
SQUIBB BELGIUM
LTD Tel : +
of these patients
, tongue oedema
300
SQUIBB SARL
average
) ,
sugar
Tel : +
incidence (
contains
placebo-controlled studies
( 30
groups
Date of last
61 Aldwych ,
aripiprazole and 3.0 %
psychosis .
ROUTE(S ) OF ADMINISTRATION
one year or less
and what it is
It is
Common : extrapyramidal disorder
( see section
dosage or
possibility of
aripiprazole
endogenous human erythropoietin that
the intravenous route .
that examined the metabolic
with
doctor
major elective
LTD Tel : +
patients with
IU of
the doctor or nurse
8.1
contains 15mg
events
the foetus
,
not
,
Cmax of dehydro-aripiprazole
,
increased
THE REACH
mg
( see
been
peripheral oedema
and 10
of EPS
.
events (
nicht
than three
see section 4.4
Pharma
blood pressure or
50 International
refers to
the dose selector returns
in rare cases
administer
If
if
with
rare
no adequate
) .
well-controlled studies in
dysphagia
taken in combination
of aripiprazole
sodium citrate
and
in 29
and
( mouse spleen cell
4.6 6.2 months
( e. g. anaphylactic
37
important signs and symptoms
and dehydro-aripiprazole
, oral
) .
or
of schizophrenia
of
unconsciousness and/ or
All
)
clinical dose
epoetin
(
In cases where there
rapid
*
The following adverse events
QT prolongation or
of fatal
practice
These effects
Taking Actos
91 ) 663
see section 4.5
at least one to
haemodialysis and adult patients
of symptomatic anaemia in
.
and
kg and adults .
for pH-adjustment )
1 ,
, D-58638 Iserlohn ,
1.25
AND
recombinant human erythropoietin
of 10
Tell your
angioedema and
hydroxylated metabolites is catalysed
inflammation
10
a
Refraction anomalies may
controls
take
below
6000 international
on
the
here .
4.4
by 32 %
0.8
Ireland
with
take
5.8 for placebo
Each orodispersible tablet
The four
maximum
Tel
was 12.1
1000 IU/ 0.5 ml
The maximum
.
: +
data
5.1
)
planning to become pregnant
may vary with age
PRODUCT AND ROUTE(S
6.2 mmol/ l )
aripiprazole
oesophagitis
incidence of EPS was
Ask
) .
per
other handling
pregnancy
for major elective
four
,
PARTICULARS TO APPEAR
5.2 )
In patients
bone marrow fibrosis of
g/ dl
Adult cancer
% )
stimulate red
stroke
the
House Highbridge
having a high
30 mg of
a daily dose of
the intravenous route
clinical
with
to starting Abseamed therapy
: + 33
a standard scale
(
the package leaflet or
The
4.5 ) .
mmol/ l )
BRISTOL-MYERS SQUIBB SARL Tél
times per week
to detect possible
treatment
are for
.
be
LHRH agonist
and
and 802
] ( weeks )
reduce insulin requirement
usual dose is
(
of death when administered
Actraphane
)
signs
mmol/ l ) should
be treated with Abraxane
,
and adult patients
subcutaneous administration
were
( see also section
is difficult
, intermediate-acting
Actual scores
is
of anaemia with
.
of
dextromethorphan ) .
risk for
recombinant DNA technology
times per week
)
s
(
, Spain
are
doses
P1NP
.
sensitive to
3 ml .
+ 358
0)20 3116 8000
brand ( manufacturer )
unused product
or
section 5.3
of ABILIFY
contraeptives , thiazides ,
diabetes mellitus (
trials
patients with
how
.
site within a
of
The injections are given
in
7.5
also
Global R &
If you
( 6.2 mmol/ l
impairment
g/ dl
pre- treatment or
hyponatremia
ACE ) inhibitors
episodes of hypoglycaemia .
5.1 )
from light
Kuhloweg 37 D-58638
, aripiprazole should
, anorexia , hyponatremia
and
In
(
increased incidence of
Although there is
4.7 Effects on
based on
63 patients with metastatic
administration
for
glycosylated haemoglobin increased
in Bipolar I Disorder
0.62
)
be reduced .
Kilruddery , County
reached
2 weeks
DISPOSAL OF UNUSED MEDICINAL
53.3 %
75
In controlled clinical
) , Storbritannien Tel
or very
aripiprazole and
and
)
skin fold minimises
section 4.4 )
)
in
In
)
.
.
patients
0.035
manic
vomiting
anaemia
or pharmacist
from precursors
(
g/ dl ( 1.25
active substance is aripiprazole
)
N-dealkylation
, pharmacist or
84 , 90
There is an
have
, colourless solution
treatment was not evaluated
parkinsonism ,
Hb 10 - 13
with epoetin alfa is
) is
( see section
NMS
or pharmacist .
.
of 15
7.5
,
3116 8951
adult
, hyperglycaemia and diabetes
The AUC and
: + 353 (
a recent
Tel
Yarvitan
This
of cleavage (
two large
kg for the 120
(
bipolar patients was 12.1
therapeutic margin
when
: blurred vision
patients
200 mg
8167
rare cases
thyroid hormones and
g/ dl
3 ml .
Industrie ,
per
.
a possible warning signal
angina pectoris ,
therefore be applied .
of aripiprazole .
renal failure in paediatric
e. g.
haemoglobin
an increased risk
insulin
that
other antipsychotics ,
or intentional
mg )
,
and
in the thighs
WC2B
6.2 mmol/ l )
) to pioglitazone or
Be sure
see section 6.1 )
% with aripiprazole and
a risk
or
ml contains 3000 international
increased Gamma
LTD
white
than 6
if the
Vascular disorders
) .
.
monkeys
full list
tablets
bone marrow
,
of 50 IU/ kg
vitamin
dosage may
(
anaemia
Actos
of
(
1 , 49
BE STORED OUT OF
or
.
use
hours after the
been reported
and
Epoetin alfa
, i. e.
D levels
may
blood pressure
300
mellitus and heart disease
doctor
following reactions
clinical trial in healthy
been performed
The recommended starting dose
blood in urine
and
Cmax
of aripiprazole alone was
0.5 ml
, akathisia ,
the
5.3 )
( 9000
See section
+ 34 (
adult patients
to 12 g/ dl
occurs
SQUIBB GESMBH Tel :
with ABILIFY
non-selective beta- blocking agents
injection ,
26-week
maximum dose
and
with
mmol/ l
Uncommon : orthostatic
and
4.5
are
immediately if
, including PANSS
metformin and /
hypoglycaemia
not
1 g/ dl (
vanillin and ethyl
and dehydro-aripiprazole ,
25 and
,
.
( 0)1628
) 663
the
s efficacy
human dose
and 15.7 %
( days 21
recommendations ,
.
pioglitazone
>
or
1HU -
are
doctor immediately if
and
Cytotoxic actions
tablets 28 x
or
with renal
.
the
the risk of
schizophrenia
: + 33 (
in Bipolar I Disorder
,
Driving
The four
.
A specific overdose of
injections
anaemia
What
, sedation
of
The
the
these trials , a
the aripiprazole dose
approximately 27 %
dosing
combined with fast-acting
(
as hydrochloride )
60 - 150
effect on
insufficiency not yet
to starting Abseamed therapy
other erythropoiesis-stimulating agents (
a
4.4 Special
should
solution
5 mg
1.5-2.5
a day .
in the
at least
What ABILIFY
Further
.
enzyme (
( Europe )
Adult cancer
mg aspartame
injection )
swelling
prior history of TVEs
(
should be
concomitant administration
)
150/ 015 98 tablets
section 4.5 )
4.4 ) .
pituitary adenoma .
angina
desired haemoglobin level may
(
with
cases of
and
treatment
efficacy
- Middlesex
, cerebrovascular
has told you .
been demonstrated although individual
years
6.2 mmol/ l
in patients (
of
intravenous
.
Novartis Pharma GmbH Tel
These trials included patients
The needle should be
For hypocalcaemia ,
4.4
( 2°C - 8°C
is 15 mg
Overdose
LTD Tel : +
g/ dl
be considered
2 g/ dl
alfa
ng/ ml
controlled
AND SIGHT OF CHILDREN
of patients with
.
cleavage
The other ingredients
) of
g/ dl ( 7.5
(
BV
alert
Storbritannien Tel :
,
. : +44 (
oral
given weekly for three
)
.
CYP3A4 ( ketoconazole
events in
Reactions usually resolve in
or
the
seriousness
your doctor
(
patients
12 g/ dl
) , 2C9
trials
epoetin alfa
Tél :
the freezer section or
60
.
7.5 mmol/
5.1
and
SPECIAL PRECAUTIONS FOR DISPOSAL
disorder
ABILIFY is
5
All of
.
in
UB8 1HU -
)
contains
- 7.5 mmol/ l
, sodium chloride
The pre-filled syringes
when
% dissolved
% )
13 g/ dl
control .
common
oedema , difficulties in
)
of epoetin alfa
of
: treatment
(
thromboembolic
.
( see
increased
have frequent
of last
in urine
In
treatment schedule
advanced solid tumours ,
Actraphane
increased
44 ( 0800
hypoglycaemia
pioglitazone
maximum recommended
with
mg/ day
.
in subjects
)
Intrinsic clearance is
(
faeces
the patient
with
into a vein
the
not
In
of CYP3A4
kg and
, feeling anxious
Due to
contains 3000 international
dopamine D4
any origin
forms of
and
( approximately 1/ 20th
5
signs
,
nausea , constipation ,
.
)
Each orodispersible tablet
, or if
section 4.5 ) .
monkeys after
g/ dl (
tablets 98 x
is given concomitantly
not
DISPOSAL
suspension
for a
was
increased risk of
.
see section 4.8
PRODUCTS
for all cancer patients
section 5.2 )
.
was
section 4.8 )
.
In
very
(
Aripiprazole
injections are given
only
a
an
, thiazides , glucocorticoids
nausea ,
less
) ,
In
Abseamed has no influence
diabetes
dizziness ,
placebo-controlled
dosage may also
the
of Abilify
4.8 ) .
9000 IU/ 0.9 ml
months when stored between
the
Aldwych ,
tablets 90 tablets 98
% of
11 g/ dl (
and
a
if applicable
dose
ise
or
the control
or
fibrosis of
for patients
has
the
to ensure optimum response
Tardive Dyskinesia :
or
the
cell production .
Actraphane is
.
and
+ 44 (
, episcleritis ,
patients with these
for aripiprazole-treated patients
or very rapid
,
9.5
or previous
or
68
by 107
with epoetin
0.6 mg/ kg
after
Kingdom
in women with
Other potent inhibitors
insulin products with fast
units ( IU
concentrations ,
beliefs
urine
see section
and method
blood pressure
IU/ kg given subcutaneously
Abseamed
administered by intravenous
section 4.4 )
,
ventricular arrhythmias
ml
significant changes
75 and
per se
treatment
for
Slovenija
use
.
(
injection site
month ) with
use
potentially
effect
0.62
of
and
example ,
study
except in paediatric
a
4.4 and
) .
insulin requirement is
and should
ml ( 10 000
,
%
Lietuva
half-life
hypertension .
260 lung
highly palatable
rare
or breathlessness
The
used
IU/ kg
, infection
43 1 60
clinically evident ischaemic heart
muscarinic receptors
Lilly
aripiprazole concentrations .
.
.
BRISTOL-MYERS
use
; 41 % )
( 4
very
Although in very rare
for major
no medically important differences
type 1
30
precautions
clinically
microsomes and tissue
and bone marrow
8.7 for
must not be
insulin and 90 %
,
In the indication
tiredness , nausea ,
pharmacokinetic characteristics
may
1 cartridge
controls
.
contraindicated for patients
R
( 2°C - 8°C
than three
.
terminal
)
4.4 Special
If you
for pH-adjustment
.
if the
pioglitazone and
subpopulation analyses
1
.
renal function
hypothermia ,
43 1 60
mean difference to placebo
is
new LHRH agonist
16
glycosylated haemoglobin increased
t½
.
inhibitors
in subjects with
on one side
with Abseamed
headache Eye
should be
seines Ausgangsgewichtes reduzierte
information on
AST ) , increased
per
.
Hb between 10 and
body weight 2 times
in adult patients with
negative impact
of transfusion requirements
is individual and determined
to have
is ready
Uxbridge - Middlesex UB8
be
Following
between 9.5 and
, Oxford Road Uxbridge
use of Abseamed
stimulate red
Road Uxbridge
)
Tel : + 31
(
units (
In a
.
with
ACE ) inhibitors
allergic symptoms , may
Limited Wimblehurst Road Horsham
by
with
CYP3A4 ,
( ALT
Alcohol should
ABILIFY 15
usually
treatment in between .
of aripiprazole
the limited
to
experience
exposures
( e. g.
5.3
achieved
In
lung , 22
of vitamin D supplementation
of
,
with
COMBINATION THERAPY WITH METFORMIN
&
Non-clinical
monitoring of
sites
suggesting hepatic dysfunction
type 1
with Aclasta
olanzapine-treated patients
a stroke or
mediated by
symptoms
Other potent inhibitors of
.
renal insufficiency .
see
be a
.
of
the
also prevents
NMS is a
, hydroxylation , and
.
CYP3A4
, metformin
a
, 30 mg
:
the thighs or
of rimonabant
of in accordance with
normal
four placebo-controlled studies
programme
no evidence of clinically
and a sulphonylurea
function
: +
and well-controlled trials
in a refrigerator
7.5 mmol/ l )
was not
when
alfa is very wide
by the intravenous
( 1 ) 524
) in patients
(
.
PRCA
diabetes
in paediatric
)
and should
injection .
49 x 1
) Protamine sulphate Water
sites of metastases
and 5-hydroxytryptamine are
with
33
of the
+
to pioglitazone
should
haemoglobin and
important that
vary with age
facilitate the
to
31.1
%
paediatric haemodialysis patients
.
on
subcutaneously )
of
and 15.7 % for
die
The rate of
Arthralgia occurred in 32
of the cardiovascular
, µ
not evaluated
of 2 units
children over 30
and water for injections
risk of cross-reaction
;
especially infections
Uxbridge
therefore
l/ kg .
in
%
, particularly if
trial
International Unit
and sight of children
are
episodes in patients
1.25 mmol/ l
patient
mmol/ l )
see section 5.3 )
lacrimation
or discontinuation of treatment
This can be
Adult cancer
%
6
parathyroid reserve
doctor
does not matter
or
to
150
controlled clinical
a stroke or
if you are
when
especially infections
using effective contraception
100
responds
increase
adults .
over one year
episodes of hypoglycaemia .
of
evaluated .
%
(
subcutaneous tissue disorders :
10 % ( 101
especially in
1 60 14 30
differences
the
indication
occurs
no fatalities
thromboembolic
six
magnesium stearate ,
aripiprazole
This
severe dehydration
vitro
.
from
significant changes
UB8 1HU - United
incoherent speech
target haemoglobin concentration
Sími
medically important differences
tablets in
chloride Glycerol
you are breast-feeding .
with
be assured
; the large
see
%
without psychotic
7.5
of recombinant human erythropoietin
,
with solid tumours
SQUIBB BV
.
ABILIFY is effective in
were observed .
IS
Europe
% dissolved insulin
Oxford Road Uxbridge
and
and
patients with diabetes
.
of 12
) Sodium hydroxide (
,
tablets are
rapid
preventing recurrence of manic
Abilify
PARTICULARS
antipsychotic drugs
( 57.3
suspension has a
,
fast-acting
MANUFACTURING
and
repeated
,
, 61 Aldwych
3.2 %
or
47
4 or
a
or
three injections in
PHARMACEUTICALS LTD
insufficient
)
:
leaflet
NORWAY LTD Tlf
,
300
the
)
to maintain urea
e. g. hypothermia
symptoms reported
.
is
are
3.2 % with
iron stores .
Hydrochloric acid
Tel :
unplanned ,
if
Uncommon :
administered
and
patients
73 %
and rhabdomyolysis
,
,
aripiprazole
approximately 6
defined by a decrease
filiaal
decision whether
treatment
in
bile
chronic renal failure
mg
ABILIFY
in the pharmacokinetics of
or
dyspepsia , vomiting
parkinsonism
Additionally , aripiprazole
two studies
with
) , increased
may include
Zoledronic acid
men
for thromboembolic events in
Wellington Road Wokingham Berkshire
1
with a
inhibitors
unused product
DISPOSAL
In clinical
symptoms can
2 352
)
or irregular heart beat
Like all medicines
x 1 tablets
diuretics that
g/ dl (
you
between 10 and 12
cell
side effects
or
x
IU/ kg epoetin alfa
+ 358 9 251
of
vomiting
signs of local infection
unconsciousness and/ or
feel better
1.25
you experience
from hypoglycaemia
.
on bone marrow cells
Hunton
dopamine
see section
after administration of
than
Increased
.
a glass ball to
.
on
)
also be necessary
not
or were
usually
or
,
+ 45 45
see
glossodynia , dry mouth
the incidence
month
advised accordingly
PRODUCTS , IF
the active substance
- 8°C ) .
to
are
three
and
product
) .
kg
should
in
Epoetin
,
should be
pre-filled syringe
agents (
patients
M-II is minimal
clinical trials with oral
line with the recommended
of the
eye pain Uveitis ,
35 trials and
receiving
patients
( thrombotic
1HU - United
ABILIFY
insulin products
.
As for
,
µ :
is
a
NMS is
observed in
.
Uxbridge -
and 50
g/ dl (
without food .
and
anaemia
with
hours has been
and well-controlled studies
.
(
see section 4.2
All special warnings
74 60
6.2
with
mg/ ml )
of the pancreas
the insulin requirement .
manic or
)
patients with
mmol/ l
should be
-
,
Takeda
) should be investigated
risk
.
the occurrence of
if you
.
symptoms
lactation
were
reported after months
.
,
ABILIFY
blood pressure , tachycardia
, the incidence
of dissolved insulin
peripheral arterial
aripiprazole in
be followed
with
while
sulphonylurea
> 0.5 % )
.
12
of
with
of 10 to 30
of aripiprazole
.
epoetin
Uxbridge - Middlesex UB8
anaemia ( e. g.
.
in pregnant women
g/ dl (
genotoxicity tests
hepatitis
Polysorbate 80 Water for
, muscle pain
mmol/ l ) per
( 34 [ 3.2
There are
are therefore affected
speech disorder , Neuroleptic
) .
Abseamed
) .
(
of
be
IU of
hip fracture
10
drive and
1
vehicles , until
.
other
tablets
6.1 months ( 300
vomiting ,
insulin requirement .
6.8 mmol/ l )
other antipsychotics
monitored
clinically
time each day .
than 1
Particular
in adult patients
tell your
and/ or
of iron
a combination of
a
9.5
itching , hives ,
Paclitaxel blocks
aripiprazole .
compared to
ABILIFY
VISTOR HF
If an elevated (
0.8 %
schizophrenia and
of NMS
and
associated with antipsychotic
Storbritannien Tlf :
per week
200 mg
( 2.5
(
AST ) ,
(
weight
disorders Common :
%
s
1
)
In
if
month or
section 4.4
injection )
PHARMACEUTICALS LTD Tel :
Like all medicines
cardiovascular therapy
potassium and
For
than
rare cases
1 to
.
is
myocardial ischaemia , myocardial
that the
to patients when indicated
If
;
or
of
dose
read
and
it less likely to
55
a
& Co KG Kuhloweg
5.1 % ) .
( 4 or
if
5.2 )
is difficult
, patients receiving
If
and approximately 60 %
women
several controlled studies
patients
section 5.2 )
and
effects
LTD Tel
rDNA
not
vorgenommen werden
Intensified control in
you
dizziness
sealed
section
Tel :
contribution
Common
Epoetin alfa should be
a dose adjustment
(
e. g. hypothermia
5.9 -
4.9 )
signs
blisters
in clinical
The recommended
,
4.4 ) .
section
anaemia
weeks
Vantas is a new
human , rDNA (
to the baby .
under
study
, Wielka
, a
needle
weight loss , emaciated
must be discontinued .
or
UK Ltd
pharmacist
Hunton House
and
.
Thrombocytosis has been
.
Distribution No
( 7.5
: + 39
.
(
Hunton
8°C
in
is reported
and
Ísland VISTOR
for males )
or unplanned ,
first trimester
pyrexia )
effect
Wimblehurst Road Horsham West
IU/ kg
an autologous blood predonation
blister
effects
rapid
Centre ( Europe
a
or without
tablets is pioglitazone
no experience in
49 x 1
that primarily
with
the Montgomery-Asberg
and transport refrigerated (
vary with age
haemodialysis and adult patients
,
has
present state
Abseamed has no
,
:
in this
or
Actos
trial
Abseamed
were
o. o Tel
pioglitazone
of NMS are hyperpyrexia
physical
4.4
and a negative
therapeutic margin of
below 100
" A-008 "
with severe agitation
vomiting and
weight gain ,
be
a
solvent-based
with fast-acting
,
tell your
was 12.1 %
(
dose .
or
danazol
)
to
RESTRICTIONS WITH
in very rare
Park ,
with
,
of
of in accordance with
the
that epoetin
ketoacidosis
.
If
stored at
.
)
with
, placebo-controlled
your doctor immediately if
.
the intravenous route ,
, must be discontinued
dogs
metformin
Treatment
.
,
:
the entire
renal
)
0.035 mg
e. g.
43 (
significantly
top .
,
of Epoetin alfa and
AND ROUTE(S )
.
, silicon dioxide
- Middlesex UB8
with encephalopathy-like
During
Actos
Global R
United
forms of
2
The following
a pre-filled syringe
a
Puh/ Tel :
35
IU of
is achieved
84 , 90
treatment with
with
hepatitis
Following the menopause bone
patient above and
27166 ,
or
should
in
pain , abnormal
1.25 mmol/ l
aripiprazole and
,
patients
.
ACTOS
trials of
increased insulin resistance
treated
- United
between 1.25
unexplained death
in
Iron
- 8°C
BLUE
Intravenous injection : over
than 2 g/ dl
revealed
mild ( Clcr
( IU
are
such as
if
and
metastatic breast cancer
Cmax
the
per month
for dehydro-aripiprazole the
with renal
from
In
intermediate-acting combined with
section 4.8
renal impairment
of continued therapy .
doctor
increased risk for
.
Any unused product
of
if
there was
8 704 71 00
352
haloperidol
of the
(
half-life
of epoetin alfa
pioglitazone and
days prior to
.
1 tablets in
mg
Latvij Tel
with a
a glycoprotein that stimulates
Do not
This medicinal
2.47 in
300 IU/ kg 3
epoetin
use
56 x 1 tablets
electrolytes
episodes of
12 g/ dl
Continuous rotation
30 Adjustment
37 D-58638
beta-sympathomimetics
t½ ) is
, aripiprazole
mmol/ l )
with the
In placebo-controlled
per week by
, there were
mmol/ l )
margin
Shunt thromboses may occur
or
occurs
Pre-filled syringes ( glass
Middlesex UB8 1HU -
15 mg
most of these
associated with antipsychotic
very rare cases
between
take possible interactions
effects of aripiprazole
must be discontinued
IU
4.5 )
and M-IV )
approximately
into
g/ dl ( 7.5
cooling element .
in healthy
and
.
arrhythmias
glycosylated haemoglobin increased
isophane
as
a medicine containing
one .
0.7 ml
44-20
will decide when
fast-acting , insulin
and
,
g/ dl
be discontinued immediately .
aripiprazole
two
Deutschland
or urticaria )
of in vitro solubility
as
free
two
jaundice is observed ,
and
.
London , WC2B 4AE
, 56 x 1
ABILIFY ,
units
also
% of
of the
should be rotated
( see
5.1 )
dysgeusia ,
tolerated in
+ 45 45
one year or less
tablets 56 x 1
) , myalgia
.
patients
how well
a
this
CYP3A4 or
.
what it is
by 32 %
or blood pressure
serious
rash and
All special warnings
the
no fatalities .
.
, constipation ,
:
section 4.2
see section
you are pregnant ,
cannot be excluded
,
epoetin alfa Abseamed
increasing
)
sodium chloride , glycine
of akathisia was 6.2
treatment with aripiprazole
diabetic
potent inhibitors
x 1
,
) and
contents of the pack
section
-
- 81
United
in adult patients
, in patients (
frequency
with
patients
Insulin human
symptoms were
If you
insulin ( human )
you
read
total clearance was
NMS is a
)
favour of controls .
15.7 % for
use
also
Subcutaneous injection : a
and
39
symptoms , such as
to
.
6.2
thrombosis ,
of the CHMP recommendations
the investigator
paediatric
: soluble
for
about this medicine
deep vein thrombosis
Geben Sie es nicht
0.4 ml ( 4000
( 0.5
11
are
)
the dose
( see section
clinical trials aripiprazole has
see section 4.4 )
injection : a
the
20 consists of 20
, thiazides , glucocorticoids
The dose
.
If any of the
retinopathy Long-term improved
to sudden
) .
All special warnings
Insulin suspensions should not
or
and 98 film-coated tablets
weeks
99 %
Actraphane
were
initial treatment response .
) corresponds to 0.035
OR RESTRICTIONS WITH
19 %
) was
contains 200
g/ dl
an apparent volume
probably need
can be
section 5.1 ) .
Treatment
effect of
pipette
Nervous disorders
advised accordingly
45
,
Park , Oxford
no known effects on
prophylaxis by
No
Although
haemoglobin is
symptoms .
Mildly anaemic patients
In most of these
the haemoglobin target range
also be necessary
speech disorder
or
subjects ,
in
dose
with chronic renal failure
patients receiving
,
aripiprazole
and
especially infections
hours after
ABILIFY
blood pressure
vomiting
regimens
.
post-menopausal women in
9.5 22.5 8.1 41.7
Water
in
may
) .
,
The
isophane insulin
include continuous electrocardiographic monitoring
in women
cases extreme and associated
have been
3.5
it may
,
single-dose tolerability
7.9 %
5.1 )
,
more information about
.
analogues for injection
as measured
The absolute oral
If
in adult and paediatric
Therefore , no
fat mass
with the
Europe
phosphatase
or
defined by a decrease
without treatment in between
doctor
ischaemic
1 tablets 56
complications
10 days
& D Centre (
is
and
of the art .
times per week
mg of aripiprazole .
somnolence
following
range of standard
is therefore recommended .
three days after
and your
In a
hypertension ,
6 hours
or lithium
the thighs or
of
testing did not
56 x 1 tablets
with type 2
België/ Belgique/ Belgien Takeda
or
effect of
for
aripiprazole or
, especially infections and
:
years
see section 5.2 )
about this medicine
subcutaneous use
mmol/ l )
g/ dl
medicine
section
of other races .
some
A number
with
Treatment of
) .
,
daily dose
rimonabant
schizophrenia and
Overall survival
Water
150
of
, anorexia , hyponatremia
very rapid or
.
.
do not
orodispersible tablet
(
injection
aripiprazole ,
,
effect of medicines used
moisture
It
.
Allow the refrigerated
, as a mitosis-stimulating
events
necessary
is between 75 and
products and
psychotic
this
of pioglitazone
see section
% )
hyperglycaemia and diabetes mellitus
that you
in
3 ml ( 3.5
300
dehydrogenation
epoetin alfa
aripiprazole as
of anaemia
dose .
60
% ) .
signs and
( type 1
There are no
placebo group
that the effect
four weeks .
indication increasing
section 5.3 )
monitoring
each day .
cartridge
or
of symptomatic anaemia in
or hyperosmolar coma
the concomitant
of 7.9 % for
of 50
lesser amount in urine
In patients with
:
12 g/ dl
or
for thromboembolic
or if
monkeys
with
International Unit
be observed
or
adequate
placebo-controlled
Functional Assessment of
the treatment
starting dose for ABILIFY
( see section 5.1
with these characteristics
section 5.3 ) .
epoetin
United Kingdom BRISTOL-MYERS
a
, headache , tiredness
dizziness
patients
chloride Glycerol Metacresol Phenol
effectiveness of Abseamed
Actos
trials of
the second
in the
combination with
after
)
, 25.9
in monkeys
One
.
.
Treatment
see section
lead to hypoglycaemia
peripheral
injection
alfa
, the incidence of
a
unknown .
, 30
In
AUC
, hepatitis ,
18 ,
, headache , dysgeusia
and
general scale
aripiprazole should
or
.
conducted in 375 anaemic
and
for a
cerebrovascular adverse events
(
weight management programme
in
aripiprazole
section 4.5 )
Finland OY
8167
headache in
and
ml
in patients
and 802
of
given weekly for three
screwed back
30 - 100
monitoring
to
The full
similar
to increase
see section
0.5 ml
aripiprazole
adequate and well-controlled
Even if you
undergoing dialysis does
CHILDREN
Tel
thrombosis
effects of
,
a
0.9 ml ( 9000
,
3.3-fold
also known as
section 4.5 )
There is an increased
,
maximum recommended
patient above and
paracetamol
Based on
Before
and paediatric haemodialysis patients
and other erythropoiesis-stimulating
and
ready to use
of 0.7
result of hypoglycaemia
The maximum daily dose
49 x
other CNS medicinal products
baseline .
after
of
combined with
intravenous
and
IU/ kg
aripiprazole treated
of excipients ,
30 mg )
SPECIAL PRECAUTIONS FOR
you
in dose should
43
nervousness ; suicide attempt
(
observed in clinical trials
tablets 98 tablets
are
of excipients , see
treatment
read
Do not
Diabetic retinopathy Long-term improved
disease is
patients
g/ dl (
4
mg once a
Ireland
.
If any of the
in type
rhabdomyolysis
( see
2
severe irritability .
literature
All special warnings
in a
or hyperosmolar coma
The second trial utilised
chronic renal failure patients
.
pyrexia ) ,
with or without
: +
%
EPS was
dissolved insulin and
be treated with Aclasta
be a moderate
kg over 2
42
30 % of patients
+
14 ,
insulin sensitivity
clinical trials
osteoporosis
)
the incidence of
) .
per se
The active substance
or
course of continued therapy
recent low-trauma hip fracture
subjects
the
Oxford Road
in the case
at least 500
7.5 mmol/ l
see
contraeptives
normal and
( Europe )
recommended ( or if
,
combination therapy
3A4
for rimonabant
of
treatment
chemotherapy
.
) per
international units
immediately
Treatment of
,
+ 40
an autologous blood
55
therefore be applied
symptomatic anaemia
the administration
of 12 g/ dl
(
route
who
used in humans .
Centre (
with two
This
or the
taking Actos 15mg
.
- 300
% with
Storbritannia Tlf : +
present state
obesity )
type 2
, each
For osteoporosis
some of your ABILIFY
reports
.
%
treatment
use
contain
immediately
the following
, maize starch
.
-
QT prolongation , ventricular
patients
approximately
France BRISTOL-MYERS
hypoglycaemia
and
3
compounds
, Te
London ,
( normal
clinical trial in healthy
, alpha-1
appreciable affinity for
for sale
chest pain
and adults .
185 patients
adequate and
.
Uncommon :
incidence (
see section
between
daily dose should
see section
Ireland Novartis
)
Aclasta
,
with
( e. g. aminoglycosides
15
administered intravenously
than 6
male patients
high fever
.
, including PANSS
.
when
5
patients ( particularly
in
( AST
2
use
to ensure
clinical
or urticaria
of
paediatric and
male and female
linearly from 2653 to
a sulphonylurea , only
mmol/ l
regard to meals .
SPECIAL PRECAUTIONS FOR
g/ dl (
insulin (
Abilify
vomiting ,
of Aclasta
,
6.2 - 7.5
34 %
for a longer
.
, 1,18 ;
g/ dl ( 6.2
30
post-menopausal
see section 4.5
fast-acting
11 g/ dl
vision
EFFECTIVE USE OF THE
)
and
( 101
)
clinical
PFT ] (
direct- acting
56 tablets 84
oral
,
process : rapid
for injections
, aneurysms
(
( 1.25
recurrence of
for
(
chloride Glycerol Metacresol Phenol
and
146 hours .
Centre ( Europe )
Highbridge
tablets
two main
bei der die
by
, monoamine oxidase inhibitors
section 4.4 )
other medicinal
and osteonecrosis (
to
risk for
contains
.
subjects
and
) and/
and young subjects
It may
time each day .
an
prior to
be monitored
no adequate and
solution .
0.62 mmol/ l )
other
6 pre-filled syringes of
management of overweight and
:
this
infusion
- 8°C )
, itching , rash
blood glucose )
timing of infusion was
49 x 1 tablets
brand ( manufacturer
with
chronic renal failure ,
,
IU ) corresponding to
( see section
( for pH-adjustment
( 1
60
combination
pulmonary
+ 351
and consists of
units of
.
Insulin human
by the liver
( GGT
weight
.
aripiprazole
should
.
possibility
Grade 1
should be considered
Cancer
.
(
that the
and
3 ml .
.
47 % .
and cardiovascular therapy ,
jaundice , hepatitis ,
children
3
.
a potent inhibitor of
) sealed in
are
%
EPS was 19 %
somnolence ,
taking ABILIFY
of 10
.
Tel :
PRODUCTS , IF APPROPRIATE
glass cartridge
ml
) general scale
and in
orodispersible tablets
.
signs
type 2 diabetes
, insulin ( human
Actraphane is
von
gliclazide as monotherapy was
in
daily dose of
4.4 Special warnings
( see
be
, the
of dosage may
than
VISTOR HF Sími
+44 ( 0)20 3116
substance
)
,
Aripiprazole exhibited
per
: up to
.
33 - 39 %
is
hypoglycaemia )
.
with epoetin alfa
Abseamed has no
see section
epoetin
under the
insomnia ,
ABILIFY
on
93 05 06
this effect
, Oxford
West Sussex , RH12
the most frequently
(
300
2 units .
with
5.3 ) .
hours
hypersensitivity
arrhythmias
marked
in
effect
the gluteal region or
) insulin .
ml
32 % and
AUC
LTD Tel
the
see section 4.4
may
also be used
and/ or a sulphonylurea
+
mg
nurse
diabetic hyperosmolar
shortened overall survival
Ask
are never to
SQUIBB SARL
)
children
75.6 micrograms
medicines used to
g. insulin dosage
as with
potassium and
tumours (
or
are
2 weeks
;
of 600
solution for injection in
When a
included only 3
in
menopause
75
, chest pain ,
, increased
administration of
haemoglobin is rising by
be followed
first
1 or
) per
section 5.1 ) .
investigated .
haemoglobin target range
between 9.5
or
achieved
normal
Abraxane after
,
.
sizes may
in pregnant women
safety
Aripiprazole is thought to
route
Less
% ,
genotoxicity ,
.
, with a similar
effect
and vitamin D supplementation
you are pregnant
in urine (
section 6.1 .
40 (
Erythropoietin receptors may
unexplained death
site conditions Common
After
100 IU of
average age of 62
not
:
supervision and monitoring should
( 1.25 mmol/ l
other .
rapid control
(
in
The
+ 34 ( 91
packed cell volume .
patients with haematological malignancies
has
, chest pain ,
2
and
human , rDNA
of 15 mg
,
with
placebo .
reactions after
over
or hepatic impairment may
you
compared
( 1 )
)
1 , 49
3 consecutive
six
studies ,
should
.
for advice before
dogs and
mixture of dissolved
,
no
with
the
doctor or
.
to
ml
If convenient ,
12
( AST
Therefore ,
the desired range
of heart failure
not be used
39 16 84
Pharmaceutical
are
-
thrombosis
may occur .
other
four placebo-controlled
following the administration
recommended
: treatment
placebo-controlled studies
per month )
and extrapyramidal symptoms
the studies
( 6.2 - 7.5
and clinically
by the intravenous
hyperglycaemia , diabetes mellitus
of patients with
overdose
Tel : + 31
or
, headache , tiredness
mmol/ l ) .
DERIVED FROM SUCH MEDICINAL
see
Latvij
tablet formulation is 87
in patients (
Uncommon - Diabetic
Gastrointestinal disorders Common
clinical
of 0.3 ml contains
and male patients
with a sulphonylurea
22
(
34
hydrochloride
In animals ,
of this population
Europe )
t½ ) is therefore
greater than 12
and controlled as necessary
1736
you
( see section 4.2
of 100
with
10
AND ROUTE(S )
,
30 on
EPS was
possible
insufficiency .
Danmark Takeda Global
clinical
alfa in
of rimonabant
6
5 and
pain
.
mg )
episodes of hypoglycaemia
1
The medicine
recombinant human erythropoietin
in Actos
medically
All patients being
1.44 % for
known as
of erythrocytes from
Depending on
( 1
from
adults
encephalopathy-like symptoms
e. g.
aripiprazole
%
contains
use in this
alfa is very
with
water
the
between 10 and
for pH-adjustment )
terminal half-life
or pharmacist
50
in
( 7.5 mmol/ l
of epoetin
(
In
administration
Neuroleptic Malignant Syndrome
United Kingdom
Business
by systemic chemotherapy
and
an increased
NORWAY LTD Tlf
( heartburn )
Common
.
difficult
episode in patients
than one year
of death and
( e. g. hypothermia
epoetin alfa
reduction of transfusion requirements
recombinant DNA technology
, who
with aripiprazole and 3.2
especially infections and
Lietuva
56 , 84
.
the incidence
) OF ADMINISTRATION
300 IU .
not
37
reducing
( oedema )
, hydroxylation ,
doctor or pharmacist
with
transitory and
, hypocalcaemia ,
.
for males )
and/ or
, and
with
dyskinesia
( also
the
, angiotensin converting
co-administration were
monitoring of liver enzymes
, glucocorticoids
SQUIBB GESMBH Tel
of epoetin alfa
medically important differences .
hypocalcaemia , hypoglycaemia ,
aripiprazole
infarction , cerebrovascular accidents
dose adjustment is necessary
IU/ kg
Gamma Glutamyl Transferase
gliclazide
the greater sensitivity
reduction of transfusion requirements
see sections 4.8 and
aripiprazole in pregnant
OF UNUSED MEDICINAL PRODUCTS
g/ dl (
per weight loss
Following initiation of
significant risk factors
this medicinal product should
cannot be excluded
greater than
monotherapy or combination therapy
and
incidence
margin of epoetin
schizophrenia
( mean age :
participants
IU
more
SQUIBB Tlf
x 1
) .
Die Schmelztabletten werden
Abseamed
.
a concomitant systemic
majority
Abraxis
epoetin alfa
10
progression
with
:
: +
encephalopathy-like symptoms
)
solution for injection in
Laboratoires
Sími : +
) sealed
or valproate
( see section 5.2
feel better
compared
with aripiprazole
the
the
of children .
a
in
Global R &
% with
sweating
month , or if
monitoring of
with
IU )
in
combination with
)
associated with antipsychotic
hypoglycaemia whilst driving
complications
: +
than a daily dose
solution
alfa ,
Aripiprazole exhibited
one vial
g/ dl (
( see section 5.3
isolated patients with
from
not metabolised
erythropoietin
trials
events (
should not
enzymes
patients
but
.
N-dealkylation .
reported cases
tablets
: +
hours after
and
below 30°C )
Functional Assessment of
: +
vomiting .
In
.
15.7 %
When
12 weeks
or 450
,
other antipsychotic drugs
oral
( 0)21 272
treatment ,
and pale mucosae .
a sulphonylurea ,
section
colourless ,
by approximately
6.6
it may
In the indication
therapeutic
mouth )
by injection
the duration of the
Cmax
rats
(
for aripiprazole
and Diabetes
of 30
months
hypersensitivity
precautions to avoid
VOLUME OR
retinopathy .
also known as
.
patients
Patients should be
.
If you
IU/ kg epoetin alfa
some
.
Microcrystalline cellulose Aspartame (
These
Oxford Road Uxbridge -
.
weeks when used or
mortality
together with two other
prospective ,
obesity )
, pyrexia )
your blood pressure should
Portugal - Produtos
,
VANTAS ( see
In the
do not seem
patients with severe
Immune system disorders
analogues for injection ,
like
50
increased risk of
by
to protect
per
pioglitazone ( see section
, 84 , 90
Tel : +
When
United
ABILIFY may increase the
(
on
your
abdominal discomfort
( IU )
be advised accordingly .
.
for
of
The recommended dosing regimen
devices for repeated use
after repeated
or
for Aclasta-treated
immediately if you
of
section 5.1 )
unit dose blisters
.
10 and
a
an albumin-bound nanoparticle formulation
.
,
,
having a high
veterinary medicinal product
.
that
(
( see
.
infusions of
BOTTLE
( see section
Starting dose of
be
, feeling anxious
Correction for anaemia
see sections 4.3 and
,
2 352 74
( such as
the
the sustained haemoglobin exceeds
section 4.8 )
25 and
missed dose
products and
or more units of
metformin is contraindicated
local requirements .
, is
, pruritus , or
events
manic episodes in
Therefore
Iserlohn ,
interactions
years and
or mixed episode of
g/ dl
subcutaneous erythropoietin
of clinically
( ca .
to
on
Dosage adjustment
may increase the effect
.
pre-filled syringe of
( see section 4.4
and
of aripiprazole ,
than 2
given subcutaneously
of epoetin alfa*
% ansteigt . Die
every
and 42
4.4 -
D supplementation
Cmax
weeks
with
ALT
Glutamyl Transferase (
Sími : + 354
therapy with pioglitazone in
PIOGLITAZONE IN
needle should be
mmol/ l ) or
In several controlled
)
occur .
condition with
contraeptives , thiazides ,
UB8 1HU - United
:
10
patients
dissolved insulin and
) .
a
are never to
and
outcome study of
a few
between
( see section
listed below
with solid
1
of individual
to 30
unlikely to
( see section 4.4
patients with
hypotension
Alcohol should
, hives
) .
Using a
67 55 53
, Km 22 ,
dehydrogenation , hydroxylation ,
order
Omission of a meal
( 95
Use should be restricted
local requirements
contains
frequency
Following subcutaneous
when Aclasta
and
section
stroke in
section
with
Moreover , monitoring of
, are
doctor
treatments
in
( 0.62
in a refrigerator
be
duration ,
If
temperature regulation disorder (
( 30 mg )
and
,
.
70 The
and this
Do not take
of
BRISTOL-MYERS
abdominal and stomach discomfort
pioglitazone
in
with epoetin
,
a lack
encephalopathy-like symptoms can occur
CYP2C8 and
cancer patients
No
allow the
thiazides , glucocorticoids ,
a clinical
1000
result of hypoglycaemia
injection ,
)
following
approximately 20
14 g/ dl (
nausea and vomiting
It
130 avoided ; guidance
9.5
diabetes
the pancreas
may feel dizzy
the
combination with insulin
aripiprazole in the bile
Very rare
can
g/ dl (
about 40 %
and
of
g/ dl
dose is 15
It is
.
important
Insulin zur
epoetin alfa
this patient population
any origin
PIOGLITAZONE IN
human .
ml equivalent to
of
(
diabetes mellitus
.
MINIMUM PARTICULARS TO
including
the treatment in this
if you
beliefs
IU/ kg
5
contains
The metabolism of
152 Tell
such as redness
g/ dl (
thus not
: anaemia in
two of the cardiovascular
EU/ 1/ 00/
zu Empfehlungen bezüglich der
before
growth factors
of dehydro-aripiprazole ,
of a full range
below 12 g/ dl
erythropoiesis stimulating agents
with solid
Renal
syringes
the dosage of
you
not take
in
ABILIFY .
with haematological malignancies .
mg of
or
% and
manic
(
, the
.
haloperidol 73
PRODUCT
.
Actraphane 20 consists of
of the art .
Insert
(
fixed-dose trial
symptoms over 3 weeks
in clinical trials
comparable
if
-
ng/ ml
shown
(
half-life ( t½
857
ABILIFY
(
or
an increased
SQUIBB BV
,
( 1.25 mmol/ l
) per month
prior to
Maintenance dose between
patient
akathisia , tremor ,
4.4 )
, delusion and
20 : soluble insulin
g/ dl (
the
( 7.5
06 5026
( see section
that primarily
the entire
clinical
.
.
, increased risk
bone
to it , donate
.
is
akathisia
pioglitazone
Insulins
( see section 4.4
some
avoid microbial
( see
be followed
epoetin alfa
glycaemic
you
the incidence
primarily
receiving
section
PRODUCTS OR WASTE MATERIALS
1 g/ dl (
the
significant
experience
Animal studies could
Medice Arzneimittel Pütter
and
tablets
.
iron
5-hydroxytryptamine
of
.
haemoglobin
1
an interaction
last approved on
is
this
Tel : + 31
per
known complication of chronic
chronic renal failure ,
were
SAFE
medicine
15.7 %
R
If you
(
800 ) 749 749
( 9 weeks
stimulate red
7.5 mmol/ l )
Driving and
hyperosmolar coma or death
BY WEIGHT , BY
peak is always well
aripiprazole ,
studies
ml
should be
in man .
of
thrombosis , arterial
the intravenous route ,
Takeda Global R &
Hunton House Highbridge
should be
iron deficiency ,
similar
a
including
to reproduction
section 4.4 ) .
ABILIFY tablets
when oral therapy
should
alfa alters
in patients with
Nordisk A/ S Novo
particularly
mellitus
or
Abraxane contains
.
be paid to sudden
and sulphonamides
trials , a
5.1 )
be considered
higher
ON THE
infection or
important differences
than a
0.62
Therapy- Anaemia (
glucose control
is
a potent inhibitor
* Produced
tumour proliferators .
treated
at least 15 minutes
Paclitaxel is
of akathisia was
in type 1 diabetes
11 g/ dl (
,
in vitro (
following
metabolite M-III
ABILIFY
clinical
severe manic episodes
2C19 (
Aclasta
( 5 ) 2649600
to 30 mg/ day
is controlled .
to
this
,
(
events
headache , akathisia
metastases
section 4.2
Takeda UK Ltd
medicinal products with
NORWAY LTD Tlf :
g/ dl ( 7.5
healthy elderly
reducing
section
39 ± 16 %
in
AUC
(
experience in this patient
below 30°C )
should
40 64
.
The potentially
Vascular
)
days prior to
pre-filled syringe of
patients scheduled for major
5.1 ) . no
your
or
of insulin
epoetin alfa is
with
,
,
you
sealed in a
than
maintain haemoglobin values
or
high fever
Limited Wimblehurst Road Horsham
The usual dose
in patients with
.
, tachycardia ,
shown significant benefits
rather
be observed
serious
OF UNUSED MEDICINAL
IU/ kg
) , and
of
In most of these
10 000
USE
the abdominal wall
clinical trial in healthy
in order
approximately
osteoporosis
This multi-centre
(
you experience these
Novo Allé DK-2880
:
,
Hypoglycaemia may
or
ACOMPLIA , see
,
N-dealkylation .
than 1 %
month
and
placebo , or were
&
of liver cirrhosis
Ltd Tel : +
Consequently ,
defined .
, followed by
when treating your
not been
aripiprazole
times per week
of 200 mg
tablets
greater
Actos 15mg
wurde durch
ventricular arrhythmias , sudden
.
extreme and associated with
Since insulin and
epoetin alfa is
10
safety
mmol/ l
diaphoresis and cardiac dysrhythmia
inhibitors of
akathisia
Allé DK-2880 Bagsværd Denmark
solution
If the
valproate or lithium
43 1 60
31 34 857 42
micrograms epoetin
humans
,
be
g/ dl
alfa in
Warfarin ( CYP2C9-Substrat
,
disorder
, itching ,
doctor immediately if
and
, reduced
( see section 4.5
tell
( e. g.
insulin
,
hepatic impairment on
412
rats
Aripiprazole
BRISTOL-MYERS SQUIBB Tlf :
see section 4.8
BRISTOL-MYERS
REGARD TO THE
can be
General
The
paclitaxel
CYP2D6
in Saccharomyces cerevisiae
%
The AUC and
or
with epoetin alfa
alfa
see section
danazol
well-controlled trials
recombinant DNA technology
( 0)20 3116
products
VISTOR HF
Allé
and 12
are
a
100 , less than
60 % in
Abseamed 9000 IU/ 0.9
The maximum daily dose
maintain haemoglobin concentration
been reported .
is 150
wastewater or household waste
g/ dl
% )
syringes contain
.
should not be
products and
.
are
will
inhibitors of
experiencing potentially clinically significant
doses
QT prolongation ,
or
.
patients with
and
10 ml equivalent to
1 orodispersible tablets
( rhabdomyolysis ) ,
insulin
of children
site conditions Uncommon
.
3.0 % with
,
(
Insulin treatment of the
infusion
mg
uncommon in
6.2 mmol/ l )
tumour proliferators
characteristics of aripiprazole and
in
MUST BE STORED
, the
calcitonin ,
needle top
with renal
, sodium chloride
(
between
and Cancer Linear
impair fertility in
)
Pioglitazone is also
below
with the
, especially
the pharmacokinetics of
cognitive
( 139
given
loss category
(
trials , uncommon cases
Abraxane
with
DISPOSAL
Adult
g/ dl
is
) and
in
( dextromethorphan
see section
45
)
Abseamed 5000 IU/
haemoglobin of
biological efficacy of epoetin
when a
food
.
Similarly
safety of
no adequate and well-controlled
100 , less than
with
or irregular heart beat
84 ,
time until
ACE ) inhibitors
section
nurse
2 (
, including those
)
the incidence
% with placebo .
given area may
Due to
Beta-blocking agents may
is always well below
before injection so
ABILIFY
the intravenous route
& D Centre (
Nordisk A/ S
significant
of
or
.
.
SUPPLY OR USE
of hypocalcaemia
not
may
need
15 on one side
month ) with
for injections
the
aripiprazole
Reticulocyte count
during
with
tense .
6.2 mmol/ l
this should be
ABILIFY
ABILIFY and
should
Actos
.
Overall survival
( see section
.
.
mg
orodispersible tablet is bioequivalent
incidence of EPS was
( human ) .
the active substance or
OUT OF THE REACH
section
15 mg has
FINLAND )
alfa
administered intravenously
clinical
week by
mellitus ( see
Serum electrolytes
) to
Hb between
and
12 g/ dl (
overweight and obesity
in patients
should
BRISTOL-MYERS SQUIBB GESMBH
other
Actraphane
receiving chemotherapy
of
In both studies
patients with
32 2
hours
pharmacokinetics of
pioglitazone vs.
contain
insulin and
or
the
was 9.5 years .
differentiating hormone , the
Your doctor
its metabolites
Tel : + 40
mg sodium per dose
rare
Leaflet .
solution
the active substance or
without
trials
starting dose for
mmol/ l
less than
in this patient
Dosage Dosage
, dyskinesia
of rimonabant
)
: in
ABILIFY solution for injection
(
isophane insulin
Highbridge Business
formation
at increased risk
hypersensitivity
Malignant Syndrome ( NMS
and
you have further
.
Aldwych London WC2B
,
15mg tablets
see section 5.3 )
or
hypoalbuminaemia
The possibility of
,
absorption
liver problems
As for other
be marketed
.
emergence of such
to placebo
(
or death
be monitored closely
trials (
INTERMEDIATE PACK
weeks
pre-filled syringes
( two studies
as
+ 45
hypoglycaemia may
other oral
monoamine oxidase inhibitors (
recombinant human
alfa has been
epoetin alfa is
of CYP3A4
( 7.5
a manic or
administered after a
the
+ 46 8
7000 international units (
use
SQUIBB
International
Tel : +46 8
.
vascular events ,
any remaining contents .
other antipsychotics
elevated liver enzymes
to drive and
well
Injection sites
to starting Abseamed therapy
disorders
)
The effect
%
Actraphane
in man
if
in two studies
60 25
Epoetin
)
eliminated
95 % CI :
surgeon
following
human ) .
in pregnant
of the
,
( 34
pharmacist .
recommended
PRODUCTS
Adult patients with
,
>
131 )
Road Uxbridge
one of these
receptors on muscle
.
:
to
.
see
Injection sites
creatinine
which
and approximately 60 %
200 mg
Adult cancer
complications
2 weeks
with
and
) insulin .
Tel : + 46
signs
a
with
,
15 mg
populations ( see
> 27
with
use of Epoetin
The dosage should
manic
resorption
water for injection
)
terminal
Treatment should be
pioglitazone
,
pharmacokinetics
(
%
D Centre (
between
) with
,
rapidly
for
approximately
In
broken their hip ,
negative impact on
by the intravenous route
the CYP3A4
adjustment
factor and
the
clinical
pharmacist if you are
Nevirapin und Johanniskraut
patients with normal
The active substance
.
As for other
Takeda Global
.
risk of
see section
) .
Aclasta
rising by more
few
effect
,
chest pain
days immediately
a
intentional
and
SpA Tel :
.
disorder
subsets ranging from
no
.
no adequate and well-controlled
, increase
5.2 )
95 % CI
specifically
in patients
antidiabetic medicines (
treatment with
of NMS
Based on results
with or without psychotic
of the hormone .
be used (
, neuropathic pain ,
in breathing
with cyclosporin ,
The dose
clinically significant
trial ,
The initial dose
not been established
and
the active substance
should be
,
5.1 )
% isophane insulin .
PRCA ,
increase
5 and 10
using an
and 4.3
, Oxford
.
möglicherweise nicht alle Packungsgrößen
order
different
30mg
% with aripiprazole
with an apparent volume
recombinant DNA technology
,
,
Lilly
The
studies
dosage or
(
Tel : + 39
6 % )
a
g/ dl
the treatment of
, and water for
30 kg require higher
the missed dose
than 1
if you are breast-feeding
Units (
before
Highbridge Business
levels and with
margin
- Produtos Farmacêuticos
of
Hb increase
NovoLet
male patients ( see
or insulin .
, the treatment will
see
(
g/ dl (
demonstrated that
pioglitazone
sleepiness , shaking
dysgeusia , oesophagitis ,
HF Sími : +
g/ dl
61
The initial dose is
increased
and behaviour and emotional
.
, infection
30 60
The
aripiprazole
;
4.3
Diabetes Mellitus : hyperglycaemia
may help to
,
ready to use (
no
and
be necessary when
if they
Sverige BRISTOL-MYERS SQUIBB AB
- Diabetic
ABILIFY is not
ABILIFY
a
in
.
and sight
or
GmbH &
-
( dextromethorphan
speech disorder ,
aripiprazole
.
in plasma
of
increased Aspartate Aminotransferase (
.
If
(
%
of adult
epoetin
France BRISTOL-MYERS SQUIBB SARL
,
and nerve cells
,
interactions
Kuhloweg 37 D-58638
fatal
be
recombinant human
should be considered
engraved
be
64 gynaecological
the
trials
significant benefits
of death when administered
1 orodispersible tablets
, especially in patients
copious amounts of
and 6
by the intravenous route
predonation
to
, 2C9
every 3 weeks .
both decrease and increase
After
sustained haemoglobin exceeds 12
by
bottle
4.8 ) .
% ) of
of anaemia
aripiprazole in
Tablet Round and
not
respectively
insulin
:
and
pharmacist for advice
both fast-acting
that
was used
other antipsychotics
a prospective
.
,
and
)
Actos is and
be avoided
This
, the plasma concentration
with epoetin alfa
.
wurde
Based on in
aripiprazole ( see
infusion
to prevent dehydration
(
Do not take ABILIFY
.
seriousness .
treatment with
(
Activated
levels of
ml ( 5000
the entire
compared
,
mixture
respectively , the
and
in
should
At therapeutic concentrations ,
and
necessary amount
placebo-controlled trial ,
also be used
diabetes mellitus , diabetic
for ABILIFY is 15
4.2 Treatment
mild
overall survival
blisters
It
aripiprazole in
daily )
therapy
with placebo
use of Aclasta
Common :
of 1 ml contains
a full range
.
further comparative studies are
2°C -
snack containing carbohydrates
some blood
for all
.
than
1.5-2.5 hours
)
other clinical
of pioglitazone
with aripiprazole and 3.0
; suicide attempt ,
the active substance
without psychotic features
and what it is
7.5 mmol/ l )
injection under the skin
laboratory parameters
events cannot be excluded
vary with
PROactive
in the bile
the
DISPOSAL
In placebo-controlled
polycythaemic mice )
Frequencies of
of
, diabetes mellitus ,
Your doctor may check
.
is therefore
25
healthy elderly and
Centre ( Europe )
or
( IU )
another
,
Unit ) corresponds to
sweet or fatty foods
5.1 ) .
see section 4.5 )
Aclasta
There
Takeda Europe R &
is
the clinical
trials , the incidence
, headache ,
)
may
pack
in men with
8.1 mmol/ l
.
a sulphonylurea
has
as the
myoglobinuria
and
lithium concentrations .
.
starting dose
(
(
Glycine Polysorbate 80
advised
patient above and
of anaemia and
.
experience in
ABILIFY can be
starting dose for
Seizure
potent
experience
Maintenance dose
medicinal products with
, the patient
.
( 7.5 mmol/ l
half-life is
about 40
in
patients with
500
The
.
with
100 IU of insulin
cannot
tumours
,
8.4
A/ S Novo Allé
90
studies
to treat type 2
administered by intravenous
case of insulin resistance
no
tablets
treatment
and " 5 "
aripiprazole
your doctor immediately
(
,
(
,
may
.
(
are
12 g/ dl (
:
that pioglitazone
growth factor
gp-Substrat
and increased
dehydro-aripiprazole
Abseamed
mmol/ l )
.
headache , tiredness ,
glucocorticoids , thyroid hormones
ACOMPLIA , see
pruritus
802
patients with
in
If
)
use
4.4 ) .
( FACT-An )
Abraxane is
and this
not be used
untreated
46 8 704
alters
pad .
blood pressure
SQUIBB GESMBH Tel :
metformin
( normal
g/ dl (
.
( 2°C - 8°C
in this
Reticulocyte count
or if
controls (
, somnolence ,
5 hours
6000
reported
) .
aripiprazole
.
in
of daily
and inter-individual variation
mg Aclasta .
a clear-cut
hours
There
dosage
Global
zu um
vomiting
be
Follow
:
CYP2D6
cold-formed aluminium perforated
per
the rise in packed
.
patients with
month ) with
: dyspepsia , vomiting
to the baby
into 2 equal injections
Peripheral neuropathy
manic symptoms
delay recovery
Bipolar I Disorder
blood glucose is controlled
24 hours
.
.
product at 52-weeks was
410
or
aripiprazole
period .
However , this did
42
should not be diluted
Two-year clinical studies
, long-acting
patients
15 minutes
patients participating in
, marked with
In
other
of
kilogram bodyweight .
( 1.25
patients with
Uncommon - Diabetic retinopathy
1 pre-filled syringe
Gustave
and
dizziness , headache ,
aripiprazole
55
704
on in vitro studies
(
, sudden
lung ,
in type 1
( for pH-adjustment
moderate binding affinity
) .
the mouth is difficult
.
in children
In clinical trials
Novo Allé
for a long time
the
The
is
with
no
with reported estimated
use of
half-life ( t½
40,000 dalton
than
after
These trials
aripiprazole concentrations .
.
in vitro
, Abilify
or
Abseamed should
monitored
tablets are
,
ACOMPLIA should not be
and
g/ dl (
12
events
Aripiprazole also exhibited
to placebo
STRIPS
events (
wastewater or
x 1
to the
SQUIBB SARL Tél :
Österreich BRISTOL-MYERS SQUIBB
chemotherapy
or 45 mg of
solution for injection in
Es
Kuhloweg 37
The
see section
10 and 12
erythropoiesis-stimulating agents (
pioglitazone
1
should be
acute renal failure
.
daily
( see
for
, vomiting ,
,
) , Storbritannien Tlf
Before
and danazol
after
section 5.3 ) .
hypoglycaemia
358 9
) .
In
listed below .
In clinical
your condition
56-99 years
infections and
manic
einer
4.8
insulin ,
(
of pioglitazone
between
,
see section 5.1 )
in the bile
32 2 352
3.0
% and isophane insulin
Unit ) corresponds to
and
fall
of the
up to 36
In
.
increased
14
2 g/ dl (
de pointes ,
trials
( colds )
A clinical trial of
treated
:
of
contains 8000 international
instability ( irregular
)
no
4.7 Effects on
of ABILIFY
paclitaxel
patients
information about
Metabolism Human
studies
problem of
2
, including
observed
a
, thiazides
: + 358
,
with
in
R & D
%
clinical factors warrant
NMS
the
male patients
Park Westhoughton BL5
prior
2 units
Erythropoietin is
Middlesex
your blood pressure
other
,
In
food
.
per 8
749 749
, nausea
+ 44 ( 0)1628
31.0
30 mg ,
) .
a meal
Special
agents
( particularly overweight
A cardiovascular outcome study
dosing
and rhabdomyolysis ,
Inadequate
undergoing dialysis does
an autologous predonation programme
+ 32 2 352
Limited Eesti filiaal Tel
study
The
dopaminergic hyperactivity and agonist
( see sections 4.8
( 2°C -
is 600 International
,
micrograms epoetin
3 patients
Global
notice
and 4.9 ) .
what it is used
000 IU/ 1 ml
day
g/ dl
corresponding to 25.2
monitored
administered intravenously
and
infections
corresponding to
(
IU ( International
ketoacidosis
The
its metabolites are
see section
and
, the
g/ dl ( 6.2
and
rhinitis , hoarseness ,
Norge BRISTOL-MYERS SQUIBB NORWAY
)
mmol/ l )
be given .
international
clinical trials with
rare (
:
bacterial and mammalian cell
diabetes mellitus ,
a meal or
adult patients scheduled
headache ,
from
(
Hb
sedation , headache
of
Diabetic retinopathy
trials
( 1.25
) gene mutation
Abseamed 3000 IU/ 0.3
, see section 6.1
muscle pain
pre-filled syringe of 0.5
for pH-adjustment
be avoided when
7.5 mmol/ l
machines
4.5 Interaction
exceed
,
%
.
pioglitazone vs.
BRISTOL-MYERS SQUIBB BV
during treatment with
( 7.5
of
of this population
R
)
ABILIFY
- 8°C )
in pregnant women
Uxbridge - Middlesex UB8
( 7.5 mmol/ l
studies
g/ dl (
has not
,
month )
clinical
Takeda UK Ltd Tel
) of EPS including
ACOMPLIA is
per
Actos 45mg
may occur in
active malignant disease
alfa
chest pain ,
or more
with
or
of the patients
muscle
: the levels
x ULN
below the
to 12 g/ dl
8167 patients )
all
Starting dose
trials
Occlusion of
chemotherapy induced anaemia
days immediately
( N=70
but
(
its application for
and bone marrow
plasma concentrations
ALT levels remain
clinical trials
or higher
Creatine Phosphokinase ,
rare
this condition may also
epoetin alfa
and rhabdomyolysis ,
clinical trials
,
significantly impact
or
)
ABILIFY is
, less than 1
per
, as a mitosis-stimulating
section 4.4 ) .
in
%
precautions for
(
pioglitazone vs.
highest concentrations
tell
with a cartridge
50
injection
.
,
section 5.1
receptors
other medicinal products :
93 05
not be exceeded
during
.
)
0 2 year )
Ltd
elderly
Hypersensitivity reactions including
see section 5.1 )
and
is not
and
30mg
mg
3 ml
95 % CI :
whole .
clinical effects of
you are pregnant
with renal impairment :
human insulin .
Following
is no accumulation :
to
important differences
units in increments of
condition with
of
is available as
g/ dl
:
in pregnancy
32
on one side .
placebo-treated patients
in women
5 mg tablets
Uncommon
week
AND BOTTLE LABEL FOR
ready to use
two years
used
the food .
products to affect ABILIFY
mellitus , diabetic
see section 4.4
The
manic symptoms
Roonstraße 25
:
%
product
label
treated
, in some
GESMBH Tel
If
of
of excipients , see
OR
the local representative
clinically
and
including
, Te . :
1HU - United Kingdom
pre-filled syringe of 1
+ 39
the cells cannot
)
olanzapine-treated patients .
ketoacidosis
rash
overall survival between
and
smoking
in
+ 354 535 7000
NMS
.
human
involving
alfa
experience
using
.
.
1st-line
effective , and
be used
maintain haemoglobin values
is not
the
a pre-filled syringe
is achieved ( this
12 g/ dl
Holder :
5 hours
symptoms
recurrence of
( 6.2 -
with insulin
osteoporosis
be discontinued immediately .
trials with pioglitazone
be followed
Novartis
QT prolongation , ventricular
tablets 49 x
sections 4.3 and
mmol/ l
,
or
in schizophrenic
dogs
)
mentioned in
:
were women , 87
subjects
+ 358 9 251
, pyrexia )
with
In a
antipsychotic
the
The
an increased
, the dosage
aripiprazole
section 4.4 ) .
benefit
hyperglycaemia (
.
, headache ,
than 2
56 x 1
x
,
.
very wide
from light
patient group .
recommended ( or
,
The peak is always
,
patients studied
paediatric haemodialysis patients
aripiprazole
Royaume-Uni Tél/ Tel
action of the
Malignant Syndrome (
over
.
should
In clinical
of 12
21
D (
Absorption The absorption
Tel
of the manufacturer
1.5-2.5
solution for injection in
mmol/ l
vary with age
kg
:
This is given 2
paclitaxel .
in every 100 patients
,
) .
tolbutamide )
.
and
Benommenheit
to maintain haemoglobin
either valproate or
Middlesex UB8 1HU -
per month or
9.6 for lorazepam
on the other
human .
complications
duration
margin of epoetin alfa
For a full list
.
month or
mg ( 1.3
Vantas
Treatment of anaemia
)
micrograms epoetin
has been
abdominal discomfort
100
55 ml :
in clinical trials
an
tell your doctor
for your doctor
information on
3x/ week
no relevant
edetate , fructose ,
site
over the
kg BW 120 ml
.
also
scheduled for major elective
and
and Cmax of dehydro-aripiprazole
pre-filled pens x
metabolites
Water for
patients
and disturbed behaviours
mainly
%
(
precursors
by symptoms
products
apparent molecular weight of
blood
e. g. ,
needle should be
another ( see
40 ( 0)21 272
or if the
64
If
is
the
alters the metabolism of
see section
Novartis Pharma GmbH
are shown
CYP3A4
with
g/ dl (
) ,
.
00
, increased risk of
( 0.5
of these patients
2 diabetes mellitus and
the CYP3A4 inducer
patient
+ 31 34
5.2 )
) .
chronic renal failure and
30 mg ,
for pH-adjustment )
Most
, patients with
Hb between 10
.
a
how
be
in favour
with chronic renal failure
This
episodes
regard to meals
exactly as your doctor
Oxford Road Uxbridge
,
biological efficacy
Ask your
other
third of
section 4.5
a
, an
2 g/ dl
hours
AND
(
or
6000 IU/ 0.6
and
and isophane
%
PACK SIZES OF 14
Hunton House Highbridge Business
,
between 10
g/ dl
doctor or
50 00
( see
or
Finland OY
- If you are
hypotension
for
/ N. V.
and you
placebo
or very
glucose
diabetes
mellitus , diabetic ketoacidosis
( please see
, dizziness , somnolence
Highbridge Business
,
pre-filled syringes of 1
human milk .
haloperidol .
( 1.25
at least one
At therapeutic concentrations ,
) and
pharmacist for advice
LTD Tel :
%
.
Takeda Global
(
)
treatment with
The
that
( 0 )
pancreatitis , dysphagia
ABILIFY is
insulin .
100
treatment
impairment ,
: the levels
12
, face oedema
use of
eaten the complete portion
l
not
of the
( Europe ) ,
in paediatric patients
12 g/ dl
after subcutaneous administration
aripiprazole tablets , with
0.5
Common
placebo -2.9
trials , a
less than 1
of children
various
Interaction with
and 3.0
patients )
,
gastro-intestinal
a glass ball to
insulin and isophane
a meal or unplanned
- 150
monitored and
BRISTOL-MYERS
with
PACKAGING UNITS
with
together with two other
,
between
dose
.
Puh/ Tel
In
Treatment
increased
( e. g.
treated
or
how
but
section
provide a PSUR
you
treatment
PRODUCTS
maximum of 30
( 0 )
behaviour
gynaecological , 23
.
aripiprazole or
(
Creatine Phosphokinase ,
see section 6.1
in
should be
stroke
IU of insulin
less
section 4.4 )
8°C
.
200 -
pharmacist
PRODUCTS OR WASTE MATERIALS
Cmax
patients with
,
clinical judgement
trials , an increased
reports are based on
and anaphylactic reaction
the following pharmacokinetic data
chemotherapy induced
the pharmacokinetics
,
13 g/ dl
a
% )
.
911 273 0
treated with haloperidol
in
95
ketoacidosis
in some
aneurysms
nausea
weight gain ,
not
- General )
erythropoietin
hours after
6
BRISTOL-MYERS SQUIBB BV
g/ dl ( 7.5
aripiprazole
( NMS
)
information is
of epoetin alfa*
Iron
-
has
300 IU/ kg given
2 352 74
indicated
39 % )
or
.
an interaction
of manufacture ( recombinant
and
compromise or
not
chronic kidney failure (
see section
272
,
should
substitution
day
;
parenteral benzodiazepine therapy
patients with or without
)
allow the
(
be necessary
subjects
see section 5.1 )
values above
( 2°C -
Die
and symptoms
daily dose
with solid tumours
Subcutaneous
Authorisation Holder and
risk
administration
)
: + 354
entire dose
-
been reported
- 14 g/ dl
%
and
1.25 mmol/ l )
doctor .
increase in haemoglobin
.
at least 500
73 %
PHARMACEUTICALS LTD Tel
clinical fractures The incidence
but
serious
.
2 g/ dl (
The patient s ability
in patients
sections 4.3
with an apparent volume
and
In
physician must therefore
severe hepatic impairment should
ml 6
tremor ,
food with
,
) and
after
PRCA ,
4 or more
is a
see sections 4.8
anaphylactic reaction
patients with these characteristics
contain 0.4 ml
gemfibrozil (
.
There is no accumulation
:
90 and
of the pharmacological effects
epoetin alfa .
aripiprazole
glass of
pregnancy and
see section 4.8
of efficacy or
ABILIFY may increase the
hours in
7.5
had
The majority
Actraphane 30 consists of
The
is
30 60 25 800
taken
(
( MAOI
PRODUCT
der folgenden Tabelle
of dissolved insulin and
be monitored and the
Common :
or
of pioglitazone (
AND ROUTE(S )
Very
groups
minor metabolites ,
Co KG Kuhloweg 37
mmol/ l
mg/ day .
180-minute
:
solution
receptors on muscle
- Produtos Farmacêuticos ,
with
GmbH & Co
BV Tel :
or
headache
or planned G-CSF support
BRISTOL-MYERS SQUIBB
In
psychotic
therapy should be discontinued
insulin requirement .
with aripiprazole
NovoLet
by 107
6
in
BV Tel : +
Cmax of dehydro-aripiprazole
to protect from moisture
Cedex
5.3 ) .
patients
produce effects that
study .
haemoglobin
condition
after the first
the patient
efficacy and
Abilify , aripiprazole ,
faeces
,
or
weekly dose is between
on the
0.6 ml
erythropoietin
pharmacokinetic profile demonstrates
blood cell production
if
) .
into a vein
7.5
use machines
and
parkinsonism ,
in
CYP3A4 (
(
weight gain
Tell
benefit clearly justifies
genotoxicity tests ,
( see
UB8 1HU -
Business
Road Horsham West
(
The
) .
and post-marketing experience
the granting of
or more weeks after
39 % )
,
28
and
supplied in vials
the dose selector returns
inside
A
dose ,
one of these trials
hypoglycaemia
200 mg
.
local requirements
.
11.6 63.8
of the
172 breast ,
300
( see section
placebo .
of
product
disorder , akathisia ,
,
Tlf : + 45
( see section 5.1
and
transient ischaemic attacks ,
infection or
be followed .
monotherapy
both
. no
be avoided
of
below 12
labelling and package
100 IU of insulin
patients
) .
safety
,
5.2
%
to
revealed no medically important
an increased
manic or mixed episode
daily insulin requirement
studies
reduce the epoetin alfa
with haematological malignancies (
section 6.1 .
(
CYP3A4
The
if you
IU/ kg
of liver cirrhosis
factor and
ml
this
% with
to
ACOMPLIA
(
OF ADMINISTRATION
influence
In patients with
, especially
, the incidence of
+
( 5 ) 2649600
,
not
primary efficacy variable
physicians
,
NMS
A/ S
patients receiving
tablets are white
rapid
a cartridge
schizophrenia patients
your doctor
included patients
the intravenous route
.
rDNA ( produced by
)
France
to protect the environment
73 %
Hb increase
, 5 and 10
the most frequently
metformin
.
Novo Allé DK-2880 Bagsværd
normal and anaemic
, bradycardia
.
NovoLet
see section
schizophrenia
Vantas
6
pioglitazone
to avoid
see section
is always
with
diabetes
12
clearance
the
5 mg
on
diabetes mellitus
(
: in clinical trials
epoetin alfa
The pharmacokinetics of
should be
IU/ kg 3 times
Abseamed
CYP3A4 and
is
inhibitors
and
Wichtige Informationen über
some cases
OUT OF
in paediatric
reduce insulin requirement .
EMEA
clinical trials that
6.6
Aluminium perforated
and
mixed episode
of anaemia
Centre ( Europe
your doctor
than
be added to
been reported
mmol/ l )
or
section
see
tablets
the levels remain the
with
turnover markers .
bioavailability of mitratapide (
.
1 cartridge contains 3
( see sections
.
with
10
SQUIBB
60
injection site
to be
of
007 , 009 ,
washed and
drive
ABILIFY can
5.2 ) .
, especially
clinical trials , uncommon
measures will help
( normal
gene mutation
to drive and
.
is not
,
or
( e. g.
study population had an
whom
( 30 %
the patients
THE
,
erythropoiesis stimulating agents
and
, inform
- if
very rare cases
shortened
In the HORIZON
1 %
you are pregnant
should be considered on
individual insulin requirement is
.
epoetin alfa has been
Changes in strength
MEDICINAL PRODUCT
see section 4.4 )
in
taking ABILIFY .
reduction of transfusion requirements
Functional Assessment of Cancer
with
E218 ,
observed after the
.
See section 4.4 )
)
possible warning signal .
with
of
- Store
culture mutagenicity tests and
Aripiprazole
per
1 pre-filled syringe
dose , i. e.
of ketoconazole or other
(
.
40
patients
EPS was
occurs
in
24 hours after the
unusual
The
or unplanned
may
parkinsonism
Patients
and swelling of
at least one
sodium hydroxide
intravenous administration
did not show any
been reported
vials x 10
ABILIFY
than
- 8°C
and/ or pain
or
The
in the thighs or
events :
flatness .
of which were
5-hydroxytryptamine and dopamine
)
and 11
hours
treatment
Not all pack
section
see section
the
1HU -
,
retinopathy
Patienten
33 (
did not show any
% isophane insulin .
or
based on conventional studies
section 4.2
Upon regaining
carefully weighed against the
.
.
.
:
,
and
the limited number of
)
.
,
Takeda Global
were
.
, the
14
g/ dl
( IU
1
,
( see
, including PANSS and
monkeys
see section
long-acting insulin
, non- smoking
make sure the
pioglitazone
100 IU of
This medicinal product
19
)
Aripiprazole is metabolised
g/ dl
AST
Uncommon
.
may
.
This data
the
children
6.1
of 10
that dissolve the paclitaxel
be avoided .
of
should be avoided .
Peripheral neuropathy
thyroid hormones and beta-sympathomimetics
as
the patient should
products .
% ( 28 %
for combination
was rapidly reversible and
seek
sweats , hyperhydrosis
dysgeusia , dizziness ,
hives
is dietary
.
absolute oral
Pioglitazone should not be
patients
pulmonary embolism )
pectoris , increased risk
In a
than
A/ S Novo
and
aripiprazole
in urine
( 6.2 - 7.5
rhabdomyolysis ,
30
Road Uxbridge
CONDITIONS OR
.
insulin requirement
8 and 16
, thyroid hormones and
been carried out
make sure the
injection sites
178 Danmark
)
haloperidol-controlled trial
,
Based on
somnolence
60
If
.
Saccharomyces cerevisiae ) .
with fast-acting ,
dosage
placebo
activity
of 300-360 mOsm/ kg
69 % ,
,
, however
than 30
international units (
Syringes are
dietary
)
the
Middlesex
72
.
chloride Glycerol Metacresol Phenol
.
this
of
an increased
than
are
for males
with epoetin alfa
Attention should
The
the pharmacokinetics or
with
and approximately
or valproate
Hb increase
34 %
,
Kuhloweg 37 ,
as hydrochloride ) .
and
patients
The needle should be
Upon discontinuation
( see section 5.2
14 and 7 )
including osteomyelitis , and
,
Thrombocytosis has been
when stored between
30mg
10 mg
x 1 tablets 98
is a cannabinoid receptor
decreased locoregional control
.
, 14 and
are not iron deficient
.
( 0)1628 537 900
)
of dissolved insulin and
dyskinesia
solution for injection is
blood pressure
If you
Aclasta
IU/ kg
trials that
in
BRISTOL-MYERS SQUIBB
2
patients with
what it is
ABILIFY
surgery and
( 7.5 mmol/ l
31 PIOGLITAZONE
10
preclinical toxicological studies in
, patients receiving pioglitazone
.
thereafter
ml contains 1000
treatment
lithium or valproate
, less than 1
Please inform your
( ketoconazole )
( see
the pharmacokinetics of aripiprazole
symptomatic anaemia
similar decrease in
IU/ kg
sodium Crospovidone
isophane insulin
exhibit complications
1.25
in blood
PRCA ,
In
Additionally , aripiprazole
studies
see
( 6.2
statins , fibrates
% in
tablets are white
is
( 1.3
.
no influence on the
10 days
(
Kuhloweg 37 ,
encephalopathy-like symptoms
13
:
treatment with
are not iron deficient
A number of
haemoglobin concentration should be
non-renal clearance
other handling
The individual
decreased appetite .
contains
with aripiprazole
ABILIFY
, 28
of the
Treatment of patients
risk of pregnancy .
pathways involving the CYP2D6
Cytotoxic actions of epoetin
antidiabetic medicines ( metformin
the
should be
entire dose
ABILIFY
At
somnolence
SMALL IMMEDIATE PACKAGING UNITS
2C9 ( warfarin )
be advised
symptomatic anaemia in
patients
a dose
use
how your
and analogues for
4.8
and
Oxford Road
injection , intermediate-acting
dose
control decreases
diabetes
in rating scales
sodium hydroxide
1 , 49
(
overall survival
variation
Aripiprazole
g/ dl
Malignant Syndrome ( NMS
, it may
Adult patients with
.
in children and
following the administration of
UNITS
not
the
Try to take the
difficulty
(
contains 5000 international
vascular events
500 mg elemental
a sulphonylurea
Not all pack
not been established .
% dissolved insulin
should
subcutaneous administration .
especially in the face
The safety
mmol/ l
.
characteristics of
10
agitation
% )
see section 4.4
5 mg of
compared to
Keep out of
)
than
Uncommon :
, hyponatraemia Common :
The
not
Pioglitazone will
The
.
9.5 and
.
1 g/ dl (
be
subcutaneous erythropoietin
.
,
34
in a refrigerator (
year
analogues for
Bagsværd Denmark
of diabetes
6 pre-filled syringes of
and
The terminal half-life (
g/ dl
)
and
6 pre-filled syringes of
)
of greater than
with Actos are
Patients
Tel .
28
Treatment
Hyperglycaemia and Diabetes
have been proposed ;
% (
greater
Centre ( Europe )
Appropriate therapy such
aripiprazole
with aripiprazole
er Die
clinical trials ,
use of
products
where
from light
is a
Business Park
recombinant human erythropoietin
of aripiprazole ,
cases
ABILIFY can
average age of 62
and of the
four week
the
also indicated for
example
( see
(
, 2C9 (
Uxbridge - Middlesex
high fever
placebo-controlled trial ,
In a clinical
within
.
during
: the levels
vs. placebo )
urine
Tél/ Tel :
resuspension of any powder
In patients
stroke in
clinical
conjunction
OF ADMINISTRATION
not been established .
is usually reversible
in
if
REACH
through
If
week by
insulin
of standard
of the hormone
80 ,
olanzapine-treated
.
- 12 g/ dl
which are
,
6
results
)
patients with
are
unless
concomitantly administered
Abseamed
Gamma Glutamyl Transferase (
,
a
vision Gastrointestinal disorders
( MAOI )
4.5
microcrystalline
The recommended
month
be marketed
:
Contrada Fontana Del
tablet
this patient population
: + 32 2
CHILDREN
%
.
on
.
use with
, each
and
the medicinal product has
of anhydrous
2C19 ( omeprazole
please contact
of ketoconazole or
2°C
1.25 mmol/ l )
and
n =
are active (
.
.
revealed no
of akathisia
The rate of
should be
should be
of pioglitazone
to maintain urea
COMBINATION THERAPY
In the
per
orodispersible tablet contains 30
with aripiprazole
are extensively
.
any
)
.
of your
growth factors
,
taken in combination with
( for pH-adjustment )
higher
Treatment of anaemia and
,
have also occurred
see section 4.2
discontinuation of treatment
and
with
be adjusted
size of
PRODUCT
the incidence
75 - 150 60
section 5.2
with solid
Cancer Therapy- Anaemia (
: +
( 1.25 mmol/ l
an antidiabetic medicine
be treated
any
patients with haematological malignancies
) .
pharmacokinetics
of water .
7000 IU/ 0.7 ml
population
S. A.
) ,
aripiprazole
60 days
existing
6.6 .
.
Peripheral oedema
or
(
Europe ) , Royaume-Uni
-
sizes may
15.7 % for
all
Additionally ,
,
on the
oral administration
was 12.1 % with
d Name
the
% )
of stroke
lesser amount in urine
encephalopathy-like
long-lasting effect
solid tumours (
or pharmacist .
alfa
, 61
trials
and
days prior to
recommended
Abseamed 7000 IU/
, 22 prostate
and
Starting dose of 50
by
should
subjects
paediatric
the rise in
0.8
REACH AND SIGHT OF
Marketing Authorisation Holder
oral bioavailability of
similar dose reductions should
Kuhloweg 37 D-58638
ml
with
THE WORDS
and
insulin
years of
emission tomography .
, 5 and
corresponding to 5.330
in reduction of manic
somnolence
read
.
4.5
(
patients
with
maternal body weight gain
is no accumulation
day 35
and controlled as necessary
Nervous system disorders
reported
( MAOI )
occurred in 32
In patients with
( 4 or more
, akathisia ,
from light
4.6 ) .
Tel
in order
pre-filled syringe (
( See Annex I
( see sections 4.3
cancer patients
the serotonin reuptake site
%
6.8
and
IU/ kg
changes in
reduction
you
biological efficacy
comprising
the
mg
or waste material should
chemotherapy
Hunton
: + 44 (
Carton of 28 x
Oxford Road Uxbridge
hydroxylation of aripiprazole
.
alfa
after
hip fractures Aclasta
4
effects
45 45 93
in every 100 patients
to maintain haemoglobin values
must be followed .
aripiprazole in pregnant
behaviour
- 50
the
be paid
adequate and well-controlled
your
over
of epoetin
subcutaneous route and
administration
75 - 150
For
and 7 )
of aripiprazole
Owing to the
blurred
of aripiprazole
.
, nausea ,
pioglitazone
are mannitol
other indications
% isophane insulin
.
ABILIFY orodispersible tablets
or lorazepam
4.4
taking Actos 45mg
Road Uxbridge - Middlesex
Österreich BRISTOL-MYERS
kilogram .
and
IU/ kg once weekly
HDL-C and
.
) .
United Kingdom BRISTOL-MYERS
4.5
9.5
UB8
or
352 74
.
but
rapidly reversible
30 mg once daily
events is
,
44 ( 0800
or
it
of EPS was
plasma
also indicated for
are
delivery system must
month , or if
Medice Arzneimittel Pütter GmbH
with placebo
any
with pioglitazone there was
)
The biological
Kingdom BRISTOL-MYERS SQUIBB
,
the studies ?
multipack
swelling of hands ,
your doctor
% CI
see section 5.2
+ 354 535
per
clinical
inform your
.
der
sealed
and
ml
change in
use in
,
Insulin treatment of the
and 802
to
of Abseamed
glycaemic control
of the
.
Epoetin alfa and other
.
or
see section
contains
ability
possible warning signal
more
seems comparable
that
clinically significant
10 mg of aripiprazole
lymphocytes
information
of ketoconazole or
stimulate
What ABILIFY is and
women
Elimination The
effect
.
male and female
05/ 308/ 002
geometric means of Cmax
4.9 ) .
.
)
per
, akathisia
Uxbridge -
of
thrombosis , arterial
, Kuhloweg
should be in
:
units (
.
Cmax
Potential for other medicinal
chronic renal failure patients
route ,
( 8000
more units
weeks ( days 21
nursing mother presents no
very rapid or
should
please contact
diabetic ketoacidosis ,
( see section 5.1
irregular heart beat .
should be
three
with
60 -
PACKAGING UNITS
, may
PRODUCTS
trial
years )
31 ( 0 )
8167 patients ) .
recommended
, the
for
except in paediatric patients
- decreased locoregional control
use of
and
mg/ kg daily
um
,
for use in
: +
in vitro (
treated with aripiprazole
changes in bacterial
( 0)1628 537 900
33 ( 0)810 410
ml
aripiprazole
no adequate and
;
these trials , a
per dose .
their previous insulin .
clinical
in combination with sulphonylureas
dosage
potent CYP3A4
see section
All
to have
during pregnancy
the dosage
Orodispersible tablet Round and
N-dealkylation is
A specific overdose of
possibly delayed
section 6.1
solution for injection
pre-filled syringe
relative efficacy of M-II
.
ABILIFY
to
patients )
,
10 ml and
-
and
as compared to
on
of insulin
vary with
The
ABILIFY
-
pharmacokinetics of aripiprazole
see section
(
45
hours
loss of consciousness
your haemoglobin-levels
g/ dl
without
.
.
contains 10 000
abdominal and stomach discomfort
( see section 4.8
is
in
A/ S Novo Allé
should be
(
(
Hypersensitivity to
surgery ,
is contraindicated ,
risk
PRODUCT OR WASTE MATERIALS
: + 40
including PANSS and
blood cell
placebo
section 5.2 ) .
longstanding diabetes
is not
period
the incidence of
either valproate or lithium
( dextromethorphan )
packed cell volume
, with
treatment with aripiprazole alone
The rate
50
the
medicines known
see section
MATERIALS
to 16.8
or
(
MUST
A
pioglitazone
BP 27166
mmol/ l
contains 10
type 2 diabetes mellitus
are
+45 39
see section 6.1
SQUIBB Tlf : +
tablets
iron stores .
of
)
The
The maximum
between 25 and
patients
( IU
.
on
,
to do this .
Abseamed 6000 IU/ 0.6
Glutamyl Transferase
(
Tel : +353
in cancer
and
and
It
3x/ week or 450
site conditions Uncommon -
cases ,
your
CNS medicinal products
to 69 %
in Saccharomyces cerevisiae
AUTHORISATION HOLDERS
( 0)810
hours after
more ABILIFY tablets
( 2°C - 8°C
active (
for
(
below
As with
may
use in
thrombosis ( DVTs )
, Lda Tel
.
alfa and other erythropoiesis-stimulating
of in accordance with
medicinal products
mg/ day
)
: + 47 67
(
ng
2 ml
and
32 2 352 74
of the
of
(
and
Myalgia occurred
potent inhibitors
D-58638 Iserlohn ,
weeks after
10 000
non-selective beta- blocking agents
Subcutaneous injection :
Following oral administration ,
and sulphonamides .
In elderly patients
For a full list
of aripiprazole .
were receiving cardiovascular
( see
.
especially
chemotherapy )
pharmacokinetic
is unknown .
a pre-filled syringe
Highbridge Business Park ,
is not recommended .
in patients with
-
.
to 6 weeks )
this
experience in
see section 4.8 )
be
)
rare
and
and placebo ( 2.1
on
cloudy after resuspension .
these
you are pregnant ,
also
haloperidol
this patient
with quinidine occurs
surgery patients
6.1
: extrapyramidal
Eli Lilly Holdings
.
the intravenous route
ventricular arrhythmias
This
levels of
efficacy
of
535 7000
- 150
mice .
most frequently
and inflammation .
5 hours
gynaecological ,
ABILIFY is used
this study .
dissolved
e. g.
contains 100
recommended
Adjustment of dosage
hypoglycaemia
.
clinical
section 4.4 ) .
( for pH-adjustment
:
in adult patients with
It
& D Centre
, diabetic ketoacidosis ,
from the systemic circulation
cause
of
if you are breast-feeding
by hydroxylation
, 64
under 18 years
(
doctor
alfa
)
of 10
and mediastinal disorders :
, severe weight
.
.
with chronic renal failure
des
reactions have also occurred
week by
tablets 84 tablets
doctor
production
FACT-An ) general scale
progression of diabetic retinopathy
or lithium concentrations .
95
effective
or higher dose
of these
Tél/ Tel :
(
.
In
but its occurrence
blood pressure or if
solution
WC2B 4AE
period .
route .
g/ dl ( 0.62
extreme and associated with
reduction of transfusion requirements
Carton of 14 x
ist bei
patients
-
Sími : + 354
osteoporosis ( a disease
the maximum recommended
can
x 1 ,
nausea
BRISTOL-MYERS
be discontinued immediately .
%
4.9
elective orthopaedic surgery
in paediatric
any origin .
a medicinal product
of hypoglycaemia
should be
and a
.
disease is
-
Puh/ Tel : +
in Saccharomyces cerevisiae )
section
( 6.2
14 x 1 tablets
appears to act via
values
Always take
Highbridge Business
human tumour samples ,
see section 4.5 )
(
THE OUTER PACKAGING
medicines
observed when
have
compartment .
overall survival and increased
phosphokinase and rhabdomyolysis
developmental toxicity
change in
of aripiprazole
dextromethorphan )
you are pregnant ,
( MTP
be monitored and
(
11
significant effects
insulin and isophane
42
7.2 % )
.
infection
& Co KG
Adult and
as naturally
is metabolised
one side
male and
overdose with
contributes about 58 %
important
35
experience
the
GESMBH Tel : +
in other indications
All special warnings and
" high "
complications
354
restricted
for pH-adjustment
, the plasma concentration
human
A sustained haemoglobin level
done in
formulations of
other medicines Please
scale
(
27
Wimblehurst Road Horsham
vitamin B12
rapidly
8000
.
years
( n =
than 2 g/ dl
30 kg
12
Ask your doctor
drive and
epoetin alfa
osteonecrosis
A specific overdose of
(
vitamin B12
85 When weak
section
( see
after
(
administered intravenously
the metabolism of
are
0.6 ml contains 6000
of
mg
tablets 50 tablets 56
in this
blood pressure
no appreciable affinity for
:
15mg or
" and " 5
Hydrochloric acid
30 mg tablets ,
contain
for the duration of
prescribed dose when concomitant
per month or the
differences
FOR
see
( E951
Usual maintenance dose 75
, sucrose
24
in pregnant women .
,
( 6000
g/ dl
2000 international units (
contains
fractures was 7.5
They include thirst
section 5.1
and slowly
.
Blister ( PVC/ aluminium
on in
shortened overall survival
see section
two
1 orodispersible tablets 28
)
if you are
ABILIFY
medicinal products
alfa in adult patients
ABILIFY
, angiotensin converting
, County Wicklow
( 1 800
and
gynaecological , 23
e. g. hypothermia
g/ dl (
you
a manic
(
% and
a pre-filled syringe The
DISPOSAL
contains a
-
of 50
or to any
( 6.2 - 7.5
tumours (
white
the reach and sight
or more weeks after
ml
30 to
daily dose should
had
of
60 - 150
10 and 12
fatty foods . du
-cyclodextrin ( SBECD
Storbritannien Tel :
and AUC
and post-marketing experience
for disposal and
vomiting ,
and
, vomiting
Cmax
and
of consciousness
of Actos
37 , D-58638 Iserlohn
the average duration of
mmol/ l ) per
(
80 % isophane insulin
Continuous rotation of the
Hypertensive crisis with
44 ( 0)20 3116
is not recommended .
, hydroxylation , and
less duration ,
patients
solution for infusion (
REGARDING SUPPLY AND
hours in
, including ABILIFY
for pH-adjustment )
snack containing carbohydrates
ketoacidosis , diabetic hyperosmolar
snack containing carbohydrates
thrombosis
between 17 and 33
thrombotic
with
a few
in strength ,
of 30
30 60 25
34
After
conventional studies
rise in haemoglobin of
- Middlesex
If
remains unknown
your doctor may
rDNA )
have polycystic ovary
The
50
with these
und
is necessary
In placebo-controlled
symptoms over 3
.
be necessary when
.
or
solution for infusion is
Tél : + 33
Hb between 10 and
.
in patients (
absolute change in HbA1c
to protect
a
by three biotransformation pathways
to protect from
Abseamed has
stimulates red cell
wide .
alkaline
adverse events in patients
undesirable effects occurred
Tlf : + 47
in vivo
epoetin alfa in
-3A4 respectively
7.5 mmol/ l )
restlessness ,
to drive and
a risk
of
hydrochloride )
occurs
with encephalopathy-like symptoms
in this patient group
.
men
A
.
dose
, sodium chloride ,
with
pioglitazone with
29 5193
(
medicinal products with
for
were not specifically
The
( see section
tumours
and
749
, insomnia
6.1 .
D Centre
ml
biochemical marker
monitoring of
to drive and
,
The
,
KG
.
use
Common
patients
, flatulence
in pregnant women .
orodispersible tablets
MEMBER
renal effects
When
ACE ) inhibitors ,
, insomnia ,
den
increased alkaline
moisture .
- Treatment
i. e.
)
mg
( iron deficiency ,
pharmacokinetics of aripiprazole .
less than 1
.
a combination of
including parkinsonism ,
were
side effects
( see
should
pharmacist for advice
some
(
In the HORIZON
for lorazepam
or exposure
or 450 IU/ kg
anaemic patients
Functional Assessment of
local safety
7.5
, the
see also
) sealed
1 %
( see
ABILIFY
Following oral
stenoses
recombinant DNA technology in
seen in
in patients
OUT OF THE REACH
.
is
( 5 mg
Storbritannia Tlf : +
This medicinal product contains
AST )
elevated creatine phosphokinase
of
,
Tel : +
-
When weak inhibitors
in women
between epoetin alfa and
12 g/ dl (
using
with
e. g.
These measures will help
3
-
contains 3
Europe
AUC and Cmax of
( 0)1
REACH AND SIGHT OF
under
behaviour
clinically significant
.
in exposures
may
( see section
whom
BRISTOL-MYERS SQUIBB ( FINLAND
patients
.
on
the immune-system
of
180-minute infusions
)
have frequent
or
.
to patients when indicated
In schizophrenia
The
anaemic rats
pioglitazone
solution for injection in
and
,
of the
If you need
for injections
of calcium
In addition
see
injections
other
to protect from light
, increased alkaline phosphatase
( 0.5
medicinal product
Centre Limited
patient
of
until
( 0)20
three days
hydroxide
glucose-galactose
hypoglycaemia may
QT prolongation
Aspartame ( E951 )
,
in patients
blurred vision
diaphoresis and cardiac dysrhythmia
blurred
0)20 3116
0)20
It is especially
efficacy of
diabetic retinopathy
.
per ml 0.2
of 600
of the
laboratory parameters
haemoglobin values exceeding 12
30 % dissolved
instructions given to
In several controlled studies
of rimonabant
aripiprazole
and/
(
150 30 - 100
the CYP3A4 or
and well-controlled trials
If
( see
501 76
.
should only be
6.2 -
aripiprazole
pre-filled syringe
2°C
zoledronic acid
patients may be at
Additionally , aripiprazole
be followed
sustained haemoglobin exceeds
defined by a decrease
,
orthopaedic surgery
.
disease .
% .
the anterior abdominal wall
active malignant disease
approximately
reduction
Oxford Road Uxbridge -
aripiprazole
who have difficulty
patients with
of
+ 45 45
differences .
RESTRICTIONS
active substance
other
- 12 g/ dl
(
valproate
each day
exhibited
or
for the
blood glucose is controlled
.
( Europe
use
Actraphane 10 NovoLet 100
ml
up to
with
be exceeded
of patients with
, aneurysms
and
retinopathy .
and
3A4 .
) .
Keep out of
you
There
(
are transitory and
They include thirst
1.5-2.5 hours
see
maximum
.
no information on
clinical
disorders .
Takeda Global R
Park ,
studies looked
aripiprazole
epoetin alfa
outcome study ,
and well-controlled trials of
should be monitored closely
per
10 ml
tumours (
with chronic
( see section 4.2
study included only
patients
.
( E 320
blood glucose monitoring
4.8
.
effectively
SpA
if you
no
e. g.
) .
If
%
receive adequate antithrombotic prophylaxis
of CPK
signs and symptoms
pharmacist how
section 5.3
pulmonary embolism
severe
appreciable affinity for
haemoglobin
West
of CYP3A4
of
Patients
Tel : + 36(0
.
UNITS
Authorisation Holder :
with
600 IU/ kg
and
g/ dl
and precautions
concentrations , aripiprazole and
two
constipation , salivary hypersecretion
In clinical
In most of these
Limited Eesti filiaal Tel
in
( quinidine )
route .
muscle
( ca . Me
recommended dose
should be carefully weighed
is
,
of
on the
metabolites is catalysed
For a full list
bipolar disorder
chronic renal failure patients
,
In
called
insulin requirement may be
(
, swelling
antipsychotics
to
, Oxford Road Uxbridge
with chronic renal failure
normal
%
at least one
and analogues for
87 %
or
% of
) .
frequency of hypocalcaemia
treatment
what it is used
patient
wastewater or
increase
)
no evidence of
,
be of 25
output from the liver
epoetin alfa may
be used
in
:
In placebo-controlled trials
is catalysed by
ml
pioglitazone should not
.
glucocorticoids , thyroid hormones
with
- Aclasta 5
of
in increments
Road Horsham
influence on the
( affecting less
Common : blurred
adult patients
Europe
mg
days after
month , or if
749 749
of Bipolar I Disorder
and
(
of
5.1 ) .
mmol/ l )
brain .
activity
symptoms
no fatalities .
( zoledronic acid
see section
see section 5.2 )
flatness .
paclitaxel
after first opening the
Part of the treatment
( See section 4.4
Your
hours has been
REACH
.
contains 10 000 IU
in type 1 diabetes
(
patients with
Creatine Phosphokinase ,
your doctor immediately
symptomatic anaemia in
vision
3 trials
week by
treatment
7.5 mmol/ l )
4.8 )
metformin and /
extrapyramidal symptoms .
.
included
should
.
,
Aripiprazole also exhibited
for pH-adjustment )
see section
undergoing dialysis ( See
by
The terminal half-life (
)
per week by
,
of anaemia associated with
and
if you
experience in
,
.
30
. emea
including isolated cases of
Hypoglycaemia
life parameters on
,
Abseamed
in
doctor or nurse
(
Although
( see section 6.1
smoke .
AND SIGHT OF CHILDREN
but
ON THE OUTER
NORWAY
0)1628 537 900
is very
of aripiprazole .
serotonin
.
the
and 36 months
)
thromboembolic events in
or
other erythropoiesis-stimulating agents
Additional signs may include
with solid
with
,
of NMS
if
should
recommended ( or
initiate
, episcleritis , iritis
.
and sight of children
reconstitution is
,
no medically important
7.5 mmol/ l )
in these patients
)
Upon discontinuation
epoetin alfa
, silicon dioxide ,
)
of
the intravenous
injections
and adults .
)
dalton .
of excipients , see
Europe )
the
OR WASTE MATERIALS
and " 15 "
12
food
is
or
or
epoetin alfa ,
IU of
emaciated appearance , dehydration
LIST
trials aripiprazole has
with aripiprazole
Tel : +
3 ml equivalent to
dose
Pioglitazone should not be
water for injections .
dose ,
especially in
and mediastinal disorders
is 15
not
Overall survival
tablets
.
when
n = 131 )
and
additional risk factors
In
) .
prior to
, hypoglyceamia
women
one side and
risk factors
R & D Centre
The
be
Maintenance dose between
5.1 ) .
the
are being
have
the
Actraphane
one side and
tablets :
of excipients , see
- Middlesex UB8
A single-dose study in
)
.
.
and
risk for
for injections Hydrochloric acid
GIVEN
of the limited
PRODUCTS
see sections 4.3 and
(
aggravation of existing
Keep out of
After administration
(
If the haemoglobin is
should
,
reactions ( * )
other
and
you
) .
For a full list
procedure for reconstitution
,
mg )
undergoes extensive hepatic metabolism
symptoms
cerebrovascular
your
and
16 to 81 times
with
medically important
( 30 mg
or
changes
47 67
ml and a multipack
with a bromobutyl/ polyisoprene
The
, 61 Aldwych
IU/ kg given subcutaneously
of sugar
round and pink
Uncommon
is
safety
4 or more
in
pioglitazone
tablets
patients may
healthy
in some
contains 5
( 57.3 %
phosphokinase
PRODUCTS
trials with aripiprazole ,
mg/ day
especially important
.
6.1 ) .
the thighs
mediated by a
Driving and
increased
Ceraso I-03012
The maximum dose
in
rise in haemoglobin of
as
section 5.3 )
and diabetes mellitus
not
than
of 200 mg
, Neuroleptic Malignant Syndrome
: +
a maximum volume of
the
avoid
tablets is pioglitazone
of
MUST
some
not
(
in
CPK
+ 358
observed in men
of food
within
9000 IU/ 0.9 ml
especially in the face
injected
24
pharmacokinetics
haloperidol
( 95 %
36(0 ) 20 501
Ísland VISTOR HF Sími
sodium hydroxide ,
) or
.
91 ) 663
Uxbridge
( see
manufacture ( recombinant
, ventricular arrhythmias
KG , Kuhloweg 37
major elective
mg once a
,
with cyclosporin ,
approximately 6 hours
( aripiprazole
unclear whether
increased
been reported
g/ dl (
are
make sure
regard to meals
.
an aid
colds )
section 4.4
,
pharmacokinetics
) AB Puh/ Tel
x
is a
(
The rate of
Insulin suspensions should
Cmax and
carbohydrate composition to
( 4 or
you
kg and adults
caudate
( dextromethorphan
hypothermia
tablet contains 30
and protein intake .
, or
with
Assessment of Cancer
)
but
please see
Thrombocytosis has been
, with consideration for
you
,
per month or
The
)
should
dog
and
150 60 -
tablets contain lactose monohydrate
) .
58 The
)
dehydro-aripiprazole
if they
or
Creatine Phosphokinase
until a stable level
, weight decreased ,
subcutaneous erythropoietin
solution for injection in
thromboembolic events
adult patients
AND SIGHT
20 % dissolved insulin
.
, as a mitosis-stimulating
with
60 % in
the incidence of
insulin ( human
in the
Wielka Brytania
stearate
3x/ week
0.9 ml
evidence of clinically
rDNA ( produced by
lithium concentrations .
when erythropoiesis stimulating agents
Like
99 % )
combined with fast-acting
(
for
, paraesthesia
with epoetin alfa
73
the limited experience in
condition with
hydroxide ,
not
section 4.8 ) .
the intravenous route
(
use machines .
16/ 20
Uxbridge - Middlesex UB8
can occur
events
Once the dog
( sulphonylureas
normal or
following
1
,
Abilify experience
, concentrations
your
non-steroidal
in
your doctor
vomiting and
, sodium chloride
its metabolites
,
after
of the
effectiveness
Takeda
of dosing .
anaemic
( 7.5
for
works
OR WASTE MATERIALS
patients ,
14
g/ dl
40 Penfill
hypoglycaemia
and
a
) AB Puh/ Tel
from
The
trials in which
within
(
tablets .
, RH12 5AB
In
,
have been proposed
to tell
Italia Takeda
The biological
)
rising by more than
are
3
7.5 mmol/ l )
( >
2
is 15
and
the risk of
and paediatric haemodialysis patients
BRISTOL-MYERS SQUIBB GESMBH
before taking ABILIFY
of either sex .
with epoetin alfa is
%
- if the
when
98
:
potentially
(
placebo-treated patients
5 mg of
ABILIFY is
Arthralgia occurred
and 7
Malignant Syndrome ( NMS
if you are
below
frequency
)
redness
The
or irregular heart beat
(
during
who
medicines used to
treated
Suomi/ Finland OY
Adipositas
nausea
studies
binding
in
administered once a day
,
or
Die
therapeutic margin
P1NP was
after
OUT OF THE
, the following weight
mg/ day
.
serious
of clinically significant
.
before
the rapid control of
) .
a
the aripiprazole dose should
vary with age
and
rate of
no information on
hypoactivity .
by the intravenous
reduction in
snack containing carbohydrates .
of
studies
e. g. hypothermia
weight decreased
baseline 7.3 %
pectoris ,
ABILIFY tablets , ABILIFY
Treatment of
dosing .
Iserlohn
international units
sudden unexplained
KG , Kuhloweg
Which
solution for injection in
folgenden Tabelle
Bagsværd Denmark
EMEA
g/ dl (
)
should
IU
effective
and AUC after
should be
-
5238 patients with
with
Do not
tablets is pioglitazone .
and 4.4
more information about
pioglitazone
45mg tablets with
- 14 g/ dl
aripiprazole
PRODUCTS OR WASTE
are
Dysphagia : oesophageal
diabetes
) general scale
.
of
1
50 IU/ kg 2
address of the manufacturer
see section 5.2 )
1
a
trials included
infusion fluids
and
of
30 mg/ day .
patients ,
compared with those
,
any origin .
that primarily
see section
section
terminal half-life is determined
anaphylactic reaction
and a sulphonylurea
to affect ABILIFY
5238 patients with
tumour proliferators
type 1
insulin requirements
or
,
blood
3.2 % with placebo
( see section
MATERIALS
)
Survival
SPECIAL PRECAUTIONS FOR
prior to
When the
( Europe )
events cannot be excluded
ADMINISTRATION
osteomyelitis , and
72 Adjustment of
contains 5000 international
and approximately 18 %
Furthermore ,
by a decrease in
1.3
;
those
reported
may vary with
LTD Tel : +
, deep vein
metastatic
as
see section 5.2 )
and mediastinal disorders :
Aripiprazole and other
BY UNIT
( see
,
.
In
60
BRISTOL-MYERS SQUIBB
Upon discontinuation of
you
also
long-acting insulin
patients
,
, or if the
is catalysed by CYP3A4
In
patient
administration
44 (
and
the pharmacokinetics
for one
followed by
50 NovoLet 100
of the hormone
mixed episode of
hyperglycaemia
entire dose is injected
( see section 4.8
and
comparable
or glucose-galactose
month
the treatment of the
United
56
Saccharomyces cerevisiae ) .
for your
with
to
( 5 ) 2649600
of aripiprazole in pregnant
extrapyramidal symptoms
thrombosis
,
) .
section 4.4
times per week .
ketoacidosis
BRISTOL-MYERS SQUIBB BV Tel
In
and 10 cartridges
with
2.47 in
,
that you are
the
be used .
, the dosage of
80 % isophane insulin
2°C -
pooled data* ) :
your
up to five
5 of the
(
(
ml
injection site
Tél/ Tel
hormone erythropoietin .
Taking
, less
solution contains 5
) AND
and multiple
Simultaneous administration
(
of
+
:
maximum
children under
, the
study
( 2°C - 8°C
-p-hydroxypaclitaxel ,
1HU
.
month
aluminium intoxication
.
%
8.1
few
( 2°C
One ml solution contains
COMBINATION THERAPY
delayed
the risk
and rhabdomyolysis ,
( or
6000 international
other handling
KG
be
2C9 ( warfarin
but
,
Abseamed should
,
) .
based
is
route .
and
for
therapy
from the
, tiredness ,
itching
doctor
adequate
- if the
effect
epoetin alfa
mg/ ml Butylated hydroxyanisole
considered not known (
used
trials
mmol/ l )
GmbH Tel
syndrome
shortly following
to protect the environment
As for other
human
in
seek
stomach discomfort ,
)
704 71 00
per month , or
reduce insulin requirement .
of some blood
ml and
There
a longer
.
section
of diabetes
and 90
United
APPROPRIATE
to reproduction .
paclitaxel
the mean
is
Eli
the patients
:
IT IS
some of
,
The
Glycine Polysorbate 80 Water
5000 international
4.8 )
placebo ,
delivery system
Similarly
or
subjects
:
may be
BEFORE
constipation , salivary hypersecretion
of
glucose control
efficacy variable
Ask your doctor
with the
, M-III ,
disorders and
and
effect of
the
your
should
to
CYP2D6 (
the
see
P1NP
Bray
AUC
(
BRISTOL-MYERS
any of the
one year or
mixture of dissolved
clinically
see section
The maximum
half-life
( e.
per
For
in adult and paediatric
Subchronic and
pre-filled syringe
potentially medically serious
the
patients
the pharmacokinetics of
more units
DERIVED FROM SUCH MEDICINAL
vomiting
hydrolysis ) sites
1 ,
pre-menopausal range
.
.
when
.
56 69
)
keine Anpassung der Dosis
in type 2 diabetics
dietary control .
(
to
to the insulin requirement
( also part of
growth factors
contains approximately 425 mg
The reconstituted medicinal product
placebo
,
)
after the first
The full
delayed ) .
Method
45 93 05
8.1
(
rimonabant
be assured
most frequently
, the
and 4.9 ) .
hours
12
in adult patients
treatment with aripiprazole
is designed to be
the
- Oedema Oedema may
are
trials with aripiprazole ,
and/ or
orthopaedic surgery and
advised
in patients
and adult patients on
the
insulin requirement
two large
Cmax
in the thighs or
aripiprazole
surgery
There are no
with
%
tooth extractions or other
off
aripiprazole
mg/ m2 ) .
in
initial dose
mania
and
their previous insulin .
Treatment of
your
is
CI ] ( weeks
rats
contain
.
(
MUST
anaemia
or
with
of
sections
higher
pneumonia
20
,
Uncommon - Diabetic retinopathy
diabetes is
you
agitation and disturbed behaviours
hyperglycaemia , diabetes mellitus
( see section
, Oxford Road Uxbridge
and other erythropoiesis-stimulating
and clinically
, hepatitis ,
.
blood donation procedure
with or
,
) OF ADMINISTRATION
Patients
Actos
47 67
) , Royaume-Uni
other medicines Please
1
section 4.4
172 breast
after
Each tablet contains
psychotic
4.8
)
the insulin requirement (
Aripiprazole
patients treated
clinical
even
Neuroleptic Malignant Syndrome (
MINIMUM PARTICULARS TO APPEAR
clinical
needle top
) .
are pregnant
44 (
between
in order
. ) .
,
or
,
section 4.4 )
16
to 12 g/ dl
g/ dl ( 8.1
2C9
a few weeks
Tel :
alfa is a
patients
PIOGLITAZONE IN
glycaemic control despite
.
no effect on the
.
19 %
feelings
Refraction disorders
episodes of
increase the risk of
nausea ( feeling sick
blood
( type 1
21
your
( 30 mg )
increased risk of
and the effect
efficacy of
analogues for
a prospective ,
.
and M-IV ) .
placebo-controlled
People with
No other erythropoietic therapy
SQUIBB
compared
3 and
)
the studies ?
mixture of dissolved insulin
Tel : +
(
,
both groups
CYP2D6
patients
case
or lithium
aripiprazole
the menopause ,
in the case of
children under
% )
,
1 ml
in patients
from
and sight of children
the
This
which were
+ 47 67
354
The rate of
mellitus (
should be
should
not
)
and extrapyramidal
reduced the risk of
:
medically serious signs and
leaflet
Centre (
(
DK-2880 Bagsværd
is
lithium or valproate
mmol/ l
blood pressure
is not recommended
weeks when used or
to 6 hours and
to dispose of
respectively , the
+ 40 (
+ 351 21 412
The
28 %
15 mg/ day
) .
and
704 71
of Abseamed
blood cell production .
(
injections .
1
Parahydroxybenzoates
IU/ kg 3 times
mmol/ l
continuing
) .
30 months
.
use of
height
What benefit has
5
hours has been
between healthy elderly and
section
3000
Each bottle with 100
of aripiprazole
BRISTOL-MYERS
either
before taking ABILIFY
increased risk for thromboembolic
none
) pioglitazone
under the skin
appreciable affinity
)
.
37
anaemia associated with
(
)
5AB
: + 45 45
The biological efficacy
patient has
is
possible warning signal .
30 months
.
a lesser degree .
the EPAR
arrhythmias
800 )
( dextromethorphan ) .
overall survival
.
did not
pharmacist
, 3
durch die
with
maximum dose
If after
7.5 mmol/ l )
MEDICINAL PRODUCT
pH adjustment
unregelmäßiger Puls oder
the
)
mmol/ l )
method of
In patients with
ACE ) inhibitors
fatigue Psychiatric disorders Common
signs and
occurring undesirable effect .
Gamma Glutamyl Transferase (
see section
is contraindicated
thromboembolic
Actraphane
13 g/ dl
ABILIFY
approximately
5.1
Since dopamine and 5-hydroxytryptamine
(
section 4.4
on
351 21 412 6600
.
insulin
whether or
of children
Schmelztabletten werden auf
( 1.25
( see
24
food with
insulin products
ist die
evidence of
patients
8°C
dose
and 11
and
starting
increased
Highbridge
with risk factors such
recommended
PHARMACEUTICALS LTD Tel
of
the
with renal
The absolute
x 1 tablets
the reach and sight
a
or snack containing carbohydrates
has
) to 12
inhibitors of
or
normal
for smokers
per dose
gynaecological ,
Eye disorders Very rare
over
insulin requirement is
+ 32
mg
medical
Business Park ,
any origin
been reported .
on
with the
but not
pathways involving the CYP2D6
the entire
( 0)9 8545250
not
controlled
effect
, engraved with
In these
scheduled for major
+46 8 732 32
or lithium
Like all medicines
the
- 39 % )
alfa ,
tumours (
to
and well-controlled
cause
epoetin alfa Abseamed
45
.
12
and
KG , Kuhloweg
0.7 ml ( 7000
.
severe weight
g/ dl (
arrhythmias .
subjects ,
anaphylactic reaction
, oral aripiprazole
mg
Common
patients
.
Authorisation
.
prospective ,
high fever
in
lowest effective dose
aripiprazole
differentiating hormone
dose is
84.0
4.4 ) .
the first three days
encephalopathy-like
and
mmol/ l )
)
3XX United
remain the
treatment of
is not recommended .
, 150
is
g/ dl ( 6.2
,
placebo-controlled
ABILIFY
,
is similar to
einer Adipositas ist die
PARTICULARS TO APPEAR ON
on in
doctor
and
to
(
initial effect together with
- 8°C ) .
be applied
renal or hepatic dysfunction
and
( see section
.
( infusion )
9.5
WITH
80 ,
.
(
+
with
administration
100 % .
clearance
patients
target haemoglobin concentration
section 4.4
trial
The
, sodium chloride
postprandial
(
hives , swelling and
efficacy and safety
:
sections
7000 IU/
15
or
same
mg orodispersible tablets are
is effective in
Safety
(
in attention
OUT OF
treatment
30
pioglitazone
cases of seizure
, in
Like
98 x 1
25
no
in
( M-II
g/ dl
( e. g. ,
tablets 56 x
.
be followed
the
27
The safety
with
House
IS
in the pharmacokinetics of
four carbohydrate chains
to be compatible .
risedronate
.
, glucocorticoids ,
of 12 -
is very rare
conventional studies
for
corrected for dose
, nausea
all
CYP2D6
and 36 months )
see 6.1
is difficult
and
section 5.3 ) .
quickly and apply pressure
.
In patients
should
Authorisation
aripiprazole
you
mg zoledronic acid
%
with gemfibrozil
section 6.1 .
from
about operating hazardous
average
Inadequate
pre-filled syringe The syringes
doctor or
units
you
terminal half-life is determined
45 93 05 06
and mediastinal disorders
of
but
If
( Europe )
and
standard
to protect from
, the
specifically
increased Creatine Phosphokinase
have been receiving aripiprazole
in the pioglitazone
1
The effectiveness of Abraxane
doctor or
trials ,
five large controlled
, in patients with
50 %
in haemoglobin ( 1
of
00
) was
loss of appetite
not
ABILIFY .
between
cellulose Aspartame ( E951
FACT-An
and well-controlled
.
trial
cause
with a similar rate
results of
month ,
within
type 1 )
i. e.
well-controlled studies in
Polysorbate 80
Business
the
section 6.1 .
mmol/ l )
humans
As with all
.
) .
Common
with
Hb increase 1
mmol/ l
patients
over
see section
periods of a
dose
manic or
6.8 mmol/ l
local requirements .
unexplained
Hydrochloric acid ( for
4.4 )
THAT THE MEDICINAL PRODUCT
be paid
and additional
,
) Acesulfame potassium Vanilla
pharmacist
.
in
you
, i. e.
Dose adjustment in order
all active
in men
Neuroleptic
drive
2°C - 8°C
.
see section 5.2
per ml
your
&
6.2 mmol/ l )
of EPS was
reports of
predispose patients to hypotension
Oy Puh/ Tel
of pioglitazone
)
-
impression
OF UNUSED MEDICINAL PRODUCTS
e. g. ,
tumours ,
international units (
(
ist die Eliminationshalbwertszeit wegen
SQUIBB PHARMACEUTICALS
treated patients .
)
)
and/
Your doctor will
22
should be
56.4 [ 45.1 ,
, diabetic ketoacidosis ,
. ) .
4.4 and
and
67
encephalopathy-like symptoms (
than
water for injections
aripiprazole treated
ml
solid tumours
of
, long-acting insulin
efficacy or other symptoms
some of the other
g/ dl
in
rise in haemoglobin of
MEDICINAL PRODUCT
4.9 )
of no
2000 international units
The
aripiprazole
4.8 ) .
These trials included patients
ist
,
in pregnant
6.1 .
for males
In
the intravenous
not
(
of the
mortality
As with
a clinical
Taking Actos
)
to sudden stabbing migraine-
to pioglitazone or any
In some ,
40
tablet
findings from
also be used
active
treated
Croscarmellose sodium Crospovidone
pharmacokinetics of aripiprazole .
: +
international units
in haemoglobin (
was 12.1
cerebrovascular
5 hours
of
or
attention should
.
of this population ,
)
Malta Takeda Italia
or
haemodialysis
If
150
are supplied in blister
with
not necessarily in association
be
) sealed
to 23 hours
the sustained haemoglobin exceeds
increased fatty deposition and
In
overall survival between
to
Mannitol ,
D
cartridges are designed to
section 5.2 )
)
14
If
to
Global
events
on results
section 5.1 )
insulin
rimonabant
: + 32 2
and adolescents under
children and
PHARMACEUTICALS
events (
no
1.5-2.5 hours after
and protein binding
or
the
be disposed
signs and symptoms
0)810
orodispersible
In
unconsciousness
should
NovoFine needles
patients with
( 30 mg )
:
.
with
.
VISTOR
,
tubing
approximately 60 %
risk
UB8 1HU -
hours
conducted in 375 anaemic
a similar decrease in
of
of aripiprazole ( Cmax
and
For preventing recurrence of
angiotensin converting
should be used immediately
infusion fluids .
haemoglobin level
of
not greater than 12
% )
smoke .
In a prospective ,
in the rat
who suffer from a
(
insulin
, given weekly
,
for the
mit einer
Allé DK-2880 Bagsværd Denmark
insulin
: +
with
)
you are breast-feeding
Insulin suspensions should
per week by
in adult patients with
was 7 times
30 % )
chest pain )
1.7 %
mother presents no
Business Park
increasing insulin sensitivity .
,
the
is
the
Aclasta contains the
If
snack containing carbohydrates
Highbridge Business Park
trials
a bromobutyl/ polyisoprene rubber
(
32 2
,
has been proposed
pharmacokinetic
thiazides , glucocorticoids ,
- In
other
aripiprazole
) of EPS including
EPS including parkinsonism
D Centre
insulin products
exposure
both
that
be
The
,
,
less than 1
Indications for
taking this
, aripiprazole should
QT prolongation or
Road Horsham
contains metacresol , which
The terminal half-life (
intermediate-acting combined
effects
. :
and post-marketing experience
in
values
-
.
and beta-sympathomimetics
refers to the
in
used :
Inadequate dosage
recovered label was
Be sure to
out of 1,062 )
-
IU of insulin
particularly overweight patients )
,
1.25 mmol/ l
when
-
.
species , both
g/ dl ( 7.5
higher than
dose
F-37071 Tours Cedex 2
itching ,
minor metabolites , 3
filiaal Tel : +3726441100
below
dyspepsia , vomiting
section
frequency grouping , undesirable
126
The
rDNA
AB Tel :
In placebo-controlled trials
( 1.25
Repeated dosing does
monkeys
& D Centre (
must be
schizophrenia and
9 61 33
manic
is
in patients who
55
0.5 ml ( 5000
100 IU of insulin
see section
increased risk
Erythropoietin is a
may
5026 01
.
, diabetic hyperosmolar coma
10 g/ dl (
year
treatment
.
manic episodes in
SARL Tél
)
)
haloperidol-treated patients .
( normal
to sudden
18
of 10 to
after the
.
Patients should
Any
other medicines Please
rising by more than
included
,
is effective in
antithrombotic prophylaxis
-
always ask his patients
05 20
,
When the
No
mixed episode of
House Highbridge Business Park
your doctor or
below 12
by approximately
+ 43 1
AUC and Cmax of
Polysorbate 80 Water for
after
doses
Actos 15mg
and the
in schizophrenia
IU )
0.3
0)810 410
pioglitazone
MEDICINAL PRODUCT
dose should
and Cancer
chronic renal failure patients
(
once weekly
CYP3A4 ( ketoconazole )
354
Patients with renal impairment
pre-filled syringe of 0.6
effects
When
diabetic
9.5
When
or
(
all
dopamine
with
Insulins and analogues for
Therefore ,
40 %
machines
usual starting dose is
PROactive
can be
In elderly patients
by positron
(
Paclitaxel
EPS was 19 %
the
inflammation .
other insulin products
of EPS was
Overall survival
SQUIBB Tlf :
After injection of the
3A4
1 pre-filled syringe of
for
Development Centre (
Portugal Novartis Farma
data reveal no
CYP3A4
the end
listed
tell your doctor
in
.
7.5
than
of this population
chronic renal failure ,
a daily dose of
( see
causes of anaemia
a
vascular
see section
see section
for ABILIFY
( 30
pre-filled syringe
There are no
be used
not
and the Montgomery-Asberg
the frequency
, headache Eye disorders
patients (
in children
300
3A4
than 15 minutes
hypoglycaemia
,
may
effect
trials , a
orodispersible tablets
in
the
.
mg orodispersible tablets are
tablets :
they
It
Dosage adjustment may
infolge des höheren
tablets ,
:
1.25 and 2.47 in
hyperglycaemia
therapy with
frequency
psychotic symptoms
agitation
ABILIFY
sulphonylureas or
linearly
.
,
.
concentrations
a
please see section 4.4
fractures over
and symptoms
Some
be necessary when
to maintain haemoglobin values
.
by the intravenous
see
or
( see section
bound to plasma protein
5.4
In combination with
,
The AUC and Cmax
of in vitro solubility
Following subcutaneous
and 11
and disappear
A proconvulsant activity of
treatment
7.5 mmol/ l )
four
meal or unplanned ,
polycythaemic mice
and headache ( 5.1
) 524 40 64
avoided ; guidance
is
Europe R & D
The four carbohydrate chains
.
aripiprazole tablets , with
below 25ºC )
thiazides , glucocorticoids ,
that
although development of
if you
in order to protect
5 and 10
patients with severe
.
802
should be
3 times per
clinical studies
Hunton House Highbridge Business
of anhydrous
,
of overdose
is necessary
United Kingdom
All special warnings and
placebo
a
APPROPRIATE
.
of
pneumonia ,
pharmacokinetic
The four
see section
recommended
24
0.4 ml ( 4000
overdose with aripiprazole ,
of the
elective orthopaedic surgery
injection
12 g/ dl
.
, but
the
revealed no medically important
haemoglobin values exceeding
glossodynia , dry
500
not
In some
Kuhloweg 37
be managed cautiously .
in strength ,
clinical studies for
0.5
,
after
150 30 -
of Abseamed
aripiprazole
planning to become pregnant
.
valid Summary of
doctor
;
2C8 although
an apparent volume
.
avoided ; guidance
alfa
Nordisk
SQUIBB
Tel :
(
%
1
times per week .
, 50 , 56
increased
800
given weekly
this
Unit ) corresponds to
The mean
observed ( see sections
severity
has no
of
Hydrochloric acid
hour ,
RESTRICTIONS WITH
of
particularly overweight patients )
.
( IU
Highbridge Business Park ,
enzyme
the pharmacokinetics of
( see
4.8 Interaction with
patient above and
( FINLAND ) AB
other three
)
1 tablets
defined
Industrial Park Westhoughton
lowest available dose
units
route ,
be marketed
approximately
moderate hepatic impairment .
.
patients of other
Water for
aripiprazole and
pre-filled syringe The syringes
6.2 - 7.5
months when stored between
greater sensitivity of this
95 % CI
United Kingdom BRISTOL-MYERS SQUIBB
%
your
( days 21
suckling reflex .
or
with or without
in a blister
pregnant or
from
, insulin requirements
before
+370
:
units ( IU )
Cmax =
QT prolongation
is
section 5.3 )
Slovenská
the placebo group
,
should
with
the geometric means of
patient
in
patients
The
with consideration for
section 4.4
you are given more
g/ dl (
see section 5.2 )
weeks
.
EPS was 19 %
tablets 28 x 1
.
Kingdom
Hunton House Highbridge
haemoglobin ( 1
.
1.5-2.5 hours
n = 131 )
possibly protein disulfide isomerase
or hospital
SQUIBB BV Tel :
patients
g/ dl
dyskinesia
Dystocia
and such patients
OR
Dosage adjustment may
chest pain
)
4000 IU/
20
DK-2880 Bagsværd Denmark
In
Special warnings and precautions
rare
Attention should be paid
This summary
,
.
anaphylactic reaction
with aripiprazole and 3.2
.
Novo
It
After administration of
MUST BE STORED
intramuscular .
standard genotoxicity tests
What ABILIFY is
of a multi-pack comprising
)
4.4
as hydrochloride )
aripiprazole
2 weeks
factor and differentiating hormone
dihydrogen phosphate
is
epoetin alfa
or
transitory
medicines may
.
5.2
drive and
two
a
.
of the
,
the gluteal region
in
retinopathy .
section 4.2
3
given subcutaneously 3
a stroke or
solution for injection
with
PRCA
ABILIFY is not
: + 43-(0)800
( 0)810 410 500
anaemia ( e.
,
of
such as
26-week ,
Always administer
, may
.
of insulin resistance
see
,
to
month ,
see section
unexplained death
30
The therapeutic
in paediatric and
(
of the Marketing
( 7.5
see
Haemoglobin levels
none
and Cmax of dehydro-aripiprazole
myocardial infarction
)
)
contain 0.9 ml
infarction , cerebrovascular accidents
,
of these
ketoconazole or
NMS is a
treated with aripiprazole
( CLAS
Business Park ,
Abseamed
of liver cirrhosis
and no
to reproduction .
a
(
8167 patients )
orodispersible tablet at the
, especially
Limited Wimblehurst Road Horsham
,
trials
: blurred vision
In
as
of
haemoglobin values exceeding
on bone
cell production
ml glass cartridge
) .
see
The
BE STORED OUT OF
, elevated creatine
and other erythropoiesis-stimulating agents
Only
Oxford Road
a meal or unplanned
patients the incidence
no influence on the
and/ or
if you
OR
minutes ) .
placebo
in patients
13 g/ dl
with encephalopathy-like symptoms
SMALL IMMEDIATE
a sulphonylurea .
.
nausea , constipation ,
2
0.5 ml
of
aripiprazole
patients with
with lithium
of the pancreas
the dose
see section 4.4
of multiple medicinal
ABILIFY contains
, less than
patients may
4.4 and
urine
tense .
D-58638 Iserlohn
stroke
65
and
a manic
with
mean age
or no
mg Aclasta
the
case
The absolute oral
OUT OF
dose
not routinely
this medicine is available
mouth
dalton
1 tablets
prior to
you
.
,
(
and
a daily dose of
- 8°C ) .
is concomitantly administered
in a blister .
to the baby
see
:
12
section
(
% ) following
Phlebotomy may be
or pharmacist
mmol/ l )
2 weeks
, and therefore
15mg of pioglitazone
of paclitaxel
discontinuation of treatment
between healthy
2000 international units
administration of
ABILIFY is
the
metformin ,
days 21 , 14
be
(
dose reduction
and
;
in
or if
clinical
and
34
cartridge contains a
ABILIFY is
have
.
Actraphane
)
60
18 , or
trials
section
.
therapy
bipolarer
165
produce effects that
6.6
following pharmacokinetic data
NMS
, the dosage
insulin products
if
0.6 ml
.
must be followed
male
32 2
syringes contain 0.8 ml
a maximum volume
of epoetin
mg
to
without treatment
with two
56 x
increased risk for thromboembolic
pharmacist .
.
be disposed
) .
.
x
3A4 (
and
) , Wielka Brytania
)
House Highbridge Business
placebo-treated patients
a
in the
palliative treatment
.
)
:
a
.
a dose range of
well
, aripiprazole
with
sections 4.3 and 4.4
Magnesium stearate
,
0.5 ml contains 5000
In clinical trials ,
trials
in dogs
(
One IU (
( see sections
g/ dl (
, angiotensin converting
ABILIFY in
and
, gender , and
3 weeks
KG ,
(
Conventional types of paclitaxel
.
especially
in
Tlf : +47
, restlessness ,
your doctor immediately if
of 1 ml
, IF ANY
EPS was
.
The study
severe irritability
sulphonamides .
cannot be excluded .
+33 (
injection site within a
Die
type 2
%
.
,
risk
subjects ,
NovoLet
patients
unused product
feeling anxious ,
pre-filled syringes
Actos
your
30
abrupt improvement in
,
to
rectangular and
Hyperglycaemia and
is
,
such veterinary medicinal
of anaemia and reduction
The
orthopaedic surgery
placebo
IU )
than 2
the exposure of
.
+
as soon as
the following :
Lda
Eli
" A-009
but not in monkeys
corresponding to
, ventricular
risks
Aclasta should
+ 46 8 704
manic symptoms
increase the risk of
7.5
must be discontinued .
.
risk of cross-reaction .
course
this
from 2 60
other
95 % CI ]
% CI
( 7.5
+
)
to
not be used
other erythropoiesis-stimulating agents (
mg
( N = 789
1
the
(
Co KG ,
diabetes mellitus
43-(0)800
in patients with
is a
( DVTs )
,
, Kuhloweg
lung ,
patients ,
patients with
route
you
of overdose should
63 % reduction
marked with A-007
At therapeutic concentrations
dosage
of the pancreas
Kuhloweg 37 , D-58638
should
pH adjustment )
Attention should
patients with
In patients with
in patients
in
pharmacist if you are
if you are
daily dose of 15
section 6.1 .
,
the safety of pioglitazone
g/ dl (
infection
the
21 412 6600
associated
is 50 International Units
three
patients
contains 15mg
not show an interaction
beta-sympathomimetics , growth hormone
ml
Treatment of
if
14
+ 43 1
vary with age
+ 44 ( 0)1628
your doctor
entire
l ) .
medicines may
medicines
In clinical trials and
dehydro-aripiprazole the
to
,
15mg tablets
epoetin
year .
Insulin suspensions should not
4.4 and 5.2
and
There
has been
with
- if
Oxford Road Uxbridge -
( t½
: blurred
In clinical trials
Summary of
receive adequate antithrombotic prophylaxis
of
vorgenommen werden
marked with
maximum of 30
24
in paediatric and
week
women in
West Sussex , RH12
section 6.1
of progression of diabetic
having a high
four week
manic or mixed episode
.
hepatic impairment
with fast-acting ,
not
without
.
Always take ABILIFY
Hb between 10
insufficiency .
0)1 46 25
young subjects
patients
similar decrease in
and
for haloperidol
.
and
cancer patients
to
see section 5.1 )
Inadequate dosage or
the
Park
administered to target a
1
use
concomitant systemic disease
recommended
was
IU of insulin human
)
migraine-like
Less than 1 %
than 1
, metformin ) were
dogs
:
patients
include continuous electrocardiographic
000 IU/
( see
IU of insulin
stopper .
AB Puh/ Tel :
to starting Abseamed therapy
, Te .
minutes
4.8 and 4.9
you
not
with
What ABILIFY
of greater than
.
,
take
fed dogs ,
or more
the
molecule contributes about 58
with a
route ,
tablets
,
patients
that epoetin
Erythropoietins
insulin
is effective
children
,
not
and
see section 6.1 .
could be
mg orodispersible tablets
a pre-filled syringe (
section
anaemia
alfa in adult patients
The cartridge
Abseamed 8000 IU/
with ABILIFY
BW 120
section
Ask your
aripiprazole ,
BRISTOL-MYERS SQUIBB (
its application for
by approximately 25
administered
When
Insulin suspensions
Recurrence prevention of
contain 0.6 ml
H1 receptors
131
, growth hormone
see section 4.2 Treatment
current
should be investigated
,
your doctor
and
treatment .
.
was 12.1 % with
section 4.4
The needle should be
2000
6000 international units
of 0.6
The pharmacokinetic
patients )
84
with the
( 1
:
additional
Kuhloweg 37 , D-58638
the blood pressure is
and beta-sympathomimetics ,
Park , Oxford
blood sugar (
in order
rDNA (
dehydro-aripiprazole the geometric means
aripiprazole and dehydro-aripiprazole are
tablet contains 15
MANUFACTURING AUTHORISATION
International
+ 47 67 55
mg
3
are
aripiprazole
Frequencies of
1 tablets
side effects (
Co- administration
patients
, 25.9 ] (
The
the suckling reflex .
(
medicines called antipsychotics .
epoetin
Cmax
% for placebo
, the formation
healthy
seek medical
London WC2B 4AE
, the
.
x 1 tablets 28
anaemia associated
100
of
used
.
that in patients
medicines may
ABILIFY
OUT OF THE REACH
also
) .
margin
trials ,
mg aspartame ( E951
trials of
aripiprazole should be
open-label studies
diabetic hyperosmolar
the
hyperglycaemia ,
in
80
71
Read all of
+ 43 1
of aripiprazole .
2 mg
( 1.25 mmol/ l
placebo
section 4.4 )
or
(
,
use of ACOMPLIA
It
pre-filled syringe of 0.9
)
a
and patients with
infusion fluids
only on
% ) .
ketoacidosis , diabetic hyperosmolar
listed below
unit dose
0.5 ml contains 1000
,
in men (
than
and mediastinal disorders
and behaviour and
tablet contains 15mg of
is
, including PANSS and
with placebo
clinical trials
Iron
hypertension
If
150 International
Aclasta
is controlled .
Treatment
renal insufficiency
You
] ( see section
Product Characteristics ,
patients
of
after repeated
, salivary hypersecretion Vascular
phosphokinase
The pharmacokinetics of rimonabant
hoarseness ,
haemoglobin target range
Therefore ,
United
- if you
30 mg/ day .
of the
,
or exposure
atstovyb Tel .
should be
g/ dl ( 7.5
9 251 21 230
49 x 1
ketoconazole )
6.2 mmol/ l
and dehydro-aripiprazole did
with
in haemoglobin ( 1
dosage
with type
Posology
,
ba
one year
)
IU of
APPEAR ON
MEDICINAL PRODUCT
to
.
between 9.5 and 11
type
to reproduction
used
with aripiprazole
+36 1 457 65
and
the dose
result of hypoglycaemia .
Bagsværd
,
of Epoetin alfa
% ( 10
see
speech disorder
in one of these
treatment schedule
carefully weighed
Hypersensitivity to
9 251 21 230
(
4.3 and 4.4
required ( see
addition
x 1
See section 4.4 )
insulin and 70 %
, the
( see section
syringes
below 100
, pioglitazone
- 7.5 mmol/ l
Actos
.
by the intravenous
(
mmol/ l
daily dose of 15
In
lactose monohydrate
maximum daily dose
The study population had
the local representative
% with
characteristics (
The
nursing mother presents no
(
is
in a
signs
of the patients received
the
of consciousness and
g/ dl
.
dose
products
increasing
, aneurysms
vomiting ,
(
Following
groups
aspartame (
been
Hb
or
section 4.5 ) .
of ABILIFY
days immediately
( AST ) ,
rDNA (
adult patients
Special
in
amino acids .
60
Peripheral
) is
cell line by
ml
PACK SIZES OF 14
medical staff
Uncommon -
whether pioglitazone
)
patients
healthy subjects
)
: +
intermediate-acting combined
,
In
patients
,
is
response
, or if
In
e. g. increased
elective orthopaedic surgery
reaction
,
of aripiprazole in
Lda Tel :
several controlled studies
a
Aclasta
,
of
%
route
Important information about some
the blood pressure is
for thromboembolic
the foetus
malformations and
, 14 and
(
3.0 % with placebo
.
vials are for
section 5.3 )
10 g/ dl
hours
AND
g/ dl ( 7.5
.
or hyperosmolar
0.5 ml 6
monoamine oxidase inhibitors (
between
In clinical
exhibited antagonist properties in
to maintain urea ,
epoetin alfa may
the
blood in urine
: + 34
anaemia associated with
( 1 800 )
manic episodes
patients ( particularly overweight
this
experience in
treatment
pharmacist
SQUIBB
not
four carbohydrate chains
inflammation
can occur
SARL Tél : +
The vials
4.8
they
see
in bipolar patients
impairment ,
should be
of controls
symptomatic anaemia
female
receiving
, (
insulin and
,
After
per
women treated with pioglitazone
) ,
in patients
reduce insulin requirement .
insulin or
of 2 units
important
to protect from light
at least
conducted in 375 anaemic
tense
SPECIAL WARNING
anaemia
prostate
( 24-hour
see
bei
magnesium stearate , red
)
not recommended
)
IU/ kg body weight
1
with
of anaemic patients
cytochrome
condition with
chemotherapy induced
and
of obese
.
section 5.1
pregnancy
, D-58638
25
, for
following
of epoetin
this medicinal product must
to draw conclusions
risk for
( n = 131
recommended
four
7.5 mmol/ l
ml
15
another
and
see section 5.1 )
treatment with epoetin
potent
if
with
of aripiprazole
contains
reactions
white ,
NAME OF THE
PRODUCTS
Eli Lilly
,
of thrombotic vascular events
: dehydrogenation
haemoglobin (
-
of patients with the
, oesophagitis
and
Treatment of osteoporosis in
AUC
The
Reticulocyte count
symptoms of hypocalcaemia
,
Puh/ Tel
pre- treatment or
Vantas is a new
and heart disease
NPH ) insulin
NovoLet
normal
fixed-dose trial
) , if
medicines
(
and
times per week .
to
Fe2+/ day is
administration
.
.
7.5 mmol/ l )
( t½
)
.
>
patients
see
Therefore ,
the
adverse
terminal half-life ( t½
patients with
by
especially
: +
6
: oral
section 4.4 )
: extrapyramidal disorder
is indicated for
an increased
g/ dl ( 6.2
mg
bei Patienten mit einer
precautions
than 1 %
, or if the
between 9.5 and 11
based on
,
,
should
and beta-sympathomimetics
,
no significant
Tardive Dyskinesia :
( 2°C -
, suicidal ideation ,
(
experienced with
with
dehydro-aripiprazole
in dogs
the risk of cross-reaction
intentional
of 0.5 ml contains
,
the four placebo-controlled studies
.
pancreas
United
within a
postural dizziness
( 7.5
your doctor
approximately
g/ dl
sterile but unpreserved
been
trials
can cause
15 on one side
for disposal and
The orodispersible tablet
; the
from the use of
g/ dl
WHAT
increase
118
or lithium concentrations .
and
possibly
renal insufficiency .
A
effective in
: + 358
of epoetin
syringes contain 1 ml
generally
.
;
not
(
psychosis .
with aripiprazole
with
may also
, concentrations and
lung ,
meal
,
) , 2C9 (
patients
symptomatic therapy should
may vary with
chronic renal failure
undergoing dialysis (
.
of
influence on the
pre-filled syringe
if you
.
When weak inhibitors
Patients
( 0)20 3116 8951
4.5 )
.
arrhythmias ,
,
Horsham West
Alcohol
4.9
humans
Uncommon - Peripheral
tablets can be
and
* Additional
3.5
,
except in paediatric patients
.
of
mmol/ l )
not routinely measured
g/ dl (
Takeda Global R &
as measured
The safety
and dyskinesia
24 hours
injection site
your doctor or pharmacist
) in vitro
Actraphane contains
and adolescents under
PRODUCTS , IF
) in
.
) ,
years
when
( mean difference
Taking ABILIFY
incidence of EPS was
autologous
IU/ kg
)
55 53 50
of
improvement in
7.5 mmol/ l )
12 g/ dl
not
: in clinical trials
.
PHARMACEUTICALS LTD Tel :
The following maintenance doses
to the baby .
proliferation
3116
under
%
more
)
to
, 23
BRISTOL-MYERS
of dosage may
30mg tablets
.
938 ;
,
approximately
of the Marketing Authorisation
rare
) , increased alkaline
for
packed
the
; suicide attempt ,
mild to moderate
Tel
(
Allé
especially
Arzneimittel Pütter GmbH &
IU/ kg/ day .
and
a
.
OF THE MEDICINAL PRODUCT
a stroke or
of 0.3 ml
Special precautions
,
encephalopathy-like symptoms (
CHILDREN
(
or if you
be considered
SPECIAL WARNING THAT THE
fructose
, diabetic
between 10
- metformin , in
with
Madrid ) Spain
,
4.5 Interaction with
anaemia in
.
ml contains
contain 1 ml (
solid tumours (
contains 100
Die
(
approximately 25
(
infusion , becoming
or
rare cases
Glutamyl Transferase
isophane
and symptoms
g/ dl
)
Dose adjustment in order
epoetin
reproductive toxicity studies .
Middlesex
controls .
The blood glucose
be marketed .
4.2
50 ,
14
and 4.9 ) .
recommendations
2 hours
Aclasta works for
but not clinically
The following maintenance doses
ng/ ml ;
of Cmax and
therapy with
from light .
that
: + 33 (
who
clearance is
ABILIFY
weeks
(
:
,
One ml solution
diabetic ketoacidosis ,
the relative efficacy
solution contains 2000 IU
Park
pioglitazone should not
Owing to
.
the greater sensitivity
precautions for
( or if
Pharma Tel .
in
aripiprazole Intramuscular
in subjects
type 2 diabetes
1 ml contains
some of the other
) .
1HU - United
section 4.5 )
the dose should
a prospective ,
THE OUTER
been
.
, glucocorticoids ,
section 5.3 )
412
durch die
, a potent inducer
LTD Tel : +
aripiprazole and 3.0 %
increased
patient above and
been
dated Final
be presented
) and
per week by
vomiting , an
Special populations (
most of these patients
with
rare cases of
be
irregular heart beat .
for pH-adjustment
Pioglitazone
.
wide .
1
)
(
use
and diabetes mellitus (
) Acesulfame potassium
pH adjustment )
, diarrhoea
.
+ 358 9
(
)
The metabolism
: +33
your doctor or
before
cases of
anaemia
683 breast
effective
10 days following
3 and
of
section 5.2 ) .
parenteral benzodiazepine may be
and
Aripiprazole is
THE
.
to
This effect
Immune system disorders
( see
Road
of post-dose symptoms
, 56
especially
unknown
, please tell
of
with
, less than
or if
by
intravenous route has to
The white
18 ,
skin
Oral
.
myocardial infarction
ml .
%
children over 30 kg
of
1HU - United Kingdom
:
and
be used if
developmental toxicity
your doctor
PRODUCTS OR WASTE
.
8.1 mmol/ l
BRISTOL-MYERS SQUIBB (
1.25 mmol/ l )
.
( 2°C -
not
Treatment of anaemia
The majority of reported
observed .
Increased
:
300 mg Fe2+/ day
the pack with you
QT prolongation
in increments of
doctor may
only 3
, Kuhloweg 37 ,
benefit
no evidence of
45
3
placebo-controlled trial
-
signs and symptoms
See
with
352 74 60
the
of the absorption
, 56
rDNA
, must be discontinued
active ( M-II
and
mg
Steady State
human .
of
Slovenija Eli
OncoEurope Tel :
x
358 9 251 21
(
.
thrombosis
The terminal
due to co- morbidities
Aclasta
in one of
headache
over 3 years
pioglitazone
may
not
95
.
showed
4.5 ) .
open-label study there was
signs and
pioglitazone
4.4 ) .
warfarin
it
most common
United
in
on the use of
If
infection including osteomyelitis ,
dose
)
to ensure
on the other .
contents of the
normal and anaemic rats
one side .
headache
:
, the dose should
( and ,
per month
the
a recent
administered
aspartame
months
four placebo-controlled studies
Conjunctivitis , eye
of the patients
mmol/ l ) or
epoetin
HOMA analysis
of
)
diabetes mellitus
within the pre-menopausal range
nurse .
The syringes contain 0.6
938 ; mean age
dose is
how
clinical trials that
pregnant women .
white to off-white
and a negative impact
controlled
Patients with
weight gain
interaction
hives
3
A " over
90
will
)
:
orthopaedic surgery
16
& D Centre (
and vitamin
.
Accumulation of triglycerides
,
,
has Abilify
immediately if
DERIVED FROM SUCH MEDICINAL
terminal half-life is determined
common
been observed
haemoglobin target range
) or the
diabetes
,
hypertension
doses
( dextromethorphan/ 3-methoxymorphinan ratio
, nausea
This medicinal product contains
untreated
in all of whom
.
dose
used for 2.
.
48 The recommended
( see
effective
The
ml ( 2000
water for injection .
the sustained haemoglobin exceeds
In
6 %
isophane ( NPH
may also
patients with
signs
a
12 g/ dl
gliclazide .
THE
56 , 84
reactions
( human ) .
Actraphane
be monitored and
for aripiprazole-treated
section
The
rhabdomyolysis ) , and
Unit ) corresponds to
, the gluteal region
,
erythropoietin
.
45
Abseamed has no
may
with
arrhythmias .
with aripiprazole
myoglobinuria
the intravenous route
and
consists of
Ask
PIOGLITAZONE IN COMBINATION THERAPY
are
.
The
663 50
)
)
.
, there was
from
hypertension
of epoetin alfa
Abseamed
your
Actraphane is
7 )
of
in
events
(
haemoglobin of greater than
, open-label studies ,
the
,
from hypoglycaemia .
doctor or
the abdominal wall
, the
lead to an increase
epoetin alfa
by
nausea , vomiting and
4.4 ) .
.
placebo-controlled trial , the
events
of clinical
alkaline phosphatase
a number of other
increased
a
with
substitution of
, long-acting
should be
(
with ABILIFY
2°C -
infection or
, increased Alanine Aminotransferase
( 1.25 mmol/ l
be
two equal
blood pressure and
solution for injection
Epoetin alfa
and the
angioedema and anaphylactic reaction
of
5.1 ) .
overweight
been treated
two
ABILIFY :
to a
The
in
see section 6.1
) .
.
mg
5
to epoetin alfa
of
Syringes are
1
hours
administered by intravenous infusion
enzymes .
per month or
use of oral aripiprazole
(
: in clinical
165 amino acids .
on
the pharmacokinetics
ml : 22
1
.
,
United
with
recently
87
4 hours
(
should
sensory neuropathy ,
.
PARTICULARS
-
patients
started as soon as
300 mg Fe2+/ day
, inadequately treated
with renal anaemia
injections
treatment with aripiprazole
(
12 g/ dl
Cmax and AUC after
149 MINIMUM PARTICULARS TO
isolated patients with
controlled
,
Actos
products and
section 4.8 )
44
severe renal
= 50 80
: +
reactions
not show an interaction
controls
ng/ ml
Aripiprazole
with
see also
a negative impact
rather than of the
in children and
.
reactions
(
of
on
below 100
of 12 g/ dl
if you are breast-feeding
and N-dealkylation .
) .
0.99 , 1,18 ;
increased Creatine Phosphokinase
ABILIFY
should be
Kingdom Takeda
REGARDING
children and
%
8°C ) .
this effect
: + 36(0 )
your doctor
.
10
but
(
control type 2 diabetes
mg , 10 mg
placebo
30 mg tablets
of EPS
laboratory parameters
fall
medicinal products
nausea
( two studies
(
or
Adverse reactions
g/ dl
use of oral aripiprazole
with aripiprazole
Erythropoietin receptors may
undergoes extensive hepatic metabolism
% with
of
doctor .
Hypersensitivity to
Use
large
SQUIBB BV Tel :
during the course
Europe ) Ltd 61
, somnolence , tachycardia
Luxembourg/ Luxemburg
to drive and
forms of interaction
Do not
67 55 53
household waste
34 % ,
,
very
Water
of excipients , see
especially
For a full list
solution for injection in
One
) ,
33 - 39 %
and
of
, insomnia ,
with
in
sulphonamides .
fold
see
1
transient
minutes
,
l
+33 ( 0)1
05
syringes contain 0.4
ml solution for injection
with severe renal
Following subcutaneous injection
a
,
of
75
minutes ) .
patients
and should
your doctor immediately
4.8 ) .
see section 4.5
except
specific frequency can
im
Always take
the haemoglobin target range
33
of the hormone
as
Business Park , Oxford
, marked with
observed
and
10
SQUIBB
with metformin and/ or
(
time each day .
The study population had
epoetin alfa is
+ 354
London , WC2B 4AE
CONDITIONS OR
disposition phases
- shortened
If
contains
to affect ABILIFY :
an apparent volume
begins
, µ : +44
32 2
of distribution in humans
evidence of clinically
dopamine
weight decreased
antihypertensive treatment .
has told you .
.
of 10
or
rDNA (
, oesophagitis
over 30
2C8 although
:
no
factor
(
) after
several
VOLUME OR
in Saccharomyces cerevisiae )
The terminal half-life
,
6.8 mmol/ l
epoetin alfa
see
physical activity , non-
, 56
6.2 - 7.5
30
, engraved with
Actraphane is
Patients
Aclasta is available here
study
) .
during
encephalopathy-like symptoms
.
,
aripiprazole
6.1
,
)
ON BLISTERS OR STRIPS
(
of aripiprazole
of
( 44-20 ) 74
potentially medically serious signs
These studies have shown
effectively
other
:
2
%
irregular heart beat .
Clinical
below 12
dose
Based on in
e. g.
) .
6
Patient information pack
dextromethorphan ) .
:
weight
condition
concentrations , aripiprazole
32 2 352 74
of epoetin alfa
respected
the
Hypersensitivity to
Patients
of 100 mg
.
well-controlled trials of
QT prolongation
the incidence of
if you are
a
; ATC code
) , chest pain
insulin
manic
(
Malignant Syndrome (
300
.
13
and
( 0.5
( mean age
,
.
300
when
de pointes ,
events
These measures should
in
and
The absolute
type 2 diabetes mellitus
) of
and
, or if the
solution contains 10 000
closely monitored throughout this
1 ml
large
FINLAND
+ 32 2 352
Tel :
pioglitazone
and a negative impact
1
receiving non-platinum chemotherapy
,
affect
doses
approximately 18
,
insulin , metformin
.
ability
children .
month or the
administration
orodispersible tablets
The individual
1.25
unplanned
When the CYP3A4 or
rats , dogs ,
is
products
of
, peripheral
5
side effects (
.
, open-label studies ,
patients treated
occurs .
carbamazepine
Special precautions
)
)
comparable to
United Kingdom
221 multiple
patients
may vary with
.
significant
cartridge contains
,
manic episodes in
of EPS was
epoetin
no appreciable affinity for
effect
Centre (
cardiovascular
R & D Centre
is 50
trials involving 1,228 schizophrenic
and with or
Farmaceutici SpA
,
three
other symptoms
syndrome
in section 4.2 .
is necessary .
A vial provides
example
,
or
The AUC
placebo
is always well
1 )
39
is metabolised
medicines
MATERIALS
weakness )
as
in
the
solution
is
AST ) ,
.
(
)
Aripiprazole and other
should
Changes in strength
: extrapyramidal disorder
and
As with other
formation
interactions
of angioedema
coated
Actraphane is
injection .
6600
, and the
IU/ kg
and heart disease or
, HORIZON
0)21 272
fibrillation
except
.
discontinuation of treatment .
with 100 ml
)
6 hours has been
mmol/ l
)
is
flavour ( including
patients with
GESMBH Tel : +
pregnant women
growth factors
and 53.3 % for
4.2 Posology
% of
patients
decreased
or higher
12 g/ dl
MAOI )
)
into a vein )
)
At therapeutic
respected
ABILIFY
see section 5.1
D
treatment .
260 lung ,
and protracted absorption respectively
for aripiprazole-treated
administered after the completion
unit dose blisters
tablets
osteoporosis
of
.
)
metabolised
g/ dl
quinidine occurs .
30 mg/ day .
children over
1
negative
6 -hydroxypaclitaxel
Aripiprazole is
use
during pregnancy
be used .
or
Hunton House Highbridge
In
mmol/ l )
, 14 and 7
correct
see sections 4.3
between
is
may also
Any
Sími
and dose regimens
AB Puh/ Tel :
reached
4.2 Method
two
wide
because
of
of the pharmacological effects
trial
of continued therapy .
Tel : +
decreased
doctor
transient and asymptomatic ,
daily dose of
+
including
the incidence
32 %
Treatment
the
(
Tél/ Tel
paediatric patients
BRISTOL-MYERS SQUIBB SARL
statins , fibrates )
pharmacist .
For preventing
up to
it
or nurse
These trials
in Actos
section 4.4 ) .
6.2 - 7.5
most frequent adverse reaction
are
take it
may require discontinuation of
4.5
( see section
1
.
the taxanes
been carried out .
, treatment
pharmacist
(
, Neuroleptic Malignant Syndrome
alfa
%
and
Seizure :
of
section 5.3
FACT-An )
be treated
for
.
33 IU/ kg
and 10 cartridges
with
the intravenous route .
1HU - United Kingdom
and
pharmacist
international units (
30 mg/ day .
( NMS
rhabdomyolysis ) ,
A number
with
increased
28 tablets 30
surgery , and
45
also
)
9.5 and 11
disorders and
.
contributes about 58
Common
between
mainly
with high fever
(
,
similar
.
Business Park ,
and
and
DERIVED FROM SUCH MEDICINAL
)
.
7.5 mmol/
not
angiotensin converting enzyme (
Disodium edetate Fructose
(
per
and
not
pharmacist .
Tel : + 44
data
,
recommended starting dose
side effects
Latvij
dexamethasone
the
Insulin suspensions
keine
atypical antipsychotic
)
most of
or
and
Alcohol may
, especially
, 98 x 1
mg tablets
6.1 )
peripheral
osteoporosis
,
32 2 352
Treatment
Pharma GmbH Tél/ Tel
strenuous physical exercise may
Like
sodium hydroxide
to
The maximum dose
. emea
after
in patients with
in haemoglobin (
.
,
Aripiprazole
with insulin ,
patients
)
with epoetin
sse
when taking ABILIFY
2 weeks
products to affect
days 21
Insulin human ,
the
should only be
four placebo-controlled studies
mg tablets are
, abnormal
haemoglobin values exceeding 12
,
of
aripiprazole .
ready for use .
manic episodes in
and
anaemia
of effect of
( normal and
.
.
is between 75 and
,
indication
Westferry Circus
(
decreased
water for injection .
& D Centre (
may vary with age
and
United Kingdom
aripiprazole .
44
products .
dysphagia
in clinical trials
alfa is
cases of seizure
g/ dl
given weekly
, injection route
outcome study of
( IU
aripiprazole
two or
2.5 %
mmol/ l )
KG
or
instability ( irregular
of
(
placebo
Owing to
.
As with other antipsychotics
at the infusion site
Tlf :
,
peak plasma
paediatric patients
aripiprazole
children over
(
populations (
Business Park ,
Eye disorders
( dextromethorphan/ 3-methoxymorphinan ratio
( MAOI
KG
.
.
self harm
taking Actos 45mg
of
45 45 93 05
or blood pressure
dosage of
events
24
( 0)20 3116 8952
none
patients
D Centre ( Europe
within a
Suomi/
with severe agitation
800 ) 749
a measure
infusion
) .
g/ dl (
.
.
.
that rimonabant is
therefore
mg
, 1,18 ; 42
dose
30
BRISTOL-MYERS
increased risk of
medically important differences
of CYP3A4
done
approximately
g/ dl (
weeks prior to
If convenient
ABILIFY
Your veterinary surgeon will
greater than
,
glass cartridge (
300
,
in
patients
only
is
trials of
section 4.4
no
followed by
, including
Europharm Limited
syringes contain
encephalopathy-like symptoms
and dose regimens
.
by
15 and
on
discontinuation of treatment
the four placebo-controlled studies
- Diabetic
of anaemia
and disturbed behaviours
other three
with encephalopathy-like
treatment with
United Kingdom
- 12 g/ dl
physician must therefore
potentially medically serious signs
relative
rimonabant
Uncommon - Peripheral neuropathy
pulse or
average age of 62
is not appropriate
, vitamin B12 or
doctor ,
pharmacokinetics or
( e. g.
This medicinal product
has
mg
a mixture
,
4.4
of
subcutaneous tissue
An
round and pink
.
Aripiprazole did not
be considered (
( 44-20 ) 74
)
of 15 mg
or if the
solution for injection in
g/ dl (
liver enzyme levels should
.
( possibly delayed
and
IU/ kg epoetin
Non-clinical data reveal no
healthy
mutation
been
6.8
Survival
of
with
a similar pattern of
to male patients (
hours
nausea , constipation ,
both via subcutaneous
Multi-pack
mmol/ l
preclinical toxicological studies in
make sure the
Tell
AND
closely monitored throughout this
immediately
special warnings and
14 g/ dl
Erythropoietin is
Portugal
Glutamyl Transferase
prevention of a new
1.25 mmol/ l )
( see
3 times per week
is unchanged ,
Since dopamine and 5-hydroxytryptamine
with
healthy
)
and
times per week
or worsening
than
Nordisk A/ S
other
doctor or pharmacist
especially
aripiprazole
significantly
.
especially
adult patients
and
copious amounts
the present state
,
of excipients ,
mg tablets are rectangular
tongue .
Medicines should not be
been
6.1 .
therapy with pioglitazone in
,
from light
with
Try to take
insulin
(
inter-individual variation .
an increased risk
mmol/ l ) .
antipsychotics , aripiprazole should
effectiveness was whether
.
alfa
may increase
see sections
12 g/ dl (
placebo
and swelling of
,
,
of Epoetin
cancer patients .
Thrombocytosis has been
, marked with
and protracted absorption respectively
19 150
a combination
75
repeated oral
(
,
events
maximum daily dose
,
or combination therapy
44 (
and
comprising
with
Elevations of CPK
greater
patients
Hunton
for three
your
Dose adjustment in order
during
Centre ( Europe
the insulin requirement .
at least
improvement in
Any
)
on the ability
: +371 7364000
other
Treatment of adult
(
too high ,
- United
: oral
some of the
: + 44
of the
injections
reported in children
safety
, the dose should
and 11
, 30 , 50
: anaemia in
ABILIFY
of
-
ABILIFY
tell your doctor
mellitus
metabolites .
mg
blood pressure
in place ,
Aripiprazole is metabolised
should be
( Europe ) ,
by a decrease in
-
( 1.3 ml
should be
In cases where there
non-
orodispersible tablet
foam subsides
vitro
( for pH-adjustment
akathisia , nausea and
with increasing
overlapping undesirable effects
: + 44
and method of
;
ABILIFY is
.
DK-2880 Bagsværd
any
)
a few weeks
BW 120 ml
per dose ,
ABILIFY
alfa
antithrombotic prophylaxis
of 12
diarrhoea
Tel
for
] ( n =
dose
,
trials of
, that patients
overdose
of 600 IU/ kg
or
4.6 6.2 months
vomiting , nausea ,
cases extreme and associated
fast-acting
stability results in
- Oedema Oedema may
and
9 In a
controls
( hypoglycaemia ) ,
section 4.3
a
other insulin products ,
and reduction
be used .
and sight of children
associated with
rimonabant 20 mg (
and weight
in
and
and
Storbritannien Tlf :
) .
, sugar
should
165
see section 4.4
.
than
and
of
(
Uncommon
the intravenous route
-hydroxypaclitaxel
4.3
of clinical fractures
The Marketing Authorisation Holder
blood )
The daily insulin requirement
receiving non-platinum chemotherapy
Medicines
insulin human
The usual
( as hydrochloride
increased risk
cells/ µl
should
is 32,000 to 40,000
.
x ULN )
pregnancy
risk
one side
for the treatment
ise or uth
aripiprazole
of the hormone .
included patients with
.
other medicinal products
or hospital
and protein intake
another ( see
MEMBER STATES
( see
( 2 )
alfa should be
immediately
The potential risk for
LTD Tel :
These studies have shown
be used
a dose
EPS
TO APPEAR ON
of children
Aripiprazole
.
different dose
a
or
.
higher
two 6-month
RH12
Common
resulting suspension .
your surgery .
7.5 mmol/ l
needle should be
)
administration of recombinant human
.
.
to
Hb
% of
The
other
and extrapyramidal
are
( for pH-adjustment )
Sverige BRISTOL-MYERS
patients
all
all active metabolites
efficacy or
study included only 3
prior to
extrapyramidal disorder
Arzneimittel Pütter
dose
and sometimes severe irritability
placebo
(
( CLAS )
, vomiting and diarrhoea
.
insulin products with fast
MINIMUM PARTICULARS
molecule
, hoarseness
in
Owing to
is unknown .
of ketoconazole or
of aripiprazole alone was
( weeks
if
local requirements
, i. e.
The
four
8°C )
In another
potassium
only
section 5.2 )
risk
section 4.5
and isophane (
( NPH )
%
the
compared to
.
and
jaundice ,
358
from
( 6.2 -
the
of
, treatment with two
is not appropriate
patients
hospital
6
section
injection :
In addition ,
A number
few minutes )
is less common
Units ( IU )
break .
the four placebo-controlled
increased risk for thromboembolic
or
ABILIFY
SQUIBB SARL
and rhabdomyolysis ,
Clear
tablets :
haemoglobin ( 1
see section
blurred vision .
extrapyramidal symptoms
sustained haemoglobin exceeds
of fracture
two
by
the relative efficacy
warnings and precautions
to target a haemoglobin
surgery and
initiation of convulsions
to target a haemoglobin
risk
of
In
R & D Centre
, or
After injection
with solid tumours (
to sudden
paracetamol
with
or too near
,
&
epoetin alfa may
and for
,
a potent inhibitor
doctor immediately if
Latvij Tel :
a
open-label
adrenergic and histamine
is between
incidence of EPS was
(
a dose of 600
therapy .
in 1.3
0.4 ml
this
prior to
and/
between
isophane insulin
or
you
in type 1 diabetes
Patients who
15.0 ,
be observed
00
and
main measure of
receiving radiotherapy
In clinical
the
) should
Bipolar I Disorder ,
medicinal products .
,
shown reproduction toxicity (
or
Common : dyspepsia ,
cautioned
has told you
Excipients
some
solid tumours (
contain
, IF APPROPRIATE
The
has been
Ltd commits to
%
in
stroke
30 kg require higher
( 1.25
greater than 2
, discard
days 21
5HT2a receptors
epoetin alfa
more than
chronic renal failure
remain at
Treatment
be marketed
been reported in patients
In
, corresponding to
.
2
mellitus and
, alpha-1
the
)
ABILIFY :
blisters
times
5.3 )
Glutamyl Transferase
days
infusion and
taking or
- 300 mg
The
increased
a
isolated patients with normal
.
aripiprazole
in
with reported estimated doses
should be advised accordingly
and
:
of clinical
agitation/ behavioural
0.5 ml contains 1000
ketoacidosis (
be used in
patients
with
:
7000 international units
men and women
,
this
As
, itching ,
Hb between
see section 4.4
Intravenous injection : over
Erythropoietin receptors
per
Each tablet contains
to become
3 ml
insulin
of rimonabant
- 7.5 mmol/ l
exposures
%
e. g. stenoses
)
hour ,
)
Kingdom Takeda UK
" on
.
of the patients
in
the pancreas
should
,
" 5 " on
If after
MUST BE STORED
after
the
in the individual studies
haemoglobin ( 1 to
in patients with
and
by the
Cmax of dehydro-aripiprazole ,
initiation
Arzneimittel Pütter
anaemia
Aripiprazole
of hypoglycaemia
.
(
for use in
Oral
of
MAOI
pooled atrial fibrillation
your doctor
intravenous route
( See section
increased Gamma Glutamyl Transferase
UK Ltd Tel :
and isophane ( NPH
28
or
auf
reported in children .
name and
route
be
and 8167 patients
when
may
is
start of
7.5
Die
anaemic rats ,
prostate
clearance
not greater than 12
trials ,
the
of Bipolar I Disorder
ON THE OUTER
three
Hb between 10
with aripiprazole
interaction
GmbH
taking ABILIFY
pioglitazone
These measures will help
this
NPH ) insulin
75 - 150 60
between 10 and
After injection of the
)
: a maximum volume
changes in
If
marked
taken in combination with
to
than for haloperidol
clinical trials with pioglitazone
years Shelf-life
of EPS including parkinsonism
use
For
2000
.
pancreas
frequency
or
,
aripiprazole
Co KG Kuhloweg
one side
and
patient
solid tumours
0.62 mmol/ l
and 3.2
section 4.8 )
11.6 63.8 31.0 65.1
to 6 weeks
.
The data from the
.
Oxford Road Uxbridge
In some
subcutaneous tissue
.
should be
Highbridge
Be sure to
, glycine ,
at the desired level
patients )
be
150 30 -
with
the
23 mg )
on the other
that the
blood pressure
Omission of a meal
manic episodes in
see sections 4.3 and
dose adjustment is necessary
please see
insulin and 90
of the pancreas
seriousness .
, rDNA (
( 7.5 mmol/ l
,
ml )
beta-sympathomimetics
BE STORED
see section
a
g/ dl
this product , ask
was
: in
may be harmful
and
30 %
7.5
intramuscular
with
for
to tell
or the
Aclasta
and adults .
CYP2D6
12
,
been determined
be observed .
, or
FINLAND )
The syringes contain 1
than
is very
outcome has been reported
vial provides 9.75 mg
malabsorption ) .
the concomitant
in
over 3 weeks
rifampicin
dose regimens
and
an increased risk
WHAT
healthy elderly
a
over 3 weeks .
to protect from light
drink the
The
as packaged for sale
of overdose
unit dose blisters
7.5 mmol/ l )
a
06 5026 01
, uncommon cases
.
alfa
or pharmacist .
in
in
diabetes mellitus
is achieved .
four carbohydrate chains
Elimination
patients
40 %
0.8 ml
.
two
or the
Aclasta and 0.8
combination with sulphonylureas
section 4.8 ) .
) .
hours
not
61 Aldwych
complications .
.
40,000 dalton .
patients , antibodies
of ketoconazole or
SQUIBB ( FINLAND )
infection
hypotension
prior to
pioglitazone in patients
and the
in a
2 units
mg
,
The active substance is
with
Erythropoietin
is unknown .
medicinal products .
the
Saccharomyces
33 ( 0)810 410
of
352 74 60
Abraxane
Abseamed
but
aripiprazole
has been observed
doctor
you
alfa ,
Tel : + 40
Polysorbate 80 Water for
.
mmol/ l )
vertebral fracture
the
times per week by
laboratory parameters revealed
AUC
a
patients
dextromethorphan ) .
.
& D
to 21 % of
patients with
taken orally once daily
WC2B 4AE ,
manic
and preventing them
( see
and
Abseamed
no
( 6 %
Alle Patienten unter
schizophrenia
patients with a manic
or
is effective
% ]
treatment of
should
a
.
, close medical
symptoms can occur
and risedronate
,
IU
of aripiprazole
favour of
by the intravenous route
in
of
.
compared
a dose range of
Tel : +
with
and symptoms
is therefore
clinical studies ,
between healthy elderly and
g/ dl
If you
pioglitazone
When seen , it
UK Ltd
to
.
.
In
also carried out studies
Aclasta , see section
be administered
children
sulphonamides .
The following
other antipsychotics ,
haemoglobin
IU/ kg
increased
in children
Mildly anaemic patients
chemotherapy
) may
8°C ) .
If
preventing recurrence of manic
After
.
are extensions
erythropoietin
has been studied in
.
.
absolute
facilitate the
to
units ( IU
One IU (
.
The
Europe ) Ltd 61
TABLETS ONLY
, Oxford
6 hours has been
1
mitratapide
The peak
or more
150 60 - 150
60 -
Aripiprazole should be
has been proposed that
of malformations
and 76
vary with
the
subcutaneous
is
a mixture of dissolved
3A4 ( dextromethorphan
: extrapyramidal disorder
the reach
benefit
patients
and
300
treatment with
If
insulin
physical
some
programme ,
of
)
adult patients
only 3 patients
If
one year
.
at doses
12 g/ dl (
Dose adjustment
to affect ABILIFY :
races .
)
with
In addition , cases
per
) increased
not
use of oral aripiprazole
Effects on
(
weeks
of 14 , 28
50 IU/ kg 2
um 5 % ansteigt
In the
patients
in a dose range
possibly protein disulfide isomerase
the faeces .
monoamine oxidase inhibitors (
is therefore
effect
of 12 g/ dl
, that
.
less duration
isolated cases of
3 times per
compound
mediated by
skin
after
(
rising by more than
Treatment of symptomatic
The
is not a substrate
medicines
see section
) per month
please see section
and
) or the
7.5
- In
between 9.5 and 11
for the
)
WHAT
LTD Tlf : +
the patient on
fructose per
animals
of
and
receiving radiotherapy
doctor
and
this
and
is
.
process : rapid biphasic
significant
or
see section 5.1 )
The Abseamed pre-filled syringe
, pruritus ,
ml
this effect
150
%
weeks
CYP2D6
,
than 1
,
in
R
90 and 98
Abseamed
44 ( 0)1628 537
LTD Tel :
3A4
,
based
reactions
- 200
(
the
tablets 56 x 1
the deltoid region may
phosphate dihydrate ,
the
been
acute renal failure .
contain
women in
, accidental
some or all of
Centre
the
, where prophylaxis
has been
tablets 98 tablets
dosage of
If
%
that
output from the liver
both
have been proposed ;
with
g/ dl (
mmol/ l
to that seen
REACH AND SIGHT OF
between 9.5 and
84 , 90
than 2 g/ dl
additional
experiencing potentially clinically
thyroid hormones and
for
solid
pre-filled syringe
gliclazide )
less
Kingdom
or
No
( 57.3
:
Treatment
Global
of
manic
episode in patients
Tél/ Tel
40 64
every 3 weeks
, alpha-1
Patients who
to
) is
approximately
, the
patient
Abseamed has
patients
857 42 22
dementia ( loss of
Finland OY BRISTOL-MYERS
and
contain 0.5 ml (
and
ventricular arrhythmias
seizure
was
daily dose
or
mit einer Adipositas ist
)
.
Keep out of the
of stroke
from light
the gluteal region
if
.
Bagsværd
in a refrigerator
Dysphagia : oesophageal
on results of
LTD Tel : +
%
Contains
mg
by 32
or
which are
doctor
After administration of
of dissolved insulin
affects you .
24
the
and
a total of
exhibit complications
ketoconazole
from
30 kg
or other symptoms
Starting dose
this
month
are
daily dose
.
you
in
BRISTOL-MYERS
200 mg
( or if
In three
placebo-controlled trial ,
.
orodispersible tablets
.
warfarin
of aripiprazole AUC
is therefore
trials , the incidence
a meal or
%
Aclasta
overall survival between
and 15.7
too low
trials
and
week by the intravenous
interaction
in
and bone marrow
times per week .
.
If
blood pressure
1
treatment schedule .
,
or 13
30 kg require higher
and/
in order to
If convenient ,
for
Farmaceutici SpA Tel :
take
Manufacturer Marketing authorisation
6.8
intravenous route
500 film-coated tablets .
mit einer
g/ dl (
these
4.2 Posology
.
from
recurrence of manic
Mellitus : hyperglycaemia
.
)
following undesirable effects occurred
used :
for all
,
not been evaluated .
.
pH adjustment
for
Cardiac
and
rats ,
150
no
only 3 patients
section 4.2 )
with
,
Seizure : in clinical
including
Similar changes in
use
of
tumours ( 172 breast
usually
if
, and
between 9.5 and 11
experience in children
Effects on
is
akathisia
) or the
.
ng/ ml
:
see section
49 orodispersible tablets
rather than
10 g/ dl (
The
section 4.4 )
not using effective
in
pre-filled pen .
D
recommended for
diabetic
Bagsværd
.
MEDICINAL PRODUCT
healthy elderly and younger
contraeptives ,
:
increased tactile hyperesthesia were
Dose adjustment
as
and 33
6.2 mmol/ l )
less than
22 prostate
a slight appetite decreasing
orthostatic hypotension*
15
(
elective
, sodium citrate and
adequate data on the
.
2 weeks
mg/ ml
0.035 mg
and completed suicide
you
.
dose of
.
and a multipack with
dose is injected .
been
are
Functional Assessment of Cancer
4.8 and 4.9
margin of epoetin alfa
Erythropoietin is a
Finland OY
the recommended
BEFORE
information on
in two studies was
injection
is not recommended
any information
maintenance doses
or
or any of the
RESPONSIBLE FOR BATCH
to treat
Consequently ,
effects
1HU - United
clinically
alfa
isolated cases of
insulin human .
production
risk for thromboembolic
of the
-
e. g. ,
refrigerator
other
ml
,
, Oxford
or
substitution of
12
Bei
1.25 and 2.47 in
be increased
: + 44
in a
Authorisation
32 2
.
de pointes , bradycardia
, the dosage
treatment with aripiprazole
with caution
-
This may constitute
( dextromethorphan )
.
see
in type 1 diabetes
TO APPEAR ON
phenprocoumon and metformin
solution to reach
( iron deficiency ,
Unit ) corresponds to
The biological efficacy
in
Aripiprazole exhibited
and pink
increased
the treatment
( 0.5 to
section 5.2 ) .
The
)
32
intravenous infusion of
g/ dl
)
, the
,
study .
to your
on the pharmacokinetics
, as
ketoacidosis , diabetic hyperosmolar
medicinal
appropriate doses
and all active
,
ketoacidosis , diabetic hyperosmolar
mmol/ l )
Following subcutaneous injection
tablets
myocardial infarction
usually
with placebo .
soluble insulin 50 %
The
aripiprazole should
four
you
Treatment of
3.2 % with
with epoetin alfa
However , since cyclosporin
and
Actraphane
muscle pain
) and
the
use of
reported estimated doses
starch Microcrystalline cellulose
)
or combination therapy
Within each
see section
of
In three
shown significant benefits
of 10
MAOI )
In patients with
the occurrence of
Phlebotomy may be
Highbridge Business Park ,
SQUIBB
treatment with aripiprazole
, 2C9
% isophane insulin .
SQUIBB GESMBH Tel :
, constipation ,
in
of in vitro solubility
in
,
the dose should
pectoris , increased risk
33 - 39
5.1 )
+ 46 8
Uncommon - Peripheral
and other
desired haemoglobin level may
treatment
4.4 Special
nausea ,
haemoglobin
An increased 3H-thymidine incorporation
, 23
tiredness
of insulin
hydroxylation of aripiprazole
g/ dl (
administration
CYP3A4 or CYP2D6 inhibitor
MANUFACTURER OF
and
(
also part
of
.
,
solution for injection contains
in patients at
effect
with encephalopathy-like symptoms can
symptoms .
and
PIOGLITAZONE IN
AND SIGHT OF
Brytania Tel :
Portugal
should be considered (
.
( See
of the
+ 33 ( 0)810
their previous insulin
1,000
272
1 and 10
of one year
The
medically important
D supplementation
cartridge .
than
2 ml calibrated dropper
PRODUCTS , IF
, 22
and
or with
300 gastro-intestinal
6000
Nordisk A/ S Novo
Italia Takeda Italia
is controlled .
50 IU/ kg
section 5.3 ) .
clinical trials , an
week
with haloperidol
of
hours
of
is
completed suicide ( see
)
anorexia , hyponatremia
proportion
safety of
Ltd Tel : +
)
.
Units (
The
Therefore ,
with
40 (
be necessary
half-life
with residual
isophane insulin 80
( below 30°C
11 g/ dl (
Limited
schizophrenia
STRIPS
schizophrenia and manic
Common : blurred vision
undergoing dialysis :
patients
3.0 %
352 74 60
and haloperidol
been observed
7.5
with
and approximately 45
humans
not
and dehydro-aripiprazole ,
aripiprazole
4.4
the
differences
.
fragile
of the
46
Abseamed 8000 IU/
,
pre-filled syringe
Global Research and
Seizure :
Iron status
WITH METFORMIN
rimonabant ; therefore
mean weight increase with
for three
with chronic renal failure
of aripiprazole
per ml
correct
anaemia associated
sulphonylurea
g/ dl ( 0.62
flatness
n =
Puh/ Tel : +
within
vials
,
acting and/
and
Limited
extended follow-up
SQUIBB PHARMACEUTICALS LTD Tel
Bei diesen Patienten sollte
The
in haemoglobin ( 1
Based on
of
should be
in order
)
- 39 % )
statistically
.
speech disorder
:
with encephalopathy-like symptoms (
, it may
from
treatment-related
controlled as necessary
to
daily .
characteristics
on
and
and lymphatic system disorders
that
forms of interaction
to the
,
is always well
advised accordingly
observed when
and 8167
based on mg/ m2
no
not necessarily in association
a
75
This
patients
not affect your ability
.
in patients
is 50 International Units
severe agitation ,
In controlled clinical
use
Hydroxypropyl cellulose
2°C
orthopaedic surgery
cardiovascular
alfa
in haemoglobin
1.8.1
:
WC2B
the
body weight 2 times
or
in proportion
When considering concomitant
aripiprazole
4.4 and
( 0.5 to
with
,
0 ) 30 60
isolated cases of angioedema
a
01
the
adequate
are
67.2
,
declined
even several
trials and 8167
the
endorsed (
Injection sites
sodium citrate and water
t½ of
Epoetin alfa and other
high fever
) , Royaume-Uni
are not
,
Dosage adjustment
should
Tlf : + 44
.
observed
2
The cartridges are designed
30
increased risk
rare cases
) corresponding to 16.8
, alpha-1
( e. g. ,
of administration
entire dose is injected
ml ready-to-infuse solution )
listed below is
half-life (
ON BLISTERS OR
1
12
e. g.
section
patients
with
)
what it is used
impact
to drive and
treated
and
Development
(
this leaflet carefully
and 12
oral bioavailability of
a
of
a similar rate and
and
to ensure
15 mg once a
of consciousness and extrapyramidal
of
, thiazides , glucocorticoids
of dosing
glucocorticoids ,
pharmacist .
However , elevated creatine
] (
to
.
with haematological malignancies (
EPAR für die
.
, aripiprazole
in adult patients
haemolysis
see
(
see section 6.1
.
6.1
route
restricted
sodium hydroxide (
in a
,
IU/ kg 3 times
hyperglycaemia ,
Aripiprazole also demonstrated
two safety pharmacology
fractures
Following concomitant administration
; none
(
Treatment of osteoporosis
epoetin
) of EPS
1 tablets
hypoactivity
If
In order
tablets 56 x
1 ml
are not
8.1 mmol/ l )
sudden
shown significant benefits
802
contain 1 ml (
and
should be considered on
of glucose
with
Hypersensitivity to
of
.
metastases
to protect from
studies
Use
you
patients
Norge Novartis Norge
und
levels remain the
with
haemoglobin target range of
,
Seizure : in
ml
after
is
, every
than 2
.
alfa
of
not
Water for injections
clear ,
insulin
- 14 g/ dl
medically
be used .
in
this
SMALL IMMEDIATE
)
, 23
weight
BRISTOL-MYERS SQUIBB (
isophane insulin .
haemoglobin (
an autologous blood
or
25
psychotic symptoms
See
with
difficult
between .
4.8 ) .
/ N. V.
of rimonabant
shortened overall survival and
M-IV
patients with
in
Omission of a meal
The AUC and
of
patients with reported estimated
some of
not
schizophrenia
4.4
Dose adjustment in order
tubulin
tumour proliferators .
may
incidence
+ 44
with renal
4.5
are never to
2
children over
heart failure was
60
discontinuation of treatment
hypoglycaemia
.
ideally starting
days
ABILIFY is
353
sections 4.8 and
, in some
carton .
transient loss
section 4.6 ) .
% ]
other clinical effects
1 to
with
ventricular arrhythmias , sudden
see section
aripiprazole ,
swelling and inflammation .
number of
Actraphane
A
the
by
United Kingdom BRISTOL-MYERS
AUC
,
MINIMUM PARTICULARS TO APPEAR
reconstituted
The
to the insulin requirement
this
.
in bipolar patients
when
solution for injection
.
Common : blurred
mg/ m2 ) .
Since dopamine and 5-hydroxytryptamine
survival
.
, tachycardia ,
phosphokinase
the intravenous
is
of epoetin alfa may
the dose should
not exceed
dehydro-aripiprazole ,
therefore a measure
for use in
) is
)
platelets ( thrombocytes )
undergoing dialysis ( See
inhibitors of CYP3A4
some
ULN
alpha-1
g/ dl (
8
use
and
not
to patients with moderate
( see
In order
( see section
a
Subcutaneous injection into
of epoetin alfa
.
have
your
or
rats
mixture
have
44 ( 0)20
an increased risk
creatinine
your doctor
epoetin alfa .
of
in
16.8
and healthy
.
(
AND
one vial of
( human )
human dose
4.4
,
Middlesex UB8
the
- After opening
ABILIFY
glycine ,
in two studies was
constipation
Renal dysfunction
Results of
in a refrigerator
BW 120
) AB
the same dose
with
for pH-adjustment )
75 - 150
thereafter yearly PSURs unless
in this
g/ dl .
Actos 15mg
,
see section
hypothermia ,
IS
663
be
with
was the same
is necessary ,
There are
8.1 mmol/ l
to
be disposed
lithium concentrations .
mg/ m2
this
of aripiprazole
of 33
children over
solution for injection
)
Moreover ,
lead to hypoglycaemia
might make
and 8167
your
resolved
) .
to protect from moisture
contains The
shunt and
or
epoetin alfa
one year
Tél/ Tel : +
metacresol , which
4.4 )
including parkinsonism
The therapeutic
Adverse reactions
unconsciousness and/ or
of
.
) .
half-life of
contains 10 mg of
has been
should
large controlled
bipolar disorder
if
of recombinant human
a pre-filled syringe (
or hyperosmolar coma or
events
50 IU/ kg 2
chronic renal failure patients
, peripheral
oral administration
In two large
your doctor or
" A-008 "
alfa
Even if
injection
in paediatric patients
syringes contain 0.6 ml
and
,
7.5 mmol/ l
and/ or dark
aripiprazole
underlying
30 mg tablets may
THE SAFE AND
tiredness
the active substance
)
three
6.6
CYP2D6 inhibitor
when Aclasta
:
, is recommended .
CHILDREN
with cyclosporin
on mg/ m2 )
the
with
such as
(
one of
353 ( 1
given weekly for three
the
.
in man
an increased risk
breast-feeding
may
heart beat .
.
REACH AND SIGHT OF
your
( below 25ºC
surgery
Owing to
.
Authorisation Holder and Manufacturer
and
30 mg should be
,
ABILIFY is and
.
Dose adjustment
: + 358 9
alfa
zoledronic acid
clinical trials with
and
+ 34 (
of the
of specific nuclear receptors
indicated that
disorder ,
mg
mmol/ l
are active
the administration
and
, tiredness
)
Dizziness
adult and paediatric
(
(
lithium
, growth hormone
, especially
between
supervision and monitoring should
starting dose for ABILIFY
8.1 mmol/ l
dose
Wharf
, serum levels of
of stroke or
use
with
doctor .
dogs and
aripiprazole or any
of
and analogues for injection
38 When either
women .
that
1 orodispersible tablets
ml
clinical studies ,
The four carbohydrate chains
London WC2B 4AE United
and
ON
Europe ) , Te
1 diabetes
taking ABILIFY .
% .
ACOMPLIA ,
Forest
aripiprazole
THAT THE MEDICINAL PRODUCT
some of your ABILIFY
The study population
male and female
when a
to affect
tiredness , nausea
4.8
A number of cleavage
Norge
are
patients
2°C
When a
, Royaume-Uni
( FINLAND ) AB
clinical trials
Tel : + 46
patients
hydrolysis ) sites
was
significant effect
concentrations
3.0 % with
Read all of
for pH-adjustment
will also
safety of pioglitazone
hepatic metabolism
) 30
g/ dl
faeces
aripiprazole
pH adjustment
to
,
30
anaemia the medicinal product
clearance is therefore
.
in up to
of ABILIFY
Common : dyspepsia
clinical
children over 30 kg
Hb
4.4 ) .
is
30
with aripiprazole
hours after
UK Ltd
serum levels of
solution for injection in
for you to
At therapeutic concentrations ,
6.2 - 7.5
.
BRISTOL-MYERS
of NMS are hyperpyrexia
Abraxane
or
levels
medicinal products with
as metformin
event
be paid
patients
-
studies
e. g.
not
- 8°C
g/ dl
The
and
17 and 33
per month ,
in
of CPK
entire dose is injected
not
be paid
75 and
13 g/ dl
caution
at the desired level
Oxford Road
KG Kuhloweg 37 D-58638
manic
and 30
by 32 %
PROactive
treatment with epoetin
.
HF Sími
" high "
% .
and
.
of administration ) .
doctor
treatment with epoetin
30 months
or 98 tablets .
45 93
and 300 IU per
43 ( 1
infusion fluids .
section 6.1 )
with epoetin alfa
.
,
hepatic impairment on
At therapeutic concentrations
Middlesex UB8
shown
over a period
in this
neuropathic pain , tremor
patients
EU/ 1/ 00/
It stops the
-
improvement
)
trials of
metformin and a sulphonylurea
type 2 diabetes
is therefore
, vomiting ,
bottom
for
two or
with
Kingdom Takeda UK
( e. g.
( 0800
factor
In
daily
conventional studies
Patients scheduled for
12 g/ dl
dosage
patient
longstanding diabetes
(
whom the
women
.
.
Otsuka Pharmaceutical Europe
and post-marketing experience
levels
WITH
site conditions Uncommon
or
brain
, polycythaemic mice
a measure
and
with ketoacidosis
Road Uxbridge
of
United Kingdom
Name and
injection
anaemia
353 ( 1 800
see section 4.5 )
a
delay recovery
based on conventional studies
with haematological malignancies
75 - 150 60
Centre
need to be treated
In
adverse
Actos is
in pregnant women
The patient s ability
Treatment with Abseamed
Eye disorders Common
is therefore
Tel : + 46
,
Protamine sulphate Water
efficacy of epoetin
they
Bipolar I Disorder
2.5
machines
Assessment of Cancer
,
section
with or
eská republika
the
The patient s ability
treatment
and haloperidol
similar dose reductions should
.
medically serious
( see
,
( please see section
been
food
TO APPEAR ON BLISTERS
patients
.
, ketoacidosis
273 0
Ireland BRISTOL-MYERS SQUIBB
subcutaneous injection ,
over a period
in patients
.
in men with
45
Therabel Lucien
is very wide
,
and
includes a nutrition programme
229
( 0800
terminal half-life (
method
24 hours
,
in
of patients with
.
IU/ kg 3 times
- if the
known complication of chronic
.
with
( see section 4.4
of
)
4.5
risk
12
blood
1.25 mmol/ l )
(
how
,
use
patient
)
% )
a
pneumonia
Abseamed in patients at
of 50 IU/ kg
7.5 mmol/ l )
alfa in adult patients
can
you
The
maximum dose should
in cancer patients
normal dynamic
than 1
see section
YOU USE
possibility
patients with
may be necessary
pioglitazone
be
and dehydro-aripiprazole are
manic
Allé DK-2880 Bagsværd Denmark
other ingredients
)
approximately 6 hours
Sverige
in
Aripiprazole is
responded to treatment
OR
receptors on muscle
)
units
per month
when
periodically
) , Te
The cartridge
+47
( 0)810 410 500
g/ dl
patients
is necessary
Road
, and 3A4
1000 international units (
, the incidence
g/ dl (
and headache in
BMD )
patients with renal
In the
if
anaemic
schizophrenia and
.
or
The
is
-
Fever and chills ,
the treatment
) , Wielka Brytania
Each tablet contains
100
with encephalopathy-like symptoms
, accidental or intentional
post-menopausal women and
The cartridge contains
In
or of
very rapid or
% )
300 mg Fe2+/ day
Store and transport refrigerated
.
by a decrease in
, the incidence
.
after
Tel :
glycaemic
.
Nederland BRISTOL-MYERS SQUIBB
but not
.
and
per month ) with
Thrombocytosis has been observed
75 - 150 60
in
without treatment
.
Magnesium stearate
.
cancer
contain 0.8 ml
is
, vomiting and
the
unplanned ,
section 6.1 )
of fatal
hospital and take
For
section
may
Scientific Discussion (
+44 (
- United
Wharf ,
6
55
these
.
at the lowest
affinity for muscarinic receptors
, M-III , and
hydroxylation of aripiprazole
were
by the intravenous route
or pharmacist
28
of the
(
10 000 IU
)
Union , for
( e. g.
duration
of these
+353 1 260
ABILIFY is
of excipients ,
the pack with
9.5
,
paclitaxel
was
and take
outer
medicinal product contains
.
mixed episode
and behaviour and emotional
7.5 mmol/ l )
was the same
(
.
(
, uncommon cases
doctor
Bone biopsy results showed
.
especially in the face
x ULN or ASL/
mmol/ l )
by
0)21 272
medically important differences
and
( 30 mg )
potent CYP3A4
.
Adult cancer
type 2 diabetes
0.7 ml
should
at the maximum recommended
1
water
trials of
.
outcome study of pioglitazone
been reported
Common :
4.2 Posology
.
production
scale
phosphatase
been reported while taking
cell production
evidence of
.
of this
ml contains 1000 international
The AUC and Cmax
% had >
between 10 g/ dl
BRISTOL-MYERS
12 g/ dl (
pituitary adenoma
It is
Ask your
with renal anaemia ,
the more
from
your veterinary surgeon
epoetin
haemodialysis and
56
revealed no
patients
, ventricular arrhythmias
g/ dl
-hydroxypaclitaxel
should be
you
case of accidental overdosing
1HU
and transport refrigerated
analogues for injection ,
France
)
agents (
] ( weeks
of Cmax and AUC
once weekly
is
reduction of
( t½
with
aripiprazole
the
prior to
should be
also prevents
4.5 Interactions
In the four placebo-controlled
Elevations
reduction of bone
contain 0.8 ml (
, pyrexia )
(
(
of
30 mg tablets ,
, reduced
HOLDER(S )
SQUIBB Tlf
Hypertension
2.5
Uxbridge
g/ dl (
and
with
see
of
, 56
mmol/ l )
erythropoiesis-stimulating agents
if the
)
specifically and
)
film-coated
(
suicidal ideation ,
the dosage of
50 IU/ kg 2
,
10 g/ dl
OF UNUSED MEDICINAL PRODUCTS
BRISTOL-MYERS SQUIBB BV Tel
an
thigh or
was not
the
28
.
, 84 ,
When weak inhibitors of
doctor or pharmacist .
not
of anhydrous human insulin
hospital and
in pregnant women
g/ dl (
Abseamed 8000 IU/ 0.8
% isophane insulin
2.5 % ( 96
Dosage adjustment
600 IU/ kg
its 1-adrenergic receptor
only
pre-filled syringe
.
no
risk
.
tablets 98
the risk of
be
If
reported
The observed excess
or
Bipolar I Disorder
no evidence of
Water for
see
e. g.
pharmacist how
site conditions
is
House Highbridge
56 ,
a
, and
mmol/ l )
CYP2D6 (
is a
phosphokinase and rhabdomyolysis
: + 32 2
,
results in
compared to
Latvij Tel : +371
30
rimonabant is
the number of patients
: blurred vision
and a multipack
Do not
and beta-sympathomimetics
most common
or
, lactation
In
,
The recommended weekly dose
Aclasta has
06 5026 01
may
elderly
trials
aripiprazole
to protect the environment
and 3A4
speech disorder
STRIPS
Tlf
insulin human
and the Montgomery-Asberg
of the hormone .
substance
and rhabdomyolysis
e. g. prior
than 1
( 2.5
74 18 84
Since insulin and pioglitazone
chemotherapy
4.5 )
and insulin
of potent CYP3A4
with
take
(
dose
rats
For
D Centre
of excipients ,
month ) with
( see
that month .
trials
were five short-term studies
-
patients were 39.5
50
On this basis
2 352 74 60
compromise or additional
sulphonamides
CYP2D6
Tel : + 43
)
a
in
e. g.
and transport refrigerated (
, or to other
fluids before and
1 pre-filled syringe of
by 107 % ,
,
infusion ,
possibly protein disulfide isomerase
uptake into
.
the
.
:
recommended dosing regimen is
section 4.4 ) .
OR
- 39 % )
19 %
Global Research and
30mg
by approximately 25
and
alfa ,
valproate
hour ,
in a pre-filled pen
of children
severe manic episodes in
These trials
Glycine Polysorbate 80 Water
, 14 and
Limited
from light
and
greater than 12
>
,
If blood pressure
aripiprazole
will ask you
( see section
.
( cycloolefinic polymer )
hyperosmolar coma or
the
before
know how ABILIFY
% and
.
on
Keep the
should be
.
reduction
alfa should be
The AUC
blister
see section 4.8
use in children
greater than
-
Committee
of aripiprazole
NAME OF THE MEDICINAL
TO APPEAR
Lactose
patients
lacrimation ,
with sulphonylureas
.
observed
diabetes
several
or
+ 46
OUT OF THE REACH
,
The
BRISTOL-MYERS SQUIBB PHARMACEUTICALS
urticaria
on
shown
MANUFACTURING
pharmacist
In
a
40
particularly
1
aripiprazole
and
patients
( see section
was considered non-genotoxic
ml .
27 % of the
adequate and well-controlled
aripiprazole
average duration of diabetes
In PROactive ,
decreased sensitivity to a
,
chemotherapy
ml of solution contains
suicide
the
prevent dehydration
to
starting dose
with lithium .
in
Actos and insulin
(
study
and 53.3 % for
UB8 1HU - United
3 times per week
aripiprazole was administered concomitantly
.
( iron deficiency
of bone tissue )
all active metabolites
schizophrenia
events
, round tablets contain
Aclasta
of
(
in patients
,
Seizure : in clinical
27 %
mg zoledronic acid monohydrate
aripiprazole dose
approximately 20
by hydroxylation
and
on the
contains 5000
, sedation ,
other antipsychotic drugs
6.1
are pregnant ,
significantly
glucose
solution
with a
the
)
pregnant women
,
Zometa
, constipation , stomatitis
in a
136 )
snack containing carbohydrates
Insulin suspensions should
In
% ; 19 %
the
myocardial infarction
(
and postprandial
75 and
see
in increments
section 4.4 )
recovered in the urine
or
ABILIFY is
mean weight increase with
(
pharmacist .
from hypoglycaemia
,
necessary amount
If
NMS are
all cancer patients
7.5 mmol/ l
if
in pregnant women
pH adjustment
.
Global R & D
and
is
or
tumours ,
- 200
4.2 Posology
.
allergic symptoms , may
see section 5.2
.
, peripheral oedema
which
Premixed insulin products
BRISTOL-MYERS SQUIBB (
Erythropoietins are growth factors
20
12
children under 30
ready for use
and
-
situations
with a
D-58638
24
units ( IU
administration
patients
followed by
infusion lasts for a
)
to
0)1 46 25 16
clinical
a
.
33 (
with renal impairment :
syringes contain 0.5
.
) is
of Actos and insulin
kg bodyweight
-
of
ABILIFY dose should be
Manufacturer Marketing authorisation
administration site conditions
Europharm Limited Wimblehurst
, headache , tiredness
and yellow ,
during pregnancy
which
a
and
oedema
use in
,
Insulins and
rhabdomyolysis ) ,
injection .
der die
or
,
.
: + 46
and
patient
in half-life was due
SPECIAL PRECAUTIONS
beta-sympathomimetics
If
and
agents
dose adjustment
and 3.2 % with
of reported cases
of a full
lead to hypoglycaemia
of dehydro-aripiprazole ,
hepatitis ,
and inter-individual variation
.
Ireland
you are
dysphagia
The rate
Tel : + 46
insulin and 70 %
to be treated
or very
+ 34 ( 91
of 15 mg
D-58638 Iserlohn
route
The therapeutic
Each
0.99 , 1,18 ;
Patients
is also
.
to 21 %
trials included patients
7.5
of
.
, Oxford
Over the first
Dizziness
hepatic impairment :
( See section
537 900
may increase the effect
.
and
10 and 12
in a
events
, insulin ( human
6
aripiprazole and 3.0 %
dry mouth
93
In
%
increased
from the
adult
( FACT-An
less pain from
than
QT prolongation , ventricular
33 IU/ kg
demonstrated
four week
aripiprazole should
slowly be
be more common
the incidence of
1
is
and
gene
4.4 ) .
When
undergoing dialysis :
adequate
maximum of
mmol/ l )
alfa is given concomitantly
the nearest hospital
60
valproate or
in
at
: +44 ( 0)20
contains
9.75 mg ( 1.3
pharmacokinetics of aripiprazole .
% isophane insulin
( see
population of
% with placebo .
adult patients
33 Fasting and postprandial
)
no fatalities .
be
achieved
serious cardiovascular events was
and
for all
.
is a
,
the
solution for injection
should be considered .
and anaemic rats
) , with
diabetes
in all
,
white and
(
Using
)
501 76
until it
Treatment
Glycine Polysorbate 80 Water
reduction in
administration of epoetin alfa
during the course
pioglitazone is rapidly
pulmonary embolism ) .
after
must be discontinued
ABILIFY
or
In
bottle - 100 ml
lithium
should
for disposal and
)
0.5
,
+353
solution
dehydro-aripiprazole ,
30
the impression
weeks
study (
require higher
by
.
98
ml of the product
kg over 2
and isophane insulin 70
n =
.
aripiprazole and
but its occurrence
patients who
dehydro-aripiprazole increased by 77
it is
becomes very significant
is also indicated
SQUIBB GESMBH Tel
(
most common
DISPOSAL
The
the
and
pack with
Tel : + 31
metformin , in
/
MEDICINAL PRODUCT AND ROUTE(S
vitro
or
fractures
Insulin human , rDNA
study population had
with residual
after the first
21
with
Overall survival
vniec ba Latvij Tel
take possible
efficacy
is
section 4.4 )
or during lactation
two
mmol/ l )
IU/ kg 2
hypotension
medically important differences
Oxford Road Uxbridge
effects
four carbohydrate chains
or if
section 4.4 )
of
bacterial
.
As with other antipsychotics
is
,
precautions
Therefore , no
it
Tel : + 31
flatness
other medicines
versus risedronate-treated
SPECIAL PRECAUTIONS FOR DISPOSAL
,
initial dose is 150
0.5 ml
in whom the
Zoledronic acid is
of insulin
thigh or
of
further reduction of bone
gynaecological
.
mg of
is
: +
studies
not
the
28 , 56 ,
is
Uxbridge - Middlesex UB8
If convenient
Do not use ABILIFY
a dose adjustment
maximum of 30
especially
of
55 53
the following
such veterinary medicinal
(
7.5 mmol/
in
Very rare -
, Oxford Road
-
whilst the relative
mellitus ,
%
of 5.25
cleavage
than
expected to
aneurysms
condition may
to sudden
by the
and rats
1
West Sussex
KG ,
Aripiprazol
20 ACTRAPHANE
30 mg
of CYP3A4 ( ketoconazole
ABILIFY
therefore
slightly between
37 (
Eye disorders
a
30
HF Sími : +
exposure
The physician must therefore
may be
0)20
, dysphagia
treatment with aripiprazole alone
.
ausgeschieden
3 ml equivalent to
.
hydrochloride )
30 kg and adults
,
with
.
,
and
There are no
.
( approximately 1/ 20th
(
2007
essential
but
0.62
of epoetin
defined
placebo
route
-
is very
shortened overall survival
(
be managed cautiously .
VOLUME OR BY UNIT
effect
n oder ohne (
the
the
93 05 06
of excipients , see
section
and
e. g.
of
.
Mellitus : hyperglycaemia ,
dementia ( loss of
4.4
and
: +
8.1
Pioglitazone is also
It
(
increased risk for
of
Summary of
clinical trial in healthy
of 5 mg
a recent
both
recommended
)
with insulin
of anaemia associated
DERIVED FROM SUCH MEDICINAL
dose
not been studied .
% of
3A4 (
34 857 42
clinical
a risk
The
treatment with
AND SIGHT OF CHILDREN
,
followed by a
substrate of P-glycoprotein
) .
IU of
ABILIFY
human )
dosing
-
which is primarily hepatic
patients
900
Anaemia symptoms and sequelae
If
5.1 )
a
.
Tel : +
, dehydro-aripiprazole ,
support long-term safety
the desired range .
Bipolar I Disorder
incidence
,
disorders Common
, vomiting ,
solution for injection
31 ( 0
type
mg
:
you
not been carried out
.
machines
formation
anaemia
and 2.47 in favour
insulin
some of your ABILIFY
including parkinsonism ,
should be
: + 353
effect of medicines used
CYP3A4 or
ABILIFY orodispersible tablets
myoglobinuria (
(
fever
even several
, serotonin 5HT1a
for injections Hydrochloric acid
Erythropoietin
peak is always well
see section
especially
Hb between
4.4 ) .
In
This medicinal product
.
IT IS USED FOR
or
,
5.1 ) .
bottle
Special precautions
.
and
, but not
by
20 mg
patients
mortality : in
(
obesity
ACE ) inhibitors ,
OUT OF
ON BLISTERS OR
) .
haemoglobin target range
In
14
.
products
below 30°C )
should
) of
3 times
no appreciable affinity
while taking aripiprazole
you
6.2 % with aripiprazole
glycine
hypocalcaemia
) should
was rapidly
-
%
the
dose
It is not known
see
in
in
and 3.2 %
and
18 , or
at study
isophane insulin 80 %
4.9 ) .
of
following
that the
can
haemoglobin values exceeding
% ) of
, especially infections
has multiple well
If
may
Aclasta
.
, 50 , 56
A
,
effect
) .
for
women
in adult and paediatric
of anaemia
3x/ week
is
approximately
:
total dose of ABILIFY
they
1HU - United Kingdom
danazol .
patients with bipolar
deep venous thrombosis
of
- hypersensitivity
.
The educational programme contains
1.35 , 2.06 ,
pre-menopausal range .
+
of the compound or
( e. g.
other forms of interaction
should be
or
enzyme
of sex
machines .
daily dose of 15
some of the other
of
formation of erythrocytes
4.8 )
but its occurrence
should be
significant
When a
23 lung
years .
see section
than 1
.
There is an increased
difference to
NAME OF THE MEDICINAL
in the HORIZON-PFT
of in accordance with
maximum dose should
orodispersible tablets
and water
Europe
time
difficulty
a
patients in
starch Microcrystalline cellulose
The syringes contain
In cancer patients
1 pre-filled syringe of
( 0)810 410 500
g/ dl ( 6.2
for advice before
)
or if
g/ dl (
clinical
and
Do not use ABILIFY
,
) , 2C9 (
the insulin requirement .
7.5 mmol/ l
aripiprazole and 3.0 %
on
see sections 4.3 and
) .
of digoxin
gynaecological
x 1
) .
with caution
impairment
within
in vitro permeability and
solution for injection in
18
.
you
PRODUCTS OR WASTE
RFT
Aclasta
- blood clotting (
reported
multiphasic
fatal
)
Nervous disorders :
possible ,
Each ml of
orodispersible
NPH ) insulin
was
of 1 ml 6
in a pre-filled syringe
aripiprazole
g/ dl
placebo
metformin
recommended that the
may
epoetin alfa
Store and transport refrigerated
this medicinal product should
, the
)
not result in accumulation
g/ dl
24
alfa
d
during
pre-filled syringe
evidence of clinically significant
(
)
to
g/ dl (
you
( see
kg and adults
duration , there were
or
ON BLISTERS OR
NMS
and
The syringes contain
with renal
dose of
.
42 trials and
who
indicated when
50
( Madrid
F-37071 Tours
by significant intra-
with this condition may
mg
the dose should
precautions for
and
IU/ kg
6
Ask your pharmacist
MEDICINAL PRODUCT
.
Pioglitazone and all active
44 (
Farma - Produtos Farmacêuticos
in
significant
+46 8
14 x 1 ,
alkaline phosphatase (
(
with
,
The efficacy
49 ,
In elderly
( haematocrit
insufficient glycaemic control despite
units
) .
and symptoms
efficacy or other symptoms
significantly
IU (
ml
, sodium citrate
times per week
when a
%
added to
after
pectoris , increased risk
other medicinal products .
trials , rare
-
not result in accumulation
patients
are therefore affected
SPECIAL PRECAUTIONS FOR
FOLDING BOX ( WITH
Tel
use in children below
in a refrigerator
) .
( please see section
( e.
LTD
receptors
, nausea ,
15 mg once a
lowest
Hunton House Highbridge Business
dose
In
g/ dl (
increased risk for thromboembolic
with
This medicinal
ability
patients
effects
1.25
body weight 2 times
no
with
.
: in clinical
Bristol-Myers Squibb Srl
( see
of dissolved insulin
2 times
, thiazides
patients with normal
be presented .
pioglitazone should not
,
see
SQUIBB
,
the medicinal product
47
should be investigated .
tablet
ABILIFY is used
of consciousness
.
The following reactions
contains
or
ALT
aripiprazole in
refrigerator
aripiprazole should
week
a
2
ml
, including
AST )
) .
tumours ( 683 breast
more units
protein intake
in a
Maternal toxicity
treatment schedule
be used .
aripiprazole
, especially
risk
: +
has
between 17
ABILIFY can
LTD Tel
heart failure ,
6.2 - 7.5
extent of
lung
,
( 7.5
sse Der Anteil der
, see section 6.6
should
female rats
, aripiprazole
oral bioavailability of
a
IU/ kg epoetin
with
alfa ,
aripiprazole and dehydro-aripiprazole ,
over
epoetin
randomised , controlled ,
a
)
to
FINLAND
please tell your
.
patients with
immediately
worsening
and
10 g/ dl (
THE OUTER
The recommended
SQUIBB BV Tel
feeling anxious
TO APPEAR
( 7.5 mmol/ l
ABILIFY
When
YOU
71 %
.
this is superfluous
50 IU/ kg
the dose
Die
haloperidol and
doctor or pharmacist .
efficacy
Patients
,
(
one side .
, increased risk of
%
patients
total dose and rate
( 1
between 10 and 12
Sími
significant risk factors
renal impairment :
IU
see section 4.3 )
15mg
maximum of 30
than
Global
20 mg
a reduction
human ) .
be disposed
with renal anaemia
14
as measured
iron stores
,
IU .
that
Consequently ,
)
)
.
45 93 05
United Kingdom
patients with
46.7 [
Actraphane is a
This
t½ ) is
QT prolongation
coma ,
biliary excretion
of epoetin
4.4 ) .
.
sucrose .
increased production of saliva
days following
patients
.
.
Centre ( Europe
Cmax
) .
dehydro-aripiprazole the geometric means
5.1 ) .
with
or tense
dihydrogen
should be
with subsequent
rimonabant treatment in
The terminal
,
5HT2a receptors
adjusted to
see section 6.1
treated
THE
, diarrhoea
1
and Cmax of dehydro-aripiprazole
) and
section 4.8 )
Smoking status
potassium in
APPEAR ON THE
medically serious signs and
effective , and
treatment outcomes
are lactose monohydrate
in men ( study
one single-use
significant
If
) or
IS
androgen dependent
or
decreased
: +
CHO/ HGPRT ) gene
prior to
pregnant
(
unknown .
,
,
kg over 2
for
should be considered on
160 Danmark BRISTOL-MYERS SQUIBB
75 ± 33
g/ dl (
or
see section 5.1 )
rash
Abseamed
The
sometimes severe irritability .
if
0.62
below 12 g/ dl
treatment
0)1628 537 900
Mitratapide and
with
PARTICULARS TO
Hypoglycaemia may occur
, the
Treatment with Abseamed
these
occurs ,
Danmark BRISTOL-MYERS SQUIBB Tlf
obesity in adult
: +353 1
An increased 3H-thymidine incorporation
Tél : +
be presented .
and anaphylactic reaction
by being a
Interaction with receptors
If
, for dehydro-aripiprazole the
, take
( for pH-adjustment
: +
intravenous route has to
aripiprazole in pregnant
should
at the
, which showed
allergic reaction
The pharmacokinetic characteristics
1 cartridge contains
vitro (
12 - 14
effect
especially infections
included only
is
with
solution contains
: +
alfa
Alle Patienten unter Abseamed
2 352
Risiko ist mit
(
suspension has a
or
shortened overall survival and
a pre-filled syringe
%
and other
International
of myocardial infarction
( see section
dose regimens .
)
whom
decided
greater
with or
When weak
weight gain
In patients with
combination therapy
.
.
doctor or pharmacist
( 5 mg/ ml
mg of anhydrous
IS USED FOR
.
rare cases
treatment ,
12 g/ dl (
your
or
mg
of glucose
urine
l ) .
haloperidol-treated
* Produced in CHO
section 6.1
patients with
tablets 50 tablets 56
Insulin human
environment .
Uncommon
Limited p
you experience
reactions
as measured
0.4 ml
is necessary
multiple medicinal
, 30 or 45
,
hours
mg
events is
10
associated
% ,
.
is achieved ( this
dose
OUT OF THE
of
is designed to be
of
( 0.62 mmol/ l
, syncope
or pharmacist
achieved
( see section 5.1
see
kg
2 g/ dl
dose
rectal
glass ball to
for at least 2
reported in children .
to 12
the aripiprazole dose should
favour
Takeda Tél
jaundice , hepatitis
Insulins and analogues for
mixed episode
approximately 60 %
.
of
is
in
47 67 55 53
The
observed
and
the present state
,
Abilify
therapy
in
, long-acting
enzymes
with a
is necessary
with aripiprazole
pregnancy
oral aripiprazole
Ireland
aripiprazole ( 30
patients
% and haloperidol
maximale Tagesdosis
and
standard
vehicles , until they
observed
weeks
and
34 857
TO APPEAR ON BLISTERS
% of
,
, increased Gamma
between 10 and 12
must be discontinued
a dose of
complications
treatment with
the local representative
with
, feeling anxious ,
300 IU .
and 8167
symptoms
,
European
pioglitazone in all
2 g/ dl (
taken
( see
% with
ABILIFY contains The
e. g. anaphylactic reaction
models of dopaminergic
06
-
or lay
In clinical
.
by the intravenous route
: +33
Eli
is between
clinical trials that
weeks ( days 21
weight
- Peripheral neuropathy
emergency procedures
reactions
This medicinal
trials that
should
alfa
Haemoglobin variability
Business
It
hydrolysis ) sites
& Co
impairment
Uncommon - Diabetic retinopathy
.
3 ml .
ABSEAMED
8000 IU/ 0.8 ml
blood cell production .
may
other
machines
,
of 0.7 ml
mixed
Absorption The absorption
with a bromobutyl/ polyisoprene
elective orthopaedic surgery
Tél : + 33
and
000
( AST
.
in
cumulative
The
in the
of anhydrous
mixture of dissolved
not be used
hypoglycaemia
human dose or exposure
to maintain haemoglobin
events )
reported estimated doses
dose of
aripiprazole should
is
fractures ,
they received risedronate
: treatment
with
the safety
a
Tel : +
14
)
France
100 ml .
from 2653 to
the pharmacokinetics of aripiprazole
arrhythmias ,
In clinical
ABILIFY
2
see section 6.1 .
you have
BRISTOL-MYERS SQUIBB GESMBH
or
of anaemia with epoetin
treatment with epoetin alfa
more
not
syringes
10 ml and a
pregnancy and
with aripiprazole
50
of excipients , see
to take
insulin
your doctor immediately
the
advised accordingly
% CI :
4.3
Pioglitazone
epoetin alfa
MEDICINAL PRODUCT AND ROUTE(S
mmol/
pre-filled syringes of 0.8
is achieved
inhibitors of CYP3A4
the pharmacokinetics
recommended that
dose
mmol/ l ) per
hours
LTD Tlf
What ABILIFY contains The
of the necessary amount
glucocorticoids
human dose or exposure
considered not known
monotherapy or
or
or body weight .
androgen suppression
möglicherweise
minutes
: + 353 (
the
Norge
Treatment with Abseamed
In a
10 or
.
in
clinically significant
Bipolar I Disorder
: + 46
adverse
4.5
epoetin alfa
be
, increased risk of
aripiprazole ( see
a
12
Eli Lilly
Cmax
of which were
.
) .
,
)
especially infections
risedronate-treated
It is
Intensified control in
the doses that
with pioglitazone
(
,
that
BRISTOL-MYERS
alcohol or
The four
As for
75
placebo
for haloperidol (
a
especially
some cases
observed
Erythropoietin receptors may
Dose adjustment in order
aripiprazole
consequence
, long-acting insulin
obesity ) and
severe
PRODUCTS , IF
Glutamyl Transferase
risk factors such as
)
risk
children
an increased risk
,
)
IU
AND EFFECTIVE USE OF
diabetes ,
.
if
harm and suicide
)
valproate or lithium
Characterisitics
ABILIFY
the anterior abdominal wall
products and
not
, diabetic
of 15
All other
serious
bradycardia
3000 international
32
kg .
.
may
[
Cytotoxic actions of
clinical studies
mg
treatment with
subcutaneous use of
hypothermia , pyrexia
- Treatment of
mellitus ( see section
revealed no medically
between
with
with
2
In
.
15 mg of
.
23 Adjustment
.
.
,
the
The
can cause side effects
) .
.
Intravenous injection : over
twice daily is
the risk
mmol/ l )
insufficient data
pulmonary embolism ) .
Glycine Polysorbate 80 Water
35 trials and
APPROPRIATE
, long-acting insulin
with encephalopathy-like symptoms (
(
Non-clinical
risk
including
syringes contain 0.5
higher than the
not
.
the
+ 31 34 857
20 %
.
Oral contraeptives , thiazides
1 g/ dl (
hydroxylated metabolites
Abseamed
The therapeutic margin
the
special warnings and
local requirements .
epoetin
)
) .
incidence
pharmacokinetics
fatigue Psychiatric
in Saccharomyces cerevisiae
should be avoided .
pain Uveitis , episcleritis
the majority of
In the indication increasing
of glucose
is
Glutamyl Transferase (
KG Kuhloweg 37
)
The
or
and 5HT2a receptors and
been
: in clinical
.
COMBINATION THERAPY
Severe hypoglycaemia
please see
interaction
REGARD TO
1
of the
not take ABILIFY
D-58638 Iserlohn
.
read
injection under the skin
risk
oedema
)
Common :
.
is dietary
in a
Similar
with insulin
of stroke or
This is given 3
.
)
aripiprazole
.
Abraxane
About
LTD Tlf : +
per kilogram bodyweight
14
clinical trials that
in
After administration of epoetin
749
treatment
with or without psychotic
: treatment
Effects on
is necessary ,
the
)
All special warnings
( human ) .
, inadequately treated
and
Horsham
per week by
40 :
Insulins
clinical
Stattdessen ist Paclitaxel in
patients
1 , 98
Conventional
and pink
cases
following
-
section 4.4
the medicinal product
Common : extrapyramidal
for males )
higher
150 30 -
Subcutaneous injection into
354 535 7000
direct- acting
,
GESMBH
not
(
reported
also
84
14 x
the
observed
no medically
corrected
treatment
with associated
see
46 8
adequate
In
1 ,
Hunton House
) ,
there were
in isolated patients
long-acting
initial dose is
reactions have also occurred
In pregnant or
active substance
findings
or
0)810 410 500
the sustained haemoglobin exceeds
: + 43
the treatment of
in a blister .
CYP2D6 and CYP3A4
731 1736
tablets
with a baseline of
The potential relevance of
including those
EACH
Abseamed has no
5.9 -
95 % CI
) .
of death and
other
)
may
pioglitazone , whilst the
settling are
The cartridge
34 857
:
14
is a
In
.
before
oral bioavailability of the
angiotensin converting enzyme (
There have been
of controls .
from
PHARMACEUTICALS
Sucrose Purified
with chronic renal failure
products and
studies
Common
1
mg )
effects
, madarosis
should
was 9.5
increase
greater than 14
4.4
clinically significant
other medicines
ALT )
- Middlesex
from a
in
Mellitus : hyperglycaemia ,
) may
Centre (
lower the blood pressure
As with
a
, IF
, corresponding to 0.0533
and aspiration have been
please tell
1 diabetes
injection
Cmax and AUC
CNS medicinal products
and
Based
tooth .
IV
none
other clinical effects
100 , less than
Highbridge Business
should
nursing
know
to
ml
,
maximum daily dose
levels remain the
.
4
.
about 40
24
If
your doctor immediately
Based on results
be assured :
psychosis
LTD
of the
,
( and
at 36 months
with gemfibrozil (
of
approximately 27
the
of overdose
or ibuprofen shortly following
animal models of
in Saccharomyces
occurring undesirable effect
, chest pain
.
] (
clinical
and
clinical studies
lay
dosage of medicinal
AUTHORISATION HOLDER
fatigue Psychiatric disorders Common
) )
Saccharomyces cerevisiae ) .
The usual
also indicated for
.
muscarinic receptors
be
)
what it is
inter-individual variation .
clinical trials aripiprazole has
+ 31 34
for muscarinic receptors .
of the hormone
with
Appropriate therapy such
: in
Conjunctivitis
opening the bottle ,
may be
as measured
24 hours may
risk for
Severe hypoglycaemia
paediatric patients
Assessment of
open-label studies
and vascular
out of
OR
patients were receiving insulin
is
in
adults
and
of the
A few
Tablet core
Hypersensitivity to
is
,
be
blood levels of cyclosporin
.
the
)
of agitation
if
Highbridge Business Park
of
in patients
tablets :
,
Co KG
+ 43
.
anaemia
the vial
contains 7000 international
50
followed by
scheduled for major
bone marrow
ml 6
In
) .
snack containing carbohydrates .
and inter-individual variation .
insulin
hypoglycaemia
nausea ,
by 32
+ 33
ketoacidosis ,
and
allen außer einer
and young subjects
Tel :
by the intravenous route
and
weeks prior to
30
in
Hydrochloric acid (
Global R & D
section
tumours (
Novo
over
cell production .
malabsorption ) .
Actraphane is
with
Jahr 5
.
,
Park , Oxford Road
- in patients (
solid tumours
As with
.
When a
in humans
(
considered
pectoris ,
somnolence ,
solution .
( 8.1 mmol/ l
use machines have
contain 0.8 ml (
.
) .
treated
CYP2D6 inhibitor
37
by three biotransformation pathways
CONDITIONS
Gustave Eiffel , BP
is given concomitantly
recommended in these patients
Interaction with receptors other
(
4.7
aripiprazole
or other CNS
sometimes severe irritability .
, uncommon cases of
characteristics of
see section 5.3
to be expected .
mg
2 weeks
.
is
+
.
vision
76 03
of 50
fibrates )
(
Aclasta strengthens the
this condition may also
7.5 mmol/ l
24 and 36
Use should be restricted
- if the
IU/ kg 3
a
The following reactions
MUST BE STORED
Actos 45mg
are
g/ dl
cell line by
x 1 tablets 49
Middlesex UB8 1HU
should
abdominal wall .
,
)
(
been receiving
of
47
50
are not sufficient
a pre-filled syringe
( 6
by the intravenous
your doctor or pharmacist
Actraphane 30 consists of
with
10 to 30
The most common
patients with
antagonism of serotonin
section
thrombosis ( DVTs )
a
should
aripiprazole during
, recovered label was
.
30 60
" A " over
,
analogues for injection ,
particularly overweight patients )
After
.
especially
veterinary surgeon how
difficult
It
in
and
symptoms
of
) per month
arrhythmias
thoughts of
or less duration ,
)
%
In
a prospective ,
in vitro
The potential for inhibition
should be considered .
and
blister
side effects with
Hypoglycaemia
Interaction with receptors
(
.
of symptomatic anaemia
12 g/ dl
( see section 4.5
(
the insulin requirement
chest pain
/ N. V.
given weekly for three
to
ABILIFY
for
,
g/ dl (
fall
12 g/ dl (
7000 IU/
the
.
should
controlled studies
OUT OF THE REACH
in patients
respectively
, United Kingdom
paclitaxel
rats
60 14 30
international units
contains
extrapyramidal
e. g.
1
per week
, thyroid hormones and
.
wide .
is a
( CLAS )
see section
CLAS ) .
( for pH-adjustment )
the
and 3.2 %
your doctor immediately
3 weeks
.
of the other
in all
For
of the
between 10 and
tell
clinical
.
of
is effective in
60
epoetin alfa
be used .
adolescents has
treatment with epoetin alfa
atrial fibrillation
, the dose should
In controlled clinical
or
side effects (
) .
with
g/ dl ( 7.5
and
( DVTs )
changes in
In a
growth hormone
be followed
controls
no difference in
the dosage of ABILIFY
and
with
5.1 ) .
or
was
zu Empfehlungen bezüglich der
per ml
alfa is given concomitantly
Oral contraeptives
Each ml of solution
from human tumour samples
observed
less
of
is a
.
or
Nervous disorders :
er
insulin , metformin )
potent
children
in
% isophane insulin .
ABILIFY contains
patients
therapeutic margin of epoetin
doctor or
maintain haemoglobin
2 times per week
initial treatment response .
severe
case of
been performed
( see section
infusion ,
the administration of
4.7
Intravenous injection : over
and haloperidol
)
The maximum daily dose
Takeda Global
and
in every 100 patients
43 1
tense .
Cancer Therapy- Anaemia (
What benefit has
somnolence ,
-
be treated with Aclasta
15.7 % for
% and haloperidol
section 5.1 )
of this population ,
This
&
or the
-
section
and
The
Novartis Europharm Limited Wimblehurst
, 14 and 7
The
7.5
Global R &
4.4 )
declined in
should
in schizophrenic
and take
a
, for
Norge Takeda Global R
this condition may
your doctor or
and isophane (
Sími :
enzyme (
per month or
of local infection including
Tél/ Tel
antidiabetic medicine )
approximately 60 % in
patients
in 32 % of
8°C
ULN
of the elimination
.
seizure
Store
Eli Lilly Holdings
blood pressure
and
for major elective
and Cmax
(
the
needle should be
as assessed by the
The dose is
to affect
or pharmacist
should be
the entire
,
tumours ,
Fe2+/ day
from human tumour samples
of the art
, tiredness
with
for
hypocalcaemia
Finland Ab
( 0.62 mmol/ l
nausea , vomiting
randomised , double-blind
2ºC - 8ºC
pregnancy and lactation .
Animal studies could
Abseamed 4000 IU/ 0.4
pulmonary embolism ) .
)
treatment
NPH ) insulin .
occur
: anaemia
of Abseamed
pharmacokinetics of aripiprazole .
majority of reported cases
than
)
not take
receiving non-platinum chemotherapy
1 tablets 28
sollten ähnliche Dosiserhöhungen
VOLUME OR BY UNIT
the
and
patients
to detect possible arrhythmias
rare - Refraction disorders
mg of
haematological malignancies
is
alfa
the freezer section or
50 IU/ kg
1/
50
+ 46
less than three
the limited number of
water
In clinical trials
,
Enthält Lactosemonohydrat
times per week by
less than three
aripiprazole
hour ,
package leaflet or
The safety and
see section 5.1 )
clinical trials with aripiprazole
per se
to patients with moderate
200 -
ABILIFY solution for injection
to
of medicines
15.0 , 19.3 ]
soluble insulin 30
ABILIFY
treatment .
risk
should be
x 1 tablets in
Many of these patients
This
between healthy elderly and
occur in
in the
or
section
or other symptoms of
4.5 ) .
of 1
or previous
compared with those
D2 and D3 ,
, the doses that
.
.
suspension
full list of
an
either
, Neuroleptic
in
Hypertensive crisis with
.
Arzneimittel Pütter GmbH
and danazol .
2
( 6.2 mmol/ l
may
patients
and
as hydrochloride )
reactions
Cancer
109 PARTICULARS TO
Intravenously
liver
by 32
g/ dl
cerevisiae
( for pH-adjustment )
injection
mellitus
and 33 IU/ kg
)
and should
body weight
( or if
When the CYP3A4 inducer
the
excluded
was 12.1 %
formally investigated
When
of
See section 4.4
10 g/ dl (
PHARMACEUTICALS LTD Tel
of
Close supervision
preventing
women ,
on the pharmacokinetics of
in
or
) and 802
,
recombinant human
The biological
placebo ,
other erythropoiesis-stimulating agents
placebo
doctor or pharmacist .
QT prolongation
than placebo , or
Alcohol may
in
can only be
or
pyrexia ( fever )
. lp
or of
in order
units
, increased Alanine Aminotransferase
Alcohol should
4.5 Interaction
minor metabolites
g/ dl (
.
section 5.1 )
information on the
receptors .
)
(
.
107 Patients
9000 IU/ 0.9 ml
injections Hydrochloric acid
below 12
break down their internal
of the
with
( see
alfa alters
aripiprazole concentrations
( see section
should
HOLDERS
12 g/ dl (
2C19 (
)
potentially medically serious
section 6.1
see section
, in
( 7.5
16.8 micrograms epoetin
Following
epoetin alfa on
g/ dl (
.
( 2°C -
aripiprazole and dehydro-aripiprazole ,
.
study )
Eye disorders Very
some medicines
untreated
per
and
glass cartridge
)
)
given more ABILIFY
)
stabbing
see
is usually maximal
during treatment
1
0)20
placebo
21
45 93 05
The following
may
patients
is
you
pH adjustment )
(
,
, which showed a
using machines
,
patient
6.7
412 6600
no
( See section 4.4
lithium concentrations .
angioedema and
been carried out
, itching ,
scheduled for major elective
mixed episode
,
Adult surgery
3 times per week
a
stopper .
diabetes
)
has
should
GmbH Tel . +
In
studies
- 150 30
If patients
contains 3000 international
a potent inhibitor of
in Saccharomyces cerevisiae )
100
,
Yarvitan 5 mg/ ml
zoledronic acid
should be
than those
be applied .
.
. It can be
)
When the CYP3A4
study )
shown reproduction toxicity (
Laboratory tests did
with
is
events
all medicines
50 IU/ kg
chemotherapy
when
Takeda Global R
PACK SIZES OF
)
- 150 30
risk
among men and
(
alfa in
alfa
10
Following oral administration
nursing mother presents no
section
is always well below
If
00
nurse
+ 49 (
(
the
ADMINISTRATION
see section
25 16
patients with
a few weeks
olanzapine-treated patients .
see section
of the
gliclazide
of Epoetin alfa and
vomiting , diarrhoea ,
:
from
FACT-An ) general scale
)
times
is fever .
,
Sodium hydroxide (
:
of HIV )
route
5.1
)
forms of
with
reported
influence on the
The
following the administration
)
ausgeschieden
maximum
the
)
and
you
.
ingredients
waist circumference ,
epoetin alfa
The
contains
to the foetus
28108 Alcobendas
hydroxide
.
RH12 5AB United
include continuous electrocardiographic monitoring
The AUC
controls .
IU )
28
in
.
4 hours
12
oedema , difficulties in
pre-filled syringe of
,
300
ACE ) inhibitors
( i. e.
, inflammation of
ml ( 3000
of 100
:
for
outer
monkeys
to be compatible
to the baby
used
factor
Occlusion of
on the
g/ dl (
.
15 mg once a
alfa
and
or
.
subcutaneous administration
4.6
of the art
in
blurred vision .
manic
Denmark
was 12.1
based on mg/ m2
Finland Oy Eli Lilly
see section 5.1 )
, vomiting and diarrhoea
63 patients with metastatic
an autologous blood
) to
with
and safety .
Development Centre
a
yellow ,
.
dihydrogen
1
and inflammation
and
patients may be at
SQUIBB
ABILIFY
and Cancer
of
occurs ,
: + 354 535
hours
18
average duration of
insulin (
The dose is
margin
)
for combination
whose arteriovenous fistulae
as
the pharmacokinetics
of excipients ,
,
10
precautions for
6.1
)
once daily
IT
doctor immediately if
should be
is
another
34
retinopathy
limited
.
Aclasta works for
,
if the
potent inhibitors of
are for use
mixture of dissolved
should be considered
diluted
of the event onset
no
.
a
It is an
your
sections 4.8
safety of
, treatment of
Glycine
No studies
g/ dl ( 7.5
( 44-20 )
the pharmacokinetic
be
THE WORDS
and sulphonamides .
with
of the
Taking
5.1 ) :
Very
generally not
bottle
to
in cancer patients .
half-life
, restlessness
commits
been receiving
the geometric means of
( see
epoetin
sealed
symptoms of
and
the
1.25
50
dextromethorphan ) .
the
renal insufficiency .
not
-
with renal
of
on the ability
an interaction .
Erythropoietins are
Treatment of symptomatic
" A-011
%
alfa
and protein binding
overweight
of akathisia was
a
60 - 150
1 ml ( 2000
( 8.1 mmol/ l
is metabolised
Centre ( Europe )
considered
and
In patients with diabetes
clinical
.
section
reaction ,
per
5
.
% ( 96
+33
WHAT
, patients receiving pioglitazone
less
KG , Kuhloweg
thromboembolic events in
:
11
% with placebo .
ABILIFY .
pregnancy
dose
use in
dihydrogen
0)21 272
aripiprazole and dehydro-aripiprazole are
once a
of
non-cancer cells such as
.
pyrexia
SQUIBB
Non-clinical data reveal no
( E951 )
)
.
of these events
and
1
subjects
a
your doctor
BRISTOL-MYERS SQUIBB Tlf :
Hb
antagonism , aripiprazole has
of anaemic
of the
IU/ kg 3 times
ml
oedema ,
ABILIFY is not
doctor
your doctor or
,
in
vision Gastrointestinal disorders
and the
how
vascular events
your doctor or
When
in strength ,
with solid
agitation/ behavioural
)
,
in
to protect
only 3
schizophrenia and
or
Uncommon
for 2 weeks
thyroid hormones
Use during pregnancy
+ 40 ( 0)21
3 patients with
an inhibitor of osteoclast-mediated
of aripiprazole .
a combination
of
when oral therapy
& D
patient group .
normal or
to protect
(
the studies ?
. emea
with epoetin alfa
scheduled for major
the
for
of
patient population
within
2C19 (
Your doctor
had a previous
will help
with
After injection of the
minimal
other medicines Please
: +
( see
( 7.5 mmol/ l
malfunction of
randomised , double-blind
D
(
this medicinal product should
meal on the
.
hypertension .
.
glycine
be used .
GESMBH Tel :
Cmax
the
daily insulin requirement
on bone marrow cells
,
forms of
174 gynaecological
4.2 Posology
dose
until
: +46 8
; Ctrough
month or
NMS is a
to light yellow liquid
0800 ) 731 1736
.
been treated
The absolute
ABILIFY is 15
in
a measure of the
.
if you
and protracted absorption respectively
.
severe irritability .
.
in
+386 ( 0)1
patients
not
.
is
type
infection
trials and
,
after
fed dogs
Road Uxbridge
in
the
alfa in
is there any detectable
hours
REACH AND SIGHT OF
subcutaneous
.
patients with severe renal
of
humans
is
)
epoetin alfa is a
the
pharmacokinetics
the percentage
% with
range of standard
significant
ensure
used for 2.
siehe Abschnitt
.
Insulin human
or
can
Meta-analysis of overall
in plasma .
of
to years of treatment
agents (
of ABILIFY
Royaume-Uni Tél/ Tel
and
200 mg
the
surgery
times per week )
to
1.5-2.5 hours after
in this
aripiprazole
a
)
Lactose : patients with
alfa is a
erythropoiesis-stimulating agents
of controls .
into 2 equal injections
or
with ABILIFY
,
not
34
antihypertensive treatment
of potent CYP3A4
is
( 7.5 mmol/
in
of excipients ,
is
12 g/ dl
to be
not to
month )
8 704 71
human erythropoietin
in
) .
of 1
treatment with aripiprazole
: blurred vision
, Oxford Road Uxbridge
section 4.4 ) .
Tel :
IU ) of solution
AUC
only be obtained with
Hunton House Highbridge Business
the
microcrystalline
12 g/ dl (
,
Takeda Global R &
not
100 IU of insulin
,
of Actos and insulin
,
0)20 3116
2000 IU/ 1 ml
4.8 ) .
diabetes
05 06
If
than
7000 IU/ 0.7 ml
Product
should
in patients
) with
baseline on
apparent molecular weight of
In another
comparable to that
Benommenheit
units of
1
,
significant
5 % ansteigt .
and
taken in combination
this
( 1 800
4.8 -
Ab
baseline body weight after
United
the missed dose
( 6.2 -
4.5 ) .
the haemoglobin
ml
cytochrome P450 .
pregnant or
IU ( International
accepted .
is a single intravenous
pancreas
of Abseamed between
and
trial , the incidence
patients who
trials
kidney
% of
Overdose
Uncommon
should
metabolite M-III
of ABILIFY
Common :
should be carefully weighed
No studies
similar
If you
:
, antibodies
of ABILIFY
.
mg has not
.
)
and 802 with
, diabetic hyperosmolar
KG ,
cloudy after resuspension
to you by
Treatment of anaemia associated
the
and
clinical
orthostatic
Ask your pharmacist
.
)
will take this
alfa is
of the hormone .
,
,
in adult patients
of the hormone .
severe symptoms is less
:
ml contains
trials with pioglitazone
ml
the
Functional Assessment of Cancer
effective
12
100
, Gastrointestinal dyspepsia
(
is
,
epoetin alfa
humans
354 535 7000
of
for aripiprazole-treated
responsible for dehydrogenation
injection
( produced by
of
38 When either
measures will help
15 mg
with epoetin
2°C - 8°C
.
recommended weekly dose
cartridge
potent
( 0800 ) 731
24
.
diabetic hyperosmolar
blood pressure
alkaline phosphatase
The
+ 358
is no accumulation :
, increased
the
is achieved
or
SQUIBB
weeks
) or
thrombosis
Middlesex UB8 1HU -
:
200 - 300 mg
sustained haemoglobin level
Linear Analogue Scale
( haematocrit of
contains 45 mg pioglitazone
In addition ,
aripiprazole
(
with
existing treatment with
g/ dl (
.
packs of 14
for pH-adjustment )
.
has
.
and
contains 40 IU of
b-cyclodextrin ,
of overdose should
started as soon as
,
dated Final (
6.1
of Abraxane is
were
the risk
between healthy non-smoking subjects
.
.
aripiprazole (
.
27
or
-
patient .
In
your doctor or
on
pre-filled syringe ( injection
with normal
in 384 patients
mmol/ l )
recommended
mg/ ml ) and
in
and
scientific advice
for pH-adjustment )
D-90429 Nuremberg
the dosage of
is 15 mg
and +0.1 on placebo
a
4.8 and 4.9
, tachycardia ,
.
the treatment in this
PARTICULARS TO
Although
or exposure
or mixed episode
treated with aripiprazole
to protect from moisture
both decrease and increase
vitro
of 1
.
KG , Kuhloweg 37
05 06
PRODUCTS , IF APPROPRIATE
.
25 and 50
manic
pioglitazone
in subjects
PRODUCTS
is
epoetin
43
patients
.
the medicinal product
not to be
IU/ kg given subcutaneously
have the following causes
or other CNS
:
The
increased risk of
000
may
sse Der Anteil
,
any
to
as compared
3 times per week
weeks (
95 % CI
4.5
Abseamed
der
rats after
United
)
section 4.4
Actos
range of
What
subcutaneous route and
or
) per
combination
IU/ kg epoetin
of the patients
clearance is
and was rapidly reversible
epoetin alfa has been
2°C - 8°C )
terminal half-life is determined
use of Abseamed
products to affect
such as
section 4.4 )
.
observed in clinical trials
therapy
combination therapy (
IU )
of children
indications .
±
solution
g/ dl ( 8.1
epoetin alfa has been
,
between healthy
be administered intravenously
or
) .
CHMP )
If convenient it may
sodium per dose
2 times
In clinical trials
Actraphane 40 :
Special warnings
the levels remain the
rise in haemoglobin of
indicated
blood pressure
mg/ m2 )
by the intravenous
16 00
with
SPECIAL WARNING
for Aclasta and risedronate
aripiprazole
crisis with
geometric means of Cmax
Europe
tell your
patients was 12.1 %
non-lethal
drug exposure ( AUC
3 times per week
normal quality
years )
Pharma GmbH Tel :
12
the following
risk of death and
medicinal products :
pharmacokinetics of aripiprazole
(
hours .
combination with
the blood pressure is
: patients
, constipation
If
insulin in
must not be
paclitaxel , which
60
( 2°C
Between
with
, peripheral oedema
Pharmacotherapeutic
93 05
Based on in
your doctor immediately
of
.
was
calcium and
All
12 g/ dl (
mg/ day
House Highbridge Business Park
Takeda Global
with medicines
storage conditions
you
hypersensitivity reactions ,
1
adjustment
other
dose adjustment
also affects
,
all patients receiving
ba
+ 46 8
dose
dyspepsia , vomiting ,
- Middlesex UB8
mg daily
Do not
contain
, µ
There is
in vitro
the intravenous route .
13
pharmacist .
749
the insulin requirement .
shortly
tablets with
West
and
Neuroleptic Malignant Syndrome (
ml solution for injection
and beta-sympathomimetics
when erythropoiesis stimulating agents
trial
DISPOSAL
was
after
administered by intravenous infusion
-
, ROUTE(S )
haloperidol
condition with
a
6.1 )
local requirements
variation
increased
and 15.7 % for
, such as
microcrystalline
studies
section
and
( see also section
the gluteal region or
(
14 and 7
aripiprazole
as hydrochloride )
concomitant
In patients with
.
on the tongue
in
,
other
potent
,
especially in the face
other
%
Omission of a meal
use of
98 x 1
- Oedema Oedema may
wide
administration of
of progression of diabetic
clinical trials
hepatic impairment on the
4.2 Method
age group
7.5 mmol/ l )
diabetes
recombinant human
maintain haemoglobin concentration
Therefore ,
Insulin human
41.7 11.9 47.3
and 11
the
to ensure
three
chronic renal failure in
increased risk of
12
Uncommon
syringes contain 1 ml
and
bone marrow cells
your doctor or pharmacist
the
think
vascular
aripiprazole has
( mean age
patients with
a
normal or
insulin
programme , the
clear , colourless ,
patients
2 ml
33 -
Aseptic techniques
( 0)810 410
in pregnancy
Uncommon - Diabetic
If
( see
of paclitaxel ,
with
mg
Paclitaxel
may increase
time
and dehydro-aripiprazole
10 mg of
) of
is not
It is
should
2C9 ( warfarin
cases
and " 10
and
you
g/ dl
for
- increased risk
.
and adult patients on
,
In
mg
greater
g/ dl ( 1.25
alfa .
in reduction of
OF THE MEDICINAL PRODUCT
although development of
dosage
the incidence
( iron deficiency
dissolved insulin and 80
.
risk of pregnancy .
of the
2 352
haemolysis , blood loss
therapeutic response
or
and 10 cartridges
and
a cartridge .
- This
Irland.Lilly S.A.
mmol/ l
route
be added to
and
with encephalopathy-like
mean age
1.25 mmol/ l
Tardive Dyskinesia :
less common
508 men were randomised
AUC
4.4 )
Erythropoietin
.
of
Thrombocytosis has been
olanzapine-treated patients .
.
same
Global R
,
Danmark
Your
Highbridge Business Park
.
.
other
10
injections
) .
, peripheral motor
the
nurse
not
of glucose
effects
PRODUCTS OR
and
of adult
in
sealed
condition may
patient
or
tell your doctor
cannot be excluded
patients
and possible
control
to
: +49 911 273
trials , uncommon cases
of
- Refraction disorders
4.4 )
The
see
of
( 2°C - 8°C
Less than 1
evidence of clinically
oedema ) .
g/ dl
this medicinal product should
Oxford Road
23 lung ,
not
.
" A-009 " and
subcutaneous use
,
1.35 , 2.06 ,
but with
Kingdom BRISTOL-MYERS SQUIBB PHARMACEUTICALS
to
elective orthopaedic surgery
, feeling anxious
93 05
] (
.
orthopaedic surgery
was administered concomitantly with
.
23 lung ,
pre-filled syringe
2°C - 8°C )
300 IU/ kg 3
insulin .
.
.
2°C -
Adult cancer
chloride Glycerol Metacresol Phenol
stomach discomfort ,
ACOMPLIA
the
monkeys after repeated
:
of
long-acting
but its occurrence
10 g/ dl
APPROPRIATE
following the administration
in
has
,
those receiving placebo
risk
thiazides , glucocorticoids ,
& Co KG Kuhloweg
should be rotated
metabolites 6
to
50 IU/ kg 2
and
therefore
, IF ANY
complications
, the
)
in
with
not
,
patients
of
impact on overall survival
contains 5000
:
the dose
of these
Tél : + 33
2007
Within each
with pioglitazone .
)
defined
to placebo
.
)
dose is
patients
Glutamyl Transferase ( GGT
ml
indication increasing
A/ S Novo Allé
years )
medicine
open-label studies
anaemia
Be sure to
06
.
of the
MUST
Patients with
followed during preparation
or tense
treatment
salivary hypersecretion Vascular
Vascular
use
Annex I )
ABILIFY is effective
3A4 (
products and
see section 6.1
,
49 ( 0
if they
,
,
iron stores .
of a full range
and 50
and 3.0
clearance
Die Schmelztabletten
, suicidal ideation ,
for
be
)
no
in the thighs
150 60 - 150
study
essentially sodium- free
skin
use of oral aripiprazole
on
cells/ µl
in addition to
chemotherapy induced anaemia
women
Carton of 49
greater than 14
Novo Allé DK-2880 Bagsværd
Abseamed
unused product
deep vein
In three
,
duration , there were
see
peripheral
HF
and precautions for
.
stroke in
12 g/ dl
is usually reversible
.
95 % CI :
Italy
patients
in a
( including all formulations
IU/ kg/ day .
humans and
,
THAT THE
1 pre-filled syringe
, salivation , anorexia
for injection ( 7.5
, RH12
the incidence of EPS
.
%
in
angina pectoris ,
angiotensin converting enzyme (
in children and
in pregnancy
.
because
less
, fibrates ) .
insulin and 70
pulse or
any remaining contents .
and
see section
,
Effects on
with or
Renal or
Actos 30mg
treatment-related
00
alfa
for the
indicated for
mg/ m
cancer
dosing should
50
tablet formulation is 87
similar
hours after the
rash and
target haemoglobin concentration
of ketoconazole
, especially
]
l
Aripiprazole
( 1 ml )
patients
,
.
of
RESTRICTIONS WITH
section
,
transitory and
diarrhoea
This medicinal product
based on mg/ m2
) and
6.8 mmol/ l
shown significant benefits
round tablets contain 15
drive and
PFT ]
impairment .
pre-filled syringes
,
is
vivo
a
epoetin alfa alters
.
of the
Tel :
with
than children
epoetin alfa
If you
- if the solution
Common : blurred vision
or
with
, especially
surgery patients
1 ml ( 10
alfa
.
or
information on
In subpopulation
silicon
digoxin ,
swelling of
44 ( 0)1628 537
aripiprazole
Uxbridge
[ 95 % CI
the immune-system
be avoided .
injection
diet
allergic reaction
( two studies
Wielka Brytania Tel :
( 2°C -
with haematological malignancies
cartridge
3
effective as metformin and
a
only
have been proposed ;
a pre-filled syringe
of your
stroke
discontinued
g/ dl
( see section 4.8
hyperglycaemia and diabetes
kg .
) .
in
32 2 352
12 months
mg once a
clinical
be exceeded .
in the thighs or
is extensively metabolised
0.4
( N = 229
of
+
and paediatric haemodialysis patients
you
36
REGARD TO THE
none
:
( 1.25 mmol/ l
(
aripiprazole should be
.
should be advised accordingly
or
4.8 and 4.9 )
aripiprazole
not metabolised
,
quickly with racing ideas
greater than 12
bipolar mania
acid blocker ,
constipation , salivary hypersecretion
population
MAOI ) ,
is
clinical
is necessary
patients with
The pharmacokinetic
, 23 lung ,
0.035
than
or
week by
the risk
type of white
the metabolism of
4.4
an
Takeda Global
be
,
clearance
+44 ( 0)20
tablets are white
2 weeks
% )
irregular heart beat .
haemoglobin target range
+371 7364000
greater than
an
or
, tremor , dizziness
% isophane insulin .
or
.
patients
dehydro-aripiprazole
not use
Patient information pack
target haemoglobin concentration
within a
as
of generalised hypersensitivity
in vitro (
.
43
has
growth factor
no evidence of clinically
.
.
immediately
with
.
6 weeks when used
are
( rhabdomyolysis ) ,
a
)
SQUIBB
is therefore
( 2°C -
,
( 0)20
Gamma Glutamyl Transferase
,
more common
, including ABILIFY
all
for injection in a
your
THAT THE
.
and
mg
appears to act via
isophane
maintain haemoglobin concentration
your doctor immediately
patients with
in adult patients
7.5 mmol/ l )
in clinical
be marketed
epistaxis , pharyngolaryngeal pain
more
: blurred vision
23 hours
the percentage
Educational leaflet
Your
metabolites , 3
serious
for injections
in patients
these
g/ dl (
tablet with water
Phlebotomy may be
1.25 mmol/ l )
This medicinal product
rare
5HT2a receptors
.
SQUIBB AB
is effective
recovered label
in adult patients
with a cartridge
)
a
In patients with
of androgen suppression
in
-
IU/ kg 3 times
.
of P-glycoprotein .
5.1 ) .
of
- 12
substance (
- 8°C )
.
( see sections 4.8
in one of
the
of aripiprazole
on overall survival
from moisture .
( cycloolefinic polymer
, nausea
the desired range .
nausea ,
on one side .
after
,
, headache ,
g/ dl
Do not use
.
Global R &
patients
including PANSS and the
treatment
Functional
Intravenously
should be considered on
26-week ,
of
)
34 %
and
sometimes
patients
Starting dose
-
aripiprazole
,
10 cartridges
you
32 2 352 74
-
in clinical trials
in haemoglobin
5.3 )
.
and sight of children
alfa
akathisia was 6.2 %
is an inhibitor of
when
,
The recommended
.
dentistry
13 g/ dl
SPECIAL PRECAUTIONS FOR
8953
Weight gain :
When the CYP3A4 inducer
(
(
of a
than 1
is
with
method of
3 times per week
Carton of
measures
with
strenuous physical exercise may
352 74 60
enzymes
with
nausea , vomiting ,
Norge BRISTOL-MYERS SQUIBB NORWAY
conjunction
.
and extent of absorption
number of symptoms
n = 131
33 -
and hyperglycaemia
renal
, especially
BRISTOL-MYERS
.
of the
Fe2+/ day for paediatric
.
035 - 480 ml
hives
( see section
of epoetin
somnolence , sedation ,
SMALL IMMEDIATE
full list is available
before injection so
(
alfa
.
) .
, sodium chloride
.
or
incidence of
33 22 11
initiation of therapy with
2 In combination with
with ABILIFY
Centre (
a risk
with
, vomiting , nausea
data available
by approximately
other
, inadequately treated
:
aripiprazole
during continued treatment
, arterial
in subjects
epoetin alfa
feelings
( below 30°C )
the levels of
( see section
and protein intake
children over
or
(
The
5.3 ) .
30 mg .
is
and
food .
) 30
and
,
for males )
:
mg
insomnia ,
3 times per week
of
The rate
(
decreased blood sugar
Sími
e. g. hypothermia
Malta Takeda
%
.
chronic
A
In elderly patients with
werden
, London ,
d.
and differentiating hormone
Each tablet
you are breast-feeding
IT
trials ,
Close supervision
,
and
Name
with
and death in utero
Very rare -
between 10 and 12
, the
NovoLet delivers
.
other
observed .
.
, or were
Taking
1 pre-filled syringe of
mellitus ( see section
the
300 mg Fe2+/ day
)
sudden unexplained death
can be
long-acting insulin
D Centre ( Europe
in the
mg zoledronic acid
Most reactions are
or coma ,
Highbridge Business
with pioglitazone
In
ml
:
to the insulin requirement
bone marrow fibrosis of
angina pectoris
g/ dl
sweating
Treatment
)
4.4
E216 ) ,
are round
manic episodes
95 % CI :
, Lda Tel
% ) .
that
ABILIFY ,
neuropathy ,
cellulose Aspartame ( E951
ng/ ml
see section 4.8 )
in
of malformations
4.2
The study population had
, Neuroleptic Malignant Syndrome
eliminated
Hb
may
30 kg require higher
86 68
( 1.25 mmol/ l
House Highbridge Business
studies
When your
2.
anorexia ,
reported with
7.5 mmol/ l )
osteoporosis ,
not
Keep out of
akathisia was
on
section 4.4
section 4.4
ml equivalent to 300
use
( 0)1 580
with
hypertension .
in
D Centre ( Europe
+ 32 2 352
or the
The
similar
or 13
7.5 mmol/ l )
Aclasta
rapid or
.
weeks after
Pioglitazone
children under 30
R & D
with aripiprazole
, abnormal
Non-clinical
haemolysis
patients
Actraphane is
see section
, with or
significant
manic episodes in
( including
effects of
a
a kidney patient
in a
Like
in patients
4.7
nausea , vomiting
, headache ,
and adult patients
female rats
and
should be
g/ dl
and
2°C - 8°C
half-life
dosage
*Survival
you
effects
such as
hypoglycaemia whilst driving
specific frequency can
for use with
When
VOLUME OR
and rats ,
17 and
R
signs of
doctor or
22 out of 3,852
should not
contributes about 58 %
metabolites
300 mg
international units ( IU
12
Insulin suspensions should
your doctor
, round tablets contain
If convenient
vomiting diarrhoea
you
have been proposed ;
, D-58638 Iserlohn
10 ml
x 3
) , increased Gamma
favour of controls .
.
injection site
Treatment
an
speech disorder
150
warnings and
with
2 5 %
be increased .
evident ischaemic heart
during continued
not
recommended starting dose
included only 3
.
Business Park ,
+ 44
6.1
especially infections and
trials in which
to years of
) 30 60
7
is
(
42
patients
.
myalgia
or placebo
section
use
medication
in
M-II , M-III ,
Good blood management
is especially
trials ,
than
of epoetin
contains The
contact
Ireland Takeda UK
ABILIFY is indicated for
of diabetes was 9.5
less
epoetin alfa
, Germany
production .
House Highbridge Business Park
under the skin
trials
THE REACH
section
long-acting
mortality was 10
manic
a
patients with a manic
of
the
g/ dl (
once or
colourless , aqueous solution
and
anaemia
the
.
Patients should be
signs
If you need
patients who
danazol
therapeutic
hypothermia ,
patients dosing should
see section 4.4 )
, sudden unexplained
g/ dl (
is
treatment
In
( an
What ABILIFY is and
Hunton
House Highbridge
10 mg tablets are
.
Finland OY
some
the intravenous route .
women ,
treated
,
+ 31
of Abilify experience
Dosage adjustment Concomitant illness
patients
of transfusion requirements in
with pioglitazone
human ,
2000 IU/ 1 ml
, the
15
Die
for
and
in
Acesulfame potassium Vanilla
medicinal products :
for smokers .
SQUIBB AB
THAT THE
a
98
using machines
g/ dl ( 0.62
extreme and associated with
( CLAS ) .
dehydro-aripiprazole ,
0)1 580
four placebo-controlled
elimination per se
93 05 06
111
5.330
Epoetin alfa
.
moderate affinity for
, Oxford
cellulose
84 tablets
of administration
hypoglycaemic agents ( OHA
of
weight gain is
products to affect ABILIFY
mainly via
psychotic
about 40 %
2 g/ dl
antidiabetic medicines (
elective
forms of
section
ABILIFY 30 mg tablets
olanzapine-treated patients .
Common
is individual and determined
considered
:
hydroxide , and
the patient
:
not be added to
patients )
However , elevated creatine
werden möglicherweise nicht
the reach
including ABILIFY
.
maximum recommended human
.
1
+ 40 ( 0)21
should be
+
with
of the bone
improvement
Nordisk A/ S Novo
should
taking
7.5
,
.
ml
use of Abseamed
ketoacidosis , diabetic hyperosmolar
adequate and
16
the effect of
from light
N-dealkylation is
50
OF UNUSED MEDICINAL PRODUCTS
no experience in
aripiprazole
jaundice , hepatitis ,
and
the
Other
other medicines Please
[
In PROactive ,
, the difference in
ml
to ensure
g/ dl
( IU
products to affect
) and
mg
treated group
is
treatment
changes in routine
Erythropoietin is a
:
, 84 , 90
to
adults
monitoring of
with
Ltd , 61
dose
13
chronic renal failure ,
dose
% of the administered
It could be
both
injections are given in
AQ ) ,
When activity ,
or waste material should
in adult patients
.
than
aspartame ( E951
Male patients should seek
,
is
kg and adults
infusion
,
evidence of clinically significant
50 %
,
to
aripiprazole
clinical effects
( baseline
, abnormal
with aripiprazole
between 10 and
.
.
see section 5.1 )
: in clinical
.
recommended
to treat
should
- United
carton .
rarely reported in
5.1
of children
and "
251
tumours (
injection of the
akathisia was 6.2
in vitro
will help
FINLAND ) AB
(
adverse events
affects you .
1
doctor
of the nursing
symptoms
.
Carton of 14
425 mg sodium per
before
In elderly
KG
in
insulin requirement
while taking aripiprazole
or
N-dealkylation .
When aripiprazole
with
1.25 mmol/ l
or hyperosmolar coma or
international units ( IU
Arzneimittel Pütter GmbH
international units (
very wide .
of the
in
contributes about 58
antipsychotic drugs
)
or even death .
from light .
of children .
The maximum dose should
A-011 and
5 mg
1HU
your doctor
suicidal ideation ,
Patients
mellitus
Detailed instruction accompanying the
18 %
, Wielka
for dogs
pH adjustment
is
bacterial
weakness
The
(
Cmax
negative
with
The white ,
and
It
greater than 2
were
be
be used
- increased risk
.
IU/ kg ,
Hb increase
insulin requirement may be
g/ dl ( 0.62
:
( 2.5 % ;
The
female rats
akathisia in bipolar
that
mg Aclasta
tremor
to 75.6
increased
monitoring
pulmonary
If you
the intravenous route .
Most reactions are
or
: +49 911 273
, the dose should
4.4
endogenous human erythropoietin that
a meal
What
with type 2
6 months ago
4.9 )
for signs
between
18 , or 13
The decision whether
5 mg zoledronic acid
the thighs or the
by
Highbridge Business Park ,
epoetin
ABILIFY
KEEP OUT OF
of in accordance with
no difference in
This medicine has been
10
is
findings from
was
given subcutaneously 3
and in
.
patients with
) ,
is
blood clotting (
about 5-10 hours
5-hydroxytryptamine
patients
if
did not receive
after
population ,
in
In
potent inhibitors
,
)
,
including
insulin
ABILIFY
Sodium
Tlf
50
of
trials , an increased
of
satisfactorily
,
dose ,
risk of pregnancy
and safety of
events
.
mg )
n oder ohne (
House Highbridge Business Park
see section 4.5 )
a growth factor
,
(
be discontinued
.
of
the
OR WASTE MATERIALS
pregnancy
most of
The
.
In the
Upon discontinuation of
solution for injection in
Takeda Tél : +33
the patient
favour of controls
first 10 days after
reflected differences
a
4.2 Treatment
,
SMALL IMMEDIATE PACKAGING
with
The physician must therefore
of epoetin
the indication increasing
for humans
( International
,
some cases
and 1.1
1 tablets 56 x
see section 4.4
most clinical
( see
not
If
increased
vision .
pioglitazone
in
epoetin
EXP Use
on one side
events in
P450
stomach discomfort , diarrhoea
pre-filled syringe
and
D
events in
insulin in
treatment with
( MAOI
,
Less than 1
marked with
In
(
: + 40 (
,
of
a pre-filled syringe The
no
(
.
Use should be
Fast improvement in blood
episodes or
loss
following undesirable effects occurred
patients
the desired range .
mg/ m2
Tel : +353
NMS
mmol/ l )
following
the
unchanged
.
encephalopathy-like symptoms can occur
aripiprazole
rash
Patients
see section 5.1 )
)
Tel :
For
65 to 200 kg
on ABILIFY
,
if you are breast-feeding
Hunton House Highbridge Business
BRISTOL-MYERS
studies
ml solution for injection
.
anaemia
increased alkaline
metacresol , which
.
Aripiprazole exhibited
week by the intravenous
pharmacist how
: + 44
was
in humans and may
or
CYP2D6
See section 4.4
contraeptives ,
dose of Abseamed accordingly
valproate or
UB8 1HU
see section
orodispersible tablet
type 1
may vary with age
lithium concentrations
the dosage of
30 % and
, especially
.
or
(
NMS
other causes of anaemia
, especially
section 4.5 )
14 g/ dl
erythrocytes from precursors
hyperglycaemia and diabetes
of approximately 6 hours
moderate and go
MINIMUM PARTICULARS
In
antidiabetic medicine (
358 9 251
you
the
with placebo
)
.
UB8
The AUC
225 ) , or
concomitant
mean
atstovyb Tel . +370
a
Tel :
g/ dl ( 8.1
with ABILIFY
)
on overall survival
the
50 %
the intravenous
If
hours after
you
and
clinical
and sometimes severe irritability
4.8
glass of water
,
beta-sympathomimetics ,
dose should
to patients with moderate
) with
valproate or
Therefore ,
56 69
insufficiency not yet
with
( 0)20 3116 8000
the effect of
possibly protein disulfide isomerase
0.4 ml contains 4000
cerebrovascular adverse
and Cancer Linear
.
was
for 2.
or
of
Aripiprazole
.
In
important
the active substance or
first trimester
, weight decreased ,
in
and
aripiprazole
(
IU/ kg
should
AUC
stopper .
patients ,
Laboratory tests
n = 135 )
in two equal injections
Eye disorders Very
cancer
UK Ltd
"
elective orthopaedic surgery
product
with
,
defined as
:
sections
28 %
recent low-trauma
two weeks
controlled by systemic chemotherapy
section 5.1 )
6.6
, 14 and
31 PIOGLITAZONE IN
ability
Ab Puh/ Tel
(
If
, 2C9 ( warfarin
men ,
parenteral benzodiazepine therapy
associated
Yarvitan 5 mg/ ml
suspension
In
as measured
mmol/ l )
is achieved
Abseamed 6000 IU/ 0.6
Women
In
treatment with epoetin alfa
and 10
and
sedation
.
10
,
MATERIALS
(
After
and
(
disorder
adrenergic and histamine
( e. g.
or
dose
.
contraeptives
of Epoetin alfa
and method
5.2 ) .
or
interrupted and
levels
, hyponatraemia Common
30 mg once daily
( 95
be necessary
should be monitored closely
.
) .
to reproduction .
second trial utilised
the
patients scheduled
per month or
not be used
of
UB8 1HU - United
the
section
clinical trials
if possible
mit
- if
should be
.
The usual starting dose
dysmotility and
ideally
- 14 g/ dl
pharmacokinetic
without food .
Europe ) Ltd
for
of stroke
THE
the treatment in this
and water
mania
not
Sverige BRISTOL-MYERS SQUIBB AB
.
iron stores .
32 2 352 74
intentional acute
including
.
a
x 1 tablets 49
you
production
, intermediate-acting
in Saccharomyces cerevisiae )
the incidence
in more than 30
not there
headache ,
( 2°C - 8°C
3 ml ) .
dizziness , somnolence
moisture .
The recommended
recommended that the
of the mouth or
speech disorder , Neuroleptic
symptoms of heart failure
Aripiprazole
week by the intravenous
section 4.8
anaemia ( e. g.
you
times per week
per ml
Each tablet contains 45
) .
they
anticipated toxicities
after
and
:
section 4.4 )
deep vein thrombosis
investigated
172 breast , 64
a cardiovascular
should be avoided
Centre ( Europe )
for
last updated in 10-2007
some cases
.
laboratory parameters
oral
mean
Centre ( Europe
, vitamin B12 or
,
l
.
INSULIN Metabolism
Sodium hydroxide (
( 7.5 mmol/ l
aripiprazole tablets ,
or
wastewater or household waste
weight decreased ,
(
Hunton
treatment in this
)
(
has been
severe dehydration )
pioglitazone
oral solution is
g/ dl
patients with
45mg tablets
the
reduced
Europe )
- 7.5
is 15
AUC
patients
see section 4.5
mg orodispersible tablets
a
both fast-acting
tachycardia ,
of 33 -
a combination of
see
in dose should
) to
a
year
sterile
with renal
for use
Insulin suspensions should not
ml contains
should be
high
see section 4.4
cases
If
may
protein intake .
20
Uncommon : dysgeusia
the
unknown ,
CYP2D6
e. g. hypothermia
a
24 hours .
have an
.
in subsets ranging from
patients
PHARMACEUTICALS LTD Tel :
seems
It may
direct effect of rimonabant
signs and symptoms of
Overall ,
patients
the intravenous route .
and
IU/ kg
.
7.5 mmol/ l
is
subcutaneous use of
as
1HU - United Kingdom
THAT THE MEDICINAL PRODUCT
of multiple medicinal
to
a combination of
source insulin
route
inadequately controlled by diet
, that patients
.
and sulphonamides
the insulin requirement (
should not be
after the
30mg tablets
observed
OR WASTE MATERIALS
- Produtos Farmacêuticos ,
are no
time
after
Method
; none
not
42 trials and
CYP3A4 ,
haemoglobin target range
Patienten
g/ dl
mmol/ l )
N-dealkylation
and
be administered intravenously .
on
In elderly patients with
could be
aripiprazole
AUC
6.1
or 24 hours after
-
DK-2880
Insulin
Additional signs may include
.
.
Experience in
to 12 g/ dl
all instructions given to
the intravenous route
.
18 , or 13
presents
increased tactile hyperesthesia were
arrhythmias ,
(
inhibitors
(
,
Global R
is
(
a cartridge (
1 )
1.5-2.5
.
0 2 year )
cleavage (
& Co
TO APPEAR
in dose should
) .
:
on
rare
" 15 " on
cells/ µl
of anaemia
)
: extrapyramidal
into less pain
.
with chronic renal failure
of cancer cells
clinical
other antipsychotics
other erythropoietic therapy
is a
in order
, randomised , double-blind
Actos is
sealed
Bipolar I Disorder
and adults .
acts
placebo
including parkinsonism ,
No
active substance is aripiprazole
cerebrovascular adverse
and/ or
Actraphane
NPH )
cannot be excluded
aripiprazole ,
pioglitazone was
As with
of consciousness and extrapyramidal
treatment
section 4.4
the effect
Kingdom
( see section
dose regimens
% dissolved insulin and
with your doctor
, aneurysms , etc.
)
24 hours
to protect the environment
bradycardia
:
: + 39 06
with
solution
rimonabant
(
4.4
, Abseamed may be
14 g/ dl
a
dosage
but
,
(
.
four weeks .
akathisia in bipolar patients
old
high fever
in
, or were
7.5 mmol/
or 24 hours
forms of interaction
ON BLISTERS OR STRIPS
( see section
pharmacokinetics
alfa
dizziness
) , 2C9 (
and
also
wide
section 5.1 ) .
, increased
in
redness ,
to
application
.
this
( omeprazole )
0.62
metformin and /
CYP3A4
and
and water for injections
with haloperidol
from light
MEDICINAL PRODUCT
meal
: + 44 (
Actraphane Penfill is
,
placebo-controlled
erythropoiesis-stimulating agents (
The
international
Special precautions
current
the intravenous route
alfa
less than 1
and a
on the pharmacokinetics
no
renal anaemia
.
)
Ireland BRISTOL-MYERS
a stroke or
.
.
(
Mannitol , sodium citrate
% with
isolated patients with
and
section
AB Tel :
Ísland VISTOR HF Sími
aripiprazole during
(
human
LTD Tel
(
,
(
after
and M-IV ) .
( 0)810
-
-
.
a
Arzneimittel Pütter
symptomatic
section 6.1 ) .
extended follow-up
the use
(
approximately
treatment with aripiprazole
Thrombocytosis has been observed
is necessary
the dose
than
.
Actraphane contains
000
, the
anaphylactic reaction
+ 43-(0)800 29
seen in
thiazides
with baseline
versus
Actraphane 10
g/ dl ( 7.5
ABILIFY is not
except in paediatric patients
patients with
with less
6.6
labelling and package
.
pharmacist
.
and
of in vitro solubility
3 weeks
in
dose adjustment
The effect
l
ready for use .
and
in
local requirements .
%
Hypertension
and
, ventricular arrhythmias ,
is individual and determined
.
in children and
. : +44 (
1 60 14 30
toxicity In
There are no adequate
.
enzymes .
androgen independent
dogs
If blood pressure
for haloperidol
Abseamed 6000 IU/
infusion fluids
or
pigment ( haemoglobin )
with
20 In
of
and anaemic rats ,
.
Paclitaxel is a
45
( 2°C
or
storage conditions .
( please see
to pioglitazone
ABILIFY
12 - 14
of transfusion requirements
should
, vomiting , an
disorders
- 7.5
moderate
Severe hypoglycaemia
% and AUC
or pharmacist
supplements
insulin .
ON
treatment of
disorder , akathisia
therapeutic
0800 ) 731
dogs and rats ,
cases of
.
signs and
United
When
A
.
humans
use
than 1
section 4.5 )
the
antihypertensive treatment .
+33 (
in a cartridge .
treated patients .
protein binding
reactions
Protamine sulphate Water
1
, 64 gynaecological
increased
or Hb increase
in
initial dose is 150
also
12 weeks the
was well
Hunton House
effect on
metformin
treated with aripiprazole
doctor
monthly
, nervousness
dose
the pipette
if you
known
- 8°C ) .
1 )
pharmacist how
sections 4.3 and 4.4
( anhydrous )
was
administration
are round
There is no accumulation
Ask
)
events
( ALT
.
drug and
medicinal products with
see section
and
treatment with epoetin
hypersensitivity reactions ,
4.4 ) .
BRISTOL-MYERS SQUIBB PHARMACEUTICALS
28 x 1
in part , by
.
be observed .
clinical effects
treatment in this
)
section 5.1 )
times
Fontana Del Ceraso I-03012
6 % )
Aclasta
.
In clinical trials with
2 g/ dl
the heart
(
46
.
12 - 14
of patients
which
also looked at
-
however
If
diabetes
on the tongue
: + 32 2
The following side effects
of
recommended
the human insulin molecule
in whom
dose adjustment
men
535
358 9
44 (
agents (
749 749
vehicles , until
( 2.5
, growth hormone
19
Kontrazeptivums
unplanned ,
take possible interactions
,
and
manic episodes in
of the necessary amount
over 30
and
12 g/ dl
3116 8950
or unplanned
reactions
)
or pharmacist
.
- 100
on ability
the following
]
of cytochrome
clinical fractures
the haemoglobin target range
or breathlessness .
aripiprazole .
within
Alle Patienten unter Abseamed
should
medicinal products with
or
see section 6.1 )
anxious or tense
your
should be investigated .
Middlesex UB8
mixed episode of
be administered intravenously .
trials , the incidence
of the
aripiprazole
did not
Oxford
be reduced .
6-7.5 and
adult patients
55
, Nevirapin und Johanniskraut
models of dopaminergic
ESAs ) have shown
at 180
human ) .
of children .
CLAS ) .
)
)
your doctor
greater than
7.5 mmol/ l )
or
muscle
no
sealed
g/ dl (
( for pH-adjustment )
FINLAND ) AB
tablets 28 tablets 30
inter-individual
syringes contain
and sometimes severe irritability
fast-acting , insulin
.
Maintenance dose between
Insulin treatment
a mixture of dissolved
sulphonamides
renal impairment :
Functional
3 times
is
significant changes
1 tablets in
Gustave Eiffel ,
with hypocalcaemia ( see
Effects on
infection or
Highbridge Business Park ,
-
ise Sanofi Winthrop
haemoglobin
: +
require higher
.
)
thiazides , glucocorticoids ,
should
IU/ kg
time each day .
% of
Kingdom BRISTOL-MYERS SQUIBB
See
on the
The maximum dose should
carton .
diabetes mellitus
with treatment with
mg
12
tablets are
values
aneurysms
,
other
without
,
type 1
systems ( durable
%
,
been reported
Treatment of anaemia and
44 ( 0800
than
CYP2D6 and
condition is controlled
If
the reach
may
In
or hepatic impairment
,
route
section
Takeda Global R
experience
used in humans
pyrexia ) ,
( 6.2 mmol/ l
and
existing treatment with metformin
or pharmacist
outer
Development Centre (
98
pregnancy
352 74
)
28 x
) .
In combination with
to 75.6
30 mg/ day
24
between
otherwise decided by
.
medically important
0.5
: +
lithium or
see section
4000 IU ) of
events
30
( haematocrit of 33
REGARDING SUPPLY OR
, there was
CYP2D6
of progression of
hemmt.
of glass ( type
no medically important
adjustment
IU )
products
myocardial ischaemia , myocardial
12 g/ dl
data reveal no
There is an increased
anaemia
inhibitors of CYP3A4
prior to
combined with
Other potent
in humans and may
the pack with
IT
30
are lactose monohydrate ,
than 2
vitro
,
not other
or
) to pioglitazone or
Abseamed 6000 IU/ 0.6
a
section 6.1 ) .
In two
Fe2+/ day for paediatric
28 x 1
)
units
the reach and sight
.
and
,
placebo
vision
patients
means that aripiprazole
all timepoints (
micrograms epoetin
No other erythropoietic therapy
with
.
see section
Actos 30
on
in type 1
( AST )
multiple medicinal
AND
% )
( see
AUC
The
or
g/ dl
dose
The physician must therefore
.
N-dealkylation
%
Actos 15 mg tablets
after dosing
doses
decreased
akathisia was 6.2 %
and
Survival and
reducing
hours
aripiprazole
is
the
symptoms
hours after the
( below 30°C )
patients
, tremor ,
: significant
Tardive Dyskinesia
but
In clinical trials of
.
section 4.4 ) .
reactions are transitory
zoledronic acid
of the
fructose intolerance ,
) of EPS
Peripheral sensory neuropathy
AUC and Cmax of
In
.
- 7.5 mmol/ l
for
use machines have
, with or
in
in order to
1 orodispersible tablets 28
is similar
The
you
in
,
the major
very wide .
, nausea
alfa
more ABILIFY tablets
mmol/ l
IT
However ,
with associated risk
Safety
be avoided
( 1 ml
sizes may
49 x 1
femoral neck
well-controlled studies in
(
in
Therefore
Treatment
manic symptoms over
, sucrose ,
medicines known to
DERIVED FROM SUCH MEDICINAL
Business Park ,
%
bile
This medicinal product
be
coma or
UB8
primarily
as
from the
should
programme .
important
major
shown significant benefits
inter-individual variation
( 4
2
ise Nervous disorders
inter-individual
of the value )
in men
disorders Common
usual
) ,
)
urticaria
a
sections 4.8
, but a
blood pressure
300
(
section 4.4 )
signs and
71 % of
pituitary adenoma .
units ( IU )
being treated
1 bottle
several
,
- 7.5
AND
0.5
Novo
.
,
Puh/ Tel : +
may occur
impairment
is limited .
.
and 30
is
the
may be observed
lithium
routine volume replacement should
the
Park
Takeda
contains 2000 international
3.5
It
Sverige Takeda
g/ dl
ketoacidosis ,
3 times per
15mg
above
2007
of
by significant intra- and
re- suspension
dose
alfa
between 25 and
route .
with
feelings
diabetes mellitus
The natural course of
, tiredness ,
and
, in some cases
,
is necessary ,
unregelmäßiger Puls oder
%
45
; therefore ,
If an elevated (
g/ dl
two minor metabolites
, sedation , headache
risk
is necessary ,
for
and
The possibility of
With their skeleton still
ability
weeks
, the incidence of
)
and
5.2
, discard
no
of the art .
neutropenia
based on
Holder .
of excipients , see
8°C ) .
; 95
than
Package leaflet
pharmacokinetics
administered by intravenous
45 45
,
This medicinal product contains
by
12
.
, antidotes )
(
.
trials
.
any remaining contents
In patients with
Rimonabant ist ein
oral
haloperidol
(
) .
products
in patients with
type 1
t½
be
maintain haemoglobin concentration
in men (
can be found
( see
OF THE MEDICINAL PRODUCT
( see
revealed no
not been established
SARL Tél :
used for 2.
and
.
study
dose
.
.
in reduction of
be
.
WC2B 4AE United
Be sure to
, Kuhloweg 37
is
shown
haloperidol-controlled trial
(
a meal
Patients
of
parkinsonism ,
than
of anaemic
(
131 150 IU/ kg
FINLAND
to
risk of cross-reaction
OUT OF
3 times per
or CYP2D6 inhibitor
was administered concomitantly
with
chest pain ,
section 4.2 Treatment
( 6.2 - 7.5
Abraxane therapy .
days 21
or
Abseamed
half-life
,
in patients with advanced
nausea ,
,
- if the
100
placebo-treated patients
of the Marketing
300 IU/ kg 3
of adult patients
was
as
renal
between 10 and
-
clinically
stimulates red cell
section 4.4 )
is
( see section 5.1
,
Healthcare A/ S
lung
.
.
4.4
Cmax
,
Treatment
enzymes
paediatric
the
the
on
dietary control
safety
Chest
R
reduction
see section
activity , concentrations and
section
of
)
section
for four days
100 ml .
)
disorders
strengthens
rDNA (
( see section 4.4
mg or
United Kingdom BRISTOL-MYERS SQUIBB
hypoglycaemia whilst driving .
with
seriousness .
.
and
)
inhibitors
due to the
epoetin
cerebrovascular adverse
week
.
.
( 7.5 mmol/ l
treatment
with
see section 4.8 )
of
aripiprazole
on all
following undesirable effects occurred
anaemia and reduction
Therapy- Anaemia (
surgery
The therapeutic margin of
a day
Abseamed should be
contains
,
Abilify
) Ltd , 61
.
Tel : +
Medice Arzneimittel Pütter
50
manic
ml
g/ dl
3 times
(
An
to 2 g/ dl
.
of epoetin
( 7.5 mmol/
the
in
years )
.
rhabdomyolysis ) ,
l ) .
in
, Storbritannien Tlf :
) general scale
types of paclitaxel
( MAOI )
inter-individual
administered intravenously
rare
4
be presented
( NPH ) insulin
local requirements .
water for
with aripiprazole
g/ dl ( 6.2
5.25 mg
1
Adult cancer
per month
Similarly , for
Abseamed
,
hours after
Die
to
keratoconjunctivitis sicca ,
not exceed
as
whether
)
A-007
Cmax
human erythropoietin
aripiprazole and
heart beat
suicidal ideation , and
, accidental or intentional
some of your ABILIFY
Not
metabolites are active
hypoglycaemia whilst driving
evident ischaemic heart
with
Carton of
cumulative
major elective
Road Uxbridge -
, 25.9 ] (
metabolites
dosage
be considered (
:
or
Seizure :
can
into
,
may
at 25
are not iron deficient
dose
corticosteroids
ABILIFY
1
, serotonin
should
alfa
LTD Tlf : +
, accidental or intentional
.
and 3.2
and controls
.
of
148 Even
SMALL IMMEDIATE PACKAGING UNITS
with epoetin
Refraction anomalies may
all instructions given
below 12 g/ dl
,
Eye disorders
including PANSS and the
a sulphonylurea , only
another
49 x
)
effectiveness was the
be used .
a clinical
other handling
In
and
and sight of children
,
or all
( see section 4.2
delayed
of efficacy
the
injection
and
healthy
hospital and take
meal on the pharmacokinetics
have
) AB
restricted
47 67 55 53
whether
Hypoglycaemia may occur
535 7000
.
AUC
see
76
cardiac failure
with lithium
with
In
10 to
+ 351 21
+ 40
are currently
weeks prior to
For
30
is a
lowest effective dose .
Method
,
not specifically
.
effective
BOX
( 44-20 )
manufacture ( recombinant
including dose reduction
be
or
with
are usually
,
the intravenous route
loss , emaciated
patients
Tel
%
section
Serenade ) ,
is
Erythropoietin receptors may
monotherapy
events
, diabetes
in
.
9
medicine
.
5.3 ) .
substitution
, therapy
of 200 mg
4.5 ) .
patients
formation of
6.2 - 7.5
the thighs
6.2 mmol/ l )
treated ,
ge reported with
DK-2880 Bagsværd
.
should be monitored closely
your doctor or
.
.
known
.
after
24 hours
see section 4.8 )
all
Your doctor
( see
.
female
,
see section 4.8
glucocorticoids , thyroid hormones
)
be
,
between 10 g/ dl
recommended
BRISTOL-MYERS SQUIBB PHARMACEUTICALS
( 5.9 - 6.8
It may
:
renal insufficiency not yet
should
Gastrointestinal disorders
.
is
epoetin alfa
clinical studies ,
danazol .
section 4.2
have
,
human , rDNA (
Uncommon - Peripheral
well
the
0.8
controls .
of hypersensitivity
and water for
neuropathy
increased alkaline
Uncommon - Peripheral
Sími :
desired haemoglobin level may
15mg tablets
- 8°C )
data reveal no
15 mg has
Very
events cannot be excluded
.
the insulin requirement
bei
in vitro solubility
mean total
, and :
your
month or
.
Section
In
The majority of these
Studies in animals have
starting dose for
, thyroid hormones
or
mmol/ l
sex
800 ) 749 749
alfa
a
or
to a stimulus
three
It
be administered intravenously .
possibly protein disulfide isomerase
clinical fracture variables are
be marketed
metabolites
has told you .
ALT
symptomatic
during treatment
10
of manic
A
Eye disorders
the use
Italia Farmaceutici
with
,
common
1 g/ dl (
per week
cells/ µl
(
especially
which were
the nearest hospital
patients participating in
schizophrenia patients
The absolute
may
of
Aldwych London
in the individual
( see
the
bioavailability of the
paediatric
DK-2880 Bagsværd
or
learn
patients
( see section
or
The
dose of 600
of
not
Thrombotic events can be
to treat
(
until
, in some cases
retinopathy .
solid tumours
of
this condition may
.
The
below 30°C ) .
for ABILIFY is 10
-
)
anterior abdominal wall
not clinically
contains
has
dose
no adequate
IU/ kg once weekly
approximately
SMALL IMMEDIATE PACKAGING UNITS
per month , or
ON THE OUTER
within
epoetin
FACT-An
in
Cancer Linear Analogue Scale
use
Protamine sulphate Water
.
%
France BRISTOL-MYERS SQUIBB
incidence of EPS was
studies
less likely to
Tel : +
IU
of excipients , see
between
.
but
with
, or
18
scheduled for major
.
injection site
e. g.
is usually maximal within
control group .
trials involving 1,228 schizophrenic
450
Italia Farmaceutici
11.9 47.3
)
; 1.0
see the Package Leaflet
a
;
In
where
antagonism of serotonin
of these findings
CYP3A4
the symptoms of
with
repeated
concomitantly .
.
to
and
week by
or CYP2D6 inhibitor
% )
tumours
(
,
and sight of children
be
concentrations
but
6
.
84 ,
Lilly Portugal - Produtos
.
angina
to
mmol/ l
In
Actos 45mg
patients with
times per
1 g/ dl
74 60
contain 0.5 ml
353
contains The active
BRISTOL-MYERS SQUIBB SARL Tél
, chest pain
)
1.7 %
of
the
orodispersible tablets 49 x
AUC and Cmax of
with a glass of
EFFECTIVE USE OF THE
Malignant Syndrome ( NMS
DERIVED FROM SUCH MEDICINAL
- if you are
of adult
,
Adult and
from 2 60 mg
GGT
patients
maximum recommended
by
, Neuroleptic
, the dosage
the
of
injections are given in
10
, as
Oral contraeptives ,
peripheral oedema
units
)
units ( IU )
Justification for
section 5.3 )
210 ml : 40
"
myalgia
well absorbed , with
or
sealed in a
The following
patients
isophane insulin 60 %
can occur
range of
trials
100
or
, or if the
your doctor
,
36(0 )
and
on
, the following weight
(
only
CYP3A4
injection site
metabolism
in this
from
50 IU/ kg 2
received
instruction for use to
anaemia may
before
9 251 21
, sudden
repeated dosing
Therefore
with
Kingdom BRISTOL-MYERS SQUIBB
tense .
clinically significant change in
of anaemia associated with
.
nurse .
,
epoetin
mmol/ l
In addition
to a
product
aripiprazole :
time each day
If
The potentially medically serious
g/ dl (
)
in
of excipients , see
below
) , µ
antipsychotics
7.5 mmol/ l )
statins ,
)
dose
cumulative
a
,
12
Further
D-58638 Iserlohn ,
pain ,
of CYP3A4
possibility of
orodispersible tablets are round
( 1.25
,
by
to
occurs
epoetin
with
of Epoetin alfa
g/ dl ( 7.5
patients
trials with aripiprazole ,
, close medical
and
9.5
the
only 3 patients with
, Oxford
in Bipolar I Disorder
15 mg of
g/ dl
Co
with Aclasta
means the
of
The
SPECIAL WARNING
placebo
of greater than
,
in a refrigerator (
(
)
high risk from
the
hands
patients
symptomatic
clinical trials and
1
Abseamed has no
( 0.5
potentially medically serious
g/ dl
information
.
and 11 g/ dl
IU of epoetin alfa*
few minutes
of epoetin
.
Kontrazeptivums mit einer ng
with the product
medicines
, D-58638 Iserlohn ,
patients
somnolence
, Wielka Brytania Tel
Diabetic retinopathy Long-term improved
overdose with aripiprazole
, somnolence ,
dogs and
chest pain , peripheral
cardiovascular
It
renal
stenoses
IU/ 1 ml
Read all of
)
.
be used
epoetin alfa on
be
-
)
antagonist properties in
At therapeutic
below 12
insulin and 60 %
increases
2C9 (
for use in
you
40,000 dalton
hours after
without
33 IU/ kg
as the
and
ABILIFY solution for injection
bei
of
local
hypersensitivity reactions
placebo group .
anaemia
more information
When concomitant
insufficiency .
.
1.25 mmol/ l
( see
effect
Polyneuropathy , areflexia ,
UB8
Authorisation Holder .
, Royaume-Uni Tél/ Tel
from
SQUIBB
see section 4.5
In
The
Use should be
are
5000 international units (
you have
KG ,
When
acute renal failure .
such as
aripiprazole .
be considered (
arrhythmias , sudden unexplained
including
has
The daily dose
of ketoconazole or
or
clinical
in patients with a
cancer
hours
is a
18 years of age
( 0)9 8545250
itching
over
( two studies
Consequently , haemoglobin
section 6.1 .
100
vomiting ,
the
No
combination
3 times per
See section 4.4
75 and
(
the reach and sight
for
lithium
reported after months to
alfa
( e. g.
,
of 10
E218
.
aripiprazole
,
.
weight gain and oedema
thyroid hormones
section 4.4
Adult cancer
all active metabolites
daily
Changes
( 0)20 3116 8000
.
IU ) of solution
6.6 .
prior history of TVEs
, the
0.4
laboratory parameters revealed
, uncommon
.
orodispersible tablets 49 x
risk
study
doses
( 1.25 mmol/ l
is a
and
study included only 3
patients
, itching ,
Special populations ( see
about 40
blood pressure
hypertension
close medical
of Aclasta 5 mg
.
each day
enzyme (
from hypoglycaemia
.
these
placebo-controlled
When
per month
The patient s ability
alfa
anhydrous
mg )
If
g/ dl
adequate and well-controlled
Novo Allé
,
.
of distribution
diabetes mellitus ,
of clinical fractures was
,
a manic
Highbridge
with
As with all
,
against the
for ABILIFY
2 352 74 60
and
change in their usual
are white
in
care
with
CYP3A4 or CYP2D6 inhibitor
anaemia with
in order
( see section
Europe )
Alcohol may
group
( 6.2
orodispersible tablets
two
tablets
on
type 1 )
dose should
tell your doctor
risk for
most cases ,
is
rats
with
.
of these findings is
of anaemia associated
symptoms
elective orthopaedic surgery
, diabetic ketoacidosis
0.5
In
hospital
the
16 00
3 times per week
with
and diabetes mellitus (
,
the dosage of ABILIFY
Method of administration
shown
diabetic ketoacidosis
+ 44
is
,
) .
Recurrence prevention of
solution .
with
anaemia with epoetin
,
.
deficiency or
mild agitation before use
Abseamed 2000
section 5.3
with cyclosporin
metabolised by multiple
After administration of
Uncommon
other medicinal products
area was
IU of insulin human
There are no adequate
.
single-agent paclitaxel
clinically
Cardiac
, pyrexia ) ,
study
no
Common
or 5 or more
50
controls .
% CI :
8167 patients
also
(
Centre
the majority
12 g/ dl
)
ml
is not
.
Takeda Global Research and
3 ml equivalent to
on the use of
g/ dl
tell
features
and consists of 165
be followed
ABILIFY
The
10
improvement in
subcutaneous
or of
a
.
solution for injection
4.2
& Co KG ,
ABILIFY ,
Road Uxbridge -
with
alters
and
of the
ketoacidosis ,
given
,
9 251 21
, itching ,
vitro findings
.
pioglitazone
all
(
%
patients
- Middlesex UB8
alfa
% with
.
Global R
to
Insulin human ,
is necessary .
Patients
5.2 )
have the following causes
to have
: soluble
, even several weeks
mmol/ l )
infection
- 14 g/ dl
no
of
4.4
pituitary adenoma .
The
10 g/ dl (
g/ dl
and
- 150
total weekly dose
conventional paclitaxel-containing medicines
and swelling
from
during treatment
symptoms can occur
,
and
% with aripiprazole
An
animals ,
A direct effect
3000 IU/ 0.3
with
primarily
blurred
to
2
the geometric means
in cancer
see
all instructions given to
treatment with
combination therapy
ml 400 mg sucrose
medicines known to
) .
dose of ABILIFY
with Abseamed may be
( including
aripiprazole
The
your
life parameters on
section 5.1 ) .
3x/ week
clinical
BRISTOL-MYERS
% ) of
in urine , proteins
SQUIBB
titanium dioxide (
are
,
renal impairment :
surgery
patients
manic or
-
crisis with
an
rats
other indications
subjects ,
House
.
1 , 49
, the incidence
tumour proliferators .
( 1.25 mmol/ l
and blurred vision .
observed
, the
at 25
placebo-controlled trial , the
Common
are transitory
500 mg elemental
) .
treated
devices for repeated use
pharmacist if you are
and
t½
.
the levels of
1 orodispersible tablets
of
with
from
warfarin ,
%
to
30 mg orodispersible tablets
see section 4.8 )
See also section
SQUIBB AB
use machines
mmol/ l ) to
100 ml .
857 42
a clear , colourless
The
524
nursing
1.25 mmol/ l
products .
dyspepsia ,
products
the
Hypertension
( See section 4.4
section 4.3 ) .
effect
: +33 ( 0)1
the
.
patients
In clinical
Subcutaneous injection into
and
of a full range
vomiting
cerebrovascular adverse
three
with a cartridge (
by significant intra- and
for
mmol/ l )
the
the dose may
dose should
younger
genotoxicity tests
physician must therefore
a
pharmacokinetics of
and
12
( days 21
18 84 16
of
Some patients
glucose control may
with
, glucocorticoids ,
Abseamed
,
of
of children
( 683 breast
very rare
machines .
The
diabetes ,
dose should
Within each
TO APPEAR
Cmax
NPH ) insulin .
extrapyramidal symptoms
treatment
has
observed
monitoring to detect possible
are ready to use
aripiprazole dose
may require discontinuation
decreased
)
be marketed .
to protect
with
.
is therefore
The
)
,
,
hours
the
)
is given subcutaneously (
to
8000 IU/ 0.8
greater than
.
,
meal on the pharmacokinetics
of standard
Premixed insulin products
)
) , µ :
% ] )
section 4.4
schizophrenia
2007
usual
30 - 100
The treatment
carbamazepine ,
epoetin
to the active substance
.
of anaemia associated
defined by a decrease
use
of excipients , see
(
of erythrocytes from
0.5
children under 30
61
.
is used
THE REACH
is therefore recommended .
6-month
and
857 42 22
trials involving 1,228 schizophrenic
(
, thiazides ,
efficacy of
chest pain
.
pectoris , increased
.
animal models
15
,
354 535
: + 351
Analogue Scale (
15 minutes caused
this product , ask
immune system
hydroxylation of aripiprazole
Treatment of symptomatic anaemia
Insulin treatment of the
alfa
a
agents Certain medicines
( 1
see section 4.4
Treatment
with
, monoamine oxidase inhibitors
patients with
the foetus
Appropriate therapy such
over
Overdose
( 172 breast
to the baby .
been shown to
In several
the
may
)
PARTICULARS TO
In clinical
sites
important differences .
%
ABILIFY
Dosage adjustment to
or
revealed no medically important
If you
% (
The
4.8
not
less than
possibility
ohne Adipositas
4.4 )
the reach
is
above indications
treatment
clinical trials
or unplanned
than
(
recommended
other
may
10 or 15
physical
tense .
human
)
doctor
should be
environment .
swelling and/ or pain
Concomitant administration
site conditions Uncommon
,
the
administer .
of epoetin alfa
antagonism of serotonin
,
If epoetin
This
4.2
, concentrations
of pioglitazone as
therefore
the intravenous
may require discontinuation of
30
3 times per
aripiprazole
( 30 %
calcium and 400
adverse
weight regain .
, chest pain ,
42 trials and 8167
see section 5.1
not generally
:
of ketoconazole
receiving
cartridge
.
of
of diabetes was 9.5
per month ,
.
with epoetin alfa
, but not in
If
After administration of epoetin
with
of NMS are hyperpyrexia
month
, becoming
Octreotide/ lanreotide may
well-controlled trials of aripiprazole
Alopecia
Takeda
less than 1
- decreased locoregional control
not
anaemia
information on
.
Based on in
(
Yarvitan 5
unknown ,
not
overall survival between
be marketed
Very
neuropathy
episodes of hypoglycaemia
important
or stroke
,
This leaflet
is
two
45 93 05
or 450 IU/ kg
%
Trial [ PFT ]
.
Maintenance dose between
section 4.4 )
) ,
recent
In
, thiazides ,
,
are pregnant
the
56
increased
you
.
bottle
contains 15 mg
+ 353 (
international units ( IU
hyperosmolar coma or death
France
ventricular
an apparent volume
.
of Actraphane
Read all of
therefore
In
1,062
The AUC
patients
pancreas
myocardial ischaemia , myocardial
(
Non-specific skin
of
ABILIFY
If you
be marketed
Abseamed has no influence
in
even several weeks
hypoglycaemia
mixed episode of
% Actraphane 50 :
The
( 0)20
pharmacist
have
sometimes severe irritability
AST )
overall survival between
blisters .
doctor or pharmacist
, County Wicklow .
especially important
another antidiabetic medicine )
and
- 200
cytochrome
eliminated
the possibility
found in
and
should be
14 g/ dl (
the
surgery and
.
CYP2D6 or 3A4 inhibitor
and
and
four placebo-controlled studies
61 33 22
Abseamed
haloperidol
, peripheral oedema
SQUIBB GESMBH Tel :
is
.
(
and protein intake
or higher
in patients
anterior abdominal wall
3 weeks .
renal insufficiency
aripiprazole ,
count has increased
no data available
section 5.1 )
values
enzymes .
mellitus : hyperglycaemia
)
.
reports
Weight gain :
especially
the
bacterial
tell
glycaemic control is associated
Sodium hydroxide
- Treatment
9000 IU ) of
agitation before use .
of ketoconazole or
Tel :
,
potent inhibitors
.
extent of
.
4
.
to
toxicity The
( FINLAND
- 39 % )
,
to
vision Gastrointestinal disorders
ABILIFY
immediately
terminal half-life is determined
your
or mixed episode
It is not
were
PHARMACEUTICALS
patients with the
or mixed episode of
( see section
for
(
elective
clinical trials of aripiprazole
in women with
What
when
patients
clinical trials
change in
.
In a
cancer
there was
on ABILIFY
alfa
at increased risk
in pregnant women .
history of
, the dose should
The
Hyperglycaemia
or glucose-galactose
, ventricular arrhythmias
anaemic patients .
APPEAR ON
with
for all cancer patients
.
Although there is
significant
are given Aclasta
pharmacokinetics of
( 5 mg in
When the CYP3A4 or
injection route
plasma concentrations were 1
pharmacist
of the
a growth factor
(
3.0 %
ABILIFY is
.
4.7 Effects on
an
the following
TO APPEAR ON BLISTERS
of
) .
14 , 28
section 4.8 )
-
.
some
when
corresponding to 0.05330 mg
osteonecrosis
84.0 micrograms epoetin
Finland Oy Eli
or other CNS
8°C
- 12
maximum of 30 mg
if they
KG , Kuhloweg
somnolence , tremor ,
neuropathy
were
In a
one .
renal
ml
pre-filled syringes are
naturally
see
the
programme , the
in haemoglobin
day
of angioedema and
)
one
hives
should not be
also
)
monoamine oxidase inhibitors
4.2 Posology
g/ dl
anterior abdominal wall .
stimulus
of 300-360 mOsm/ kg
g/ dl
.
to be
-
in patients
colourless to slightly yellow
with epoetin
of the other ingredients
units
aripiprazole
is not recommended .
& Co KG Kuhloweg
4.4 )
is especially important in
)
hours
Adult patients with
pulse or blood pressure
in
5HT2a receptors
unchanged aripiprazole was
the
(
chronic renal failure
, hydroxylation , and
and sight
ABILIFY is effective in
.
patients
273
,
AND SIGHT OF CHILDREN
mmol/ l ) in
orthostatic hypotension*
Aripiprazole exhibited
- 8°C
micro-ophthalmia
Mildly anaemic
the dose selector returns
aripiprazole
Aclasta works
per month )
FINLAND ) AB
) ,
and
when
PRODUCTS , IF APPROPRIATE
Limited Eesti filiaal
the studies
patients with severe
and
and
- United Kingdom
In
your dose of
patients
and 12
in women
Very
products
you
In
by the
If
the aripiprazole dose should
a cartridge
CI ] ( weeks
) 2
In
important signs and
of NMS
Uxbridge - Middlesex UB8
patients presenting with agitation
after
( see section 4.4
rimonabant
with
of increase in haemoglobin
section
monkeys
RESTRICTIONS WITH
% isophane insulin .
CYP3A4 (
reactions are
aripiprazole in the
section 5.1
(
well below
ml equivalent to
& D
( see sections 4.3
The following reactions
strenuous physical exercise may
with
+ 31
OF UNUSED MEDICINAL
, the
to
extrapyramidal symptoms
Any unused product
x 1
normal and
All patients being
rare cases
week by the intravenous
events
a combination
CYP2D6
are ready to use
Actraphane
areflexia , dyskinesia ,
( 0800 )
events
below 12 g/ dl
Paget
% and AUC
aripiprazole
.
of
See Annex I
) , chest pain
infertility
entire dose is injected
maximum
death
a
blood
pre-filled syringe
Mannitol , sodium citrate
combination
Dosage adjustment Concomitant illness
aripiprazole
,
If convenient ,
one of two
with aripiprazole ,
Uncommon -
is
2 352 74
in treatment of
, or
increased risk of
, ,
and 3.2 %
recommended
they
both
bone marrow cells
test values
.
with a
subcutaneous tissue .
,
adequate and well-controlled
of
chronic
,
be
incidence of
bone marrow cells
affects you .
9 251 21 230
apparent molecular weight of
Epoetin alfa should be
and dehydro-aripiprazole are
, restlessness
5.3
was
von
7.8 % )
not
76
a single intravenous
and
storage conditions .
is
intermediate-acting
0.5
ml 6
between
Special precautions for
administered by intravenous
responded to treatment
controlled as necessary
:
hypertension
for injection
In PROactive ,
and
without a rapid-cycling course
The maximum dose
( 0)20 3116
3
e.
Aripiprazole
specifically
,
157 Tell
of epoetin alfa in
between 10 and 12
had a previous
have been
be avoided .
times per week ,
extrapyramidal
a small minority
or
of the
( type
Takeda Global R
(
or
experienced the development
: if your dog
of these symptoms decreased
subjects ,
If
and
Patients
alfa
n oder
a lesser amount
Taking Actos
Aripiprazole
Fe2+/ day
, nausea
your doctor or
- Produtos Farmacêuticos
, episcleritis
,
mellitus
)
ON
schizophrenia
Finland OY
( 7.5
15 mg orodispersible tablets
hepatic impairment
Actos contains
before
administration
fed dogs
may
pharmacist
90 %
die
the solution
and
)
safety of
0.4 ml
, are shown
orthopaedic surgery
other handling
haemodialysis and adult patients
doctor or pharmacist
more units
could be
501 76 03
retinopathy .
4.5 Interaction
the entire dose
that primarily
or
meal on the pharmacokinetics
sensitivity
,
Approximately half of the
solid tumours
12
these
( see section
impact
of
discontinuation of treatment
1 bottle
( 7.5
feel dizzy ,
Tel
either
R
, an
)
,
of the art .
be more common
and
of food with
patients
Conjunctivitis
see section
and
or if
overweight patients
)
daily dose should
see section 4.4 )
or waste material should
see section 5.3 )
in
.
.
and further comparative studies
study ,
patients with
(
should
30mg of pioglitazone
specifically
10
ventricular arrhythmias
a
.
anaemia (
population pharmacokinetic
Be sure to
,
unlikely
with renal anaemia ,
doctor
with chronic
greater than
reported
,
oral solution for
into less
recent low-trauma
It is
approximately 60 % in
possible warning signal .
Business Park
of
ml contains 1000 international
with pioglitazone
Farmacêuticos , Lda Tel
other erythropoiesis-stimulating
14 , 28 ,
+ 47
34
between 10 g/ dl
If
well
Medicines
with
,
patients
a potent inducer
are
)
alfa
Abseamed between
There is
:
vitro
Adult cancer
under 30
complications
, glucocorticoids ,
section
2C9
increased risk
the exposure of rimonabant
is between 75 and
( NPH ) insulin
lifestyle
Abseamed
heart failure
by the intravenous route
procedure for
The formation of
Danmark
symptoms
10 and
,
of Vantas is sufficiently
patients in
over 24
insulin and 70
inter-individual
4.3
reactions after
in routine
- 7.5
is
patients
alfa
hepatic impairment may
micrograms epoetin
, nausea ,
men
In placebo-controlled trials
.
Risiko
.
, the dosage of
no
x
Irregular heart rhythm
should be given
1
active substance is aripiprazole
BEFORE
and 2.47 in favour
aripiprazole
, open-label studies ,
all
the occurrence
schizophrenia .
aripiprazole ,
of the Marketing Authorisation
pharmacokinetics
both a
a
comparable to
see section 6.1 )
is a mixture
sustained haemoglobin exceeds
United Kingdom
- 7.5 mmol/ l
, somnolence ,
ml solution contains
g/ dl
alfa is
reactions
deep venous thrombosis
risk for humans
In addition
Tlf
In
indicated for
44
Treatment
( insulin
Like all medicines
.
In the
of anaemic patients
on insulin
, WC2B 4AE
analogues for injection ,
aripiprazole
slowly
± 16 %
1 )
Cartridges should only
method
.
pharmacokinetics of aripiprazole
contains
+ 44
(
or
.
( 2°C -
use machines have
see section
see sections 4.3 and
of
tablets
when pioglitazone
) .
oesophagitis
and well-controlled trials of
This medicinal product
hepatic impairment on the
of angioedema and
and
used
.
to protect
( iron deficiency ,
can only be obtained
,
-
ensure
anorexia , hyponatremia
for
international units ( IU
may
55 53
patients
intensify and prolong the
restlessness ,
,
of
as
aripiprazole ( 30
IU/ kg 3 times
to aripiprazole
a sulphonylurea
1 tablets
4.4 -
and
of ABILIFY
sudden
tell
and precautions for
Hb between 10 and
Novartis Europharm
infusion
on the
hypoglycaemia
[ 95 %
avoided
all
mellitus ,
165 amino acids .
on the use of
retinopathy
in
of
pharmacist for advice
SQUIBB
to take
carton .
site
sulphonamides
combined with fast-acting
0.62
AB Tel :
humans
events :
56-99
50
.
dose is 600
clinical
or pharmacist
8°C
combining
CLAS )
,
were
pioglitazone with gemfibrozil
of erythrocytes from
12
when
the pharmacokinetics of
section 5.3 ) .
tablet formulation is
clinical trials
are therefore affected
mellitus , diabetic ketoacidosis
from 2653 to
.
Although there is
.
avoid
whole
The injections are given
injection
.
of dissolved
30
treated
In clinical trials
and dehydro-aripiprazole
Detailed instruction accompanying the
not take
Cmax
is necessary ,
from light
) with
ml contains 100
or
no specific frequency can
including
patients with a manic
as
,
.
see sections 4.8
% being
If
based on
uptake into
than
AUC and
27 %
last very long
( see section
,
potent CYP3A4 inhibitors
METFORMIN AND
although development of
) , 2C9 (
have been proposed ;
;
participants received
1 800 ) 749
,
Hunton House
,
.
Schizophrenia -
marked
have
in
be
(
( 2°C -
hydroxylation of aripiprazole
&
of other races .
7.5 mmol/ l )
( 95 % CI
completed suicide
pioglitazone ( see
.
two
Do not use ABILIFY
following the administration
7.5 mmol/ l )
Not all pack
mg zoledronic acid (
AUC and
, 98
IU
use ,
Actos 15mg tablets
epoetin alfa .
immediately
) 731
eliminated
43 ( 1
12
( see
nausea
elderly
zoledronic acid anhydrous
bei Patienten
potent CYP3A4
,
with these
orodispersible tablets
weight
150 30 -
contains 10 000
between 17 and
14 g/ dl
.
active substance is
the blood pressure is
80 ,
1
with gemfibrozil ( an
doses of
wastewater or
with
Park , Oxford
hepatocellular
dalton
or tense
active (
30
These measures
product at 52-weeks was
x 1 tablets
may
take
and cardiorespiratory depression
12 g/ dl (
it is recommended
not
Renal or hepatic impairment
(
use ,
or
not
to store ABILIFY 6.
that epoetin alfa
is
encephalopathy-like symptoms can
In a
be increased .
)
)
: in clinical trials
with
1
Ísland VISTOR HF Sími
your
or
10
of erythrocytes
injection
with
is a
Do not take ABILIFY
)
doses
majority of these symptoms
.
35
diabetic retinopathy
in haemoglobin ( 1
see section
in patients with
pre-filled syringe
Aclasta
interaction
myocardial infarction or stroke
: +371 7364000
8000 IU/
patients
In
Actos 30mg tablets
glycaemic
:
4.4 )
,
1/
of paclitaxel
353
renal impairment :
,
with
6 , 12 ,
BY WEIGHT , BY
site conditions Common
)
and 2.47 in favour
Tel
carbohydrate chains
39.5 %
( human ) .
%
have
3 days.
In
and dizziness
weight
alfa
feeling anxious
1.4 , 4.0
blood pressure
+
, 64 gynaecological
,
oral bioavailability of
aripiprazole or any
200 - 300
In a clinical trial
in pregnant
Global R &
therapy
to reliably
be
thrombosis
with
times per week
you
insulin
you
Takeda Global R &
, pyrexia ) ,
ABILIFY IS AND WHAT
to
thromboembolic
.
defined by a decrease
administration of
450 IU/ kg
children under 30 kg
mmol/ l
polycythaemic mice ) .
is effective in
DISPOSAL
with
see
Pioglitazone is also indicated
of
Therefore
should therefore
A clinical trial
agents (
per week by
%
TO APPEAR
9000 international
.
in
as compared
alters the metabolism of
Nordisk A/ S Novo
with Aclasta
x
ABILIFY
a visual aid indicating
APPEAR ON THE
SUPPLY OR USE
sulphonylureas ,
x ULN
of
, 30
hours
1 g/ dl
to be compatible .
,
or without psychotic features
30 %
, peripheral
your doctor immediately if
% with aripiprazole
1800 ml
33 IU/ kg
300
805
, the
contributes about 58
Iron supplementation
, 5
5.1 ) .
ba Latvij Tel
exercise
and
Subcutaneous injection : a
Global R &
hypoglycaemia
haemoglobin target range of
This data
% with placebo .
or
ABILIFY is not
repeated
tablets 56 tablets
.
or hepatic impairment may
Saccharomyces cerevisiae )
or pharmacist
as measured
particularly
with epoetin
angina
3A4 ( dextromethorphan )
-
decision
see
and Manufacturer Marketing authorisation
may be observed
, please tell
7,736
vary with
,
generally not
(
increased Creatine Phosphokinase ,
(
times per week .
marked with
or if the
,
)
pharmacokinetics of
, ventricular
or lithium
reactions are
overall survival and increased
: blurred vision
be
,
the active ingredient
hypothermia
section 4.5 ) .
prior history of TVEs
450 IU/ kg
Arzneimittel Pütter GmbH &
Eye disorders Very rare
Actraphane NovoLet
section
and
or
In
schizophrenia
be administered
.
,
insulin .
bacterial
N-dealkylation .
dehydrogenation
A-009
these patients
Studies in animals have
other erythropoietic therapy
aripiprazole in the bile
(
patients with haematological malignancies
patients
ketoacidosis or
76.9 ]
patients with
population
( e. g. anaphylactic
are rectangular and pink
are
see section 5.3
per 100
.
section 4.4 )
chemotherapy induced
not clinically significant
Cytotoxic actions of epoetin
adult patients
placebo group
(
result
,
.
.
including dose reduction
of
see
be used
mellitus ( see section
D Centre
18 ,
are pregnant
not
in
( insulin
rats , but not
units
study (
R
If
There is an
Elimination
See section 4.4
to
Uncommon -
Medicines should not be
6.2 mmol/ l )
pharmacist
mixed episode
)
and
(
75 and
overall burden of disease
g.
( see section
, akathisia , tremor
In patients with
section
of
with
Aripiprazole
with
to maintain haemoglobin
,
VISTOR HF Sími :
studies
are
with cyclosporin ,
5-hydroxytryptamine and dopamine
)
heart failure
( 0.5
Treatment of symptomatic anaemia
to
15 mg
is not
,
major elective
including
peak is always
) , µ
,
should be
with
aripiprazole was administered concomitantly
As for other
your doctor or pharmacist
patient
patients with these
of
( 7.5
therapy
,
in the placebo group
tablets
Park
In clinical trials with
( see section
blurred vision
.
In
thoughts of
Mutagenicity
cloudy after resuspension .
for
headache Eye disorders
restricted
for pH-adjustment
Kingdom BRISTOL-MYERS SQUIBB PHARMACEUTICALS
with
influence
( see section 4.4
3
will ask you
mellitus
will help
( IU )
cancer patients receiving chemotherapy
PROHIBITION OF SALE ,
kg require higher
2°C
IU/ kg
Each
dissolved insulin
treatment with epoetin alfa
: + 32 2
the risk of malformations
orodispersible tablets 49 x
.
more
g/ dl
disorder .
you
, aripiprazole
A few
N-dealkylation .
are
, creatinine
treatment
, tachycardia
vomiting , nausea
For a full list
AND 98
use machines .
of anaemia
( IU
IU/ kg
with
, dizziness
6 pre-filled syringes of
is
patients with severe
of the CHMP
top
post-menopausal
reactions are transitory
Within 60 days of
Kingdom BRISTOL-MYERS SQUIBB PHARMACEUTICALS
Takeda Global
Severe hypoglycaemia may
starting dose
to
not
first trimester
to protect from moisture
When a
what it is
stabbing migraine-like
SAFE
mmol/ l ) .
4.4
(
)
per
.
Treatment of
unused product
aripiprazole
.
,
Actos is
Italia Farmaceutici
6 weeks when used
.
hypoglycaemia
or hepatic impairment may
(
based on
to affect ABILIFY
adult patients
ABILIFY
Taking
Patients with renal impairment
Abseamed
Tel
arrhythmias , sudden unexplained
the patient
-
significant
and 12 g/ dl
- 12
and
Aripiprazole is well
Starting dose of 50
OF UNUSED MEDICINAL
When weak inhibitors
of the hormone
24 hours .
14
episodes
standard
Most reactions are
the
from light
(
.
,
: +
0.5 ml
ansteigt .
Be sure to
48
per
route .
medicinal products
administered by intravenous
with aripiprazole
The blood glucose
insulin human .
anxiety Uncommon : depression*
or
tumours
ABILIFY solution for injection
have the impression
pharmacist .
% isophane insulin .
NPH ) insulin
with epoetin alfa
( 1.25
g/ dl
:
neuropathy
patients with
into account and should
patients
ESAs ) have shown
(
are
( 2°C -
with Actos and insulin
& D Centre
Haemoglobin variability
IU/ kg 2
administration
needle should be
clinically
13 g/ dl
CYP2D6
epoetin alfa
.
20
ABILIFY is
.
the haemoglobin is
If you
and should not exceed
Uxbridge - Middlesex
(
Insulin human , rDNA
,
patients scheduled for major
Highbridge Business Park ,
the start of
is
.
the
dose is 5
86 %
to
BLUE BOX )
Any unused product
subcutaneous tissue
a measure of the
Taking
epoetin
or
source
times per week .
from light .
of 1 ml contains
this medicine is available
if you
Omission of a
significant
.
five large controlled studies
time each day
18
)
, somnolence ,
5.1
( IU
56 x 1
Uncommon
(
see section 4.8
alfa is
peak is always well
( dextromethorphan
(
Women
UK Ltd
insulin
tachycardia ,
section
those
epoetin alfa
activation of
less
a
E218 , and E216
In cancer patients
OF THE MEDICINAL PRODUCT
or
margin of epoetin alfa
+ 358
clinically
phosphokinase and
previous stroke who
risk
is
was found in one
infection or
slight appetite decreasing
,
on the use of
mellitus ( see
specific frequency can
Middlesex UB8 1HU -
- 39 % )
- Middlesex UB8
well below
HORIZON-PFT
,
mucositis
> 99 %
.
the
30 %
the potential risk
( see section 4.2
blood glucose
risk
)
thiazides
decision whether
Changes
All
.
therefore a measure
with a
the
conduct investigations ,
:
and
to placebo
( see section 4.4
of Vantas
, intermediate-acting combined
and placebo
.
, but
% CI ] (
isophane insulin 90
of fracture ,
: +47 23 05
without
,
(
diminished parathyroid reserve ,
the
a meal
12
,
insulin requirement may be
,
%
) .
an autologous predonation programme
Global R
Insulin treatment
.
the
(
pack
300
and/
trials of
61 Aldwych London
,
sections 4.8
and 3.0 %
retinopathy .
headache
three days
monkeys after
approximately 425
Cmax
Recurrence prevention of manic
D
effects
of EPS was
Business Park
by the liver primarily
effect of
epoetin alfa
higher plasma concentrations
,
In the study of
not been
added to
patients the incidence
maximum daily dose should
.
MEDICINAL
performed
a
sections 4.8 and 4.9
all medicines
severe renal
e. g.
dosage of ABILIFY
metabolites is catalysed by
a
)
% isophane insulin
(
,
lead to an increase
and
OR
treated with Abraxane
Metabolism Human
7.5 mmol/ l )
pregnant
section 6.1 .
packs of
, but
These measures
acute
between
consists of 50 %
If
with food and drink
to maintain urea ,
has not
a
large
before
vomiting and diarrhoea
you
Patients
537
Marketing
(
5.1 ) .
and 802
+ 31 34 857
.
and
pharmacist .
the
of overdose should
oder
and binding
during
IU/ kg
Thrombocytosis has been
- Peripheral
27 When either valproate
of Actos
and its metabolites
(
exhibited antagonist properties in
( e. g.
10 %
Vascular disorders Uncommon :
oral iron substitution of
0.3 ml
should be
and no
solution
facilitate the re-suspension
( see section 4.6
before use
similar dose reductions should
side effects
anaemia ( e. g.
per week by
in paediatric patients
other
phosphatase
by the intravenous
%
Allé DK-2880
epoetin
of how well the
route
1 ,
and
or
patients
similar
,
by
: +
of akathisia in
and should
about
receiving dialysis
children
, may
The
of food with
local requirements
+ 353
may also
the ABILIFY
diabetes
severe irritability .
)
symptoms
should
based on conventional studies
frequency
6.2 -
dehydro-aripiprazole ,
,
per month ,
study (
weeks
mg/ kg daily was
times per week
:
a
a type of white
the
1.87
significant
4.4 )
)
) after
Less
of liver cirrhosis
of akathisia
.
of therapy with
In controlled clinical
vitro findings
exhibited
(
Uxbridge - Middlesex UB8
) .
plasma elimination half-life of
This
recommended that the
anaemia ( e. g.
diarrhoea
with diabetes mellitus
,
six
The white ,
or
In clinical
your ABILIFY tablets
and
354 535 7000
the geometric means of
may
diabetes
Medice Arzneimittel Pütter
with consideration for
67 55 53
) , increased
, and the majority
8.7
the relevant modules
treatment in this
.
(
by significant intra-
any of the
g/ dl (
antipsychotic
%
.
,
reactions
.
The mean
recommended in these patients
in patients
35 trials
alfa and
1 and 10
pH adjustment )
g/ dl (
n = 135 )
You will
, long-acting insulin
dose adjustment
, in some
Tel : + 40
Following
( see
patients
is contraindicated
48 kg
see sections 4.3 and
IU/ kg
only
the
cartridge (
diabetes
7.5
of zoledronic acid
of insulin resistance .
ABILIFY solution for injection
(
with
reported in children .
VISTOR HF Sími
should be closely monitored
dose should
) of
of
below
immediately
, as
während der
.
(
women treated with pioglitazone
the rise in
( Europe
recombinant human
other clinical
are
.
monitored
injections .
2 352 74
. : +36 1
see section 4.5 )
residual
the administration
for placebo
be
between
%
Epoetin alfa and other
revealed no medically important
of the value )
make sure the
either valproate
(
and AUC
and
. ) .
: +
353
the rise in
blood glucose monitoring
UK
7.5 mmol/ l )
Paget s disease
carbohydrate composition to
and Cmax
week
tell your doctor
t½
SQUIBB PHARMACEUTICALS LTD Tel
danazol .
order
: + 44 (
not
adjustment
mmol/
(
MUST
44
section
metabolites are active
neuropathy
both groups
or
30 %
pharmacokinetics of
results
-
Road Uxbridge
epoetin alfa
to 12
severe
, pyrexia ) ,
increased Alanine Aminotransferase
of pioglitazone
+ 45 45 93
regard to meals as
delivery system
,
the
, somnolence , tremor
the occurrence of
Silicon dioxide Xylitol
Effects on
1HU -
section 4.8
(
( see
THE
is fever .
In patients with
and
at the
.
( see section 5.2
)
) , 2C9
see section 4.2
FOR
5
E171 )
versus animal source insulin
50 IU/ kg
to treat
consists of 30
, Neuroleptic
)
colourless , aqueous
epoetin alfa
aripiprazole treated patients
significantly
.
see section 5.1
week by the intravenous
with encephalopathy-like symptoms
could not be detected
(
a
- If you
)
1000 IU/ 0.5
management of overweight and
not
or
THE MARKETING AUTHORISATION
hours has been
the blood pressure is
in addition to
risk
Aripiprazole
,
Insulin treatment of the
renal impairment
increase peripheral
diabetes
risk
( 6.2
IU/ kg
23 lung , 22
other
section
BRISTOL-MYERS
in up to 10
Middlesex UB8 1HU -
see section
Puh/ Tel :
to
in some
defined .
insulin and isophane
see section
dehydro-aripiprazole
.
reported
" 30
1 pre-filled syringe
.
aripiprazole or
see section 6.1 .
activity ,
, or if the
or insufficient
alfa may
isolated
ketoacidosis
) of EPS
the product
, 84 ,
have also occurred
every
international units ( IU
monoamine oxidase inhibitors (
patients
31 34 857
and
treatment
but
needle should be
enzymes and
Storbritannien Tel : +
was the most
For Paget s disease
Some patients may
was 9.5 years .
reaction (
4.8
and you will
See section
,
.
34
per
even several
occurs
or any
4.4
98
BRISTOL-MYERS
; suicide attempt
0.4
8°C )
Aclasta
aspiration have been
haemoglobin
known as non
on
between 9.5 and 11
with
.
Following oral administration
or
938 ; mean age
- if the
of
-
ml
( see
alfa therapy
.
5.2
cell
see
)
other ingredients are
therapeutic margin of
trials and
machines , until
section
fever
, especially
Tel : + 31
patients with
Park ,
with or
address of the manufacturer
, 15
with epoetin alfa
than 1
treatment
pharmacist .
dalton .
, and
%
% CI :
0)20
should
Severe hypoglycaemia may
1 orodispersible tablets
more information about
patients
patients
IU
was administered concomitantly
CHILDREN
AUC
discontinuation of treatment
( 8000
15 mg/ day (
should be observed
)
or discontinuation of treatment
.
( see section
) .
, especially infections
LTD Tlf : +
approximately
(
.
pre-filled syringe
Actos and
only
population ,
be
%
g/ dl
%
should only be
to
or urticaria
events
during
third infusion
4.4
please contact
( 1.25
patients
greater than
- United
make sure
sizes may
with renal impairment :
.
.
( 57.3
of akathisia
, hives ,
(
x
and
on the pharmacokinetics of
For a full list
1
ml
should
no
1 tablets
or
been receiving
increased
12 g/ dl (
machines
for
or
30
formation of erythrocytes
Danmark BRISTOL-MYERS
Global R &
of
than a
46 8 704 71
between healthy non-smoking subjects
Road Uxbridge -
patients
, M-III , and
Therefore ,
injection .
patients with
aripiprazole (
Tel : + 46
malfunction of
may
Activated charcoal ( 50
ABILIFY
these patients
studies
increased risk
for the duration of
of
% with placebo
to
)
pharmacokinetics
clinical
: +
tablet is bioequivalent
90 % of the
GGT ) ,
ABILIFY
802
placebo .
24
label
medicines used
or pharmacist
with a number of
Based on in
solution for injection
This medicinal product
Weight gain has
production .
82 For
patients
see section 5.1
anaemia and reduction
no effect
with haematological malignancies .
such as
(
and
Co-administration
BRISTOL-MYERS SQUIBB
aripiprazole tablets ,
( DVTs )
reactions have also occurred
mmol/ l )
Co KG Kuhloweg 37
( type III )
1
is
Clinical efficacy
If
in
rare cases of
of patients
study
range of standard
Neuroleptic Malignant Syndrome
.
.
be of 25
patients with the
in
increasing
differentiating hormone , the
0)1 46
4000
significant effect on
hyperglycaemia
:
in adult patients
whose first treatment
4.8
, oral aripiprazole
12 g/ dl
renal failure
.
50
or blood pressure
and diabetes
of
blister
contains
and analogues for
No dosage adjustment
,
- 8°C )
time to
In the four
and 500 film-coated tablets
Abseamed
(
trial was
hours after
populations (
NovoFine needles
40
rDNA ( produced by
SQUIBB BV Tel :
ABILIFY is 15 mg
rare cases fatal
chronic renal failure and
compartment .
and 10
with
aripiprazole
or
5 mg Aclasta
increasing
should
alters
insulin it produces
AST ) ,
Iserlohn
studies
150
the effect
Although
obesity
your doctor
injections
150 IU/ kg
mean age :
CYP3A4
Kingdom BRISTOL-MYERS SQUIBB PHARMACEUTICALS
, 64 gynaecological
this
healing was comparable between
month
events in
Interaction with receptors other
75
Bipolar I Disorder
on
and
mg zoledronic acid anhydrous
of daily
Aclasta 5
or waste material should
Following concomitant administration
Adult and
longer
exhibited
treatment with epoetin alfa
mammalian cell
.
, the
g/ dl
indicated
Pharmacodynamic effects
.
" high "
iron stores should
approximately 18 %
The vials are
chronic renal failure patients
angiotensin converting enzyme (
a
and other erythropoiesis-stimulating
pancreas
and 12
less duration ,
while approximately 86 %
, the
median time to
x
jaundice
,
should
There are
Kingdom
slowing of
your doctor
and
been observed .
carton .
.
of
(
A number of cleavage
one vial of
thrombosis , arterial
only
with
indication of
, in patients
, insulin requirements
Allergic reactions have been
( e. g.
or
5.9
,
x 1 ,
, less than
of ABILIFY
used for 2.
During
further reduction of bone
7.5
and 16 mg
Premixed insulin products
or during lactation .
g/ dl
do
should
sensory
impact on overall survival
decreased locoregional control
-
in
.
10 and
ml solution for injection
see 6.1 .
common
g. insulin dosage
- After opening the
United Kingdom BRISTOL-MYERS SQUIBB
have been
for Aclasta-treated
may vary with
OF ADMINISTRATION
headache , dysgeusia ,
Following
Abseamed has no
Global
with encephalopathy-like symptoms
75 -
1 tablets
may
studies
trials , an increased
In
%
DK-2880 Bagsværd
paediatric
Erythropoietins are growth factors
51 Adjustment
has
insulin human .
possibility of your becoming
chemotherapy
)
g/ dl
An increased 3H-thymidine incorporation
see sections 4.8 and
When a
can cause side effects
.
Nausea , diarrhoea
effects
week
( See section 4.4
or 45 mg
When the CYP3A4 or
aminoglycosides or
nausea and vomiting
arrhythmias
section 4.4
to drive and
(
maximum daily dose
isolated cases of angioedema
Blister (
Eli
mg
potent
epoetin alfa
3116 8952
(
Treatment should be
this should be
may
several controlled studies
glass ball to
QT prolongation , ventricular
patients
,
34 ( 91
during pregnancy
( E951
section 6.1 .
and 2.47 in favour
ABSEAMED IS AND WHAT
recommended dose is 600
treatment
and
and
Teil
except
studies
14
,
be presented .
animal model of familial
1 pre-filled pen contains
the haemoglobin target range
dose
due to co- morbidities
is not
subcutaneous
transient ischaemic attacks
in isolated patients
10 and 12
( anhydrous ) .
which were
and 12
they
with
36
and
by
chronic renal failure
Actraphane
( symptoms
, ketoacidosis
of excipients ,
Ltd Tel : +
172 Danmark
, ventricular arrhythmias ,
, diarrhoea
non-cancer cells
-
of
,
76
section 5.2
wurde durch
name
1 800 )
your doctor
see section 4.8
of adverse
, the dosage of
: + 40 (
moderate affinity for
administered
Common :
minor metabolites , 3
SQUIBB NORWAY
or
sizes may
of Actraphane
,
DNA
to the baby .
sensitive
.
reports
KG , Kuhloweg
.
stools
into 2 equal injections
, especially infections
physical activity
,
may
,
patients
, 98 x 1
Functional Assessment of Cancer
.
either valproate
or stroke
haemoglobin
.
evidence
, 84 , 90
in bacterial
cancer patients receiving chemotherapy
is a
diarrhoea , vomiting
between 9.5 and 11
exposure
for
relevant effect on
not clinically
ml
,
0)21
cases of stroke
Europe
they
high risk from
a prospective ,
see section 4.4
Ask your veterinary surgeon
may
, corresponding to 5.330
very
+ 44 ( 0)1628
Co KG
clinical studies ,
, especially when
IU ) corresponding to
authorisation . du
cerebrovascular adverse
-
bone marrow cells
for
( IU ) per
revealed no medically
stabbing
Bristol-Myers Squibb
:
( for pH-adjustment )
to protect from
Medicines
and
with a
( e. g.
Elevations
kg over 2 years
.
and
)
100 %
rare cases
solution .
an increased risk
MATERIALS
,
pharmacokinetics
22 kg BW 210
doctor or pharmacist
.
.
A-009 and
when a
% isophane insulin
+44
(
and a
) .
The
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LTD
whether
human
elderly
your doctor may
In patients with
,
placebo
a
active ( M-II
come into
.
and
is usually reversible
not exceed 200
Inadequate dosage
mmol/ l )
ensure that
neuropathy
isophane insulin .
patients
transient ischaemic attacks ,
to
with
and death in utero
irregular
34 Elimination The
section 4.8
in schizophrenic
route
insulin products ,
.
ABILIFY
take more
ABILIFY
more effective than risedronate
was
per month )
Middlesex UB8
FOR
.
s efficacy
a vial
taking ABILIFY
clinical trials
72 ( 31 %
10 g/ dl
hours
type
mmol/
BSAP
are usually
erythropoiesis stimulating agents (
data reveal no
and 400 mg
Adult surgery patients
to aripiprazole tablets
haemoglobin and blood pressure
in type
ABILIFY
the dose
.
may require discontinuation of
6
anaemia
1 ml
to
contain
should not exceed 200
or if
Aripiprazole did not
chemotherapy
treatment outcomes
doses of Aclasta .
treatment
potassium
and
.
effect of
children and
, in some cases
anaemia ( e. g.
or
1.25 mmol/ l
65
rare cases
24 hours after the
.
by
multiple medicinal
effect of insulin
this
type
, especially in
treatment
a clinical
450 IU/ kg
,
of glass
manic episodes and
monitoring of
the
% with placebo
(
(
(
growth hormone and
haemoglobin values exceeding
may be
0.3
.
in both
( 30
therapy
and
less severe
mg aripiprazole
needle should be
ACTOS on the
.
Uxbridge -
or obesity
: + 32
see section 4.6 )
% ,
to
30 mg
ABILIFY tablets
has
see also
and
may impact
is
overall survival and increased
alfa
in
and isophane ( NPH
of this population
precautions for
should be
retinopathy
Due to
.
0.0533 mg
There is
study included only
The
are white to off-white
or mixed episode
The
um 5
g/ dl (
the blood sugar .
werden (
and approximately 60 %
11
) ,
patients with
randomised , double-blind
)
Weight gain has
and 2.47 in favour
of
metabolised
( CLAS )
. They include thirst
(
>
outer
,
in the
efficacy of M-II
)
.
Luxembourg/ Luxemburg Takeda Global
and
with
4.5 .
as hydrochloride )
3 trials
n =
, Oxford Road
in vivo
Package
to 12 g/ dl
between 25 and 50
: + 32
40
dose
15.7 % for
Upon discontinuation
erythropoiesis stimulating agents (
metabolites
haematocrit of
the dose should
Glutamyl Transferase (
agitation and
stroke or
-
or
Male
,
, or
,
unused product
4.5 Interaction with
Carton of 14 x
(
.
patients ( particularly overweight
more
and
in
32
not
per
in haemoglobin ( 1
has multiple well
,
moderate affinity for
contains 45 mg pioglitazone
lower the blood pressure
11
carefully
use
orodispersible tablet at the
should be rotated
(
5.9 -
considered
in
that
184
30
see section 6.1 .
subcutaneous tissue .
with a
.
n = 131
headache , tiredness
3 patients with
type
cancer patients receiving chemotherapy
doctor
139
used in humans .
,
terminal
. :
on
(
benefit has Actraphane
followed during preparation
hyperglycaemia
akathisia in
symptoms
inside
with normal
of thrombotic
patient group .
%
solution
isophane insulin
a
of akathisia in bipolar
physical
.
nausea , vomiting
( see
of in vitro solubility
per week
the
Ltd ,
or 13
Medicines
- If you have
patients
sodium hydroxide (
of
your
is unknown .
.
30mg
( 8.1 mmol/ l
treatment
see section 4.4 )
(
source
and
per month , or
Arzneimittel Pütter
trials of
50 %
6.1 .
These measures will help
and
The
risk for
administered
may cause allergic reactions
.
(
solution for injection
and 16 mg
edetate , fructose ,
Insulins and analogues for
9.5 years
158 Do
12
BRISTOL-MYERS SQUIBB
OF UNUSED MEDICINAL PRODUCTS
All special warnings and
of aripiprazole .
Patients
In
aripiprazole should be
influence on the
d
that epoetin
sedation ,
Bipolar I Disorder ,
immediately if
should
below 30°C )
4.5 Interaction
.
between 10 and 12
given subcutaneously
MEDICINAL PRODUCT
PIOGLITAZONE IN
and
)
of the pancreas
are transitory
metabolites
(
Multi-pack
IU
to
dehydro-aripiprazole ,
section
patients
unexplained
lead to hypoglycaemia
PARTICULARS TO APPEAR
epoetin
dose
for injections
34
.
:
healthy
your doctor
1.25
United Kingdom
SQUIBB Tlf
insufficiency .
see section
of greater than
the
with Aclasta ,
to 15 minutes
the limited experience
13
, headache
nutrition programme
inhibitors of CYP3A4 (
( see
control decreases
.
patients should
for
headache , tiredness ,
the serotonin reuptake site
that
.
dose
,
with
Close monitoring of
%
.
medicines
type 1 )
serious
of ketoconazole or
section 4.4 )
, tiredness , nausea
bradycardia
% with
Tél/ Tel : +
30 mg
19.3
all timepoints (
allergic rhinitis
different dose
( hypoglycaemia
than normal
( 53
or
[
analogues for injection ,
manic or
or too near
be exceeded
women in
is
individual insulin requirement is
and
more
In
Authorisation Holder and
7.5
Lilly Holdings Limited
on
1 or 2
high
2°C - 8°C .
stenoses
placebo
local requirements
days
98 film-coated tablets
and should
28108 Alcobendas
580 00
Road
22
Norge BRISTOL-MYERS
from light .
procedure
LTD Tel :
,
patients (
,
or
At therapeutic
Increased
Holdings Limited
Common : somnolence
of the hormone
the
pioglitazone in
of children .
Anaemia symptoms and sequelae
.
The educational programme contains
hypoaesthesia ( decreased sensitivity
( 5.9
may
In two
or without
treatment
femoral neck
and symptoms
your
cardiac failure ,
.
.
hydrochloride
Deutschland
in paediatric and
any origin
administration of
akathisia was 6.2
aggravation of existing
dose of
subcutaneous route and is
)
haemoglobin
stroke or
mg paclitaxel
10 to 30
Diabetic
)
local infection
to
pioglitazone
Business Park , Oxford
ml
adult
( Europe )
39 %
symptoms
10
and
SQUIBB PHARMACEUTICALS LTD Tel
The
251 21
.
.
However ,
blood
both fast-acting
Abseamed
)
of 12 -
and
cardiovascular
of NMS
relevance
be
haematocrit
After a single
over three weeks in
or
14
who suffer from a
Road Uxbridge -
)
rare
oral bioavailability of the
with Actos are
00
in the
a mixture of dissolved
aripiprazole .
symptomatic
,
Abseamed
D levels
the placebo group .
, i. e.
of adverse
The syringes contain
the
In CYP2D6
,
maximum
.
and dehydro-aripiprazole did
for
increased Aspartate Aminotransferase (
in
12
mother presents no
in section 4.2 .
AUC
The blood glucose
controlled
no
:
meal
62 Cardiac
or very rapid
of children
fatal
to the events
patients was 12.1 %
swelling and inflammation
0.3 ml
, constipation ,
improvement
of administration
.
remain at
a
evaluated
Norge
IV
Tel : +
(
international units
Treatment of anaemia and
to
section
very
PRODUCTS
64
.
insulin resistance
AUC and Cmax of
section
In
30 mg
metformin
and
treatment
non-selective beta- blocking agents
moisture
Pregnancy and breast-feeding You
Other
very
1
) of
signs and symptoms
is 0.25 l/ kg
6 %
see section 4.8 )
.
If you
with
differences .
product at 52-weeks was
2 352
.
PRODUCTS
and
data
: +44 (
In two
a
House Highbridge Business Park
below
Aseptic techniques
mg
.
2.5
feeling anxious ,
D Centre (
.
1
defined by a decrease
, including PANSS
prior to
.
or
each
in the
1736
and inter-individual variation .
day ) .
Analogue Scale (
50
disposed of via
:
number
risedronate .
( 7.5
placebo
and 12
in order
United
Uncommon
(
, diabetes
children .
may vary with age
100 IU of insulin
to 12
The study was not
.
who
Uncommon - Diabetic
and
the
and pink ,
.
studies
43
all
and
when
ml
: + 36(0
%
x 1
was 12.1 %
paediatric and adult patients
route
section
:
a
not
aripiprazole
use of
last approved on
in Aclasta
in Bipolar I Disorder
Most reactions are
more than
disorders and
the intravenous route .
myocardial ischaemia , myocardial
the risk
) .
IU/ kg
over 6 months
.
haemoglobin is rising by
g/ dl
an increased risk for
.
,
28 x 1
with chronic renal failure
in routine laboratory parameters
Potential for other medicinal
Actraphane
hydrochloride )
hypertension .
l/ kg
diabetic
.
4.7 Effects on
unclear whether
not
Use should be
dose is
, 30-36 Avenue Gustave
no clinically
:
multiply .
.
g/ dl ( 8.1
with
section 5.1 )
with renal anaemia ,
g/ dl
Takeda Global
every
.
initial treatment response
pre-filled syringe of
cerebrovascular adverse events
GGT ) ,
1 pre-filled syringe
is considered to
the active ingredient
for
adult patients
,
in very rare
is not
6
an increased
)
and inter-individual variation
) .
treated , if necessary
observed (
contains 10
male patients
It
events cannot be excluded
, less
160 Danmark BRISTOL-MYERS SQUIBB
5.1 ) .
is
.
Aclasta
D-58638 Iserlohn ,
in post-menopausal women in
of standard
should be
on in vitro studies
aripiprazole
few
.
been carried out
conducted in 375 anaemic
with
, warfarin
) corresponding to 67.2
alfa in cancer patients
syringe onto
reconstituted
Each orodispersible tablet
be
or
be treated
: up to
in patients
Centre ( Europe
by three biotransformation pathways
in a cartridge
24 hours
see also
oral
heart failure ,
receptor , and
and Manufacturer
mmol/ l
( 30 % )
to
reported
In a prospective ,
sulphonamides
reduced
and
+ 351 21
other insulin products ,
pregnant
)
renal
clinical effects
to
-
At therapeutic
Your doctor can recommend
of ABILIFY
studies
, nausea ,
with
, sleepiness , shaking
may help to
therapy
week
.
4.4 )
during treatment with
most frequent adverse reaction
and
experience
to a
hypertension
symptoms
.
mg )
severe renal
clinical
be disposed
with
after
354 535
quinidine occurs .
such patients .
patients
It
several controlled
Safety
( DVTs )
ABILIFY
( 0)20
- if the
Hunton
during treatment
mmol/ l
weight gain
, even several
Microcrystalline cellulose Aspartame
patients
The patient s ability
CHMP
Global Research and
not
5 mg of paclitaxel
IS
.
difficulty
section 6.1 .
insulin requirement .
(
the
44 ( 0800
Glycine
MATERIALS
done
.
aripiprazole .
unconsciousness
bacterial and mammalian cell
for signs
ABILIFY
and
and
the limited experience
, the incidence
laboratory parameters revealed
is no accumulation :
somnolence ,
very wide .
the gluteal region
( t½ )
of
schizophrenia
patients
standard genotoxicity tests ,
has
rare
Storbritannien Tel : +
.
.
200 mg
should not
injection
or hepatic impairment
.
in Saccharomyces cerevisiae )
-
agents (
see section 4.4 -
with solid
3A4 ( dextromethorphan )
be used .
levels remain the
( 6.2
be marketed .
AB Tel : +
Recurrence prevention of manic
%
%
zoledronic acid monohydrate .
: dyspepsia , vomiting
and transport refrigerated (
of agitation
aripiprazole .
diaphoresis and cardiac dysrhythmia
) of EPS
you need
the intravenous
the dose should
a
be discontinued immediately
12
, are not
5.1 )
34
the active substance aripiprazole
Co KG
respected .
adult
haemoglobin of greater than
are
:
in two studies was
.
see section 4.2
you are
of the
other
D Centre ( Europe
experience
patients
and disturbed behaviours
the
, ketoacidosis
and a
,
8°C .
in
mg has
ml equivalent to 300
the mean
1
Product Characterisitics
information on
of children
)
of clinical
pregnant or
Read all of
4.4
% ) of
30 kg require higher
of
has not
If you
greater than
dehydro-aripiprazole
cleavage (
from
serotonin 5HT2c and 5HT7
a dose adjustment
, uncommon cases of
mg )
or
is effective
of anaemia associated with
of 1
( for a
CYP3A4
to
and
the
.
Business
practice .
(
15mg tablets
1 tablets 28 x
the
If
either Actos or
dextromethorphan/ 3-methoxymorphinan ratio
myocardial infarction or
the pack with
renal
g/ dl
insulin 50 % and
body weight 2 times
cases of
not
can be
injection :
172 breast , 64
( e. g.
4.4 )
hospital and take
mmol/ l
other erythropoiesis-stimulating agents
.
efficacy
reconstituted
Road Uxbridge - Middlesex
hour
,
BRISTOL-MYERS SQUIBB
units in increments
0800
As for
In the
medicine (
Ísland VISTOR HF
, for
dehydro-aripiprazole
HF Sími : +
Consequently ,
Actos
with ketoacidosis or hyperosmolar
WC2B 4AE , United
to
the pharmacokinetics of aripiprazole
orodispersible tablets 49 x
D Centre (
If
and inter-individual variation
is
with
site within a
Maintenance dose between 25
maternal body weight gain
and lymphatic system disorders
An
for three weeks
The biological efficacy
BE STORED OUT OF
% ) and
event of an overdose
of Epoetin alfa and
,
1 60 14 30
(
are
haloperidol
( see
4
a
20
2697
.
below 25°C ) .
and transport refrigerated
daily dose
are growth factors
from
fragile
bound to bone tissue
0.62
anaemia with epoetin alfa
.
Like
) .
epoetin
of
2 352 74
The therapeutic
schizophrenia
see also section
during treatment
)
0)1 580
soluble insulin
but excluded other bisphosphonates
of one year or
micrograms epoetin alfa
other forms of interaction
, thyroid hormones and
of adult
maximum daily dose
% with
wurden. er
of
haematological malignancies
terminal half-life ( t½
the active substance
active substance in
fibrosis of
their previous insulin
manic episodes
is designed to be
anaemia
%
antihypertensive medications
elective orthopaedic surgery
for pH-adjustment
ml
observed after the
is achieved (
over
one year or
14 and
Novo Allé
epoetin alfa .
Do not use ABILIFY
84 , 90 and
doctor
In clinical
in
with
N-dealkylation is
, sedation ,
( 1 to
solution for injection
Actraphane 30
( see
insulin .
Studien bei Schwangeren
lactose monohydrate
may
, 56 ,
,
is
than
than
and 3A4 ( dextromethorphan
Erythropoietin receptors may
If
solution .
of aripiprazole AUC
200 -
monotherapy or combination therapy
weeks (
the medicinal product
every four
The
, open-label studies ,
in
or pharmacist
you are
House Highbridge Business
chloride Glycerol Metacresol Phenol
.
with residual
the
A
safety
thiazides
no
.
535
events which
patients with
)
away within
.
with ABILIFY
warning symptoms of hypoglycaemia
.
.
section 4.4
be
MINIMUM PARTICULARS TO
pioglitazone
Conventional types of paclitaxel
and
is 150
regularly
Arzneimittel Pütter GmbH &
%
control group .
.
risk
including PANSS and the
In
at the
6.1
Before
is
with
7.5 mmol/ l )
paracetamol
and
and inflammation
- 14
( see section 4.4
section 5.1 )
mix
be used
a pre-filled syringe
your doctor
increased risk for
reactions
PRODUCTS , IF APPROPRIATE
&
(
.
35 trials
are
, Oxford Road Uxbridge
7.5 mmol/ l
all
per
local safety
5
, United Kingdom .
production
44 ( 0)1628 537
clinical
, increased risk
days
.
studies ,
0.8
the active substance
trials
%
symptoms of agitation
half-life of approximately
56 ,
Table 1 lists
aripiprazole
% )
Belgique/ België/ Belgien
and analogues for
Farmacêuticos
with
to affect ABILIFY :
4.8
present state
is available as
and death in utero
the
pharmacist
environment .
In clinical
per week by
may
with
will use
is
epoetin alfa
have
cancer
Abseamed
PRCA
: blurred
myocardial infarction
study
Eli Lilly Holdings
vitamin B12 or
allergic reaction (
from light
thus not necessary
after
Aripiprazole orodispersible tablets
The syringes contain 1
insulin and 50 %
Uncommon
following
epoetin alfa Abseamed
of
schizophrenia ,
- 300
%
Tel : +
( IU
be presented
these
The
4.2 Method
4.8 -
patients
section 4.4
and
4.7 Effects on
A
possible warning signal .
warnings and precautions
was
of 200
based on
women with
2.47 in favour
unexplained death
in
A number
additional risk factors (
.
( not
ability
difficult
you
see
by the intravenous route
of the warning
medicinal product contains
than
and danazol .
to protect the environment
not
lung ,
-
heart failure
by significant intra- and
by significant intra- and
:
below the
300 IU/ kg 3
United Kingdom
of
function
with
not
, thiazides ,
patients of
daily dose of 15
Each
the
dextromethorphan
Intensified control in
as hydrochloride ) .
x 1 tablets
should
2697
but not
be avoided .
( E218 )
165 amino acids
12 g/ dl (
versus animal source insulin
or more
or
mg/ ml )
( 2°C -
per
vs. placebo ) was
hour
other
headache Eye disorders
of your concern
, aripiprazole failed
House Highbridge Business Park
- 8°C
There
, exertional dyspnoea
is therefore recommended .
for the
PRCA
present state
a pre-filled syringe
or
or during lactation .
pioglitazone
rare
Actraphane
and
mg (
may be
and blurred vision
sudden
.
including bisphosphonates
or
such as
to tell your doctor
with
presents
insulin sensitivity .
,
the
type 1
0)21 272 16 00
warfarin )
is
hypertension ,
The biological efficacy of
contain 0.3
In
)
section 4.2
(
5 and
10 pre-filled pens
patients
be followed
:
of diabetes was 9.5
of
has been
Kingdom
normal
260
.
monitor
werden mit
on tightly .
%
the pancreas
Nordisk A/ S
a few weeks
All
,
evidence of clinically significant
heart failure
not clinically
(
after
must be followed .
and what it is
0.035 mg of anhydrous
.
bottle
section 5.1 )
study
vision .
,
other CNS medicinal products
taken in combination with
clinical studies ,
)
.
. ) .
on one
is not recommended .
50 IU/ kg
treatment with aripiprazole
( e. g. stenoses
of
trials ,
Carton of 49
absorption
, especially infections
of white
3 patients
was
.
Hydrochloric acid
ABILIFY
DERIVED FROM SUCH MEDICINAL
pneumonia ,
patients
The
and
e. g. increased
11
epoetin alfa
given
in
BY UNIT
9 61 33 22
intentional
358
(
paracetamol or ibuprofen shortly
.
particularly
g/ dl ( 7.5
per
1 )
was
Protamine sulphate Water
obesity in
between
of
and
BE STORED OUT OF
,
coldness , orthostatic hypotension
( with a baseline
, 23 lung
150 60 - 150
stomach discomfort
United Kingdom
per
50 , 56 ,
fast-acting , insulin
in
or pharmacist
95 %
use
pre-filled syringe
vary with age
flavour ( including
in paediatric and
use
to
12
diabetes mellitus and
5.1 ) .
.
when
study
Uncommon :
werden auf die
product immediately
between 10 and 12
Portugal Lilly
Nederland BRISTOL-MYERS SQUIBB BV
was
60
30 mg tablets may
of
The recommended dose is
nausea
the
rimonabant
section 4.4 ) .
treated
of these
maximum
the
Eli Lilly Holdings
not been studied
28 In the
Diabetic retinopathy
site conditions Uncommon -
,
large controlled
,
for
- 150
please contact
( two
see section 5.1 )
RH12 5AB United Kingdom
important
PARTICULARS TO APPEAR ON
maintenance doses
21
NMS
and approximately 60
effects
is
orthopaedic surgery
) The
and
,
.
Although
may increase
heparinisation ) may
human
Non-clinical data reveal no
.
during
and
mmol/ l
patients with
A-009 " and
- Middlesex
40
solution for injection in
rare ( see
clinical effects of
.
tablet
, the
CYP3A4
.
patients participating in
,
( see
dysmotility
aripiprazole
severe renal
(
compared to
route .
Adverse reactions
was
Following concomitant
What ABILIFY is and
, diabetes mellitus
therapy
or intentional
Epoetin alfa and other
colourless
by
in
patients had a previous
4.4 )
pharmacist
7.5 mmol/ l )
not be exceeded .
or worsening
third of
* Produced
.
the anaemia
units
10
rDNA ( produced by
mmol/
12
- Middlesex UB8
povidone
in a pre-filled syringe
49
All patients being
Oral
some of
human )
favour of controls
IU/ kg
and
and
When either valproate or
0)20 3116
pioglitazone
pigment ( haemoglobin
patients
in
Strada Statale
( 172 breast ,
ml
( see sections 4.8
per
.
following
and Cmax of dehydro-aripiprazole
refer to the
.
patients
,
% isophane insulin .
and
study population had
significant risk factors
the haemoglobin target range
The absolute oral
) .
.
,
therefore
renal
valproate or lithium
patients with
looked
600 IU/ kg
other three
Actos or
not
Analogue Scale
in
glycaemic control decreases
OR
the reach and sight
clinical trials
In
of controls .
symptoms over 3 weeks
autologous
of CPK (
patients with
been receiving aripiprazole
Recurrence prevention of manic
recommended weekly dose
glycosylated haemoglobin
+44 ( 0)20
or
FINLAND )
5
human .
other
a
section 4.4
4.4 ) .
2
For a full list
Purified
( 0)21
in
76 The
cannot be excluded
( days 21
other
)
cannot be excluded
OR
25
: +
The initial dose
They include thirst
, combination
an
with an apparent volume
Concomitant administration
or exposure
of erythrocytes from precursors
other
may
and
, hyperglycaemia
administration of ketoconazole or
Vascular disorders Uncommon :
( see
of cytochrome
Patients
12 g/ dl
blurred
in healthy subjects ,
, Kuhloweg
starting dose for ABILIFY
third
healthy subjects
12 g/ dl
Takeda Italia
to 6 weeks )
retinopathy
This may constitute
cell production .
g/ dl
contain 0.3 ml (
,
systems
the
dehydro-aripiprazole
marked with "
used for 2.
glucocorticoids , thyroid hormones
(
occurs ,
administered by intravenous infusion
of myocardial infarction
condition
declined in
pioglitazone
)
recommended (
Tel : +
2 352 74
progression of diabetic
of these
The recommended
+ 45 45
suggest
( anhydrous ) .
the medicinal product
-
alter laboratory
g/ dl
methylene groups .
this
administration .
once weekly
.
hyponatremia
It can be
)
per
( see
be considered
events compared
very
Middlesex UB8 1HU
to patients with
)
than
adult and paediatric
4.7 Effects on
3.2 % with
AUC and
Upon discontinuation
.
family history of
12 g/ dl
0)1 46 25
,
route .
mixed episode
(
DK-2880 Bagsværd Denmark
pioglitazone with gemfibrozil
tumours
and
of CYP3A4
population
clinical trials of
) , chest pain
of the compound or
g/ dl
be applied
in
disturbance ,
clinical
.
or more
preclinical toxicological studies in
45 93
-
four weeks .
is injected .
clinical
ng/ ml
aripiprazole
placebo-treated
The
ready to use (
and completed suicide (
important signs and
and
,
ischaemic
following reactions
epoetin
the
mg )
Pharmacotherapeutic
based on mg/ m2
13 g/ dl ,
placebo group .
.
30 mg (
weeks
performance
,
.
.
05
other
children and
.
Highbridge Business
units ( IU )
other ingredients .
.
1
diabetes ,
months after
( 30
fast-acting , insulin
possibility of multiple medicinal
Europe )
If epoetin
be a moderate
3 sites of metastases
.
AS
450
overall survival and increased
This regresses
cellulose Aspartame
anaemia ( e. g.
Actos is and
if
- if the solution
If
after
effects were
) and
Glycine Polysorbate 80
cumulative
RH12 5AB United Kingdom
mellitus ,
United Kingdom .
ml
and
to
diabetes
is catalysed by CYP3A4
)
,
infusion
haemoglobin values exceeding
studies ,
patients
) .
or snack containing carbohydrates
and
no fatalities .
recommended starting dose
, Spain
reported in children .
to
21 230
l/ kg .
dysfunction
Business
The
Produtos Farmacêuticos ,
designed to be
are rectangular and
treatment with aripiprazole
.
achieved
and
Some
Blister (
of
specific frequency can
below 100
Authorisation Holder
be
9.5
( Europe )
731
15
Correction for anaemia
dietary control .
study .
mg/ ml
or hyperosmolar
administered
Hb 10 - 13
than
1 , 5 and
any origin
.
of insulin
or Hb increase 1
The
: orthostatic
or
trials
REACH
Your
in
reported
in
, akathisia
of the
4.5 Interaction with
Patients with renal impairment
For
tumours (
from the
40
: +
mother presents no
.
no
with aripiprazole and
.
5.2 ) .
.
The
+ 32
or
SPECIAL PRECAUTIONS FOR DISPOSAL
not
, suicidal ideation ,
five
.
8°C .
the thighs
( 50
enzymes
a
Protamine sulphate Water
reactions may
Pre-filled syringes ( glass
once a year
has been injected
in
month ) with
, polycythaemic mice )
two
studies
.
with a
mg
2 g/ dl
with ABILIFY
)
severe renal
a daily dose of
and
%
ml
treatment with
in vitro solubility .
injection
white
chronic renal failure and
APPEAR ON THE
4000 IU ) of
, were
.
patients with
for
If
1HU -
or
Oral contraeptives
Nervous system disorders
have any further
patients
15 mg tablets may
of P-glycoprotein .
g/ dl - 12
with bipolar disorder
treatment with
medications
the risk of
patients with a
and
33 -
emaciated appearance ,
used
see sections 4.8 and
young subjects
method
.
Finland Oy Eli
1HU - United Kingdom
or
ketoconazole
with
by 107
environment
see section 6.1
, growth hormone
.
,
Since the
of the
to the foetus
patients
not
doses above 45 mg
the
,
mixture of dissolved
increased
be necessary
vascular events ,
diabetes
epoetin alfa ,
1
and
.
) should be avoided
Business Park ,
15 mg tablets may
Effects on
during treatment
may be a moderate
ml equivalent to
of greater than
the EPAR )
,
74 60
mean difference
mean
cancer
or combination therapy
The maximum
than
21 412
Park ,
placebo-controlled trial
nursing
and
patients with
IU ) of
Do not use ABILIFY
how
international units (
3
Frequencies of adverse
a potent inhibitor
EU/ 1/ 00/
haloperidol-treated patients .
measures will help
per 100
It may
not
, 64
( 0)20 3116
If
the tablet with
has been proposed that
effect of medicines used
( 0)20 3116
pharmacist for advice
Functional Assessment of Cancer
93
significant risk factors
mg
as
of sucrose .
Abilify and placebo over
trial of
Diabetes Mellitus : hyperglycaemia
increase in haemoglobin
the risk of
34 ( 91
trials and
0.62 mmol/ l
adjusted
and mediastinal disorders
% and
unchanged aripiprazole was
have
manic
In clinical trials and
Do not take
and/ or non-healing
It
CONDITIONS OR
difficulty
)
preventing
controlled
: +
below 30°C )
and
of solution contains
mmol/ l ) in
from the
Aclasta
and should
combination
section 5.1
with renal
post-marketing experience
transport
coma or
in isolated patients with
+
Adult and
dose
with
chronic renal failure patients
alkaline
2 diabetes
) ,
route .
:
with these
mmol/ l
( 6.2 -
experienced
aripiprazole
ensure the safe
aripiprazole treatment
.
in
DISPOSAL
the
, Oxford Road Uxbridge
&
decreased by
rats , polycythaemic mice
section
both fast-acting
for
trials
in clinical trials
.
Highbridge
SQUIBB
type 1
BRISTOL-MYERS SQUIBB Tlf :
, oesophagitis ,
these characteristics
8°C )
glass cartridge (
higher dose to
subjects ,
)
1800 ml .
.
haemoglobin values exceeding 12
% )
,
with
and behaviour and emotional
but its occurrence
.
2°C - 8°C .
3 weeks
the following
chemotherapy
serotonin 5HT1a
anaemia
from human tumour samples
with a
(
40
UB8
anaemia in
and
the
contains 100 IU of
ein
inhibitors of
or 450
Owing to
obesity )
two
and 50
)
in
haemoglobin is
week
30 % dissolved insulin
injection site
studies
Kuhloweg 37
5-hydroxytryptamine are involved
within two weeks
any 24-hour
.
BRISTOL-MYERS SQUIBB
usual starting dose is
[
patients with chronic
in a refrigerator (
ABILIFY
: in clinical trials
45 mg of
observed
be necessary
called serotonin ) .
4.7
doses of Aclasta
500
The maximum
use
, the
the CYP3A4 or
24 hours .
two other
physical
Assessment of Cancer
The
.
or
bisphosphonate .
of
including parkinsonism , akathisia
33
In type
from light .
are lactose monohydrate
with
with renal
administered intravenously
programme
has
is
the
be marketed .
with
4.8 - General
carbohydrate composition to
REACH
over 24
wastewater or household waste
see section
.
not
Aripiprazole and other
,
solution for injection in
from
(
Potential for other medicinal
aripiprazole
THE WORDS
( see section
doctor
rapid control of
isophane
Saccharomyces cerevisiae ) .
LTD Tel :
,
during continued
alfa is a
ml
Road Uxbridge
or other
2 352 74
conventional paclitaxel-containing medicines
and/ or dark urine
clinically
is
and
and/
by the intravenous
duration
" 641 "
those receiving placebo
Takeda Ireland
) per
no
for males )
Peripheral sensory
of agitation
undergo periodic
undergoing dialysis does
When
If
stenoses
and
pack
may
by
OR RESTRICTIONS WITH
AB Tel :
was
with epoetin alfa
hives , swelling and
.
Kuhloweg
use machines
compared with patients
production
precautions
than children over
the recommended
.
: dehydrogenation
cerebrovascular adverse
be marketed .
of
and extrapyramidal
active malignant disease
characteristics
70 %
Glycine
not exceed 200
6 pre-filled syringes of
solution for injection
Patients who
MEDICINAL PRODUCT
(
) .
30 kg require higher
should
per week
United Kingdom
g/ dl
adequate and well-controlled
( 683 breast
Kingdom BRISTOL-MYERS
.
the
In a prospective
patients
are
dose
.
alfa
N=70
insulin requirements
suicidal ideation ,
UB8 1HU - United
.
chemotherapy
( MAOI ) ,
Centre
a prospective
from
see section 4.5
on in vitro
and
If the haemoglobin is
5HT2a receptors
,
the blood pressure is
.
to sudden stabbing
Subcutaneous injection
2°C - 8°C .
see section
.
following
.
Refraction disorders
Elevations of CPK
forms of
4.6 )
Effects on
formation of erythrocytes from
observed ( see
Particular attention should
,
potassium and
MUST BE STORED
.
,
.
1.25 mmol/ l )
accepted
, but
your condition
aripiprazole )
(
The
is to check that
to the possibility
12
years
myoglobinuria (
,
Dose adjustment
children and
.
to
) ,
bipolar
+
USED FOR
1
.
of the
The
in this
10
, hepatitis
are
but this effect
the aripiprazole dose
)
carton .
of epoetin alfa on
or
74-week extension
this patient population .
medicinal products with
thiazides , glucocorticoids ,
once daily
This may constitute
month or the
potentially medically serious signs
and
be used .
with
in 24 %
greater
headaches as a
The aripiprazole
Uncommon - Peripheral neuropathy
itching , hives
In the four
use in
section 5.1
,
Elevations
for 2.
over 3
exhibited antagonist properties in
cases of NMS
phosphokinase
blurred vision .
for
, sedation
which is potentially lethal
(
can occur
APPEAR
)
18 %
therapy
alfa
of
Ltd ,
The rate of
D-58638 Iserlohn , Germany
increased
after
individual insulin requirement is
4
IU/ kg
cancer before ,
7.5
g/ dl
defined as the patient
psychotic features
diabetes
data
controlled as necessary
(
74
of medicines used
A/ S Novo Allé
your doctor .
dehydro-aripiprazole did
272 16
were
BRISTOL-MYERS SQUIBB ( FINLAND
.
do
use machines .
with
to patients with
dose is between 75
of insulin
6.8
Water for injections
with
8 704 71 00
in
subcutaneous erythropoietin
-
, diabetes mellitus
4.4 )
4.9 ) .
3 times
, the formation of
-
,
( cycloolefinic polymer )
of the other
neutropenia
Before use
orodispersible tablets
Malignant Syndrome (
clear and colourless
( 0)20 3116 8000
12 g/ dl
% )
LTD Tel : +
.
,
epoetin alfa
tremor , dizziness
BLUE
, aneurysms , etc.
Ísland VISTOR
1
usual dose
when taking ABILIFY
rather than of the
in strength
revealed
by
avoided
with epoetin
(
a quick
.
be exceeded .
a
oral
methods
increased
House Highbridge Business
( normal
with renal
sterile but
& D Centre (
28 x 1
tablets 49
of epoetin alfa
to dogs results in
a benefit-risk assessment with
of epoetin alfa
.
must be discontinued
hours
If blood pressure
, long-acting insulin
increasing insulin sensitivity .
Insulin treatment
than 1
or mixed episode
clinical trial of
: dyspepsia
l/ kg .
, itching ,
renal impairment
( IU
of
,
Deutschland Takeda
recommended total weekly dose
aggravation of existing
and
- 150 60 -
symptoms can occur .
and
and hypoaesthesia
PHARMACEUTICALS LTD
In some
or
12
ABILIFY is
.
)
Overdose of epoetin
allergic reaction
or pharmacist .
CYP3A4 ( ketoconazole )
of liver cirrhosis
between 10
including isolated cases
after the
significant effects were
dose
40 ( 0)21 272
)
, or as
liver
.
mmol/ l )
cases of
with insufficient glycaemic
a single
or
zoledronic acid
having a high
patients with a
5.2
Takeda
dalton
.
two
recommended
active
in
in haemoglobin (
and
ABILIFY 15 mg
1 , 98
at
if
may
mg of aripiprazole
a dose
Patients
Tlf : +
24 hours
of greater than 12
hours
stomatitis
) .
of
and
(
and
Tél/ Tel
Oxford
)
cerebrovascular adverse events
with consideration for
growth factors
population ,
repeated
and
1.25
Manic
listed below .
It is
patients
mellitus
fructose per ml
malformations and
or 450 IU/ kg
.
, Oxford
and sight
changes
dehydro-aripiprazole
risk
%
calibrated
IU/ kg 3
both
should be
versus animal source insulin
.
regimens including bisphosphonates
5.2 ) .
improvement in
risk for
after
anaemia
Oxford
that the effect
) .
N-dealkylation is
as measured
exhibited antagonist properties in
paediatric and
( 0)20 3116
( ALT ) ,
headache , dysgeusia
Middlesex UB8 1HU
Uncommon - Diabetic retinopathy
) .
with
are
other medicinal products
( 10
to patients with
and
60 % isophane insulin
to become
with
(
Deutschland Novartis
N = 30 )
and
Tel
of continued therapy
prior to
United Kingdom
symptoms is less common
of specific nuclear receptors
.
: + 43 1
58.8
with
epoetin alfa
pre-filled syringe ( injection
The
2°C -
Belgique/ België/ Belgien BRISTOL-MYERS
, rDNA
.
.
a bromobutyl/ polyisoprene rubber
severe
trials , a
>
that aripiprazole
0.035 mg of anhydrous
,
, diabetic hyperosmolar
International Units (
.
7.5
,
reported in children .
rats after
The dose
manic episodes
doctor
) or the
Usual warning symptoms may
or
from
42 trials and
.
g/ dl (
the
biological
result of hypoglycaemia
PARTICULARS
erythropoiesis stimulating agents (
and
(
clinical
> 5
levels
to reduce the metabolic
480 ml
for ABILIFY
and
or stroke
,
ALT ) ,
BRISTOL-MYERS
parkinsonism
the
unit dose
.
40 (
transient
Actos is
solution for injection in
for pH-adjustment
:
necessary
result of hypoglycaemia
( 30 % )
In an
and sulphonamides
: soluble insulin 20
products
2000 IU/
will receive
episodes
of the cardiovascular
physical
other medicinal
please see section 4.4
mean
well
water for injections
best to treat
order to protect from
shown significant benefits
32 % and
g/ dl (
or Hb increase
AND SIGHT OF
behaviour
)
in clinical
Similarly
absorb orally administered
you
5 ) 2649600
other insulin products
with epoetin alfa
, or 13
Additionally ,
renewal :
very wide .
EPS including
the administration of
glucose control
for smokers .
to
tablet
anxiety Uncommon : depression*
, 56 x 1
)
of excipients ,
your doctor
ABILIFY orodispersible tablets
g/ dl (
below 30°C
Hyperglycaemia
also be used .
with
in women with
increased
were receiving insulin in
before
in isolated
hepatic impairment on
( see
of efficacy or
1 cartridge contains
undergoing dialysis :
the
, vomiting , nausea
blister
Highbridge
Before
Not all pack
of NMS are hyperpyrexia
following the administration
.
brand ( manufacturer )
on the ability
courses
for 2
in
no significant
used
either
sollten ähnliche Dosiserhöhungen
contain 1
diabetes mellitus ,
sizes may
also
treatment with epoetin
vitamin D supplementation
iron stores
mmol/ l )
hours
daily dose should
The potentially medically serious
diabetic hyperosmolar
)
solution
IU
Dosage adjustment may
44 ( 0)1628 537
investigated
9 251 21
IU/ kg 2
(
in plasma .
33 -
Authorisation Holder :
dose
anorexia
the
section 5.2 )
that
: +
,
, hydroxypropyl
the risk
or
no experience in
mmol/ l
alfa
or
Febrile
the
than
to the
should
hypoglycaemia
skin (
than
abdominal wall .
suspected , therapy with
1 pre-filled syringe
formation
)
( see
may
dosing pipette .
(
see section 4.4 )
syringe
5.2 )
is ready to use
ready to use .
dizziness , headache ,
.
not
.
patients should
Tel : + 44
clinical trials
5.3 ) .
Unit ) corresponds to
%
the administration
of
events
no information on the
in the case of
be disposed
, including PANSS and
and anaemic rats ,
recommended
France BRISTOL-MYERS SQUIBB
OF THE
aripiprazole and dehydro-aripiprazole
( 7.5
, nausea ,
with aripiprazole
and
CYP3A4 ( e. g.
period
1
some of
to
given area may
,
clinical
.
may
( injection
56
of diabetes was 9.5
monkeys
week by
maximum
taking pioglitazone compared to
local requirements
.
(
insulin human
1
reactions
most of these patients
)
section 4.8 ) .
NPH ) insulin
Treatment
In combination trials
(
moderate binding affinity for
SpA Tel : +
,
and 2.47 in favour
60
Non-clinical
kg require higher
in
of 0.5
brain function
5.3
the placebo group
l
insulin products
6
human insulin
, 90
see section 5.1 )
not
2C9 (
aripiprazole
.
doctor or
patients
)
such as
,
more units
and
1
you
patient
section
differentiating hormone
solid
, the haemoglobin
) OF
daily
symptoms
be marketed .
electrolytes
are transitory and
the
for major
) .
of
DNA
Treatment of anaemia
section
in
individual insulin requirement is
- Diabetic
values
under the skin
in patients
( 8.1 mmol/ l
the ABILIFY
with osteoporosis
is
other
( e. g.
sections 4.3 and 4.4
pink , marked with
insulin and 50 %
, London
and
ACOMPLIA , see
hyperosmolar
,
reported in
as a mitosis-stimulating factor
- 8°C ) .
,
( e. g.
orthopaedic surgery
vomiting and
.
( haematocrit of
not
UK Ltd
.
( E218 )
in bipolar patients
with
Neuroleptic Malignant Syndrome (
than three
for
in the eyes
adequate
mg )
can occur
not
( 7.5
aripiprazole
Each ml of
opening the bottle ,
PRODUCTS OR WASTE MATERIALS
see section
(
revealed no medically
mg of
treatment
epoetin
could not be detected
patients with a
units
France BRISTOL-MYERS SQUIBB SARL
,
as a mitosis-stimulating
headache ,
However ,
in order to
the same
Takeda Global R
and rats
and
)
and protein intake .
or
solid
no medically important
See also
insulin human
as
1.25 mmol/ l
Hypersensitivity to
healthy
in
symptoms
and 3A4
Activated charcoal ( 50
no
Overdose of epoetin
with
6
.
5000 IU/
studies
baseline
a
elective orthopaedic surgery
your doctor
,
Common : extrapyramidal
the study of
taken
metabolised
(
8 tomography ( CT
in a pre-filled syringe
aripiprazole .
by a decrease
1 ml contains
16 to 81 times
of
lorazepam
STRIPS
.
- 12
30
of 0.6 ml
and 15.7 %
reduction of manic symptoms
Kingdom BRISTOL-MYERS SQUIBB
worsening
)
KG Kuhloweg 37 D-58638
, may
agitation
272
.
It
Europe )
with
.
Abseamed 2000 IU/
OUT OF THE REACH
.
section 5.3 ) .
pharmacokinetics in
in pregnant women
Studies in animals have
of
studies
The local safety of
Denmark
not
with your
Aripiprazole
( e. g.
in line with
Tél/ Tel : +
are
or 98 tablets .
variation
or
The decision to administer
controlled
on
,
Saccharomyces cerevisiae )
has been accidentally frozen
or hepatic impairment may
see section 5.1
tongue
signs of
than 1
(
- United Kingdom
WC2B 4AE United
2
Seizure
receiving pioglitazone
34
When
Novartis Europharm Limited
symptoms
in adult patients
the
UB8
it
to 12 g/ dl
anterior abdominal wall
,
+ 44 (
No studies
influence on the
(
8.1
.
be performed in
should be considered on
increased
epoetin alfa
mg of aripiprazole
% CI ] (
.
injections
with chronic
Do not
seriousness .
:
.
20 % and
doctor
you
carton .
reduce the epoetin alfa
information on
ABILIFY ( all formulations
treatment with
or
.
action .
5 % ansteigt
THERAPY WITH
.
not generally
aripiprazole
greater than
can only be
you
haemolysis ,
APPROPRIATE
t½
effectiveness was the number
treatment ,
terminal
or were
patients experiencing
may
activity
weeks
overall survival
about 40
international units
usual
after
0)1 47 56 69
.
your dog
alfa is
)
cases
between
observed when
when pioglitazone
see section 4.5 )
)
route
The potentially medically
37 D-58638
) AND BOTTLE
ml
pharmacist .
before
studies
some
pre-filled syringe
in patients at
hydroxylation of aliphatic
260 lung ,
a mixture of dissolved
;
98 TABLETS ONLY
and
monkeys
200 mg
.
be exceeded
House
IU )
stroke
change in their usual
Cancer Therapy- Anaemia
dosage may
Oxford Road Uxbridge -
of substances
Common
7.5
only
Tel
necessary amount
g/ dl ( 5.9
to
g/ dl (
.
In a
The following side effects
widened brain ventricles
more than 2
antipsychotic medicine )
days
children over 30
einer Adipositas ist die
IU ) corresponding to
plasma concentration
.
weeks prior to
is needed .
for
of Aclasta
If you
events have been
placebo-controlled trial ,
22 , 67019 Scoppito
is achieved
for 3
times per week
the
days ) low- trauma
358
5
% with placebo
Tél
%
used in
, and therefore
be
) per kilogram bodyweight
56
vitro (
cannot be excluded
zoledronic acid (
or more units of
of
pioglitazone
weeks in a total
products
and a negative
unlikely to
12
Distribution No
other clinical effects of
Actraphane
blurred vision
times per
dose of Abraxane is
and
as measured
for the
tablet formulation is 87
also
.
taking
)
Co- administration
Peripheral
Changes in strength
between 17 and 33
Population pharmacokinetic evaluation has
.
see section
.
(
, arterial
dysmotility and
reports
insulin
initiation of
Renal or hepatic impairment
during treatment with
vision
bioavailability of
No
the medicinal product has
Slovenija Eli
(
effect on
placebo-controlled trial , the
1
in
patients
: +
( hypoglycaemia )
bipolarer Störung
( 1.25 mmol/ l
Following
as measured
.
the
6.2 - 7.5
.
in vitro (
.
for
the
and
and isophane
,
erythropoietin
Lietuva Eli
and isophane
aripiprazole
MEDICINAL PRODUCT AND ROUTE(S
your doctor
pioglitazone (
in this
on the use of
SpA
disorder ,
.
with
and anaemic rats ,
used
Shunt thromboses may occur
and
prior to
programme .
increase in haemoglobin
In the
hospital as
23
programme .
Very
is a
and
be observed .
)
% with placebo
g/ dl (
the frequency
.
)
should be advised
headache
and post-marketing experience
( 7.5 mmol/
recombinant human
ON THE OUTER
patients in
may impact on
at least one
controlled
cerebrovascular
the first
:
Europe ) , µ
( 6.2 -
terminal half-life ( t½
pathways involving the CYP2D6
patients with these
4.5 Interaction
in
patient
mitratapide
4.5
and controls .
unused product
( below 25ºC
g/ dl ( 0.62
,
: fatigue Psychiatric disorders
0.5 to
Each ml of solution
diabetes
, marked with
both
Effects on
undergoing dialysis
and
The following adverse events
therefore
.
be followed .
)
GESMBH Tel
plasma concentration
:
:
5.2 ) .
called serotonin )
. : +36 1
and of the
section 4.8 ) .
of
differences .
, IF APPROPRIATE
maximum daily dose should
The
no
, ventricular arrhythmias ,
clinical trials and
of
IU
of
, the incidence
added to
signs
be exceeded
Opaque white
4.4
of malformations
preventing
) is
The
of 15
43
of
constipation
of the
, D-58638 Iserlohn
It could be
( 6 %
and 12
, weight decreased ,
the aripiprazole dose should
D
with ABILIFY
human
)
%
(
33
- 8°C )
clinical studies
Tél : +
AND SIGHT OF CHILDREN
safety
3 times per week
unique Vantas
7
no
the concomitant
Actos
A number of cleavage
diabetes ,
,
and
of this
%
SPECIAL PRECAUTIONS FOR DISPOSAL
pioglitazone
mean
ml
(
insulin ( human )
see section 5.1 )
All
, diabetes
therapy .
]
substitution of
were five short-term studies
104 The
) Blister
well-controlled
Adult
medicinal product contains
of the stem cell
.
elective
.
, even several weeks
and you
solution for injection
.
dizziness , neuropathic
tense .
( t½ ) is
after
,
protect the environment
Hydroxypropyl cellulose
LTD Tel : +
washed
Since the
IU/ kg/ day .
retinopathy Long-term improved glycaemic
a
pre-filled syringe of
%
atrial fibrillation
dose
subjects ,
4.8
Erythropoietin receptors may
.
lorazepam solution for injection
has
AUTHORISATION HOLDER
weeks prior to
affinity for
,
1
the pharmacokinetics
.
effect of insulin
of administration
all growth factors
Abseamed
(
AND SIGHT OF
,
active substance
stroke or
,
Europe
of NMS
Thrombotic events can be
to 50.4
the active substance or
before you
IU/ kg
:
( or
,
of one year
.
( e. g. hypothermia
greater than 12
.
epoetin
that
%
patients with diabetes mellitus
on one side .
you are pregnant
Clinical manifestations
patients with severe
other
1 tablets .
a
data
see section
TRIPLE ORAL
in pregnant women
( 4
and danazol .
mmol/ l )
3000 international units (
( 8.1
was
in
TO APPEAR ON
,
with
of epoetin alfa is
be discontinued immediately
to 6 hours and
crisis with
, use of
) .
can
polycythaemic mice
,
(
exhibit complications (
05 06
amino acids .
you
This
g/ dl (
Abseamed can be
.
or
hours
ketoacidosis or
(
g/ dl (
28 x 1
Abseamed
of EPS was
The physician must therefore
should be advised
% dissolved insulin
, especially
the
Elimination The
BRISTOL-MYERS SQUIBB SARL
.
and for the
alfa
alfa
( GGT ) ,
pharmacokinetic
and 10
polycythaemic mice ) .
or
200 mg
days
When
um 5
, increase
avoided
is endorsed
shortly following
retinopathy
sometimes
pioglitazone ,
BRISTOL-MYERS SQUIBB Tlf
clinical
.
Uxbridge - Middlesex UB8
pharmacist
sucrose
the pharmacokinetics of aripiprazole
is indicated for
)
loss of consciousness
should be discontinued
monkeys
or
in
following
or higher dose
patients with liver problems
,
below the
75
and colourless solution .
family history of diabetes
with
AND SIGHT OF CHILDREN
g/ dl (
.
13
)
than
4.4 ) .
days 21 , 14
% )
medicinal products
or additional risk factors
interactions
6 %
14 g/ dl (
for injections Hydrochloric acid
in
which are
taking ABILIFY
administration
Do not take
,
risedronate-treated
increased
,
tiredness , nausea ,
especially infections and
solution for injection
The
for
syringes contain 0.9
Although there is no
480 ml
per
section 4.4 )
the
( see section 4.5
and blood pressure
Abseamed should be
enterocytes
+44 (
mg )
Assessment of
see section 4.4 )
randomised
one
30 -
,
, including PANSS and
of a full range
(
observed
with
BRISTOL-MYERS
Hyperglycaemia and Diabetes
signs and symptoms
nervousness
) ,
: soluble insulin
1.25 mmol/ l )
your doctor immediately
2
alfa
an
% with aripiprazole
INTERMEDIATE PACK
D Centre ( Europe
with solid tumours (
( CLAS
and
.
temperature regulation disorder (
this condition
211 patients in
type
Centre
alfa ,
) .
chemotherapy
1 pre-filled syringe of
with a
to affect ABILIFY
.
, die
or
and
potassium in
40 64
In patients
if they
altered mental
ON BLISTERS OR
trial , the incidence
mg
g/ dl
in vitro solubility .
the
Based on
medically important
ABILIFY is used
, cases
chills , pain
this
weeks
g/ dl (
animal models of
could be
mouse spleen cell
shown during
75 - 150 60
dosage
( Europe )
of specific nuclear receptors
production
, thiazides , glucocorticoids
interactions
For a full list
( 0)810
150
experienced with
pruritus
& Co
, diabetes mellitus ,
adult and paediatric
g/ dl (
CYP3A4
with encephalopathy-like symptoms (
cell volume .
schizophrenia and
Cardiac
and
death in utero .
,
The biological efficacy
by three biotransformation pathways
insulin
and the
open-label studies
signs and symptoms
pre-filled syringe
PRCA ,
% ) of EPS
efficacy
chemotherapy induced
sudden unexplained
) and 802
isolated cases of
clinical
pre-filled syringe of
.
in urine (
8167 patients
tablets 98 x 1
blister .
international units
ml contains
, alpha-1
of
is
Park
per
low-trauma hip fracture
%
) ,
1
see section 4.5
5 hours
.
)
United
example ,
effect of
prior to
your
insufficiency .
Your
no fatalities
aripiprazole
of Aclasta .
copious amounts of water
g/ dl
should be considered .
no evidence
also
)
Highbridge
blisters
antipsychotic drug
, nausea
6.2
: soluble insulin 20
4
At equivalent doses ,
26-week
to ensure
& D Centre
USE
Four
-
The potentially
the
cytochrome
difficult
following the administration
be cautioned
dosage of ABILIFY
aripiprazole
signs
for
.
( see section 5.1
in
%
pioglitazone
t½ ) is therefore
5.2 ) .
and Cmax
4.2 Indications for
enzymes
of
opening the
)
with
, Wielka
body weight
Slovenská republika OncoEurope Tel
Adult surgery patients
carbohydrate chains are
0800
Tel . + 49
,
Treatment
see section 4.2 Treatment
should be
% dissolved insulin
and
-
and
genotoxicity tests ,
loss category for mitratapide
and adult patients on
, especially
infection including osteomyelitis ,
higher
: soluble insulin
Erythropoietins
should be observed
4 or
aripiprazole
trials aripiprazole has
possibly delayed )
receiving non-platinum chemotherapy
the risk of cross-reaction
Geben Sie es nicht
a
increased
see section 4.5 )
)
you
2 g/ dl per
inter-individual variation
LTD Tel : +
( 4 or more
the insulin requirement
, metformin ) were
see
that epoetin alfa
ähnliche Wirkungen
.
in
administration of epoetin alfa
with encephalopathy-like symptoms
SQUIBB PHARMACEUTICALS
, adequate
orodispersible tablets
or valproate
) .
to protect the
of akathisia
minutes
are
g/ dl (
with
and for
food and drink
ON BLISTERS OR
in a
or
.
insulin
.
Close
by a decrease
section 5.2
, hydroxylation ,
Ireland Takeda UK Ltd
reported
alfa is a
800 ) 749 749
(
sodium chloride
50 NovoLet
1
patients with
Magnesium stearate
red blood cell
medicinal products
the aripiprazole dose
the patient should
1 g/ dl (
and
may be
with
an
Aclasta and
normal
above baseline
to reproduction .
, Oxford Road
in renal failure patients
rats , polycythaemic mice
g/ dl ( 7.5
osteoporosis in post-menopausal women
84 AND 98
16.1
a
in pregnant women
alfa
muscle
1
duration
elderly women ,
that examined the metabolic
Cmax of
.
with
reach maximum concentration
the intravenous route
Many of these patients
Sverige BRISTOL-MYERS
The
how the
Sverige Takeda Global R
trials
The effects of
,
: store
Glycine
.
In clinical trials ,
& D Centre
treated , if necessary
with alcohol
45 93
hepatocellular dysfunction
)
R & D Centre
sometimes severe irritability .
anaemic
from
and yellow ,
rimonabant
intravenous administration
should
The cartridges are designed
included
Limited
rate
( 1.3
6 pre-filled syringes of
47 %
of hands
pharmacist .
Patients
when
260 lung
as compared to
medically serious signs and
0.6
insulin .
blood pressure
The
needle top .
Saccharomyces cerevisiae ) .
,
dose reductions should therefore
with chronic renal failure
kg
and behaviour and emotional
Silicon dioxide Xylitol Microcrystalline
re- suspension .
should be
SQUIBB AB Tel
below 30°C )
.
than a daily dose
1.25
events (
occurs
less than 15
to 23 hours
medically
in osteoporosis
and anaphylactic reaction .
USED FOR
medicine :
.
hydroxylation of aripiprazole
increased alkaline
)
to be administered intravenously
.
or urticaria )
The peak is always
shrunk in size
glucose control
with 100 ml of
as
5.1
Iron supplementation should be
1.2
in all
be disposed
them
6.2
0.7 ml
6.2
(
( days 21
12
increased risk for thromboembolic
with a similar
in the face
For
be increased
in the jaw .
or 24
wastewater or
91
and
AST ) ,
Oxford Road
The physician must therefore
of the other ingredients
discard any unused amount
may
, polydipsia ,
hypoactivity .
10
(
use
800 )
4
quickly with racing ideas
5.1 ) .
VISTOR HF Sími :
SULPHONYLUREA
)
% ) following
Insulin
:
no
only 3
manic
first reconstitution
10 g/ dl
the insulin requirement
Adult
,
sugar
or
)
by the
% and
weeks
7.5
(
dehydration
each
Insulin treatment
or
and other
.
, especially when
with
The
pulmonary embolism
, Neuroleptic
the incidence
Abseamed 6000 IU/
with encephalopathy-like symptoms
OUT OF
patients with
BRISTOL-MYERS SQUIBB SARL
No
scientific advice from
11
)
nefazodone)(see section 4.5 )
mmol/ l
see section
appropriate dose adjustment
.
other
machines
treatment
1 tablets
Your
ABILIFY
with
patients with diabetes mellitus
Each
for dehydro-aripiprazole
overdose with aripiprazole
( E951 ) per
of dosage
for three weeks
days
in two studies
The solution
prescribed by
1
Allé DK-2880 Bagsværd
may be
Hb between
)
battery of
0.5
*Survival [ 95
bisphosphonate
Business
contain 0.4 ml (
and
CLAS
mmol/ l ) .
IU
( see section 4.2
both via subcutaneous
and symptoms
metabolites
44
Pioglitazone
loss , emaciated
,
lung ,
with
Since insulin and
precautions
Authorisation Holder :
or
alfa and other
P450
between 10
minutes
with
Patients
with high fever
s efficacy
see section 6.1
FACT-An fatigue scale
IU/ kg
to
, tiredness
in
adult dogs
be
risk for
Patients
Nevirapin und Johanniskraut
interrupted and
Patients
favour
symptomatic therapy should
Arzneimittel Pütter GmbH &
should be discontinued
Treatment with Abseamed
IS
source
no information on the
with or without
12
human , rDNA (
(
revealed no
see section 4.4 )
pioglitazone and
) .
and
.
metabolites
hives ,
with
clinical trials , an
with
Be sure to tell
who
metformin
(
1 ml contains
doctor
ABILIFY
presents
impact on
3.0
that primarily
to years of
In
20
several
reduction of
recombinant human
section 4.4 -
or
22 PARTICULARS
30 :
.
.
If
(
isophane insulin
) ,
and/ or dark urine
could not be detected
des Steady State
, the formation
pioglitazone
infusion
tablet contains
50 %
mean age :
of
of
)
of Epoetin alfa
data
retinopathy
- increased risk
chronic renal failure patients
is
( 0)21 272 16
30 mg
general scale
cancer patients
die gleichzeitige Gabe von
of ketoconazole or other
incidence of
Activated charcoal
there is
( 1 ) 524
Penfill 100
post-dose symptoms occurring within
Actraphane
the
30 consists of
of
98 film-coated tablets .
Starting dose of 50
and repeat-dose
hypertension
frequency
patients
face
1
cartridge
this
approximately
pregnant women .
for pH-adjustment )
water
a
mg
Meta-analysis of overall
daily
the pack
and
WITH METFORMIN
Tel : +
some
adverse events have been
of these findings
THE REACH
of a
anorexia
time
a 43 %
The recommended starting dose
placebo
Dysphagia : oesophageal
35
mmol/ l
the
with
, serum levels
should be
Try to take the
type of
SQUIBB AB
The
the
aripiprazole
starting dose
or
than
the PANSS
and
section 6.1 .
from
the
elective orthopaedic surgery
CYP3A4
should be monitored closely
not
d ise
the
in vitro solubility
in healthy subjects ,
clinical trials
very rapid
use in
elimination per se
)
was found in
baseline 7.3
)
of these
signs of
In clinical studies ,
is fragile ,
N = 225
IU/ kg
systemically
alpha-1
( 6.2 -
The pharmacokinetic characteristics
,
Male patients should seek
112
sodium chloride
sulphonamides
aripiprazole
Increased
OUT OF THE REACH
or stored at
for cerebrovascular adverse events
insulin products
per
the
which were
,
, dizziness , somnolence
Belgique/ België/ Belgien BRISTOL-MYERS
favour of controls
mmol/ l )
The
is
the dose
clinically
with
events
loss of consciousness and
AND SIGHT
5000 IU/
in
be
1000 international units
,
mg )
23 lung
) .
%
elective
medically important signs and
major elective
the
the active substance
normal and
other
incidence of vertebral fractures
exhibit complications (
absorption .
,
machines
aminoglycosides or diuretics
l ) .
enzyme (
epoetin
( 1 )
of
for injections
ml contains
treatment was not evaluated
4.8 ) .
Abseamed has no
is very
alfa
section 4.4 ) .
( see
in both
KG Kuhloweg 37
or pharmacist
aripiprazole
gluteal
1
mg
,
margin of epoetin
margin of epoetin alfa
insulin requirement
amino acids .
Lancaster
2C9 ( warfarin )
)
,
8.1 mmol/ l
lower the blood pressure
Treatment of symptomatic anaemia
(
is
,
children
g/ dl
(
diabetes mellitus and
13 g/ dl
24 hours
and
patients
long-acting insulin
-
for
Uxbridge - Middlesex
beta-sympathomimetics
and
in one of
95 %
75
this
experience
of
,
a
contains 6000 international units
hepatic impairment
the abdominal wall
to be administered intravenously
- shortened overall survival
faeces
aripiprazole
, including
monitoring
cannot be excluded
of 0.5 ml contains
reduction in
18 %
LTD Tel :
(
3 times per week
and completed suicide (
systemic
serious
duration , there were
local requirements .
used in humans
Road
% of
BRISTOL-MYERS SQUIBB NORWAY LTD
)
between
aripiprazole
the
autologous
human )
( hydrolysis ) sites
mg calcium
and
The
effective
.
and 50
erythropoiesis stimulating agents
AUC
)
15
carton
:
with
the tablet with
in post-menopausal
25 and 50
a full range of
and
disposal and
Novartis Sverige AB Tel
hours .
the medicinal product has
to
It is
CONDITIONS OR RESTRICTIONS
contains
patient
:
,
,
mmol/ l )
.
on in
mmol/ l ) or
2°C - 8°C
combination of
source insulin
MEMBER STATES
450 IU/ kg
is necessary
has multiple well documented
closely
Non-clinical
if you
ähnliche Wirkungen
These measures
in
Actraphane 50
such patients
Cmax
data
those mentioned
Actraphane contains both
.
Medicines should not be
)
aripiprazole
and cloudy after resuspension
source
treatment
insufficient
and
absorption rather than
the pharmacokinetics of
trials
see section 4.4 )
CONDITIONS OR RESTRICTIONS WITH
eská
adequate and well-controlled trials
take
10
2 Adjustment of
and
bone marrow cells
Abseamed
of
Orodispersible tablet Round and
, 2C9
any origin
two species ,
for whom
with normal or
meal
for the
if
administration
) .
no
,
36 (
2 g/ dl (
in
No evidence exists
See
Montgomery-Asberg
15 and
and
of epoetin alfa
( below 25°C )
warfarin )
a potent inducer
or
section 5.1 )
epoetin
times per week
- blood clotting (
a prospective
APPEAR ON SMALL IMMEDIATE
6
NORWAY
.
)
,
Holder :
diabetes ,
other
findings
Common : blurred vision
after
,
glass of
ml and
CYP2C8 .
for the
3A4
& Co KG Kuhloweg
diabetes ,
human
after
Actos tablets contain
transient ischaemic attacks ,
must
oedema
blood pressure
that
ischaemic
.
patients
administered alone
ABILIFY
a similar decrease in
( 0)21 272
84 ,
and 3A4 (
.
doctor or pharmacist .
approximately 60 % in
temperature regulation disorder
treatment of post-menopausal osteoporosis
g/ dl .
is necessary
or
APPEAR ON BLISTERS OR
This is given
chronic renal failure patients
Cmax
, including ABILIFY
according to standard medical
France BRISTOL-MYERS SQUIBB SARL
0.5 ml
given .
tablets
mg
thiazides , glucocorticoids ,
is between 75 and
cancer patients receiving chemotherapy
If
Long-term improved glycaemic
erythropoiesis stimulating agents
ABILIFY IS AND WHAT
have
patients with severe renal
15mg of pioglitazone
ABILIFY
receiving
Women
Treatment
decision to administer
potassium and
a
when
another
5.1 )
In the indication increasing
solution contains 10 000
.
women .
+ 33
Abraxane is not
between 10 and
SQUIBB SARL Tél :
and
of
management of overweight
( see section
local requirements
tremor
its
(
not
260 lung
Glycine
and drink the
at the maximum recommended
10 g/ dl
.
&
pre-filled syringe
potentially
ml
GESMBH Tel :
similar to
800 )
is an
medicines used to
These studies have shown
may be
) 524 40
of
of akathisia in
.
affecting less than 1
of glass
-
of
is catalysed by CYP3A4
London WC2B 4AE United
What ABILIFY contains
administration
patient in
therapy
The
300
,
,
study .
white ,
the
patients
loss
the following
( see section
ABILIFY
or mixed episode
on
in patients
Business
,
rats
if the solution
frequency
PRCA
if they
Moreover , in patients
a full
Cmax of paclitaxel
2°C -
.
epoetin
) .
AUC and Cmax of
CYP3A4
Like all medicines
)
Non-clinical data reveal no
R &
Common
a
358 9 251
, nausea , constipation
increased
see
units
or
If
combined with
+ 43
and Cmax
with cyclosporin
having a high
consider clinical
dosage of ABILIFY
and inter-individual variation .
studies
( 30 %
ACTRAPHANE 20 ACTRAPHANE 30
pH adjustment )
in patients
generally not well
)
not
by the liver primarily
in healthy
Date of
and clinically
as
myocardial infarction
8000 international units (
is
antipsychotics , aripiprazole should
mg
Tel : +
vision Gastrointestinal disorders
be considered
,
Research and
whose arteriovenous fistulae
4.8 ) .
CHMP
see section 4.8 )
x 1 orodispersible tablets
the
, akathisia
subcutaneous use of
to sudden stabbing migraine-
patients
:
In a
Abilify
( NMS
(
situations
.
and aspiration have been
.
significant
filiaal Tel : +3726441100
the
IU
of HIV ) .
% with
30 % dissolved insulin
( 6 %
patients
randomised
reaction
Kingdom
Tel :
in
diabetic retinopathy
BRISTOL-MYERS SQUIBB SARL Tél
.
Abseamed
or
and
during
control group
treatment of
20 mg
Adult cancer
injections .
risk
important signs
disposed of via
for males ) .
weeks
%
.
crisis with
Vanilla flavour ( including
Neuroleptic Malignant Syndrome
) No dose adjustment
120
.
- 150 60
ABILIFY is indicated for
,
, usually in
In placebo-controlled
reduction of manic symptoms
or
be followed
the pack
products
.
facilitate the re-suspension
use in this
with
see
28
see section
,
4.8 and
insulin and
Patients
of osteoporosis in
in these circumstances
STRIPS
TO APPEAR
When concomitant
moderate binding affinity
and other
should be
LABEL FOR UNIT PACK
Lilly Holdings Limited
> 1.5 x
sustained haemoglobin exceeds
5.3 ) .
in adult patients
38 When either valproate
baseline
Abseamed should be given
and
pioglitazone
731 1736
, the dosage of
large
.
Europe ) ,
reconstitution ,
anti-fungal
repeated annual dosing
in
Consequently ,
Middlesex
14 g/ dl
mmol/ l )
see section 4.8 )
section
see
were
cartridge
This
What
Common :
cancer
terminal half-life
warnings
the dosage
pioglitazone with
Uncommon
supervision and monitoring should
to
for the
subcutaneous route and
4.4 -
the intravenous route
inside
target haemoglobin concentration
and 33 IU/ kg
Oral contraeptives
analysis
.
(
Eye disorders Very rare
AND ROUTE(S
,
administration of
in
OUT OF THE
some of the
to protect
patients with
this is superfluous
,
of epoetin
a
warfarin )
be
The most frequent
in the face
.
,
(
Very rare
per ml
other medicines Please
or
.
to
events
approximately
will help
undesirable effects occurred
( see section
% )
to the insulin requirement
)
emission tomography
antipsychotic drugs should be
the
and cardiorespiratory depression
) or
be given .
The individual
Hunton House
Croscarmellose sodium Crospovidone
in
)
.
Slovenija
controlled
Some
combination therapy ( see
not affect your
4.4 ) .
49 x 1
and "
from
headache ,
( FINLAND )
favour of
Kingdom
other potentially toxic compounds
)
be discontinued immediately
swelling and inflammation .
over
Kingdom BRISTOL-MYERS SQUIBB
possible
should be
epoetin alfa is
of the sulphonylurea
) should be avoided
flatness
.
should be investigated
of these
with
Treatment of anaemia associated
these trials , a
)
mmol/ l
( renal
the
West Sussex
3.5 hours
Renal
individual
.
duration
of these patients
) .
until hyperkalaemia has been
other causes of anaemia
clinical
MINIMUM PARTICULARS
risk for
solution contains
the
manic symptoms over 3
sections 4.3 and
141
Therapy- Anaemia ( FACT-An
treated with pioglitazone
Very
is 15
to
to maintain haemoglobin values
of the
.
be
clinical
70
sulphone 0.0471 µg/ ml
maximum
of Abseamed
with ABILIFY
, salivary hypersecretion
pharmacist
recommended that
in the placebo group
, insulin
R & D
may
that Abseamed
your doctor :
once a day .
in paediatric patients
% of
a
Seizures Rimonabant has not
for
is necessary ,
anaphylactic reaction .
Hunton
intervals
g/ dl (
: + 358 9
be applied
and transport refrigerated
GESMBH
administered once a day
of children .
300 IU/ kg 3
,
Due to
patients
cooling element .
Patients who
after
on day
% )
an increased risk
medicine .
44 (
patients with chronic
of the
there were
15
carbohydrate composition to
history of
Treatment of adult
thrombotic
,
(
and
(
1
%
absorbed , with
1 g/ dl
patients dosing should
.
Uncommon - Diabetic
schizophrenia patients
APPEAR ON
.
dose
product
The
facilitate the re-suspension
or lay
mmol/ l )
after
patients with a
hour ,
patients )
sleepiness , shaking and
treatment
were observed
dogs .
mother presents no
.
completed suicide (
be
especially in
.
.
of a
+ 33
SPECIAL PRECAUTIONS FOR
% with aripiprazole and
( see section
or pharmacist
,
per se of insulin
or the
.
isophane ( NPH
increased
see section
Hypertension
the suspension contacts
Aclasta
g/ dl
inclusion
Abseamed is presented
, and
to
with
,
0.9
of bipolar
and discuss
Limited Eesti filiaal
.
,
CYP2D6
women
of
a
)
than risedronate
and
administered
.
increased production of saliva
be reduced
,
61 Aldwych London WC2B
sounds ,
g/ dl
change in their usual
Maintenance dose between 25
: orthostatic hypotension* ,
not
be used
see
isolated patients with normal
should be
)
150 60
section
16
.
times per week by
11 g/ dl (
40 (
symptoms decreased
,
not
and
usual dose
tablets
and sight
is
26.5 [ 18.98
information is
obesity
aripiprazole
Tel
see section 5.1 )
solid tumours (
two safety pharmacology studies
45 93 05 06
when a
or mixed episode of
but
is therefore recommended .
and
with
ischaemic
myoglobinuria
pre-filled syringe
,
effects
% .
In
mg once daily
Special warnings and
between
.
l )
increase 40,000/ µl or
a
( 2°C - 8°C
ml ( 10
with
and
the pack
House
Therefore , no
three
EPS including parkinsonism ,
and
maternal body weight gain
the
is
dehydro-aripiprazole ,
.
1.7 %
Kingdom
) to
,
65 Adjustment of dosage
of angioedema and
cerebrovascular adverse
) or
and adolescents under
,
Aripiprazole also exhibited
and swelling of hands
(
fast-acting (
Europe ) ,
mmol/ l
8.1
to 12
less
to patients when indicated
human dose or exposure
and treated
alfa in adult patients
Depressive disorders were
( 0.62 mmol/ l
dose
When
reported
iron stores .
of
or without
IS USED FOR
the
.
dose of the
pharmacist or nurse
.
longstanding diabetes
( t½ ) is
study population had an
cooling element .
machines
) and
here
.
international units (
or
myoglobinuria
adjustment
) ,
start of
elective
see section
ABILIFY
.
: the levels
The frequency
12
100 ng/ ml
itching
, thiazides , glucocorticoids
Nausea occurred in
see section
60 - 150
OR
73 % ) .
(
in
of the pancreas
between 17 and 33
, or
) .
timepoints (
clinical
with solid tumours
Following oral
therapy .
.
mixture
see section 5.1
in some
Dysuria
47 67 55 53
, tongue oedema ,
doctor
isophane insulin 80 %
The rate of
after the first
product
1 vial contains
172 breast
R
with
In some
(
,
insufficiency .
3000 international units (
trials
450 IU/ kg
ml
polycythaemic mice
should
71
not
USED FOR
the dose should
to affect
methylene groups
2 times per week
die gleichzeitige Gabe von
with renal
in healthy
other
SQUIBB ( FINLAND
alfa
in
.
or death
adverse
daily dose
blood pressure
,
mg
of heart failure
with epoetin
Hb between 10 and
( injection )
, peripheral oedema
machines
creatinine
patients )
that
Takeda UK
,
WHAT
blood pressure
clinical trials of
mg
without treatment in
- United Kingdom
this
should be
and
male patients
(
swelling and inflammation .
Uncommon
g/ dl
:
approximately
ml
)
up to 2 years
in these circumstances
Takeda
between 17 and 33
risk for thromboembolic events
see section 4.4
( anencephaly
.
your doctor or
patients scheduled
is very wide .
treatment with
g/ dl
( e. g. anaphylactic
5
effects
units
200
symptoms
( see section
to
CI :
children and adolescents has
Maintenance dose
.
pre-filled syringe
not
of the
( two
than 1
should be considered (
dizziness
of
with caution
A
vitamin B12 or
rare cases
and 33
see section 6.1 .
% )
Geben Sie es nicht
.
Uncommon - Diabetic
.
It is
6.2
the medicinal product has
products and
+49 911 273 0
existing
, oedema ,
( see sections 4.3
or
heart failure
or 98 tablets
men
( See
, arterial
8°C .
) to
due
defined
( AST ) ,
( see section 5.1
Aripiprazole is well
, myoglobinuria
tablets 56 x 1
the
with
, creatinine and
or
international units ( IU
of
weeks
manic
recommended
comparable to placebo .
clinical trials of
measures will help
) .
in a dose range
the
between 17
especially
routine volume replacement should
of children
the
.
.
.
renal failure
LTD
provide additional benefits .
insulin resistance
significant
cardiac failure
If
after
for injections
of epoetin alfa in
significant
to drive and
Luxembourg/ Luxemburg Takeda Global
episodes in
,
diabetes
The biological efficacy of
Aclasta ( 5
comparable to that
Aripiprazole
see section 5.2 )
des
Hb between 10 and
5.1 )
] )
P1NP )
10 and
of
in rating scales
of epoetin
section
and weakness )
weeks
unit dose
ml contains
Some
AB
especially infections and
2 (
inter-individual
and
ABILIFY
enzymes and
ist keine
+
Business Park
In
37 ,
be followed
should be
each patient
In
marked with A-011
The vials are for
anorexia , hyponatremia
generally not
(
, Kuhloweg 37
230
,
Abraxane
and
.
with a
the
and 12
12 g/ dl
For any
mmol/ l
[ PFT
for
aripiprazole in
by multiple
and
be necessary
dogs Mitratapide
.
episodes
IU ) per
6
:
were
has multiple well documented
more units of
.
hospital and
with aripiprazole
Tel : + 44
pioglitazone with
und
15 mg has
following the administration
the administration
In patients
with aripiprazole and 3.2
Special
.
6.2 -
genotoxicity ,
of aripiprazole in
(
,
: + 358 9
and its metabolites
and
12 g/ dl
12 g/ dl
tablets
other handling
.
dalton .
tablets
Uxbridge
In
patients
your doctor
blood pressure
associated
Patients should be
you have the impression
wastewater or household waste
3
of seizure
5000 IU/
are
is
1 tablets
.
haemolysis
over
elderly
2 units .
ON BLISTERS OR STRIPS
What ABILIFY
Omission of
the freezer section or
hour ,
6 %
:
- 150 30
Holder :
per week
(
.
PROHIBITION
mucositis
In patients
evaluations
entire orodispersible tablet on
Very rare -
not been established .
usual , talking very
.
( please see section
(
diabetes
:
of 12 g/ dl
14
g/ dl (
KG
therapy .
doctor
) ,
patients )
mg
) .
patients
overall survival and increased
injections .
disposed of via
of
150 30 - 100
( 2°C -
2°C - 8°C
Treatment
( injection
section
the first
well
see section 4.4 )
1 ml )
( anti-fungal medicines
IU/ kg once weekly
use of
,
nausea , vomiting and
16 When either
.
shortened overall survival and
than
354 535 7000
between
Additionally ,
be performed in
United Kingdom
) .
60 14 30
contains a
pathways involving the CYP2D6
with or without psychotic
risk
Uncommon
and
cooling element .
(
entire
The
Like
g/ dl
including isolated cases of
4.9 ) .
and
intermediate-acting combined with
side effects
)
MEDICINAL PRODUCT
CHILDREN
your doctor or pharmacist
of overdose
or
recommended
ON BLISTERS OR STRIPS
in water and
your doctor immediately
and
8.1 mmol/ l
and should
with fast-acting
Additional signs may include
children and
Pioglitazone
44 ( 0)1628 537
and
( normal and anaemic
.
ketoconazole
Consequently , haemoglobin and
patients
your dose
haloperidol-treated
bioavailability of
symptoms
of 15
more
defined .
) :
have
( 6.2 mmol/ l
65 Adjustment
with lithium
90 %
in
or
deficiency or
therapy
pioglitazone
please contact
mmol/ l ) .
to approximately
74-week extension
no influence on the
( aripiprazole
7 )
( ALT ) ,
infusion fluids .
solution contains
) .
be
chronic renal failure
take possible interactions
.
Centre
not clinically
A/ S
not routinely
risk of
What ABILIFY is and
A number of cleavage
no influence on the
.
In placebo-controlled
in paediatric and
Development Centre ( Europe
than children
be
Europharm Limited
(
insulin
)
Recurrence prevention of manic
be paid to sudden
your
dosage
Finland Oy Eli
HF Sími :
In clinical trials
Before use : store
but no
residual
per month or the
mmol/ l )
( ca .
Lda Tel :
131 150 IU/ kg
to
during continued
You will
, thyroid hormones
200
g/ dl
epoetin
In
children
packed
benefits
As
.
of
79 %
The AUC and Cmax
Adjustments of daily dosage
immediately
changes in
the
) .
or
It
psychotic
in all
.
dose is 5 mg
and rimonabant may inhibit
contain 1 ml
)
Cmax and AUC
be used (
( International
is given
by hepatic metabolism and
insufficiency not yet
ABILIFY contains The
to be
mmol/ l ) per
or
Not all pack
If epoetin alfa
.
The
route
Syringes
,
OR
.
and
: +45 39
be monitored and
91 )
are growth factors
Epoetin alfa and
aripiprazole
should be
not be administered
more than
syringes contain 0.8 ml
patients
Ask
and
1
was administered concomitantly
risk
another
or mixed episode
( 8.1
should
hours after the
One IU (
treatment of
Europe )
Haemoglobin levels should be
or
50
, growth hormone and
.
,
, diabetic ketoacidosis ,
Kingdom
or
7
or
preventing
not
human
diarrhoea .
adult and paediatric
In patients
, tiredness , nausea
, 14
transitory and
The
and vitamin D
epoetin alfa
unless
change in their usual
vitro studies
55 53 50
and a negative impact
the patient should
in
International
vitro (
by the liver
section 5.1
chemotherapy )
LTD
In
solution for injection contains
300
a
with these
none
(
Inadequate dosage or
What
.
aripiprazole
clinical studies ,
Ireland
Treatment of
Units ( IU )
may be observed
RESPONSIBLE FOR BATCH
possibility of
, Lda
(
patients
In several controlled studies
month
monitored
greater than 2
.
corresponding to
,
.
the study of
In most
they
with a
section
Finland OY BRISTOL-MYERS SQUIBB
hypoglycaemia
" A-009 " and
should
psychotic
irregular
section
Eiffel ,
dose regimens .
haemoglobin
comparing
diabetic retinopathy .
Studies in animals have
the CYP3A4 or
+ 46 8 704
4.4 -
decreased
of 10 to 30
orthostatic
fast-acting ,
6 hours has been
this product is available
for pH-adjustment
injection site
6.8 mmol/ l )
Eye disorders
for three weeks
Tel : +
sites
no
in
the risk
micrograms epoetin
disorders
medicines called antipsychotics .
.
it may
or
)
CONTENTS BY WEIGHT
more units of
colourless to slightly yellow
with high fever
,
( e. g. gemfibrozil
& D
sedation
or
inter-individual variation .
see
aripiprazole
Hunton House Highbridge Business
post-marketing experience
.
dose
of any
( 0)20 3116
.
14 x 1 tablets
somnolence
product must not be
changes
subcutaneous tissue .
puberty or due to
a
most of
with
, placebo-controlled trial
bottle
tablets
or
a dose adjustment
see section 6.1 )
and
25°C ) .
.
attention should
the gluteal region
( injection )
& D Centre
intentional acute
only in patients who
, insulin (
(
antagonist properties in
site conditions Uncommon
in clinical trials
the dose should
, randomised , double-blind
of
6.6
suspension contacts the
solution .
with
this medicinal product must
take it with
)
( see
vomiting and diarrhoea
diabetes was 9.5
One IU ( International
of 12 -
at long-term use
used in combination
also
10
tachycardia
approximately 1 %
hypersensitivity
myelosuppression
section
ON THE OUTER
altered mental status
ml
days
.
well-controlled trials
medicine
a prospective ,
90 tablets
% ) and
-
arrhythmias
with
)
t½
administered after the completion
,
mellitus and
response
see section 5.1 )
g/ dl
4.4 ) .
studies ,
the
) 524
.
Germany
should be discontinued .
Erythropoietin receptors
effective in
epoetin alfa on
with aripiprazole
within
standard genotoxicity tests
hours
the
are
a potent inducer
children and
,
7.5 mmol/ l )
When either valproate
contains 45mg of
infection , folliculitis ,
or
solution for injection in
one side
(
for
) .
renal failure
Aclasta (
of Abraxane as
Actos
patients scheduled
in water
can
tell your doctor
: +
mg/ day
of anaemia associated
of
reproductive toxicity studies
- 7.5
maximum dose
in
OR WASTE
D
The mean
of the
be impaired as a
in
osteoporosis in
hours
, with
(
NovoLet
A
or if you are
pioglitazone
in
with
receiving non-platinum chemotherapy
)
of aripiprazole .
approximately
hydrolysis ) sites on
Eli
rDNA
13 , 36)*
no specific frequency can
After each dose ,
you are pregnant
lithium concentrations
meal
The
a pre-filled syringe
of dosing
following
,
the desired range .
Special
.
PRODUCTS , IF APPROPRIATE
reported
all medicines
diabetes ,
a
D2 and D3 ,
and
Each ml of solution
been observed
and
(
Uncommon -
weight gain
KG
see sections 4.8 and
75
Additionally , aripiprazole and
the skin
.
If
syncope ,
potent
Aripiprazole did not
the
,
thiazides ,
terminal
.
( 1.25
at least
CYP2D6
is used
and
and
pre-filled syringe
or hyperosmolar coma
studies
.
generally
and increased
including
gastro-intestinal
People
see
clinical
medicines used
with a manic
,
: +47 23
aripiprazole during
insulin
fibrillation serious
per
of children .
infusion ,
of
be
mmol/ l )
with epoetin
Europe )
clinical
in
efficacy
potent CYP3A4 inhibitors with
fibrillation
PRODUCTS
.
case in a
60
controlled studies
patients
( see
during continued
(
your
the
3
with
Vorsicht anzuwenden
mean weight increase with
years
experience in
MINIMUM PARTICULARS TO APPEAR
doctor
over 12
usual
aripiprazole
11.9
in man .
6 hours
section 4.4 )
weeks
are therefore affected
The effects of ACOMPLIA
, 23 lung ,
mg orodispersible tablets
whilst the
,
daily insulin requirement
,
initiation
trials
- 200 mg
ABILIFY
Uxbridge - Middlesex UB8
haloperidol-controlled trial
administered to target a
without food
The active substance
including ABILIFY
pen cap on
more
and
especially
of
which is potentially lethal
aripiprazole (
monkeys after
patients
tiredness , nausea ,
insulin products
mainly
+33 (
and
Following
intermediate-acting
patients
- Oedema Oedema may
- 300 mg
Uxbridge - Middlesex
5
The oedema rates for
safety data revealed no
thiazides ,
10
, insulin (
Park , Oxford
In
Tel :
.
%
: + 43 1
172 breast
no adequate
30 or
2.5 %
lips
(
Wichtige Informationen über
per se of insulin
OUT OF
the
a rapid-cycling course .
or
, sweating ,
in the
:
including
) ,
see section 4.4
feeling anxious
of
with
: osteoporosis ( a
of epoetin alfa
10 ACTRAPHANE 20 ACTRAPHANE
1
,
order to protect from
% CI :
of
important differences .
,
mmol/ l
( see
N-dealkylation is
a
.
be
label
the
retinopathy Long-term improved glycaemic
It
pancreatitis
revealed no medically
-
in a blister .
of cleavage (
OR STRIPS
g/ dl ( 7.5
73 %
in men (
( this should be
1.25 mmol/ l
see section 4.8
days to
via subcutaneous administration
rare -
.
with diabetes
with quinidine
:
zu
blood loss and haemolysis
alfa
monitored and
)
carefully weighed against the
half-life of
The
half-life
high
most of these
56
This
carbamazepine
% and consists of
than children over
mixed episode of
in
;
with
of ABILIFY
controls
, Te .
5.1
clear
Each carton contains
severe irritability .
pharmacist
iron deficiency
Global R & D
of
Middlesex UB8
580
tablets
after 6
approximately 60
with cyclosporin
human .
most of
concentration is unchanged
a
half-life
aripiprazole has not been
Eye disorders Common
other erythropoiesis-stimulating agents
,
County Wicklow .
of the absorption
and Cancer Linear
100 , less than
.
157 MINIMUM PARTICULARS TO
may
with
The decision
(
COMBINATION
than
a
by
and
pharmacist
ABILIFY
and
( 5 mg in
activity
,
Glycine Polysorbate 80
Treatment of
of Aclasta
Ab Puh/ Tel :
Any
and haloperidol 73 %
cell
are
pregnancy .
in
.
Abseamed
sucrose per
) .
Additional signs may include
rare
Seizure : in
COMBINATION THERAPY
with
g/ dl (
a
be avoided when
40 kg BW
Therefore ,
of 1 ml
in
with consideration for
a
to
or intentional
pyrexia
pre-filled syringe
300 mg
.
and clinically
epoetin alfa
insulin
food .
recommended starting dose for
The
pre-filled syringe
,
section 4.5
and
should only be
mmol/ l ) per
( see section 4.4
use of pioglitazone
hypersensitivity
from light
2°C
Sussex , RH12 5AB
of 1 ml
14 g/ dl
should generally
that erythropoietins
and
phosphatase
The possibility
be
0800 ) 731 1736
occurring undesirable effect
" on one side
Highbridge
is necessary
with
diabetes ,
the tongue
7.5
veterinary medicinal product
the reach
,
solution .
not
is
t½
serious
is 150
aripiprazole
protein intake .
However
especially when
the effect
in dose should
with aripiprazole
defined by a decrease
Anaemia symptoms and sequelae
safety and
the
significant change in
YOU USE
House Highbridge Business
It can be
g. insulin dosage ,
aripiprazole
)
mg of aripiprazole .
and
group
(
: + 43
subjects the
studies
cerebrovascular adverse events in
Diabetes
& D
epoetin alfa should
g/ dl
When the
mean age
solution for injection in
and
some
insulin
.
with a similar
products
events
diabetes
metabolites
motor
Uxbridge - Middlesex UB8
, thyroid hormones and
D Centre ( Europe
of
)
ABILIFY orodispersible tablets
hypoglycaemia
you
to protect from
not
Particular attention should
frequency
placebo
)
If
in this
indication
patients
trial
the active substance or
significant effects
increased by 77
acts
six months
and isophane insulin 90
injected by medical staff
to be compatible
can
VISTOR HF Sími :
Actraphane 30 consists of
.
clinical trial
There is no accumulation
,
in
tablets are rectangular and
.
phosphatase (
CYP2D6
, Aclasta
tumour progression ,
,
patients with a manic
a similar rate and
)
* Produced
isophane ( NPH
4.8 )
on
The active substance
please see section 4.4
the dosage of ABILIFY
vitro genotoxicity assays
of patients with
07/ 412/ 004
)
blister .
after
4.4 ) .
undergoing dialysis
per
at least
be reduced .
- 8°C )
+ 358
+ 32 2
severe
of hypoglycaemia
here
and cloudy after resuspension
has no
Sverige
of each patient
a prospective ,
.
In paediatric patients
placebo-controlled
8.1
dose
has not been
with encephalopathy-like symptoms
solution for injection
.
In patients with
use
patients with
the
with
retinopathy
4.4 ) .
%
What benefit has Aclasta
N-dealkylation
loss of consciousness
concomitant nephrotoxic
( iron deficiency ,
no relevant effect
.
than
-
(
(
hydrochloride .
of stroke or
maximum
following
system . lp
and 3.0 %
At therapeutic concentrations ,
56.4 [ 45.1
in women with
or
12
patients
been
of akathisia was 6.2
,
and
should be carefully monitored
plasma concentration
evidence
epoetin alfa should
dizziness
frequency
warfarin
g/ dl
.
.
should be closely monitored
g/ dl ( 1.25
Abraxane 5
for injections
3 times
Cancer Linear Analogue Scale
l
overweight and obesity
trials with aripiprazole ,
,
anxious
Many of these
insufficient safety information
efficacy
finding
.
200
800 to 1,200
other .
In
39 %
Tel
patients with
of solution contains 5
.
on the
episodes of hypoglycaemia .
received
your individual situation
CHO/ HGPRT
favour
aripiprazole
( see section 4.8
of
be followed
Patients
) .
The
placebo-controlled trial
half-life of approximately
are
by
.
, IF APPROPRIATE
OUT OF THE REACH
pioglitazone during
( GGT
Novartis Ireland
and extrapyramidal symptoms
Centre (
hyperglycaemia ,
benefit
dose
-
All participants
, an
reduced
In
motor neuropathy , ataxia
hypoglycaemia
could
and
Keep the vial in
4.5 Interaction
% CI :
of Actraphane
(
without psychotic
100 ,
mg
( 57.3 %
species
The
lung ,
( see
achieved
,
unit dose
with reported estimated doses
of recombinant human
.
The active substance
serum creatinine level
concomitant
sections 4.8 and
OR WASTE
12 g/ dl (
)
thereafter
subcutaneous tissue
the dose
of
) or
5.1
or
.
.
,
,
oral
4.8 and
clinical studies ,
several controlled studies
a dose range
renal anaemia ,
solution for injection
data
of these symptoms
)
changes in bacterial
but not clinically
epoetin alfa
( CLAS ) .
is
knows how
.
Lilly Holdings Limited
:
100
may
and 5
( rhabdomyolysis ) ,
of
of
loss of efficacy or
by positron
BL5 3XX
84.0 micrograms
of in accordance with
and symptoms of
risk of death and
If the
aripiprazole
Be sure to tell
but not
and M-IV )
In
the compound or
ibuprofen
THAT THE MEDICINAL PRODUCT
- 14 g/ dl
GmbH &
, pulmonary
a
to
human insulin
Abseamed between 17
may
165 amino acids .
haemolysis ,
multiple medicinal
therapeutic
4.5 )
injection :
characteristics of aripiprazole and
.
Iserlohn ,
.
( haematocrit
oral
in
17 and
, where prophylaxis
is
) , macrogol
third of
see section 5.3 )
.
a manic
UB8 1HU
ml .
33 - 39
intramuscular .
.
including ABILIFY
.
10
CYP3A4 or
patients ) .
The active substance is
bipolar mania patients
patients with
studies
or
.
patients
order
duration
ml contains 6000 international
per
Renal or hepatic impairment
(
SMALL IMMEDIATE
with
method
other
difficulty
insulin
insulin
placebo -2.9 kg
60 - 150
:
x
Penfill 100
,
.
paediatric patients
.
or
thiazides , glucocorticoids ,
placebo .
NovoLet delivers
are
of NMS
tell your
contains
of
at the maximum recommended
4.4
vision .
, round tablets
medicines used
chronic renal failure
, accidental or intentional
6 , 12
AB Puh/ Tel :
, in
Belgique/ België/ Belgien BRISTOL-MYERS
) ,
any
63 In clinical
IS
(
- if the
and
10
1.25 mmol/ l
reduction of
treatment
.
is a
4.4
) gene mutation
side effects
the dosage of ABILIFY
Following oral administration of
Results of
BRISTOL-MYERS SQUIBB Tlf
of
clinical
dehydro-aripiprazole increased by 77
hypoglycaemia
+ 358
solution contains 10
between 1.25 and
(
of
+ 46 8 704
.
followed by a
and therefore
Following subcutaneous injection ,
elimination
use of
used for 2.
doses
In clinical
specific frequency can
are active (
of anaemia
clinical trials
anaemia
including isolated cases
for
and reduction
or
is pioglitazone .
by the
see
cell
the pharmacokinetics of aripiprazole
in haemoglobin
monoamine oxidase inhibitors
MANUFACTURER OF
Seizure
this product
between 10 and 12
.
3
(
(
sweating
than 2 g/ dl
,
4.4
12 g/ dl
human
thiazides ,
,
Fe2+/ day is
1.25
of 200
The AUC and Cmax
if you are
, combination of
the patient
patients
LTD Tlf : +
not
this patient population .
.
and
are never to
.
hip fractures
in patients with a
d
injection )
g/ dl - 12
haloperidol .
by the intravenous route
injection
-
.
Each tablet contains
( local )
Tel : +
d In
?
in schizophrenic
6
patients
mellitus
somnolence , tremor
+353
of anhydrous human insulin
and
and younger
this weight management programme
( produced by
%
vary with
R & D Centre
much
those receiving placebo
Tlf : + 44
( 1 800
use
clinical
If you
1.8.1 .
10
Hb between 10 and
this
are
Tel
2°C
)
.
Starting dose
micro-ophthalmia
0)810 410 500
variation .
.
benefit
contains 10
If
somnolence
47
with placebo .
lung
and
dose adjustment
2.5 % )
.
anaemia
KG ,
,
a manic
investigated and
x 1 film-coated tablets
.
the
also be used .
, 90 and 98
in patients with
trials included
of aripiprazole alone was
the pooled results
of epoetin alfa
( see
symptoms over 3 weeks
and
The following reactions
in a
diabetes , ketoacidosis (
see section
2 g/ dl
of Epoetin alfa and
the administration of
% and
10 g/ dl
or
use
doctor
adult patients scheduled
blood pressure or
the nearest hospital
with a
( please see
, especially in
in patients with
insulin suspensions for
agents (
or
3 times per week
Tel : +386
has been proposed that
and
male patients ( see
including isolated cases
OR WASTE
) general scale
individual insulin requirement is
the end of treatment
RH12 5AB United
, hyponatremia
administered by intravenous infusion
below
hypoactivity
.
in
section 6.1
epoetin alfa
.
( also called serotonin
very wide
in
300
epoetin
,
100
12
and danazol .
)
PARTICULARS TO APPEAR
you know how
.
) is
)
1 tablets
351 21 412 6600
behaviour
-
differences
osteoclast-mediated
Tel : +
included only 3
and
to maintain haemoglobin
Takeda Italia Farmaceutici SpA
Patients
and
.
+44 (
start of
,
insomnia
renal
or
,
.
Europe )
.
stroke
treated
, London , WC2B
is available
If
administration
be marketed
.
of water
used
few
be monitored closely
for
, especially
protein
: + 43 1
.
ABILIFY
2
ischaemic
)
kg and adults
in adult and paediatric
an
when pioglitazone
In
ml ) .
mellitus ( see section
the patient
.
forms of
doses of
in
, the
Abseamed should
.
SQUIBB BELGIUM S. A.
chronic
CLAS )
alcohol or other
active
Shelf-life
,
Introducing appropriate
or
)
800 to 1,200
: + 40
efficacy of
warnings
included
Common : dyspepsia
If
placebo
pulmonary embolism ) .
than
is
this product is available
68
over one year
( 6 %
Do not use
.
see section 4.2
haemoglobin of greater than
KG , Kuhloweg 37
epoetin alfa alters
Uncommon
patients
Middlesex UB8 1HU -
300 IU per
Aclasta (
from the mouth is
+
oder ohne
recently taken any other
,
)
important differences .
injection
on
GmbH &
in a blister
per month or
Te .
pre-filled syringe The syringes
( 3 ml )
, the dosage of
or
of
and
that indicates an
2.47 in
] ) and
be of 25
,
signs and symptoms
tumours ( 172 breast
aripiprazole dose
and
vein (
alfa therapy
have been receiving aripiprazole
as
1.25 mmol/ l )
of
cerebrovascular
have also occurred
with
.
thromboembolic events
effective in
you
how
should be given
32 2
malfunction
between thumb
(
use machines
a negative impact
ongoing
comparable to placebo
, with a similar
pioglitazone treated
Sussex ,
( 0)20
, nervousness
Abraxane until
,
between 10 and
,
vomiting diarrhoea softened
increased
Cancer Linear Analogue Scale
and mediastinal disorders :
.
two of the cardiovascular
to
in
no significant effect
ml solution for injection
and discard any
than
Lilly Holdings
contraeptives , thiazides
room temperature before administration
observed for
recent
unplanned
receiving radiotherapy
t½
.
months
IU .
.
HF Sími : +
) .
the active substance
.
outer
recommendations
and dehydro-aripiprazole
account when
) ,
disorders Common
haematological malignancies (
mg
insulin
risk for
see
epoetin alfa should
Patients
%
hypersensitivity reactions ,
than a daily dose
not exceed 200
ml ready-to-infuse solution
was shown
49 x 1
nausea
in this
efficacy
this condition may also
metabolites ,
gynaecological , 23
was 3.9 kg .
in this patient group
Allergic reactions have
The following side effects
incidence of EPS was
.
5.3 ) .
of
THE REACH
.
+
.
of children .
manic
hyperosmolar coma or death
.
in
included patients
should be
.
cancer patients .
with
Common : blurred
in some cases
has a pH
section 4.8 ) .
an
Business Park
see section 5.1
GESMBH
The
The pharmacokinetic characteristics
2 g/ dl (
Patients scheduled for
260 12
with renal
: anaemia
until your condition
In
strenuous physical exercise may
) .
infection or
hepatic impairment
.
Laboratoires
less duration
vision
D-90429 Nuremberg Germany
on
because
& D Centre (
frequency
Pharmaceutical
has no
.
These
and well-controlled trials of
the risk of
sections
the frequency
epoetin
,
from light .
pre-existing
,
- In
treated
Ask your
4.7
diabetic retinopathy .
of ABILIFY
37 , D-58638
not
in
15 mg
aripiprazole
considered
data available
,
on
below 12
renal insufficiency not yet
tablet contains
Actraphane is
: + 358 9
SQUIBB NORWAY
37
treatment with epoetin alfa
or
, accidental
)
.
your doctor
experienced with
Business Park
epoetin alfa
and approximately
30 to a similar
subcutaneous
trial
study included only 3
with normal or
doctor will
between 9.5
erythropoietin
.
see
.
pre-menopausal range .
30 %
of ABILIFY
( see
45 mg
insulin ( human )
common
tablets
The use of Abraxane
60 %
and
patients
sudden
fibrosis of any origin
vivo
UB8 1HU
food with
Polysorbate 80 Water
See
Cancer
most common side effects
10 g/ dl
At
All special warnings
pioglitazone concentration is unchanged
and
)
12 g/ dl
)
CI
need to
0.5 ml
toxicity ( reported in
because of the
when
x 1
30 mg
- 6.8
more long-lasting effect
( NPH
anaemia associated with chronic
.
mmol/ l )
6.8 mmol/ l )
131 )
between
,
mitratapide has not been
( See
.
3 weeks .
If you
229
a dose
Zinc
aripiprazole (
In
six identified metabolites
)
Treatment
After injection of the
placebo-controlled
Abseamed 5000 IU/
ABILIFY
) insulin
Frequencies of adverse
) .
( type
of these patients
or pharmacist
no clinically
suspected , therapy with
tumours
mmol/ l )
g/ dl (
These
scheduled for major elective
is difficult
schedule .
, aripiprazole
per dose ,
tablet with
safety
.
placebo
epoetin
overall survival
:
monitor closely
isolated patients
AB Tel :
of EPS including parkinsonism
therapy
trials
)
in
tablets , as 10
1 g/ dl
The
:
patients
pulse or blood pressure
or pharmacist .
Abseamed
hypoglycaemia whilst driving
equivalent to 300
100 IU of insulin
.
,
hours
lithium
ABILIFY
Treatment of anaemia associated
populations ( see section
diabetic
In
the
.
should be rotated
serious cardiovascular events was
.
Within each
haemoglobin
section 4.4 )
12
indicated as an aid
+
All
Latvija Eli
) ,
alfa
dosage
.
200 mg
not
units ( IU )
reaction
bottle
patients
aripiprazole and
whether or
, feeling anxious ,
forms of
1 The
1 , 98
be applied
thromboembolic events
constipation
clinically significant changes
treated group
Population pharmacokinetic evaluation has
solution
antipsychotics
The following adverse
resulted
.
with epoetin alfa
& D Centre
Due to
renal
of white
London
medicinal products
from
.
human .
chemotherapy
humans
increased
fractures
clinical fractures over
food and drink
Pre-filled syringes ( glass
with
and/
Actos 30mg tablets
growth factors
with
concentration is unchanged
Insulins
of anhydrous human insulin
recommended starting dose
is 10 or 15
the
Renal or
insulin
% ,
inject
stopper
a
: +44 (
This is especially
- 6.8
Changes in strength
AUC
: + 44 (
no
hypertension .
see section
,
The
hyperglycaemia
doctor , pharmacist or
a
5 mg
( 6.2 -
,
PRODUCTS OR WASTE
glycine ,
of diabetes
Pioglitazone and all
section 4.4 ) .
Cancer Therapy- Anaemia
,
version 3.0
PROactive ,
muscle
.
at the
Tél
of
Saccharomyces cerevisiae )
approximately 60 %
mmol/ l )
medicine can only be
study
the reach and sight
The other ingredients are
the pack with
neurotransmitters
A number of cleavage
10
your doctor
:
( e. g.
beliefs
2
revealed no
UB8 1HU - United
.
recommended ,
name and
and
Die
ABILIFY tablets , ABILIFY
Adult surgery patients in
suspected , therapy with
Treatment of
epoetin
.
closely
(
recommended
compared with those
The
use in
)
Adult cancer
the infusion
SPECIAL PRECAUTIONS FOR
7.5
oral
of
whose arteriovenous fistulae
mg
more units
The recommended dose
Effect
27
ABILIFY
blood loss and haemolysis
itching , hives
cleavage
intermediate-acting combined
to have
.
effects
.
( see section
intermediate-acting combined with
34 %
,
been observed .
should be advised accordingly
in dogs
section 6.1 ) .
haloperidol 73
of these
risk
myoglobinuria (
renal
Co KG , Kuhloweg
other medicinal
tablet is bioequivalent to
terminal
If the haemoglobin is
increased
of continued therapy
see section 4.4
of a CB1 antagonist
) ,
see section 4.2 Treatment
with aripiprazole and 3.2
: + 31
in
no
increase
and anaphylactic reaction .
and 3A4 (
section 5.3 ) .
the
+ 353 (
after repeated
1 cartridge contains
5
If epoetin
attention
be followed .
causes of anaemia (
round tablets contain 15
or
Propyl parahydroxybenzoate (
93
: dyspepsia ,
treatment of
( see section
hours after
reconstitution is
or
g.
risk of pregnancy .
is
,
in patients with
and
that
.
)
orthopaedic surgery
Sverige BRISTOL-MYERS
pioglitazone
any information
to
of
:
and death in utero
after
Survival
a comprehensive battery of
from light .
%
3 ml )
headache , tiredness
be
of the
been observed .
dosage
humans
the deltoid region may
)
behaviour
Co-administration of
D-90429
.
and 3.0 %
,
of liver cirrhosis
% of
the
( 0)20
women
7.5
and precautions for
pain reliever such as
should
In patients with
37 ,
and other
g/ dl
] )
including
products to affect ABILIFY
Medice Arzneimittel Pütter GmbH
with
Road Uxbridge -
the warning
tablets
severe renal
patients
compared with those
the
, but
than you
haemoglobin is rising by
in a
g/ dl
)
with
be used in
the risk of
administration of
below 30°C
Close
Aripiprazole and
you
very
)
) , Te
or exposure
with
The
( GGT ) ,
Bipolar I Disorder -
was last approved on
Refraction disorders
M-II
other
well-controlled trials of
, D-58638 Iserlohn
of greater than 12
+ 43 (
g/ dl ( 6.2
distal radius relative
and
doctor
of the
(
immediately
Sverige BRISTOL-MYERS
suicidal ideation ,
section 4.5 )
whether
efficacy or
( MAOI ) ,
If
hydroxylation
Due to
44 ( 0)1628 537
Overall survival
a
4.8
Cmax
reactions
+
see
or
.
( see
) .
150 International Units
dietary control .
ketoacidosis
on
)
(
fibrosis of any origin
oedema
and
to
receiving chemotherapy
including PANSS and
included patients with
metformin
COMBINATION THERAPY WITH
response
In
10 or 15
treatment-related
)
&
duration ,
had
between 25 and
, serotonin 5HT1a
Sími :
When
epoetin alfa is very
section 4.4
of EPS including
necessary
mean
(
nausea , vomiting and
The cartridge contains
tablets 28
the pre- and post-natal
either sex .
this should be
the
doctor
In patients with
ABILIFY
Nederland BRISTOL-MYERS SQUIBB
clinical studies ,
,
elevated liver enzymes
an autologous predonation programme
,
used for 2.
therefore
white
When
OR
Sverige BRISTOL-MYERS
and in
should be monitored closely
aripiprazole
contents
The
% ( 75
after
.
to detect possible
of
of patients
equivalent to 300
daily insulin requirement
pioglitazone
erythrocytes
is
(
,
and
ml glass cartridge
salivary hypersecretion Vascular
until
large
clinical trials aripiprazole has
for
not highly
agents .
by the intravenous
mg , 10
,
wide
with two
and sulphonamides
of glass (
sedation
of
Co KG Kuhloweg
.
is expected to reduce
in patients
600
Novartis Europharm Limited Wimblehurst
trials and
dose of 600
is
In clinical trials with
1
should be
receiving non-platinum
increases
store
human , rDNA (
x
changes in
( e. g.
doctor or pharmacist
solution for injection
chest pain
in part
and adult patients on
= 229 ) .
.
.
, United
hours
approximately 1 %
12 g/ dl (
of
x 1
treatment with epoetin alfa
days 21
800
ABILIFY is
Peripheral neuropathy
27166
hypotension*
male
a
of 30
in
injection
) ,
medically important signs and
section 4.5
manic or mixed episode
akathisia in bipolar
,
4.8 )
and 11 g/ dl
bone Aclasta was
ketoacidosis
Pre-filled syringes ( glass
Intensified control in
Each tablet contains
%
8000 IU/ 0.8 ml
and pink
has been
to maintain haemoglobin values
patients with a
Abseamed has not
solution for injection
father
( 1.25
( 7.5 mmol/ l
maximum daily dose
4.4 -
+ 40 ( 0)21
not be used
:
+ 44 (
192 Adult
sse
Medice Arzneimittel Pütter GmbH
pharmacist if you are
MAOI )
with
(
section 6.1 ) .
or
Functional Assessment of
at 0.1 mg/ kg
Hunton House Highbridge
contains 9000 international units
in increments
7.5 mmol/ l )
& Co KG Kuhloweg
9.75
whether
with epoetin
: a
their
sections 4.8 and 4.9
(
all
l
of aripiprazole ( Cmax
of
Aclasta is
.
or
haemolysis ,
see section
times
( see section
pulmonary embolism )
,
,
the
peripheral
: soluble insulin
weight decreased , anorexia
surgery
,
of the
about 40 %
( Europe ) ,
on results
.
of the
solution for injection
.
6.6
oral bioavailability of the
with baseline
)
see section 4.4 )
( 6.2
and controlled as necessary
Subcutaneous injection :
approximately
if
an
the placebo group .
300
7.5
45mg tablets
.
pregnant women
and
,
make sure the
)
45
353 ( 1 800
BRISTOL-MYERS
Aldwych London WC2B 4AE
and
reported
this condition
CYP3A4 (
to reproduction .
Nausea , diarrhoea ,
) .
see section
D Centre
may
These
,
olanzapine-treated patients
of 0.4 ml 6
30
-
be necessary when
& Co
.
5 and
long
or urticaria
treatment
injections
patients
the EPAR )
aripiprazole
well-controlled
of
retinopathy .
Ask your pharmacist
years or in Asian/
( 0)20 3116 8000
( e. g.
children
drink
isolated patients
disease
and
the
.
occurs
epoetin
Like all medicines
Read all of
per
Sodium hydroxide Sucrose Purified
to affect
of dosage
1 diabetes
in
diabetes mellitus
two short-
R & D Centre
10
sections 4.8
Neuroleptic Malignant Syndrome
terminal half-life ( t½
+ 47
27 When either valproate
,
.
anterior abdominal wall
Novartis Pharma GmbH
The active substance is
before
The Marketing
and
Aldwych London WC2B 4AE
your doctor
dopamine
Actos 45mg tablets
GGT ) ,
and
section 5.3 )
2 units .
of
( see section
should be
other medicinal products
be assured :
Use should be
rimonabant was found in
of
Erythropoietin receptors may
chronic liver
, the patient
half-life
Following subcutaneous
(
aripiprazole in the bile
are pregnant ,
One IU
In
injection
of
gliclazide
The absolute oral
, 50
.
following
that aripiprazole
formation of
Based
efficacy of epoetin
After first reconstitution ,
SQUIBB BV Tel :
hours after the
tell
17
and mammalian cell
.
, Oxford Road Uxbridge
46 8 704
adequate data on the
increased
of
thrombotic
30 % dissolved insulin
condition may
patients with
x 1
known whether pioglitazone
affect
and the
of
( reported in 79
In the
alfa may
treatment
you think
than a
clinical trials with
t½ ) is therefore
CONDITIONS
a
first 10 days
administration of
6 hours has been
faeces
effect
8167 patients )
The
.
thyroid hormones and beta-sympathomimetics
the rise in
The total dose
ba
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LTD
where
of
THE IMMEDIATE PACKAGE
-
)
treated
water
symptoms
.
1 bottle
a
Ireland Limited Tel
g/ dl (
subcutaneous tissue
% ) and
seizure
advised
use
Actraphane contains
without
( hypoglycaemia )
days 21
- General
additional
aripiprazole
of
pioglitazone
injection
,
352
may
50 International Units (
unexplained
after
x 1
than
given subcutaneously 3
There are no adequate
clinical trial
15 mg or
units ( IU )
in vitro solubility
information
to 6 weeks )
Abseamed
of 10 g/ dl
Bei älteren Patienten ist
8.1 mmol/ l )
blood pressure
.
sudden unexplained
Spain
with
15mg
target haemoglobin concentration
manic
dose regimens .
in
SARL Tél : +
injections .
with
reports are based
,
patients
and
hyperglycaemia and
50
In clinical trials of
decreased
cerebrovascular adverse
, 14 and
you
MEDICINAL PRODUCT
increased
alfa is very wide
and
43
and contents of the
not
treated
of the other ingredients
( 2°C - 8°C
KG ,
.
tachycardia , nausea ,
which also
warfarin
Hb 10 - 13
, read
a pre-filled syringe
)
or waste material should
ON THE OUTER
SQUIBB BELGIUM S. A.
the blood pressure is
The full
210 ml
alfa
you
kg BW
doctor
dose
CYP3A4 ( ketoconazole
aripiprazole
a
dose adjustment is necessary
ml
,
Patients
increase
special warnings
improvement in
men
pharmacokinetics of
myocardial ischaemia , myocardial
pneumonia
MATERIALS
, µ
the administration of
and
lithium
with a
for injection (
95 % CI
-cyclodextrin (
However ,
( 7.5
higher
.
the
reported after months
) or CYP2D6
Adjustments of daily dosage
danazol .
and
.
essentially sodium- free
Actraphane is
units
be used
epoetin
alfa
chemotherapy
Sodium chloride
AUTHORISATION
when a
and
of NMS
should
33 22
patients
potent
epoetin alfa
prior to
a
with
Less than
than
production .
the
differentiating hormone , the
listed below
,
, are not
human )
active substance
IU (
, and
in bacterial
:
In 2
,
of greater than 12
insulin ,
leaflet was
.
10 and
In a clinical trial
peripheral oedema
Aripiprazole
treatment ,
aripiprazole in the bile
( 1 to
having excessive
- Middlesex UB8 1HU
pioglitazone
( see section
6.1
than 1
+43
patients
with
000 IU
] )
experience in children
aripiprazole during
study
vomiting and
Cmax
first treatment
aripiprazole
and post-marketing experience
with
cannot be excluded
If any
or very
of glucose
( please see section
Epoetin alfa
dose
mg
ketoacidosis ,
thrombotic
50 NovoLet
)
in a
trials
in
osteonecrosis
maintenance doses than
14 x
of greater than 12
a meal or
carefully all
14 and
experience nausea
the type of food
published literature
severe irritability .
the active substance or
of
of
a meal
section 6.6
) pioglitazone
a
renal anaemia
repeat-dose
.
ml
a prospective ,
% and consists of
a
The
mg should be
All
, feeling anxious ,
diabetes
a total of 357
the
30mg tablets
(
oral
potentially medically serious
ready to use .
Benommenheit
be
for
products and
autologous
Hydrochloric acid (
four carbohydrate chains are
per month
given subcutaneously 3
rDNA )
, the
and
& D Centre Limited
60 -
between 9.5 and
have also occurred
rDNA ( produced by
the
makes bones fragile
blurred vision .
pulse or
and
and
Ireland
akathisia was 6.2 %
( omeprazole )
of epoetin alfa
patient group .
of 1,900 patients .
patients
5 mg
measure
100
diabetes
and
monkeys ,
a
for
the serotonin reuptake site
N-dealkylation is
studies
a lesser amount
x 1 ,
.
maintenance doses than
%
treatment of
Insulin
SQUIBB BELGIUM
(
than
order
.
x 3
Hunton House
)
of overdose
a
( 50
-
not necessarily in association
weight gain ,
renal insufficiency .
Subcutaneous
growth hormone and
Read all of
50 IU/ kg
more than 2
injection
AUC
)
or too near
or 24 hours
with
Subcutaneous injection : a
period
act as growth factor
g/ dl
with hypocalcaemia
headaches as a
International Units (
weeks
in four
risk for
This medicinal product
cumulative
the
000
Patients
e. g.
the
neuropathy
doses of Aclasta .
and 4.9 )
or pharmacist
, ketoacidosis
,
for
or if
in
14 g/ dl
UK Ltd
or
and
fast-acting
aripiprazole ,
These reports are based
.
) .
major
trials
erythrocytes from precursors
and/ or dark
that primarily
500
efficacy
London WC2B 4AE
a growth factor
(
aripiprazole
the
( 2°C - 8°C
be
600
Uxbridge - Middlesex
in
x
replacement insulin
with
see section 4.5
cartridge ( 3 ml
of the
)
50
maintain haemoglobin values
significant effects
liver
the
renal
Verkehr gebracht . Me
are
alfa
to act mainly
vial
only
as compared
see
additional
minutes .
177 MINIMUM
of symptomatic
33
placebo ,
If
the intravenous
maximum
44
trials , rare cases
.
mg
Eye disorders Very
)
Before
.
in vitro solubility
investigated
with encephalopathy-like symptoms (
daily dose
risk
, labelling and package
with
EPS including
- United Kingdom
unexplained death
or
children
your doctor
)
Effects on
- decreased locoregional control
hyperglycaemia ,
55
with
the dose
mg
.
.
reduction of manic
with epoetin alfa
)
the risk of
to
4.4
mean age
Epoetin alfa
swelling , redness ,
this leaflet carefully
but
a
1
and
cooling element
+ 43 1
tremor
unconsciousness and/ or
intravenous administration
This may constitute
In
Actraphane
,
( AUC )
by significant intra- and
patients with
prior to
) .
People with this
to IV )
to reduce side effects
1 pre-filled syringe of
therapy .
dog
If blood pressure
in
of women
(
- Treatment
any
monitoring to detect possible
dextromethorphan/ 3-methoxymorphinan ratio
haemolysis , blood loss
should be investigated .
use machines
upper respiratory tract
negative impact
normal or
see section 4.8
fatal outcome has
annual dose of
units
reproductive toxicity studies
at least
may be
section 4.4 )
instructions given to
one
deep vein
.
information on
353
of 15 mg has
glucose
20
with aripiprazole and
, 22
pectoris ,
be added to
oral
30
one single-use
g/ dl (
% isophane insulin
of 50
4.4 Special warnings
alfa
of
orthostatic
trials
trial
4.5 )
see section
be a moderate
section 4.4 ) .
,
and
in
therapy
Inadequate dosage or
47
than the
anaemic rats ,
has no
absorption rather than
possible ,
)
87
45
siehe Abschnitt
7.5 mmol/ l )
human dose or exposure
a
for disposal and
see section 5.2 )
subcutaneous (
equivalent to
( possibly delayed
x 3 ml
or
retinopathy
patients
section 4.5 )
events
Tardive Dyskinesia : in
Sími : + 354
patients with
The cartridge contains a
Sodium chloride Glycine
and
on
contains 6000 international
years
and
In the indication
( see
a pre-filled pen
- United Kingdom
)
below 12 g/ dl
)
20
the
without
.
your
and death in utero
is always well below
ventricular
or if they
mouth
increased
)
whom
bone tissue )
10 cartridges
a dose adjustment
Aclasta was
: +44 ( 0)20
1
Upon discontinuation
Cmax of dehydro-aripiprazole
see section 6.1
(
necessary
.
pregnancy
(
l/ kg
see section 5.2
thiazides ,
medicine
and
whom the
, mucosal
only
,
ABILIFY
+44
the desired range
resolved
between 25
Units ( IU )
aripiprazole as the
blood cell
( see section
safety of Vantas is
study
that
.
after an
.
General disorders and administration
see section
active substance is
hypothermia ,
Uncommon
.
dyskinesia
has no
in exposures
the
cytotoxic
pharmacokinetics
are active
followed by
is similar
(
resulting in discontinuation
Consequently ,
AUTHORISATION HOLDER
recommended dosing regimen is
as hydrochloride
treatment with epoetin alfa
not
or if you are
, but with
The
also had a similar
be
facilitate the re-suspension
( see
tumours ,
metabolites are active (
SPECIAL PRECAUTIONS FOR
glycosylated haemoglobin increased
165
the
.
10 000 IU
be
Epoetin alfa
of Epoetin alfa
daily
Cytotoxic actions
,
Hypoglycaemia
1 pre-filled syringe of
see
section 5.1 ) .
( 57.3 %
less than 1
unit dose
EMEA
and women
residual
APPEAR ON
are
UB8 1HU -
doctor or pharmacist
trials , uncommon
Phlebotomy may be performed
:
has Actraphane shown during
tumours (
mg , 15
in clinical trials
aripiprazole
cause side effects
sections
manic
The four
should
ml equivalent to
blurred
a negative
of unchanged pioglitazone
% ; 1.0
people with phenylketonuria .
2°C
is
and
recovery in
100 IU of insulin
new
with
been
of
in 24
Aripiprazole
Middlesex
not be used
Abilify
, the dose should
every 3 weeks
, inform
Rare cases of
at 6
Roonstraße 25 D-90429 Nuremberg
de pointes , bradycardia
is between 75
account when
There are no adequate
QT prolongation or
abrupt improvement in
(
.
( renal
, 72 ( 31
your blood pressure should
Grade 1 or
In the
increased risk
with
3116 8000
women in
ist
per se of insulin
should be
patients
aripiprazole and
section 4.4
recovered label was
with
generally
a
hepatocellular dysfunction
(
for the
- a sulphonylurea
.
Road Uxbridge - Middlesex
are
Cartridges should only
Deutschland Takeda
ABILIFY
with
can
feeling anxious ,
.
acute
infusion of 5
orodispersible tablets
.
ml equivalent to 300
ml
West Sussex , RH12
inhibitors of CYP3A4 (
signs and symptoms of
site conditions Uncommon -
an
( produced by
2697
including isolated cases
than children
Global R & D
Intravenous injection : over
read the
Aldwych , London
administration
( e. g. hypothermia
iliac crest 1
therapeutic
blurred
use of Epoetin
patients
see section 5.1
the
microtubules throughout the
of
UB8 1HU -
) , with an
t½
reference laboratories .
not
no
by
THAT THE
human tumour samples ,
(
use of Abseamed
and
5.2 )
, even several
2
If
makes bones fragile )
the
and CYP3A4
Actraphane is
specifically
should
West
reported
dose
between 17 and 33
here
and paediatric haemodialysis patients
75
)
in patients with
more ABILIFY
of seizure
4.4
extrapyramidal disorder
BRISTOL-MYERS
5.1 ) .
reduced
a
the
mg/ m2
epoetin alfa
to be expected
Even if
Metabolism Human
)
geometric means
in
-
+ 40 (
for thromboembolic
defined
(
.
153 Even if
)
%
alfa and
um
mmol/ l ) or
of epoetin
.
Aripiprazole
+ 43
(
transient and asymptomatic ,
three days following
in
per
, adequate
and
pack with
is
an antimicrotubule agent
possible warning signal .
controlled studies
) , where
see
pregnant women .
g/ dl ( 1.25
: + 32 2
17 and 33
on
Dose adjustment in order
If
unchanged pioglitazone
.
is given when
( fever
patients experiencing
in
10
and mammalian cell
Abseamed
in
56 x 1
42 22
haemoglobin of
Uncommon : orthostatic
should be avoided .
SMALL IMMEDIATE
intermediate-acting combined
: +
mortality
IU )
30
, therefore
erythropoietin is 32,000 to
R & D
CNS medicinal products with
used for 2.
and
the pack with
with
them
:
and
diabetes mellitus
patients participating in
in healthy subjects ,
medicine .
in milk
attention should be paid
study .
4.8
of death
Park , Oxford Road
doctor
anorexia
is minimal
unit dose
margin of epoetin
The biological efficacy of
425 mg sodium
may result
)
) , µ
56-99
3 patients
of
, hyperglycaemia
)
; the
( FINLAND
the
4.4 )
appreciable affinity for
forms of interaction
or the
see section 4.5 )
and
scale or
in
10
and
9000 international units (
CI ]
( 0)810 410 500
of rimonabant
( see
the
combination with metformin
two
anaemic
, 2C9
levels
in adult patients
, increased alkaline
hyperglycaemia and
can occur
, headache Eye disorders
with
tablets
dosing
is a mixture
: orthostatic hypotension*
0.1 mg/ kg
additional adverse reactions
adults
may
%
Studien bei
10
your ABILIFY tablets
( IU )
rDNA (
contains 5 mg
CYP2C8
and
OF THE MEDICINAL PRODUCT
be paid to sudden
191 Cancer patients or
102 avoided ; guidance
( 2.5 %
dose
hip fracture
of the
dose
In
the
Abseamed
absolute
to 375
dose is 15 mg
inter-individual variation .
,
Avenue Gustave
is
,
:
Malignant Syndrome
Marketing authorisation holder
Dosage Dosage
type 2
12
epoetin alfa
the ABILIFY
- 8°C
and of the
hands
Pharma GmbH Tel .
increased
of pioglitazone
Severe hypoglycaemia
metastases
is
glycaemic control
into account and should
than
alfa Abseamed 7000
in
products
United Kingdom
are growth factors
any
) .
mmol/ l ) to
: + 31 34
Serum electrolytes
)
g/ dl
of epoetin
.
of
In clinical
or
for reconstitution is
section 4.5 )
information on the
patients with
no influence
Renal or hepatic impairment
be disposed
adult patients
Sverige
few
,
of
, aripiprazole
anhydrous
3 ml
(
.
while taking
orthopaedic surgery
approximately
, increased alkaline phosphatase
given weekly for three
with ABILIFY
to any of the
g.
tolerated
stenoses
chronic renal failure
and water for injections
3.2 % with placebo
trial ,
This medicinal product contains
In a study
Cmax
- 8°C )
benefit
reported
.
The other ingredients
PRODUCTS OR WASTE MATERIALS
episode in patients
treatment
PARTICULARS TO APPEAR ON
clinical effects of
IU/ kg 3
Ongoing major
refrigerate . This
how the
, 84 ,
United Kingdom Takeda UK
anaemia
or higher dose
,
of progression of
the active substance or
wurden.
humans
Anpassung der Dosis notwendig
A
per
the
Authorisation Holder
diabetes
Europe ) Ltd
The effect
, please tell
1 month after
Water
dosage of ABILIFY
and
- increased risk
.
be marketed .
cause
2.5 %
auch
episodes of hypoglycaemia .
the reach
you
8.1 mmol/ l )
9
)
alfa
starting dose for
lie down
with
prostate
of thrombotic
ketoacidosis (
alfa is very wide
controls
Abseamed 4000 IU/ 0.4
with renal impairment :
half-life
.
8°C ) .
pioglitazone
haloperidol
)
given subcutaneously
other
trials
%
of no
statistically
The syringes
symptoms
Aripiprazole and
)
( less than
for aripiprazole-treated
and
with
For any information
50 %
dose of
your
a
the
of 1 ml
develop
haemolysis , blood loss
alfa
Each carton contains
and
other CNS
clinical trial
lung ,
was 7 times
epoetin
diabetes
should be
psychosis .
Each ml of solution
:
14 g/ dl (
of
28
rubber
SQUIBB GESMBH Tel :
to
activity ,
.
, nausea ,
with aripiprazole
(
4.8
Abseamed
be added to
44 ( 0)20
10
of food
of
and
severe neutropenia or severe
existing
undergoes extensive hepatic metabolism
antipsychotic
: + 47
R & D
Latvij Tel :
5.2 )
with
see section
Male patients should seek
In
significant
rare (
Highbridge Business
Actraphane is a mixture
+ 43
experienced the development
mit einer Adipositas
30 %
to sudden stabbing
the active substance
with placebo
and
,
at the desired level
Bei Patienten
AB Tel : +
ABILIFY
in the thighs
important for
alpha-1
indicated for
risk
Mildly anaemic patients
.
.
and no
administration
Hb
CYP3A4
. They include thirst
of
treatment with aripiprazole
be applied .
4.8 and
Uncommon -
in the thighs or
( 6.2 - 7.5
N-dealkylation is
The reconstituted medicinal product
a
both
11.6
In some ,
the patient
should be
with pioglitazone
below
in the
(
) .
may
week
NORWAY LTD
)
manic or
( ALT ) ,
e.
use
be added to
carbohydrate composition to
,
.
the
1800 ml
vivo
epoetin
) .
oral clearance
Tel : +
98
g/ dl
maximum recommended
(
1 orodispersible tablets
DISPOSAL OF UNUSED MEDICINAL
epoetin
. They include thirst
74 60
product
.
known if paclitaxel
NMS
also be used .
bei allen
a pre-filled syringe
study population had an
of the art .
to starting Abseamed therapy
Effects on
) AB
ABILIFY
MUST
pregnant women .
be
+ 44 ( 0)20
especially in patients
epoetin alfa
) is
ESAs ) have shown
epoetin
176 MINIMUM PARTICULARS
diabetes mellitus , diabetic
dissolved insulin
, IF
active malignant disease
a
Patients scheduled for
13 g/ dl ,
in patients
23 mg )
%
( 6.2 - 7.5
alfa
faeces .
: hyperglycaemia , in
Aripiprazole
between
, but not
not
other insulin products ,
100 IU of insulin
Abseamed 3000 IU/
aripiprazole
be observed .
insulin
before injection so
.
section 5.3 ) .
below
.
These measures will help
SPECIAL WARNING THAT THE
the
SQUIBB
been observed .
( rhabdomyolysis ) ,
(
trials
Treatment
and
.
should
and
recommended
first trimester
ON
Do not use ABILIFY
glucose
reached
haemoglobin is rising by
metformin , in
, less than 1
combination
fatigue scale
14 g/ dl (
possibly protein disulfide isomerase
difficulty
may
or
units ( IU )
with
non-
clinically
In patients with diabetes
for ABILIFY
172 breast , 64
.
mmol/ l )
mortality was
than 2 g/ dl
of this
immediately if you
.
and female
impact on overall survival
Research and
as monotherapy
as monotherapy or
genotoxicity tests ,
of greater than 12
may
a pre-filled syringe
, were
elective
humans
haemoglobin
( 1.25
EPS was
of akathisia in
1 260
maintenance doses
Any
the active substance or
see section 4.4
-
treatment with
in healthy subjects ,
no
pneumonia ,
or pharmacist
rapid or irregular
0)20 3116
antidiabetic medicine
epoetin alfa .
The following information is
Based on
except in paediatric patients
Actos 45mg tablets
Puh/ Tel
needle should be
( see section 5.3
should
from
fractures after
a
A calibrated
before injection so
In the
the intravenous route .
The peak is always
or 24 hours after
,
, hydroxypropyl
with
events cannot be excluded
In the four
Patients
efficacy of epoetin
and
:
and vascular
with type 2
doctor
lead to hypoglycaemia
MINIMUM PARTICULARS TO APPEAR
,
In
placebo-controlled
84 Dysphagia : oesophageal
as a mitosis-stimulating
usual
product and
%
, tiredness , nausea
surgery
see section 4.5 )
of the
times per week
Aclasta
should
laboratory parameters
or
following the
and the
reproductive toxicity studies .
mmol/ l
Overall survival
%
ABILIFY 10 mg
days to
of
section 4.8 ) .
(
.
cartridges x
in combination with
neurotoxicity
,
sensory neuropathy , headache
and 4.9 ) .
nausea
the
and
exposure
+ 31 (
aripiprazole
metabolite
symptoms over 3 weeks
haematocrit of 33
IT IS
epoetin
Global R
IU
stroke
in patients
cannabinoid type
the
, may
have been receiving aripiprazole
you have
,
5.3 )
is the
especially
on
be marketed
mean total clearance
and 33
15 on
route
, 5
similar in both groups
The
CI ] (
maximum recommended
including those with
and 36 months
and
,
type 2 diabetes mellitus
jaundice
be
SQUIBB
section 4.4 ) .
important signs and symptoms
30 mg
- 14
As ABILIFY
in patients
of one year
:
starch Microcrystalline cellulose
of Epoetin
g/ dl
24
blood
,
75
in paediatric and
7
0.99 , 1,18 ;
five large
and anaphylactic reaction .
per
-
Tel :
15
with normal
In case
like headaches as
(
4.5 ) .
aripiprazole
are
in monkeys
you
30 % ) .
and take
not to
may
.
of
of the
has not been established
In clinical trials of
Arzneimittel Pütter GmbH &
clinical
dissolved insulin and 80
from
of
D
, pulmonary
GmbH & Co KG
signs and symptoms
7.5
, weight decreased
and 8167 patients
,
30
to
anaemia ( e.
39 % )
dalton .
the
and
should be
haemoglobin ( 1 to
section
Es
UB8 1HU -
%
cooling element .
of these events is
if you
(
The peak
30 kg
and anaphylactic reaction
2000
IT
your
and
renal impairment
of metastases
controlled
result
blood pressure
Eli
" 15
Park ,
occurred in 29 %
300 IU/ kg given
IU ) of
, accidental or intentional
been
a
increases
Co KG
Aclasta
a clinical
120 ml
than 1 % of
The pharmacokinetics of rimonabant
improvement in insulin sensitivity
injections
placebo (
adult patients on
, the
pectoris , increased risk
free fatty
serious
Taking
Immune system disorders Uncommon
more units
exposures
.
ventricular arrhythmias ,
358 9 251 21
and
%
possible
thus not necessary
of CYP3A4
Elevations of CPK (
and
D Centre Limited
(
CLAS )
not
.
a
pathways involving the CYP2D6
40,000 dalton .
732 32 00
effective in
doctor immediately
Detailed instruction accompanying the
) should be
in Saccharomyces cerevisiae
see section 4.4 )
the patient on
of 2 units
months
precautions for
symptoms
and
and
used
, 98
(
and
a
of your concern
and diabetes mellitus
exactly as your doctor
(
type
adequate and
of aripiprazole
g/ dl ( 5.9
and
control
and
increases
used
.
, salivary hypersecretion Vascular
All
the reach and sight
incidence
insomnia ,
NPH ) insulin .
to ensure
of greater than 12
, Oxford Road
23 Patients scheduled
People with this condition
is always well
heart failure
pharmacokinetics
Aripiprazole
times the mean steady-state
13
in children
tell
liver cirrhosis
, in some
children under
( 3.5
30 %
and ,
intravenous route
(
pharmacokinetics of insulin products
patients ) .
the placebo group
( see
Cancer
chemotherapy
GESMBH Tel
In the four placebo-controlled
pharmacist .
Use should be
in plasma .
) erythropoietin
your doctor or
SBECD ) Tartaric acid
In
section
that pioglitazone
glucose control may
or
may
receptors on
See section 4.4
patients with
In a
.
and this
olanzapine-treated
of glucose
patients experiencing
DERIVED FROM SUCH MEDICINAL
6.2 - 7.5
margin
between healthy elderly
+
( FACT-An
disturbed behaviours ,
Uxbridge - Middlesex
as a mitosis-stimulating
, especially infections and
values
are
alfa
1
,
epoetin
units ( IU )
at 6
the
not systemically
pregnancy .
patients
25.9 ] (
,
anxiety Uncommon : depression*
type of
cytochrome P450
genotoxicity tests , aripiprazole
insulin products with fast
47 % .
if you
elective orthopaedic surgery
.
5000 IU ) of
(
angina pectoris , increased
a
4.2
jaundice ,
avoid
Abseamed
daily dose of 15
3 sites
( see section 4.4
maintain haemoglobin values
solution for injection
4.8 )
,
of anaemia associated
vomiting , nausea
vivo
LTD Tel :
other handling
and parenteral
IU/ kg 3x/ week
in the
Actos
should be given
.
(
of 200 mg
see section 5.1
human )
260
possibility of
to 143
a blister
Arzneimittel Pütter GmbH &
administration of epoetin
siehe Abschnitt
Linear
This medicinal
44 ( 0)20
patients
rDNA
5.2
to 30
:
,
eight
other
complete ,
abdominal discomfort
with
(
and adult patients on
or
carbamazepine
Europe )
than
This may constitute
THE MARKETING
human ,
sleepiness , shaking and
) per
and
30 60 25 800
.
per dose ,
women
even several
This is similar
SARL
the nearest
between
This
IU of insulin human
this
SARL Tél :
patients
under 30 kg
: +
of the art .
Kingdom
In
clinical trials , an
beta-sympathomimetics , growth hormone
, the gluteal region
A number
renal impairment (
This medicinal
week by
in
time to disease progression
150 30 -
and all active metabolites
In clinical trials of
doctor .
mmol/ l
to
section
the
of death when administered
unchanged aripiprazole was
observed
50 IU/ kg 2
SQUIBB (
Ask
1 and 10
It
Taking
into less
Laboratoires Takeda Tél :
172 breast ,
and isophane ( NPH
Erythropoietins are
or
for
However ,
14
6.6
.
treatment .
bacterial
23
is
42
somnolence ,
10
the entire
treatment
and mammalian cell
approximately 60
.
)
: store
, less than
for thromboembolic
entire dose is injected
.
.
recommended dosing regimen is
patients with diabetes
LTD Tlf : +
( NMS
clinically
for three weeks
If you
and well-controlled
by significant intra- and
)
.
how
( 6.2 mmol/ l
enzymes and
also
treatment
of aripiprazole
section 4.2
haemoglobin and blood pressure
of the value )
per month , or
,
, brand ( manufacturer
6.1
proportion to
epoetin
.
some
effect
, followed by a
, 90 and 98
neuropathy , ataxia ,
dose adjustment
contains 10 000
see section 4.5
33 IU/ kg
,
the desired range
: + 354 535
is an
% and haloperidol 73
)
the
a
, 56 , 84
than
based on conventional studies
patients with
or
sodium
controls .
a
, rDNA (
by
(
and
or
.
.
incidence (
the placebo group .
stroke in
stabbing
300 IU/ kg 3
of hypoglycaemia
) once a
and
or
( see section 5.1
especially
1.35 , 2.06 ,
of 12 -
,
OF UNUSED MEDICINAL
formation of erythrocytes from
.
90 %
in
motor neuropathy , ataxia
last
) 2649600
attention should be paid
epoetin alfa is very
severity
Following subcutaneous injection
not
: + 47 67
see section
33 IU/ kg
five large controlled
IU/ kg
from the
, for dehydro-aripiprazole
15
Centre
, and water for
in the bile
200 -
53 50
: + 39
treatment
schizophrenia ,
lung , 22
The
mmol/ l
If any
hypocalcaemia , hypoglycaemia ,
dextromethorphan ) .
elective orthopaedic surgery
increased
a stroke or
aripiprazole
thereafter
and
may
gastrointestinal
thromboembolic events in
32 2
Abraxane is not recommended
forms of interaction
cause side effects ,
ABILIFY is effective
000 international
effects
bile
.
dyskinesia , hyporeflexia ,
5.1
most frequently
of epoetin
mg orodispersible tablets
Tel
gliclazide .
moderate affinity for
) .
and sight of children
(
therefore , not
and
; the average
week by the intravenous
the aripiprazole dose
,
2.5
tense
to target a haemoglobin
in
and
until
irregular
open-label study there was
Important information about some
.
.
occurs with carbamazepine
, London ,
ability
UB8 1HU
(
between 10 and 12
300
potent
injections are given
use machines
: patients with
patients were receiving insulin
1.25 mmol/ l
GmbH Roonstraße 25 D-90429
aripiprazole (
mmol/ l )
number
for rimonabant
or
with aripiprazole
products
other ingredients
inter- and
blood pressure
,
dosage of
Phlebotomy may be performed
and
dyspepsia ,
iron stores .
over
adult patients scheduled
the dose should
mg
or pharmacist .
blood pressure or
,
.
agents (
(
epoetin
46 8 704
sudden
for
products .
incidence of EPS was
9.75 mg ( 1.3
below
1.25
is necessary
inhibitors of CYP3A4 (
a
beta-sympathomimetics , growth hormone
OUT OF THE REACH
patients
aripiprazole treated
treatment
The
ml contains 3000
TRIPLE ORAL COMBINATION THERAPY
Actraphane
be followed
your
ACE ) inhibitors
, United Kingdom
-
recommended in these patients
liver cirrhosis
tumours ( 683 breast
arrhythmias
of increased primary
: +
patients
Kingdom
section 5.1 )
Hydrochloric acid (
range of standard
mortality
dose adjustment
your doctor
is not
) .
vanillin and ethyl
g/ dl
.
features
from precursors
ventricular
of Aclasta in children
dosage adjustment
( 0800
with
+ 354 535 7000
After
alfa
4.5 Interaction with
tablets 98 x
300 mg
with consideration for
about hurting yourself
or
NovoLet
insulin
been carried out
10 000
33 Fasting and
before you
,
( 0.62 mmol/ l
rare cases
did
Manufacturer Novartis
to detect possible arrhythmias
or
g/ dl ( 5.9
type of
( FACT-An )
)
,
of the nursing
weeks
may
mg
) 749 749
, while the
insulin requirement .
.
increased risk of
TO
47
Diabetes is
,
SQUIBB PHARMACEUTICALS LTD
between
When either
bilateral
diabetic hyperosmolar
SARL Tél
recommended total weekly dose
1
CYP2D6 or 3A4 inhibitor
30mg
Polysorbate 80 Water for
Your
permitted recovery from the
% )
side effects
Each ml of
:
can be added to
BE STORED
15 "
those
month
In clinical studies
and safety of Aclasta
effect
If you
patients
the treatment of diabetes
isolated cases of angioedema
zoledronic acid
name and
Safety
rapid or
2 g/ dl (
insulin .
trials
incidence of
or
contains
Using a
crisis
with a cartridge (
(
106 A MANUFACTURING
of aripiprazole in
:
) per month
is
At
. emea
Road Uxbridge
of
,
for
advise you
14
mmol/ l )
diarrhoea
Consequently ,
Road Uxbridge -
peripheral oedema
subsets ranging from 517
in
or
5
trials
- 6.8 mmol/ l
LTD Tel : +
combined
human ,
doctor .
However , as with
or
months when stored between
pharmacist
TO APPEAR
the levels
for
and
A clinical trial of
.
Park ,
for
30
standard genotoxicity tests
should
.
172 Danmark BRISTOL-MYERS SQUIBB
If
The
alfa
administer
( e. g. increased
machines
syringes contain 0.8
For a full list
rats ,
cerebrovascular adverse events
tremor
0)810 410 500
It acts by blocking
Be sure to tell
mellitus : hyperglycaemia ,
contains 1000 international
Oxford
, 25.9
.
with haloperidol
( e. g. anaphylactic
have any
IU/ kg 3 times
must be discontinued
and blood pressure
.
administered after the completion
of aripiprazole
section
stomach discomfort
mmol/
also
Maintenance dose between 17
, the incidence
, diabetic hyperosmolar
in proportion to
) or
Interaction
2 diabetes mellitus
aripiprazole should be
of
and
see section 4.4 )
of the
with
psychotic features and with
the
Lancaster Way Wingates
increased Creatine Phosphokinase ,
63 In
the
extent of absorption
Störung
injection sites .
, 2C9
.
haemoglobin ( 1 to
or
section 4.2
and all
in
this patient group .
or
from
ABILIFY
times the mean steady-state
not
70 %
tumours (
, Te
the
no clinically significant
) , Storbritannien
the
patients with
Belgique/ België/ Belgien
specifically
.
contains 8000 international
47 % .
or
infusion
vitro
- 8°C
,
.
appropriate dose adjustment
not
In a
Effects on
30 ) .
in increments
-
When
Kuhloweg
%
is
liver
with or
10 ml
of
There is no accumulation
antipsychotic
trials with aripiprazole ,
10 and
three
of Epoetin alfa and
insulin .
not necessarily in association
47 67
tremor Common :
pioglitazone
)
seizure
,
After
Takeda
(
Ethinylestradiol/Levonorgestrel-Kombination
PHARMACEUTICALS LTD
until
&
patients with
RMP
adjustment
be
not
4.4 )
) increased linearly
)
, nausea , vomiting
vitro genotoxicity assays .
well-controlled trials of
transient and asymptomatic
of the population
Be sure to tell
observed ( see
Patients
or
monotherapy
maximum of 30 mg
per week by
- if you
No
similar
In some ,
g/ dl ( 1.25
%
UK Ltd Tel :
.
Treatment with Abseamed
incidence of EPS was
apparent molecular weight of
haemoglobin is
cancer
tablets
the suckling reflex
the
: + 45 45
Development Centre
ABILIFY
been receiving aripiprazole
, including
the thighs or the
10
251
of
a
been carried out
ability
.
+ 44
a t½ of a
no difference in
1.5
of ABILIFY
, oral
8 704 71 00
should
with epoetin alfa
, insulin ( human
than placebo
Road Horsham
in a
reduction of manic symptoms
4.4
( 2°C
in 64 patients yielded
.
dose to
daily dose should
, the incidence
( e. g. stenoses
55 53 50
the
more often
in the eyes
have
ABILIFY
, itching , hives
E 320
risk
In
with aripiprazole
rats , polycythaemic mice
AB
of the art
.
a cartridge (
ml
)
of administration ) .
while taking aripiprazole
antihypertensive treatment
In cases where there
glass cartridge (
efficacy
hydrochloride .
pioglitazone , whilst
diarrhoea
of aripiprazole
EMEA
4.5 )
8
Lilly farmacevtska dru
have frequent
12 g/ dl
one of
such as sedation
The absorption of
is 50 International
hypothermia ,
and
exhibited
90 %
in
ESAs ) have shown
doctor
doses above
( 7.5
insomnia
cerebrovascular adverse events
Co
( days 21 ,
blurred vision .
UB8 1HU -
(
) ,
always ask his patients
Hunton House Highbridge
occurs
13
mg of
effect
.
of consciousness and
x 1 orodispersible tablets
7.5 mmol/ l
product
,
pioglitazone
, dizziness ,
five large controlled studies
What
12 g/ dl
Store
will receive
000 IU
thigh or
of dosage
Produtos Farmacêuticos , Lda
ABILIFY
x
Studies in animals have
duration
may reduce insulin requirement
events
, respectively , the
of
placebo ( 29
.
no
in the treatment
of
reports of
( NovoLet
with
a
with ABILIFY
with chronic renal failure
units (
(
controls
month )
11 g/ dl (
Refraction anomalies may
mg/ day
make you
or 24
8.7 for aripiprazole .
and ,
Road
and the median
BRISTOL-MYERS SQUIBB
If blood pressure
200 -
( see section 5.1
above baseline
tract
,
ABILIFY
3 mg aspartame (
TO
irregular heart beat
( 7.5
) , Royaume-Uni
Europe ) ,
in subsets ranging from
)
studies
,
to function safely
administered after the completion
or more weeks after
haemoglobin and blood pressure
an increased
increased Alanine Aminotransferase (
the pharmacokinetics
18
0)20 3116 8950
1
modifications in patients
dosage adjustment
condition
site within a
( 1 800
2°C
( hydrolysis ) sites
and anaphylactic reaction .
should be
laboratory parameters
.
duration of diabetes was
Patienten
Using
with rimonabant in overdosage
of anaemic
occurs
.
risk
33
( 7.5
:
precautions
renal insufficiency
.
Therefore ,
12 g/ dl
medicines called antipsychotics
pioglitazone
, pioglitazone
consists of 50 %
and
7
IU )
( see section
physical activity
reactions
.
of Epoetin alfa and
, chest pain
Effects on
IU/ kg
( see section
in a
pre-filled syringe The syringes
,
patients with
ml
the
of CYP3A4
events
In clinical
221 multiple
The
order
,
with
is less
30 consists of
healthy elderly
two
A/ S Novo Allé
Long-term improved glycaemic
thoughts of
lithium
% )
.
1.5-2.5 hours
week by
intravenous administration
% )
% with aripiprazole and
potassium
see section 4.4
an increased
OR WASTE MATERIALS
0
is individual and determined
by
95 %
benefit clearly justifies
.
GGT
ml contains 2000 international
)
surface
in
a sulphonylurea , only
of EPS was
, in patients with
experience
:
Units ( IU
31 34 857 42
was evaluated in
5.1
,
tablets
on the PANSS Excitement
or
mmol/ l )
serum levels of
atypical
local requirements
programme .
vial
[ 3.2 %
in
The biological
healthy elderly and younger
% with aripiprazole and
these trials , a
aripiprazole .
or unplanned
unused product
Be sure to tell
22
.
, 64
production .
month , or if
Decreased circulating levels
blood pressure and
15 mg
hours in
3
West Sussex ,
thyroid hormones and
thyroid hormones and beta-sympathomimetics
about 40
to affect ABILIFY :
10
higher
, increased Gamma
therapeutic
the dose
Gamma Glutamyl Transferase (
patients )
12
172 breast , 64
of
D
dopamine
transient .
aripiprazole
in a pre-filled syringe
Pioglitazone and all
IU/ kg 2
- Diabetic
injection : a
15.7
,
( 2°C -
(
specifically investigated .
- Treatment
without
and
sleepiness , shaking
see section
this leaflet carefully
between 10
( see section 4.4
and/ or
mg
excipients , see
you
, Germany
84 , 90 and
, Wielka Brytania Tel
Changes
This
In addition
in
.
used
caution
25 and 50
two
) ,
and symptoms of
you have severe
.
S. A.
hypoglycaemia
not
therapy .
local requirements .
of
Abraxane has minor
REACH AND SIGHT OF
how
see
week
, thiazides , glucocorticoids
the dosage of ABILIFY
from 2653
diabetes mellitus
26.7
should be monitored closely
aggravation of existing
on the
Ltd Tel :
patients with
in
adjusted
30
Which
( 683 breast
of consciousness and
.
genotoxicity tests
use
after
rubber
% of the
SQUIBB ( FINLAND )
251
8.7 %
Otsuka Pharmaceutical Europe
your doctor
with
GmbH &
overdose with aripiprazole ,
medicine
.
TO APPEAR
.
not recommended
bioavailability of
reported in children .
, hydroxylation , and
increased Aspartate Aminotransferase
.
.
a
to 2
agitation , nervousness
the pharmacokinetics
Aripiprazole
male patients (
your
anticancer agents
BRISTOL-MYERS SQUIBB PHARMACEUTICALS
manic
reductase inhibitors are
epoetin alfa
patients
both a
n =
(
of
be used
standard genotoxicity tests ,
those receiving placebo (
hours
patients
,
of ketoconazole
recommended
In patients
ml ( 1000
1 g/ dl
The other ingredients
rDNA ( produced by
in pregnant women .
Ireland Takeda UK
is
with
usual dose is
take
mice .
or
+ 358 9 251
when stored between
Centre
and no
Hypersensitivity :
and differentiating hormone
+ 44
species
Es
be exceeded .
you are breast-feeding .
per
95 % CI
,
common
ketoacidosis or hyperosmolar coma
if you
35 trials
patient
of
than 1
BY UNIT
studies
site conditions Uncommon -
is contraindicated
) should be avoided
The peak is always
itching ,
see section
be
& Co KG ,
the metabolism of other
insulin and 50 %
In
is necessary
increased Alanine Aminotransferase
at least 15
kilograms .
CARTON OF
93 05
and CYP2D6
patients in
55 53 50
migraine-like headaches as a
(
)
section 5.2 )
.
-
is 32,000 to
ketoacidosis , diabetic hyperosmolar
, increased risk of
Ltd Tel : +
.
of the mouth or
:
If you
are
initiation of therapy
on the other
Norge BRISTOL-MYERS SQUIBB
Hb between 10 and
akathisia
see section 5.3
growth factors
and
: soluble
.
sections
50
,
should
Actraphane 10 : soluble
Gastrointestinal
,
.
well
a full range
: fatigue Psychiatric disorders
being treated with Aclasta
or blood pressure ,
30mg
SQUIBB
Patients
arrhythmias , sudden unexplained
the
, 90
Overdose of epoetin alfa
than 2 g/ dl
the Summary of
patients scheduled for
maximum daily dose should
( see section 5.1
The pre-filled syringes
MEDICINAL PRODUCT
2.5 % )
29 %
e. g. hypothermia ,
, akathisia
therapeutic margin of epoetin
15mg
than 2 g/ dl
In paediatric patients
,
Seizure
, IF APPROPRIATE
reported
unused product
with
0.6 %
)
in
across endothelial cells .
,
10
no
Maintenance dose between 17
for longer
300
, avoiding
,
renal
disposal and
% after
of greater than
more ABILIFY tablets
your shunt and
placebo-controlled trial , the
required ( see section
used
Therefore ,
your haemoglobin
an autologous blood predonation
has been
contribution
In
ABILIFY .
aripiprazole and 3.0 %
Eye disorders Common :
Common : dyspepsia
vascular events
this
and
recommended
mother presents no
, and
.
% dissolved insulin and
(
3 trials
growth hormone and
At
.
over 30 kg and
itching , hives
clinical
contributes about 58 %
the
44
Novartis Norge
,
Insulin human , rDNA
in the
.
0.62 mmol/ l )
incidence of
symptoms
will advise you
SQUIBB PHARMACEUTICALS
section
47
19 %
mmol/ l
the treatment will
.
you are
100 , less
patients
39
trials
given
dose
5
SQUIBB BV Tel
not
2 352 74
bei
+ 31
the freezer section or
differentiating hormone
e. g. hypothermia
, which showed
BLISTERS OR
67 55 53
) .
the
and
,
are
aripiprazole and
international
be
Tel :
.
Global R & D
It
,
MEDICINAL PRODUCT
was observed in 90
( fever ) .
The incidence
aripiprazole and dehydro-aripiprazole ,
.
Allé DK-2880
been observed
can
variation
10 and 12
mitratapide/
data reveal no
be
Use
Introducing
30
clinical trials and
)
of insulin
.
- 6.8
ml
,
epoetin alfa
ml contains 100
4.7
sedation ,
)
in a pre-filled syringe
( see section
23 mg )
used
should
( 0 )
blood pressure
(
EPS including
If you
Tlf
patients with
( see
23 lung ,
times per week by
section 5.3
( e. g. gemfibrozil
,
hypoglycaemia , hyponatraemia Common
reactions have also occurred
of
ABILIFY orodispersible tablets
pectoris , increased
2 hours after administration
the
insulin
consists of 30
.
extrapyramidal disorder
,
isolated cases of
human
from 65 to
patients with
57
the same
85 When weak
that
In patients with diabetes
pectoris
200 - 300 mg
the
mg , 10 mg
faeces
sie durch den
) 663
164 Do
30 mg tablets
incidence of
be
3 times per
trials and
9000 IU/ 0.9
the active substance or
recommended starting dose for
of
, intermediate-acting combined
Incidence of individual
ABILIFY is and
bipolar patients was 12.1
thromboembolic events in
over
is usually reversible
abdominal wall
( 0)20
haemolysis
.
%
% )
,
that epoetin
contraeptives , thiazides ,
for
healthy
with
,
placebo .
hours
Nederland BRISTOL-MYERS SQUIBB
Kuhloweg 37 ,
and
D Centre (
37
.
25ºC )
,
.
Te
warnings
ESAs ) have shown
The
insulin
( 0800
)
marked with
5.2
.
section 4.5
shown to
There
- 8°C ) .
)
diaphoresis and cardiac dysrhythmia
and paranoia
injection , intermediate-acting
well
to ensure
red blood cell
AUC
Insulins
type 1
complications
.
.
200
Development Centre
of
expected .
As
ALT > 10
times per week )
per week by
with
.
008 , 010 ,
associated with
anaemia
(
This
injections
the patient
of
studies ,
been
to protect from moisture
concentrations and
98 TABLETS ONLY )
daily dose should
, antibodies
characteristics of aripiprazole and
in paediatric and
55
fall
in a dose range
with
prospective ,
of Abraxane
widened brain ventricles and
of
, 14
section 4.8 )
about operating hazardous machines
( see section 4.4
Abseamed
by approximately 25
.
Pack size one
.
Abilify
:
,
Cmax
is
) per ml
Takeda Italia
:
( ketoconazole
source
mixed episode of
As
49
When either
.
9
tablets 50 tablets
.
of patients
4.8 ) .
anaemia ,
therapy
30mg
to
) per month
If
dosage adjustment
isophane insulin
corrected
per
haemoglobin
.
the
serum proteins
three days.
no
Aclasta was
orodispersible tablets 28
Typ-2-Diabetes
a
fibrates
,
of
) .
before
MUST
SQUIBB PHARMACEUTICALS LTD Tel
Each ml of solution
one single-use
.
may
the incidence of
other medicinal products
( see sections 4.8
, IF
IU/ kg
was
(
Actraphane 10 NovoLet
4.4
nausea
measuring cup
61 Aldwych London WC2B
* :
renal failure in
insulin requirement
) , 2C9 (
)
or 24 hours after
dose
at least one
vomiting
aripiprazole
usual starting dose
The following
mg tablets may
,
x 1
The
not
affinity for
of
target haemoglobin concentration
with
appropriate dose adjustment
dose of Abseamed accordingly
in association with
- United
disorders and
once a day
is
8 732
Forest Gate
and
presumably
Abseamed
%
House Highbridge Business Park
,
cancer patients
and
with subsequent doses
be used
rapid initial effect together
insulin cannot be
insulin in
life parameters on
Nervous system disorders Uncommon
ensure
(
165 amino acids
, Oxford Road Uxbridge
, 23 lung ,
.
in
The
in favour
, 64 gynaecological
1 g/ dl
ABILIFY
of pioglitazone
ml
.
(
Starting dose
-
The frequency
antipsychotics ,
: + 43
) .
Introducing
with a cartridge
result
treated with Abraxane
300
) ,
as hydrochloride )
Abseamed
Units ( IU
tiredness ,
if you are
The
) .
more
.
stopper
rDNA )
) , increased
bipolar
baseline
the next dose after
your
patients with chronic
diabetes
contains
by 32 % and
decreased locoregional control
Road Uxbridge -
,
to
mit einer ng
t½ )
patients who
( particularly overweight
increased alkaline
pregnant women
Ask your pharmacist
What Actos contains The
renal anaemia ,
doctor ,
:
ABILIFY
indications
your
patients with renal anaemia
epoetin
and beta-sympathomimetics ,
ABILIFY
be disposed
.
.
.
stability results in
- United
of
repeated (
(
before
60 -
.
( for pH-adjustment
, hypocalcaemia ,
mg , 10 mg
recommended dose is 600
also
.
with
, fibrates )
results of a full
% ,
When a dose adjustment
than
from light .
tablets in
.
Ísland VISTOR HF
have been accompanied
,
be observed
the
14 g/ dl
insulin
45 mg
g/ dl
risk
Excipients
diabetes is
see section
Abseamed has no
.
with epoetin alfa
if the
or
is
ensure
, combination of
Die
The
86 %
.
may also
NAME OF THE
included
clinical trials of aripiprazole
film-coated tablets .
when
Bei
see section
scheduled for major
pectoris , increased risk
,
(
)
your doctor may
of osteoporosis in post-menopausal
contains 7000
,
Similarly , for
disorders and
The maximum
,
45 % )
Starting dose
your dog
pharmacokinetics of
dose regimens
in patients
salivary hypersecretion Vascular
compared to
increased
the frequency
and lactation
opening
30 minutes , every
.
,
Usual maintenance dose
most frequent adverse reaction
ml
When seen , it
,
R & D
the dose
contain 0.5 ml
,
not
- increased risk
44 ( 0800 )
Insulin
1HU -
& Co
and
Insulins and
g/ dl ( 7.5
:
or irregular
,
trials
each day .
receiving non-platinum chemotherapy
of 1 ml
.
1.25
In
cases
mellitus , diabetic
.
( anhydrous ) .
on the disposition
other insulin products
, and
,
in the
for the treatment
for
to maintain urea ,
not
.
% of the
mean age :
75
of the reconstituted
erythrocytes from
Obesity is
from
In clinical
such
pre-filled syringe
.
placebo-controlled
of thrombotic
cerevisiae )
mmol/ l
more than 1
clinical trials ,
should be
.
use machines .
patients ) .
.
renal insufficiency
, 14
intravenous administration
with
the
or
surgery
% of
on CYP2C8
Effects
64 gynaecological
snack containing carbohydrates .
to treat
The daily insulin requirement
for
CYP3A4 ( e. g.
,
For
, Wielka
MAOI
.
4.2 Treatment of
trials with pioglitazone
are
( Europe ) ,
thyroid hormones and
trial
placebo-controlled
.
necessary
a
was more effective
, creatinine and
All patients being
cases fatal outcome has
injection
United
Like all
)
:
nausea , vomiting and
years ; the average
is very
Abseamed
has no influence
and
by
the incidence
)
hemmt.
to
you
or ibuprofen
in a
trials
mmol/ l )
pharmacist
peripheral
IU/ kg
month
.
controlled studies
l
more units
30mg
A
greater
.
entire dose is injected
KG Kuhloweg 37
IU
normal
parkinsonism , akathisia
30 mg
of 1 ml
g/ dl ( 6.2
Storbritannien Tlf
an antidiabetic medicine )
should generally
33 ( 0)810
of 0.8 ml 6
benefit clearly justifies
60
Storbritannien Tlf
,
( see section
anaemia ( e. g.
(
be presented
complications
in section 4.2 .
surgery
4.8
tolbutamide
a meal or unplanned
related to
ON BLISTERS OR STRIPS
a sulphonylurea
refrigerator
may
is not known
tense
is
20.9 [
human tumour samples ,
Tel : + 40
.
or
g/ dl (
STRIPS
haloperidol .
or lithium concentrations
sodium per dose
take it with
and
1.25
, 90 and
KG Kuhloweg
incidence of
and
ml oral solution
2 weeks
D Centre
and water for
the
experienced
in women
, both via
4.5 Interaction
maximum of 30
28
in a dose range
schizophrenia
taking
molecule
to years of
by being placed
dummy
nausea , constipation ,
3116 8954
should
IU )
and
wird
When looking
cases
, long-acting insulin
blood pressure
contain 1 ml (
, long-acting insulin
insulin
these trials , a
them
hypersensitivity reactions
patients
see section 4.5
a
is pioglitazone
aripiprazole (
than
patients
and
male patients
sizes may
) are
calcium
a mixture
use machines have
as 5
but
61 Aldwych , London
especially
bioavailability of the
skin fold minimises
or
the
hours in
.
.
Oxford Road
by the intravenous
or lithium
West
coma
doctor
mmol/ l
day
diabetes
patients with
,
recommended
has been accidentally frozen
) .
insulin human (
+ 353
agents (
absolute oral bioavailability of
rather than
subcutaneous use
a
Arzneimittel Pütter
the administration of
you
Very rare
172 breast , 64
condition may also
a glass ball to
See section
8°C
1.25
ml
mmol/ l
potentially medically serious
Effects on
to
with
It is especially
menopause
.
all patients receiving
study included only 3
nausea , constipation ,
dosing did
MEDICINAL
) or
of clinically
If
blurred vision
per dose
developmental toxicity
if you
12
aqueous
of Abraxane has been
tremor , syncope
and sometimes
( 0.5 to
The initial dose
taking
for three weeks (
change in
akathisia
at least one to
Dose adjustment in order
rats after
of
, brand ( manufacturer
aripiprazole
a stable level
over
treatment
5000 international
: + 44 (
, hydroxylation ,
mmol/ l )
isophane insulin .
64 gynaecological
atrial fibrillation )
or
used
with consideration for
was
When the CYP3A4
whether you
patients with
.
the incidence of
machines .
immediately if you
& Co
reported
6.1 .
in Saccharomyces cerevisiae
,
Treatment should only be
6
in
solution for injection in
: +
of 0.5 ml
by
plasma concentration of pioglitazone
paclitaxel following
and bone marrow
:
If it
the risk
loss of consciousness
IU/ 1 ml
: dehydrogenation
the pharmacokinetics
4.4 )
glycaemia
In
and
)
(
tablets 98 x
recommended ( or if
or worsening
+ 39 06
transient
pre-filled syringe The syringes
of
with severe agitation ,
the
used :
warnings and precautions
epoetin alfa
controlled
and
80
taken
and patients who
doctor immediately
anaemia
epoetin
are therefore affected
and
Insulin treatment
pH adjustment )
oedema
take
Please
mg
(
patients
patients
One
prior to
which is potentially lethal
in a pre-filled syringe
femoral neck
ng/ ml
mmol/ l
than 1 % of
dopamine
It
" A
OF UNUSED MEDICINAL PRODUCTS
4.4
please tell your
and
or
Kingdom BRISTOL-MYERS SQUIBB PHARMACEUTICALS
times per week
From
than 1
is aripiprazole .
or
66
should be
in other indications
in patients with less
If
this
%
ml ( 8000
(
haemoglobin
14 and
The following reactions
increased
50 IU/ kg 3
DISPOSAL OF UNUSED MEDICINAL
usually did not require
dehydro-aripiprazole are
alfa is very
clinical
and
Abseamed
attention should be paid
Less than 1
diabetic
2.5 %
45mg
80 %
target haemoglobin concentration
,
to sudden
effect
route
the intravenous route .
BRISTOL-MYERS
increased risk
this product is available
Some patients
on
+ 43 1 60
, even several weeks
.
possibility of multiple medicinal
over 12 weeks
the human insulin molecule
the
+
,
11 g/ dl (
of insulin
result of hypoglycaemia .
When a
or
section 5.1 ) .
dextromethorphan )
cardiotoxicity unequivocally
units
, sedation
a
8.1 mmol/ l )
2°C - 8°C )
AND ROUTE(S
time
of erythrocytes from precursors
PHARMACEUTICALS LTD
for four days
not known
to target a haemoglobin
27 %
to 30 mg/ day
OF UNUSED MEDICINAL
see section 5.2
food .
increase 40,000/ µl
changes in bacterial
Finland OY BRISTOL-MYERS
ml
, including those
8167
an increased
haemoglobin
.
see section
.
1 pre-filled syringe
in
patients
Dose adjustment in order
.
g/ dl
, somnolence , tachycardia
epoetin alfa should
the
2 g/ dl
irregular heart beat
in favour
µ : +44
537 900
Any unused product
all
nausea
akathisia in
precautions to
study )
contains metacresol , which
5.2
the intravenous route ,
,
,
Peripheral
aripiprazole AUC
risk
combination with
( normal
tumour due to
by
A
tumours ( 172 breast
at least
2697
patients
and whose
hours
0.5 ml
re- suspension
DERIVED FROM SUCH MEDICINAL
not take ABILIFY
to the
] (
House
take possible interactions
(
omeprazole
13
NAME
elderly patients with
Die
headache ,
Your doctor will check
.
Abseamed
maximum
.
next
, Aclasta
a blister
The following
, 72 (
did not
aripiprazole and dehydro-aripiprazole ,
stopper
3 ml
no
In
, aripiprazole
to ensure
sodium hydroxide (
:
QT prolongation or
OR WASTE
in the
erythropoiesis stimulating agents (
.
hyperglycaemia
Laboratoires Takeda
and danazol .
3 or 5 times
for the
Research and
,
should be avoided .
alfa and other erythropoiesis-stimulating
Es werden möglicherweise nicht
.
.
3x/ week
an increased risk of
, nausea
the dose should
type
, vomiting
from the
42 trials and
.
clearly
bound )
( see section
erythropoiesis-stimulating agents
Tel : +
the label to the
trials and
0.5
its use is
8°C )
pharmacokinetics
) than
and
insulin
injection
dose regimens
%
Tél/ Tel :
,
in these
Actraphane is a
and
especially in patients
is necessary ,
heart disease or
week by the intravenous
patients with bipolar disorder
other
agitation ,
doses of
for
in a refrigerator (
der
.
Severe hypoglycaemia may
vitro
section 4.4
in isolated patients
4.7 Effects
stroke or
influence
therefore
defined
.
.
other antipsychotic drugs
13
corresponds to 0.035
is metabolised
metabolites
- 12 g/ dl
undergoing dialysis :
e. g.
therapeutic margin of epoetin
, µ : +44
the
( for pH-adjustment
& Co KG Kuhloweg
by 32 % and
placebo .
is between 75 and
Bagsværd Denmark
Oral contraeptives , thiazides
(
1.25 mmol/ l )
this
% with placebo
headache Eye disorders
Abseamed
ALT )
2°C - 8°C )
haloperidol .
maternal
and danazol
see section
.
( see section
postural dizziness , neuropathic
, sodium chloride ,
( see
with
aripiprazole
46 25 16
of
formation of erythrocytes
1
Norge BRISTOL-MYERS SQUIBB NORWAY
Europe )
: +
the vial
.
this
Starting dose
chemotherapy
%
of agitation ,
of the limited experience
dose of
be considered (
or
tablets
in haemoglobin (
to epoetin alfa
, rDNA
: + 44
) than
obesity in adult dogs
flushes ,
may occur
are breast-feeding .
one of
below
When considering concomitant
refrigerator
they
placebo
of the
cartridge
patients
leaflet
weeks
receptors on
contact
without food .
is therefore recommended .
( t½ )
The
.
with
60
while taking
704
for 3 consecutive
a clinical trial
The biological
vorgenommen werden
reported estimated doses
here .
for major elective
diet
warfarin ,
section
using
the
016-018
factor and differentiating hormone
+33 ( 0)1 46
Nederland BRISTOL-MYERS
.
with baseline
95 % CI
+ 358 9
bioavailability of
,
.
The
e. g.
in section 4.2
% with placebo
solution for infusion
The maximum
.
for smokers .
section 4.6 ) .
4.7 Effects on
and
and
creatinine and
younger subjects .
dosage of ABILIFY
mellitus , diabetic ketoacidosis
angioedema and anaphylactic reaction
% with aripiprazole and
.
ml
you are pregnant ,
see section 4.8
with
0.5 ml
than for haloperidol
The dose of
thumb
dosage of ABILIFY
insulin (
section 6.1
Renal or hepatic impairment
( see section 4.2
the administration
study ( 19.5
. vomiting
blood pressure
.
effectively
contains 0.05 mg
g/ dl
efficacy .
,
vomiting diarrhoea softened stools
of Bipolar I Disorder
be
36(0
.
or combination therapy
hypoglycaemia whilst driving
( see section
of clinical
5.3
of anaemia and reduction
that
see section 4.4
patients
and sometimes
Abseamed
TO APPEAR ON BLISTERS
less than 1
kg .
,
the dosage of ABILIFY
to treat adults
years ) of
with chronic
4.9
HF Sími :
.
in
recommend dose modifications
MANUFACTURER
PIOGLITAZONE IN COMBINATION
following
300 mg
ABILIFY is 15
and diarrhoea .
:
vomiting
A sustained haemoglobin level
other
a
.
Abseamed has not
.
to maintain haemoglobin
+ 44 ( 0)1628
reported estimated doses
chest pain
during
hours after
potent
or
60 -
in a
)
insulin
intravenously )
Storbritannia
- metformin
clinical studies
diabetic ketoacidosis
14
a
SQUIBB BELGIUM S. A.
patients
.
REGARDING
regresses
l/ hr/ m2 .
(
Dysuria ,
+44 ( 0)20 3116
12 -
- If you have
All special warnings and
)
and Cancer Linear
, somnolence ,
20 In
blood donation procedure
Moreover ,
alfa
,
the
orodispersible tablets
recommended
patients
.
5026
section 4.4
immediately
migraine-like
section 4.4
aripiprazole treatment
, and doses
8545250
in vitro
A
dysphagia
ml ) .
ON BLISTERS OR STRIPS
is extensively metabolised
pre-filled syringes of 0.4
in
was evaluated in
bottle contains 5
you are considering stopping
with your doctor
recommended ( or
In clinical trials
( rhabdomyolysis ) ,
and 47 %
.
,
of epoetin
.
and
surgery
clinical trial in healthy
1
.
vary with age
%
human
valproate
hyperglycaemia and diabetes mellitus
bisphosphonates in
in a pre-filled pen
the
5.8
did
trials included
blood in urine
epoetin alfa
of aripiprazole
day .
section
of
combination of
a clinical trial
see
+ 33 ( 0)810
the intravenous
recently taken any other
Common :
and other
monoamine oxidase inhibitors
patients with
For
1 g/ dl
with
0.63 mg mitratapide/
psychotic features and
0)20
both
a
When a dose adjustment
anaemia (
56-99
1
stroke
blood pressure
.
scheduled for major elective
and 15.7
haloperidol
In clinical
and administration site
Cytotoxic actions of
l
( see
mmol/ l ) should
) or the
On this
the
or they received
with Abraxane
use of Epoetin
deep vein thrombosis
per
in section 4.2
and
(
what it is used
pioglitazone
,
200 mg
.
60 %
site conditions Common
Insulins and analogues for
of
.
not
,
Tel :
42 In
)
OF THE PRODUCT
start
taken in combination with
.
in men
use in this
of greater than
patients with
plasma elimination half-life
Manufacturer Novartis
the freezer section or
antagonism , aripiprazole has
Do not
WC2B
one of these trials
, glucose-galactose malabsorption or
result of hypoglycaemia .
see section
dose
, headache ,
this medicine :
in
.
ABILIFY may increase
or
patients
501 76
)
in the pioglitazone
per
.
unless
.
ABILIFY
to be compatible
, including ABILIFY
,
Lilly Holdings Limited
0)20 3116
COMBINATION THERAPY WITH METFORMIN
efficacy and
Farmaceutici SpA Tel :
a negative
with
over
In
50 %
of dehydro-aripiprazole
studies
significant
hypoglycaemia may
dopamine D4 ,
control decreases
monkeys .
may
Lactose : patients
IU/ kg
Europe ) , Royaume-Uni
In clinical
haemoglobin concentration should be
Abseamed
, increase the risk
.
likely
0)9 8545250
the reach
without psychotic features and
cannot be excluded .
14
clinical fracture variables are
46
Therapy- Anaemia ( FACT-An
6.1 .
second trial utilised
see section 4.4
However , in
should
9000
dose
risk
5.2 )
done
metformin ) were
Paget s disease
weight decreased
450
Abilify
,
is therefore recommended .
forms of
30 mg
.
) per month
Upon discontinuation
zu
10
thrombotic events
take possible interactions
2
)
This
, warfarin ,
( hypoglycaemia )
analogues for
open-label studies
Suomi/ Finland OY BRISTOL-MYERS
common
the incidence of
95 %
152
Treatment should only be
IT IS
3
% dissolved
, inform
Tel :
by 32 %
E951
+ 358 9
3 x
of the
mg/ kg
with encephalopathy-like symptoms (
genotoxicity ,
% )
Farmacêuticos ,
When
3 times per
i. e.
isolated patients with normal
In
50.4
type
.
vascular events
tablets 98
In patients
given subcutaneously 3
once a year
after
total administered dose with
with
when
if you are
symptoms over
(
ml contains 100
.
dysmotility and
x 3 ml .
clinical trials and
cases
800 )
negative impact
Read all of
1.5-2.5 hours
( see section
with subsequent
risk for
this is
provide a
the dose should
the patient on
ml ( 8000
, constipation
Following oral administration of
binding
)
your doctor or pharmacist
increases
hospital
procedure for reconstitution
.
Epoetin
BRISTOL-MYERS
approximately
between 9.5 and 11
,
It is especially
4.8
water for
reduction of transfusion requirements
greater than
)
Norge BRISTOL-MYERS SQUIBB
excipients or to any
The frequency
.
and
In
In case
survival
1.35 , 2.06 ,
)
in addition to
.
measures will help
e. g. hypothermia ,
blood cell
thyroid hormones and
of erythrocytes from precursors
epoetin alfa
: dyspepsia , vomiting
) ,
(
)
therapy
or
, or
and
lung , 22
existing
( see section 4.4
psychotic features and with
anaemia
be followed
effect
half-life
but not
epoetin
, or if
insulin 40 %
your ABILIFY
:
site conditions Uncommon -
alfa
.
receiving non-platinum
, 49 x 1
aripiprazole and dehydro-aripiprazole
10
CYP3A4 ,
with a
35
Tlf : +47
discontinuation of treatment
Treatment
adult patients
Anaemia symptoms and sequelae
trials
patients
Adult and
) .
with
the incidence
) ,
37 D-58638
House
minutes
are given Aclasta
see Table 2 )
subcutaneous tissue disorders :
, headache
,
the
flu-like
,
packed cell volume
international units (
nurse
section 4.4 ) .
long-acting
The possibility of
4.8
, maize starch ,
)
When the CYP3A4
epoetin alfa
The
% of the
0)20 3116
negative
of diabetes was 9.5
dissolved insulin
inhibitors
or
water for
cerebrovascular adverse events
loose stools ,
( see section
atstovyb Tel . +370
Studien
relevance of these findings
an increased risk
retinopathy Long-term improved
.
) and
may
Characterisitics , Section 4.2
:
Kilruddery , County
patients
,
of
.
5.2 )
may
interactions
not be used
,
for dose
(
is
reduce the epoetin alfa
Aclasta
section 4.4 )
long-term use
patients with
in
characteristics of
Common
, there was
treatment
United
People with this
)
,
hypoglycaemia
to the foetus .
injection ,
in vitro solubility .
followed during preparation
with
with residual
or higher
angioedema
and
with
Middlesex UB8 1HU -
recovered label
Arzneimittel Pütter GmbH &
Upon discontinuation
Die
of stroke or
Finland OY BRISTOL-MYERS
of
and such
Malignant Syndrome
the
Abseamed
( see section
first trimester
should
suspension contacts
patients
and biliary excretion .
sections 4.3 and 4.4
.
a cartridge
.
Oxford
insulin
(
, a
12 g/ dl
5.9
of
tooth extractions or other
AUC
and extrapyramidal symptoms
A proconvulsant activity of
with solid tumours (
of children .
solid
You will
Insulin suspensions should not
antipsychotic drug
, 39
see
dementia ( loss of
precautions to
Erythropoietins
in
contains 100 IU of
with placebo .
The pharmacokinetic characteristics of
the
of this population ,
occurred in
supplements
0.5
8.4
abdominal discomfort
7
rats
( dextromethorphan
patients with severe renal
in
carbamazepine
EPS was
a
from
be
may
(
immediately
regresses
17 and 33
and completed suicide
of
and
This
, pruritus , or
.
is always well below
5.2 ) .
of
hours after the
and isophane insulin
+
month , or if
insulin and
50 ,
treated with
The AUC
55
+ 44 (
reported
with these
and
4.2
in
and
was 12.1
5.2 )
restricted
or
Highbridge Business
. ) .
remain at
blood pressure
, vomiting , constipation
( iron deficiency ,
lower the blood pressure
are
, headache ,
the
controls
use of Epoetin
or
epoetin alfa should
consists of 30 %
see section 5.2 )
or urticaria
and adult patients
for
g/ dl ( 1.25
6 weeks
once
Overdose
human , rDNA (
contains 3
insulin and
>
treated patients
pH adjustment )
Farmaceutici SpA
pre-filled syringe of 0.7
or
medicines
when
contains
possible ,
is
802 with haematological malignancies
peripheral
extreme and associated
)
can occur
effect
you
to 12 g/ dl
In most of these
renal impairment :
.
( as
is
.
of
- if you
been reported
and
) 74 18
( see section 4.4
extent
with Abseamed
Luxembourg/ Luxemburg
in pregnancy
not be added to
15mg tablets
61 Aldwych London
administration
or
should be considered .
33 IU/ kg ,
should be
BRISTOL-MYERS SQUIBB
trials
with
to
hyperglycaemia , diabetes
Eye disorders
Business Park , Oxford
should be avoided .
experienced the development
are
or hospital
works in
In
23 hours .
7.5 mmol/ l )
a dose
and/ or dark urine
reactions
and 10
.
34 (
)
Blood pressure
vial .
epoetin alfa
part , by
( i. e.
and
in patients with
In clinical trials
treatment
controlled clinical studies
Abseamed should
aripiprazole .
Tel : +
mmol/ l
If blood pressure
see section 6.1 .
not been established .
The cartridges are designed
usual
( particularly
4.2
contains
and consists of
.
35 trials
no relevant
clinical
25
with chronic renal failure
epoetin
Co KG ,
section 5.3 )
patients
pioglitazone
in
recommended total weekly dose
g/ dl
(
.
other .
the
( 7.5 mmol/ l
MUST BE STORED
of cytochrome
.
trials aripiprazole has
injection sites
118
4.2
to
It can be
aripiprazole and 3.0 %
variation
as compared
section 4.8 )
Oral contraeptives ,
and
of
contributes about 58 %
580 00
- 8°C )
contains metacresol , which
and
, vomiting and
of the
starting dose for ABILIFY
as measured
administration of
day of that month
België/ Belgique/ Belgien Takeda
type 2 diabetes
IU/ kg 3
% )
because osteoporosis
of greater than 12
route .
the thighs or
Doses below
.
.
any of the excipients
.
3116
to
sulfobutylether b-cyclodextrin ,
speech disorder
Pioglitazone is also indicated
the
of 50
defined by a decrease
between 10 g/ dl
Insulin suspensions
should
bone marrow fibrosis of
dose should
efficacy
malformations
H1 receptors
is
pioglitazone
maintain haemoglobin
-
and
ml
Detailed information on
shortened
vomiting , nausea ,
mg
not
with fast-acting ,
approximately six weeks
It
not
occur
patients with
in
carton .
temperature regulation disorder (
of overdose should
In clinical trials
information on
of the body
safety pharmacology
potentially
should generally not
At least one new
dosage
.
in
short-
urine
recommended for
,
or
and controls
) .
data available
1.25 mmol/ l
rats
be managed cautiously .
mmol/ l
Park ,
and
33 IU/ kg
Myalgia
surgery patients
aripiprazole
1 %
recommendations .
week
( e. g. hypothermia
inform your
renal failure in paediatric
approximately 18
that
other dental surgeries .
32 % and
diabetes , ketoacidosis
Medicines
GmbH &
clinical trials and
AUC
subcutaneous administration
approximately 60
4.4 )
the incidence of
in
antipsychotic drug
rare
The vials are for
In patients
the incidence of
ml glass cartridge
round and yellow
of this population
with ABILIFY
.
( 2°C
Pioglitazone should not be
take possible interactions
:
.
duration of diabetes
active substance
aripiprazole ( 43
, restlessness
from
ml equivalent to 300
one year or
overdose with aripiprazole
of greater than 12
somnolence , sedation ,
The
( see section 4.2
decreased
l ) .
of patients with
.
Aluminium perforated unit dose
and 33 IU/ kg
a
be
.
oral
clearly
or
-
utero and
thrombotic events
Nederland BRISTOL-MYERS
The biological
g/ dl ( 7.5
the
see section 4.4 )
is always well
of NMS
Danmark Takeda Global
only
, elevated creatine
in
can
60 14 30
also
The recommended
is
monoamine oxidase inhibitors (
Ask your pharmacist
events
The tablets
A MANUFACTURING
treatment with epoetin
.
regimens including
are
7.5
.
stopper
severe manic episodes in
the
use of
are
of digoxin ,
ml
30 kg require higher
Epoetin alfa
,
If you
Italia
The effect of the
diabetes
nervous
,
lead to hypoglycaemia
events in
Three of the six
obesity )
of effectiveness was
, antibodies
,
25 and
incidence
have
33
4.4
, growth hormone
50 IU/ kg
tremor
) .
experiencing potentially clinically significant
rash
for
)
the
, 2C9 (
symptoms can occur .
you
Complete
anxiety Uncommon : depression*
Global R
acute renal failure .
mmol/ l ) .
tablet formulation is
not
nausea ,
BRISTOL-MYERS
SARL Tél :
clinically
.
6000 IU/ 0.6
When weak
patients presenting with
if
-
.
no
or
FINLAND )
schizophrenia
injection ,
hyperglycaemia and diabetes mellitus
month ) with
(
be monitored and the
some of your
trials of aripiprazole
between healthy elderly and
negative impact
Tél
,
18 84
a full range of
of akathisia in
in
Epoetin alfa
concerns
carbamazepine
.
Following subcutaneous injection
, 87
.
,
.
Kingdom Takeda UK
akathisia , tremor ,
mg
storage conditions .
MEDICINAL PRODUCT
trials and
therapy .
household waste
patient group .
)
( Europe ) ,
information on the
Diabetes is
a
without
Butylated hydroxyanisole
patients
who suffer from a
If blood pressure
12 g/ dl (
: +47
.
feelings
ABILIFY
supervision and monitoring should
8°C
of 10
glass ball to
recommended .
in proportion to
micrograms epoetin alfa
be
.
chemotherapy
approximately 60 %
large controlled studies
patients
it
are
of the art .
)
the
clinical
only 3 patients
scheduled for major
no appreciable
per
Injection sites
significant
such as
,
but this effect
Malignant Syndrome (
4.2
cancer
, swelling
Treatment of patients
and :
Before
of aripiprazole in
,
of
of aripiprazole
of 84
and
risedronate-treated
should be closely monitored
weeks (
( days 21 ,
.
the
tremor ,
pruritus
Moreover ,
.
with your doctor
Tlf
other medicinal products
R & D
over 30 kg
9.5 and 11
take
contains a
ABILIFY 15 mg
been reported in patients
site conditions
based
tell
environment .
by the intravenous
in the three days
,
In
peak
has not been
the
In a
alfa
not
should
hydroxylation of aripiprazole
MEDICINAL PRODUCT
the
or
should
is
children under 30
.
.
(
R & D Centre
or settling are
United Kingdom
on
you will
in healthy subjects ,
erythropoietin
e. g. hypothermia
no
than children over 30
( 7.5 mmol/ l
VOLUME
to
or
PIOGLITAZONE IN COMBINATION THERAPY
1 tablets 98 x
4.4 ) .
mild
with reported estimated doses
intravenous
12
.
Tel : + 46
and
, 1,18 ;
alfa
or without
injections
cannot be excluded .
injection
and of the
(
g/ dl ( 5.9
decision
It
.
%
aggravation of existing
Tel : +
,
patients with
or snack containing carbohydrates
alfa in
these trials , a
epoetin alfa
is
Thrombocytosis
a maximum volume
the active substance paclitaxel
and no
The
to epoetin alfa
defined .
In three
characteristics of aripiprazole
of
patients treated
see section 5.1 )
appropriate dose adjustment
Increased
pruritus
who have a
What ABILIFY contains The
the incidence of
Table 1 lists
women treated with pioglitazone
mmol/ l )
, restlessness ,
epoetin
between 10 and 12
12 g/ dl
features and with
.
abrupt improvement in
products and
7.5 mmol/ l )
of
signs of
and danazol
produced by
Three of the
the
the treatment of diabetes
weeks .
and symptoms
trials that
( see section 4.4
a dose
because
1 to
)
should be
and
0.62
effect
pioglitazone is rapidly
5.3 )
injections
:
tell
.
aripiprazole
your
anorexia
: orthostatic hypotension*
and inter-individual
Uncommon -
12
units ( IU )
of the
is used
) sealed
to
.
patients
insulin ( human
average age of 62
1
of
in patients
4.4 )
the
(
.
mg
5.2
12
is
an
and
with pioglitazone
In clinical trials
39.0 , 55.3 ]
)
glass cartridge (
53
is
schizophrenia
.
contains metacresol , which
15
data
orodispersible tablets
4 or more units
If you accidentally
.
treatment
minimal
The
weeks
)
( AST )
about 5-10 hours
muscle
70
is authorised provided the
THAT THE
in mortality in this
: in clinical trials
thyroid hormones and beta-sympathomimetics
+
controls .
see
are
.
( 7.5 mmol/
the intravenous route .
Oedema Oedema may
%
Kingdom
neuropathic pain ,
PRODUCTS OR WASTE MATERIALS
to starting Abseamed therapy
survival
should be
cannot be excluded
,
) 20 501 76
CYP3A4
or
in strength
in patients with
to drive and
a
neutropenia or severe
:
938 ;
Uncommon
.
+ 45 45 93
more than 2
cardiovascular
when erythropoiesis stimulating agents
, polycythaemic mice )
first trimester
Europe ) ,
)
mixture of dissolved
your doctor
administered
evidence
in
24 hours
IU/ kg
used in combination
with consideration for
in
(
are pregnant ,
in a refrigerator
in strength
of your
9
ON BLISTERS OR
Hypersensitivity reactions
, fibrates )
a bromobutyl/ polyisoprene rubber
-
LTD Tlf
respected
, and
be
857 42
)
with epoetin
Takeda
available
the dosage of
.
,
) That
provided
doctor or pharmacist
concentrations ,
10 days following
aripiprazole in
five large controlled studies
humans
64 gynaecological
g/ dl ( 5.9
The individual
.
any
mg tablets are rectangular
A sustained haemoglobin level
pharmacokinetics
in this
Storbritannien Tlf : +
diarrhoea .
to
the freezer section or
g/ dl
& D
usual , talking very
be
Abseamed
Polysorbate 80
.
and
a rapid-cycling course
encephalopathy-like symptoms
with aripiprazole
pioglitazone (
of 0.3 ml 6
:
Business
MEDICINAL PRODUCT
these trials
of
can
haematological malignancies (
.
.
significant
children
less
on the ability
after
.
Methyl parahydroxybenzoate
.
activation
) .
Each bottle with
infusion fluids
unused product
, or
and controlled as necessary
failed
fibrosis of any origin
OF UNUSED MEDICINAL PRODUCTS
The
3000 IU ) of
differences in hip fracture
with
, IF
of transfusion requirements in
prolonged
with
see section
)
a
biological efficacy of
your doctor
(
g/ dl
of in vitro solubility
10
but not in
were
g/ dl
- Treatment of
should be considered .
increased risk of
in vitro solubility .
MUST
events
.
49 x 1 ,
a measure
As weight increases
is given concomitantly with
precautions for use
Ask your
225 ) ,
Cmax of dehydro-aripiprazole
vision .
trials of aripiprazole
The
the
OF UNUSED MEDICINAL PRODUCTS
be
alfa alters
used
in patients with agitation
with
concentrations
Pioglitazone is also indicated
131
approximately 6 hours
,
see section 4.5 )
)
see section 4.6 )
section
; none
section 4.4 -
several
67 55 53
with a prescription
(
is
acts by blocking
.
your ABILIFY tablets
section 5.2
week
- 150
of
ml 6
7.5 mmol/ l
placebo
6.2
)
200 - 300 mg
1
see section
Co KG Kuhloweg
%
, chest pain ,
or
, dehydro-aripiprazole ,
product
unexplained
: fatigue Psychiatric disorders
BV Tel :
clinical
Bipolar I Disorder and
,
)
x
( 7.5
100 IU of
( for pH-adjustment )
( 6.2 -
treated
and
,
The
, somnolence ,
dyskinesia
medically important
if
Treatment of anaemia associated
1.25 mmol/ l
information on
with aripiprazole and
had a
be avoided .
fatigue scale
for
of epoetin
- Peripheral
ml equivalent to
per
is
) is therefore
been reported
duration , there were
Lilly
.
the
.
pulse or blood pressure
,
tubulin
10
ABILIFY
16 to 81 times
units
.
in strength ,
well
patients with diabetes
Within each
The
)
reduction
bisphosphonate-naïve patients and 42
N
for 3
and
United
extensive extravascular distribution
terminal
Upon regaining
(
after
8°C .
vomiting
is unknown
)
ml solution for injection
daily
generally not
( injection )
and
food
feeling anxious ,
) and 802
active
and
the
5 and
(
intravenous administration
( Europe )
than 1 % of
insulin ,
, thiazides , glucocorticoids
source
a
ABILIFY is used
aripiprazole
dextromethorphan/ 3-methoxymorphinan ratio
Portugal - Produtos
existing treatment with
After each
in a cartridge .
in
not
.
, pruritus ,
important signs and
Usual maintenance dose 75
Concomitant administration
incidence
trials
symptoms of hypocalcaemia
in combination with metformin
+
and precautions
soluble insulin 40
even
or hyperosmolar coma or
What benefit has
recommended ( or
and extrapyramidal
approximately 60
syringes contain 0.5 ml
:
Ask your
of the
are breast-feeding .
)
in all
in patients
e. g. stroke
diabetic
is
and
( see section
, infection or
emission tomography .
Results of
There
serum levels
Tell
. They include thirst
Patients
myocardial infarction and
,
THE OUTER PACKAGING
mg )
of
61
Kingdom
see section
.
pioglitazone and its
difficult
about 5-10 hours
% and
.
were receiving cardiovascular
in whom the
reported concurrent peripheral
+
)
IU/ kg 3
site conditions Common
) .
( see
than 2
pigment ( haemoglobin
Common
(
acute renal failure
trial of pioglitazone
Glutamyl Transferase
, followed by a
2 g/ dl
generally
greater than 2
of children
6.1 )
.
THE
+
rare hereditary problems
and
1
in clinical
of anaemia associated with
white
recommended
.
Actos 45 mg
patients with agitation
( 2°C - 8°C
acid
%
loss of consciousness
In patients
of 33
indicated that
thrombosis ,
erythropoietin
comparisons
vomiting and
patients
CLAS ) .
Storbritannia Tlf :
Dysuria ,
.
section
HF
of the
see
2C19 (
- 8°C )
ba Latvij Tel
aripiprazole
allergic reaction (
trial
other erythropoiesis-stimulating agents
hypoglycaemia whilst driving .
four weeks
Intensified control in
pain , itching
clinically
.
placebo .
15 mg/ day
WHAT
is
of
section 4.8 )
and
paediatric and
week
neuropathic
4.4
, aneurysms , etc.
:
.
& D
blood pressure
Fever and chills
vomiting , nausea
.
mellitus
,
30
with a
five
of
What Abseamed is and
The total dose
) per
of patients
general scale
00
somnolence , sedation
effect
studies ,
may lead to hyperglycaemia
)
with
, and
one injection .
dehydro-aripiprazole ,
with a glass of
Takeda Global
Serum electrolytes
no
.
Treatment of
hypoglycaemic agents ( OHA
44 ( 0)20
nurse
your
of unchanged aripiprazole was
, but more frequently
- 14
.
)
by
to drive and
not necessary
be avoided .
can be found here
4.5
antipsychotic
are
time each day .
times
50 %
.
sizes may
models of dopaminergic
with
.
45 %
dose
200 mg
hyperosmolar
40,000
+ 44 (
aggravation of existing
has been studied in
(
also
with
In patients with
your
use in
,
,
pancreas
Each tablet contains
)
and a
5HT2a receptors
&
manic symptoms
the
57
.
is always well below
given subcutaneously
in the thighs
take it
some cases
Protamine sulphate Water
1 to
,
contains approximately 425
week by the intravenous
other
than 1
& Co KG ,
the symptoms
.
,
of clinical fractures following
reconstitution
may be
Abseamed should be
omeprazole )
weeks
the intravenous route
combination with insulin ,
IU/ kg
- 8°C
by the intravenous
g/ dl (
is more common
(
OR
pioglitazone as
creatinine and
section
younger
, angiotensin converting
in
QT prolongation ,
; ATC code
should
exhibited
M-II
3.5
insulin cannot be
and
effect
concomitant administration
with placebo
34 857 42
22
um 5
haemoglobin (
when oral therapy
11
.
,
Storbritannien Tel
45mg
in
and 10 cartridges
NAMES , PHARMACEUTICAL FORM
Development Centre
the
considered
albumin-bound nanoparticle
pre-filled syringe of
feelings
ABILIFY is 15
, with a similar
likely to break
a
Arzneimittel Pütter
opening the bottle
Within each
half-life
clinical trials
stabilization phase
(
9 Adjustment
4.4
your doctor or
or
study
of
ml
Diabetes Mellitus : hyperglycaemia
ml
) .
doses
If
up to 2 years
as soon as
HORIZON Pivotal
In a
per
substitution
In
In clinical
France BRISTOL-MYERS
of Bipolar I Disorder
for
increased risk
Even if
treated ,
in routine laboratory parameters
if you are
pre-filled syringe
, nausea , constipation
of glass ( type
dose
and
section 4.5
position , or
and 8167 patients )
g/ dl ,
) to 12
scheduled for major elective
that the
in
serotonin
skin
( n =
epoetin alfa
alfa alters
Assessment of
and
injection route
administration of ketoconazole or
of epoetin alfa
, Oxford
43 ( 1
abdominal wall .
and disappear
some cases
( 5 mg
rectangular and blue
,
0.6
contains 100
product must not be
may
alfa
31
with
of the
In clinical trials
In the
20 mg
by at least
8.7
precursors
:
route
x 1 tablets
pharmacist
, deep vein thrombosis
The
.
alfa may
33 IU/ kg
,
, therapy
immediately if you
1HU - United Kingdom
are
aripiprazole and 3.2 %
isophane insulin
Treatment
44 (
, elevated creatine
43
Oxford Road
infusion fluids .
rats , but not
patients with
is difficult
and
or hepatic impairment may
, pyrexia ) ,
There
Ltd , 61 Aldwych
aripiprazole
from
.
Other disturbances of
experience in this patient
NORWAY LTD Tlf
In order
3000 international
of
Farmacêuticos , Lda Tel
section 5.1 ) .
(
the use of Abraxane
see
28 x 1
and analogues for injection
this condition may
15mg
compared with those
of this population
It is
for three
international units
levels remain the
well-controlled studies in
Uncommon
under
( e. g. anaphylactic
DK-2880 Bagsværd Denmark
per ml 400
is a clear
aripiprazole ,
+ 353
Multi-pack
.
in
2ºC - 8ºC .
.
France BRISTOL-MYERS SQUIBB SARL
clinical
ml
the
At equivalent doses ,
incidence
Common :
It is
and
AND ROUTE(S ) OF
QT prolongation ,
(
be administered intravenously
The pharmacokinetics of
aripiprazole
patients
25ºC
hypoglycaemia ) , sugar
section 4.4 )
aspiration have been
)
have been receiving
1 diabetes
55 Elimination
section
, followed by a
ABILIFY
5AB United Kingdom
disorders
irregular heart beat
clinical
of administration ) .
: + 43-(0)800 29
food .
98 x
patients
on
syringes contain 0.8 ml
the intravenous route
Aripiprazole and other
- Middlesex UB8
g/ dl (
risk of
with
2C9
patients with
In
Lilly Holdings Limited p
these side effects
in a
epoetin
Severe hypoglycaemia
ischaemic
Non-clinical data reveal no
orodispersible tablets 28 x
Hunton House Highbridge
epoetin alfa
line
6.8 mmol/ l )
Co-administration of
at least two
see
or
.
rats after
mmol/ l
events
, contact
source
, open-label studies ,
in humans
that primarily
brand ( manufacturer )
very wide
blood in urine
if
SQUIBB
your doctor immediately if
Special
peripheral
Thrombocytosis has been
the
before taking ABILIFY
and
( 6.2
sodium chloride , glycine
.
The
aripiprazole
be
1.25
What
the insulin requirement
transient
see
.
,
In
16.1
It
) per kilogram bodyweight
per
Vantas
patients
four
programme
Diabetes
lithium concentrations
be at risk
not
and dehydro-aripiprazole did
,
)
days to
,
in
,
,
After
manic or
)
years
efficacy of
and adults
your
) ,
of
transparent plastic ( cycloolefinic
N-dealkylation
61
information on
less than 18
.
412 6600
illnesses
.
of children .
section 4.5 ) .
:
contains one single-use
biological efficacy of
the
ABILIFY
started as soon as
of
in men ( study
5.1
rDNA ( produced by
five large controlled
dyspepsia ,
administered
e. g. hypothermia
g/ dl
Uncommon : orthostatic hypotension*
, monoamine oxidase inhibitors
AUC and Cmax of
alfa
contains 100
epoetin
and
dose-dependent increase in
,
4.7 Effects on
or
: + 44
Road Uxbridge
LTD Tel
epoetin alfa
in
the indication increasing
the
OF
with solid tumours
is
risk
42
significant
GESMBH Tel :
g/ dl
fracture variables
is less common .
- Middlesex
Following
recent low-trauma hip fracture
increased risk for thromboembolic
should be avoided .
over
be administered
Weight gain :
daily
parathyroid reserve ,
with baseline
information on the
terminal half-life is determined
placebo
g/ dl ( 6.2
to the
plasma
needle should be
Common : extrapyramidal
16 00
pre-filled syringe
malformations
% of
(
Hypoglycaemia may occur
and
treated
doctor or
and
in a blister
anaemia
solution .
1
% with aripiprazole
4AE
the proportion of patients
combination of
50
patients
)
syringes contain
Sodium chloride
and
is
section 4.8
,
9.5
and
in
you
.
pioglitazone as
epoetin alfa is very
460 women
before
, aripiprazole should
be
in
after
) .
usually
1 g/ dl
%
a
, less
: dyspepsia
been observed .
the pack with
under
pain
6.1
efficacy of
daily dose of
Analogue Scale
dose
essential
no clinically
,
.
manic episodes in patients
treatment
.
elderly patients with
warning symptoms of hypoglycaemia
If you
is
the
These
THE DISPOSAL
hip fracture ,
see section
type 1
tablets 56 x 1
) or
is
.
- 39 % )
30 Adjustment of dosage
:
Subcutaneous injection :
your doctor
relative
Europe Ltd
Any unused product
-
7.5
.
)
Pre-filled syringes ( glass
the patient should
or
40 NovoLet
, the formation of
( 7.5
and
Hb increase 1
known whether pioglitazone
Co
effect
with Abseamed
in
this medicine
If
clarithromycin
solution for injection
blisters .
clearance
28 , 56
possibly protein disulfide isomerase
your doctor or
before
used to treat diabetes
g/ dl ( 0.62
Hyperglycaemia and
(
by
below 12
with
is individual and determined
carefully weighed
patients (
is
should
sudden
or stroke in
alfa and other
of controls
Europe
ABILIFY is effective
notice any
a number of other
or intentional
specifically
The following
with a similar
What
seriousness .
of
Tel : + 44
renal
of 33
other
with other
vascular
.
(
in
%
, or if
, muscle pain
acute
danazol .
aripiprazole
Horsham
.
and
solution for injection
1
Less than 1
outcome study ,
epoetin alfa
as
and
the maximum recommended
4.5 ) .
efficacy
SQUIBB
Uxbridge - Middlesex UB8
(
.
The blood glucose
Cancer Therapy- Anaemia
The syringes
(
If you
concentrations ,
allergic symptoms , may
normal and
a prospective
of greater than 12
Kingdom BRISTOL-MYERS SQUIBB PHARMACEUTICALS
to sudden stabbing migraine-
Tablet core
:
haemoglobin ( 1 to
Oy
has not been
600 IU/ kg
mmol/ l
.
, or if the
5.3 ) .
to avoid
.
dosage
( 2.5 %
PRCA can result in
Osteoporosis
vitamin B12
all
Insulin suspensions are
7000 IU/
6.1 .
type 1 )
SQUIBB
The
be administered intravenously
use
Lactose monohydrate Maize
R &
and with or
:
, Aclasta
10 g/ dl (
( for pH-adjustment )
1 ml
could damage
of EPS was
and/ or a sulphonylurea
to
ketoconazole
.
Following oral administration of
to reproduction
of CYP2C8 in vivo
thigh or
more
%
haloperidol
) ,
% isophane insulin
410
. vomiting diarrhoea softened
.
(
REGARDING SUPPLY AND
Proportional increases of the
(
study
SQUIBB BV Tel :
pre-menopausal range .
human
12 g/ dl (
sedation ,
.
Uncommon
,
Common :
to drive and
other medicinal products
vomiting ,
involving 460
tumours (
, becoming
2.5 %
epoetin alfa is very
hours after
to be compatible
These trials
CPK (
:
insulin
a manic
reliever
If you
if you are
, uncommon cases of
mg once daily .
of
metformin and
possibility
SMALL IMMEDIATE
treatment
week by injection
in
Cmax
risk factors such as
levels
see
tremor , dizziness ,
supervision and monitoring should
10 and
solution contains 10 000
Abseamed or
SPECIAL PRECAUTIONS FOR
to years of
1 orodispersible tablets
the
of whom
Germany
15 mg pioglitazone
as monotherapy was
,
However
,
done
symptoms can occur .
progression of diabetic
CYP3A4
.
, ,
PRODUCTS OR WASTE MATERIALS
for
.
rat
, especially
1 tablets 98 x
effects on ability to
.
PRODUCTS , IF APPROPRIATE
recovered label was
in type 1 diabetes
( NMS
and 12
episodes
placebo
mg of
clinical
15.7 %
significant benefits
of aripiprazole .
EPS was
doses of Abseamed
14 , 28
2C9 (
:
95 % CI :
The following
98 x 1 tablets
32 % and
your
patients
adults
aripiprazole
In combination with
to
Horsham West Sussex ,
chronic renal failure
40
no
Denmark
includes
,
while taking aripiprazole
+ 44 (
monitoring
ABILIFY
and
Kingdom BRISTOL-MYERS
results of a full
, especially
)
In clinical trials of
not
a pre-filled syringe
if you are
of dissolved insulin and
of CYP2C8 in vivo
( haematocrit
The infusion must be
GGT ) , increased
epoetin alfa in
per week
)
and is
your
,
doctor or
section 5.3
osteoporosis ,
1
a
IU ) of
Ltd 61 Aldwych London
.
route .
40 %
haemolysis
weeks
or tense .
was
favour of
undergoing dialysis :
suicidal ideation ,
and
hypertension , lymphoedema
)
compared
programme , the
and dehydro-aripiprazole
the
SPECIES , ROUTE(S )
possibly protein disulfide isomerase
Although there is
two of the
is
pharmacist
comparable to placebo .
causes of deaths were
.
, sudden
administered by intravenous
suspension in the
no evidence of clinically
The pharmacokinetic characteristics of
more ABILIFY tablets
data
. de
535 7000
BRISTOL-MYERS SQUIBB Tlf :
the pharmacokinetics
However , elevated creatine
%
aripiprazole
4.3 and
.
Europe )
( days 21 ,
recommendations ,
children
450
and take
64 gynaecological ,
with a
,
Abseamed should be
respectively ,
from 65 to 200
358 9 251
nausea ,
, including those
( ca .
over 3
incidence
10
mg tablets are
,
REGARD
:
disorder
60 %
4.8 )
- Middlesex
of
by
The potentially
refrigerator
measures in order to
be used .
should not
included
see section 4.4 )
,
SQUIBB SARL
mixture of dissolved insulin
of two
diarrhoea
Centre ( Europe
require higher
and
seriousness .
may
+
Even if
.
section 4.4 )
see section 4.3
days
g/ dl
This summary was
patients
Aclasta 5
t½ of
tablets 56
.
: + 46 8
study
0)21 272 16
12 g/ dl (
of
epoetin
if
on
, less than 1
to ensure optimum response
the
Taking ABILIFY
11.9
potent CYP3A4
tachycardia ,
section 5.3
dogs
in order
.
AND
defined .
of a full range
dopaminergic hyperactivity and agonist
see sections 4.3 and
6 pre-filled syringes of
not
solution (
of
trial ,
or joints
In
Global R & D
controls .
.
effective
CHMP
% dissolved insulin and
reported
)
, United Kingdom
alfa
( see section
or pharmacist .
body
site within a
administration
dose regimens .
from
34.05 ]
patients with
of 1
have
If you
)
in
30 mg
per month ,
ability
At therapeutic concentrations ,
Posology
patients with a
.
20 on
reactions
.
with haematological malignancies (
ml
reduction of insulin resistance
)
- 200 mg
, thyroid hormones
observed
is
Diabetes is
.
ml
)
Treatment of anaemia associated
been
scheduled for major
, IF APPROPRIATE
LTD Tel :
a cartridge ( 3
15 mg
the
.
less than
reduction in
.
Sussex
dissolved insulin
6.2
margin
Following
1.8 mg
The
] (
,
to
Carton of
the active substance
dehydro-aripiprazole increased by 77
7.5
a
the
Middlesex UB8 1HU -
60 - 150 30
, itching ,
SPECIAL WARNING
for major
dihydrogen
5
section
, vomiting and
than
Iron
children under 30
E216 .
( 0)20
- 300 mg
SQUIBB
diabetes mellitus
aripiprazole
factors
incidence
What
the
important signs and
is a
,
( Europe ) ,
, headache Eye disorders
hepatocellular dysfunction
( e.
6.1
) Ltd ,
per week
plasma
of malformations
occurred in 32 %
be followed
/
Oxford Road
contributes about 58 %
administration of
,
fat meal
The
of
drive and
1 and 5
remains unknown
Aripiprazole exhibited
or pharmacist .
MUST BE STORED
you
What ABILIFY is and
.
between 10 g/ dl
Centre (
In clinical trials
)
similar to
The syringes contain 0.6
( ALT ) ,
of medicines used
ADMINISTRATION
4.4 ) .
your
0.4 ml (
the
only
*frequency is based only
.
When
3x/ week or 450
e. g. increased
enzyme (
.
than
only inject the amount
a
or 5 or more
( see section
.
) Ltd ,
meal or unplanned
of
Farma - Produtos
Before use
who has
trials
:
tablets 30 tablets
.
of aripiprazole
.
section
The usual
beta-sympathomimetics
infusion bag
50
monitoring of
section 4.4
solution
) 74
pharmacokinetic characteristics of
if the
GmbH
protect the environment
and
in 29 %
decreased sensitivity to a
Abseamed
( 1 ) 524
more than 2
comparable to placebo .
ml contains 7000 international
SQUIBB Tlf : +
, Oxford Road Uxbridge
patients
(
Like all medicines
a pre-filled syringe (
,
elective orthopaedic surgery
of 10
50
ability
solution for injection contains
after the
and placebo ( 29
In clinical
mg
%
on results of
.
10 or
to 6 hours and
the doctor or nurse
valproate
medicines
mmol/ l ) per
treatment
30 %
on the
,
Many had
CYP2D6 and CYP3A4
) ,
study included only
to reproduction .
(
+ 43-(0)800
) ,
)
anaemia with
Actraphane is
of the
and
AUC
Europe ) , Te
rare - Refraction disorders
a
clinical fractures
61 33 22 11
precautions
IU ) per
3 patients
and danazol
or
+
section 5.3 ) .
with
is a colourless
mmol/ l ) .
that indicates an
ml contains 100
%
Farmaceutici
section 4.4
increased risk of
angiotensin converting enzyme (
solid tumours (
.
, the
Detailed information
injections Hydrochloric acid
28 tablets
taxanes
.
Centre (
should be monitored closely
with or without
engraved with "
( human ) .
food
OUT OF THE REACH
reports are based
1 ,
.
Interaction with receptors other
concomitant
When a dose adjustment
( 7.5
human insulin .
)
humans
with residual
not alter rimonabant exposure
in
medicines known
patients with
a day
( 6
bioavailability of the
Patients who
extensive extravascular distribution .
4.4 ) .
programme ,
compromise or additional
once daily
12
2 g/ dl
route .
Park , Oxford
%
male and
elderly and younger
pioglitazone , whilst the
99 % )
with two other
after
to protect the environment
other medicinal products
Insulin human ,
(
contains
water
target haemoglobin concentration
- 200
300 IU/ kg
of the hormone
is indicated for
cause mortality was
symptoms
In patients
epoetin
patients
weight gain and oedema
+
under the
hydroxylation
dementia ( loss of
disease progression was
aripiprazole
, IF APPROPRIATE
days to
In a
, dizziness ,
)
individual clinical
doctor can recommend a
( 95 % CI
patients
(
no
disposed of via
14 x
in this patient group
.
" A
A number of cleavage
animal models of
the insulin requirement
:
be
.
overdosing
prophylaxis
been receiving aripiprazole
and haloperidol 73 %
Based on
results were
mg/ ml
)
One IU
section 4.8
S. A.
The potentially medically
6
:
not
spezifische Interaktionsstudien bestätigt ,
.
Abseamed has
Eli
pulmonary
ABILIFY
, even several weeks
g/ dl , the
medical practice
type 2
the mean
(
, 98 and
isolated cases of
Aldwych London WC2B 4AE
injection
or
The maximum
Iron status
not using effective
weeks
30 % )
, or
a multipack with
ml (
dyspepsia , vomiting ,
urinary
CHO/ HGPRT )
,
+ 32 2
with
dose
of
with aripiprazole
take
solution for injection in
mg
2-78
usual , talking very
- 39 % )
conventional studies
you
physician must therefore
section
be administered intravenously .
for the occurrence of
a similar rate
other
and/ or
,
(
is
may vary with
.
Abseamed has
7
the administration
other handling
six identified
) .
in Saccharomyces cerevisiae
,
six identified metabolites are
8951
, including ABILIFY
The reconstituted medicinal product
with diabetes mellitus
with
intensify and prolong the
human , rDNA (
AB
and obesity in adult
week by the intravenous
should
Before
infusion ,
a blister
retinopathy Long-term improved glycaemic
epoetin
,
in
of efficacy
Orodispersible tablet Round
( 1.25 mmol/ l
vitro
25
pre-filled syringe of 1
ABBREVIATIONS
IU/ kg 3
efficacy
cell production .
are
749
- 7.5 mmol/ l
to any of the
be at
14 g/ dl
,
orthostatic hypotension*
GESMBH Tel
solution for injection in
7.5 mmol/ l )
cooling element
For preventing
the
these two medicines
for use
significant risk factors
and
of
CYP2C8 in vivo
more than 2
95 % CI
000 IU/ 1 ml
see
with encephalopathy-like symptoms
transient loss of consciousness
, the gluteal region
should be advised
or
or
- Middlesex
no clinically significant
) .
8°C
ABILIFY
) to
than
OF
pharmacokinetics of aripiprazole
physicians for
United Kingdom BRISTOL-MYERS
and swelling of
you
g/ dl (
of
x
Other potent inhibitors
the pharmacokinetics
The
)
to other
between 1.25 and
anorexia
the
.
what it is used
of
serotonin 5HT1a
vary with age
subcutaneous erythropoietin
should
if the solution
or
.
effect
abdominal wall .
patients with
.
50.4
95 % CI
studies
heartburn
cerebrovascular adverse events in
hypoglycaemia may
Abseamed
occur
)
aripiprazole
15mg tablets
clinical
The
single intravenous
Excipients :
IU/ kg 3
should receive
to avoid
( see section
10
between 10 and 12
epoetin
adequate and well-controlled trials
quinidine
the
14 x
no adequate
,
p rst vniec ba
e. g. diminished
People
that indicates an
,
R & D Centre
the
and 98
solution
PRODUCTS
thromboembolic
the intravenous route
(
and
. emea
with these characteristics
source insulin
Die
: + 47
25 and 50
trials
.
to
seriousness
in
Peripheral oedema , mucosal
- United
.
dextromethorphan ) .
Increased mortality : in
hypoglycaemia , hyponatraemia Common
Frequencies of adverse
your doctor or
39 06 5026 01
SQUIBB ( FINLAND
Anaemia symptoms and sequelae
ABILIFY is
and
is
and
syringes contain
i. e.
increased
Owing to
cyclosporin
should be
3 times per
.
the
84.0
clinical trials
49 x
rapid or irregular
doctor
dose is between
the
17 4.7 Effects
Epoetin
PRODUCT AND ROUTE(S )
see
12 ,
: + 44
of these
anaemic
,
trials of aripiprazole ,
take
monitored
small
had already
Centre (
or severe
,
dose
Cancer Therapy- Anaemia
dose of
vial contains 10
and extrapyramidal symptoms
adjustment
patients with these characteristics
evidence of
subcutaneous route and is
solution for injection in
aripiprazole
been reported
is 10 or
very wide .
Safety
above indications
.
,
used
not been established .
)
g/ dl
medicinal
in
epoetin alfa
know
significant effect on
hour ,
treatment with aripiprazole
in very
(
( e. g.
dehydration )
%
following
precautions for use
emea
epoetin
Uncommon : orthostatic hypotension*
)
trial in healthy
and
5 hours
.
during pregnancy
variation .
this should be
side effects
elderly
The
on
epoetin alfa
paediatric patients
RG40 2AQ United
Haemoglobin variability
( this
dose is 5 mg
0.5
.
moisture
AND SIGHT OF CHILDREN
1.25 mmol/ l
mellitus , diabetic
opening
NMS
For
,
clinical trials with aripiprazole
ABILIFY
200
metabolism
renal function
a slight appetite decreasing
,
or
insulin
2
.
as
more
values
The
- In
ng/ ml
than 2 g/ dl
elemental
controlled clinical studies ,
, please tell
a daily dose of
and
) are neutropenia
manic episodes in
- 100
most
NPH ) insulin
of Abseamed
in
Therefore ,
, including
49 orodispersible tablets
between
injections are given in
thrombosis , arterial
is
(
hepatic impairment :
safety
,
Hypertensive crisis with
1 g/ dl
should
in order
patient
OUT OF
,
R &
section
treated with
84
- 150 60
to affect ABILIFY :
trials
by
in patients with
t½ ) is therefore
increase in haemoglobin
trials of aripiprazole
.
for mitratapide
in dose should
In
elderly
an
see section
Overdose of epoetin
USED FOR
patients
in a multiphasic manner
most of
patient
needle top
The decision to administer
in 24
children
(
CHMP recommendations
protein binding
, gender , and
data
mean age
to avoid
46
( see Table
pioglitazone
aripiprazole during
AUC and
a manic
Highbridge
the
+358 9 61 33
you
Use should be restricted
of anaemic
) .
of the Marketing Authorisation
zoledronic acid must be
efficacy
14
Paget s disease
vitro genotoxicity assays
units ( IU
( see
should
(
have also occurred
.
the
is contraindicated
of the stem cell
cancer patients receiving chemotherapy
2.47 in favour of
,
section
Erythropoietin is
osteoporosis ( a disease
Syringes
13 g/ dl
suicidal ideation
12
:
that
Diabetic
a growth factor
haemoglobin (
and
time
mg
treated
Actraphane 10 :
In order
A specific overdose of
) , increased Gamma
8.7 % for
If
Each tablet contains
30 mg
injections .
EPS was
of
31 ( 0
experienced with
Pre-existing
reactions have also occurred
this
United Kingdom
(
ml (
hypotension* ,
YOU
variation .
.
The potential relevance of
mixture
human dose or exposure
dehydro-aripiprazole
these two medicines
Die maximale Tagesdosis
section 5.1
require higher maintenance doses
facilitate the
of administration
has been accidentally frozen
2000 international
who
bottle - 100 ml
patients
Very rare
, concentrations
an
g/ dl (
SpA Tel :
be
Use (
( 2 )
.
or too near
recommendations
vascular
,
episodes of hypoglycaemia
concentrations
doses of Abseamed
( see
Therefore , no
such as
802 with
(
of these symptoms
.
)
In
compromise or additional
especially
specific frequency can
.
mmol/ l )
4.5 ) .
see section
with
is between 75 and
* Produced in CHO
is no accumulation :
is not recommended .
IU )
see section 5.1 )
have been proposed ;
chronic renal failure and
therapeutic
has been
or
once a day
chemotherapy
and a
nausea
alfa is
, marked with
: +33 ( 0)1
of pregnancy .
with
controls (
The
its
trial
with or
see
)
United Kingdom
benefit
to
also be effectively treated
43 1
(
endogenous human erythropoietin that
ABILIFY is used
a
pancreatitis
possible ,
children
Takeda Global
.
.
the
defined
There are no adequate
or
Cmax of
3.0
of
and beta-sympathomimetics ,
61 Aldwych London WC2B
elderly patients
the
solution contains 10
alfa in adult patients
advised accordingly
(
aspirin
cerebrovascular adverse
epoetin alfa on
,
pioglitazone (
( 2°C - 8°C
alfa
compartment
( 57.3
and adolescents under
section
occur
condition
pharmacokinetics are
July 2007
section 5.3
UB8 1HU -
four placebo-controlled studies
%
after
Detailed information
patients
events
Inadequate dosage or
swelling
6.1 .
, the incidence of
,
DERIVED FROM SUCH MEDICINAL
of clinically
and
, Abraxane contains approximately
g/ dl .
15
Non-specific skin
quinidine
or placebo
74 18 86
receptors on
a number
to
to protect from light
in
Abseamed
alfa
solution
and 12
:
45mg
Europe ) Ltd 61
clinical trials aripiprazole has
and
of
anxiety Uncommon : depression*
The recommended
was
24
Tel : +371
ALT )
patients receiving
The
For a full list
reach and sight
, osteoporosis in
Adult and
( haematocrit of
MAOI
49 ,
of anaemia
of
the parent substance
coma
( 57.3 %
.
residual
be considered
and
and
four weeks
antihypertensive treatment
defined as the patient
metabolism
corresponding to 16.8 micrograms
GESMBH Tel
IU/ 0.3
of 0.5 ml
It
of aripiprazole in pregnant
increase the risk
contains metacresol , which
feeling anxious ,
%
metformin and a sulphonylurea
The study population had
VISTOR HF Sími :
of aripiprazole
significant
increase the risk of
- 14
about this medicine
mellitus , diabetic ketoacidosis
see also
11
1.25 and
, metformin ) were
Oxford Road Uxbridge
71
Europe )
patients with the
patients
,
.
mmol/ l ) should
in healthy subjects ,
no
1.3 ml
) .
use
risk factors
GmbH
.
after
therefore
, intermediate-acting
.
after
to
450
: + 40
and precautions for
you
DERIVED FROM SUCH MEDICINAL
31
2-78
be monitored
reaction
the
tell your doctor immediately
in other indications .
or
( 4
alfa
.
of clinically significant
for
4 or more
OR WASTE MATERIALS
of glucose
accumulation
These
reduction of transfusion requirements
very rapid or irregular
fast-acting
appropriate dose
reported after months
injection
Some patients
in
been established .
warnings and
of
see section
with metformin
24 hours
diabetes mellitus
REACH
in cancer patients
the
Tel : +
The mean total clearance
infusion
five
paediatric
76 % had >
GmbH
SARL Tél : +
) :
sedation ,
alfa is very wide
rhabdomyolysis
to
cancer patients receiving chemotherapy
the pancreas
aripiprazole
of 200
adult and paediatric
controlled
) to
chronic renal failure ,
PRODUCTS , IF
14 , 28
a result
BRISTOL-MYERS
medicines called antipsychotics
(
in type
of the bone
2-hour endpoint
15mg
were
( 1.25 mmol/ l
) .
aripiprazole
CYP3A4
,
effective than
the
orodispersible tablets
the pack
be exceeded
of pregnancy .
under 18 years of
PRODUCTS OR WASTE MATERIALS
from light
without
blood pressure ,
risk
.
18 , or
28 x 1
1
been reported while taking
)
g/ dl
The pharmacokinetic characteristics of
For the treatment of
warfarin )
and clinically
.
(
needle top .
mg
was
,
( e. g.
: + 47
- Produtos Farmacêuticos
sizes may
blood donation procedure .
- if
see section 6.1
0.6
, the haemoglobin
pulmonary
2
patients
Your veterinary surgeon will
of
( aripiprazole
migraine-like
were
,
:
Eye disorders Common :
Carton of 49
mg or 30 mg
The recommended
BRISTOL-MYERS
of
characteristics of aripiprazole
)
Educational leaflet Summary
44
6.1 .
( see
are transitory and
of 10 to
, constipation ,
approximately 25
and
)
fat
to disease progression
trials of aripiprazole
sulphonylureas or insulin
Mitratapide also has a
) Protamine sulphate Water
orodispersible tablets
OR STRIPS
ABILIFY
40 %
serum levels
Dose adjustment in order
with normal
respectively
if you
lesser amount in urine
beta-sympathomimetics , growth hormone
, pain
)
patients
( 6.2 -
( NPH ) insulin
the
insulin .
of administration
exposure
- Middlesex UB8
anaemia associated with
whole .
.
two
Close supervision
or
between 10
.
, this
Common : extrapyramidal
significant weight gain
It
Insulin suspensions
.
ON THE
other erythropoiesis-stimulating agents (
mmol/ l
the
n = 136
be avoided
cannot be excluded .
10
of anaemia
In
dextromethorphan ) .
, increased Gamma
Keep out of
It
and efficacy of
about this medicinal product
. :
in vivo appears
age
Tel :
cartridge .
scheduled
131 )
and
, somnolence , sedation
therefore a measure
Also contains
Dose adjustment
Very rare -
were
the
( for pH-adjustment
.
1.3
the dosage of ABILIFY
QT prolongation
D-58638 Iserlohn , Germany
safety data revealed no
in
mmol/ l
to
IU/ kg 3
the placebo group .
A
and
based
monotherapy or
.
seriousness
mg pioglitazone (
significant change in
alfa in adult patients
given subcutaneously 3
before use
( 30 mg )
are never to
therapy .
for
(
at doses
) is therefore
patients receiving
0.2 mg propyl parahydroxybenzoate
.
cell production .
Ísland VISTOR HF
less
(
patients
than
patients with
in
epoetin
children over
Patients
insulin ( human )
( see section
, respectively
,
manic episodes in
or
on in vitro studies
Takeda Ireland
A
) .
,
such as
is usually
should be
symptoms
all
2°C -
or irregular heart beat
month
or
effectively
United Kingdom .
routine volume replacement should
been receiving aripiprazole
, sedation ,
example
- Treatment
.
or
that
absorbed , with
- Middlesex UB8 1HU
, 49 x 1
clinical
NPH )
Adipositas
and
, insomnia
France Therabel Lucien
section 4.2
expected to
in two studies
Park
and dyskinesia
been treated
a few weeks
Business Park , Oxford
male patients (
should be investigated
and
be exceeded .
or
.
the intravenous
in the
Abseamed 4000 IU/ 0.4
6.8 mmol/ l )
in
.
be managed cautiously
than
enzymes
by the intravenous route
section
inhibitors of CYP3A4 (
patients
% of
dyslipidaemia ( abnormal
and controls
( IU )
6.2
insulin sensitivity
usual dose is 15
34 857 42 22
( also
in
is a
factor and differentiating hormone
.
In
the duration of the
to drive and
( IU )
approximately 20 %
Takeda Global
package leaflet of the
Effects
% ) .
patients
terminal half-life
Hunton
( heartburn ) ,
at least
should be rotated
Die
, headache ,
.
50 %
kg
treatment
2000 IU
of diabetes was
% ;
affects you .
maximum of
.
AST
: + 353
33 IU/ kg
between
of patients
administration of
section 4.2
( IU )
patients
deep vein
section
AB Tel : +
the intravenous route .
.
is 10 or
The frequency of these
is between
6.2 mmol/ l
Ísland VISTOR HF Sími
(
be reduced
-
defined by a decrease
equivalent to 300
respected .
elimination per se
of pioglitazone ( as
mmol/ l
and
not
hypoglycaemia
epoetin alfa
with
anterior abdominal wall .
total administered dose
within
.
in
SpA Tel :
headache
should
for the
cerebrovascular adverse events in
at increased risk
an
in paediatric
the
21
irregular heart beat .
kilogram bodyweight .
%
section 5.1 )
ketoconazole
discontinuation of treatment
351 21 412 6600
,
( 7.5
352 74
(
especially infections
section 4.4 ) .
the
- Diabetic
] ( weeks )
.
similar
22 to 143
out of
: + 47 67
of aripiprazole .
,
TO APPEAR
14 g/ dl
mmol/ l )
West Sussex ,
pre-filled syringe of 0.7
45mg tablets
should be considered .
Based on in
8000 international
Hypoglycaemia
approximately 6 hours
- The
study
epoetin alfa .
daily dose should
products to affect ABILIFY
(
14
Danmark BRISTOL-MYERS SQUIBB
The maximum daily dose
not
( hypoglycaemia )
to the insulin requirement
or
with alcohol or other
per week
large controlled studies
aripiprazole
anaemic rats
this leaflet carefully
is excreted in
,
Park
syndrome .
%
week by
active substance in Abilify
(
in exposures
diabetes mellitus
pregnant women .
of hands ,
injection site reactions
8.1 41.7
( 2°C
and
Contains fructose
A-009 " and
of
source insulin
in type 1 diabetes
% with aripiprazole
information on the
and 12 g/ dl
on the
. europa . eu/
The
dopamine
aripiprazole
and
about hurting yourself
7.5 mmol/ l )
Takeda Tél :
all growth factors
hyperglycaemia , diabetes
and should
.
doctor or
for orthopaedic surgery
of
52 Activated
with chronic renal failure
Tel :
is expected
a clinical
When a
When
Takeda
insulin
observed
MEDICINAL
aripiprazole
signs and
Aripiprazole
150 60
D-58638 Iserlohn
growth hormone
and
haemoglobin
%
overall burden of disease
.
34 857 42 22
treatment
5.2
sustained haemoglobin level
ABILIFY
.
they
: +
white and
the haemoglobin
(
cleavage (
too low
.
WITH METFORMIN
pioglitazone-treated
clinical dose
the four placebo-controlled
) insulin
(
very
episodes
( mean age :
antihypertensive treatment
(
or more
tablets .
and for the
lung , 22
to the last day
in the
controls
local requirements
of akathisia was 6.2
5.330
SPECIAL PRECAUTIONS
general scale
in
reconstitution is
;
-
3 ml equivalent to
and safety
During
Lilly Portugal - Produtos
% being
are
and other erythropoiesis-stimulating agents
product
unplanned
, it may
4.4 and 5.2 )
ability
17 and
pharmacokinetics
,
Nederland BRISTOL-MYERS
a
remain the
mean age :
produce effects that
.
doctor or
from
substance (
, IF
the
recommended ,
of this
The
smaller
arrhythmias ,
The pharmacokinetic
compared
week by
and
)
% ) were receiving
g/ dl :
findings from
dosing ,
Global R
(
than a daily dose
2
30 % dissolved
two
treatment
) per
12 -
with haematological malignancies .
hours
are not sufficient
Acesulfame potassium Vanilla
, increased risk
; or
or
When concomitant
BRISTOL-MYERS
are active ( M-II
100
parkinsonism
The
(
doctor
section
route ,
mmol/ l
(
Highbridge Business Park
vascular events
Tel : +
( see section 5.3
)
at long-term use of
1st-line
.
the incidence
, teardrop- shaped tablets
see section 5.2
tablets are
alfa is very wide
to the foetus
treatment
be presented
.
for injections
or lithium concentrations
) and
loss of efficacy or
OncoEurope Tel :
or too near
increase 40,000/ µl
delayed ) .
adult patients
tooth extractions or
this
Common : dyspepsia ,
patients
study included
Cmax of paclitaxel ,
BOX )
)
121
Hb between 10
patients
three
: anaemia in
UK
, areflexia ,
designed to be
Patients should
clinical factors warrant
,
alfa
1.25
with renal
015 98
.
the patients were
except in paediatric
in
( see
during pregnancy
a t½ of a
) corresponding to
: + 44 (
from hypoglycaemia .
dose regimens .
haemoglobin
The therapeutic
route
eská
and well-controlled
Pre-filled syringes ( glass
20 mg
of
1 orodispersible tablets 49
duration
usual dose is
patient
15mg tablets
and 3A4 (
g/ dl ( 7.5
is
, aripiprazole
and
.
)
, but with
of anaemia
given weekly
Europharm Limited
and
.
.
observed (
with
have been proposed
) or the
Polysorbate 80
but not in
ABILIFY
In
resulted in recovery
dopaminergic hyperactivity and agonist
receptors on muscle
undergoing dialysis :
in
significant
1 to
is
If you
approximately 6
patients
European
warfarin
on the total dose
Subcutaneous injection : a
) and
production .
days after
epoetin alfa .
such as
(
AUTHORISATION HOLDER
of aripiprazole
increase in haemoglobin
( FACT-An
For
Winthrop
present state
to sudden
see section 6.1 .
carbamazepine
,
be added to
experiencing potentially clinically significant
treatment
Abseamed
have
peak
, Storbritannien Tlf
having excessive
)
average duration of
A
354 535 7000
pulmonary embolism ) .
H1 receptors .
Aclasta after
overdose
transient loss of consciousness
caution
)
Haemoglobin variability
05/ 308/ 002
half-life ( t½
measures will help
SQUIBB BV
.
SPECIAL WARNING
combined with
)
may
or very
sections 4.8 and
during pregnancy
in conjunction
a pre-filled pen .
in clinical
When concomitant
has not
ABILIFY can
insulin products
30
month or the
4.4
especially in the face
100
see
molecule
has been
Long-term improved glycaemic
the
After each dose ,
antipsychotics , aripiprazole should
manic
nausea ,
lithium or valproate
)
.
and water
3
see sections 4.3
section
reversal
dizziness
the entire dose
or obesity
of your ABILIFY
if you are
be
A vial contains
There are no
in paediatric
Cmax
mg )
vascular events
to
cannot be excluded
% and AUC
As with
given area
.
all
including isolated cases of
margin
of overdose should
of 0.4 ml contains
to
tablets
(
plasma concentration of
, tachycardia ,
food
frequency of these
pre- and post-natal
with treatment with
Cancer Linear
such as
therapy
to
from moisture .
-
in patients
disorder , akathisia
the
IU )
(
see section 4.4 )
section
recombinant human erythropoietin
.
is
an
effect
8.1
2°C - 8°C .
)
added to metformin in
30
treatment with lithium
a week .
2
PARTICULARS TO APPEAR
absolute oral
be paid to sudden
Tel : + 39
Die
.
% )
8.1
g/ dl (
in Bipolar I Disorder
Generally ,
this condition may also
.
5.1 ) .
to
and danazol .
lithium
children over 30
( dextromethorphan
6.1 months (
,
CYP2D6
pectoris , increased risk
( type 1 )
by significant intra- and
)
or
alters the metabolism of
Frequencies of adverse
medicine
risk
should be
, 49
other
mg )
will
symptomatic anaemia
% ,
studies
or 5 or
AUC and
outer
0.99
mg of anhydrous
28
overdose
The
section 4.5 ) .
as monotherapy or
between healthy elderly
(
conventional paclitaxel-containing medicines
7.5 mmol/ l
attempt
possibility of
45 mg once daily
or joints
acute renal failure
extent of
USED FOR
excluded
or
rats ,
and
caution
patients
conditions
and symptoms
to dispose
(
unexplained
64
not
or
known whether
( for pH-adjustment
Tel : +49
nausea , constipation ,
observed
the CYP3A4 inducer
phosphate dihydrate ,
treatment
,
10
the
and rhabdomyolysis ,
In a
( see
may
40
4
Further studies
nervousness
Tel
gp-Substrat
) 524
clinical trials of aripiprazole
human ) .
should be monitored closely
efficacy
has
patients
contains 10
more
,
.
hypertension
water for
week by
extreme and associated
hypocalcaemia
with a recent low-trauma
patients
polycythaemic mice
as low
be reduced .
THE OUTER PACKAGING
hypotension Rare :
1,000
your
Although there is
in
co-administration were
;
pregnancy
or
in patients
It is
is
more effective than
monthly
this medicine
is
there is
)
a
placebo-controlled trial
All patients being
30 mg
or
of children .
haematocrit of
,
) 749 749
on bone marrow cells
There is an
should
ml .
the treatment
( 2°C -
.
50 : soluble insulin
or
4.7
elderly and younger
tablets
möglicherweise nicht
12
) and
pioglitazone (
7.5 mmol/ l )
98
( for pH-adjustment
for Abilify
no adequate
adolescents under
United Kingdom
.
.
and
IU
, placebo-controlled trial
a quick
extent of
or
g/ dl
.
mediated by a reduction
Centre ( Europe )
4.2
%
your
in a pre-filled syringe
+ 33
( 4 or more
of paclitaxel , which
that
of daily
Authorisation Holder and
( IU )
is
The active substance in
) .
.
unknown , but
for signs
of
clinical studies
,
heart failure was observed
were
Hunton
affecting less
with pioglitazone .
and
, 56
on
scheduled for major
Die
insulin ,
aripiprazole has not been
( 6.2 -
per ml
dosage may also
.
UB8 1HU -
ml
0.62 mmol/ l )
shown reproductive toxicity
section
(
in
who have a
Abseamed
may
to drive and
9000 IU/ 0.9 ml
glycaemic control may be
.
and
a small reduction in
,
clinical
, which
are currently
;
DISPOSAL
medicine
: a
9 251
Like all medicines
inside the enterocytes
biological efficacy of epoetin
000 international units
( see section
month )
and
may
per week
section 6.1 .
(
know how ABILIFY
.
)
in section 4.2 .
no
LTD Tlf :
similar
folgenden
ketoconazole
all medicines
16.1
USED FOR
been
placebo
( NMS
46 25
infusion
2°C -
may
THAT THE
25.2
.
,
The terminal half-life (
who have a
Common : blurred
adverse
Beta-blocking agents may
, or if
.
other symptoms of
a
that
% ) were receiving
other
l ) .
( IU )
been observed
)
or Hb increase
,
The
of 10
89 150 IU/ kg
from light .
ROUTE(S ) AND METHOD
UB8
, anaemia
ABILIFY is effective in
retinopathy
dosage
the
alfa
use
maximum daily dose
cell volume .
or
scheduled
AND EFFECTIVE USE OF
tablets
to protect
The
valproate
blurred vision
pioglitazone
or pharmacist
Animal studies
with a
trials
some cases
if
days immediately
, 61 Aldwych
mit Vorsicht anzuwenden
first trimester
akathisia
of CYP3A4
controlled
longer
daily dose
, there were
symptoms
ready to use
human , rDNA (
be
the
( e. g.
usually
12 g/ dl (
or hyperosmolar coma or
in children and
haemoglobin
( 1.3
subcutaneous
30
(
AUC after the
your doctor
of
the
as
surgery
all patients receiving
administered once a day
dosing
Effects
been treated
1
use
.
and
if
If
dose should
Sverige
In a clinical
in case of HIV
trials , uncommon cases
should be
of 600 IU/ kg
, less
20.9 [
pharmacist
mg has
medicine can only be
treatment
.
,
who
( 30 mg )
within
fructose per
nausea
aripiprazole or
was
with
of
The maximum dose
mellitus , diabetic
with placebo
during continued
of epoetin
polyps ) :
adverse
België/ Belgique/ Belgien
.
have been receiving
.
treatment
on Abraxane
the active substance
ABILIFY
these trials ,
may be
;
should be
of the Marketing
before you
study
:
60
Abseamed
effects
with
see section 5.2
active
of glucose
see section 4.4
or 45
decreased appetite .
be considered when
a dose
% of
chronic renal failure patients
the dosage
aneurysms
)
e. g.
+ 46 8 704
,
dose
, D-58638
3 times per week
of
ABILIFY
from light
during
solution contains 0.05 mg
kg
further comparative studies
.
time
)
surgery
activity ,
ON
effect
like headaches as
55 53
% with placebo
THE WEEK (
, peripheral coldness ,
%
4.8 ) .
disorders
anaemia
Hydroxypropyl cellulose Magnesium stearate
the
non-healing
insulin
56 x 1 ,
ein
these
300
and rats ,
(
.
doctor or pharmacist
VOLUME
( 221 multiple
,
.
When the CYP3A4 or
achieved
aripiprazole .
be used
(
dose
soluble insulin
10
) were 2 5
more
.
trials that
.
.
.
12
Aclasta
and take
2°C - 8°C
trial in healthy
, Oxford Road Uxbridge
, insulin (
or
times per week )
For any information
4.8 and 4.9 )
lithium concentrations
NORWAY LTD
, 49
.
and
signs
injection
What
Squibb Srl Contrada Fontana
also be necessary
are therefore affected
patients (
toxicity The highest
average
Aclasta
Business
vehicles , until they
mmol/ l
isolated patients with
:
Kingdom
about
meal or unplanned ,
reconstitution
( 0)20
rats
intermediate-acting
pioglitazone
in two main studies
is a
be a moderate
is
clinical trials , an
all of whom it
to
,
95 % CI :
route
large
.
pruritus
g/ dl
Therapy- Anaemia (
be
. no
comparable
Usual warning symptoms may
aggravation of existing hypertension
or waste material should
1 film-coated
of Abseamed
CYP3A4 ( ketoconazole )
factor and
(
,
Distribution No
increased risk
- 150
enzymes and
172 breast ,
injections
glycaemic
4.8 and
increased Aspartate Aminotransferase (
and cardiovascular therapy
than
A half-life
no medically important
a potent inducer
complications .
is
see section
received dic
manic symptoms had already
receiving
or nurse
analyses
due to
to
g/ dl ,
-
( dextromethorphan/ 3-methoxymorphinan ratio
with pioglitazone .
group .
suspected , therapy with
placebo-controlled trial
satisfactorily
)
you
130 avoided ; guidance
a negative impact on
Adult cancer
a few weeks .
Frequencies of adverse
to the baby
notice any
alle
contains
and
PVC/ aluminium ) Blister
, deep vein thrombosis
in women with
354 535
section
,
occurs ,
see
)
patients with severe renal
section 4.4 ) .
see
g/ dl ( 6.2
% and
doctor
and adolescents under
occurs
If epoetin
) of
symptomatic anaemia in
CZOL446M2308
For preventing
Actraphane
detected following
+ 354
) per month
starting dose for
patients with
patients who
type 1
12 - 14
placebo-controlled trial
Treatment with Abseamed
)
2 times per week
enzymes .
should be
granting
-
VISTOR HF
revealed no medically
cancer
12 -
BRISTOL-MYERS SQUIBB AB
.
doctor .
of
FINLAND
packed cell volume
Oral contraeptives ,
reports
cancer patients
and
.
VISTOR HF Sími
of
( 95 %
Syringes are
risk
red blood cell count
adverse
.
+ 353 ( 1
NORWAY LTD Tlf :
There is
kidneys
aripiprazole
between
increase in haemoglobin
effect
no information on the
What
) or
.
(
and adult patients
Arzneimittel Pütter GmbH &
dose of 5
12 g/ dl (
Insulins
64
of EPS
epoetin
)
SPECIAL WARNING
hypoglycaemia
6.6
and
cooling element
% ) of
in type 1 diabetes
These studies have shown
of
symptomatic
70 % isophane insulin
Insulins and analogues for
The
5
46 8
% ,
Smoking status
weight gain
symptoms .
(
and
- Peripheral
,
52 weeks
haloperidol
alfa
Product Characteristics
units ( IU )
after
the
and well-controlled studies
blurred vision
in patients
in
undergoing dialysis (
Road
Uncommon -
mmol/ l ) .
may
other medicinal products
which
.
The starting
result of hypoglycaemia
WC2B 4AE United
(
not
the mean
the
Abseamed
In several
prior to
:
the patient
,
is very wide .
carton in order
rimonabant 20 mg
MAOI )
,
anthracyclines
to existing treatment
epoetin alfa is very
County
10 g/ dl (
13
studies
site conditions Common :
)
tablets
patients
if
aripiprazole
of which were
recommended total weekly dose
: + 33
in
, weight decreased
may
doctor or
and
of
and
:
Elimination The
see section 6.1
human
with
Actraphane
.
.
0.3
( this
dissolved insulin
solid tumours
of insulin
with type 2
.
and
) insulin .
Road
has
and
between 10 and
patients
in this patient group
) .
Hydrochloric acid ( for
5
Depending on
result in foaming .
exhibit complications (
mean age :
pharmacokinetics
60 %
Epoetin alfa
12
very
danazol .
.
,
7.5
Do not use in
pre-filled syringe
the
may
hypocalcaemia were observed
or
placebo to
The
mg elemental
) ,
aripiprazole in
five
5.1 ) .
not been established
In
In
1HU
460 women with
active substance
class differs
1
with or without
.
be used
In
with
) .
Creatine Phosphokinase
the
0.35 %
and
+ 32
) should be avoided
3 ml ( 3.5
but more frequently
, episcleritis , iritis
should
solution
( see section 6.1
1 % of
( see section
to protect
of 100
- increased risk
tachycardia
and
may be harmful for
half-life
mg Fe2+/ day is
also known as non
of
achieved
the Scientific Discussion
, hyperglycaemia and
in
than
& D
%
45 mg
)
, aripiprazole should
of adverse
studies
in Actos 45mg
( approximately 1/ 20th
risk of cross-reaction .
female
patients should
,
.
The efficacy and safety
, or
Novo Nordisk A/ S
37 D-58638 Iserlohn
Cardiovascular
There are no
and
In clinical trials and
BY WEIGHT , BY
been carried out .
cannot be excluded
CYP3A4
and
the levels
tablet at the same
The
( 0)20 3116
be
+353 1 260
from moisture .
) .
(
: + 44 (
the incidence
is used :
as hydrochloride
: fatigue Psychiatric disorders
TO APPEAR
.
6
target haemoglobin concentration
(
(
This medicinal product contains
-
Ireland BRISTOL-MYERS
hours .
of 15 mg has
and sulphonamides
with type 2
observation
ml ( 8000
4.5 ) .
g/ dl
with severe
.
with
or
, brand ( manufacturer
the
prescribed dose when concomitant
before you
,
insulin
Changes in HDL-C
mellitus :
angina pectoris
4.8 )
g/ dl
adjustment
independent
CYP3A4
in
therapy
- Peripheral
OR WASTE
vomiting and diarrhoea .
stopper .
patients
be
lactose monohydrate
rate
.
a
Lilly Holdings Limited
,
+ 44 ( 0)20
adjustment
section 5.3
,
United
are transitory and
( see section 4.4
and N-dealkylation
In
Europe ) ,
.
dementia ( loss of
)
6.2 - 7.5
and
other
UB8 1HU - United
or
especially
two
Consequently ,
and
patients with
THE DISPOSAL
pregnant or
for thromboembolic
below 12
If
with some medicines
a lesser degree
haemoglobin target range of
Hypersensitivity
section
- Refraction disorders
surgery
Tel
5 x ULN or
, sucrose
disposition phases (
45 mg
The
,
three
vitro studies have shown
also indicated for
international
divide and
AUTHORISATION
General disorders and administration
47 %
Sexually
levels of
Therefore ,
epoetin
House Highbridge Business Park
and
of no
first
be monitored closely
and
The data from the
Serum
hot
know how
Park
. It
daily
patients may be at
This means
only
, nausea
,
to affect ABILIFY
%
episodes
and anaphylactic reaction
whilst the relative efficacy
tablets 28 x 1
Actraphane
and
elderly patients with
hypertension .
differences .
.
patients with normal or
a
patients
dehydro-aripiprazole
It
frequency
,
signs
a
Highbridge Business
The
no evidence
.
.
aripiprazole
hypertension
)
Marketing authorisation
use of Epoetin
micrograms
300 gastro-intestinal
please see section 4.4
therapy
is 15
The patient s ability
Owing to
.
4.4 ) .
with gemfibrozil ( an
+ 44 ( 0)20
.
following
the injection
(
aripiprazole
anaemia ( e.
Androgen ablation is
.
altered mental
6.8
be
) per month
episodes
, nausea
of
at the desired level
in
aripiprazole
.
cloudy after resuspension
incidence of EPS was
to
.
( 0)20 3116 8952
well
or
to protect from moisture
14 tablets 28
the mouth is difficult
g/ dl ( 6.2
.
are round and
OR
,
placebo
MUST
chemotherapy
are for use with
hyperglycaemia and diabetes
scale or
the Montgomery-Asberg
alfa therapy
.
D Centre
the treatment
abrupt improvement in
7.5
Activated charcoal
4.4
when
and a
have been proposed ;
.
In osteoporosis
machines .
a dose
of
your doctor or pharmacist
on
you
)
4.4
- In
In clinical
( type 1
is
need another dose
may
following undesirable effects occurred
cartridges are designed
fatigue scale
Abseamed
studies in pregnant women
e.
undergoing dialysis :
( 7.5 mmol/ l
be monitored closely
.
or
, somnolence
Abraxane
The therapeutic margin of
Abraxane is not
haemodialysis
reduced
.
should
when haemoglobin values exceeding
14
or
of
or the blood vessels
interaction
of greater than
.
:
1
the first
use in animals
.
7.5 mmol/ l )
44 (
: +
the
) , µ :
1
of the excipients
patients with a
was 10 %
and
occur .
order to
:
in Saccharomyces cerevisiae
amidohydrolase ( predominantly
with high fever
a meal or unplanned
6.2 % with aripiprazole
- Aclasta
harm and suicide .
is
was
(
Actraphane 40 Penfill 100
use of
alfa
vitro
significant
of epoetin alfa
.
and
e. g. stroke
: osteoporosis
,
Using a
vitamin D supplementation
.
.
white and
nursing
,
treated with
siehe Abschnitt
3 ml
in humans
.
Bei
.
of EPS
site conditions Uncommon
treatment
monkeys
THE
for aripiprazole .
should
of the members
a
to protect the
After
,
endorsed ( two relate
GmbH Tel
They include thirst
see
dehydration and pale mucosae
observed
( 57.3
in vitro solubility .
, tremor ,
Use should be restricted
disposal and
the orodispersible tablet
and
The
well
aripiprazole
jaw have
as
reducing
REACH AND SIGHT OF
,
If
ml .
patients
for 3 weeks
and insulin
,
at least two
occurs ,
lapp lactase deficiency or
including parkinsonism , akathisia
g. insulin dosage
hyperglycaemia and diabetes mellitus
is
.
aripiprazole solution for injection
medically important signs
cases of NMS
3 times per week
)
for
may vary with age
12
DK-2880 Bagsværd
aripiprazole in
emea
increased Aspartate Aminotransferase
4.7 Effects on
a daily dose of
haemoglobin is rising by
most frequent adverse reaction
+ 44 (
and
ABILIFY
% .
( mean age
2
transient and asymptomatic ,
children and
1 ml (
( 1 800
,
when
without
metabolites
5000 IU/ 0.5 ml
be increased
method of
your doctor
vital
E951
, dysgeusia , dizziness
in patients with
in
and
all cancer patients
If epoetin alfa
thigh or
4.4
epoetin
Insulin human , rDNA
, reports
:
BRISTOL-MYERS
mixed episode of
calcium levels )
IU ) of solution
4.2
If
: in clinical
the
mg
Overdose
The usual
if you
for injections
recommended
.
medicines
akathisia
; suicide attempt
37 , D-58638 Iserlohn
see section 6.1 )
only
(
minutes .
hyperglycaemia and
150 or
aripiprazole
.
ml
of heart failure ,
It
this study .
-
Atrial fibrillation Headache
Vantas
several
experience in
0.6 ml contains
aripiprazole
taking
the dose should
.
mellitus and heart disease
decreased
UB8 1HU -
have been
,
valproate (
most
.
4.3
the intravenous route
treatment with two other
patients with
) ,
and
AND
relevance of these
56 69 00
In two
to
human ) .
ml
polycythaemic mice )
also
ml equivalent to 300
)
.
Tlf
than 1
the bottle
for pH-adjustment )
the
dose
AND SIGHT OF
Mitratapide 5
intervals
and no
trials
a stable level
,
%
benefit has
and 5HT2a receptors and
Common : blurred vision
, serotonin 5HT1a
there was
and hyperglycaemia
: + 45
terminal half-life is determined
patients with
In
in urine
2 weeks
and
)
4 hours in
manic episodes
:
tiredness , nausea ,
mmol/ l )
animal models
( see sections 4.8
.
hypersensitivity
9000 international units
for injections Hydrochloric acid
be
please see section
What Actos is
upper respiratory tract
week
oedema
face.
shows that pioglitazone improves
.
( see section 5.2
rimonabant
injection :
, neuropathy ,
30mg tablets are
than 2 g/ dl
and severity
+371 7364000
, including zoledronic acid
6
blood loss and haemolysis
11
for a
.
and
and
consider clinical
starting dose
increased
7.5 mmol/ l )
)
Particular attention should
mg
56-99
4.2 Treatment of patients
) or the
clinically
30
two
.
infusion of
.
Before use : store
)
dose
.
propyl parahydroxybenzoate
,
can
Tel :
Patients who
of children .
g/ dl ( 1.25
3x/ week or 450
)
, the dosage of
daily dose of 15
55.3
Common : blurred vision
Glycine Polysorbate 80
.
of epoetin
Treatment of anaemia and
paclitaxel contain
THAT THE MEDICINAL PRODUCT
concentrations ,
trials of aripiprazole
g/ dl ( 8.1
mmol/ l
( 0)1628 537
no influence on the
United Kingdom
e. g.
in isolated patients with
7.5
The rate of
over 3 years
NPH )
200 mg of
androgen dependent .
and
cause side effects ,
, diabetic ketoacidosis ,
of greater than
patients
Aripiprazole
immediately
, headache
Park ,
pink
mg )
NAME OF THE
moisture .
to
be assured
continuing to
.
x 1 orodispersible tablets
your doctor immediately
of
revealed no medically important
children and
4.4 )
maintain haemoglobin concentration
remain the
) .
be performed in
, pyrexia
EPS including parkinsonism ,
, anorexia
other forms of
.
SQUIBB GESMBH Tel :
cerebrovascular
Detailed information on
blurred vision .
)
12 g/ dl (
of aripiprazole
12
no adequate and well-controlled
44 ( 0)20 3116
.
.
, reports of
)
result of hypoglycaemia .
been
BRISTOL-MYERS
Uncommon - Diabetic
Cmax
see section
)
and
in patients
) sealed
also
appropriate dose
following diseases
.
will use
, warfarin ,
42 trials and 8167
about 40 %
tablets 56 x 1
.
the medicinal product has
timepoints
,
( see
) Ltd
addition
a blister
because
until your condition
with epoetin alfa is
clinically
stabbing migraine-like
% )
BRISTOL-MYERS
in line with
are
human
and
and
epoetin alfa
patients
may
(
: blurred
UK Tel .
by three biotransformation pathways
reactions
dose
the intravenous route
SQUIBB AB
recommended dosing regimen is
stroke
CYP2D6 inhibitor
trials with
insulin
manic
As with any
Europe ) ,
for signs and
6 hours has been
.
contains 10 000
excreted in the urine
into less pain from
clinically significant
the
by renal
oral bioavailability of the
hypoglycaemia .
and
(
,
less than
if you
reduction
(
Road
and the
of
from 2 60 mg
24 hours .
the pharmacokinetics of
to move )
generally
following
,
to
Dosage Dosage
2.5 % ; 0.5
a
enzyme
.
.
cell line by
patients with
clinical trials and
4.4 -
in isolated
women
with
mmol/ l
in patients
was
see
observed
in
Tél : + 33
, 56 , 84
less than
( ALT
Urticaria , rash Very
siehe auch Abschnitt
efficacy
is achieved ( this
two
or of no
of 30
increased
vomiting
LHRH agonist and
BRISTOL-MYERS SQUIBB ( FINLAND
of 0.9 ml contains
This
administered after
hypertension .
solution for injection contains
a
longstanding diabetes
over
dose is
only
(
x ULN
disorder
unplanned ,
10 and 12
The therapeutic margin of
) or coma ,
the blood pressure is
per 100
2.5 % ; 0.5
bacterial and mammalian cell
hypoglycaemia
tachycardia ,
mmol/ l
on
given
Thrombocytosis
Der Anteil
statins , fibrates )
,
or
done
7 )
infections
recently taken any other
in
injection
calcium levels )
patients
problem
)
aripiprazole
3 and
( 95
be
) .
.
%
or
a sterile syringe
hypoglycaemia whilst driving .
- if
reported with Abraxane
( e. g.
coma or death
Centre ( Europe )
2C8/ 9
for pH-adjustment )
to any
be cautioned
in man is 5
oral solution contains
7,736 patients ,
below the
Europe
after
Therapy- Anaemia ( FACT-An
taking
- if
, may
target haemoglobin concentration
OF
,
The in
,
vs. gliclazide as
result of hypoglycaemia
In cases where there
combination with insulin
Abseamed
other erythropoiesis-stimulating agents (
%
see
for patients
: +44 ( 0)20
but not in monkeys
3000
44 ( 0)20
increased
solution
-
in bacterial
.
4.5 Interaction with
pre- treatment
If epoetin
disposal and
24 hours after the
61 Aldwych , London
treatment with aripiprazole
medicinal products .
ABILIFY
If
or
per
pancreatitis , dysphagia
)
analyses
between 10 and
from a
, but
has been
:
x
(
the risk of
section
(
or
month
significant
Storbritannia
vitro studies have shown
see section
are
potent
This
A/ S
.
56
the
that
Changes in strength
( produced by
or
, sleepiness , shaking
to
or
) .
peripheral
SQUIBB
is between
( see section
patients
to 6 weeks )
erythropoietin
CYP2D6
with
,
Tel :
medically serious signs and
cartridges
headache , tiredness
NORWAY LTD
( see sections
.
- If
, it may
during treatment
, serum levels
EPS was 19 %
is therefore
patients
Keep
using a
of dosing
that epoetin
of Product Characterisitics
) Ltd
7.5
symptoms can occur .
12
and N-dealkylation
S. A.
were
16.8
progression of
) and
no relevant
In the
Following subcutaneous
daily dose of
4.8 and 4.9
haemoglobin
:
Hunton House Highbridge Business
dose
proliferation
is no accumulation :
Immediately upon
x 1 ,
that
with haematological malignancies
and sight of children
( 7.5
- Middlesex UB8
or
SQUIBB BV Tel :
34 [ 3.2 %
Aclasta-treated group
28 , 56 ,
UB8 1HU - United
10 pre-filled pens
( see
and were
of children
the treatment of bipolar
per
)
side effects
A
sections 4.8 and
the dosage of
8167
food with
(
,
12 g/ dl
heart rhythm
(
peak is always
United
normal or
RH12 5AB United
the dose should
)
(
FOR DAYS OF
half-life of
mmol/ l )
or
)
mg )
Actraphane is a mixture
e. g. during
:
between healthy non-smoking subjects
or
and
with aripiprazole
of either sex .
Abseamed 7000 IU/
the
use machines
,
of patients with the
been demonstrated although individual
(
The majority of these
0.8 ml
intravenously )
the
is not recommended
placebo
or
human tumour samples
,
no
to
tumours
In
(
the incidence
abrupt improvement in
USE ,
, infection
active (
.
Rimonabant displays high
t½ of
, nausea , constipation
rimonabant
of CYP2C8
In another
5HT1a
When either
,
:
Montgomery-Asberg
,
cloudy after resuspension .
Black patients
treatment
at 6
or if the
einer
the incidence of
Km 22
and Cancer Linear
14 g/ dl
an increased risk
-
.
A cardiovascular
( 0)21 272
the
tablets 98 tablets
carbamazepine ,
the desired range .
see section 4.4
acute
There is
a dose of 600
other medicinal products
of the elimination
Aripiprazole
Read all of
) .
be used .
given weekly
)
Portugal
9.75 mg
see section
see
0.035 mg of anhydrous
should
0.035 mg of anhydrous
reported
Erythropoietin is a
with aripiprazole
4
coma
( IU )
, tachycardia ,
A
existing treatment with
very wide .
product must not be
)
( haematocrit
g/ dl (
Polysorbate 80 Water
studies
49 ,
x 1 tablets
is always
and
has
1
Good blood management
Europe
) of EPS including
,
34 857 42
especially
g/ dl
combination therapy
the
without
10 cartridges x
dose reductions should therefore
seizure
no
areflexia ,
a
In a prospective ,
[ PFT ] (
) of EPS including
FACT-An
of
and
is very
1 g/ dl (
For any information
potent CYP3A4
Bei Patienten
Anpassung der Dosis
could not be detected
genotoxicity tests
)
to drive and
iron stores should
pharmacist
)
and
free
aripiprazole
placebo group .
London ,
(
make sure
.
or
including
can occur
non-lethal
section
were :
12 g/ dl
as measured
and
clinically significant change in
clinical trials aripiprazole has
osteoporosis
notable
per weight
Aclasta
CYP2D6
a
shown during
in section 4.2 .
or
is
is not appropriate .
Abseamed 10
dose adjustment is necessary
)
and approximately 60 %
with
for rimonabant 20 mg
of the
including ABILIFY ,
) may
section 4.4 -
and 2.47 in favour
,
Starting dose of
(
blood pressure
g/ dl
volume of distribution
.
tablets 84 tablets
side
The syringes contain
than
(
1.25
mg of
trial , the
active substance
LTD Tel
, 14 and
this product is available
12 g/ dl (
,
of epoetin
of adult
ABILIFY tablets
patients with
especially infections
filiaal Tel : +3726441100
Interaction with receptors other
some
There are
essentially sodium- free
Diese Beobachtung wurde klinisch
, 23 lung
or
for pH-adjustment
,
30 -
,
56 , 84
of
87
The
undergoing dialysis
this
solution
PRODUCT AND ROUTE(S
the intravenous route
( see section 5.3
( 0.5
were
or
may vary with age
and
ABILIFY
especially important
(
The
patients
be
1.25 mmol/ l )
)
.
the human insulin molecule
machines
potentially medically serious
CYP3A4 inducers
any
.
( 0.62
with
47 67
three days.
and approximately 20
(
Medice Arzneimittel Pütter
is extensively metabolised
isophane insulin 90
It
Actraphane 20 Penfill
49 x
Orodispersible tablet Round and
for injections
in
or
In
VISTOR HF Sími
insulin and 90 %
in
sollten ähnliche Dosiserhöhungen
The
and 11 g/ dl
Interaction with receptors
efficacy
Eli Lilly Holdings Limited
g/ dl (
Non-clinical
Takeda Global
30
sedation
In
the
patients with
.
and CYP3A4
aripiprazole
, 49 x
between 9.5
a
unknown
of
of 12 -
The pre-filled syringes
3
and water for
not
- Middlesex UB8 1HU
vary with age
a pre-filled syringe
.
Similarly
patients
hepatic impairment may
10
)
,
pharmacies
The usual
.
adults
see section
or waste material should
:
and what it is
The effect
mg
in
1 diabetes ,
risk
After first reconstitution
Co
no evidence of clinically
condition may also
alfa
was
a
Ireland Takeda UK
OUT OF THE
receive appropriate training
day
human tumour samples
the injection site
as an
6.2 % with aripiprazole
and
BRISTOL-MYERS
quinidine
or pharmacist
analogues for injection
evidence of clinically significant
The
below
, hepatitis ,
efficacy
is
in Bipolar I Disorder
+44
1
Diabetic retinopathy Long-term improved
route .
not
placebo-treated
product at 52-weeks was
( 2°C
354 535 7000
or
( MAOI
epoetin alfa
or in Asian/
In
the desired range
who
) or the
per month ) with
.
.
treatment with
levels remain the
(
tell
sodium citrate
mmol/ l
section 4.8 ) .
nausea , vomiting
to target a haemoglobin
higher than those
Aclasta and risedronate
of women
Polska
some of the other
psychotic symptoms
, feeling anxious ,
. They include thirst
.
hours
causes of deaths were
,
(
,
haematocrit of
REGARD TO THE
an
contains 5000
2C8/ 9 and 3A4
SPECIAL PRECAUTIONS FOR DISPOSAL
)
events
with or without
subcutaneous tissue .
16
per
1
g/ dl
,
1/
of
pre-filled syringes
APPEAR ON THE
.
beta-sympathomimetics
from
they
should be done in
renal insufficiency not yet
bei Patienten mit
im Nervensystem zu finden
a daily dose of
62 Elimination
elimination
and no appreciable
see section
.
e. g. anaphylactic reaction
transient
Uxbridge - Middlesex
cause dehydration
R & D
x 1 orodispersible tablets
of the
terminal half-life ( t½
of
be
[ 2.7
79
insulin sensitivity
based on
no relevant
pioglitazone
One IU ( International
infarction , cerebrovascular accidents
are
3000 IU/
( 2°C - 8°C
As with all
40,000 dalton .
mmol/ l ) should
vitro studies
dose adjustment
is
see the Package Leaflet
AB Puh/ Tel
Aripiprazole exhibited
vitamin B12 or
% CI
hypoactivity .
subjects
.
also
site within a
( 172 breast ,
was 18.7
maximum daily dose
mg pioglitazone
trials with
1
(
.
*
% with
of
for patients
;
Following dosing
14
, angiotensin converting
5
24 hours after the
.
LTD
metformin ,
)
One IU (
tablets
low-trauma hip fracture .
+
is catalysed by CYP3A4
no experience in
is
+ 44 (
a pre-filled syringe (
clinical
IU/ kg 3 times
,
fat mass .
,
mean
rare cases of
blurred
.
duration
substance in Actos
haematological malignancies .
adverse events
of anaemia
waist circumference ,
g/ dl - 12
272 16 00
chest pain )
injections .
1.3
glucose
of
-
with a bromobutyl/ polyisoprene
diabetes mellitus ,
+
therapy .
Insulins and analogues for
be marketed
pharmacokinetic
be considered
in all
with fast-acting
GmbH
People with this
pharmacies
pioglitazone
ng/ ml
in haemoglobin
extreme and associated with
paediatric
following
stabbing migraine-like
to affect ABILIFY
68 %
or
your doctor immediately
elderly patients with
pharmacology
and
, redness ,
treatment with two other
N-dealkylation
is available
of fructose and
mmol/ l
.
approximately
Risk factors
via the
chronic renal failure patients
353
for major elective
IT IS
while taking
CYP2D6 .
rectangular and pink ,
type 2
reduction
12
if you
four
177 MINIMUM PARTICULARS TO
IU/ kg
subcutaneous tissue .
unplanned ,
mitratapide ,
increased
CYP3A4 ( ketoconazole
mit
month , or if
a
,
the incidence
needle top
in patients
akathisia was
this study .
of multiple medicinal
Pioglitazone is also indicated
or
The syringes contain
from hypoglycaemia .
beta-sympathomimetics ,
deep vein thrombosis
ml contains 100
your doctor or
Business Park , Oxford
, or
risk for thromboembolic
300 mg
) per ml
( MAOI ) ,
58 The
not be used
in
Patients
A vial provides 9.75
before
count has increased
recombinant DNA technology
smoke
minute
to
%
Epoetin alfa
When
)
vomiting and diarrhoea .
you
treatment
patients
a
times the mean steady-state
NYHA stages I to
aripiprazole or
2 g/ dl
symptoms
well below
,
obesity
BRISTOL-MYERS SQUIBB BELGIUM
trials
patients receiving
)
: + 43-(0)800
by injection
should be
0.6 ml ( 6000
of hands
patients
below 30°C ) .
sweating
l ) .
4.8
and patients with
In
the
Tel : + 351
your ABILIFY
,
The cartridge contains
for
.
infusion
with
your pharmacist
, itching ,
.
Die
following adverse events
lacrimation ,
In
enzymes and
Any unused product
epistaxis , pharyngolaryngeal pain
proliferation of
.
) erythropoietin
on
the impression
common
( Europe )
with
erythrocytes
an
: fatigue Psychiatric
information
In
The absolute oral
alfa
has been
trials
is necessary
Inadequate
(
and patients
of
For
thrombotic
WC2B
14 30
more than
occur (
your doctor immediately
injections
data
% of
you
) is therefore
33.6
.
if you
5
- Middlesex
mmol/ l )
together with
:
.
, (
(
0)21 272 16 00
30 %
, oral aripiprazole
aspartame
%
with
PHARMACEUTICALS LTD
did not
and 5
the following
of the
reports of
" and "
OR WASTE
IU
e. g.
(
5-hydroxytryptamine (
0.5
Road Uxbridge - Middlesex
pharmacological
individual situation
AUTHORISATION HOLDERS
for
medically
snack containing carbohydrates .
greater than 14
.
: + 44
There are no
, especially infections and
levels
The patient s ability
give
a
aripiprazole ( see
) may
SQUIBB AB Tel :
g/ dl ( 7.5
can
hours .
section 4.4 )
IU )
myocardial ischaemia , myocardial
SQUIBB
SQUIBB SARL Tél
for 2.
0.8 ml ( 8000
of aripiprazole
, a
patients
( 2°C -
23
of agitation
orodispersible tablet can be
should be
adequate and
g/ dl ( 6.2
a maximum volume
medicines used to
packed
PRODUCT AND ROUTE(S )
ABILIFY
the incidence of
CYP3A4 ,
IU/ kg
is
to aripiprazole tablets
) .
of epoetin alfa
dogs and rats ,
a
when
the bile
The syringes contain 1
4.4
-
were
the faeces
at
61
450
a potent inducer
results of a full
of pioglitazone
patients
,
ml
56 x 1
patients with
effect of Actos
in humans is
some
) , where prophylaxis
medicinal
FACT-An fatigue scale
than 1
SQUIBB AB
lung ,
, insulin (
from
H1 receptors
the
are round and
reactions after
compartment
patients ,
with epoetin alfa
)
is an
(
other medicines Please
of
and
cloudy after resuspension .
be exceeded .
In type
to
with
Actraphane 50 NovoLet 100
kidney have
9.5 and 11
4.2
for rimonabant
with quinidine
patients was 12.1
.
% and 47
or pharmacist
, insomnia ,
when
events compared
36(0 ) 20
greater than
pre-filled syringe
4.4 and
07/ 412/ 002
isolated patients with normal
in a pre-filled pen
(
of increase in haemoglobin
patients with
amber glass
R
Kingdom
site conditions Uncommon
leaflet
this medicine after
MATERIALS
Inadequate dosage or
heart beat
a
)
also part of
versus animal source insulin
thrombotic events
rare (
:
, give
3116 8952
0.6 ml contains
coma
for
the
67 55 53 50
5.8 for
When activity ,
or telithromycin or clarithromycin
mice
programme
is not recommended
therapeutic
any
by a decrease
between 17
, 23 lung
.
patients
contain 0.5 ml
a day
12
Kingdom Takeda UK
with alcohol or other
patients (
advised
300
( IU )
or
Depressive disorders
source
lowest
evidence of clinically
preventing recurrence of manic
of the
ABILIFY
,
arrhythmias , sudden
40 ( 0)21
retinopathy
mg
known
)
45
Special
incoherent speech
in the
such products
)
not
OF THE MEDICINAL PRODUCT
ml (
see section 4.8 )
recommended dosing regimen
The use of Aclasta
with epoetin
Uncommon
( see sections
the solution
on the ability
retinopathy
Nervous disorders
5 mg of
Abseamed 1000 IU/
.
treatment
this
of death
56
2C19 (
severe manic episodes
urine
( 0)21 272
For any information
with
machines
Weight gain :
instruction for use to
or
in 2.3
with
of 30 minutes ,
exhibited
been
and transport refrigerated (
" A " over
(
aged over 65
and 5HT2a receptors and
were
( omeprazole
22
,
)
nausea and vomiting
but
in
) per month
6.2
20
is
5.1 ) .
insulin products
first
or
vs. placebo ) was
section
, the incidence of
their previous insulin .
20 In
diabetic hyperosmolar coma
Using ABILIFY
Refraction disorders
Uxbridge - Middlesex
and
)
have been receiving
Iserlohn
8.1
)
The
Takeda Ireland Limited
individual
Insulin suspensions
difficult
clinical studies ,
for injections
, 14
When the CYP3A4
and
ml
information on
tablets are
Aclasta 5 mg
mellitus ( see
mg
Hb
should
- Refraction disorders
comparable to placebo .
10 ml and
In a
and cloudy after resuspension
30
1.25 mmol/ l )
of some blood
Renal or hepatic impairment
should
of 10
your
, the
the
Business
300 gastro-intestinal
is
infection
, D-58638 Iserlohn
Slovenija Eli
Refraction anomalies may
Moreover ,
The potentially
between 25 and
extrapyramidal
weeks
contains 10 000
Epoetin alfa and
see
other causes of anaemia
.
should
blood donation procedure .
several controlled studies
.
de pointes
Tél/ Tel :
Detailed instruction accompanying the
In a clinical
the
complications .
change in aripiprazole concentrations
patient
- 7.5
human
ABILIFY
14 x 1
: + 36(0 )
.
the
IU )
section 5.2 ) .
recommendations
populations ( see section
A sustained haemoglobin level
injection site
analogues for injection
1
(
2 diabetes
be marketed
, the
human
0)20 3116 8000
non-selective beta- blocking agents
the risk of cross-reaction
or
, pruritus ,
for 2
is
the CYP3A4
in milk
until
of
them
6.2 mmol/ l
but
in
including PANSS and the
doctor , pharmacist
) .
When aripiprazole
EU/ 1/ 06/ 344/
. They include thirst
%
150 60 -
or
Sverige BRISTOL-MYERS SQUIBB AB
, in some cases
of
agents (
significant improvement in quality
A/ S
.
% )
10 and 12
,
less
.
the levels remain the
should
other insulin products
(
proconvulsant activity
below
,
When
and
in type 1
in the
CNS medicinal products
4.4
If you
+44 (
However
Glutamyl Transferase ( GGT
clinical
included
,
aripiprazole
)
no medically important
tamoxifen
see section 4.8
:
Weight gain
section 4.5 ) .
should
or
alfa
type
Global R & D
)
of the
: in
disease
GmbH & Co KG
change in
and
recommended
(
and
alfa
approximately 6 hours
PHARMACEUTICALS LTD
the
insulin
cancer patients
8°C .
If
)
for the treatment
human tumour samples ,
OF THE
62 Elimination The
(
,
and
b-cyclodextrin ,
kg
( 0)1 46
)
change in
74 60
risk factors such as
a
crisis with
insulin products
aripiprazole
ra Tablet core
than for haloperidol
Studies in animals have
( 30
mmol/ l ) .
disposition of
transient ischaemic attacks
to placebo -2.9 kg
side effects
Uncommon : orthostatic
the
Tel . +
percent received study
use of
the
( e.
Inadequate dosage
( 2°C - 8°C
haematocrit of 33
especially in patients
well below
)
than
,
THE
Luxembourg/ Luxemburg Takeda
+ 31 34 857
factors such
adjustment
Sodium chloride
and
subcutaneous administration .
while
glucose control
,
and N-dealkylation .
with a
(
:
(
in
THE IMMEDIATE PACKAGE
As for
of Abraxane (
is more common
see section 4.4 )
recovered in the urine
BSAP )
NMS
injection sites
given
Special warnings
55
of whom
8167 patients
mg
M-IV ) .
Common
unplanned
16.1
.
( 4
,
.
less than
solution
diabetes mellitus ( see
alfa in cancer patients
dose
greater than 14
of aripiprazole in
a clinical
doctor
clinical judgement .
.
inter-individual
are
BRISTOL-MYERS SQUIBB SARL Tél
mmol/ l ) per
a sulphonylurea .
(
Kuhloweg 37 D-58638
the active substance
Lilly Holdings Limited
+ 44
in
units
number of patients .
, 28
and/ or
( E218
may
, less
It
events compared
a longer
In clinical
the
56-99 years
indicated as
,
and
a pre-filled syringe
on results
During
study included only
,
with
SQUIBB BELGIUM
) .
indications , and
( 7.5
retinopathy
(
- 8°C )
of ABILIFY
orthostatic hypotension
rhabdomyolysis ) , and
on results
some
Eye
(
impairment
pregnancy and
+44 ( 0)20
United
of transfusion requirements
carton .
may
(
the pharmacokinetics of aripiprazole
4.2 Method
the tongue
and
was 9.5 years .
and Cmax of dehydro-aripiprazole
)
Uncommon : orthostatic hypotension*
common
+0.1
below 12
400 mg of
in
Pioglitazone
- 39 % )
of anaemia
)
see section
Treatment
overall survival
: a maximum volume
in type 1
considering stopping
the first three days
g/ dl ( 7.5
Diabetes
(
) .
with aripiprazole
ACE ) inhibitors
and
Kuhloweg 37
section 6.1
tablets with
for disposal and
SARL
%
g/ dl
hypoglycaemia
similar
44-20 ) 74
symptoms can
events have been
months
This regresses
cause
05 06
Cmax of dehydro-aripiprazole
Abseamed 5000 IU/ 0.5
-
, 49 x 1
the
3
than
usual
two
)
or
of children .
and
somnolence
) and
extrapyramidal disorder
, 49 x
When the CYP3A4 inducer
rarely reported
top
indications
paediatric and adult patients
,
is
section 4.4 )
common
is unchanged ,
Authorisation
aripiprazole
majority of
given weekly
14 x 1
In the
renal impairment
.
holder :
somnolence
variation
in
be applied
or
treatment with aripiprazole
patients
These measures
reactions
elderly
Dose adjustment in order
kg and adults
been through the menopause
16 to 23
and blood pressure
Immune system disorders Uncommon
: + 44
.
scheduled
commits to
Aclasta has
compared
and
.
section 6.1 .
diabetes mellitus (
and a negative impact
Activated charcoal (
(
, Oxford Road Uxbridge
should be
The
10
dose is injected .
contraeptives , thiazides ,
injections
( 0)21 272
site within a
,
been receiving aripiprazole
of ABILIFY
was maintained
dropper
range of standard
10 and 12
3116 8954
may
an autologous blood
of pioglitazone
similar dose reductions should
products
12
aripiprazole
on
patients
75 - 150 60
ACOMPLIA
with
When a
the deltoid region may
epoetin alfa
14 tablets 28 tablets
of patients
84
, in some
Most reactions
formulations
facilitate the
mg
patients on Abraxane with
controlled
( 7.5 mmol/ l
, 14
Therefore ,
, D-58638 Iserlohn
five
of Aclasta
days prior to
efficacy and safety
( 7.5
insulin
information on the
monkeys
than 1
of recombinant human erythropoietin
placebo
% of the
nurse .
this medicinal product should
, long-acting
6.1 .
1
Tel : +
74 60
treated patients .
and adult patients
inhibitors
another ( see
mg/ day for four
of greater than 12
or
, hydroxylation , and
( type 1 )
per dose .
abrupt improvement in
63 patients with metastatic
maintain haemoglobin values
( see section
.
in
60 %
outer
( 2°C
administration
in haemoglobin
patients ,
In a prospective ,
In
or discontinuation of treatment
.
and
and
or
( see section 4.8
g/ dl (
a
week
)
the dose selector returns
cyclosporin
is
the heart or
(
Kingdom
30 mg
corresponding unit scale .
A-007 and 5
alfa therapy
the level
( 2°C
or irregular heart beat
polydipsia ,
(
,
beta-sympathomimetics , growth hormone
.
alfa
, the incidence of
myocardial infarction and
following 30-
your doctor
5000 international units
you know how
g/ dl (
cartridge
that primarily stimulate
- if the solution
.
your dose
Abraxane may
should
(
with
BRISTOL-MYERS SQUIBB PHARMACEUTICALS
discontinuation of treatment
loss
) .
% ) .
37
If
Creatine Phosphokinase ,
, Kuhloweg 37 ,
cerebrovascular adverse events
while taking aripiprazole
pharmacist if you are
.
in whom
that
10
endogenous human erythropoietin that
the intravenous route ,
, a
In
progression of diabetic retinopathy
efficacy to
with
in clinical trials with
.
Alle Patienten unter
family history of diabetes
medicine :
AUTHORISATION
Abseamed 8000 IU/
administration of
( as hydrochloride
patient
aripiprazole failed
product
reproductive toxicity studies .
specific alkaline phosphatase (
)
adult patients
with aripiprazole
about 90
absorption
[
insulin and
is not recommended .
The highest
out of
: in
greater than 2
Starting dose of 50
section 4.4
Bone histology was evaluated
(
values
patient
mainly in faeces (
after
.
Insulin
ACE ) inhibitors
and
9 In
potent inhibitors
, lactation or
IU )
increased primary
, and
mg ( baseline 7.3
in vivo
should be
elective orthopaedic surgery
, for
Hyperglycaemia
patients
see section 4.5 )
,
the other .
.
valproate
23
is
intermediate-acting combined
(
both
or
Tél : +33
SQUIBB BELGIUM
and CYP2D6
experience in children
other
significant improvement in quality
of the
Treatment
they
of your ABILIFY
subcutaneous erythropoietin
.
ABILIFY
EPS was
cannot be excluded
see
each dose
you accidentally
compartment
is very wide
trials
,
10 or 15
In
compartment
( see section 5.2
AUTHORISATION/ RENEWAL OF THE
.
The needle should be
,
In cases where there
and 3A4 ( dextromethorphan
4.2 Treatment of patients
IU/ kg
the
the medicinal product has
than 1
( 1
( see section
administration of
, or
Hydrochloric acid
: in clinical
following
reduce insulin requirement
and
THERAPY WITH SULPHONYLUREA
Business
MUST BE STORED
proliferation of
per month ) with
( see section 6.1
Treatment with
150
Your
10 g/ dl
anaemia (
in men
patients
with
Aclasta , zoledronic acid
Similarly ,
.
haloperidol
investigated
itching ,
( 1
In controlled
in
medicine
-
growth factor
and the
8.1
( Europe
.
whom it resolved .
Cancer Therapy- Anaemia
:
mmol/ l
MINIMUM PARTICULARS
observed .
you or
Haemoglobin variability
avoid
and
:
pharmacist
see also
0800 )
potassium in
5.2
of mineral metabolism
of
erythropoietin is 32,000 to
, especially
the intravenous route .
% ) .
.
to
what it is used
.
,
after
section
haemoglobin
as being secondary to
)
, peripheral
with solid tumours (
but with
malformations
line with the recommended
3 times
being placed
antipsychotic drugs should be
At
if the
less duration
the effect
shows that pioglitazone improves
4.4
the
x
not
Business Park ,
Each
(
calibrated
after
or diuretics that
These
-
95 % CI :
for
, und
if you are breast-feeding
.
patient above and
incidence
64
.
,
may
Treatment of
maximum volume of
.
of
.
vascular events
that
your dog will
of the
and
have
% )
of CYP3A4 ,
pre-filled syringe
see section 4.6 )
multi-centre
This
,
significant effect on
802 with haematological malignancies
shrunk in size
aggravation of existing
pioglitazone ( see section
facilitate the re- suspension
of anaphylactic reaction/ shock
section 4.5
4
inadequately controlled by diet
approximately 1 %
the deltoid region may
at doses
mmol/ l )
well
Hyperglycaemia and Diabetes
symptoms of
and well-controlled
levels of 80
49 x
reported estimated doses
-
by 107
aged over 65
, take the
concentrations
or
12 g/ dl
( 7.5
300
.
polycythaemic mice )
mellitus
(
in
ABILIFY
of aripiprazole
pioglitazone
treatment in this
with a cartridge (
.
or previous
a diagnosis
than
aripiprazole and
isolated cases of angioedema
and
(
.
the
the
Ísland
patients
those receiving placebo (
carcinogenic potential
recommended .
1
patients
56-99
Centre ( Europe )
and sulphonamides .
% of the
oral
in bipolar
units ( IU
mmol/ l
has a pH of
starch Microcrystalline cellulose
caudate
30
weight gain
is 150
type 2
data
in cardiac status occurs
( 0)21 272
10 g/ dl
an apparent volume
BRISTOL-MYERS SQUIBB PHARMACEUTICALS
, 2C8/ 9
and a sulphonylurea ,
insulin
Smoking status
N-dealkylation .
be used
.
.
dose
or very
been observed .
One ml solution
patients with
trial
schizophrenia
.
see section
residual
especially
to avoid
900
000 IU/ 1 ml
patients scheduled
in haemoglobin (
- 7.5 mmol/ l
10 000
3XX United
Weight gain has
patient should not
Tell
100 ng/ ml
the following
Each
patients
ba Latvij Tel :
and isophane
)
a
with
in reduction of manic
studies
, Aclasta was
A specific overdose of
ABILIFY may increase
therapeutic
OR
placebo
241
,
human ,
hypoglycaemia
tablet
BRISTOL-MYERS SQUIBB SARL Tél
incidence
and
diabetic retinopathy .
) ,
contains 45mg
your doctor immediately if
,
clinical trials that
you
Zinc chloride Glycerol
United
)
10 cartridges
erythropoietin
.
a
of
ABILIFY
or
3 times per
of 10 g/ dl
in the
pre-filled syringe of 1
.
patients with
In the study of
dose ,
Global
ability
doctor or pharmacist
delay recovery
restlessness , feeling anxious
haematological malignancies (
with
(
treatment with
potentially
- In pregnant or
of continued therapy
.
: in line with
If an elevated (
Ltd Tel : +
the risk of
but not
Abseamed 6000 IU/
should be advised
(
,
hip
( mean age
and 98 tablets .
.
and
treatment
,
sedation
and clinically
33 IU/ kg
Erythropoietin
month
to
is especially
Lilly farmacevtska dru
uth
or without
given
Restlessness
( this
( 0)810
well-controlled trials of
insulin 50 % and
less than
insulin human (
has
Centre ( Europe )
Cmax and
Development Centre
for all
unused product
Takeda
aripiprazole
nicht angewendet werden
patient
months ) and 6.1
Immune system disorders Uncommon
all patients receiving
48 MINIMUM PARTICULARS
g/ dl ( 7.5
not
.
)
are therefore affected
Flushing ,
mmol/ l ) .
Park ,
There are no adequate
LTD Tel : +
, 2C9 ( warfarin
of these patients
hours
g/ dl
adequate
16 00
.
,
Owing to
%
%
the reach and sight
risk
Tél/ Tel
:
past
with
clinical trials with
)
. :
ml
recombinant DNA technology in
treatment of
,
maintenance doses than children
.
and
aripiprazole
5.1
clinical trials
not yet undergoing
Tel : +46 8
: orthostatic
tumours
in a
, nausea
the
section 4.8
with
4.5 ) .
be
compound
patients the incidence
(
0.5
AB Puh/ Tel
from light .
on bone
at least 500
an increased risk of
,
Treatment
10 and
Highbridge Business
and
.
or without
the
12 g/ dl (
.
angioedema
(
effect
and sometimes severe irritability
all instructions given
which
thromboembolic
bipolar patients
Be sure to tell
closely .
for major
g/ dl (
.
)
nausea ,
, especially
and
x
symptoms of
with
Patients should
United
higher
should be closely monitored
tablets are
with
include continuous electrocardiographic
Dosage Dosage
of this
or joints
, vomiting , an
+ 358 ( 0)9
is
contains 10 000
nausea
(
injection ,
( 0.5 to
and dyskinesia
) following the
of
patients was 12.1 %
.
65
if
mmol/ l )
in more than 30
NMS
is usually maximal within
administered intravenously
with
and 4.9
human
manic episodes
zoledronic acid
clinical trials and
)
are extensively
be considered when
is an antimicrotubule agent
Actos 15mg
epoetin alfa
0.5 ml
risk of cross-reaction
)
cases of stroke or
not be used
alfa ,
,
There is an increased
in
A half-life of
Use should be
300 IU
subjects ,
is
no specific frequency can
patients dosing should
:
mixed episode
during
route
to 12 g/ dl
and a
below 12 g/ dl
pioglitazone with gemfibrozil
If you
toxicity
your dose
monkeys
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LTD
results
Erythropoietins
meal or
of
Novo Allé
The maximum
7 )
Erythropoietin is a
rats
ADT to minimize
epoetin
see
weight increases
the
0800 ) 731
, myoglobinuria
4.8
2AQ
is very wide
reduced
hypoglycaemia
an autologous predonation programme
terminal half-life (
kilogram .
)
Abseamed
(
Aclasta should not be
0.62 mmol/ l )
Actraphane is a
anaemia ( e.
, sedation ,
) .
should be alert to
after
74
in one of these
If you
In clinical
with aripiprazole
The
needle top
hypoglycaemia
.
of
such as
at 36 months
EPS was
of Abraxane
.
(
,
erythrocytes from
in combination with
contains
to protect the environment
53 %
,
1.25 mmol/ l )
30 NovoLet 100
post-marketing experience
.
is effective
shortened overall survival and
Following
of aripiprazole ) .
In
dose of 5
.
44 ( 0)20 3116
solution contains
- 150 60
week by the intravenous
your doctor
recommended
a
1 )
of children
, a
22
tremor ,
and
United Kingdom BRISTOL-MYERS
less than 6
to
entire
)
of greater than
Nordisk A/ S Novo
,
Abseamed
In paediatric
If any of the
see section
akathisia was 6.2
healthcare professionals
two
) Sodium hydroxide
should be
Cmax
in patients with
If
clinically significant
la Es
.
who have a
by
,
e. g. during
below 12 g/ dl
D Centre (
be followed
, dizziness , headache
1
and
observed
haloperidol
should
more
In
retinopathy .
and of the
this product , ask
to
insufficiency not yet
and sulphonamides .
been
,
is
be
, the incidence of
In
hyperglycaemia and
type 1 )
of the six
A sustained haemoglobin level
an increased risk of
,
paediatric
see section 4.8
12
, madarosis
produce effects that
to
injection : a
or
active substance in
appropriate dose adjustment
) and 802
of Aclasta
unit dose blisters
is achieved
SQUIBB
CYP2D6
or
87 % .
aripiprazole and 3.2
sections 4.3 and 4.4
BRISTOL-MYERS
4.5 Interaction with
,
12 g/ dl (
comparable
patients
, anorexia
and
, increased
SPECIAL PRECAUTIONS FOR DISPOSAL
30 mg
thyroid hormones
patients over 75
.
, intestinal calcium malabsorption
observed when
,
( dextromethorphan )
OF FIRST
and transient .
oral solution for
use of
g/ dl
100
,
- 150 60 -
the
x 1
x 1 tablets
if
dose of ABILIFY
aripiprazole
40,000 dalton .
) , or as
jaundice ,
in one of
1
for pH-adjustment
be used
other medicines
in
or
aripiprazole
aripiprazole
cleavage (
12 g/ dl (
times per week
and
mmol/ l
headache , tiredness
98
30
( see section
mice
years
.
insulin 40
34 [ 3.2 %
should
unpreserved product and is
with agitation
REACH
.
If
( see section 6.1
, 50 , 56
ml : 22
, read
total dose
Takeda UK Ltd Tel
and
administered once a year
(
inhibitors of
per week
.
- Middlesex UB8 1HU
section
surgery and
anaemia (
the human insulin molecule
of age where
the
anaemia ,
mmol/ l
or
for the use of
section 4.2
, polycythaemic mice
4.4
be exceeded .
( 2°C - 8°C
Park ,
to protect from light
rate
SQUIBB SARL
therefore should not be
also
in
well
)
Cmax and
on ABILIFY
( 7.5
by these enzymes
Insulins and
combination with
: +
please tell your
, hyponatremia
,
, D-58638 Iserlohn
see section 4.4
1
minutes .
In cases where there
this
dehydro-aripiprazole
des
a combination of
see section 4.5 )
injections .
method of
the intravenous route .
a
pulmonary embolism ) .
for smokers
the
between 25 and 50
12 g/ dl (
81
untreated
and patients
and
of insulin suspensions
3000 IU/
usually
. They include thirst
.
0.5 ml
The
(
of
Do not
%
metabolised
is
Abseamed 3000 IU/
and
55 53 50
.
)
e. g.
9 Adjustment of
Tel
atypical antipsychotic agents
) ,
GESMBH Tel
that
12 g/ dl
than a daily dose
your weight
R & D Centre
300 IU .
hypersensitivity reactions
Upon regaining
usual dose
0.99
Park , Oxford Road
vomiting
Adult surgery patients
aripiprazole
section 4.4
patients participating in
placebo
Medice Arzneimittel Pütter
more units of
Use product
be paid
When the
variation .
000
the
VISTOR
BY WEIGHT , BY
administration of epoetin
with
effects
the anterior abdominal wall
the abdominal wall
1
of
symptomatic anaemia associated with
"
45 93
2C19 ( omeprazole
7.5
aripiprazole
.
,
, given weekly
Oral
pioglitazone
other medicinal products
may
patients with
defined by a decrease
g/ dl (
patients
indicated
(
patient
rare ( see
units (
45 45 93 05
, hyponatremia
4.9 )
of
IU ) of
with
5
studies for other indications
should
rising by more than
einer Adipositas ist die
This is especially important
forms of
repeat-dose
)
of your
who have a
8°C
(
(
infusion , or
human
Additionally , aripiprazole
medicinal products
the
of
BRISTOL-MYERS SQUIBB NORWAY
)
x
. emea
subcutaneous use
children and
for
than 2
treated patients
transport of paclitaxel
with
amino acids
CYP3A4 (
In clinical
when
in a dose range
influence on the
Frequencies of adverse
Driving
severe
use
the
store them in
see
the
surgery patients
( as hydrochloride )
: + 358
.
effect
, sedation
very
a
(
HORIZON-RFT study
less than three
vomiting ,
Distribution
should
.
trials
but
with
solid tumours
5.3 ) .
is a
1HU - United
vitro
studies
In type
% and
is effective in
investigated
hours
.
,
between
may have
Aripiprazole
%
There are
less likely to
the four
patients
you are breast-feeding
should
Special warnings and
and
of NMS
some blood
section 4.4
Development Centre ( Europe
and
rapid initial effect together
to ensure
7.5 mmol/ l
, rDNA
risk of
, patients receiving pioglitazone
may
ml solution for injection
g/ dl (
precautions
for
glucose control may
mg Fe2+/ day
What ABILIFY is and
, warfarin
consists of
considered
- Peripheral neuropathy
should
ABILIFY
Aldwych , London ,
537 900
comparable to placebo .
Method
mild agitation before use
occurs ,
pulmonary
to
side effects
remain at
be exceeded .
same time
ml contains 40
( i. e.
House Highbridge
section 4.2
by a decrease
7.5 mmol/
,
If
Inadequate dosage
between 10 g/ dl
atypical antipsychotic agents
)
23 lung ,
week by
, but more frequently
on the
21
BY UNIT
60 -
, Oxford Road
mineral metabolism must
)
with epoetin alfa
haematocrit
with
is individual and determined
% ) than
- Diabetic retinopathy
used to
over
(
- 12
was
doctor
risk of
3 consecutive
with
micrograms epoetin
aripiprazole
did
severe irritability
of
Changes in strength
, 14 and 7
should carefully
of one year
SQUIBB PHARMACEUTICALS
43-(0)800
) ,
and Diabetes
.
durch die
,
(
with a glass
.
section
in dose should
In
is necessary
peak
to protect from light
Danmark Takeda
loss ,
majority
restlessness ,
tablets
: extrapyramidal disorder
ABILIFY
used to treat
pre-filled syringe of
lung ,
in
of
Abraxane 5
been receiving
260
of
x 1
Global Research and
Road
drink the
and rats ,
Tel : +
and dose regimens
a
4.8 )
of excipients ,
In
44 (
is
rhabdomyolysis ) ,
mg
information
, aripiprazole
diminished parathyroid reserve
, brand ( manufacturer
: +358
.
7.5 mmol/ l )
products
dose
1 , 56 x
no
no significant
0.5 ml (
Treatment of adult
aripiprazole
your doctor or
.
24 hours after the
are ready to use
for the treatment
, ventricular arrhythmias ,
other
of 600
battery
of epoetin alfa
6.1 .
- 8°C ) .
All special warnings
71
and
treatment
be advised accordingly
adults
and
before
with
exhibited
elderly
the plasma concentration
concentrations
patients with a
bone metastases
with placebo .
a
after repeated
reduce insulin requirement .
with fast-acting ,
,
in a
65 Patients scheduled
, Oxford
of
,
See section 4.4
United Kingdom
CLAS ) .
per week by
MANUFACTURER
.
less
contains
They include thirst
haemoglobin ( 1
patients with a manic
when used
potent inhibitors of CYP3A4
Actraphane is
on the use of
,
with alcohol or
6 %
Excluding finger , toe
g/ dl ( 6.2
to ensure
by
nanoparticle
E216
dosage of
Sími : +
of
Tel :
(
+ 44
atstovyb Tel .
Eesti filiaal Tel :
intentional
by
analogues for
1 orodispersible tablets 28
maximum dose
and younger
)
a dose
.
feeling anxious
x 1 orodispersible tablets
> 3 X
3
water for injections
Co KG
patients
Authorisation Holder .
by approximately
) and
of
sulphonamides .
see section 5.3 )
and
+44 ( 0)20 3116
Yarvitan 5
patients with metastatic
normal and anaemic rats
( 16 % )
)
Aripiprazole
immune system ) during
for thromboembolic
If your levels
was
of
your doctor immediately if
insulin syringes with
Any
section
and
between
for
,
3 ml
45mg tablets
of the reconstituted suspension
Nederland BRISTOL-MYERS SQUIBB BV
stenoses
no adequate data on
is difficult
data
be increased .
and
(
)
risk of
and
that
33
diabetic ketoacidosis
of Bipolar I Disorder
weeks (
)
Abseamed has
( 4
, accidental or
rare
hours
a
total
900
in
.
( type 1
be monitored and
be paid to sudden
recommended that the
(
antidiabetic medicines ( metformin
in this
with
% CI :
hydroxylation of aliphatic
of
Oxford Road Uxbridge
0)1628 537 900
medicines used
ml contains
in approximately
contains
Bipolar I Disorder ,
marker
43
to 12
including isolated cases of
site conditions Uncommon -
with
a
,
50
.
loss
retinopathy
in Bipolar I Disorder
section 5.2 )
with aripiprazole
bone .
observed mean
pharmacokinetics and safety of
children and adolescents under
,
a
surgery
muscle pain
Iron
of the Marketing Authorisation
:
1HU -
49 x 1
12 ,
progression ,
1
5.1 ) .
alfa
humans
groups
for
dysmotility and
as
in one of
of
should
clinical trials
6.1
trials
,
The
, 14 and
potent
:
If blood pressure
products
.
g/ dl (
This leaflet
with
normal
epoetin
(
infusion fluids .
3 times per week
section
ABILIFY
tablets ,
45 mg of pioglitazone
relevant effect on
% )
other
.
has not been
mellitus
a few weeks
approximately
using
, the
Middlesex UB8 1HU
of
-
and
- 7.5
The
,
patients .
30 mg/ day .
recommended
consists of 165
the active substance
by
.
avoided
haemoglobin is rising by
biological
use machines .
Therapy- Anaemia
Highbridge Business Park
should be
dosing .
bodyweight
People with
take possible interactions
cartridges are designed to
receiving ABILIFY
, rigors
, the patient
6.6
However
hip fracture
erythropoietin
no information
elderly
ml equivalent to 300
The
methylene groups
not
IU/ kg
mg )
contains metacresol , which
In
acute
Centre
in case of HIV
with metastatic breast cancer
Decreased circulating
, tongue oedema
.
trial of
in plasma .
(
( 4
a
6.2 - 7.5
of children .
47 %
CYP2D6 and
BY UNIT
can occur ( see
clinical
placebo (
EMEA
of diabetes
2°C - 8°C )
( M-II
of
) is
of approximately
,
patients with
of Epoetin alfa and
year .
SpA Tel
FINLAND ) AB
other causes of anaemia
The absolute
, 1,18 ;
mg
mixed episode
)
4.8 - General
migraine-like headaches as a
.
manufacture ( recombinant
aripiprazole
may
Farmacêuticos ,
Maintenance dose
death in utero .
with
study population
.
controls .
dystonia and dyskinesia
) .
( see
)
in pregnant women
a t½ of a
hydrochloride
mg/ ml )
should
subcutaneous use of
used
( 1 800
potassium in
, uncommon
, D-58638
,
three times a
Tel . + 49
the sustained haemoglobin exceeds
of these
a
358 9 251
has no influence
. ) .
,
)
of approximately 6 hours
doctor
and
,
section 5.1 ) .
(
t½
unit dose blisters
all instructions given
dose dependent ;
more than 2
see section
hours
injection
the
vehicles , until
epoetin alfa
Immediately upon
,
229
outer
be disposed
dosage
.
)
( see section 5.1
the
(
in this
.
Frequencies
with
150
ml
or
anaemia in
+ 354 535
DISPOSAL
Any unused product
.
to
solution for injection in
and 50
Frequencies of
These trials
hypoglycaemia whilst driving
(
in
1
section 4.4 ) .
Patients
measure
normal and
7,736 patients ,
535
)
PACK SIZES OF
five large
:
growth hormone
and
of
dosage may also
IU )
(
of the
serotonin
type of
human insulin .
mmol/ l
after
about this medicine
not
7.5 mmol/ l
the treatment of schizophrenia
should be
than
paediatric and
%
1.8 mg methyl parahydroxybenzoate
be marketed .
, the incidence of
In clinical trials ,
a
colourless solution for injection
For preventing recurrence of
insulin and isophane
more units
and symptoms
against the
per
(
placebo-controlled
ml solution for injection
SQUIBB
Cmax of dehydro-aripiprazole ,
One ml
reported
urticaria )
Percentages of dogs
normal
see section 4.4 )
39 06 5026 01
increased
with epoetin alfa
NMS
and
The
impair fertility in
weeks the
bei
7.5
or of no
section 4.4 ) .
per
contains 5000
( see section
with
or
of dissolved insulin and
)
.
rapid initial effect together
one year or
3000 IU/ 0.3
4.2 Treatment
other
In
,
has told you
Androgen ablation
effect of
(
swelling
,
or tense
not
14 g/ dl .
Method
heart failure was observed
more
and
ein
.
patients (
interaction
Aripiprazole is
patients with diabetes mellitus
section 4.8
and
500
There have been
and dehydro-aripiprazole
, IF
other potent CYP3A4 inhibitors
Abseamed 9000 IU/ 0.9
during continued
NMS is a
aripiprazole treatment
g/ dl (
g/ dl
12
4.4 -
a doctor or
.
cases of seizure
observed
PRODUCTS
1
in pregnant women .
Common :
time
be considered
section 6.1
14
( 2°C - 8°C
Caution
and
* Produced
diabetes
,
In a
the
infusion of 5
clear and colourless
:
in
The
.
The
not
on
4 hours in
0.035 mg of anhydrous
new
SQUIBB GESMBH Tel :
on the published literature
Te
300 mg
.
, diabetic ketoacidosis
the reach and sight
treatment .
.
-
per week by
- Refraction disorders
with
Novartis
)
the
concomitant administration
/ N. V.
to existing treatment
injection .
renal
and
of angioedema and
dizziness
concomitant administration
3 ml
section 4.8 )
After
, Storbritannien Tlf
The metabolism of
with
PRCA ,
When the CYP3A4 or
subjects ,
nicht alle
,
efficacy
akathisia was
with diabetes
ml
10
Vantas
metabolites
100 IU of insulin
hours
aripiprazole
1 tablets 98 x
Adult surgery
ACTIVE SUBSTANCE(S ) AND
of Actraphane
overall survival
the
Therapy- Anaemia (
)
: +371 7364000
elderly patients with
15
of
,
in the
Abseamed 8000 IU/ 0.8
48 kg for the
(
+ 33
In several controlled studies
arrhythmias .
,
Patients with severe
with
may occur in
not
e. g.
:
events (
the blood pressure is
patients
( 7.5 mmol/ l
.
is
another ( see
What
in
contributes about 58 %
75 - 150 60
1 60 14 30
is
Eye disorders Very rare
In patients with
( see section
to
. ) .
and
ml
, vomiting
THE REACH
weight gain
not take ABILIFY
and female
Treatment
half-life (
Generally ,
patients
.
( IU
increased Aspartate Aminotransferase
tablets 84 tablets
of the
other medicinal
aripiprazole
of
.
) .
times per week
injection site
in very
daily dose
,
4 to 6
2°C - 8°C
The
your doctor
iron deficiency
93
Seizure : in
it
,
Patients with
.
+ 40
, compared
products
negative impact on
in
dose should be
Pre-existing hypocalcaemia
of aripiprazole
,
incidence
glass cartridge (
occurs ,
product must not be
large
This leaflet
with reported estimated doses
PRODUCTS , IF
to placebo
in subjects with
%
Pioglitazone
FOR
other CNS medicinal products
and headache
in some
or exposure
without psychotic features
4.2 Treatment of patients
maintenance doses than children
,
> 99
orodispersible tablets (
( see section 5.2
) .
84 tablets 90
)
, especially infections and
see
side effects
is not recommended
given weekly
with epoetin alfa is
, anorexia , hyponatremia
placebo
the incidence of
schizophrenia
AND SIGHT
need to be
studies
.
should
.
that
of aripiprazole
any information
subcutaneous use of Abseamed
1 %
)
42.0 micrograms epoetin
or exposure
reaction ,
Severe hypoglycaemia
( 2.5 % )
of Abilify experience
-
starting dose
without food
for you to
temperature regulation disorder
dose
2
A half-life
human , rDNA (
be necessary
the
patients scheduled
, 5
increased by 77
stroke who
5.3 ) .
the dose should
in
ON BLISTERS OR
121
with renal anaemia
alendronate
,
serotonin 5HT2c and 5HT7
x 1
same time
somnolence
of epoetin
recent low-trauma hip fracture
daily insulin requirement
or without
Eli
overdose
.
in which
in children
than
sollte
local requirements
rapid
growth factors
type
Jahr 5 % und
,
these
of anhydrous
After first reconstitution ,
weeks
mmol/ l )
the dosage
over
APPEAR ON THE
rate
of 200
Road Horsham West Sussex
use machines
women .
Erythropoietins
observed in clinical trials
from the use of
( for pH-adjustment
.
feelings
Simultaneous administration of
(
241 941-0
limited
per dose
sections 4.3 and
you
and
anorexia , hyponatremia
fracture
subcutaneous use of Abseamed
Centre ( Europe
( see section 6.1
, F-37071 Tours
of aripiprazole
2°C
.
of administration
your doctor immediately if
Following oral
,
impair fertility in
a type of
Tel : + 34
forms of interaction
UB8 1HU
30 kg and
and
In
4.4 )
risk factors such
calibrated
cartridge ( 3 ml
local requirements .
recommended
.
the
some cases
or
mitratapide or
indicated
EPS including parkinsonism
be used
België/ Belgique/ Belgien
be more common
diabetic retinopathy
PRODUCTS OR WASTE MATERIALS
concern
aripiprazole
surgery and
.
and potassium in
been
(
6.6
Die
The
)
effect
with
(
of children
for aripiprazole-treated
oral
)
of Bipolar I Disorder
Oral
prostate
Abseamed 9000
, the incidence of
No
Rare
Aripiprazole
peripheral
or
with pioglitazone .
psychotic features
4.7 Effects on
dose reductions should
not been carried out
Treatment of
from light
)
after the
AB Tel : +
The incidence
: the levels
meal on the pharmacokinetics
Teil des körpereigenen eim
of
Glycine Polysorbate 80 Water
alfa
glucocorticoids
to
contains
a growth factor
and
increased Creatine Phosphokinase ,
174 gynaecological
daily dose of
, the dose should
estimated volume of distribution
x
4.4 ) .
.
those receiving placebo (
( 7.5
,
trial
units ( IU
.
mg
Uncommon
.
) .
, less
10 and
in vitro solubility
1.25
( 9 weeks
women
trials
of the
before
)
women
Any
mixed episode of
,
been
,
D-58638
doses
05 06
In pregnant or
linearly from 2653
than 2
Abseamed
pharmakologischen
with
minutes ) .
The
trials , an
machines , until
.
mmol/ l ) or
Aclasta
patients
or
per kilogram .
Bipolar I Disorder
in
section 4.4 ) .
oesophagitis
coma or
system
and all
with alcohol
contraeptives ,
,
be
der nach einem
and
the most frequently
Hyperglycaemia and Diabetes
or
If
for thromboembolic events
Uxbridge - Middlesex
trials and
Farmaceutici SpA
with or
has a
)
other handling
have been proposed ;
the treatment of post-menopausal
patients
in healthy
epoetin alfa
33 -
30
healthy elderly
0.8 %
during pregnancy
and
and beta-sympathomimetics
ml
,
Aclasta (
)
effects
ABILIFY
when
: fatigue Psychiatric disorders
metabolism of
, Oxford Road
prophylaxis by
well
Actos tablets
4.4
In
anaemia
1 ml
: store
7.5
( 7.5
contains
.
e. g. stroke
Pioglitazone
and isophane insulin
contains metacresol , which
and
( for pH-adjustment
most common
8°C
of
rapid or irregular
PFT ] ( see
.
ketoconazole or
per month , or
Bipolar I Disorder
compromise or
the other
and
white and
( see section
use
3 ml )
mg once a day
D Centre ( Europe
OF
these
As with
: + 33 (
single intravenous infusion
with insulin
for all
This
mg
( see
.
A gastric
and
revealed no medically
treated
crisis with encephalopathy-like symptoms
+ 45 45 93
insulin cannot be
Uncommon -
reactions are
, 300 gastro-intestinal ,
growth hormone
Therapy- Anaemia
in a refrigerator
)
55.3
COMBINATION THERAPY WITH SULPHONYLUREA
MINIMUM PARTICULARS TO
the patient
package leaflet
, are not sufficient
-
mmol/
Complete
encephalopathy-like symptoms
surgery
Magnesium stearate
47
,
%
placebo
contain 0.3 ml (
dopaminergic hyperactivity and agonist
.
thyroid hormones and
% and
sie durch
100 ng/ ml
In a
4.4
( rhabdomyolysis ) ,
, especially
risk
should
see
hypoglycaemia may
, anorexia ,
24 hours after
sections 4.3
( type 1
instruction for use to
Cancer Linear
the warning signs of
during treatment
to protect from light
disorders
( see section 5.1
Lilly Holdings Limited
in
meal or
158 Do
feeling anxious
hydroxylation of aripiprazole
section 6.1
intermediate-acting
mg
.
and
:
no
Before
myocardial infarction or
25
prophylaxis
aripiprazole
first infusion
the dose
annual
.
( 6.2
tablets 90 tablets
haemoglobin concentration should be
with chronic
below 12
)
decreased blood sugar (
blood levels of cyclosporin
psychotic
by
during
.
of
aripiprazole
with a maintenance dose
-
.
severe irritability
Uncommon
healthy elderly
play
OF THE MEDICINAL
during treatment
Manic episodes
Mutagenicity
epoetin alfa has been
possible warning signal
for mitratapide versus
potent
It
are not
section
7.5 mmol/ l
If epoetin alfa
on
( NPH ) insulin
see
should be considered (
on
,
greater than 2
Do not
week by
should
)
PRODUCTS OR WASTE MATERIALS
the
of
Risk factors
There is an
one month
will
swelling and inflammation .
terminal half-life ( t½
OUT OF THE REACH
is not
the majority
cannabinoid receptor antagonist .
.
,
contains
of the
except in paediatric patients
Actraphane
) .
in
from precursors
elective orthopaedic surgery
concentrations , aripiprazole and
of recombinant human erythropoietin
7.5
)
(
.
are
If you
Ongoing major depressive illness
had already
%
.
of this population
and 98 tablets
in patients
and approximately
Business
of patients
in children below
no
monitoring
,
does not produce enough
The recommended
- in patients
the
be
( dextromethorphan )
and dose regimens
2/
, the
, vomiting , an
during pregnancy and
rhabdomyolysis ) , and
.
, 23 lung ,
events
(
quinidine occurs
Kingdom BRISTOL-MYERS SQUIBB PHARMACEUTICALS
of the
Abseamed 3000 IU/ 0.3
353 ( 1 800
reactions
Hb between
ABILIFY .
mass
:
Eli Lilly
all timepoints (
When the
per month
in these
Tel :
insulin 20 %
bei Patienten
brand ( manufacturer )
x 3 ml .
of the
34 %
in vitro
may
not
in
benefit
704 71 00
0.5 ml
With their skeleton still
7.5 mmol/ l
be
18 , or
There are no
surgery
in maintaining
aripiprazole
and
Tlf : + 44
(
Maintenance dose between 25
(
,
.
other
may help to
aggravation of existing hypertension
than
on
not
four carbohydrate chains
is a
(
a
if
very rare cases
Store
double-blind
is
antipsychotic drug
Thereafter
diabetes
ABILIFY is 15 mg
alfa on
HF Sími
rate
of
,
may be
.
system . lp
)
patients with residual
for
CYP3A4
In patients
the
specifically and
fibrosis of any origin
PRODUCT AND ROUTE(S
Patients
diarrhoea
under
adults
RH12 5AB United
.
6 -hydroxypaclitaxel ; and
and
medicine :
of that month
placebo .
of
(
Generally , children
: +
of hypoglycaemia
ml solution contains
Diabetic
People with
part of the
Your
machines .
.
effective ,
9.5 and 11
.
in the
well-controlled trials
two or more
.
is fever .
.
Most side effects
see section 5.1
renal insufficiency
of
The
their previous insulin
.
human
.
injections are given in
IU/ kg 2 times
.
The
dyspepsia
Park , Oxford Road
aripiprazole
specific treatment
overweight and obesity in
Puh/ Tel
programme
is no accumulation :
or discontinuation of treatment
a
and potassium in
diabetes , ketoacidosis (
adequate and well-controlled
3.0 %
Animal studies could
an autologous blood
epoetin
an increased risk
in
solution for injection in
is a
and
.
IU/ kg body weight
(
production
and
KG , Kuhloweg
The efficacy
starting dose
HF Sími :
5.2 ) .
cartridge
of
Abraxane 5
signs and symptoms of
of aripiprazole .
% with
Water
of
10
, swelling and
considered
pharmacist
with
There
the
CYP3A4
7000
of
placebo , or
of
controlled
) .
410 500
,
31
( as hydrochloride )
, face oedema
400
The oedema rates for
aripiprazole (
half-life ( t½ )
a clinical
disorder .
) ,
.
) .
OF UNUSED MEDICINAL PRODUCTS
.
observed ( see sections
)
hypoglycaemia
74
in the
identified
in post-menopausal women in
per
hypoglycaemia )
thrombosis
,
: +
.
of children .
: +3726441100
IU of
a
.
pain ,
CYP3A4 and CYP2D6
and
SQUIBB PHARMACEUTICALS
condition
0.5 ml contains 1000
,
favour
recommended starting dose for
1
39 % )
studies
events compared
been
Fe2+/ day for paediatric
recovered in the urine
the
transfer from animal
in
unused product
see section
Dystocia
Alopecia was observed
catalysed by CYP3A4 .
.
g/ dl ( 1.25
If you
recommended for
, sodium chloride
mg Fe2+/ day is
.
to patients with moderate
)
in urine (
young subjects .
should be
bone Aclasta
e. g.
3 times per
.
to insulin human (
not known
studied
of NMS
neutropenia or severe
are not
( 0)20
to
Inadequate dosage
4.4 ) .
hyperglycaemia ,
, suggesting that
vitro
:
in plasma
quinidine occurs
use of Aclasta
tiredness , feeling dizzy
the
disease such as
( dextromethorphan ) .
significant
R &
tablet formulation is 87
However
method
epoetin
30
must be discontinued .
inter-individual variation
( IU )
in pregnant
and transport refrigerated (
in vitro solubility
increased Creatine Phosphokinase ,
trials with aripiprazole
cases of seizure
mg (
studies , use
of
, pharmacist
Functional
anaemic patients .
or other
of EPS was
BRISTOL-MYERS SQUIBB AB Tel
+ 46 8 704
SQUIBB PHARMACEUTICALS
(
such patients .
The following reactions
see
( two studies
PRODUCTS
The
the human insulin molecule
approximately 425 mg
,
patients
colourless ,
of increased
that
5HT2a receptors
500
aripiprazole
Reactions usually resolve in
in
few minutes .
increased
.
studies
in whom the
well
to tell your doctor
kg over 2
)
BSAP ) ,
The frequency
are never to
(
and
, angiotensin converting
Use
.
,
The therapeutic
is used
and
R & D
Europe )
, placebo-controlled trial
IU
post-menopausal women
mg Fe2+/ day is
:
(
Haemoglobin levels
patients
IU/ kg 3
tablet contains 45 mg
1,062
heart failure
After administration of epoetin
the
(
.
ausgeschieden
a pre-filled syringe
g/ dl (
two or
is always
efficacy of
11 g/ dl
Other disturbances
be avoided
in
)
patients
- Treatment of
PARTICULARS TO APPEAR
indicated
for the
or
71
( 8000
and
danazol .
migraine-like headaches as a
10 mg , 15
your
tumours (
haemoglobin is
with
(
Epoetin alfa
epoetin alfa is very
in subjects
above 45 mg
.
section 5.2
to 6 weeks )
In addition , cases
,
the most frequently
or discontinuation of treatment
anaemia the medicinal product
including PANSS
) , sugar
0.3 ml ( 3000
of a full
pale mucosae
and
and death in utero
years of
Elevations of CPK
hours
1HU
or
all cancer patients
House Highbridge Business Park
of thrombotic
section 5.2 ) .
and inter-individual variation
for use
with
683 breast
In the indication
the intravenous route .
of weight regain .
of aripiprazole
Phlebotomy may be
( see
serious allergic reactions
the
combination therapy
LTD Tel : +
in
and
,
Occlusion of
(
of
, aneurysms
to protect from light
placebo
phosphokinase
26 4.5 Interaction
notice any
clinically
: + 43
studies in healthy subjects
two
.
with ketoacidosis
nausea ( feeling sick
1,000 , less
body
.
.
.
lon ANNEX
of
( t½ ) is
When seen , it
over a period
approximately
similar effect
section 4.2 Treatment
epoetin alfa on
from the
be
either valproate
9 251 21
g/ dl
occurrence
of these
Overdose
dose
most clinical
shown
33 ( 0)810 410
0.5
blood levels of cyclosporin
(
4.2
akathisia , tremor
30 %
injections are given in
time
D-58638
,
patients
thrombotic
cardiovascular
an injection
is 15 mg
see section
solid tumours (
please tell
1 g/ dl
is
with
hypertension
experience with
When
ml contains 8000
-
13 g/ dl
with encephalopathy-like symptoms
for injections
and
, the
given subcutaneously
is
This leaflet
: +49 911
6 %
( 95 % CI
and inflammation .
machines
g/ dl ( 7.5
) .
, D-58638 Iserlohn ,
A
red
four
H1 receptors .
been reported
the patients
symptomatic anaemia associated with
shown during the
placebo , or
SUPPLY OR USE
.
7.5
the thighs or
IU/ kg 3 times
production of saliva
kidney have
Pre-filled pen
and heart disease or
of epoetin alfa
into account and should
+ 33 ( 0)810
recommended starting dose
ml solution for injection
between
not pass it
, the bioavailability of
dose
dosage of ABILIFY
Depending on
( see
)
.
part
recommendations
local requirements .
treatment with aripiprazole
even
with
NORWAY LTD Tlf :
and
,
15 mg or
by the intravenous
trials
including
(
episodes in
events
( e. g.
should be carefully monitored
contains 10
,
trials and 8167 patients
effects were
of glucose
(
increased alkaline phosphatase
, sudden
precautions
a combination of
trials
treated ,
a clinical
or
An
GmbH Tel
.
30 mg
( M-II
.
pioglitazone
.
,
PRODUCTS , IF
CNS
g/ dl
be used
3 ml )
,
discontinued
with
)
on the total dose
see section 6.1 .
of Actraphane
- 14
In
( 8.1
Renal or
effects
headache Eye disorders Common
at the desired level
- if the
during
(
-
(
A/ S Novo
, especially when
for
experience
defined by a decrease
, the
international units ( IU
x 1 tablets
rst vniec
6.2 % with aripiprazole
with
or more
The
sulphonamides
between
,
.
)
patient
In patients with
and 3A4
:
Maternal toxicity
are transitory
BRISTOL-MYERS SQUIBB
in
with a
g/ dl
and
Tel :
alfa
Urticaria , rash Very
lead to hypoglycaemia
60
+
pH adjustment
use
of dehydro-aripiprazole
The
insulin requirement may be
route
Neurotoxictiy to paclitaxel
well below
on
and/ or
, 55.3 ]
in
.
3
about hurting yourself
solution for injection
diabetic
The rate of
.
APPEAR ON BLISTERS OR
the skin
metacresol , which
a daily dose of
initial dose is 150
appropriate
or
and 5HT2a receptors and
.
,
When the CYP3A4 or
and 5.2 )
ml solution for injection
this to
The cartridges are designed
are
, every three
)
in
section
Business Park ,
) .
haemoglobin target range
% ) and placebo
other potent CYP3A4 inhibitors
epoetin alfa is very
taking ABILIFY
adult
a
in
Pharma
patients
have
the CYP3A4 or
the primary
placebo
THE REACH
this patient population
an
in dose should
of
35 trials and
nausea , vomiting
50 %
vision Gastrointestinal disorders
USED FOR
with
4000 IU/ 0.4
over 30 kg
limited number
as compared
12
" and "
14
symptomatic anaemia
and
81
and dehydro-aripiprazole ,
of pioglitazone
clinical studies
with
is a range of
contains 7000 international units
United
adequate
The maximum daily dose
Europharm Limited Wimblehurst Road
differentiating hormone
MEDICINAL PRODUCT
75 years and
plasma concentration
see section
minimal
, sedation ,
by the liver
and
There
of Epoetin alfa
7.5 mmol/ l
race or body weight
IU/ kg
other
vivo
6.2
ALT )
ABILIFY
recommended
6.1 .
shortened overall survival and
g/ dl
type 1 )
was
injections
for
2°C -
ABILIFY
be avoided
mg once a
with haematological malignancies .
with
The medicine can
In
or
injection :
anaemia with
starting dose for ABILIFY
and
When
similar
minor metabolites , 3
the reach and sight
see section
are lactose monohydrate
reactions after
33.6 micrograms epoetin
, reduced visual acuity
) ,
hours
Muttermilch ausgeschieden
Global R & D
breast-feeding
be used
in isolated patients
Actraphane is
of dehydro-aripiprazole
Abseamed
50 IU/ kg
injection
%
no evidence of
.
1.25
tablets 98
PRODUCTS
subjects the
Danmark Novartis Healthcare
( warfarin
use of Epoetin
.
)
hepatic impairment on
diabetes
of
VISTOR
+
ml
unused product
overall survival and
repeated
)
see
.
,
with
by approximately
particularly overweight patients )
proportion
insomnia
) 74
phosphate dihydrate ,
concomitant administration
a week .
is minimal
anxious
metabolites
stroke or
patients
.
, 2C8/ 9
-
or combination therapy (
and sulphonamides .
cases of
The tablets are
antithrombotic prophylaxis
after
and
80
.
and
of epoetin
35
greater than
BRISTOL-MYERS SQUIBB
per dose ,
terminal
and
Store and transport refrigerated
therefore
that compared the effectiveness
renal anaemia ,
.
74-week extension
er
with consideration for
( see section
than
) .
should
anaemia
?
chloride
and
same time
354 535 7000
that primarily stimulate
to dispose
international units
FOR
of
should be
SPECIAL PRECAUTIONS FOR DISPOSAL
see section
+46
can be
from human tumour samples
33.6 micrograms epoetin
per dose .
( t½ ) is
after
450
appropriate you will receive
immediately if you
The following
no significant effect on
5 mg/ ml
165 amino acids
300 IU/ kg 3
machines until
: +
symptoms ,
considered
The
on the use of
paediatric patients
cartridge
6.1 .
keratoconjunctivitis sicca ,
inflammation .
on
and
in pregnant women
including
been reported
80
to zero
psychotic symptoms
.
epoetin
or pharmacist
in
to
FINLAND )
absolute
IU/ kg
,
10
injection
lung , 22 prostate
( see section
protein intake .
) ,
than a
5.1 ) .
ABILIFY may increase
and
doctor
the
- Oedema Oedema may
A
section 4.2
epoetin alfa
- Treatment of
patients
microcrystalline
per month ,
injection site reactions
) to
4.7
1.25
human ,
, swelling and
thrombotic
.
(
of
osteoporosis
.
trial
6 weeks
are
.
,
muscarinic receptors
units
)
a calibrated
developmental toxicity
PACKAGING
) or the
fibrates )
are growth factors
Limited Tel : +353
water for injection .
- 150 30
thrombotic
Consequently , haemoglobin
no significant effect on
.
must be discontinued .
and
) and/
In paediatric
300 IU/ kg 3
placebo over
children
oedema , difficulties in
has told you .
cerebrovascular adverse events in
for cerebrovascular adverse
alfa is
aripiprazole
.
consists of 165
Your doctor
40
For a full list
injection )
In controlled
)
on bone marrow cells
84.0 micrograms epoetin alfa
be
( see section 5.1
if
,
.
The oral solution
to
daily dose of
of epoetin alfa is
6
64 gynaecological
product immediately
immediate packaging
all growth factors
Treatment of
IU of
metabolites 6
aripiprazole
or
re-suspension
Diabetes Mellitus : hyperglycaemia
your
%
( e. g.
of 200
week
complications .
as
(
study
contain
x 1 tablets
in strength ,
than
disorders
:
Abseamed
.
the gluteal region
) .
1 and 5
to treat
be necessary
In two
observed ( see sections
10
also
and
some blood
pre-filled syringe
see section
for 2
Each tablet contains
VISTOR HF Sími :
risk for thromboembolic events
IU/ 0.8
10 g/ dl (
12 -
manic symptoms over
to maintain haemoglobin
Aclasta
In
obesity
15
and blurred
possibility of
isophane insulin .
%
on
read the
(
House Highbridge Business
Read all of
a prospective ,
30
and symptoms
you
appropriate dose adjustment
.
of Abraxane
30 kg
in a blister
in subjects with
10
both fast-acting
in
SQUIBB PHARMACEUTICALS
all growth factors
)
, the
aripiprazole alone was
measures will help
in the
.
give by injection
contains 4000 international
pharmacokinetic characteristics
(
600 IU/ kg
without
between 25 and
Erythropoietins are growth factors
&
.
In
in type
Norge BRISTOL-MYERS
incidence of
20 %
, creatinine and
carbamazepine ,
had visceral metastases
in
other erythropoiesis-stimulating agents (
risk
section 4.4 -
was 9.5 years .
in patients
doctor or pharmacist .
be
pharmacokinetic characteristics of aripiprazole
( type 1
placebo-controlled
,
Tel : + 44
during the course
4.8
( see section
Common : extrapyramidal disorder
Severe hypoglycaemia
and sight
IU/ kg 3 times
or
:
treatment
were women ,
elderly
in healthy
or very rapid
observed .
angiotensin converting
has been
, D-58638
The
30
in this
.
precautions
control group .
on
recent low-trauma
intentional acute
hypoglycaemia
observed mean
included only 3 patients
was
137 Tell
30 % )
UB8 1HU
rare
and acute renal failure
alkaline phosphatase (
dosage adjustment
fatigue Psychiatric disorders
versus 0.8 %
IU )
patients
Gastrointestinal disorders Common
these
been reported while taking
only
studies
for injections
If
, Storbritannien
4.4 -
surgery patients
in whom the
section 4.4 ) .
Adult
sodium chloride , glycine
of NMS
IU of insulin human
35
combination
with insulin or
of
that
mmol/ l
following undesirable effects occurred
the first
.
- Diabetic
g. insulin dosage
07/ 412/ 004
sulphonamides
not
( baseline 7.2
39
may require discontinuation of
Depending on how
Business Park
less
followed by a
( see section
,
15
five
Oxford
1 ml contains
after the first
and approximately
for
an increased
Global R & D
.
1.5-2.5 hours after
.
ABILIFY
significant
mean
nursing mother presents no
with overlapping undesirable effects
the dose
g/ dl , the
for injections
than 2 g/ dl
These
( see section
patients
10
aripiprazole and dehydro-aripiprazole
by approximately
precaustions for disposal and
%
been carried out
hypoglycaemia )
were excluded
adult dogs .
.
may cause allergic reactions
inhibitor of osteoclast-mediated
dizziness ,
the
on the
anaemic patients .
Aclasta-treated
your
by the intravenous
diabetes mellitus
erythrocytes from
in
l
16 to
conventional paclitaxel-containing medicines
no
diabetes mellitus (
from
medicines used
the pack
At therapeutic concentrations
7.5 mmol/ l
g/ dl (
QT prolongation or
administration of
( 2.5
( 55 % )
than
human )
ketoacidosis
Hypersensitivity to
x 1 tablets
28 x
68
section 5.2
t½ )
Fast improvement in blood
than
moisture
3 times per
.
of daily
clinical
12 g/ dl
7000 international units
used in humans .
may
: store
be used .
.
benefit from
USED FOR
l
dogs Mitratapide
IU
the
it
63.8
study )
Thrombocytosis
altered mental
see section 4.5 )
than
rash )
is achieved (
but its occurrence
SAFE AND
,
of excipients , see
patients
two
monitored and
( Europe ) ,
of care
Paget s disease
dog
( 7.5 mmol/
g/ dl ( 7.5
ability
358 9
peak
8.1 41.7 11.9 47.3
and water for injections
BRISTOL-MYERS
or
( see section 5.1
AB
Due
be
Tel : +
not been established
4.5 )
What
The cartridge contains
In clinical
,
Common
BRISTOL-MYERS
infusion .
by 32 %
human
of seizure
is
the
autologous
hepatic impairment
with encephalopathy-like symptoms
section
.
contains the active ingredient
( ALT )
: +
and
:
4.8 - General )
There are no data
men )
Industrial Park Westhoughton
is controlled .
taken to
12
14
,
how
5.1 ) .
, the
) with
and hyperglycaemia
symptoms .
in these
carcinogenicity
follow a nutrition programme
49 x 1 tablets
patients participating in
,
)
The maximum
IU/ kg 3
- 300
weight decreased , anorexia
GmbH & Co
.
decreased appetite .
24
10
,
they
: + 358
10 to
Adjustment
overall survival
)
dose should
1 g/ dl
patients with
section 4.4 ) .
manic
minutes
no
you
over
If you have
of this
If
ise
or
,
and
, restlessness ,
Smoking status
preventing recurrence of manic
by the intravenous route
intravenous
) of EPS
Takeda Ireland
enzymes and
to take
alfa
a
30
in
g/ dl
µ
this condition may also
when haemoglobin values exceeding
high risk from
1 % of
effects were
the
of
hydrolysis ) sites on
and
month , or if
the
including
respectively , the
pectoris , increased risk
.
Nederland
Park , Oxford
injection
than
%
epoetin
hyperglycaemia ,
medical prescription (
does not affect leucopoiesis
.
trials , uncommon
)
change in aripiprazole concentrations
( see section
schizophrenia
a full range of
studies in pregnant women
forms of
various
in 2.3
,
development
pregnant women
programme
,
medically important signs and
trials
GmbH &
for three weeks (
solution
the
when erythropoiesis stimulating agents
in a pre-filled syringe
.
There are no
warnings and precautions
800 ) 749
section
USE
see
anaemia may
rats
recent low-trauma
4.4 and
bei
4 or
serotonin 5HT2c and 5HT7
insulin
Dosage adjustment
Ísland
: + 33 (
is
haemolysis , and
dose
30 % )
rhabdomyolysis ) , and
weight gain
( 1.25
ACOMPLIA darf bei Patienten
Do not take ABILIFY
by a decrease
alfa may
the
physician
the
the recommended
.
the
must
,
, treatment
initial dose is
: + 45 45
, ataxia ,
(
inhibitors of CYP3A4 ,
on in
- 150 60 -
patients
flatulence ,
the incidence
increased insulin resistance
of
patients
meal or unplanned ,
clinical
growth
) ,
in
mixed episode of
(
(
to
(
Highbridge Business
if
weeks
in paediatric
patients
before your
(
receiving chemotherapy
.
the
battery of
medically
to protect
mmol/ l
angina pectoris
no
biological efficacy of
machines
mmol/ l )
, peripheral motor
drowsiness
a mixture of dissolved
,
.
increase in mortality from
Iron
Common :
a potent inhibitor of
( GGT )
IU/ kg
-
ACE ) inhibitors
and behaviour and emotional
the placebo group
France Laboratoires Takeda
Aripiprazole
no
What benefit
GmbH
The
No information is
treatment is
occurred in
controlled
The
47 67
Actraphane
more units of
e. g.
with
House Highbridge
of
speech disorder ,
The following adverse
at 25
( injection )
Other
manic
is given when
may occur
One IU (
an
3 times per week
rash )
Uncommon
) of
the treatment of
to
section 4.8
may
studies and
infusion should slowly
section 4.4 and section
your doctor
6.8 mmol/ l )
after
95
(
( for pH-adjustment )
, intermediate-acting
.
treatment
placebo , or
patients and
the
adult patients
a
seriousness
or if you
RESTRICTIONS
12 g/ dl (
no fatalities
In
various
& D
4.8
fat mass
the
regard to meals
bone marrow fibrosis of
, less than 1
studies
.
a mixture of dissolved
(
hepatic ) pathways
30 % ) .
of epoetin
Abseamed
and
of heart failure
% Black
see section 6.1
vitamin B12
are round
is
absorbed , with
myoglobinuria (
of 50
Syringes
, insomnia ,
with
increased Gamma
1 800 )
pharmacist .
.
recent (
,
, face oedema
overall survival
(
.
nervous system (
should be
, restlessness
an
IU of
doctor
the dose may
in the thighs or
a few weeks
than
with
corresponds to 0.035
The occurrence
month , or if
)
200 mg
-
:
Deutschland Takeda Pharma
,
risk of death and
)
The possibility of
medicines used to
(
Patients should be
Ísland
section
.
contents of the pack
In clinical trials and
insulin
trials
, or
6.2 mmol/ l
and water for
was
insulin
Novo Nordisk
for both groups )
Tel : + 44
could not be detected
very wide .
as measured
and
of 10 g/ dl
Uncommon - Diabetic
,
ABILIFY
.
Patients scheduled for
in a
cases
of hypoglycaemia
However , in
the
.
These
an
-
3 ml
Treatment
, diabetic ketoacidosis
the
thyroid hormones
,
in
diet
exercise ,
symptoms
PARTICULARS TO
(
give
Introducing
including PANSS and the
,
been established .
an increased risk
CYP3A4
recommended that
values
with aripiprazole .
12 g/ dl (
Erythropoietins
4.9 ) .
, there were
thromboembolic
, even several
.
efficacy
2,127
tablets 56 x
in the
is
Maternal toxicity
lp
a sulphonylurea .
13 g/ dl
7.5
about hurting yourself .
hyponatremia
in
diabetic hyperosmolar coma
blood pressure and
treatment with metformin and
trials
with epoetin
PVC/ aluminium )
no specific frequency can
,
40
to patients with
during continued treatment
IU/ kg epoetin
Takeda Global
is individual and determined
( see section 5.1
shown no
;
Squibb Srl Contrada Fontana
aripiprazole ,
ABILIFY
of
,
when stored between
use of ACOMPLIA and
symptoms
.
patients
8.7
should be
patients with
Abseamed can
contains
( see section
nursing mother presents no
23 lung ,
, 84 ,
in
(
autologous
0
A specific overdose of
, aspartame
) .
not
weight decreased ,
werden ( siehe Abschnitt
22
by
cannot
therefore should not be
2-78
and
- 7.5 mmol/ l
approximately
(
section 4.4 )
or
Actraphane
but not in
on bone marrow cells
( this
6 hours has been
: + 36(0
while taking
increased
)
new
( see section
5AB United Kingdom
dystonia and dyskinesia
neutropenia
,
Highbridge Business Park ,
857 42
to sudden stabbing
be exceeded .
, aripiprazole should
ml contains 5000
vary with age
(
manic episodes
with
5.3 ) .
No studies
12 -
1
Do not use
in
Do not use
ketoacidosis or
should be
4
be
32
food
or
in a
pharmacist
section 5.3 ) .
BP
administration
,
which
and
flatness
oral clearance
household waste .
. : +44 (
% )
section 4.8 ) .
similar
must be followed
and 12 g/ dl
in
tablets
% ) .
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LTD
until
In clinical
may vary with age
sedation (
after the first
patients with severe
Tel : +
10
Adverse reactions
hour ,
insulin .
, nausea , vomiting
, or
clinical trial
938 ;
have the following causes
section 4.4
, rDNA (
Actraphane
use of
for
for
( 1.25 mmol/ l
site conditions
)
.
Glycine Polysorbate 80 Water
to aripiprazole tablets
30
1/ 100 )
Ireland Takeda
Starting dose of 50
( Cmax
120 ml : 22
not
distribute
administration of
and
,
fast-acting ,
and
conditions
entire dose
of one year
the
.
9 251
.
cell production .
.
have
not
pioglitazone with gemfibrozil (
human dose or exposure
remain the
5.1 ) .
(
dehydro-aripiprazole ,
events
of ABILIFY
epoetin alfa ,
When
- 7.5
50 IU/ kg
)
dose is
adjustment
children under 30 kg
myocardial infarction or stroke
)
section 5.2 )
, akathisia
460 women with
Sodium chloride Glycine
12 g/ dl (
, the
1.5-2.5 hours after
)
.
proposal
hours .
Following
with
treatment
for cerebrovascular adverse
patient
, 1,18 ; 42
Actraphane is a
95 % CI :
)
in
150
(
symptoms can
) aripiprazole
Any unused product
Pharma
4.4
or
and
A sustained haemoglobin level
, reports
clinical
anaemia
, Spain
is 15 mg
trials
.
weeks
0.6
should be
( 7.5 mmol/ l
SQUIBB ( FINLAND )
consists of
clinical judgement .
patient
except in paediatric patients
a clinical
and
The patient s ability
or if
Like all
a mixture of dissolved
Highbridge Business Park ,
.
the
e. g. anaphylactic
comparable
, 10
were receiving cardiovascular
in pregnant women
patients
female
,
and
ABILIFY 1
including
) Ltd 61 Aldwych
epoetin alfa
)
AUC
of rimonabant
are given
ABILIFY
Middlesex UB8 1HU -
aripiprazole
taken in combination with
( NPH )
after your
)
all
The maximum
50
patients )
if you
( 0)1628
route
solid tumours
Ireland
see
dose
.
a
m²
of epoetin
should be
patients ( particularly
Eli
Purified water
epoetin alfa
E218 ) Propylene glycol
The AUC
contains
trials and 8167 patients
der nach einem
(
haemoglobin concentration should be
When either valproate or
healthy
Novartis Ireland Limited
.
out of 3,852
patients
four carbohydrate chains are
and anaphylactic reaction .
, the dosage
ABILIFY is used
, increase the risk
the
mg
large
, the incidence of
with the
see section
The following
USED FOR
pregnancy
46 25 16 16
should
see section 4.5 )
and
In clinical trials
aripiprazole
Special precautions for
clinically
patients ,
for thromboembolic
starting dose
or
ng/ ml
bottle ,
last very long
( 7.5
with two
(
800
of the nursing
on the
renal insufficiency not yet
, see
vomiting
.
37
. europa . eu/
extrapyramidal
, recovered label
How
GmbH & Co
( e. g.
Following concomitant
of the
phosphatase
REGARDING SUPPLY AND
.
episodes in
human
0.7 ml
patients may
( for pH-adjustment )
OF UNUSED MEDICINAL PRODUCTS
.
half-life
if you are breast-feeding
.
use in dogs with
high fever
)
with aripiprazole and 3.0
to
treated patients
see
( 1.25 mmol/ l
a
the intravenous route
Patients
of EPS was
Aripiprazole is well
infusion fluids
)
corresponding to 42.0
(
and
The efficacy
alfa
(
Overdose of epoetin
Business Park ,
mg
given subcutaneously (
(
section 4.4
stabbing migraine-
occurs ,
controlled
section 4.4
possibility
recommended
should be closely monitored
, diabetic ketoacidosis
its total active metabolites
,
ketoacidosis
whether or not there
for
- 12
silicon
OF
risk
.
4.5 )
Bagsværd
%
ABILIFY
other
30 mg/ day
( warfarin )
and
- 7.5
six
enzymes
jaundice , hepatitis
corrected .
the
renal
354
pregnancy and lactation
until a stable level
treated
4.4 ) .
and
more units of
of
Kuhloweg 37
osteoporosis
of
generally not well
of the pancreas
no known effects
the
3 and
no
aripiprazole
Kingdom
five
no evidence of clinically
15
aripiprazole
Abseamed 3000 IU/ 0.3
Glycine
7.5
vitro findings
clearly
anaemia associated
SQUIBB NORWAY LTD
.
be used
patients with a
Abseamed 3000 IU/
Tél :
in children and
Laboratoires Takeda
patients ( mean age
.
be monitored closely
whether zoledronic acid
leaflet was
.
natural
4.8 - General )
30
not
44 (
units (
for thromboembolic events in
in both
In
( see section
treatment
)
33
antithrombotic prophylaxis
revealed
)
( see section 5.1
should be avoided
and sight
in
Actraphane
Cytotoxic actions
in
section 4.5 ) .
Weight gain
aripiprazole
with
of manufacture ( recombinant
with ketoacidosis or
) .
( 172 breast
is
and
treatment with
)
.
3.5
mg of anhydrous
In clinical
of
for
Effects on
the CYP3A4
,
monotherapy or
placebo-treated
,
( see section
shortened overall survival
6.2 -
see section
delay recovery
, diabetic ketoacidosis ,
position , or
,
.
Highbridge Business Park
may vary with age
reports of oedema were
3 patients
skin
unit dose blisters
the
Your doctor will check
for injections
.
until your condition
( 0800 )
64 gynaecological ,
haemoglobin
reducing
is
the
that primarily
Takeda Italia Farmaceutici SpA
.
Nervous system disorders
of heart failure
of fructose intolerance
Diabetes is a
AND SIGHT OF
Abraxis BioScience
cancer before ,
you
18
anaemia
is a mixture
agents Certain medicines
clinical studies ,
to the
a
In patients
( > 99 %
be monitored closely
data
Uxbridge - Middlesex
use of Epoetin
syringes
ABILIFY is
type
: in clinical trials
, increased Gamma
In most
) )
, 22 prostate
republika
7.5 mmol/ l )
an interaction .
a
56 x 1 ,
( 4
( 0800
(
section 6.1 .
reported estimated doses
in sudden and
, Te .
metabolites
of
should be
erythropoietin
with or
see section 4.4 )
the mean
appropriate
+ 49
( normal
Maternal toxicity
observed
signs and symptoms
in patients
( see section
dated Final
x 1 tablets in
and young subjects
aripiprazole was administered concomitantly
lung
Before use : store
of the
the desired range .
,
(
After
neuropathic pain ,
.
, angiotensin converting
BRISTOL-MYERS SQUIBB BELGIUM
( 6.2 mmol/ l
your
contains sulfobutylether
11 g/ dl
rise in haemoglobin of
aripiprazole
see
from
%
Highbridge Business Park
µ : +44
pharmacokinetics of
see
Novo Allé
-
from
patients
request
2 g/ dl per
in both
treatment ,
deemed necessary in
the
aripiprazole
be
including
(
mellitus
epoetin alfa .
the human insulin molecule
In
by
30
a rapid
% and
While
352 74 60
11 g/ dl (
WITH BLUE
both
trials involving 1,228 schizophrenic
are
in patients
of one year
not
section 4.2
mentioned in section 6.6
18
8
injections are given
(
the indication increasing
Very rare -
the reach and sight
after the
epoetin alfa
, randomised , double-blind
e. g. ,
products
.
vitro findings
.
if you are
mmol/ l )
MEDICINAL PRODUCT MUST
a
act mainly
of administration ) .
cases of
section
84 ,
with
and no
of these
inhibitors of
a meal
a clear ,
or
, increased
such as
Kingdom BRISTOL-MYERS SQUIBB PHARMACEUTICALS
anorexia
metabolites are extensively
( see section
49 x 1
of
controls
controls .
( CLAS
severe manic
Cytotoxic actions of epoetin
rather than
the first
absolute
CONDITIONS OR
74 60
should be
Erythropoietin receptors
Te .
patient group
peripheral oedema
thrombotic
and 30
)
below age 18 years
( injection )
0.5 ml
if
( see
the safety of pioglitazone
.
may lead to hyperglycaemia
.
and/ or
Abseamed
doctor
per se
and adults .
whom
Posology
4.4
100 ng/ ml
to protect from moisture
a
When concomitant
of NMS
aggravation of existing
12
and completed suicide
,
.
to
and
80 % isophane insulin
%
in a blister
5.2 )
increased risk
47
Actraphane is
of
large
Road Horsham
, contact
pre-filled syringe of 0.5
prior to
blood pressure
be
tablets is
( IU )
retinopathy Long-term improved glycaemic
and
intravenous administration
6.1 .
particularly
Global Research and
Immune system disorders Uncommon
and clinically
colourless , aqueous solution
The
clinical trials ,
maximum of 30 mg
infections and
with
glucose
60
humans
( baseline 7.3
iron stores should
of
An
section
Tel
rapid
are
have
reduce the epoetin alfa
BRISTOL-MYERS SQUIBB (
this condition may
section 4.2
,
2.47 in favour of
sudden
älteren
PRODUCTS OR WASTE
.
FOR
%
taken orally once daily
Package Leaflet
50 IU/ kg
and
It
of progression of
insulin requirement .
with
and
.
0
significant change in
, with
week by the intravenous
5.9 -
, antibodies
3 times per
patients in
to be administered intravenously
.
not
measures will help
with Abseamed
the
should be
aripiprazole and
greater than 12
metabolites are
trials and
,
antihypertensive medications
(
.
4.8 ) .
a few weeks .
condition with
Global R
31 34 857 42
bottle
vitro
of 300
than
If
,
the pre-menopausal range
Abseamed
by significant intra-
fixed-dose trial
United
1 )
Actraphane
decreased blood sugar
human tumour samples
,
( 2°C - 8°C
same
in patients
precautions for use
subcutaneous
AB
200 - 300
patients
events is
schizophrenia
e.
DK-2880 Bagsværd Denmark
.
mg
hyperglycaemia ,
( e. g.
tiredness , nausea
hepatitis ,
, but not
) Aclasta
per
Before use : store
8000 international units (
see
704 71 00
.
-
taking Actos
Before use
(
OUT OF
pain Uveitis ,
blood pressure
ALT
has no
In clinical trials of
Wimblehurst
following
rimonabant
.
)
in a
, 5 and
observed for
272 16 00
, tell
alters the metabolism of
with fast-acting
Overdose
to maintain haemoglobin values
greater than 12
in both groups
patients was 12.1 %
12
per week
increased
normal
two
in whom the
either valproate or
-
( injection
21 412 6600
see section 4.4
)
monitored
.
be applied
(
patients
will help
) ,
BE STORED
up to 36
of 12
seriousness .
Renal or
KEEP OUT OF
treatment with
elective
other erythropoiesis-stimulating
and beta-sympathomimetics ,
trials
antipsychotic drugs
placebo
.
not show potential for
has
patients with diabetes
( weeks )
( see section 4.8
,
medicinal products with
4.4 -
+ 40
(
event
mean
39
and
14 g/ dl
Actraphane
:
Uncommon - Diabetic
)
+
manic
In several controlled studies
section 4.4
vitamin D
CYP2C8
fatigue Psychiatric disorders Common
60
chronic renal failure
67 55 53 50
400 mg sucrose
lithium or
epoetin alfa
epoetin alfa
toxicity
, nausea
see 6.1 .
see
treatment dose .
snack containing carbohydrates
information on
bone marrow cells
mg
aripiprazole ,
may
.
precautions
in adult and paediatric
desired haemoglobin level may
, nausea ,
of CPK
.
and
healthy elderly
of zoledronic acid
four
, each ml of
, i. e.
below
may
changes
13
combination of
tubing
cancer
decision
( DVTs ) .
( 2.5 %
tumour proliferators
difficulty
recommendations ,
ml contains 3000 international
(
g/ dl - 12
a prospective
BRISTOL-MYERS SQUIBB
D-58638
( mean difference to
) should be investigated
than
Lda Tel : +
and
more
,
IU/ kg epoetin alfa
with
.
What ABILIFY is
-
the
fibrosis of any origin
adverse events
should be
the
tablets
Nederland BRISTOL-MYERS
.
is
30 on one side
for
carbamazepine ,
Te .
t½ ) is therefore
may occur
dissolved
( human
to affect ABILIFY :
( see section 4.4
treatment with
and
.
ABILIFY solution for injection
46 25
in patients with
Hb increase
data
Insulin zur
potent
an increased
Component of a
.
Linear
insulin requirement
studies
significant effects were
is
in cancer
mean
clinical trials that
patients
(
of pioglitazone (
To
, anorexia ,
of
not
Additionally ,
6.2
Phlebotomy may be
the administration
well
is
Abseamed can be
female rats
with some medicines ,
Frequencies of
with
for aripiprazole
contains metacresol , which
24 hours after the
orodispersible tablets
clinical trials
,
Detailed information on
mmol/ l
whilst
Seizure :
Contrada Fontana
, the
and
IU/ kg 3
QT prolongation
( see section
, thyroid hormones and
56-99
1.5-2.5 hours after
in a dose range
( 8.1
.
,
study
to
mg/ day
machines
dose of
, 49 x 1
Marketing Authorisation Holder
inform your doctor
efficacy of M-II
( 6.2 -
the pharmacokinetics of
encephalopathy-like symptoms
times per week by
you
been receiving aripiprazole
0.4 ml (
per week
combination
Detailed information on
4.4
blood pressure should
:
route
water for injections
P450
the Paget s disease
with
section 5.3 ) .
this patient population
was
a potent inducer
Erythropoietin is a
IU )
safety
such as
in
after
not
of the elimination
% ; 1.0
( E218 )
44
In
( e. g.
with
.
clinical situations
post-marketing experience
the treatment of
patients with associated risk
clinical trials
Excluding finger , toe
Sími : + 354
Global R & D
Tel : + 43
over
few minutes
is especially important for
anorexia
epoetin alfa
of cytochrome
paracetamol or ibuprofen
:
, it is
the most
of
OR WASTE MATERIALS
9.5 and 11
or hyperosmolar coma
,
SQUIBB PHARMACEUTICALS
studies
and
or any
47 150 IU/ kg
300
days
of
orodispersible tablet contains 15
are mannitol
, close medical
Each orodispersible tablet
pioglitazone
and
55 53 50
,
0)1628 537 900
Hypertensive crisis with
87
constipation ,
,
once a day
but
64 gynaecological
15.7 % for
Benommenheit
patients
272 16 00
hospital
: +
In
bottle contains 5 mg
efficacy
therefore be applied .
It could be
) .
be
er Die
how the anaemia
IU/ kg 3 times
;
section 5.1 ) .
Sodium chloride
clinical judgement .
sufficiently investigated and
( 4 or more
unlikely
medically serious signs
The recommended
:
patients
3.5
corrected .
usual dose is
24
be followed
other handling
The four
and
thromboembolic
may require discontinuation of
:
:
Functional Assessment of
,
solution for injection
.
Latvij
immediately
vomiting , nausea ,
, concentrations
was the
Lilly Portugal
events
as
gliclazide
from hypoglycaemia .
in dogs
+ 36(0 )
rare
2 diabetes
the
are
131 )
anaphylactic reaction
( see section 5.2
taken in combination
or
Analogue Scale (
International
( Europe
+ 39 06
REACH
a
monoamine oxidase inhibitors (
patient
tablets are white
,
or
strenuous physical exercise may
is
40 consists of
, infection or
increase the effectiveness of
WITH BLUE
in the face
in
in HDL-C and triglycerides
sleepiness , shaking and
,
aripiprazole
maintain haemoglobin values
There
substitution of
with
76 03
of
and patients
physical
and
taken orally once daily
, 90 and
of epoetin
control decreases
this medicinal product should
chronic renal failure patients
- if
is
230
Many of these patients
.
rising by more
patients with
a few weeks
(
Abseamed
x 1 , 49
10 and
times per week
10 g/ dl
treated (
If
13
and
House Highbridge Business Park
the
approximately 25
is
, aripiprazole
should not be diluted
; 41
in
the anterior abdominal wall
Abilify can be found
of P-glycoprotein .
300
in clinical
aripiprazole ( see section
. :
0.6 ml ( 6000
the
Development Centre ( Europe
possibly protein disulfide isomerase
.
(
Effects on
in patients
epoetin alfa
CLAS )
patients
mmol/ l
inter-individual variation .
In
iron stores .
of manufacture ( recombinant
dyspepsia , vomiting
Takeda Global
, 22 prostate
Vorsicht
beta-sympathomimetics ,
was considered non-genotoxic
been
Insulin human ,
of CPK (
patient
on the total dose
MANUFACTURING AUTHORISATION
control
%
with
toxicity
included patients with or
defined by a decrease
)
lactation .
one year
clinical studies ,
control
11 g/ dl (
)
insulin it produces .
between
( Europe )
cause side effects
in
doctor
maintain haemoglobin values
of anaemia with
the
on the other
very rapid or
should be
of administration )
treatment
time
of digoxin , warfarin
days following
60 -
the treatment
the first
2.5 % ) of
isolated cases
( see section 4.6
1 , 5 and
pioglitazone concentration is unchanged
of treatment of
- 39 %
1.5-2.5
aripiprazole
mixture
Hypertensive crisis
Sodium hydroxide (
mg
and rats
5 x ULN or
Not all pack
In addition ,
the dose
Patients have
and
stopper
lon ANNEX II
total weekly dose
48
EPS including
contains The
alfa on
usual dose is 15
( see section
x 1
Any
Ireland
children
is indicated
30
tablets
between 25 and
from hypoglycaemia .
approximately 6 hours
are
, diabetes mellitus ,
should be
renal failure
that primarily
( 1
PRODUCTS OR WASTE
45
( heparin )
and
The
Rare
of
.
to protect from light
haemoglobin target range
diabetic hyperosmolar
)
.
if
The
in
recommended
, 84 , 90
pregnant
3 times per week
attempt
( see
clinical trials of
Dose adjustment
Special warnings and precautions
clinically significant
The biological
, in patients
4.8
therefore
than 2
studies
hours after
between 17 and 33
solution for injection in
consists of 20
:
section
CHILDREN
10
Any unused product
patients should
the suspension contacts the
included only
( or if
BRISTOL-MYERS SQUIBB
1
House Highbridge
is 15 mg
Patients
such as redness ,
to sudden stabbing migraine-
)
if
the incidence of
Very rare
significant
for injections Hydrochloric acid
may cause allergic reactions
international units
In
( 6.2 mmol/ l
after
In patients with
IU/ kg 3
4AE United Kingdom
g/ dl
less than 1
- 150 30 -
of
, 14 and 7
30 kg require higher
, sensory loss
and well-controlled trials of
)
The following reactions
hydrochloride ) .
Non-clinical
observed
children
all growth factors
Within 60 days of
at
23 mg )
diabetes mellitus
(
In a
,
% of
international units (
8.7 %
.
, diabetic ketoacidosis ,
7.5 mmol/ l )
in patients
.
mmol/ l
Anaemia symptoms and sequelae
potassium and
but not in
urticaria )
- If
,
Oral
patients
or
du
of Cmax
iron stores .
you
mmol/ l
( FINLAND )
needle
Maintenance dose between
tablets :
3 ml
red blood cell
( see section
disorders
of
The potentially medically
) .
.
.
manic symptoms
3.0 % with
55
the
to 6 weeks
,
aripiprazole
the tablet formulation is
( see section
the medicinal product has
Special precautions for
pre-filled syringe
or any of the
repeated oral
been reported
( see section
controlled as necessary .
not
, a potent inducer
can
suspension contacts the
and
aripiprazole ,
and danazol
.
negative
standard genotoxicity tests
need to
or
can
in
and
)
10 % , and
6.1 ) .
12
in pregnant
in subjects
renal impairment
are breast-feeding
1 60
within
+44 ( 0)20 3116
and
,
.
achieved
brain function
alfa
9000 IU ) of
Cmax
The initial dose
,
aripiprazole
and
between 10 and
human
or less
meal or unplanned
and other
to
effect of
Aripiprazole is well
you
Hyperglycaemia and Diabetes
In
10 and 12
with aripiprazole
Population pharmacokinetic analysis
172 breast
the
BRISTOL-MYERS SQUIBB AB Tel
(
section 5.1 )
blood
6
18 years of age
4.5 ) .
clinical studies ,
,
fatal
of anaemic patients
hydrochloride
repair
than 1
43 ( 1 )
men
section 4.8 ) .
room temperature
0.6 ml
MEDICINAL PRODUCT
with solid tumours
before
per
alfa
56
years ; the average
elective
) ,
placebo
or
ACOMPLIA were
be considered (
use
.
a different dose
below 30°C )
and
potassium in
,
18 , or
Actraphane 30 consists of
In a
patients
.
treatment
with epoetin alfa
If you are
Portugal
The
is 32,000 to 40,000
)
Cmax of dehydro-aripiprazole
+33 ( 0)1
epoetin alfa
patients
37 , D-58638
- decreased locoregional control
endpoint was 5.8 for
The following reactions
pioglitazone
section 4.8
After
alfa
contains 15mg of pioglitazone
mg
tumours
your doctor , pharmacist
)
scale
.
36(0
aripiprazole
- a sulphonylurea ,
60 -
is 5 mg
is estimated
l
patients
below
)
The
and its metabolites
3 times per week
The treatment
statins , fibrates
+ 43
of anhydrous
)
swelling and inflammation .
clinical trials of
the
14 g/ dl
,
warnings and precautions
%
Europe ) , Storbritannia
injection :
the
your
patients
+ 40 ( 0)21
,
not be used
Business
,
standard
considered
in
( 6.2 - 7.5
.
snack containing carbohydrates
IU ) of
contain 1 ml
siehe auch Abschnitt
or hepatic impairment
dose of
emergency procedures
Takeda
) ,
reaction
If
,
.
a
Excretion
adequate and
patients
packed cell volume
Limited p rst
taken in combination
solution for injection in
Aclasta
maintain haemoglobin
,
7000 international
patients
1 pre-filled syringe
should not exceed 200
.
.
:
(
reactions
dehydrogenation
pharmacist
357 patients
prescribed .
The terminal half-life
to reproduction
the treatment of
The
should
Insulin suspensions should
starting dose for ABILIFY
( haematocrit of 33
mmol/ l )
g/ dl
abdominal and stomach discomfort
% ) .
metabolites
it may
accepted .
However , since cyclosporin
after
insufficiency
doctor
,
neuropathy
should be
KG ,
300
Aclasta
,
blood pressure
and ,
post-menopausal
Global Research and
dyspepsia (
of in accordance with
leaflet was last
(
, D-58638
to be
with fast-acting
& D
increased
In
clinically significant
times
epoetin alfa
6
)
hyperglycaemia
or less duration ,
GIVEN
, 56 , 84
regard to meals
)
aripiprazole
daily
.
increased Aspartate Aminotransferase
mmol/ l ) to
tablets
60
.
be presented
4.5 Interaction with
difficult .
humans
SCIENTIFIC
be followed .
formation of erythrocytes from
sulphonylurea
immediately if
aripiprazole
the metabolism of other
( see section
blurred vision .
needle should be
a
thromboembolic
12
In clinical trials and
by positron
higher
THAT THE
hyporeflexia ,
by 107 % ,
product at 52-weeks was
skin
sodium hydroxide
1.25
dose dependent ; leukopenia
protein binding
- 6.8
section 5.3
Neuroleptic Malignant Syndrome (
, headache , dysgeusia
64
.
, long-acting insulin
placebo group
and
pharmacist
have
with
diabetes mellitus ,
Royaume-Uni Tél/ Tel :
MINIMUM PARTICULARS TO APPEAR
34 %
55
+ 36(0 )
medicine
international units ( IU
Eye disorders
of
both
( 1.25
98 tablets .
.
1 orodispersible tablets
.
10
.
AB Tel : +
favour of
All
Takeda
scheduled for major elective
cases
conventional studies of
Epoetin
354 535 7000
injection of the
( dextromethorphan
10 and 12
pioglitazone
be used .
the reach
maintain haemoglobin
Business Park , Oxford
is not
ABILIFY 15 mg tablets
occurs
- 7.5
and approximately 60
physicians
with chronic
more
,
with
Aclasta
or
no relevant effect
completed suicide ( see
dose should
pharmacokinetic characteristics
.
(
epoetin alfa is very
effectiveness of
NAME OF THE MEDICINAL
renal function
glycaemic
insulin
source insulin
year
of death
potent CYP3A4 inhibitors with
cerebrovascular adverse
of 10 g/ dl
,
)
schizophrenia and
very
Tél/ Tel : +
to dispose of
have polycystic ovary
of peripheral neuropathy to
each day
Interaction with receptors other
ABILIFY
of
of one year or
Only
with
a potent inducer
the
difficulty
that
inform
patients
g/ dl ( 7.5
erythropoietin is 32,000 to
pH adjustment
agitation ,
in isolated
solid tumours
: nausea
loss of consciousness and
will use
CYP3A4 and
of the
of NMS are hyperpyrexia
the
% dissolved
section 5.3 ) .
hepatic impairment on
and
48 Dysphagia : oesophageal
, pruritus , or
:
in patients
who have no obvious
( NPH )
a negative impact on
.
with
Long-term improved
or very rapid or
of excipients ,
a
150 IU/ kg
50 %
3
(
clinical
12
received
, 28
Nederland BRISTOL-MYERS
: fatigue Psychiatric
Rimonabant 20
potassium and
during pregnancy
order to protect from
weeks
5 hours
above 25°C
%
as white ,
receive appropriate training
with epoetin
)
dose is 9.75 mg
adequate and well-controlled
of one year
used in combination with
placebo
or
of daily
injection site
BY WEIGHT , BY
recommended total weekly dose
per
24 hours
( below 25°C )
taken
that
to
.
)
use
A
34
, D-58638
( less
( 6.2 -
4.8 and
.
mg
syringes contain 0.8 ml
,
(
cannot be excluded .
renal failure
8 704
(
the
clinical
: soluble
in subjects with
the
)
if
( injection )
)
multiple medicinal
of ketoconazole or
and approximately 20 %
) .
In schizophrenia
to
section 4.4 ) .
pharmacist .
blood pressure
below 12 g/ dl
of aripiprazole ,
The aripiprazole AUC
, uncommon
14 g/ dl
angioedema and
doctor or pharmacist
patients who received risedronate
) or coma ,
of aripiprazole and
severe
Holdings Limited Eesti
because
67
the
chronic liver disease .
, the dosage of
Starting dose of
this leaflet carefully
with chronic renal failure
and
: the
insulin it produces
increased insulin resistance
are usually
Although
increase
be monitored
overall survival and
one side .
alfa is very wide
Following dosing for a
growth factor
14 ,
pink
: +
, insulin requirements
49 x 1
8°C ) .
Approximately one third of
Kontrazeptivums mit einer
hypocalcaemia , hypoglycaemia ,
% .
clinical trials and
life parameters on
Business Park ,
pyrexia
not
,
to be administered intravenously
machines
wastewater or
product must not be
As with
7.5 mmol/
been observed .
manic or mixed episode
a
, dizziness
33 ( 0)1 47
.
,
even several weeks
to
,
Hyperglycaemia and Diabetes
,
pharmacist .
and/ or
WC2B 4AE , United
) .
weeks
condition
bone Aclasta was
by
and behaviour and emotional
see section
solution for injection in
but
,
.
1.25
the
studies
and adults .
Although in
received
+
Ireland BRISTOL-MYERS SQUIBB
revealed
observed
.
mild and transient
epoetin
28 tablets
-
.
ABILIFY
:
) OF
and
may be
Creatine Phosphokinase
"
ABILIFY
dysgeusia , oesophagitis
placebo group .
28 x 1
is
food
6.1 .
in
continuing to
In clinical trials
for 2.
)
.
Before
Epoetin alfa
ACOMPLIA
is achieved
( see
or
,
0 1 year )
and
.
studies
Abseamed should be
, sudden
.
puberty or due to
is
of
.
orodispersible tablets 28
epoetin alfa
and
in the jaw .
The maximum dose should
300
:
( see
47 % .
be followed
patient
a
, read
and
Tlf : + 47
not
polycythaemic mice )
mouse spleen cell
OR WASTE
No
.
.
Treatment
erythropoiesis-stimulating agents
44
WC2B
are
.
Tlf :
with two
)
.
( 0)1628 537 900
PIOGLITAZONE IN COMBINATION
28 x
.
06
)
8 704 71 00
and extrapyramidal
, aripiprazole ,
.
than 2 g/ dl
other medicines Please
can
aripiprazole
a negative impact
,
growth hormone and danazol
greater sensitivity of this
13
fractures was
your doctor
patients
epoetin
minutes
)
by
receiving non-platinum
for the occurrence
glycine ,
(
human , rDNA (
Your doctor
as measured
of which were
NORWAY LTD Tlf :
aripiprazole
and
reported
3 sites of metastases
treatment with
are active
frequency
,
influence
.
The use of
1
( 0)1 580
, placebo-controlled
If
- if the
93 Patients
(
and 2.47 in favour
or
higher than the
section 6.1 ) .
mmol/ l )
The absolute oral
half-life of
is therefore
is not recommended .
535 7000
treated
8°C
less than 1
should be
Cmax of dehydro-aripiprazole ,
intervals
1 tablets
used
, abnormal
of the
- 14
possible warning signal .
, use
per
day
see
human ,
Particular attention should
Special warnings and
your dose of
LTD Tel : +
study
Erythropoietin receptors may
in section
may be
.
sustained haemoglobin exceeds
Sodium chloride Glycine
the active substance pioglitazone
the desired range .
, vitamin B12
Saccharomyces cerevisiae )
blood pressure or
ml
It
sealed in
Abseamed has
Immune system disorders
The
the patient on
glycaemic
(
cancer patients
,
during pregnancy
- Produtos Farmacêuticos
haloperidol
(
14 x 1 tablets
to target a haemoglobin
than
Mellitus : hyperglycaemia ,
low blood
leaflet
and
a gradation
5.1
in clinical
the greater sensitivity
33 ( 0)810 410
you know how
1 ,
greater sensitivity of this
syringes contain 0.5
the
programme , the
.
or
values
lacrimation , blurred vision
rather than
insulin
: +
mg Aclasta
with haematological malignancies (
Sími
sufficiently investigated and
dose .
to
cases
syndrome
Cardiovascular
3 times
recombinant DNA technology in
Pharma
side effects
of Actraphane
pioglitazone there was
and sight of children
of
The
patient above and
Frequencies of
Distribution
other handling
in
THE
recommended
reduction of
.
observed
not
and
The
occur .
,
)
contains
diabetic
excipients , see section
the desired range .
to achieve androgen
PRCA
of 12 - 14
BRISTOL-MYERS SQUIBB BELGIUM
aripiprazole
residual
other medicinal products :
and Cmax
4.4
with an apparent volume
( see section 5.1
Cmax of dehydro-aripiprazole ,
the treatment of
week by
episcleritis , iritis
% and
density
6.1 .
danazol .
at the
and
infusion
of the
in osteoporosis ,
( 2°C -
been observed .
CYP2D6
of
: extrapyramidal disorder ,
it
a lesser degree
g/ dl
mixture of dissolved
be
a manic
30 kg
a
clinical trials and
ischaemic
0.035 mg of anhydrous
recombinant human
FOR
programme , the
of the
per se
for disposal and
7.5 mmol/ l
or the
of the bone
than 1
orodispersible tablet is bioequivalent
with your doctor
France
In
(
Vantas is sufficiently
Human
The syringes contain
1
sodium chloride
(
Do not take
with
eye
ability
.
olanzapine-treated
water
and dehydro-aripiprazole ,
erythropoietin
is based
.
aripiprazole
trials ,
2.5 % ) of
alfa in adult patients
combination
24 hours after
epoetin alfa
use
.
Actos are visual disturbance
.
active
see section 4.4 )
+47 23
machines
permitted recovery from the
effect of
The most common
)
.
position , or
well
administration of epoetin alfa
, IF
when
patients with these
did not
.
must not be
.
and isophane insulin 90
( see
complications
i. e.
has been
precautions to
,
therapy .
solution for injection
route ,
supervision and monitoring should
of 12
(
7 )
allergic reaction (
Puh/ Tel :
in
with this
Syringes
between 10 and 12
or lithium concentrations .
has
with
.
was last
disordered
as soon as
4.4 and
) .
D Centre (
epoetin alfa is a
Interactions
the
mg
.
(
migraine-like
LTD
.
comparable to
per month or the
Europe
sites
1
260 lung ,
2.47 in
A
ALT )
14 ,
treated
OUT OF THE REACH
treated
after the
except
days
treatment
on
is available
mainly in faeces (
g/ dl ( 1.25
enzyme (
statins
)
95
should be
or pharmacist .
ventricular
CONDITIONS
16 00
severe manic
rDNA ( produced by
epoetin alfa
The
quinidine occurs .
ba , d.
normal and anaemic
in
g/ dl (
in combination with insulin
or during lactation
a
( 1 ) 524
) .
vomiting , an
serum creatinine level
pain , itching ,
95 % CI :
your dose
products should be disposed
a maximum volume of
should be considered
means that
red
If
per
When weak inhibitors
in
doctor immediately
abdominal wall
.
Common : somnolence
, nausea
epoetin alfa is a
g/ dl (
(
all patients
in approximately
(
pre-filled syringe
hypoactivity
aminoglycosides
events
(
, sudden unexplained
.
, sodium citrate
x 1
12
, insulin ( human
Actos
Oxford Road Uxbridge
,
unregelmäßiger Puls oder
that
use
,
%
CONDITIONS OR
33 ( 0)810
:
Middlesex UB8 1HU
8.1 mmol/ l )
consists of
and
is 15
GmbH & Co KG
autologous
with a manic or
, treatment with
aripiprazole
Smoking status
)
bone
haloperidol-controlled trial
.
paclitaxel
In a
1.25
blood pressure
used
ra Tablet core :
loss of consciousness
In a study
medicines known to
dihydrogen
) The
)
THE IMMEDIATE PACKAGE
911
the gluteal region
no adequate and
of 10
see also section 5.2
less than 65
treated
.
section 4.4 ) .
Denmark
contain lactose monohydrate
mmol/ l )
in
6.1 .
first
in the
and patients
the plasma concentration
few minutes
that epoetin alfa
be
per month
any origin .
of
Actraphane 30 Penfill 100
fatigue Psychiatric disorders
recommended ( or if
Tel : + 39
sie
have also occurred in
anaphylactic reaction/ shock
43
&
in
Abilify experience
significant
CYP2D6 inhibitor
with epoetin alfa
in the
,
you
The four carbohydrate chains
doctor
THE WORDS FOR
other medicinal products
of the
significant
.
isophane insulin 90
hours after
formation of erythrocytes
Before use :
,
.
)
Co KG Kuhloweg 37
House Highbridge
half-life
Aspartame ( E951 )
34 857 42
infusion will
iron stores
in order to protect
20
The
less than 1
Novartis
four
.
, especially
ABILIFY 30
stopper
molecule
or
cerebrovascular adverse
important in those
sudden unexplained death
receiving non-platinum
60
Farmaceutici SpA
syringes
Tel
Peripheral neuropathy
mg/ day
times per week by
see section
, increased risk
NPH
dose
(
The
PRODUCTS , IF APPROPRIATE
pectoris , increased
are pregnant or
speech disorder ,
five large controlled studies
( see section 5.2
,
,
39
with normal
REGARDING SUPPLY OR
patients ) .
.
3.0 %
hyperglycaemia and
and
these trials , a
is indicated for
are not sufficient
13
4.4
300 IU/ kg 3
) and 802
accumulation
Any
revealed no
Changes in
and
ABILIFY may increase the
weight gain
of overdose
packed cell volume .
alfa
23 lung , 22
may
( not
the
or
ON
The daily
monitored
aripiprazole and
make
300
with epoetin alfa
BE STORED
as
younger
receiving non-platinum
defined by a decrease
than children
The safety
-
18 84 00
See section 4.4
:
.
Actos
products to affect
0)21 272
. They include thirst
Neuroleptic Malignant Syndrome
( see section
)
, anorexia , hyponatremia
ml contains 100
be used .
shown
,
in hip fracture ,
than 2 g/ dl
and
enzymes .
Actraphane 30 consists of
.
Takeda Global
a growth factor
to reliably
er
) were 2 5
.
The
symptoms
elderly patients
.
,
this patient group .
increased
RESTRICTIONS WITH
phosphate dihydrate ,
pH adjustment )
1
These trials included patients
frequency grouping , undesirable
.
: orthostatic hypotension*
section
Cancer Therapy- Anaemia
172 breast , 64
effectively
patients
)
PRODUCT AND ROUTE(S )
the
)
, 28
, and
mixture of dissolved insulin
Hb between 10
between 25 and
insulin
maintaining the clinical
section 6.1 ) .
this
deep vein thrombosis
of the value )
rate
16
%
10 and 12
ANIMAL TREATMENT ONLY AND
KG
DAYS OF
This medicinal product contains
.
50
508 men were randomised
Hyperglycaemia and Diabetes
section 5.2 ) .
( behandelte
the pharmacokinetics
The
.
preventing recurrence of manic
4 hours in
or ASL/
analogues for
) is
the medicinal product
should be
,
whilst the relative
other
infusion of Aclasta
, growth hormone
,
nervousness ; suicide attempt
,
12 - 14
Uncommon - Peripheral neuropathy
with epoetin alfa
of recombinant human
first
(
35
15mg tablets
mmol/ l )
Less than
and protein intake .
of iron
2C9
200 - 300
on the
.
g/ dl (
section 6.1 .
, the
mg
in
section
ability
APPROPRIATE
and clinically
- if you
)
not
and its metabolites
In patients with
42 %
is therefore recommended .
human
with
( below 30°C )
should be
mice
patients
have frequent
of the
of
is reported
The AUC and
( days 21 ,
( haematocrit
DK-2880
.
concomitantly
for signs and symptoms
g/ dl
Manic
44
erythropoiesis stimulating agents (
pulse
(
Aclasta
unplanned ,
mg
oral
alfa
maximum
Kingdom BRISTOL-MYERS
haemoglobin ( 1
Similarly , for dehydro-aripiprazole
98 x
Eesti Eli
10
, with
In patients with
enterocytes may be
different time zones
Germany
is
( see section 4.4
patients
Aclasta
haemoglobin
Abseamed has no influence
immediately
23 lung ,
8°C )
in a dose range
therapy
nausea ,
Correction for
treated with pioglitazone
) or
the intravenous
beta-sympathomimetics ,
.
.
44
Most reactions are
50 IU/ kg 2
during treatment with
well-controlled
- 150
) in
Linear Analogue Scale
for males ) .
of 14
controls
disposed of via
dysgeusia ,
tablets in
, for dehydro-aripiprazole the
how
statins , fibrates )
last approved on
.
patients who
15mg tablets with
.
;
In
not
* This
.
may
your doctor .
and
site
reduced with
please see
or
.
heart beat
%
,
Actraphane NovoLet
Saccharomyces
If the
)
ABILIFY .
with placebo .
.
should be
6.1 .
( 7.5
significant effects were
the
DK-2880
reduction of manic
,
well-controlled trials of aripiprazole
( 0)21 272
(
female and male
The metabolism of
:
patients )
When
(
Assessment of
Iron supplementation
patients in
very wide .
3 times
manic or
that
and
Aripiprazole
,
.
desired haemoglobin level may
condition may also
As with
than
pioglitazone
should be
84 AND
, the risk of
given area
(
the EPAR )
) , increased Gamma
with aripiprazole
taking ABILIFY .
studies
with aripiprazole and 3.0
or without
.
years
aripiprazole dose
machines
during
Hb
not be used
and
)
)
.
1 ml ( 10
peripheral
pH adjustment )
section
- 7.5 mmol/ l
Aripiprazole also exhibited
,
, increased Gamma
24 hours after the
the pancreas
,
doctor
years
)
prescription (
you
oral solution
insulin .
Units ( IU )
) in women with
: orthostatic hypotension*
THE
with chronic
the abdominal wall
l )
of rimonabant has not
to sudden
in routine
-
initial dose
,
section
+
may
for pH-adjustment
is
have frequent
and
isophane insulin 60
insulin and isophane (
, the incidence
for
In addition
recurrence of manic
, insomnia
direct-
50
CYP2D6
and death in utero
(
vomiting diarrhoea softened stools
Adult patients with
+ 358 ( 0)9
contains
or
Saccharomyces cerevisiae
g/ dl
month or the
repeated
(
dose of 600
6.8
: +49 911 273
or insufficient
renal failure
30 months
If you need
) of EPS
a result
for
machines
1 g/ dl
with insulin
300 IU .
,
and N-dealkylation .
with
of
of which were
machines
)
by the intravenous route
or stroke
doses
extensive extravascular distribution
1
paediatric and
increased
peripheral neuropathy at any
oral bioavailability of the
.
at increased risk of
of insulin
clinical trials , an
comparable
omeprazole )
be followed .
factors
of excipients ,
epoetin
trials , rare
In
complications
epoetin
mellitus ( see
other causes of anaemia
be used in
Adipositas ist die
,
for pH-adjustment )
, the incidence
) .
KEEP OUT OF THE
The
and
section 6.1 ) .
kg BW
trials in which
,
9
risk of cross-reaction .
vitro
patients with the
)
other
the same
cancer
a
male and
of
PRCA
a
Ísland
MUST BE STORED
United Kingdom
Do not take
Bei Patienten mit einer
clinically
IU/ kg 3
or
are
disposed of via
administration of
12
metformin is contraindicated
taking this
potentially toxic
per orodispersible tablet
of
daily dose should
, diabetes mellitus
is therefore
in
NovoLet
the
unchanged
DK-2880 Bagsværd Denmark
( FINLAND )
with
revealed no medically
and
of the art
In CYP2D6
international units
and bone marrow
- In
for thromboembolic
dextromethorphan/ 3-methoxymorphinan ratio )
.
metformin , in
.
All other
1800 ml .
)
aggravation of existing hypertension
in order to
1 ml ( 2000
and
Common :
.
Arzneimittel Pütter
occurs .
13 % (
Common : blurred
) or
year
Farmaceutici
storage conditions .
Patients
55 53
AUC
and
section 4.4
epoetin
Elevations of
should be considered
notable
Hunton House Highbridge Business
( 30
Each
diabetes mellitus (
may be harmful
the
blood cell production
the entire
including those with
erythrocytes from precursors
should
insulin and isophane (
and yellow ,
blood , Abseamed should
is difficult
patients with
is
; 1.0
( see section
and
,
tablets contain lactose monohydrate
between 1.25
from light .
data on the
+ 43
In CYP2D6
Effect on
patients
with fast-acting ,
following
the gluteal region
,
infusion , or
patients ,
( 8000
A cardiovascular outcome study
of epoetin alfa on
Unit ) corresponds to
polypropylene child-resistant closure
thigh or
dosage
less than 1
0.6
, typically
) per
Abraxane
trials
IU ) of solution
zu entnehmen .
including
myocardial infarction or stroke
aripiprazole
may
Date
the intravenous
( MAOI
1 month after
trials included patients
to maintain haemoglobin
, may
of ABILIFY
or 480 ml per
CYP2D6 and CYP3A4
solution for injection
the
aripiprazole
g/ dl
mmol/ l
a
SQUIBB BV Tel
of
cases of seizure
syringes contain 1
glucose-galactose malabsorption or
57
three
oral
solution
a manic or
AUC
the
.
the sustained haemoglobin exceeds
, glucocorticoids ,
%
D Centre
men .
.
insulin sensitivity
patients with
between 17 and 33
usually
limited experience
Centre ( Europe )
However , elevated creatine
Highbridge Business Park
the
patients with
%
of greater than 12
Laboratoires
pH adjustment
combination of
Mildly anaemic
) .
)
mg/ m2 ) .
:
similar
with
mmol/ l )
or
)
These measures
large
also carried out
Treatment
( see section 5.1
.
is
the intravenous route
studies in pregnant women
30
see sections
rare (
30 mg/ day
increased
West Sussex
the
One IU ( International
appreciable affinity
weeks
4 hours
7.5 mmol/ l )
not
EPS was
31.0
MEDICINAL PRODUCT
-
22.5 8.1 41.7
by the intravenous
of
)
risk
aripiprazole should
monkeys
is a mixture
2 g/ dl (
solution
to reduce
of the
.
dosage adjustment
variation .
between 1.25
of
during and
, ketoacidosis
,
In a
is
and anaemic rats ,
intentional
thrombosis ( DVTs )
)
symptoms
Anaemia symptoms and sequelae
For patients who
type 2 diabetes
including the gastrointestinal
50 ,
of 10 g/ dl
g/ dl ( 1.25
taking
VOLUME OR BY UNIT
when pioglitazone was
.
it may
thromboembolic events
clinical trials of
solid tumours (
4.4 -
on
MEDICINAL PRODUCT
specifically
5026
d
and
,
Croscarmellose
for major
% ) .
significant
Water for injections
omeprazole
.
or discontinuation of treatment
occurring undesirable effect
and 12 g/ dl
(
However , you should
Neuroleptic
haemoglobin ( 1
operate machinery
addition
and
an
a similar pattern of
with epoetin alfa
but not
Park
effect of insulin
solution for injection in
) or coma
Kingdom
other symptoms
Abilify
starting dose for ABILIFY
IU/ kg
PARTICULARS
has been proposed
42 trials and 8167
) .
in
trials of
)
,
jaundice ,
blood donation procedure
LTD Tlf : +
Erythropoietin receptors may
in
in vitro .
Road Uxbridge - Middlesex
of controls .
Elevations of CPK
, hyperglycaemia and
less than
medically important signs and
Effects on
.
with a
20 % and
)
and
of children
did not
be necessary
6.1 .
House Highbridge
itching
doctor or pharmacist
of CYP3A4
98
or
Road Uxbridge
with epoetin
followed by a
vision Gastrointestinal disorders
,
Each tablet contains
in
week by
less
epoetin alfa
treatment
been established
cases of
There is no accumulation
-
medicinal product contains
30 mg
" on one side
patients
in clinical
of
All
and completed suicide (
VOLUME OR BY UNIT
maximum
for cerebrovascular adverse events
with these characteristics
and extrapyramidal
impact
oedema .
becomes
(
in
of these patients
daily .
aripiprazole in
2°C -
the
% with placebo
100
7.5 mmol/ l
per dose
valproate or lithium
have the following causes
these patients
in
events
different dose .
The local safety
The
Diabetic
bottle - 100 ml
clinical
Centre (
without
have an
OR
mg/ m2 , paclitaxel
)
)
solution
150
Analogue Scale ( CLAS
of
4
isolated patients with
Correction for
are
For any information
immediately if
Abilify
stabbing migraine-
patients
osteoclast-mediated bone resorption
.
,
IU/ kg 3 times
renal anaemia
If
dehydro-aripiprazole increased by 77
In
or diuretics
is especially
greater than 12
a comprehensive battery of
cerebrovascular adverse
manic symptoms had already
leaflet
treatment .
in a refrigerator
diuretics
should be rotated
- if you are
by a decrease
in women with
lithium or
must not be
units .
of
study included only 3
meal
Weight gain has
AUTHORISATION HOLDERS
no significant effect
terminal
with
evaluated
with
15.0 , 19.3 ]
prescribed dose when concomitant
)
you are pregnant
(
) in
Appropriate therapy such
de pointes
clinical fractures was
ABILIFY
did
, injection route
and drink the
section 4.4 -
If
manufacture ( recombinant
this medicinal product should
metabolites
Lda Tel : +
the pipette
In cancer patients
The potentially
BE STORED OUT OF
IU/ kg/ day .
pioglitazone
experienced the development
trials
or
a
SpA Tel :
x 1
The
, vomiting , nausea
risk of pregnancy
evidence of clinically significant
40 (
- United Kingdom
the levels remain the
g/ dl ( 0.62
is therefore recommended
800 ) 749
mg
( 7.5 mmol/ l
grade
or
haemoglobin
should not be
possibility of multiple medicinal
8.7 % for
535 7000
unlikely to
dyskinesia
consists of 165
should be
orodispersible tablets
pharmacokinetic characteristics of
.
than 2
,
of
findings is
4 or
The
study
clinical fractures
15
CYP2D6 (
insulin
doctor
1.7 %
aripiprazole treated patients
(
EPS was
increased risk
given subcutaneously 3
multiply
MINIMUM PARTICULARS
.
in
of aripiprazole .
mg
, 22
effective
2 hours
and adult patients
, eye
haemoglobin of
In
30 tablets
CONTENTS
ventricular arrhythmias ,
in the
in
A sustained haemoglobin level
information on the
185 MINIMUM PARTICULARS TO
, anxious
)
than you
) should not
be consistent among men
.
.
or
,
is
, Oxford Road Uxbridge
g/ dl
12
( MAOI ) ,
12 g/ dl (
severe neutropenia or
was the same
controls
g/ dl
overdose with aripiprazole
) .
experiencing potentially clinically
symptomatic
)
ml and a
of
: +
the haemoglobin target range
hydrolysis ) sites
%
and 3.0
7.9 % for
patients with
alfa
in
the
months when stored between
times per week .
doctor
35
1.3 ml
of excipients , see
)
human
rate
below 30°C )
For
are transitory
4.4
of Aclasta
common
and
week by
different time zones
and approximately
symptoms reported
and
patient
29 % of the
The
The potentially medically
and
5000 international units
patients
elevated creatine phosphokinase
starting
dose adjustment is necessary
,
,
who
These studies have shown
and extent of
cases
investigate
solution .
the
with a
000
(
of aripiprazole
significant
Ask your doctor
therapy
from hypoglycaemia .
- Middlesex UB8 1HU
the nearest
with
Bipolar I Disorder
and
BOX )
magnesium stearate
and 98 film-coated tablets
a
corresponding to
.
13
56 , 84
except in
sections 4.3
g/ dl ( 1.25
Co
in
(
) shortly
Pioglitazone tablets are
24
planning to become pregnant
.
in urine
(
but
( see section 5.2
TO BE IMPLEMENTED BY
relevant effect on
&
tablets 49 x 1
.
of lorazepam
Analogue Scale ( CLAS
evident ischaemic heart
, the
,
United
epoetin alfa
Overall survival
than
, treatment of
- 14 g/ dl
aripiprazole
with
injection
with oral aripiprazole
) AND BOTTLE
g/ dl
not show potential for
recommended .
receptors on
on
when treating your diabetes
controlled
section 4.4 ) .
with
of EPS
discontinuation of treatment
)
and
on the
vitro
myocardial infarction and
prior to
increase 40,000/ µl or
take
, increased risk of
increased
In patients
see section 5.1
n = 132 )
obesity in
in order to
patients
Patients who
and
controlled studies
Paget s disease
with consideration for
contains 3
intervals
patients
Hunton House
Hunton House Highbridge Business
placebo-controlled studies
35
diabetes
intensify and prolong the
In patients with
lead to hypoglycaemia
12
and
, the
ready for use
one
see section 4.4
treatment ,
3 weeks
The pharmacokinetic characteristics of
at the desired level
with
( mean age :
myoglobinuria (
hours
, or 13
be marketed
of anaemia and
, in some
see section 4.2
maximum volume of 1
tablets ,
)
) .
.
lower the blood pressure
greater than
comparable
354 535 7000
part of the
:
Adult
Ireland BRISTOL-MYERS SQUIBB PHARMACEUTICALS
aripiprazole
, constipation ,
: + 44
Usual maintenance dose 75
the granting of
of progression of diabetic
Suomi/
:
( E 320 )
or
blood pressure
see
in
and a
: + 33
8,000
of
whether or not there
In a
8.1 mmol/ l
of epoetin alfa
is 15 mg
result of hypoglycaemia .
all timepoints
patients
,
not greater than
your
of
hypocalcaemia
, swelling
.
,
epoetin
The tablets
.
The tablets
of CYP3A4 ,
in
.
g/ dl
tachycardia , nausea
aripiprazole and
or tense .
& Co KG ,
. emea
Eliminationshalbwertszeit wegen des
elderly patients with
dextromethorphan
Takeda Global R
In a clinical trial
with epoetin
is difficult
oral iron substitution of
such as
should be
patient
( see
are round
with
for
transient
less
you
should be
87 % .
The possibility
below 12
more than 2
adolescents has not
g/ dl (
data
your doctor or
placebo , or were
epoetin alfa
The
see sections 4.8
treatment
g/ dl
shown no
, pulmonary
the abdominal wall
prevention of a new
ready to use
alfa
the
IU/ kg
eye pain Uveitis ,
important signs and
urticaria )
.
should be investigated .
is therefore
1 g/ dl
recent low-trauma
.
.
patients
safety
another ( see
monkeys after repeated
GmbH &
section 4.5 )
.
renal impairment :
1HU - United Kingdom
notify
may increase the effect
in the bile
may
, WC2B 4AE ,
doctor
with aripiprazole and
.
alfa
plasma
) .
30 kg and adults
) .
thrombosis , arterial
mg once
of greater than
under 30
rare cases
immediately if
initial dose is 150
0.5
8,000
needle should be
have
Centre ( Europe )
causes of anaemia
. They include thirst
combination
three
of
benefit
the effect
not
physical
Aripiprazole exhibited
between
SQUIBB NORWAY LTD Tlf
In several controlled studies
260
and/ or
continuing surveillance of
in children
6.1 )
, please tell
less
dose is 15 mg
defined by a decrease
EPS including
allergic reaction (
diabetes mellitus
150
alfa and other
of 12 - 14
( see
in two
)
,
type
Centre
for
.
, cerebrovascular
contains
pyrexia )
patients was 12.1
if
more
% ) of
may
subcutaneous use of
-
Inadequate
also looked at
meal or unplanned ,
6.1
section 4.4 ) .
and 5HT2a receptors and
intermediate-acting combined
the aripiprazole dose
diabetes
mg has
If you
Diabetes
44 (
tumours ,
inhibitors
vials are for use
events
(
receptors on
(
Pioglitazone
per
NSAIDs
was
Park , Oxford
2°C - 8°C
of
patients
ABILIFY
or
packed cell volume .
, salivary hypersecretion Vascular
in
patients
.
32 2 352
large
the incidence of
.
two
) AB Puh/ Tel
the incidence of
) to 12
Most
hyperglycaemia
and aspiration have been
angina pectoris , increased
be
NPH )
or mixed episode of
rimonabant
of
with
Approximately one third
potent CYP3A4
AUC and Cmax of
father
The procedure for reconstitution
is
g/ dl
water and
to
During
efficacy variable
pulmonary embolism
with or without
haemoglobin
anschließende biliäre
,
be used
)
(
suspension has a pH
adult patients scheduled
blood pressure
The following
MUST
is
and
GmbH Tel .
four weeks
placebo
are
patients participating in
be discontinued immediately .
units ( IU )
dehydro-aripiprazole
14 g/ dl
after
12 g/ dl (
(
1 g/ dl
2°C - 8°C
.
is very rare (
residual
pharmacokinetic
insulin
NMS
in
of akathisia
the
the placebo group
when
observed
in strength ,
for pH-adjustment
a
.
.
10 Patients
16.8
clinical
years of age
appreciable affinity for
5HT2a receptors .
be
transient
Protamine sulphate Water
was
Eye disorders Common
0 )
no information on the
.
15
( see
dyskinesia
dosage or
)
Units ( IU )
local requirements
placebo
.
cytochrome P450
( normal and
91
50 IU/ kg 2
dextromethorphan/ 3-methoxymorphinan ratio
to aripiprazole tablets ,
pregnant women .
no
to
with
subcutaneous injection
, take the
150 30 -
patient
Epoetin
for
when
, tremor , dizziness
patients
It is
No
in
1 pre-filled syringe of
( see section 4.5
ACTRAPHANE
patients with severe renal
is
a
If accidental eye contact
see section
site conditions
20
dose of
(
been
than in those with
with
, thiazides ,
vomiting
Peripheral
, akathisia
inter-individual variation
2C19
a
advised
discontinuation of treatment
is between 75
Portugal
pH adjustment
.
is based only on
, polycythaemic mice
delayed )
entire dose
If you
fatigue Psychiatric disorders Common
12 -
glycaemic control may be
international units ( IU
outer
) increased linearly
A gastric
.
If any of the
dose
Novo Nordisk
clinical
solid tumours (
:
for
Tel . + 49
OUT OF THE REACH
study
impact
micrograms epoetin
levels of 80 to
included
diabetes mellitus ,
disposal and
In particular , no
7,736
allergic reaction
transient ischaemic attacks ,
.
are
pioglitazone with
.
,
used
amidohydrolase ( predominantly
you
In
sections 4.8 and
section 4.4
Abraxane is
section 4.2 Treatment
retinopathy
surgery , and
not
well-controlled studies in
.
, with
Die
,
2 352 74
( 1.3
to zero and
skin
glucocorticoids ,
consists of
) in
surface
rapid control
months ( 300
dose
given
are
what it is used
in combination with
% )
before
should not
data
reached
necessary
and disturbed behaviours
50 IU/ kg
obtained with a prescription
pharmacokinetics of aripiprazole .
42 22
46
BRISTOL-MYERS SQUIBB NORWAY LTD
and sulphonamides .
doctor
the
(
This medicinal
131 )
in patients ( particularly
.
of 33 -
95 % CI :
on
When a
It is available
ABILIFY
Inadequate dosage
myocardial infarction
to 67.2
reactions are
90 %
and
mg/ day
24 %
Farmacêuticos
effects
)
28 , 56
and protein intake .
,
Upon regaining
about 40 %
Studies in animals have
49
fibrillation incidences
of children .
Common : dyspepsia
recommended
Patients
starting dose is
with
that epoetin
,
,
, diarrhoea
In the four
cardiac failure
) per month
251
tachycardia
cerebrovascular adverse events
for pH-adjustment
in children and
local safety of
Abseamed in adult patients
ml ) aripiprazole
studied specifically
and
until it
other medicinal
There
these
Good blood management
between 9.5 and 11
diarrhoea .
4.4 -
those receiving placebo
2 weeks
children over 30
kg BW
)
(
Patients
7.5
während der
ketoconazole
4
antipsychotic
in clinical trials
SPECIAL WARNING THAT THE
, monoamine oxidase inhibitors
Polska
55
VOLUME OR BY UNIT
6.2 mmol/ l )
49 (
anaphylactic reaction
surgery
be avoided
The
( IU )
APPEAR ON
and extrapyramidal symptoms .
maximum dose should
0)21
and 12
in
:
antithrombotic prophylaxis
, increased risk
(
1 pre-filled syringe of
isophane ( NPH
- United Kingdom
) .
your doctor
.
the
Park
mellitus
NovoLet is
10 consists of
, 2C8/ 9
adequate and well-controlled
epoetin alfa
) insulin
the intravenous
discontinuation of treatment .
signs
IU/ kg
,
, or
. emea
inflammation
( see section 4.2
Non-clinical
Patienten ,
Abilify experience
Iserlohn
the first injection .
aripiprazole
no significant effect
mellitus , diabetic ketoacidosis
oder ohne ( behandelte
or
diabetes ,
see
month
bei
difficult
day
section 5.1 )
colourless solution
kg and adults .
in a
anaemia
been
4.8
extreme and associated
,
such as sedation
initial treatment response
risk for
be
and
14 tablets 28
In clinical studies ,
(
by 61
on
month , or
that
, in
in
0)1 46 25 16
study
incidence
)
.
this
No evidence exists
Following subcutaneous injection ,
( 0)20 3116
the
inter-individual variation
( see
you think
the
:
.
It
during
TO APPEAR ON BLISTERS
45 93 05
to
active substance
A cardiovascular outcome study
and
produced by
of NMS
having a high
in Saccharomyces
chronic renal failure ,
important in those
of excipients , see
indicated for
Teil des körpereigenen eim
2
part
.
lipid soluble drugs
of
)
of fracture
dehydro-aripiprazole did
to your doctor
or
if you
.
5.1
,
Global R & D
you
Uncommon
treatment
and extrapyramidal symptoms
inhibitor of osteoclast-mediated
1
Overdose of epoetin
or
be
)
in
g/ dl (
D Centre (
diabetes mellitus ,
-
similar
rare hereditary problems
Studies in man suggest
IU/ kg
ra
1 orodispersible tablets
the aripiprazole dose should
elective
hepatic impairment should
Latvij
less
% of
-
alfa
The
(
Europe ) ,
of 12 -
.
encephalopathy-like symptoms
.
IU/ kg
QT prolongation ,
.
.
haemolysis
4.4
Oral
the
the label to the
Norge Takeda Global
with
Uncommon -
is
, even several
micrograms
per
aripiprazole concentrations .
Highbridge Business
medicines
.
as triple
LTD Tel :
syndrome .
clinical
per
use of Epoetin
:
g/ dl (
ml ) aripiprazole
initial dose
)
SQUIBB NORWAY LTD Tlf
whilst
,
.
on
50 IU/ kg 2
)
.
The blood glucose
including parkinsonism
( N = 225
other
unused product
dehydro-aripiprazole
mg
the immediate packaging
patients
in
ABILIFY
Effects
chronic renal failure
Actraphane contains
or
pyrexia
and dyskinesia
contains 3000
7.5 mmol/ l
is
Pivotal Fracture
alfa
hour ,
higher Cmax and a
heparinisation )
these characteristics
and
Erythropoietin is
during
In
and approximately 60
events
( 2°C
.
( see section
)
between
metformin
(
for 2.
of
of
3
44 ( 0)20
, or if the
, but
more ABILIFY
see
Hb between 10
Lancaster Way Wingates Industrial
section 4.5 ) .
or
0)20
d Name
of epoetin alfa
Adverse reactions
and 3A4 ( dextromethorphan
12
, RH12 5AB
Treatment of anaemia and
management
once a day .
(
) is
300
Puh/ Tel :
in combination with
cancer patients
been
contain
+ 43-(0)800
of
%
haemoglobin and
any confirmed or suspected
:
before you
.
influence
trials
treatment with aripiprazole
patients with a manic
overdose
.
The peak is always
week by
clinical trials
patients
,
( MAOI
PRODUCTS , IF
10 consists of
normal reference
The
,
2
a clinical
In the long-term studies
:
The safety of
28 x
Tel
and
administered
weeks (
, especially
, vitamin B12
-hydroxypaclitaxel ;
of excipients ,
.
complications
with
ABILIFY
and
than
between 17 and
If
200 mg
After injection of the
Actraphane .
- If you have
and/ or non-healing sores
5.1 )
)
Do not
shortly
0)1628 537 900
( days 21 ,
and
aripiprazole
of 45 mg
serious allergic reactions
and
( anhydrous
) ,
existing
the
.
,
hepatocellular dysfunction
chronic renal failure
should be considered
COMBINATION THERAPY
Immune system disorders Uncommon
.
three years
tumour proliferators .
is necessary ,
for whom
3000 IU/ 0.3 ml
, rDNA
between 17
, but not
with
4.2
not be exceeded
% )
In the
If you have
and
5.2
:
) .
be avoided
(
and
the
with
metformin and
PIOGLITAZONE IN
in
)
IU/ kg 2
or hyperosmolar
in vivo appears
are round and pink
R &
( 5.9 - 6.8
.
Potential for
days following
and
with solid tumours
or
contain 0.3 ml
polycythaemic mice )
a
without psychotic features and
periods of a
All patients being
with alcohol or
or
characteristics of aripiprazole
or
.
into account and should
when
your doctor
other CNS medicinal products
2 diabetes
solution for injection
combination with insulin
+47 23
in
low-trauma hip fracture .
.
while taking aripiprazole
involving
the most frequently
+ 43 1 60
including
In clinical trials and
used in patients
354
omeprazole )
The pre-filled syringes
erythropoietin
frequency
nausea , vomiting and
Abraxane is
reduce insulin requirement
effect
with cyclosporin
The
is very
and
recommended dose is 600
-
In clinical trials
less duration
epoetin alfa
and
73 % ) .
Abilify
6.1
or
high fever
( e.
- Middlesex UB8
tablet with
of EPS was
Hb between 10
or pharmacist
how
Farmaceutici SpA Tel :
Although there is
It may
dose
5.1
with food and drink
and
The
:
with these
mmol/ l )
this
thromboembolic events in
% ) of
84 , 90
PRCA
controlled
.
three
of the
3x/ week or
or
with
large
maximum recommended
IU/ kg
)
experiencing potentially
535
.
antipsychotics
,
to be administered intravenously
placebo
insulin
is 15
, the dosage
95 %
carton .
(
schizophrenia
pharmacist
blood glucose
.
Luxembourg/ Luxemburg
Generally , children
anthracyclines or have
patients with
increased risk
in patients
see section 4.8 )
the nearest
14 g/ dl (
& D Centre (
150 International
of aripiprazole .
rare -
the CYP3A4
either
, diabetic hyperosmolar coma
aggravation of existing hypertension
are
an
while taking aripiprazole
was
either
and
The
blood cell production
risk
should be done in
dose regimens
PSUR
can occur .
Jahr
with gemfibrozil
of
that epoetin
98 x 1
)
below
( for pH-adjustment
symptoms of agitation ,
complications
hypoglycaemia
55 Elimination The
epoetin alfa .
the recommended
but not
+44
FOR EACH SPECIES
IU/ kg once weekly
important
if you
It may
with
schizophrenia patients
When the CYP3A4
: up to 36
has
pharmacist .
The correction
AND SIGHT OF
(
be
.
recommended ( or if
in two studies
a benefit-risk assessment with
and
1 CONDITIONS OR
trials , an
and death in utero
501 76
cannot be excluded .
after
and
Unit ) corresponds to
50 IU/ kg
Tel : +
lead to hypoglycaemia
patients
N-dealkylation is
your doctor
and diarrhoea .
period .
population ,
Special
of manufacture ( recombinant
PARTICULARS
receive adequate antithrombotic prophylaxis
& Co KG Kuhloweg
corresponding to
vision
Danmark Novartis Healthcare
Product Characterisitics
medicinal
previous stroke
with
to increase the
%
and
a
.
2C9
infection including osteomyelitis
an osmolality of
44 (
glucose control
, 23 lung
hauptsächlich durch Metabolisierung und
on mg/ m2
.
Treatment of
alfa
administration of ketoconazole
Some patients
cell production .
For any information
.
30 mg tablets ,
.
male and female
mg
,
1/
cell production .
sections 4.3
an
systems ( durable
.
g/ dl
psychotic features
a
A
pioglitazone in
aged over 50 years
lung
with epoetin alfa
( this
,
ON THE
condition
extreme and associated with
in
in patients with
3.0 %
, µ : +44
4.5 )
with
.
controlled
) 749 749
pharmacist
experienced with
scheduled for major
%
headache ,
fast-acting , insulin
this leaflet carefully
the incidence of
see section 4.8
chills , pain
with
Aclasta
, insulin (
Like all
may vary with
patients
during continued
insulin and
pharmacist or nurse .
30 % )
in
MULTI-PACK ( INCLUDING
will help
due to the
(
between healthy elderly
or
doctor
Lilly Portugal - Produtos
carbohydrate chains
mg
) with
alfa
metformin
80 to 300
after repeated
especially infections
weight regain .
CYP2D6
rats
.
by these enzymes
)
metformin and/ or
Aripiprazole is
,
, angiotensin converting
.
the placebo group .
) or
below 12
and symptoms
no
,
were
syringe onto
in
.
angina
-
chloride Glycerol
presents
West Forest
men ,
.
with
of ABILIFY
tablet is bioequivalent to
, 22 prostate
symptoms ,
40
)
WHAT
.
House Highbridge Business
33 IU/ kg
on results of
trials , rare cases
Actual scores
after subcutaneous administration
insulin ( human
patients
patients with
for patients with
of
0.4
of
in schizophrenic
with
mmol/ l
doctor or
section 4.4
at the desired level
Aclasta
The usual
UB8
you have the impression
( omeprazole )
other insulin products
.
in vivo
with treatment with pioglitazone
erythropoietin
3 times per week
following pharmacokinetic data
increase in haemoglobin
including isolated cases
placebo-treated
no
hormone erythropoietin
including parkinsonism ,
thyroid hormones and beta-sympathomimetics
store them in
patients
33 - 39
Peripheral oedema , mucosal
:
retinopathy
should
was abnormal
8°C
.
-
hours
taken in combination with
below 12 g/ dl
) .
aripiprazole and dehydro-aripiprazole are
House Highbridge Business
for signs
12
within
.
some of
take possible interactions
section 4.8
store in a refrigerator
Less than 1 %
SQUIBB
treated group
4.5 )
, Neuroleptic
NMS
a
3 trials
followed by
House Highbridge
skin (
mmol/ l ) should
If
by the liver primarily
to
There are no
, 56 x 1
aripiprazole
contains methyl parahydroxybenzoate and
daily dose of 15
clinical
.
Eiffel ,
There are no adequate
Abseamed 2000 IU/
a few
a sulphonylurea ,
symptoms
( FACT-An )
to 12 g/ dl
clinical
and 5
changes
medicinal product contains
BRISTOL-MYERS SQUIBB
solution for injection
in
AND SULPHONYLUREA
should be rotated
mmol/ l
Limited
,
patients
410 500
Uxbridge - Middlesex UB8
weight gain
.
)
,
Suomi/ Finland OY BRISTOL-MYERS
and a
control
you are pregnant ,
and
, the incidence
Pioglitazone tablets are
.
treatment in this
65
of
Marketing Authorisation Holder
185 MINIMUM PARTICULARS TO
.
for
20
Tél : +33
and anaphylactic reaction .
mellitus , diabetic ketoacidosis
, pyrexia ) ,
Therefore
E951 ) Acesulfame potassium
to sudden
anaemia
23 mg )
for
[
SQUIBB
treatment
, and
when erythropoiesis stimulating agents
Always take
information is
)
Tél/ Tel : +49
Eesti
,
who have a
.
, especially
LTD Tel :
not exceed 30 mg
section 5.2 )
potent
section 6.1
Pharmacodynamic
for 2
] (
(
vitro .
.
g/ dl
and beta-sympathomimetics
heart disease
be reduced
insulin
your doctor or
in clinical trials
or if
Erythropoietin receptors may
see section
sulphonylurea
.
the
BRISTOL-MYERS SQUIBB BV
.
x
with a manic
clinical trials , an
If
pre-filled syringe The syringes
1.25 mmol/ l
mg orodispersible tablets
with
(
the
particularly
face. .
of patients
occur in
one side .
see section 4.4
clinical
give by injection
tachycardia ,
or
with a manic
Insulin treatment
( e. g.
risk
)
to be administered intravenously
.
diabetes mellitus
Insulins and analogues for
.
, the incidence of
immediately
section
isophane (
1 ,
IU )
In most of these
manic symptoms
-
mmol/ l )
the
, lactation or
of patients
additional
Some
, it may
unchanged pioglitazone
not
- 150
doctor or
,
für
elderly
fast-acting
.
,
50.4 micrograms
on
that
165 amino acids
a prospective ,
45 45 93 05
studies
.
)
clinical
pre-filled syringe
a
including
more frequently
the
the
Lilly Portugal
cancer patients
with
49
Abseamed
87 % .
den
with renal
:
with
pharmacist for advice
is
patients
%
,
which
ml
0.5
less than 65 years
randomised
hepatic impairment on
in humans
toxicity
9
of
e. g.
maximum volume of
46 25 16
mg/ ml
and Manufacturer Marketing authorisation
days 21 , 14
Actos 45mg
,
and a negative
liver problems or
,
hospital and take
characteristics of
.
Store and transport refrigerated
of the Marketing Authorisation
clinical trials of aripiprazole
include continuous electrocardiographic
Functional Assessment of
% of
0)810 410 500
.
( Europe
of dogs
ml contains
that
of continued therapy
dyspepsia ,
the following
phosphate dihydrate
your doctor immediately if
agitation and
section
clinical trials ,
tremor
has
, that patients
rare
Actraphane 10 consists of
200 mg of
)
by 32
.
in the
symptoms
In
%
diabetes
women
(
AND SIGHT OF CHILDREN
50 %
in
may vary with age
of
defined
,
anorexia ,
SQUIBB SARL Tél
Aripiprazole and other
dose adjustment is necessary
)
.
Lilly Portugal - Produtos
30mg tablets can be
GmbH Roonstraße 25 D-90429
.
alfa is
Hyperglycaemia and Diabetes
Finland
.
The
.
especially in
or 24
disorder ,
patients who
) insulin .
paraesthesia
7
dosage
in
of
summary of the European
of
weight
- metformin ,
or
and water for
fast-acting
tablet contains
of
In
epoetin alfa may
;
contains
12 g/ dl
treatment
Myalgia
receiving chemotherapy
1.25
,
do
per 100
:
anschließende biliäre
women with
an anthracycline
women
7.5 mmol/ l )
, ,
& Co
) .
ml glass cartridge
randomised
( 6.2
du
increased
Takeda Tél
A-011
evidence of clinically significant
see section
treatment
with
.
4.3 and 4.4
should not exceed 200
open-label
of
its total active metabolites
to
the
) ,
sedation (
haloperidol 73
placebo-controlled trial
14 and 7
)
or mixed episode
,
5.2 ) .
of NMS
adult dogs
see section
a negative impact on
4.5 Interaction
the bioavailability of mitratapide
is
as first-line
or
treatment with aripiprazole
( 55 %
.
) insulin .
In
Luxembourg/ Luxemburg
.
is less common
other
test values
ml solution
Die
.
, chest pain ,
moisture .
mean difference to
: blurred
after the
In elderly patients with
: + 45
mmol/ l )
Aripiprazole and
deep vein thrombosis
alters the metabolism of
This is
1HU - United Kingdom
biological efficacy of
- Diabetic
In clinical studies
are
Very
this
not clinically
2 352 74 60
see
treatment
anorexia ,
Lietuva
.
children under 30
contains The
be used .
from the
.
occur in men .
may
Like all medicines
in reduction of
contain 1 ml
-
undergoing dialysis :
, the patient
illicit
1 ml
- This medicine
VOLUME
.
23 hours
manufacture ( recombinant
the end of treatment
sedation
patients participating in
warfarin
37
of 50 IU/ kg
mean age :
this condition
by the intravenous
if you
Cmax and Cmax
There is
and
a mixture of dissolved
,
tactile hyperesthesia were
of the
taking ABILIFY .
Read all of
Adjustments of daily dosage
the
conventional paclitaxel-containing medicines
in
g/ dl (
blood
with
) and
increased alkaline
pioglitazone
% dissolved
,
of 1
once a day .
risk for thromboembolic events
may
agitation , nervousness
increased by 77
.
The procedure for
administered after the completion
aripiprazole
The maximum dose
5000 IU/
or pharmacist
standard genotoxicity tests ,
adult patients
dosing did not
with
had visceral
or 5 or
IU of insulin
difference in
(
Smoking status :
and
placebo-controlled
Abseamed
salivary hypersecretion Vascular
active
of increase in haemoglobin
overall survival between
treatment with epoetin alfa
diabetes
or
when oral
risk
Mildly anaemic
week
nefazodone)(see
between thumb and
MATERIALS
adults .
observed
18
dosing should
necessary amount
and 90
ABILIFY
, increased Aspartate Aminotransferase
insulin products
the
mmol/ l
What ABILIFY is
extensive extravascular distribution .
doctor
minor or moderate
patients with normal or
What
74 avoided ; guidance
studies ,
to have
(
the
45 93 05 06
R & D Centre
tumours (
United Kingdom
0.5
from moisture .
insulin and isophane (
acute renal failure .
and pioglitazone
with epoetin alfa
signs
per month or the
is individual and determined
stroke
of
- 6.8 mmol/ l
to recommend dose modifications
since cyclosporin
and
.
1
contains 4000 international units
.
increased risk of
achieved
In combination
usual dose
patients
7.5 mmol/ l
16.1 [
clinical trials
years ) of
common
)
(
)
%
In clinical
see section
5.25 mg
In
Road Horsham West
27 %
SPECIAL PRECAUTIONS FOR DISPOSAL
Renal or
injection :
8°C ) .
8.1
wurden. er Die
MATERIALS
studies
, given weekly
for
30
6
agents (
is
Educational leaflet Summary
,
adult subjects , nor
and
ON BLISTERS OR STRIPS
is
combination with metformin
QT prolongation
6.1
residual
data
anaemia
ml per
mellitus ( see section
concern
and
mmol/ l
weight
anaemia
patients with
4.5 Interaction
Following
epoetin alfa ,
with
incidence of clinical
a glass
Die
,
subcutaneous erythropoietin
.
pioglitazone
+
, hypocalcaemia , hypoglycaemia
on the
patients
of anaemia with
Park , Oxford Road
)
lithium
in the
For a full list
OF UNUSED MEDICINAL PRODUCTS
in
Iserlohn ,
18
,
administration of
trials and
whether or
increased alkaline phosphatase
dizziness .
effects of Abraxane
shows that pioglitazone improves
731 1736
pregnancy
.
( rDNA )
ABILIFY
- 8°C
epoetin alfa
, or 13
and pink
the
this
In some
and the
Immune system disorders Uncommon
g/ dl ( 6.2
see section 5.1
see the Package Leaflet
are not
and 3.2 % with
and a sulphonylurea ,
cloudy after resuspension .
long-acting
of ABILIFY
some cases
with
the risk of cross-reaction
subcutaneous erythropoietin
Hb between
injection , intermediate-acting
in a
g/ dl ( 7.5
paediatric and
and sight
to protect
& D
genotoxicity tests ,
and beta-sympathomimetics
Rimonabant 20 mg
for major elective
well-controlled studies
22 prostate
or
have
or CYP2D6 inhibitor
Europe ) Ltd
were
or
Following concomitant administration
"
, uncommon cases
g/ dl ( 8.1
these
(
within
received
reconstituted
in
of pioglitazone (
The
)
.
puberty or due to
of
to do this
and for the
patients with type 2
) sealed
develop
survival
antagonist properties in
hepatitis
Medice Arzneimittel Pütter
with
Takeda
5.1 )
; suicide attempt
Spain
four
the
biological
Hb
Try to take
the relative efficacy of
Aripiprazole is
PIOGLITAZONE IN
systemic exposure was generally
in cancer patients .
+44 ( 0)20
in
these trials , a
tablets are
has not been
see section 4.4 )
If ALT levels remain
and hypoaesthesia ( decreased
, thiazides
seizure
solution .
( 0)1628 537
Very
.
4.8
See
this study .
of unchanged
, while
358
mit Vorsicht anzuwenden
haemoglobin target range of
approximately 27
, 14 and 7
an apparent volume
monkeys
on
alfa Abseamed 7000
known whether pioglitazone
2C9 (
as hydrochloride
carefully weighted
taken in combination with
is 15
other
is
unused product
of 10 g/ dl
and
4 hours
no
of EPS was
levels
, and
7.2 %
Hypotension
between 1.25
of angioedema and
Special warnings and
in patients
other clinical effects
2.47 in favour
adequate
( Europe ) ,
of anaphylactic reaction/ shock
trials
Linear Analogue Scale
effect of pioglitazone (
16.1
and approximately 45
part
,
lactose monohydrate
ise
sufficiently investigated
Mellitus : hyperglycaemia
corresponding to
of epoetin alfa in
bradycardia
contain 0.3
the
remain at
( haematocrit
and isophane insulin 50
Abraxane
for
such as
- 6.8
alfa Abseamed
of greater than
open-label studies
monoamine oxidase inhibitors (
recombinant DNA technology in
see
g/ dl
increase 40,000/ µl or
mean age
mellitus (
and
( IU )
significantly
and
and anaphylactic reaction .
to placebo
use of
should be administered intravenously
below
you are pregnant
of
1 ml contains
4AE United Kingdom
If
corticosteroids
ABILIFY
, 64
.
Ísland VISTOR HF Sími
four week
The mean
daily dose of 15
90
or
listed below
patients with renal anaemia
injection
cytochrome
is
WC2B
55 % )
will receive
them
in
0.5
and
geometric means of
16.8 micrograms epoetin alfa
to maintain haemoglobin
0.3 ml
are
Co KG ,
of controls
observed
)
section 5.2
exhibited antagonist properties in
3
(
glycaemic control may be
ml contains
chronic
.
.
It
in a dose range
has multiple well documented
and for the
4.8 ) .
of pioglitazone
( mean age :
causes of deaths were
in clinical
g/ dl ( 7.5
epoetin
1 800 )
Tel : +
g/ dl (
medically
sterile but
three
( see section
the
type
dose
and disturbed behaviours ,
e. g. hypothermia
0.62
been reported .
or
( 1.25
30 % dissolved insulin
with
( 0)20
not exceed 30 mg
epoetin alfa
any
levels of
.
reduction
the
in patients with
female
increasing study duration
placebo-controlled
.
treatment with epoetin alfa
to patients when indicated
see section 4.5 )
8950
in pregnant
, somnolence , sedation
.
- if
: +
section 5.1
SMALL IMMEDIATE
was used
haemoglobin and blood pressure
IU ) of solution
or
pup mortality
see section 4.8 )
of suspension
the
15 mg has not
, 23 lung
Hypertensive crisis with
paracetamol
Hypersensitivity reactions including
followed by a
used in humans
Oral contraeptives ,
doctor
by 107 % ,
Mitratapide also has a
If
West Sussex
5.1 ) .
( FINLAND
AUC
Industrie
.
data reveal no
clinical trials of
, especially in
with encephalopathy-like symptoms (
have been
VOLUME
6.2
with
month ,
the
thrombosis , arterial
.
Abseamed has
68
weight
anhydrous ) .
:
a
What ABILIFY looks like
if
.
be
be used
Peripheral neuropathy
and
)
other symptoms
, diabetes mellitus
,
3800
to
.
Global R &
60
the
include continuous electrocardiographic monitoring
cases
The Marketing
,
4.8 ) .
in type
undergo periodic
delayed
100 , less
over 3
.
taking ABILIFY
other antipsychotics
food .
Uncommon -
,
first
(
infusion
heart failure or
of Abseamed
The biological
3
Insulin suspensions are
The rate of
attention should
to drive and
injection route
carton contains
route .
of unchanged aripiprazole was
and blurred vision
nutrition programme
cancer patients
4.8
Ísland VISTOR HF
,
could be
patients (
ABILIFY
from hypoglycaemia .
for disposal and
-
BRISTOL-MYERS SQUIBB (
, the dose should
A
other
g/ dl ( 7.5
section 4.4
with
refrigerator
Kingdom
-
9 251 21 230
,
:
can
treatment in
meal or
in two equal
if you
and approximately
AUC after
and
10 and
less duration ,
the levels
condition is controlled
NMS is a
- if
in haemoglobin (
pectoris , increased
age
(
works
Die
1 , 98
peripheral
THAT THE MEDICINAL PRODUCT
of
of individual clinical
thromboembolic
tablets
: +
output from the liver
5
OF
available
enzymes .
(
not clinically
indicated for
.
used for 2.
mmol/
bacterial and mammalian cell
Due to
(
patients participating in
the
6.2 mmol/ l
nicht
hour
of the Marketing
did
alfa is very wide
(
hours
3 times per week
with gemfibrozil
pyrexia
with
to
These effects
been established
male patients (
Overdose of
with
All women
Tablet Round and
rare
x 3 ml .
4.4 -
days
see section 4.8 )
madarosis
AND
Hb
,
1,000
of
3116
dose
mg
human
Cancer
tablets 50 tablets 56
clinically significant change in
-
at doses
26-week ,
1.5-2.5
of
stroke
and increased
days 21
)
the
drive
the anterior abdominal wall
The syringes contain 1
( 2°C -
with baseline
Royaume-Uni Tél/ Tel :
transient loss of consciousness
haemoglobin of
,
SQUIBB GESMBH
I-03012 Anagni-Frosinone
In two
:
In a
cases of
an
with
hyperosmolar coma or
clinical trials of aripiprazole
BRISTOL-MYERS SQUIBB
, sedation , headache
225 ) , or
efficacy of epoetin alfa
potent CYP3A4 inhibitors with
higher
50
when erythropoiesis stimulating agents
857 42
.
Irregular heart rhythm
,
below
x 1
disposed of via
( see section
by the intravenous
faeces .
doctor or
+
Uncommon
section 4.4 -
duration of diabetes was
injections
(
it
(
: +
metformin and
or
severe
dehydro-aripiprazole
the indication increasing
of these patients
42
acute renal failure
above baseline
)
and blurred
weaker than
events in
short-
0.8 ml ( 8000
used
patients with severe renal
contains 200 mg of
.
should be monitored closely
with normal
Lilly Portugal - Produtos
6.1
is
episodes
study population
Insulin suspensions should
000 IU
patients with
, the incidence
the four placebo-controlled
to sudden
recent low-trauma
g/ dl ( 7.5
7.5
, for
to drive and
.
extrapyramidal disorder , akathisia
been
the active substance
week by
paclitaxel-
another ( see
than 1
Each carton
in patients
IU
Arzneimittel Pütter
been
in
)
a
and
section 4.4 )
the
haemodialysis and adult patients
less
0.3 ml
: + 47 67
aripiprazole
Epoetin alfa
hoarseness
,
affects you
of the
cancer patients
3 The full EPAR
changes in
Vorsicht
The
patients
developmental toxicity
or
should be checked
tachycardia , nausea ,
episodes
42 22
- 300 mg
is a
clinically
tongue .
also occur in men
hydrochloride )
)
is
reactions are
Abseamed
very
one
the
10 and 12
be managed cautiously .
which also
.
with ABILIFY
cerebrovascular adverse events
avoid
of aripiprazole
should be
.
a blister
arterial
increased risk of
Tél : +
The active substance
,
patients
after
.
.
approximately
the dosage of ABILIFY
( t½
alfa
PRCA means the
patients
used for 2.
, nausea
against the
.
patients
of
patients
greater than
to the foetus
The peak is always
in
somnolence
blood pressure
Uncommon -
isophane insulin
more information
of epoetin alfa
observed
precautions to
pharmacokinetics of aripiprazole
epoetin
absorption
of EPS was
section 4.4
the impression
People with
the
or
Kingdom BRISTOL-MYERS
20
of CYP3A4
sudden
monthly intervals unless
insulin ( human
adult
, weight decreased ,
not
to
swelling
Interaction studies have
,
and completed suicide (
with a quick
of akathisia was 6.2
.
In clinical trials
ACTOS
sections 4.8 and
elderly
, monoamine oxidase inhibitors
are growth factors
and dose-proportional
, diarrhoea , vomiting
insulin or
Tlf : +
or
after
6.2
particularly
dogs
two studies
of
the thighs or
dose reflected differences
haemoglobin
117 MINIMUM PARTICULARS
( see section
bottle
with type 2
Highbridge Business
If
precautions
the administration
3 ml .
NORWAY LTD Tlf :
IU/ kg 2
D-58638
from
48 The
agents .
46 8 704 71
for lorazepam
In clinical
Other disturbances
and dose-proportional
tablet at the same
(
a combination of
11 g/ dl (
and
Subcutaneous injection : a
blood pressure
What benefit has
was
tablets
treated
) or
oder
300 IU/ kg given
ABILIFY
In clinical trials
of children
.
patients
,
also be used
haematological malignancies
and
injection sites .
and other erythropoiesis-stimulating
during treatment
effect
alfa
listed below
Eesti Eli Lilly
than those
)
on
keine Anpassung der Dosis
,
unknown
and protein intake
recommended
RFT
is a
5.3
different
studies in pregnant women
tachycardia ,
with
Kingdom
performed
Hunton
of adverse
and
Patients should be
your dose of
61 %
CYP3A4 ( ketoconazole
catalysed by CYP3A4
renal anaemia
.
,
agents Certain medicines
section
to the foetus
headache
in a
maximum of 30
Actraphane
: +
white and
2 diabetes
,
the correct dose
and
months
5026 01
, especially those
at 36 months
,
that primarily stimulate
.
)
Good blood management
after
) is
products .
( 91 )
4.5 Interaction
The terminal half-life
, salivary hypersecretion
) , Storbritannien
anaemia with epoetin alfa
for pH-adjustment
at least two weeks
in
used
Centre
with
by
.
see section 5.1 )
absorption
2.7
treatment
incidence of
93 05 06
, increased Alanine Aminotransferase
in
Activated charcoal
( 6.2 mmol/ l
.
(
necessary
.
M-II is minimal
to affect ABILIFY :
be impaired as a
( see
of
source
NAME OF THE
have
and swelling of hands
Actos 15 mg Tabletten
1
in patients
an
less
In
Hunton House
akathisia
risk of
, restlessness
172 breast , 64
should
Tel : + 40
a
and
dose
.
BRISTOL-MYERS SQUIBB
should
with
treatment
in
Activated charcoal ( 50
and 33
in clinical
(
, 84 ,
0.5 % ) of
,
8°C
patients
3 trials
g/ dl ( 7.5
12 g/ dl (
adequate
.
in
.
route
-
,
3 times per week
please tell
insulin therapy
greater than
effects
10
. emea
cause side effects
If
treatment with aripiprazole
- The
concentrations
has Aclasta shown during
may
% and 47
anaemia the medicinal product
frequency
the medicinal product
Takeda Ireland Limited
.
unit dose
weight increases
a manic
CB1
However , elevated creatine
A single-dose study in
- Middlesex UB8 1HU
Novartis Pharma GmbH
Denmark
mellitus ( see section
40 ( 0)21 272
1.25
the patient on
Royaume-Uni
HOMA analysis
doctor
Croscarmellose
in
less
PROactive
) or
alfa is very
+ 40 (
and vascular
children over 30 kg
to protect from moisture
clinical trial
after the
is
and diarrhoea
benefit has
only
study
- 39 % )
should be administered intravenously
eyes
Co KG
men )
The usual
solution for injection
suicidal ideation , and
and 15.7
renal anaemia
Tél/ Tel : +
hours after
one side and "
6.1 .
and
2ºC - 8ºC
55 %
local requirements
increased risk for thromboembolic
, the patient
effect
%
clinically
pioglitazone
36 months
aripiprazole or any
is given concomitantly with
( e. g.
were
OF THE
zu Empfehlungen bezüglich der
group : oral blood
) to pioglitazone
are extensively
1HU - United
1 60 14
The recommended dosing regimen
or
12 g/ dl (
analyses
transient
.
times per week by
.
well tolerated
: oral
of your ABILIFY
.
epoetin
d ise or uth
35
trials , uncommon cases
If
no
/ N. V.
the
maintain haemoglobin values
bernsteinfarbene Glasflaschen mit 55
)
your
insufficiency not yet
%
dosage of ABILIFY
have
BRISTOL-MYERS SQUIBB BELGIUM
This is
section 5.3
,
79 Patients
a rapid-cycling course
contain 1
5.2
1 ml
: + 39 06
or
aripiprazole
transparent plastic ( cycloolefinic
compared to
the insulin requirement
with
subcutaneous injection ,
,
This
no
is used
, given
pioglitazone and
ml contains
Alopecia
patients participating in
IT IS USED FOR
the levels
patients
of 50
machines
Carton of 14 x
Before use :
other medicinal products
aripiprazole
lithium
should
or
to
BRISTOL-MYERS SQUIBB AB Tel
no specific frequency can
survival
is reported
can
the patient
Hunton
Actos 15mg
) to
to the insulin requirement
THE REACH
Polska Takeda Global
reported
& Co KG
Research and Development
in
)
and sight of children
15 mg
Intensified control in
insulin requirement
not
unconsciousness
.
and
1 g/ dl
.
no
: + 44 (
34 ( 91 )
to years of
including
may
ABILIFY
Novartis
trials and
, open-label studies ,
balance
55
not
) per
und
mg tablets
used
Hb between
5 %
the bottle ,
.
shown below
you
,
0)1628
less
,
bone metastases
therefore
reflected differences in
pioglitazone
,
patients
Since
Starting dose of
+ 353 (
( 24-hour
with
( 2°C - 8°C
Hb between 10 and
15
contributes about 58
.
( see section
olanzapine-treated patients
corpora
Common : blurred
,
.
In
.
your
.
One IU ( International
submit one additional
contains 7000 international
when a
and 8167 patients
efficacy
have
transfer protein
( see section
not
N-dealkylation is
:
aripiprazole
other
see section 6.1 )
are active
Ireland Novartis Ireland Limited
experience
Hunton House Highbridge Business
clinical trials
with
House Highbridge
changes in bacterial
and 6.1 months (
units ( IU )
D2 and D3
controlled
treatment to
Cmax
In some
by
Road Uxbridge
.
hydroxylation
less than
patients
%
Eli Lilly Holdings Limited
the insulin requirement
the intravenous route
two
(
Following multiple
-
of children
injection : a
1000 IU/ 0.5 ml
In patients
10
chronic renal failure
23 lung ,
16.8
is a
a meal or unplanned
hours
Abseamed between 17
2°C - 8°C .
patient above and
the blood sugar
in
, dizziness ,
severe dehydration )
( for pH-adjustment )
angina pectoris ,
by the intravenous
following
) .
moisture .
ABILIFY
Long-term improved glycaemic
is estimated
bone .
.
be
fast-acting
When
of epoetin alfa
following
patients
153 Even if
Abseamed has
.
30 - 100
Aripiprazole and
with Actos are
trials that
not been carried out
once a day
+45 39 16
,
ml calibrated dropper
, akathisia
patients with chronic
these patients
% dissolved insulin and
( 0)810 410 500
0)1 46 25
ml
LTD
Te .
the medicinal product has
of greater than
mmol/ l
years
epoetin
8000 international units
and
should not
for the treatment
be administered intravenously
to
on
patients
1.3
in cancer patients
interaction
Cmax of dehydro-aripiprazole
myocardial infarction
treatment
trials ,
)
to protect from moisture
,
storage conditions .
D Centre
than 2 g/ dl
2 352
severe irritability
advised
you
pioglitazone in all
,
to sudden stabbing migraine-
74 60
.
WC2B 4AE United
course of
40 % in the
, especially
The biological
.
The
IU )
In the four placebo-controlled
pectoris , increased
efficacy
, less
is necessary
Bei
Subcutaneous
is unknown .
and
Do not
e. g.
5000 IU/
epoetin alfa
take
concentrations ,
) , 2C9 (
dissolved insulin and 70
& D
not
with fast-acting
active substance is
symptoms can occur
with the
hypoglycaemia
to 12 g/ dl
, pyrexia )
( MAOI ) ,
and
on in
studies
study )
ON THE OUTER
Tlf
7.5 mmol/ l )
machines
brand ( manufacturer
trials of
contains 9.75
and
with
,
cells cannot divide and
UB8
section 5.1
on
same time
severe
The effects of
AUC
,
administered to target a
These
)
.
Special warnings and
adequate and
is a
is
14 g/ dl
all
been receiving
see section
10
7.5 mmol/ l )
of these
unit dose blisters
the
coma ,
(
will
been demonstrated although individual
and patients
, the dose should
What
and
g/ dl (
Kingdom BRISTOL-MYERS
medicines known to
high fever
pioglitazone
in
of the
lung ,
dosage of
When the CYP3A4 or
) .
.
or
Actos 30mg
, diabetic hyperosmolar coma
manic episodes in
8167 patients
(
that
D-58638 Iserlohn
in
,
should
is a
see sections 4.3
.
with or
Abseamed 5000 IU/ 0.5
carefully all instructions given
anaemia
see section 5.3
) prior to
g/ dl (
.
dehydration )
international units (
8167 patients )
some of the other
contains
Uncommon
increased production of saliva
Most
200 - 300
if the
alfa alters
Tel : +
Effects on
of Aclasta
.
30
23
blood )
.
in patients
with epoetin alfa
Aclasta after
overall survival and
range of
( 6 % )
Highbridge Business Park ,
, restlessness
symptomatic
dehydrogenation
The natural course of
ABILIFY tablet at the
and approximately
a similar decrease in
mmol/ l )
paclitaxel .
15.7 % for
and
in adult patients with
5000 IU/
you
half-life (
352
Iron supplementation should be
warfarin
measures
g/ dl
use of Epoetin
increased risk for thromboembolic
patients with
by multiple
.
gliclazide .
After administration
this product is available
per week
mania
%
Reactions usually resolve in
insulin requirement may be
0.5
levels remain the
mmol/ l ) should
administration
mg
( IU )
receiving non-platinum
clinical studies ,
aripiprazole
rhabdomyolysis
major
NovoFine needles
monkeys after
Tel : +
- 12 g/ dl
and
Taking
%
mmol/ l
PHARMACEUTICALS LTD Tel :
USED FOR
reported
renal failure
bound ) and
dysphagia
intermediate-acting
concentration
or
in increments of 2
2 352 74 60
.
the
placebo-treated
be considered (
ml equivalent to
the
.
to the insulin requirement
from a
are pregnant ,
CYP2D6 or 3A4 inhibitor
weeks prior to
that
been reported .
of
with
The terminal
to protect from moisture
and
for
medications
dose is between
is therefore recommended .
weeks prior to
mg
12
,
Insulin human , rDNA
7 )
flatulence ,
25
reported after months
treatment .
rash
Park , Oxford Road
Particular attention should
Global R &
may
of aripiprazole )
, the haemoglobin
and Cancer Linear
proliferation of
weeks the
predispose patients to hypotension
: +
05 06
is
Oxford Road Uxbridge
to protect
to
5.1 ) . no
Although in very
that aripiprazole
preventing
present state
44
&
usual starting dose
Abseamed 8000 IU/ 0.8
mmol/ l )
27 % of the
0.05 mg zoledronic acid
some cases
56
and 2.47 in
during pregnancy
.
shown reproduction toxicity
.
BE STORED OUT OF
Very
)
D-58638 Iserlohn
,
( see section 4.5
other
a
5 % und
has
, the
bipolar
see section
to drive and
controlled
For a full list
Reaktion am Anwendungsort
may
The use of specialized
DNA
&
( see section 5.1
headache , tiredness
been
Patients who
of the injection site
physician .
maintain haemoglobin
In elderly patients
inhibitors
)
(
Treatment of anaemia associated
)
x 1
of glucose
Survival
EPS
Since
, etc. )
see section 4.4 )
hypoglycaemia whilst driving
tablet formulation is
As with all
weeks
or
incidence of
recombinant DNA technology
pharmacist .
tablets 28 x
duration
Epoetin alfa
diabetic retinopathy .
It is
times per
haematocrit
and
,
was apparent in
various
for
Haemoglobin levels
)
you or
total clearance was 15
.
cancer patients .
symptoms have been
1
As with all
.
.
)
patients
The
and 50
iron stores .
Fe2+/ day is
FINLAND
patients with chronic
44 ( 0800 )
see
significantly impact renal function
Abseamed 9000
, pioglitazone
controls .
Centre (
IU
Abseamed
If you
take
recombinant DNA technology
Lilly
use machines have
( 1.25 mmol/ l
Polysorbate 80
and
.
patients
3116
dogs and
Actraphane 50 consists of
use in
Co KG Kuhloweg
alfa
.
be assured
alfa
,
patients
, glycine
veterinary surgeon or
:
other
A clinical trial of
The
)
section 4.4 and section
(
the deltoid region may
appropriate dose
can be found here
BRISTOL-MYERS SQUIBB BV Tel
treatment
HbA1c ,
effect of Actos
analogues for injection
doctor
protein fraction of the
,
of 600 IU/ kg
, Lda
study
of
clinical
of
patients
Abseamed
patients
Severe hypoglycaemia
:
Liver enzymes
if you
with epoetin alfa is
90 tablets 98
of anaemia associated with
after
diabetes mellitus
injection site within a
epoetin
(
( SBECD )
aripiprazole
1 to
Following
transient ischaemic attacks ,
insulin
) per
prevent hypersensitivity ( N
protein fraction of the
] ( see
enzyme
in this
week by
combination with insulin ,
in men
for cerebrovascular adverse events
were
.
treatment
not
influence on the
3 times per
not
(
avoided
+ 32 2 352
the intravenous
It is
of children .
the intravenous
than risedronate
is
.
( 1.25
152
.
as hydrochloride ) .
GGT )
haemoglobin ( 1 to
If
,
)
sections 4.8
(
sudden rise in blood
PRODUCTS
because
isolated patients with normal
(
Hypersensitivity to
ABILIFY
revealed no medically important
orodispersible tablets
of
:
WITH BLUE
6.8 mmol/ l
greater than
more units
( see sections 4.3
, the
and other
are transitory
31 34 857 42
not
patients
NMS is a
clinical trials aripiprazole has
been observed
growth hormone and
with severe
a
treatment
vomiting
maximum daily dose should
Actos 15mg
administered after the completion
Because
.
.
the existing treatment
12 g/ dl (
Vorsicht
orally during
efficacy
g/ dl (
or
in
injection of the
In patients
3
ABILIFY
Ausschuss für
patients
in patients at
,
use of Abraxane
contains
, pulmonary
used
and
may lead to hyperglycaemia
increase 40,000/ µl or
:
.
24
+ 33
) .
an autologous blood predonation
isolated patients with
occurs
see also
Holdings
following
)
or hyperosmolar coma or
patients
significantly
drug exposure
week by
1.5-2.5 hours after
quickly with racing ideas
)
) .
of
loss of consciousness
( see section 6.1
data from
chronic renal failure in
18 ,
patients
Close
renal
human
NYHA stages I to
your doctor or
following a
.
in patients
4.4 Special
) ,
the medicinal product
of aripiprazole in pregnant
If you are
undergoing dialysis
Reticulocyte count
intermediate-acting combined with
or
on
( 1.25
pink ,
haematological malignancies
epoetin alfa
)
blood in urine
g/ dl
doctor
In
SPECIAL WARNING
Abseamed
.
Ltd Tel :
0.3 ml ( 3000
of dosage
with
of NMS
section
Oxford Road Uxbridge -
moderate
than
24
and isophane insulin
solution for injection
to the insulin requirement
and
if
( 0.5 to
-
tablets
slowly
efficacy of epoetin alfa
,
aripiprazole
in
abdominal wall .
section 4.4
with
listed below
The biological efficacy of
development were assessed
treatment
for
.
and post-marketing experience
AND SIGHT OF
revealed no
over 3
98
when
site within a
therapeutic margin
- Treatment of
, aripiprazole and
OF UNUSED MEDICINAL PRODUCTS
sedation (
,
10
effect of medicines used
pre-filled syringe
,
less than 1
Co KG , Kuhloweg
maximum volume of
only
Diabetic retinopathy
MATERIALS
.
to
.
vs. placebo ) was
is
Owing to
der nach einem
( 6.2 mmol/ l
and isophane
precautions
Development Centre ( Europe
manic or mixed episode
open-label
6
margin of
metabolised
for cerebrovascular adverse
, thyroid hormones
be at risk
patients
Novartis
.
and 5.2
solid tumours
Ltd
studies
If
psychotic features and
between
contains 9000 international units
cases of NMS
is
44 (
The pharmacokinetic characteristics of
.
and
should be
4000 IU/ 0.4
entire orodispersible tablet on
tablets 49
with
, Oxford Road Uxbridge
2 g/ dl (
Hypertensive crisis with
Sverige
10 and 12
mmol/ l ) or
Uncommon
The medicine
to 3 X
2 g/ dl per
trials in which
events
risk for
following adverse events
10
.
Uxbridge - Middlesex UB8
placebo
you have
of
Diese Studien
(
the
done in
ml
4.4
controls .
anaemic
the intravenous route
mmol/ l
body weight
131 )
Actraphane
Refraction disorders
of
before
is
and
.
,
938 ;
section 4.8 )
in a pre-filled syringe
( 43
The
such veterinary medicinal
insulin and
reduction in
vials
category for mitratapide
for
vivo
THE
+44
and
2 weeks
, a
7.5 mmol/ l )
of epoetin
with
3A4
or death
receive adequate antithrombotic prophylaxis
AND SIGHT OF
) OF
erythropoietin
No other erythropoietic therapy
ketoacidosis , diabetic hyperosmolar
of rimonabant
of clinically
, IF
, but not in
BRISTOL-MYERS
mucosae
by approximately 25
after the first
some cases
insufficiency .
2 )
) aripiprazole .
-
g/ dl
ml
to dispose
recommendations , read
the pharmacokinetics of aripiprazole
.
,
not
below 30°C )
PHARMACEUTICALS
a
, arterial
.
used
, myoglobinuria
ge
) and 802
subcutaneously ) .
with
Metabolism Human
.
below
1 tablets in
THE
(
and mediastinal disorders
x 1 tablets
control
alfa in
infection
and
is an
.
with
MEDICINAL PRODUCT
1
55 53
Weight gain
week by the intravenous
pregnant or
such as
the levels of
and other antipsychotic drugs
and
especially
formulations
1.25
g/ dl (
insufficiency
hypoglycaemia
mmol/ l
& Co
,
is a
clinical
adjustment
danazol .
blurred vision
especially in patients
( dextromethorphan ) .
Takeda Italia Farmaceutici SpA
BRISTOL-MYERS
8.1 mmol/ l
-
usually
Changes in strength
prophylaxis
N-dealkylation is
and clinically
clinically
OF UNUSED MEDICINAL
insulin therapy
)
a
patients
1 ml
28 x
into a vein (
dehydration
(
may
mg
( see
in bacterial
exhibited
15mg tablets
the
haematocrit
well tolerated in
read
0)21 272 16
Not all pack
no
The
should be
Sverige Novartis
( e. g. stenoses
R & D
IU/ kg once weekly
)
,
blood donation procedure
6.8
France BRISTOL-MYERS SQUIBB SARL
165 amino acids
10 ACTRAPHANE 20 ACTRAPHANE
EPS was
estimate
( e. g. stenoses
( for pH-adjustment )
medicines known to
) and placebo (
%
of consciousness and
,
of these patients
to 6 weeks
as
, treatment with two
epoetin alfa is
.
the
Patients with hepatic impairment
weight
mg/ day
, in patients
or CYP2D6
controlled
) ,
metastatic disease has
in a pre-filled syringe
symptoms
(
see section 4.5 )
.
Please inform your
AB
on
epoetin alfa
The four
if
and
4.5
by the intravenous
No
50
in Saccharomyces
reported in children .
of
and
Do not
and
blood in urine
and
information on
and
this
become
mmol/ l )
ABILIFY
352
39 % )
negative impact on
mg/ day for four
nitrates , diuretics
+ 47 67 55
should be
face
:
were
unit dose blisters
round and pink
more
D Centre
ml solution for injection
200
The use of specialized
given subcutaneously
lithium or
in the
with a bromobutyl/ polyisoprene
a dose range of
for all
VISTOR HF Sími
in paediatric
CYP2D6
Erythropoietin receptors
IU of
410
45 93 05
and
in strength ,
children over
patients )
41.7 11.9 47.3
kg and adults
AUC
( see sections
normal and anaemic
when
the geometric means
( see section 4.5
the
Highbridge Business Park ,
Uxbridge -
at
valproate or
Oxford Road Uxbridge -
Malignant Syndrome (
30
(
: +44
Beta-blocking agents may
mg/ m2 )
dosage
35 trials
normal
pneumonia
total dose of ABILIFY
two or more
.
E951 ) Acesulfame potassium
additional benefit .
10 consists of
controlled
clinical trials with aripiprazole
see section 4.4 )
and
Actraphane 10 consists of
patients
Aclasta
As
( see section 4.4
N-dealkylation is
.
of anaemia
is recommended , therefore
with
undergoing dialysis :
pharmacist how
, insulin (
In
major
and safety of
4
section
+ 353
( 2°C - 8°C
)
)
and
pup
maximum daily dose
4.4 ) .
applied
(
treated
and
aripiprazole
.
Pioglitazone is also
when
with normal
ability
subcutaneously ) .
unconsciousness
with Aclasta tend
Concomitant osteoporosis therapy
intensify and prolong the
may
%
In
cerevisiae
)
treatment
with
achieved
trials have
can significantly impact
-
(
with excessive sedation
The orodispersible tablet
) to
clinical
characteristics of aripiprazole
In
15.7
this leaflet
human dose
treatment of diabetes
blood pressure and
.
patients
body fat distribution on
day .
when
4.8
Saccharomyces cerevisiae ) .
.
be reduced
silicon
month ,
in
with a
300 gastro-intestinal
maximum
other erythropoiesis-stimulating agents (
, may
when administering paclitaxel concomitantly
It
- United
section 4.4
it may
People
safety and efficacy
disorder .
.
section 5.1
concentrations , aripiprazole
intensify and prolong the
Aluminium perforated
to
( CB1 ) receptors
side effects
+ 358 9
of which were
time
.
g/ dl ( 1.25
ABILIFY
,
e. g. ,
characteristic
placebo
without
Additionally , aripiprazole
Cmax
,
98 tablets
use in
.
( see
( 7.5
m²
be monitored closely
Uncommon -
28
PARTICULARS TO
Abseamed
a
or
)
section
if the
of
blurred vision .
see section 6.1
( see
4.5 ) .
within
Linear Analogue Scale (
( CLAS )
insulin ( human
501 76 03
done
of the
)
with
Aggressive
%
of 15
clinical studies ,
anaemia
the haemoglobin target range
.
(
myocardial infarction or stroke
should
the other
defined
or
( see section
change in aripiprazole concentrations
conditions
hypertension
be
, hyponatremia
is achieved ( this
and
in healthy
children .
In
Common :
+ 44
increased
or diuretics
,
the administration of
Overdose of
of
BOX
OR WASTE
crisis
and 3A4 .
Like
Centre ( Europe )
anaemic rats ,
of the absorption
6.1 .
risk
)
& Co KG Kuhloweg
20 NovoLet 100
discontinuation of treatment .
49 x 1 tablets
Uncommon :
human
aripiprazole
machines
section 4.8 )
.
pre-filled syringe of
or
All
of the nursing
pioglitazone
alfa is
due to co- morbidities
dosage
in cancer
renal insufficiency
or
with
pre-filled syringe
Annex I
of
vials x 10
( 7.5 mmol/ l
the reach and sight
A
AST )
osteoporosis , Aclasta was
mg should be
In order
and sight
and
recommended ( or if
important signs and
and
leaflet
should be advised accordingly
(
rechallenged with paclitaxel
characteristics of aripiprazole
)
increased
erythrocytes from
information
Limited Wimblehurst Road Horsham
doctor can recommend
(
) .
(
prophylaxis
+ 353 ( 1
As for other
in
14 ,
subcutaneous use of
a pre-filled syringe
before injection so
renal anaemia ,
Glutamyl Transferase (
injections
epoetin
not recommended
in
Arzneimittel Pütter GmbH
Common : fatigue Psychiatric
, glycine
(
In
Omission of a meal
)
56 tablets 84
Co KG
Hunton House
12 g/ dl (
.
metformin ) were
tachycardia , nausea ,
MUST
.
be
Abilify is
6.1 )
these
.
.
times per week
section 4.6 )
tell
exhibited
a maximum volume of
anticancer medicine
.
As with
greater than 14
daily
( see section 5.1
Patients with
( see section
to maintain urea
alfa is a
cartridges
is
a similar decrease in
to
9.75 mg (
insulin .
OR WASTE MATERIALS
tongue .
effects of aripiprazole
dehydro-aripiprazole the
(
44-20 )
and sight of children
male and
.
CYP3A4 ( ketoconazole
replacement insulin which
.
diabetic
.
aripiprazole
.
3
erythrocytes from
contain lactose monohydrate and
10 and 12
these trials , a
Actos 30mg
pregnant women .
to
treated
pioglitazone as hydrochloride .
alfa on
RH12 5AB
with renal
that
of efficacy
-
)
at
see section 4.5 )
Holder :
CYP3A4
phosphate dihydrate
neuropathy
manic
tremor
mmol/
another ( see
Foetal growth restriction
1HU - United
well-controlled trials
have
.
and
increased risk
section
in
disorder
1 ml contains
elderly
hydrochloride )
patients
by the intravenous
to ensure
CHMP recommendations
appropriate dose adjustment
speech disorder , Neuroleptic
of anaemic patients
Analogue Scale (
and
were linear and dose-proportional
of the
800 )
haemoglobin level
before
,
the skin (
1
ketoacidosis or hyperosmolar
dose
in CHO
D Centre ( Europe
United Kingdom
between 9.5 and 11
a
to the
and diabetes mellitus
for the
food
and
of aripiprazole .
see section
ml
(
In
EXP
.
by the liver primarily
are
, vomiting and
supplied in vials
Sulfobutylether -cyclodextrin
recommended starting dose
myocardial infarction or stroke
of 45 mg
few minutes
Results of
8
your
(
take it with
with
events
.
N-dealkylation
solution contains 10 000
( 8.1 mmol/ l
to
of EPS
5-hydroxytryptamine and
Marketing Authorisation Holder
is
the intravenous
and CYP3A4
administered subcutaneously in the
alfa
and
Middlesex UB8 1HU
P-glycoprotein .
Tel
10 cartridges
; none
signs and symptoms
use of
Oral
.
reactions are
Common : extrapyramidal disorder
on the use of
The cartridges are designed
Der Anteil der Patienten
.
on
of in accordance with
patients
AND SIGHT OF CHILDREN
Park ,
IU
than 2 g/ dl
(
Uxbridge -
B-CTx was significantly
hours in
( e.
contains metacresol , which
2653
- 150 30
.
.
SARL Tél : +
% ) following the
Alcohol may
more information
especially
.
,
sulphonamides
may feel dizzy
in
in adult patients
speech disorder ,
of liver cirrhosis
31 34
ACTRAPHANE 20 ACTRAPHANE
was abnormal
chronic renal failure patients
( 6.2 -
This
Abseamed
of 600 IU/ kg
,
events compared
in one of
,
blood cell production .
of akathisia was 6.2
12
the levels remain the
%
7.5
with
receiving chemotherapy
1 , 5
isophane (
delayed
per month
)
and
the CHMP
Takeda Global R
a clinical
treatment with epoetin alfa
2C19 (
with
2C9 ( warfarin )
Lilly Holdings
Manufacturer Novartis Pharma GmbH
Pivotal Fracture Trial
300 IU per
124 PARTICULARS
In the indication
after dosing
controlled clinical studies ,
on one side
serious
or
your doctor or
the injection
somnolence
Before
patients in
than children
Skin reactions such as
IU/ kg 3 times
Die
somnolence ,
.
with epoetin alfa
A
Serum
listed
is
week by
increased risk
RIO-Diabetes
see section 4.5 )
15.7 % for
hypertension .
trials
.
adjustment
contain 0.7 ml (
second trial utilised
of
anaemia
einer kürzlich erlittenen
0.8 ml
Abraxane
is
in
a
Its exact
24 and 36
for
in
monotherapy
Rimonabant
Proportional increases
the
solid
dose adjustment
contraeptives , thiazides
especially
over 30 kg and
surgery and
dihydrogen phosphate
The possibility
mg
One IU ( International
of
the
a
placebo-controlled
MATERIALS
or
REACH
longer
with consideration for
5000 IU/ 0.5 ml
,
FACT-An
Tlf
incidence
tachycardia , nausea ,
) corresponding to
10 g/ dl
to sudden stabbing migraine-like
0)20 3116 8000
) .
or without
and 3.0 %
this study
APPROPRIATE
.
-
the
, please tell
large controlled
in monkeys ,
: + 358
therefore be applied .
occurred
reported
acute
administered
, peripheral
symptoms over 3 weeks
in this
average duration of
Uxbridge - Middlesex
is therefore
SQUIBB
aripiprazole
mg paclitaxel
with ABILIFY
temperature regulation disorder (
three days.
76 % had >
des
sulphonylureas
section 5.2 )
section
inhibitors of CYP3A4 (
alfa in adult patients
patients
the intravenous route
injections
toxicity
Park , Oxford Road
consists of 165
After
.
patients
danazol
or without
Road
of
section 6.1 .
patients with a
Be sure
hypoglycaemia
patients
planning to become pregnant
16 to 23
in
by the intravenous
(
from light .
, the dosage
greater than
+ 47 67 55
or if
tongue
, engraved with
and isophane (
the pack
placebo , or were
, sedation , headache
cerebrovascular adverse events
will
see section 4.8 )
mellitus :
six
.
.
Linear Analogue Scale (
monkeys after repeated
Common : dyspepsia ,
anaemia with
see section 5.1
.
other
- Middlesex UB8 1HU
4.7
to 16736
have
blood pressure
.
, 1,18 ;
also be used
.
a full range
of administration ) .
Tel : + 43
a
.
)
Studien bei
As for
lactose monohydrate
.
for
human
In patients
: + 32
What
a
doctor
.
will
1 pre-filled pen
Close supervision
take possible interactions
mg
wide .
Committee
was 12.1 %
pre-filled pens
metformin or
is
clinical trials
patients with
injection
( 2°C - 8°C
haemoglobin concentration should be
Uncommon - Peripheral neuropathy
normal and anaemic
possible
.
.
% .
mean weight increase with
:
4.5
prophylaxis
and transport refrigerated (
intermediate-acting combined
once a
clinical trials
, nausea
site conditions Common
ml
4 or
and
.
sodium hydroxide
using machines
30
section 4.4 ) .
: +
cerevisiae
.
to the active substance
.
reports are based on
than
indication
should be
is achieved
49 ,
and/ or non-healing
Try to take
Road
and
, or
dose reduction
of
provide additional benefits
in Bipolar I Disorder
amino acids
bone marrow cells
no significant
see section
patients scheduled
other medicines Please
g/ dl
blurred vision
rash )
haemoglobin of greater than
20
of these patients
or
its use
10 000
trials , rare cases
)
reaction
It may
all
medicines called antipsychotics .
see section
Suomi/
of daily
Cmax
ABILIFY
be
with pioglitazone .
251 21 230
, IF
is
Actos 45mg
12 g/ dl
with epoetin alfa
3 weeks .
of
The
- This
.
hypoglycaemia
and infiltration were
metformin in
6 hours
and "
Tel : + 44
; 95
,
Pharma
history of
A/ S
)
over
more weeks after
London
two
absorption
of
chest pain
akathisia
; 34 %
Treatment of
few minutes
:
not
When a dose adjustment
(
ABILIFY
22
.
insulin requirement
R & D Centre
from hypoglycaemia
3
.
)
for
myocardial infarction
44 (
, vomiting
.
transport
packs of 14
may vary with
,
100 IU of
: + 45 45
be more common
peripheral neuropathy
Pharma GmbH
haemoglobin
hepatic impairment on
like headaches as
00
treatment with the product
side effects (
,
corresponding to 75.6
trial of pioglitazone
44-20 ) 74 18
human , rDNA (
contains
of the
,
than those observed after
mg tablets
of
) .
which
, nausea , constipation
tiredness
, reduced
The safety and
House Highbridge Business
mg
drink the
a medicine containing
insufficient safety information
Abseamed 2000
, dizziness ,
of adult patients
, constipation ,
,
severe
in cancer
your
ACE ) inhibitors ,
. emea
( 30
no adequate and
you are breast-feeding .
% )
is contraindicated
7.5 mmol/
about hurting yourself
Global
with
hours
These symptoms can temporally
the pharmacokinetics of
vitro
or
copious amounts of
ABILIFY
, sodium citrate
given
SQUIBB SARL Tél :
mixed episode
pre-filled syringe of
Uncommon
rare cases of NMS
46 avoided ; guidance
EPS including parkinsonism ,
THE WEEK
defined
Abseamed
cyclosporin ,
ml and
in children
Kuhloweg 37 D-58638
to patients with moderate
30 - 100
.
2000
THE
with
.
observed
If
15
with epoetin alfa
, especially infections and
month , or if
, London ,
( 6.2 mmol/ l
,
alfa ,
10
inhibitors of
( 5.9 -
with epoetin alfa is
sodium chloride
and
the
events ( see
and
, the bioavailability of
human
or
of
.
( NMS
placebo
a
should
and 47
Tlf : + 45
human
use
There is
doctor immediately
indications .
with pioglitazone .
SQUIBB GESMBH Tel
extensive extravascular distribution .
17
the use
with alcohol or other
a
see section
In
of
Aclasta
and 70 %
)
occur .
blood
) .
with
well-controlled trials of
1
Aclasta ( 5
10
nausea , vomiting
alfa
Actos is
than 1
please see section 4.4
some of
which
Hunton
ingredients
mg pioglitazone ( as
.
increased risk
rhabdomyolysis ,
the
on the pharmacokinetics
ml
see section 4.8
therefore
SQUIBB
)
Hydrochloric acid (
( see section
Tél/ Tel :
sustained haemoglobin exceeds
than 1
8.1 mmol/ l )
Oral
been performed .
not
Patienten ist
KG
should be
of 33 -
.
epoetin
other causes of anaemia
may
of Abseamed
30-36 Avenue
unused product
analogues for injection
39.0 , 55.3 ]
to maintain haemoglobin values
clinical trials that
and
isolated cases of
90 and
with
) .
.
3116 8953
and
below 100
without
epoetin alfa
%
,
testosterone suppression was
patients in
of 100 % .
have
initial dose is
based on conventional studies
)
with
been
Highbridge
doctor
Like all medicines
The
Aripiprazole
16 to 81 times
after
exhibited
Aclasta as
QT prolongation ,
14
Actraphane
Sussex
no
kilogram ,
study
to
of this population
,
1
injection site
ABILIFY
1 g/ dl
elimination
the medicinal product has
or valproate
Middlesex UB8 1HU -
OR
1.25 and
0.5 ml
a
with
haemoglobin (
or severe
1HU - United Kingdom
and
When
3 times
comprising 5
200
complications
( See section
H1 receptors
bipolar patients was 12.1
under
mmol/ l
illnesses and mood disorders
(
incidence of EPS was
The syringes contain
Aripiprazole
23 mg )
OUT OF THE
more than
,
be
section
45 mg
treatment
BRISTOL-MYERS
and water for injections
, with consideration for
) .
cell line by
the intravenous route
signs
recommended
BRISTOL-MYERS SQUIBB (
included
In a clinical trial
on
, are
patients
evidence of
As with
see section 4.4 )
.
FACT-An
Frequencies
blood pressure
trials and
tablet contains 15mg
the dose should
supervision and monitoring should
19
controlled clinical studies ,
from light .
medicinal product contains
.
67 55 53 50
of CYP3A4 ( ketoconazole
section
weakness
and
serious cardiovascular events was
Common
24
and
: fatigue Psychiatric disorders
local requirements .
of
clinical
of the six identified
Always take ABILIFY
There is
have recently
patient
0)810 410 500
recommended (
insulin
surgery
,
lithium
and 5-hydroxytryptamine
units in increments of
.
, 174 gynaecological
indication
)
x 1
and
, nausea ,
you
,
CYP3A4
patients
should generally
60
dosage of ABILIFY
each day .
In
Patients with hepatic impairment
, nausea , constipation
rimonabant
,
in pregnant women .
PRODUCTS , IF APPROPRIATE
treatment
is always well below
Be sure to
.
:
systems ( durable
l ) .
or
,
Gastrointestinal disorders Common
significant
the
of
( see section
UK Ltd Tel :
Erythropoietin
trials of aripiprazole
with
) 731 1736
signs and symptoms of
between
Bagsværd
The
44
of the art
increased Gamma
your doctor
trial
the
defined
In clinical trials with
improvement
of anhydrous
27 % of the
trials and
insulin
by an
.
in this
be reduced
symptoms of hyperglycaemia
) per ml
measuring cup and
extrapyramidal disorder
to
alfa
,
5.3 ) .
OUT OF
or
epoetin alfa
,
similar to
peak is always well
hours
of the
1
of schizophrenia
4.5 )
compared with patients
myocardial infarction
2 352 74 60
)
,
drive
, use of
to look at
, the incidence
total administered dose with
,
e. g. during
vascular events ,
acid blocker ,
monoamine oxidase inhibitors
The
in healthy subjects ,
These measures
the intravenous route
or mixed episode of
for injections
the
with a manic
see section
)
: in clinical
AND EFFECTIVE USE OF
per month
and 3.2 %
and
a negative impact on
:
subcutaneously )
cartridge
than 2 g/ dl
of controls
mmol/ l
tablet
Allé DK-2880 Bagsværd
of recombinant human erythropoietin
by
see section 4.4
.
( this
4.5 )
major elective
the relative
( hydrolysis ) sites
micrograms epoetin
CYP3A4 and CYP2D6
and pale mucosae
retinopathy .
aripiprazole
3000 IU/
with diabetes
feeling anxious
Hypotension ,
5.3
,
with
of clinically
insulin
dysmotility and
) .
OUTER
.
were excluded
be of 25
Denmark
tell your doctor
Aclasta therapy If
is catalysed
ABILIFY is effective
of
Always take the
%
machines , until
1
results
What ABILIFY looks like
effect .
patients dosing should
.
Centre ( Europe )
:
and
with chronic renal failure
33 ( 0)1 47
OR STRIPS
(
be adjusted
ml
Thus
antihypertensive treatment .
in the case
aripiprazole dose
,
cancer
: orthostatic
rare cases of NMS
haemoglobin of
potassium in
.
aripiprazole and
in these
( see section 4.4
growth factors
21
44 ( 0)20 3116
(
: + 354
or
( see also
mellitus ( see section
side effects
AST ) , increased
Europe ) , Te
effect , which
: + 39 06
psychotic symptoms
is therefore
section
were
to function safely
section 5.2 ) .
tiredness
be a moderate
Name and
rare ( see
/ N. V.
)
discontinuation of treatment .
)
aripiprazole
starting dose is
e. g.
aripiprazole
in
are therefore affected
These effects
on
for one
statistically
of
the
solid tumours
the administration of
in
)
results of
be adjusted
12
should
.
and beta-sympathomimetics ,
corrected
mellitus and heart disease
VISTOR
necessary
with
) .
17
of
Kingdom
anaemia in
Adjustments of daily dosage
, ventricular arrhythmias
and haloperidol 73 %
this
) should be investigated
of
,
Units
.
route
akathisia
or insufficient
clinical trials
for all
section 5.1 )
.
sedation ,
thoughts
of
disorder
The recommended
with aripiprazole and
) or the
significantly
01
France Laboratoires Takeda Tél
, increased Gamma
of 10
lung ,
.
21
and
- if
blurred
0.035
or as
Suicidal thoughts and
nausea , vomiting
.
Industrial Park Westhoughton
( warfarin )
.
)
product
between 17 and
of
response
e. g.
.
in routine laboratory parameters
isophane insulin .
3 x
40,000 dalton
12
in
aspiration have been
Abilify and placebo over
with
single intravenous
studies
, the incidence
( 0)810 410
to 2
5HT2a receptors .
approximately
per
following
including
90 %
or waste material should
Within each
symptoms
increase 40,000/ µl or
98 and 500
is
wastewater or household waste
( see section 5.1
the
majority of patients received
When concomitant
( SBECD )
Before use : store
.
of the
50 IU/ kg
any remaining contents
PARTICULARS
of erythrocytes from precursors
controlled clinical studies
.
aripiprazole
desired effects should be
It
such as
2 g/ dl per
15 mg once a
Kingdom BRISTOL-MYERS
no
( DVTs )
please see section
4.8
mother presents no
injected
reductase inhibitors are
animal models of
PARTICULARS TO APPEAR
blister
to be compatible
( see
and slowly
(
,
75 and
e.
extreme and associated
are pregnant ,
corresponding to 50.4 micrograms
differentiating hormone
of
and
or
vitamin
in agitation/ behavioural
the
insulin 40 % and
Suomi/
contains
the placebo group
hypoglycaemia may
over
Following recurrence of
other causes of anaemia
6.2 mmol/ l
.
insulin
days after
the patient s
des
, or if
; suicide attempt
.
between 10 and 12
: in clinical trials
to protect
you
trials of aripiprazole ,
) in vitro
1 tablets 56 x
epoetin
fractures
or
prior to
this
combined with
veterinary surgeon
.
If
,
,
Der Ausschuss für
Tél :
events in
,
Single and multiple 5
)
Common : somnolence ,
and
interaction
enzymes
based on
a
with aripiprazole
to any
ml
of pioglitazone as
only
should be monitored closely
cases
4.4 and 5.2
per
has
If
,
-
40
Treatment with
of
(
used
crisis with encephalopathy-like symptoms
that ,
, only in
treatment
or
,
SQUIBB GESMBH Tel
that pioglitazone
with solid tumours
M-III
.
In CYP2D6
and symptoms reported
effective
including
Sverige Takeda
also
2
an increased
Suomi/ Finland OY BRISTOL-MYERS
30 mg orodispersible tablets
(
.
reduce the epoetin alfa
placebo
) or the
An
a prospective ,
1 tablets 49 x
:
route ,
of the
vein (
for
1.1
symptoms over 3 weeks
and
.
.
) ,
300 IU .
30-36 Avenue Gustave Eiffel
, 15
cloudy after resuspension .
PRODUCTS OR WASTE
BRISTOL-MYERS SQUIBB
with
24-hour
g/ dl (
,
by the
12
in
ml 6
or combination therapy (
no significant
experience in this patient
p rst vniec
in one of these
the local representative
data
15 mg orodispersible tablets
des
of
x 1 orodispersible tablets
300 mg/ m2
, hydroxylation , and
,
20
how
Uncommon -
and mediastinal disorders
,
than 2
aripiprazole
is
and should not exceed
,
6.1
that primarily stimulate
)
.
Before use : store
, thyroid hormones and
( see section 5.3
Adult cancer
was
glycaemic control may be
UB8
) .
Takeda Global R
endpoint was 5.8 for
patients
predonation
haemoglobin (
.
if you
In
( two studies
well
The safety of
by
see section 5.1
may also
In
section 4.4 ) .
in CHO
intervals
peak is always
Tel : + 46
of the
or death
a few weeks .
%
(
: extrapyramidal disorder ,
the
it may
should be
)
148 MINIMUM PARTICULARS
ml contains 1000
.
and
on
Tél : +33 (
0.4
hour ,
the desired range
family history of diabetes
and precautions
Effects on
( see
These
.
Correction for
If ALT levels
42 trials and 8167
international units
primarily
with atypical antipsychotic agents
with placebo .
first treatment
other
with
Abseamed has been injected
section 4.4
one side
,
increased to the level
with fast-acting
see
section 4.4 )
patient be aware
39 06
Abseamed
of dosage may
( for pH-adjustment )
blood sugar (
did not
. ) .
( see
republika
schizophrenia and
Additional supportive
Gamma Glutamyl Transferase
and is
e.
increase
by the intravenous
MAOI ) ,
less
Nebenwirkungen , die
Polysorbate 80 Water for
direct- acting
is dietary control
if you are breast-feeding
Based on results
( IU
epoetin alfa
indication increasing
A half-life of
to
36
10
,
syringes contain 1
:
a full range of
with or
11 g/ dl (
hours
dextromethorphan
all
diuretics that
patients
be
99 % ) .
may
to any
side effects
Europe ) ,
or 24
the thighs
pectoris ,
of
GmbH &
Epoetin
contains 3 ml
maximum of 30
(
contains 4000
or
000 IU ) of
,
) per
and this
25
not
by
and sight
intravenous route has to
please tell
or
each day .
alfa on
renal impairment
and mainly via the
insulin
during treatment with
haematocrit of
with
doctor carefully before
pen cap on
of
patients
intentional acute
and 11 g/ dl
under
in
.
of
aripiprazole ( 30 mg
These
no medically important
reported in children .
( IU
221 multiple
,
see section 6.1 .
for 2 weeks
corresponding to 67.2 micrograms
not
days 21
+ 358 ( 0)9
of
patients with
in
ABILIFY is and
in bacterial
)
endorsed (
,
of EPS including
)
the
your dose of
chemotherapy
5.1
0.3 ml
trials
a
placebo-controlled trial
)
doses
from
and 8167
the effect of Actos
and 4.9 )
oral
the
24 hours
1 ml 6
,
not greater than
units ( IU
effect of
young subjects .
: in clinical trials
, nausea
significant
for longer
ml (
In controlled clinical
60
europa . eu/
some cases
administered intramuscularly as
with
) .
Cmax and
Tel . :
BRISTOL-MYERS
.
8°C )
61
0 ) 30 60
The recommended
for
patients with hypocalcaemia
other
tablets
The patient s ability
Business Park , Oxford
irregular heart beat
( see
oral solution
life parameters on
Syringes are
im Nervensystem zu finden
100
age
fat mass .
Road Uxbridge
for males ) .
)
significant effect on
BRISTOL-MYERS SQUIBB BV
patients with chronic
(
a
and
1.25 and 2.47 in
, including PANSS and
.
Authorisation
has
contains 6000
not routinely
diabetes
- 8°C ) .
, especially
15
Actraphane
,
Each orodispersible tablet
4.4
insulin and
Die
and completed suicide
0.5 % )
olanzapine-treated
Co-administration
If
VISTOR HF Sími
should be
adverse
precautions to avoid
administration of ketoconazole or
of 0.3
medically important
republika
Overdose of epoetin alfa
patients
insulin in combination with
described
In
of aripiprazole .
.
mmol/ l
tell
(
) .
is
of
medicine
16 00
in patients
the
haemoglobin
Takeda
well
Road Uxbridge - Middlesex
TG in
haemoglobin is
.
The
injection route
epoetin alfa is
thigh or
severe
the gluteal region or
Hunton
interaction
the
6
controlled
incoherent speech
general scale
may result
total weekly dose
The maximum daily dose
Actraphane .
sizes may
.
PRODUCTS , IF APPROPRIATE
IU )
a
occurs ,
Tel : + 44
The formation of these
for
6 pre-filled syringes of
In the four placebo-controlled
e. g.
300 IU/ kg 3
animal model of familial
,
12
% of
.
rhabdomyolysis ) ,
EPS was
of
mg
epoetin
) .
( insulin
Following subcutaneous injection
.
CONDITIONS OR RESTRICTIONS
1 ) 524 40
- Produtos Farmacêuticos
peripheral coldness ,
the haemoglobin
missed dose
:
parkinsonism
bisphosphonates .
The following
whose arteriovenous fistulae
10 Patients
In combination with
g/ dl ( 0.62
or 24
before taking ABILIFY
agents
12
defined
91
sections 4.3
other
and what it is
vitro
should
within three
by the gp-60
investigated
Very
524 40
of patients
.
of anaemia associated with
)
injection sites .
per dose
IU/ kg
the reach
hypoglyceamia
Generally ,
and
disorders Common :
and
interactions resulting from displacement
; suicide attempt
monitoring
renal insufficiency .
in Saccharomyces cerevisiae )
.
only
as
1.5-2.5 hours
THE
30 kg and
.
starting dose for
dose
to co- morbidities
between 17
this should be
veterinary surgeon
.
associated
thyroid hormones
than
aripiprazole concentrations
USED FOR
women
( normal and anaemic
because of the
isolated cases
2°C - 8°C )
(
and
another
g/ dl
diabetes mellitus , diabetic
of one year
redness , swelling
A sustained haemoglobin level
What ABILIFY contains
( Europe
disorder , akathisia
either Actos or
recommended that
)
of 33 - 39
contains
contain 0.9
is especially
CYP3A4
be presented .
UB8 1HU
x
hospital and take
( AST ) ,
patients with
ischaemic
of treatment .
Centre
PRODUCT AND ROUTE(S
, but
veterinary surgeon
Actraphane 40 consists of
for
patients
aripiprazole ,
contain 1 ml (
,
of
and oedema
die für
R &
, Lda Tel
außer
cannot be excluded
see section
,
0)9
events
)
-
hypersensitivity
1.25
mmol/
CYP2D6 .
(
unlikely to
30 60
5.2 )
sustained haemoglobin level
treatment of
are breast-feeding
see section 6.1 )
of recombinant human erythropoietin
The
cerebrovascular adverse events
clinical trials with pioglitazone
M-II is minimal
.
, itching ,
dogs
packed cell volume .
, a potent inducer
than 2
with epoetin alfa
pioglitazone
and aspiration have been
The initial dose
,
may occur
in
( see section
packed
Hypocalcaemia In clinical trials
was administered concomitantly
urticaria
carbohydrate chains
In addition
von
e. g. stroke
(
drug reactions from
other erythropoiesis-stimulating agents
aripiprazole ( see
soluble insulin 10 %
( 30
on the
Within each
without psychotic features
Abseamed 6000 IU/ 0.6
during
mg intramuscular
approximately 60 %
is
placebo
that
0)21 272 16 00
week by
)
6.2
Business Park , Oxford
not to be
3 times
the
( heparinisation )
It
12
is given 2
:
Treatment
and sight of children
alfa is very wide
or nurse
haemolysis , blood loss
on
a reduction
and
during the course
Lda Tel :
of aripiprazole
Pre-filled pen
international units
vomiting
vomiting
or
40,000 dalton
, thiazides
( 0)20
how your
If
of
91
half-life ( t½ )
Norge BRISTOL-MYERS SQUIBB
doctor or pharmacist
vascular events ,
(
with
haloperidol 73 % )
temperature regulation disorder (
patients
25
should be
Cancer Therapy- Anaemia
other ingredients are lactose
,
alfa and other erythropoiesis-stimulating
population ,
.
,
half-life of approximately
machinery
,
Gamma
( and , with
before
or
risk for
and
:
4.3 and 4.4
of white
with epoetin alfa
in all
see section
Novartis
not recommended for anyone
should generally
4.5 ) .
placebo-controlled
crisis with encephalopathy-like symptoms
reach
1
therefore
The procedure for reconstitution
be adjusted
occurs
of akathisia was 6.2
of administration ) .
looking
iron stores .
and Cancer Linear
,
( 6.2
sc use
, less
and other
(
corresponding to 58.8
.
included only
not
injections in
over the duration
8°C
insulin 20 % and
metacresol , which
)
dated Final
Cancer Linear
( Europe )
or
.
11.6 63.8
.
one syringe
sustained haemoglobin exceeds 12
(
or
be
corresponding unit scale .
and approximately
with
of
per se
& D Centre (
COMBINATION THERAPY WITH
For
( see
+ 39 06
clinically
, especially
after
section 5.3 )
study )
Aripiprazole is well
may
in patients
at the desired level
( for pH-adjustment )
studies
42
of
significant risk factors
Mildly anaemic
, especially in
or
Actraphane is usually
) to 12
rats
Consequently ,
is
Potential for other medicinal
: + 47
daily dose should
patients (
intravenous
As
to reproduction
of this population
117
other handling
)
production
,
The syringes
delivery system must
may
the CYP3A4 inducer
observed in clinical trials
hypoglyceamia
alfa ,
cases ,
not been established
approximately
-
of 12
802 with
started as soon as
higher dose to
infection or
type III
200 -
a measure of the
France BRISTOL-MYERS
of 33
gynaecological ,
Highbridge Business
make sure
more units
or 450
see section 5.1
dose
epoetin alfa
used
be discontinued immediately
Physician educational material
Danmark
per month or the
OF UNUSED MEDICINAL
in
)
%
56 ,
about 40 %
CONDITIONS
aripiprazole s efficacy
Syringes
controls
was 12.1
humans
instructions given to
BRISTOL-MYERS
of progression of diabetic
settling are
not
4.4 )
that pioglitazone
in patients
g/ dl (
1 pre-filled syringe
with
package leaflet before use
5HT1a
D Centre
doctor or
to other
( see
the
you to
) .
rimonabant
Nervous system disorders
may
metformin
) insulin .
-
In clinical trials
be monitored closely
Starting dose
before
is
ideas and sometimes
mg
/ N. V.
(
United
Actraphane is
In the indication
other
( AST
not
of
AUC and Cmax
high fever
lorazepam (
adults .
( AST )
a
to IV
recent low-trauma
metabolism of paclitaxel
The
NPH
tell your doctor
Oral
Novo
patients with
,
and sight of children
.
other antidiabetic medicine (
line with the recommended
epoetin alfa
Hb between
headache in
section
patients
.
SAFE
dehydration and pale
%
warning symptoms of hypoglycaemia
,
standard genotoxicity tests
human tumour samples
STATEMENT OF THE
,
risk of cross-reaction
,
and
dose
day ) .
of
experience
four carbohydrate chains are
45 45
unused product
quickly with racing ideas
and adolescents under
( see
.
.
)
) Ltd 61
with
women
ABILIFY is not
tablet
2°C -
:
251
, sodium hydroxide (
1 ml contains 2000
and of the
haematological malignancies .
( 16
,
N-dealkylation
) .
:
,
40 %
a clinical
1
is
358 ( 0)9
have been reported
from light
g/ dl ( 1.25
MANUFACTURING AUTHORISATION
weight decreased , anorexia
of in accordance with
either sex
recommended dosing regimen is
TO APPEAR ON BLISTERS
see section
)
anaemic
in
in
(
differentiating hormone
epoetin alfa
dioxide ,
moderate binding affinity for
United Kingdom
is a
mg
. dic Me
and
units ( IU
BRISTOL-MYERS
, especially in
.
.
Research and
or
Treatment of symptomatic anaemia
double-blind
between the
clinical
E171 )
in
days
The
,
the reach
section 4.4 ) .
is
gait
affects you
( 7.5
could not be detected
within
+ 44 ( 0)1628
had
( e. g.
on
room temperature before administration
of 50
overall burden of disease
elevated liver enzymes and
children under 30
30
rat
of medicines used
2-78
.
However ,
)
diabetic hyperosmolar
may
In the four
the insulin requirement
please tell your
has not been
should not be
CYP3A4
in clinical
People with this
agitation before use .
treatment with
of aripiprazole .
other
Ltd Tel
% .
is
18 84 00
of excipients , see
30
6 hours
Abseamed or
VOLUME
in type
placebo
,
storage conditions .
EPS was
with
of these
OR
dose
and
, treated
2 weeks
Febrile
pioglitazone
alfa and
( produced by
the pharmacokinetics or
use
after the
are
to drive and
)
use machines have
t½
hyperglycaemia
symptomatic
a meal
pre-filled syringe of 0.4
not
in
variation .
ABILIFY can be
: +
recombinant DNA technology
your doctor or
1 tablets
whom
of children
5000 IU/ 0.5
insomnia ,
be
Zoledronic acid belongs to
50 % and
or less duration ,
in
clinical studies ,
weight gain ,
clinical trials
receiving chemotherapy ,
(
for ABILIFY is
Tel : +371 7364000
Kingdom
with
(
50 IU/ kg
haemoglobin
and
peak is always
Very rare -
of
In a
a
with
of greater than 12
after
.
.
monoamine oxidase inhibitors (
or
1 CONDITIONS
for all cancer patients
: orthostatic
in the
IT IS USED FOR
pre-filled syringe of 0.5
of orlistat , ethanol
than children
l )
-
in
growth factors
6-month comparative
Storbritannia
most
a mean total
Luxembourg/ Luxemburg BRISTOL-MYERS
Frequencies of adverse
:
serum proteins
unknown .
.
trials and 8167 patients
4.8
AUC
with epoetin alfa
and
during
cause dehydration
how
symptoms
was
patients scheduled for major
(
two
is therefore
.
When
haemoglobin ( 1
preventing recurrence of manic
not
alfa .
be discontinued
30 ACTRAPHANE
may be
and 53.3 %
ise or uth
be stopped
alfa
and 12
for
cancer patients
In the
The
(
or if
section 5.1 )
type
+ 354
monoamine oxidase inhibitors (
)
neurotransmitters
including
microcrystalline
only in
was
What benefit
: +3726441100
8000
28 tablets 30
use
95 % CI
or
of 12
Nausea occurred in 29
and haloperidol 73
BRISTOL-MYERS SQUIBB
.
moisture
is 15 mg
medicinal product
keine ausreichenden Daten am
instruction for use to
84 , 90
tablets
30 mg )
)
g/ dl (
if
haemoglobin
1 )
hours
may be a moderate
forms of interaction
mg
or worsening
blood pressure
hydroxylated metabolites is catalysed
measures
If you
Allé DK-2880 Bagsværd Denmark
with sulphonylureas or
2 352 74 60
( see section 4.5
In the
should not exceed 200
clinically significant change in
contains metacresol , which
take it with
, Oxford
Iron
.
, but not in
dosage of ABILIFY
.
doctor
enzyme (
) should
for
, Abilify was
mean age :
,
mmol/ l ) should
:
Business Park , Oxford
9.5
if
of
aripiprazole
with
preventing depolymerisation .
(
Alle Patienten unter Abseamed
significant
, nausea , constipation
polymer )
3 times per
in adult patients
may also
)
treated
8545250
and
to
tablets
daily dose should
in
reduction of transfusion requirements
effectiveness
23 lung ,
madarosis
after
the frequency
about 5-10 hours
37 Patients
30mg
or mixed episode
Non-clinical data reveal no
that
chronic renal failure patients
per week by
observed
% )
Eye disorders Very rare
.
than
than 2 g/ dl
tablets 28 tablets
experienced
Sími
Renal
by renal excretion
3
: extrapyramidal disorder
1
to
1HU - United
section 4.4 )
of Actos .
Danmark BRISTOL-MYERS SQUIBB
haemoglobin
use in
reconstituted medicinal product
of
ausgeschieden
unable to
of aripiprazole
for
ABILIFY
dose
should be
Fast improvement in blood
Usual warning symptoms may
AB Tel
reports of
Treatment
initiation of therapy
frequency
, especially
reports
doctor can recommend a
not
international
oral administration
6 %
creatinine
(
2°C - 8°C
0.62 mmol/ l )
kg bodyweight
.
and 2.47 in favour
allergic reaction (
diabetes mellitus , diabetic
of
other
international units
not
significant
Tel :
resulted in
of rimonabant
patients with a
If ALT levels remain
.
The
section
experience
severe manic
This medicinal
1
dehydro-aripiprazole
aminoglycosides or diuretics
The
(
for
section 4.4 )
of Bipolar I Disorder
iron stores should
flatness
akathisia was
of
and was
(
See section 4.4 )
358 9 251
insulin
( see section 6.1
Gastrointestinal
administration of epoetin
6.2 -
increased risk
this area
Treatment
clinical
( warfarin )
e. g. stroke
Following oral
e. g.
,
investigator
Vanilla
hyponatremia
Store and transport refrigerated
the
not
investigated
blood glucose monitoring
,
becomes
It
necessary
recommended starting dose
to protect from
insulin
%
ABILIFY in
, 84 , 90
)
both fast-acting
up to 36
Actos
mg/ kg
dyslipidemia
and isophane insulin
Tlf : +
BRISTOL-MYERS SQUIBB AB Tel
in a pre-filled syringe
Highbridge
the intravenous route .
and
for patients
0)20
ABILIFY
may
and
veterinary surgeon how
week
and 15.7 %
,
after subcutaneous administration
(
section
before
of
.
psychotic
1.25 mmol/ l )
7.5 mmol/ l )
drug types were
,
Creatine Phosphokinase
.
enzymes and
disappear
If jaundice is observed
the perisurgical setting
your doctor immediately
Intravenous injection : over
not
levels
in adult dogs .
121 PARTICULARS
to patients with
between 17 and
has Actraphane
35 trials
with solid tumours (
( 8.1
ketoacidosis (
( 7.5
of 200 mg
Mannitol , sodium citrate
the
you have the impression
4.4 )
in
and transport refrigerated
or
if the solution
to protect
signs
of children .
glucose control
As with other
and NovoFine needles
2649600
.
with
,
treatment with
Black
+
headache ,
hepatic impairment on
angiotensin converting enzyme (
use
Insulin suspensions should not
contain lactose monohydrate
,
particularly overweight patients
you
Tel :
, the incidence of
vial provides 9.75
of children
Adult patients with
of 30 mg
ketoacidosis or
take possible interactions
with
should be
73 % ) .
, especially infections and
House Highbridge
renal
hours
values
g/ dl
.
per
.
dysmotility and
OR
SUPPLY OR USE
the
margin of epoetin
unexplained
fatigue Psychiatric disorders
) were 2 5
Multi-pack comprising
wastewater or
Global R
3.0 % with placebo
of anaemia associated
PFT ]
g/ dl (
Insulin suspensions
VISTOR
benefit has Abilify
controlled
As with other
während der
ON THE OUTER
.
its metabolites
its
hands ,
to
epoetin alfa
Limited
FACT-An ) general scale
Treatment of
see section 4.4 )
13 g/ dl
( see section
as
.
Horsham West Sussex ,
Actraphane NovoLet is
you know how
pack sizes may
g/ dl
third of
incidence (
Wielka
and 10
mg , 15
.
MINIMUM PARTICULARS TO APPEAR
7.5
7000
Aclasta as
20 mg (
Tél/ Tel
(
Accumulation of triglycerides
pioglitazone
Glycine
yellow
administered after
(
" A
your doctor ,
the
is between
Ask your doctor
pregnant women .
The
Hb
contraeptives
( 8.1 mmol/ l
Nervous disorders
tumours
aripiprazole
of
Aclasta-treated group
and patients with
is
recombinant DNA technology
Pioglitazone and all active
involved 2,127
of
,
Starting dose
7.5
13 days
products and
in
few minutes
aripiprazole
,
aripiprazole
puberty or due to
section 4.5
ml
(
RMP should
experiencing potentially
beta-sympathomimetics ,
the
a rapid-cycling course .
see section
( 0)1 46 25
second trial utilised
Tlf : +
controlled
years
the
( 6.2 - 7.5
( 2
mg/ kg daily
but not
the tablet
g/ dl
.
oral
IU/ kg 3
maximum of 30
should be
37
) .
with
and
ABILIFY
attention should be paid
feeling anxious ,
Cancer Linear Analogue Scale
- 150 60 -
10 pre-filled pens
deterioration of
by
) , chest pain
infiltration were observed
alfa alters
and
is effective in
have
)
1
,
,
events
5.9 - 6.8
In patients with
result of hypoglycaemia
clinical trials of
diabetes
units (
bei Patienten
31 (
in bisphosphonate-naïve
, aripiprazole should
( for pH-adjustment )
moisture
controlled
2C19
from the
death in utero
Saccharomyces cerevisiae
another
(
Insulin suspensions should not
are bone
mg/ day
the
(
, Oxford Road Uxbridge
corrected
of
weeks
,
treatment
4.8 ) .
prescribed by
in
akathisia was 6.2 %
& D
12
Hypersensitivity
anaemia associated
occurs with carbamazepine
or
of
this
12 -
( see also section
aggravation of existing
( see section 4.4
Dosage adjustment to
with your
renal failure
) .
anaemia and
over
production .
contains
.
in both groups
patients with
vomiting , an
administered once a day
not
Aripiprazole
medicine
the pharmacokinetics
fracture
to
OR
the haemoglobin is
If you
increased alkaline phosphatase
.
and
Erythropoietin receptors
and
will
mg Fe2+/ day
If
5.2 )
)
49
) to 12
Ltd 61
of
and 2.47 in favour
.
antipsychotics ,
in women
insufficiency .
of anhydrous
administer .
a glass ball to
see
( for pH-adjustment )
.
Epoetin alfa should be
from
.
and
.
As with other antipsychotics
adequate
In
4.3 and 4.4
pre-filled syringe The
for major elective
in
on in vitro studies
and
medicinal
The oedema rates for
PRODUCTS , IF APPROPRIATE
the active substance
One
+ 44
units ( IU
included
for pH-adjustment )
treatment with epoetin alfa
3.2 %
%
, thyroid hormones
.
Ltd.
.
hypotension*
.
vascular events
sustained haemoglobin exceeds
maintenance doses than
hypoglycaemic agents ( OHA
mmol/ l
.
93 05 06
Ask your
medicine works
0.8
.
.
)
alfa
.
g/ dl
AST )
with renal anaemia ,
in Saccharomyces cerevisiae
drive
(
or combination therapy
daily )
21 Fasting and postprandial
if
( FINLAND
serotonin 5HT2c and 5HT7
0.3
,
If any of these
)
3116 8953
similar
RELEASE
, a
metastases
of
.
by
, Germany
+ 351 21
use
The
measures
patient
possible warning signal .
:
pregnancy
a benefit-risk assessment with
tablets
in
if
(
doctor immediately
Treatment of patients
revealed no medically important
in CHO
section 4.5 ) .
in 2.3
by
;
.
.
)
is
in bisphosphonate-naïve patients
, including PANSS and
dogs
clinical
epoetin alfa is very
dogs ,
between
neuropathy , neuropathy
, especially
)
is
Protamine sulphate Water for
A/ S
regularly
t½ of
Tel
steroid pre- treatment
.
30 kg
times per week .
D Centre (
a stroke or
significant
) or
day
2000 international
Takeda Global R
inform
IU/ kg 3 times
months
was
weeks
( see section 4.8
Lactose monohydrate Maize
Uncommon : orthostatic
165 amino acids
received
.
daily insulin requirement
- 8°C
g/ dl
groups
be avoided
2
4.2 Treatment of patients
PRODUCTS OR WASTE MATERIALS
of
pale mucosae
A number of
patients
MEDICINAL PRODUCT
,
alcohol or other
signs
the dosage of
, diabetic
therapy .
The rate
to
In some , but
of
erythropoietin is 32,000 to
no
for
see
D Centre Limited
ml .
5 mg tablets
detected
40 consists of 40
)
solution for injection
planning to become pregnant
and
Takeda
Attention should be paid
, serum levels of
in
dextromethorphan
( reported in
antipsychotic
more
or coma ,
)
intermediate-acting combined
Dose adjustment
if
received
ABILIFY
after subcutaneous administration
mmol/ l )
%
with the recommended
)
20 NovoLet 100
subcutaneous administration
machines
diabetes was
and
,
taking
MINIMUM PARTICULARS TO
an autologous blood predonation
to maintain haemoglobin
be mediated by
after
same
are
common
and mediastinal disorders :
some cases
or
of
should be closely monitored
aripiprazole , there were
should be monitored closely
medically important differences
is no accumulation :
( 6.2 -
the
a pre-filled syringe
study ,
change in aripiprazole concentrations
or mixed episode
should not be
( 1.25
Thrombotic/
5 mg ,
administration
a
pre-filled syringe ( injection
and
150/ 001-003 ,
signs and
of
42 trials and 8167
than 2
mmol/ l )
years Shelf-life after
Use product immediately
5.1
section 4.4 )
as
cerebrovascular
agonists ( LH-RHas
and
international units (
.
,
ABILIFY is
trials
rising by more
Horsham West
diabetic
a pre-filled syringe
effect of
and 10
has
and
of these events is
.
FOLDING BOX ( WITH
, especially
divide
Datum der letzten Verlängerung
with
, the incidence
that
(
In patients
.
greater than 12
International Units ( IU
epoetin alfa .
and paranoia .
baseline .
vomiting , an
It
you
Aldwych ,
well-controlled studies in
There are no adequate
( 0)1
ml
Holdings Limited
see section 4.4
,
The medicine
in type 1
orodispersible tablets
is unknown ,
placebo group
100
0)810 410
Highbridge
alfa
Nordisk A/ S Novo
of which were
, swelling
adolescents under
required
( SBECD )
alpha-1
148 Even
NPH
Detailed information
should be
) .
,
body weight 2 times
subcutaneous injection
,
93 05
overdose with aripiprazole ,
4.4
doctor
Pharma Tél
the four placebo-controlled
see
4.5 Interaction with
Abseamed
alkaline phosphatase level
61 Aldwych
Therefore , no
of
,
3000 international units (
is
Hydrochloric acid ( for
two
recombinant human
Although in
fast-acting
for a longer
the
0.8 ml
approximately 60
or very rapid or
Uncommon -
not been established .
& Co
Hypoglycaemia
with
section
with type 2
) .
packed cell volume .
RESTRICTIONS WITH
absorption .
Abseamed
your doctor or pharmacist
the effect of Actos
( e. g.
in favour
your dose of
352 74
AUC
D2 and D3 ,
of excipients , see
of Abseamed
the
the
- United
of
events
or
survival
not
infusion bag :
Limited atstovyb Tel .
Abilify
pituitary adenoma .
occur ( see
and
abdominal wall
very rapid
SQUIBB
to protect from light
In cases where there
ANIMAL TREATMENT ONLY AND
.
If
to any
and
( not
2 g/ dl
Road Uxbridge
,
g/ dl ,
meal or unplanned ,
(
this
type 2
.
with a
of cleavage
Tel : + 31
with
packed cell volume
a
a few weeks .
,
a
angiotensin converting
should
with
at increased risk of
.
see section 5.1 )
reported in children .
.
of
is metabolised
counts
over 30 kg
dalton .
8.1 mmol/ l )
of the
treatment
In
, Neuroleptic Malignant Syndrome
174 gynaecological
Excretion
syringes
METFORMIN
)
Uncommon
dose modifications in
with
x
mg
If
1
When
Limited
60
or pharmacist .
1 tablets
patients the incidence
( or if
epoetin alfa
g/ dl
.
5.3 )
with aripiprazole and 3.0
( see section
are rectangular and blue
+
other medicinal products :
haematological malignancies
treatment
SQUIBB GESMBH Tel :
, thiazides , glucocorticoids
62
1,000
Aclasta
)
children
.
In a
.
mean age
Abseamed in patients at
mg of
and
instructions given to
overall survival and increased
significantly impact renal function
.
Any unused product
waist circumference
It is not known
and 180-minute infusions of
SQUIBB Tlf
3A4 (
a potent inhibitor
)
administration of ketoconazole
than 2 g/ dl
conditions (
DISPOSAL OF UNUSED MEDICINAL
- 8°C )
animal model of familial
ABILIFY
.
:
(
symptoms
Pioglitazone
2
haemoglobin
during continued treatment
with
4.8
aripiprazole and
) , Storbritannia
In
and
or
patients were receiving insulin
the dose
.
warning symptoms of hypoglycaemia
kilogram bodyweight
53.3 % for
haemoglobin
observed when
unexplained
ml contains
that
( n = 135
,
The
aripiprazole
18
United Kingdom
In clinical trials with
and water
subcutaneous administration .
is
or
Tel : +353 1
timepoints ( 6
significant benefits
to act mainly
or
reduction
concentrations
ready to use (
see section 4.4
your pharmacist
.
over 75
placebo
should
and
In
.
them .
the effect of
ml )
and 8167 patients
(
( see
: + 46 8
the
a
KG , Kuhloweg 37
on the
use of
cases of
6
section 5.1 ) .
six
patients
( injection )
injection :
atypical antipsychotic agents ,
solid tumours (
,
, glucocorticoids
5.3 ) .
be
, aripiprazole
1
described in
and 33 IU/ kg
THAT THE MEDICINAL PRODUCT
the foetus
In clinical
MEDICINAL PRODUCT
or intentional
and
patients
- 150
AB Puh/ Tel
efficacy .
following a recent
a
( see section 4.5
sure
outcome has been reported
before
and female
female
Development Centre ( Europe
ABILIFY orodispersible tablets
&
an approximate
Following concomitant administration
( IU )
increased
taking Actos 45mg
with
of efficacy
Oral contraeptives
-
discontinuation of treatment .
or The printed
two medicines
trials of
( for pH-adjustment )
of
40
section 4.4 and section
reports
dose adjustment is necessary
pioglitazone or placebo
4
the skin
Medice Arzneimittel Pütter GmbH
34
House Highbridge
increased
2 352 74
to tell
: +
and
If you
in patients ( particularly
(
local requirements .
sie durch
Storbritannia
trials and 8167 patients
was
antipsychotic drugs
syringes
75
to 12 g/ dl
clinical
( see section 5.1
patients
The
-
another
REACH
by renal excretion .
,
patients
39 %
in 152
(
25 and 50
(
including rare
should be
mmol/ l ) should
pectoris , increased risk
a meal or unplanned
section 4.8
dose
Population pharmacokinetic evaluation has
is
renal
syringes
half-life of
were
)
rhabdomyolysis
, Te . :
range of insulin suspensions
,
completed suicide ( see
for pH-adjustment
of
)
with atypical antipsychotic agents
dosage
study
, 30-36 Avenue Gustave
levels
This
not
of
% of
and/ or non-healing sores
95 % CI
Global R &
week by
therefore
factor and differentiating hormone
depressive
with aripiprazole
3 patients with
rats ,
with
elective
Aclasta
the body
metabolites is catalysed
.
)
average
of aripiprazole
,
peak is always well
4.8 -
significant effects
95 % CI
The
( see section
Tel
(
1.25
,
local requirements
ABILIFY
some cases
75
not
subcutaneous use of
7.2
trial
The
is always well
N-dealkylation .
,
in type 1
and
,
in
comparable
)
The
with fast-acting ,
may
, oral aripiprazole
OR
one of these
of aripiprazole
full list of all
and
150 30 -
The maximum
section 5.2 )
in
.
trials
% of the
, 30 mg
IU/ kg 3 times
haemoglobin target range
REGARD TO THE SAFE
see section 5.2 )
and
infection or
by injection
cases of seizure
( weeks )
with
planning to become pregnant
)
whom the
in the
less
If
( 1
.
overdose with aripiprazole
to years of treatment
24
patients
the entire
AND THE
dexamethasone
Long-term improved glycaemic
in patients at
hyponatremia
When
OF THE MEDICINAL
As with
placebo-controlled trial
26-week ,
DERIVED FROM SUCH MEDICINAL
CI
after
clinical
Be sure to
with
.
terminal half-life (
alfa
lithium or
( IU ) per
ABILIFY
aripiprazole
starting dose for
minutes
alfa ,
Protamine sulphate Water
75 and
hyperglycaemia and
AST ) , increased
49 x 1 ,
, less than
of
and
compartment .
704 71
of
two minor
,
with
recommended
with
be
32 2 352 74
must not be less
4.5 )
body weight
NORWAY
Usual maintenance dose 75
,
therapy
reported after months
( below 25°C
g/ dl (
restricted
the
vitro
your
is necessary
significantly
90
combined
administered once a year
,
for pH-adjustment
.
APPROPRIATE
therapy
No dosage adjustment
.
D-58638 Iserlohn ,
manic episodes
and
your doctor or
tablet contains 15mg of
by the intravenous
section 4.8 )
Tel :
most
observed .
, monoamine oxidase inhibitors
.
oral
or
contains 45 mg pioglitazone
delayed )
the
discontinuation of treatment .
section 5.1 ) .
or
l
insulin ,
alfa
acute renal failure
24 hours after the
from light
33 IU/ kg
.
only in patients who
weeks
reactions
weight increases
,
second-line therapy .
g/ dl - 12
diabetic hyperosmolar
sometimes severe irritability .
was
and mediastinal disorders
more weeks
oral solution for
observed (
The absolute
:
clinical
in
If you
,
contains
of anaemic patients .
dogs
the medicinal product has
reported in children
international units
is
4.5
5.1 )
48 kg for
NORWAY
type
RH12 5AB United Kingdom
may be a moderate
- 8°C )
in patients with
) .
AND SIGHT OF
by
5.1 )
recommended human
12
agents
Allé DK-2880 Bagsværd Denmark
, the incidence
1 ml
mmol/ l )
8 704 71
Hb
In several controlled
.
Research and
.
to patients with
.
Sími : +
100 IU of
moisture .
Winthrop Industrie ,
or
culture mutagenicity tests and
orthopaedic surgery
4.3
a
11 g/ dl (
,
and approximately
- Oedema Oedema may
As for
episodes of hypoglycaemia
42 22
necessary
displays
5 mg
10
delayed ) .
after administration of
doctor
weeks
haloperidol 73 % )
in the main study
Uncommon
to the insulin requirement
and acute renal failure
must be
The
is
House Highbridge Business Park
that epoetin
of dosage
and
possibility
1 orodispersible tablets
,
10
route
D-58638 Iserlohn
( see
isolated
The reconstituted suspension
this condition may also
experienced
.
cartridge contains a
0.3
.
In patients with
more information about
doses
and
of
( particularly
effectiveness
) .
international units
Diabetes Mellitus : hyperglycaemia
, diabetes mellitus ,
.
of Paget s disease
(
unexplained
Eli Lilly Holdings
5026 01
the
section 5.1 ) .
between
( human ) .
events
alters the metabolism of
the limited experience in
In patients with diabetes
,
UB8 1HU - United
as
The cartridge contains
.
.
EPS
and
glucocorticoids , thyroid hormones
2.47 in favour of
, take
and
(
extreme and associated
white
The use
352 74
Your
cleavage
or
symptoms ,
in
ketoacidosis
.
alfa in
FACT-An
Following subcutaneous injection
contain
of
and
in subjects
sulphonylureas
pulse
24
controlled
units in increments
per
be considered
aripiprazole has
studies
retinopathy
(
signs
1HU - United Kingdom
to sudden
03
abrupt improvement in
been observed .
g/ dl
ml :
OUT OF
the
LTD Tlf : +
.
, tongue oedema
and dehydro-aripiprazole
:
other medicinal products
epoetin alfa alters
tongue
KG Kuhloweg
the disease is
mmol/ l )
, respiratory
in a
and blurred
type or brand of
increased after one
Arzneimittel Pütter
study
Very rare
margin
and symptoms
and
approximately 18
contains
also has
see section 5.2 )
or
hepatic impairment on the
be marketed .
Aripiprazole
contraeptives , thiazides ,
doctor or
.
The
drive
5.2
anaemia associated
Hunton
.
given subcutaneously
alfa on
section 4.2 Treatment
in patients
( 7.5
and
CNS medicinal products
akathisia
for
- Middlesex UB8 1HU
) and
mmol/ l )
prospective
trial , the
make sure
maximum recommended clinical dose
are extensions
Pharmacodynamic effects
Ctrough
pneumonia
,
.
tablet
.
.
.
meal or unplanned ,
in healthy
ABILIFY
of symptomatic
( see Table
events (
1 cartridge contains
.
.
corrected for
chronic
meal
However ,
g/ dl
is a clear and
diabetes mellitus
Abseamed
isophane ( NPH
patients
crisis
Abseamed has no
.
last day of
please see section
comprising 5
5.1
for aripiprazole-treated
to be compatible
episcleritis , iritis
DNA
The pharmacokinetics of
% with placebo .
FACT-An
a
of
haematocrit of 33
or valproate
are not iron deficient
and M-IV ) .
30 100
alfa
ABILIFY
of EPS was
14 x 1
of EPS was
restlessness
clinical studies
tactile hyperesthesia were ro
or
alfa should be
( 7.5 mmol/ l
Park
per dose ,
IU/ kg
4.4
alfa is given concomitantly
animals
greater than 14
be necessary when
if you
patient group .
medicinal product
+ 44 (
of pioglitazone during
tablets
not
In cases where there
Tel :
without
1.25 and 2.47 in
(
all timepoints
to pioglitazone or
nicht
to protect from light
hydrochloride
residual
mg aripiprazole
of schizophrenia
four
be
:
in
two minor
5 mg
REACH AND SIGHT OF
There are no
or
: +44 ( 0)20
trials and
.
epoetin
antipsychotic
patient population and
)
incidence of
for major
minutes
placebo
Allé
% with
polydipsia , hyperglycaemia
It
( 10 000
50
the
75
section
groups
oral administration
units (
( 1.3
.
see section 6.1 )
If convenient ,
) ,
its application for the
SpA Tel : +
mg
The recommended
Slovenská republika Eli
with alcohol or other
ml
aripiprazole
, the incidence
.
.
,
be
and
see section 4.4
of
Road Uxbridge - Middlesex
and
have
SQUIBB PHARMACEUTICALS
.
of a
infection
and
,
could
in
may
with hypocalcaemia
in urine , proteins
in a
before
12 g/ dl
for
a cartridge (
products to affect ABILIFY
retinopathy Long-term improved glycaemic
not
Percentages of
cases of NMS
The AUC and Cmax
and
clinical
kilogram bodyweight .
vitro
44 (
)
and mediastinal disorders :
Treatment with
.
international units (
possible ,
or
observed for
6.1 ) .
in a pre-filled syringe
with solid tumours (
: + 353
contains
facilitate the re- suspension
anaemia
.
the
-
.
of the value )
the
or without food
pH adjustment )
the dose of the
a stable level
Overdose of epoetin alfa
)
alkaline phosphatase
) should be
overall survival between
(
)
( dextromethorphan
and extrapyramidal symptoms .
.
8167 patients )
,
also
encephalopathy-like symptoms (
(
Aclasta strengthens the
called
a
without
manic
of
-
concentrations , aripiprazole
per
and adult patients on
BRISTOL-MYERS SQUIBB ( FINLAND
dose .
emaciated appearance ,
Centre Limited
: + 40 (
doctor
In the
of medicines used
and
and
(
fat mass
epoetin alfa
a
than in those
AUC
The recommended dose of
also
pharmacokinetics
)
- 8°C
mg/ day
to treat adults
BE STORED OUT OF
,
GmbH &
clinical
pre-menopausal range
PFT ] (
metabolised
hypertension
ABILIFY
8954
carbamazepine ,
or
Insulin human
of
not
WC2B
of the
used
see
2 352
therefore
A specific overdose of
systems .
:
per
, sudden
1
thrombosis
injections .
8°C ) .
in
.
KG ,
( 2.5 %
ABILIFY
other
rDNA (
adjustment
men and women
8°C )
anorexia
use of Epoetin
with encephalopathy-like symptoms (
treatment with epoetin alfa
the
weeks
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LTD
The
hours
the local representative
small study
of the value
.
of aripiprazole in pregnant
, nausea , vomiting
in pregnant
.
a few
other symptoms
in
24 hours
five large controlled
rising by more than
unit dose
37 , D-58638
aripiprazole was administered concomitantly
0 1 year
reports
aluminium intoxication
g/ dl
associated with an increased
Puh/ Tel :
In
In patients with diabetes
)
( Europe )
increased risk of
(
caudate
symptoms
observed .
dose
3 times per
, Storbritannien Tel
( see
denen Midazolam ( CYP3A4-Substrat
% with placebo .
When a dose adjustment
take possible interactions
.
dose
antagonism of serotonin
( 8.1 mmol/ l
.
( see
Actos is and
0.7 ml (
interaction
129
Suomi/ Finland OY
Oral contraeptives
( see section 5.1
prior to
or
are
female rats
The
Irland.Lilly S.A.
As with
( 300
one year or
Also
1 ml contains
on the use of
or
and
If you
,
clinical trials
of one year
medicinal products .
to be
tablet contains 30
such patients .
40 %
in urine ,
time each day .
.
doctor
angina pectoris , increased
anaemic rats ,
contraeptives , thiazides ,
of
alfa
two studies ,
measures
hepatic impairment
epoetin alfa
(
during pregnancy
(
The
sizes may
(
trials and 8167 patients
and protein intake
and multiple
.
has been accidentally frozen
a
4
Road Horsham West
ABILIFY
medicine
Actraphane
.
the exposure of
for injections
different dose .
)
4.8 ) .
vitamin B12
by the intravenous
intervals
.
)
)
ABILIFY 15 mg
should
.
of anaemia associated with
Abseamed has no influence
COMBINATION THERAPY WITH
the
.
elective orthopaedic surgery
are never to
not
digoxin , warfarin
2°C
doses
, especially
This represents a
8
antidotes ) ,
: +
the
Aclasta
When a
with
patients
disposal and
.
Hb between 10
,
In CYP2D6
the
THAT THE
(
until
in
see section 4.5
Centre ( Europe
.
with
contraindicated
34
in a blister
of Epoetin alfa
-
Cancer Linear Analogue Scale
.
) .
of medicines used
of
used
risk factors ( e.
may occur in
incidence (
.
SQUIBB GESMBH Tel :
less
and
In
in adult patients
rising by more than
clinical trials ,
of
and 12
5
cells/ µl
( see
is
iliac crest 1
Therefore ,
starting dose for
without
and
with
and adult patients on
in
mixed episode of
of
side effects (
(
P450 2C8 although
10 and
whose
treatment
may
stroke in
2 diabetes mellitus and
They include thirst
not affect your
, may
medicine
dosage may
control group .
dosage or
of 0.7
All
liver
by the intravenous
Single and multiple
.
the risk of
your doctor
of aripiprazole
potassium and
Fracture
.
to be compatible
between 25 and
cases of NMS
are
in
manic
8
ON BLISTERS OR
alfa
approximately
If
and
Seizure : in clinical
g/ dl ( 7.5
and
(
epoetin
section
e. g.
weight gain
time until
Middlesex UB8 1HU
The four carbohydrate chains
are
2C9 ( warfarin
4.5 ) .
.
is
Business
during continued treatment
infusion fluids .
0)21 272 16
30 kg
epoetin alfa
vomiting ,
during
(
below 12
half-life
of symptomatic anaemia
( see section 4.4
and
insulin requirements
IU/ kg
.
and cloudy after resuspension
(
vision
.
administered
of
section 5.1
complications
mmol/ l
+
300 IU/ kg given
as soon as
been established
treated
and
(
)
The AUC and Cmax
angioedema and anaphylactic reaction
.
CYP3A4
ml
greater than 14
Mellitus : hyperglycaemia ,
or
studies
g/ dl
symptomatic
not
.
.
aripiprazole
of epoetin alfa
or
erythropoietin
first 21 days
schizophrenia
-
not to
notwendig
the freezer section or
participants
urine
section 4.4
IU/ kg
.
should
micrograms
Subcutaneous injection :
aripiprazole
NPH )
insulin
)
Tell
to
.
anaemia
risk
consistently apparent
10
.
may increase
heartburn ) , vomiting
patient population and
(
insulin requirement .
see section
prophylaxis
%
( 7.5
adequate
target haemoglobin concentration
with diabetes
is very wide
Uncommon
pre-filled syringe
( 95 % CI
Frequencies of
in combination
those receiving placebo
the rise in
30
the
you are breast-feeding .
4.2 Treatment of
elective orthopaedic surgery
Your doctor will
8545250
anaemic
a
should be discontinued (
mg
may
34 %
includes appropriate dietary changes
reactions are transitory
not exceed
product
aripiprazole 77 %
the treatment of
mmol/ l )
and
should be
( see section 4.4
defined
epoetin
significant
, the
vomiting , an
, myoglobinuria (
week
In particular ,
.
dose is 15 mg
360 dogs
( see section 4.5
535
site within a
704 71 00
to reproduction
to
by
and
in favour
) .
tell your
see section
female
Spain
( 0)21 272
+ 44 ( 0)1628
should be
angioedema and anaphylactic reaction
A-009 " and
)
syringes contain 0.4
) .
(
incidence
the patient
with
over 3
medicinal
4.3
PRODUCTS OR WASTE MATERIALS
is
The
observed in
elimination
the
administered by intravenous
significant
section
less
Applicant/
OF UNUSED MEDICINAL
days after
from 2 60
the reach
see section 4.4 )
softened stools
Hb between 10 and
30 %
West Sussex
times per week
factors
NMS
disposed of via
,
and
may
4.4 )
five
.
of
recommended starting dose for
( see
between
and precautions
Sporadic malformations
THE WEEK (
a pre-filled syringe
the
Peripheral sensory neuropathy ,
a
with
during treatment
.
when
in exposures
epoetin alfa
been
( 5 mg/ ml
or higher dose
see section
duration , there were
section
37 ,
year after
the
post-menopausal osteoporosis
new vertebral fracture
to the insulin requirement
.
251 21
zoledronic acid
+ 47 67
both fast-acting
10 cartridges
,
,
: store
between 10
sometimes severe irritability .
5.2
9 251 21
reports of oedema were
developmental toxicity
if
both fast-acting
of
or
1 , 5
intravenous route
25 and
.
to 6 weeks
(
( AST )
In
subjects ,
( 8.1
of a
all timepoints ( 6
not
If the haemoglobin is
pioglitazone vs. gliclazide
4.4 )
healthy elderly and younger
SQUIBB
manufacturer of the
was 12.1
3x/ week or
or 98 tablets
)
Renal or hepatic impairment
, increased
The dose
In
of aripiprazole .
S. A.
a dose adjustment
( 0)20 3116 8000
hypoaesthesia
and
ml (
an increased
and a
and
be considered ( see
Persistent
40
(
thromboembolic events
,
%
, headache , tiredness
( see section
:
also be used .
experienced the development
beobachtet . For lp
total weekly dose
monkeys
and
Actos and insulin
AB Puh/ Tel :
Epoetin
the
;
Novo
controlled studies
absolute change in HbA1c
is
of
section 5.1
Saccharomyces cerevisiae ) .
ON THE OUTER
impairment .
those receiving placebo (
vomiting , nausea
7.5
1 tablets in
Cancer
epoetin alfa
: + 32 2
pharmacist how
angina pectoris ,
0 1 year )
in combination
) to 12
in strength ,
daily insulin requirement
death in utero
Ltd Tel
you
to
please see section
pioglitazone
and 15
diabetes was 9.5
)
symptoms
8000 international units
a multiphasic manner
source insulin
with
.
see section 5.1
on mg/ m2
following
.
they
alfa and other
clinical trial in healthy
, given weekly
patient above and
Suicidal thoughts and
bacterial and mammalian cell
of epoetin
without treatment
from the
multi-centre trial was
.
included
)
paclitaxel
8
monitor ACOMPLIA
+ 46
international units (
alfa
be necessary
to ensure
Starting dose
, the patient
In the
doctor .
and
Actraphane 10 consists of
in 6
) .
with aripiprazole and
House Highbridge Business Park
(
800 ) 749
Uxbridge - Middlesex
COMBINATION THERAPY WITH METFORMIN
Ask your
, and
to maintain haemoglobin
in a cartridge .
Medice
.
43
should be monitored closely
is contraindicated
D2 and D3 ,
below 12 g/ dl
) , macrogol
dose
be used
: + 44 (
.
in monkeys
is not recommended
- 12 g/ dl
25 D-90429 Nuremberg Germany
wastewater or household waste
ähnliche Wirkungen
OR RESTRICTIONS WITH
Italia
growth factor
g/ dl
times per week
, 14 and 7
PHARMACEUTICALS LTD Tel
per se of insulin
in healthy subjects ,
%
fast-acting
( 0)1
meal
Benommenheit
renal failure in paediatric
on
.
13 g/ dl ,
HF Sími :
death in utero
IU/ kg
CONTENTS
and N-dealkylation
and 3A4 .
in a
) .
if possible
is very wide .
H1 receptors .
pre-filled syringe
after
) and/
and severe
overdose with aripiprazole ,
(
hydroxide Water for injection
with
no adequate and well-controlled
placebo ,
e. g. ,
g/ dl
a
,
a mixture
Epoetin
medical practice .
, increased risk
or settling are
pharmacist .
when treating your diabetes
used to treat diabetes
time until
and
contains
occurrence
dose
between
.
chemotherapy
Recurrence prevention of
(
in this
be cautioned
per
human , rDNA
of
,
The
, or if the
pregnancy
not show an interaction
Use should be restricted
33 - 39
patients with
In
30
stabbing migraine-like
dry eye , keratoconjunctivitis
mixed episode
epoetin
you are pregnant
8.1
be
to your doctor
with cyclosporin ,
0.8 ml
Treatment
Refraction disorders
of dissolved insulin and
of aripiprazole in pregnant
stroke in
in women with
women in men
,
large controlled studies
clinical trials
puberty or due to
combined with fast-acting
dogs
(
treatment with epoetin
Similarly , for
.
Glycine Polysorbate 80
1.25
once a day .
conducted in 375 anaemic
per month )
by
a doctor or
Although there is
times per week )
cyclosporin
efficacy
and
section
13 g/ dl
signs and
aripiprazole
,
ABILIFY
,
demonstrated
R & D
added to metformin in
cartridges are designed to
.
1.25 mmol/ l
,
1.3 %
that
ACOMPLIA and placebo
measure
swelling
per kilogram bodyweight .
SQUIBB PHARMACEUTICALS
doctor
with severe renal
following
Global
your
recommended starting dose
cases
blood donation procedure
should not exceed 200
x 1 orodispersible tablets
in the pharmacokinetics of
The terminal
, accidental
)
Laboratoires Takeda Tél :
) insulin
BE STORED OUT OF
bone markers stabilised
of pioglitazone
clinical
alfa ,
tachycardia
peripheral
during
clinical trials ,
excipients or to any
Pioglitazone
your doctor
patients
if they
lung , 22 prostate
or
.
ketoacidosis
on the
CONDITIONS
Aspartame ( E951 )
have
.
see sections
renal
1800 ml
insulin human .
Epoetin
Aclasta
Limited atstovyb Tel .
Roonstraße
7.5 mmol/
, a type
in this
.
of pioglitazone (
diabetes mellitus and
approximately 60
increased
.
GmbH & Co
alfa
hyperglycaemia , hypocalcaemia
fatigue Psychiatric disorders Common
hepatitis ,
of
(
pharmacokinetic characteristics of aripiprazole
Europharm Limited Wimblehurst
(
clinical trials ,
The pharmacokinetic characteristics of
- Treatment
( 6 % )
Kingdom
50
100
. They include thirst
levels , while
with
the
to reproduction
UB8 1HU -
the
mg
protein intake .
B-CTx was
: +
The
cause mortality was
epoetin alfa
if you are
and diarrhoea
heart beat
2°C - 8°C
mmol/ l
For
epoetin
data ,
you
( t½ ) is
and hypoaesthesia
medicines
sudden
dose of Abseamed
0 ) 241 941-0
) in
33
:
is between
Although there is no
in
Nederland BRISTOL-MYERS SQUIBB BV
placebo-controlled trials
the
ataxia ,
next appointment
instructions given to
Studien
advice
Suicidal thoughts and
)
intravenous
+
.
skin fold minimises
not
patients
of
possibly protein disulfide isomerase
Abseamed has
when
small amount of
A clinical trial of
in
of excipients , see
a dose-dependent increase in
% )
to 23
PRODUCTS OR WASTE MATERIALS
,
especially
be discontinued immediately
section 4.2 Treatment
Reticulocyte count
32 2
PRODUCTS , IF
probably need
.
of the pack
speech disorder , Neuroleptic
see
monitored
Ask your pharmacist
tablets in
contraindicated for patients
: +43 1
and 30
(
7.5 kg over 2
ketoacidosis
insulin products
of vitamin D supplementation
jaundice is observed
& D Centre
, accidental
%
sulphonamides .
)
0.3
, or
solution
insufficient
for signs
appropriate
experience in
( 6.2
patients with
surgery
elective
by the intravenous route
,
,
similar dose reductions should
Finland Oy Eli Lilly
with
to 23 hours
, Oxford Road
2000 IU/ 1 ml
medically serious
and 3A4 ( dextromethorphan
with
.
in men In
no
clinical fractures The incidence
exhibit complications (
( mean age
18.3
Glutamyl Transferase ( GGT
%
% for Aclasta-treated
) or
with
overall survival
(
patients
Hunton House Highbridge Business
until hyperkalaemia has been
the insulin requirement (
IU )
forms of
,
red blood cell
akathisia in bipolar patients
ketoacidosis
section 4.4 ) .
kg and adults
to aripiprazole tablets
male patients ( see
take it
mg tablets are round
The terminal half-life (
in monkeys ,
MAOI
that
acts
a clinical
27
, read
stroke
site conditions
treatment to
days following
tablets
7.5 mmol/ l
-
) .
be followed
42 22
come into
as
73 % )
Tlf : +
2
aripiprazole concentrations
per
schizophrenia .
or the
%
epoetin alfa may
hours
%
sulphonamides
in
is
50
Correction for
, headache , tiredness
pH adjustment )
- Middlesex UB8 1HU
peak is always
rare - Refraction disorders
0.3 ml ( 3000
, 56 , 84
&
with a quick
daily
Most reactions are
to
aripiprazole
Hydrochloric acid ( for
more
or
.
.
.
)
mmol/ l
.
should only be
ability
Gastrointestinal
ACOMPLIA
10
in
causes of anaemia
ml
with
less than 1
( International
12
a maximum volume
dissolved insulin and 60
)
In a prospective
as soon as
2
change in their usual
Starting dose of 50
dopamine D4
mixture of dissolved insulin
mucositis
> 0.5 %
,
12 g/ dl
pregnant women .
in vitro studies
( 1.3
Hypersensitivity to
.
the EPAR )
or even death .
.
cases of stroke
and
HbA1c
change in their usual
blood
patients
: orthostatic
aripiprazole
13-10-2000 Date
4 or more units
.
( Europe
Treatment with Abseamed
preventing recurrence of manic
greater sensitivity
(
,
clinical fractures The incidence
BRISTOL-MYERS
alkaline phosphatase ( BSAP
FINLAND
.
effectiveness was
OF UNUSED MEDICINAL PRODUCTS
risk
) )
order
, Royaume-Uni Tél/ Tel
week
to
with
is
( 0.62 mmol/ l
epoetin
in
few minutes
de pointes
is reported
( 0)20 3116
patients scheduled for major
somnolence
should be
or
Aclasta
enterocytes
in combination therapy with
products
until your
4.4
given weekly
Kontrazeptivums mit einer ng
human tumour samples
and
- metformin ,
mg , 30
BRISTOL-MYERS SQUIBB PHARMACEUTICALS
.
3 times
be harmful
with renal anaemia
increase
Dose adjustment in order
section 6.1
between healthy elderly and
Es werden möglicherweise nicht
mmol/ l )
It may
Each ml of
mmol/ l )
of Abseamed between 25
( 0)21
104 The recommended
) and
different time zones
g/ dl (
should
Treatment
( 6.2 - 7.5
0.2 mg propyl parahydroxybenzoate
epoetin alfa ,
pioglitazone (
reduction in
Hypersensitivity to
a dose range of
.
symptoms can occur .
in
months when stored between
, aripiprazole ,
in clinical
a
injection
of cleavage (
contains metacresol , which
diabetes ,
,
by
(
or
Taking
of clinically significant
ABILIFY is
a meal or
The
constipation
exposure
12
prior to
- Treatment of
ml and
effect
- Peripheral neuropathy
whether you
, decreased
:
. emea
male patients
In
tremor ,
units
but unpreserved product
9 251 21
CYP3A4
absorption rather than
from 2653 to
,
,
of the
chemotherapy )
pharmacokinetics and
and
the
Tel : + 353
be
efficacy
meal or
.
7.5
400 mg sucrose
1
of symptomatic
in
IU .
patients
between 17
between 10 and
> 99 % )
the incidence
( see
are
.
%
( days 21
of the
carton in order
and adolescents under
,
by significant intra-
alfa
A cardiovascular
mg ,
with aripiprazole
(
If blood pressure
( e. g. anaphylactic
be avoided
probably need
contains
of 10 g/ dl
Overdose of epoetin
3A4 ( dextromethorphan )
.
of in accordance with
hands ,
of
Epoetin
pioglitazone
impact on
of
of consciousness
, placebo-controlled trial
aripiprazole and 3.0 %
, a
P450
osteoporosis ( PFT
a measure
observed
insulin and 60
reported in children .
ct
1 pre-filled syringe
0)1628
Kuhloweg 37 ,
as this will
or other
93
The
observed
third infusion
clinical
not
a
skin fold minimises
pre- and post-natal
strength
not generally
advise you on
( M-II
no
meal or unplanned
and
contains 30
0)1 46 25 16
and
OUT OF THE REACH
needle top
.
as metformin
clinically significant change in
with treatment with
of diabetes
on
on
you to do this
of 1
suicidal ideation , and
,
insulin (
not
) .
they
Tlf
aripiprazole and dehydro-aripiprazole
in monkeys
the
possibly delayed )
ability
(
or
99 % ) .
)
cerevisiae
ABILIFY
1 tablets 56
e. g.
Close
1 film-coated
.
BRISTOL-MYERS SQUIBB GESMBH
(
30 mg/ day .
of
with
The
4.8 )
the
heart disease or
Global R &
especially infections and
unit dose blisters
the intravenous route
epoetin alfa is
necessary
pioglitazone
diarrhoea
cancer patients
events
unconsciousness
vomiting
this medicinal product
with a
the
3.3-fold
without food
-
352 74 60
+ 36(0
aripiprazole and
( Europe )
)
,
.
of 14
patients with
This leaflet
headache
no fatalities
orodispersible tablets 49 x
.
non-selective beta- blocking agents
reactions
carton
People
and
,
should consider clinical monitoring
insulin and
brain function
In another
subcutaneous administration .
dextromethorphan/ 3-methoxymorphinan ratio
25 and 50
with
be performed in
is
with solid
of
, the dosage of
%
thus not necessary .
to reproduction
only 3 patients with
therapeutic
12 g/ dl (
risk for
Caution
Patients
carbohydrate chains
: + 44
anaemic rats ,
of
section 6.1 ) .
and symptoms reported
.
mmol/ l ) per
0.8
) .
.
and
CI ] (
potent CYP3A4 inhibitors with
2 diabetes
Park ,
( for pH-adjustment
important differences
45 45 93 05
than 1
is contraindicated
12 g/ dl (
,
% )
+
usual , talking very
no influence on the
or
CYP2C8
g/ dl
53.3 % for
0.62
BV Tel :
, 30 mg
, or
HbA1c (
Highbridge
are therefore affected
cardiovascular therapy ,
signs of local
section 4.5 ) .
risk of cross-reaction
: tachycardia*
, 24
active substance is
signs and
cancer patients receiving chemotherapy
30
a pre-filled syringe
between
R & D
epoetin
and CYP3A4
with
alfa is
diabetic
and
Research and Development
or pharmacist
,
mg )
tell your
not been evaluated
dehydro-aripiprazole are
Penfill is
chronic renal failure patients
may
, Nevirapin und Johanniskraut
and the Montgomery-Asberg
Abseamed 10
and should
observed mean improvement
:
possibility
Subcutaneous injection : a
was 7 times
given
:
years
1.25 and
( the
transitory and
additional
of the Marketing
4.4
ml
per 100
Malta
a pre-filled syringe
kg require higher
)
trials
pre-filled syringe
of clinically significant
oral
dehydro-aripiprazole ,
in subjects with
should not
BRISTOL-MYERS
The maximum
0.035 mg
-
260
or
pre-filled syringe of 0.6
30 minutes
effective
zoledronic acid
the first
in both groups
) That
should be investigated .
section 4.5 ) .
administered
of 12 - 14
The active substance in
parkinsonism ,
Actos 45mg tablets
has been
(
Less than
or
rapidly reversible
weight
dose
pharmacokinetics
blood
only
been reported in patients
the
thiazides , glucocorticoids ,
Actraphane
and
and
is
patient
is
Kingdom
corresponding to 67.2
autologous
Uncommon - Peripheral neuropathy
margin
only 3 patients with
pioglitazone
, especially infections
not been established .
III )
following
section 4.8
for haloperidol (
ABILIFY
, anxious
overdose
contains 5 mg
, and was
adverse events
39 06 5026
the
or 24
anaemia
mmol/ l
g/ dl ( 6.2
Actos is
be followed
Glycine
also
) per month
is
( 5.9 -
5.2 )
from the
Tablet Round and pink
EPS including
75 - 150
of
manic or
study included only 3
, suggesting that
or 2 )
Dose adjustment
a
recommended
30
% of the
,
correction
if
speech disorder ,
% )
with alcohol or
with
isolated patients
, 2C9 (
epoetin
aripiprazole :
Overall , in the
-3 -p-dihydroxypaclitaxel
:
divide
especially when
7.5
14
.
another
, creatinine
Sími : + 354
solution for injection
.
g/ dl (
tablets 84
must be discontinued
In
,
units in increments of
bone marrow fibrosis of
, vomiting
- Treatment
with
, accidental
x
days
sections
Insulins and analogues for
Distribution
safety data revealed no
phosphokinase
of ABILIFY
IU/ kg
with solid
contain 0.9
2°C -
90 or
, Kuhloweg
a
CYP3A4 ( ketoconazole )
1
- Treatment
, oedema ,
creatinine
may
especially in
.
each
and
.
during pregnancy
consists of
quickly with racing ideas
peripheral oedema
with a quick
of children
and treatment with
( hydrolysis ) sites
see
mmol/ l )
Highbridge Business Park
:
cases of stroke or
in
alfa is a
with
.
see section 4.6 )
with
IU ( International
well-controlled trials
, somnolence , sedation
period .
in clinical trials
(
Analogue Scale ( CLAS
.
10 days
Uncommon - Peripheral
ABILIFY 10 mg
of excipients , see
and no
ABILIFY is used
alfa
40,000 dalton
211
3 and
93 Patients
another
the
.
6.2 - 7.5
(
significant
you are breast-feeding
may vary with age
AST ) , increased
patients in
House Highbridge Business
events
.
the recommended
animal models
( e.
disposition phases (
( 6
3 times per week
Moreover ,
of stroke or
information on
machines
and
.
aripiprazole and
and
Ask
children over
, 56
,
The company
surgical castration )
D-58638
the nearest hospital
This
+ 47
and approximately 20
200 kg
2 g/ dl per
with haematological malignancies
( see sections 4.8
If you
including osteomyelitis ,
after
children and
10
LTD
ml
of the warning
epoetin alfa
IU/ kg
that
Abseamed
patients
precautions for
you
deep vein
37 , D-58638 Iserlohn
oedema
epoetin
is 15
start
subjects ,
30
in patients with
with aripiprazole
in a pre-filled syringe
Gastrointestinal
signs and symptoms
6.2 - 7.5
( 4 or more
Abseamed 5000 IU/ 0.5
in type
medicines
symptoms
OF UNUSED MEDICINAL PRODUCTS
1
diabetes
BRISTOL-MYERS SQUIBB (
10 and 12
denen Midazolam ( CYP3A4-Substrat
)
patients with
solution
,
Justification for
Microcrystalline
1 % of
alfa may
.
Park
units (
alfa alters
chronic
BEFORE YOU
(
akathisia was 6.2
( see section
epoetin
with
Keep out of
studies
the
or
section 4.8 ) .
rDNA
in
rapidly
ml
per month ) with
to protect from light
THE SAFE AND
fibrosis of
hip
diabetic ketoacidosis ,
healthy
see section
risk
for ABILIFY
0)20 3116 8951
Intrinsic clearance is
Arzneimittel Pütter GmbH &
tumours ( 683 breast
:
pharmacist or nurse .
is not
treated
and Cmax of dehydro-aripiprazole
jaundice ,
symptomatic anaemia associated with
chronic liver disease .
A sustained haemoglobin level
and clinically
1.5-2.5 hours
a blister
(
.
.
hydrolysis ) sites
.
.
,
metabolites are
section 4.4 ) .
,
.
sc use
blood pressure
and
.
with
of 12
for reconstitution is
-
, 64
keine ausreichenden Daten am
+36 1 457 65
should be rotated
and
see section 4.4 )
Phlebotomy may be performed
Centre ( Europe
Research and Development
.
of greater than
one year
insulin ( human
pharmacist
with
Activated charcoal
glucose control may
in Saccharomyces
two medicines
Tel : +
.
within
will
the local representative
.
6.8
closely monitored throughout this
blood pressure
tablets
,
no relevant
Lilly Holdings Limited
Hunton House Highbridge
study population
thyroid hormones
should be
the
active substance
between healthy
the geometric means
Squibb
,
Aripiprazole did not
of
how well
(
each patient
and
in strength ,
elevated liver enzymes and
-
SQUIBB BELGIUM S. A.
0)20 3116 8950
The
Pre-filled syringes ( glass
take
,
of epoetin
( AQ
gliclazide .
,
significantly
150 60 -
controlled
5 mg/
pharmacist if you are
APPROPRIATE
.
0.7 ml
the
:
reactions
.
The
adipocytes (
mg tablets may
particularly overweight
Cmax of dehydro-aripiprazole
:
+ 43
levels , while
32 2
section 5.3
levels of
Uncommon :
products
terminal half-life is determined
chemotherapy
58.8
large controlled
medicines
REGARDING
,
.
with haematological malignancies
There is
%
Very
or
Propyl parahydroxybenzoate (
and no appreciable
( e. g.
e. g. increased
more units of
or
Undesirable effects known
Global R
patients ( particularly overweight
NPH
60 - 150 30
8°C ) .
, aqueous
Limited
in a blister .
31 In a
may
Adult
Date of last
.
and
shortly following
Adjustments of daily dosage
+
haemoglobin
pharmacokinetics or
D
per
House Highbridge Business
ABILIFY
reduction of transfusion requirements
epoetin alfa .
of
The following maintenance doses
terminal half-life (
by a decrease in
( 5.9 - 6.8
vial of 100 mg
dosage
with
.
0)21 272
ra Tablet core
epoetin
enalapril
have been proposed
( see section
28
severe irritability .
with
bone remodelling
of paclitaxel is
be marketed
07/ 412/ 010
metabolism of
as a mitosis-stimulating factor
influence on the
the dosage of ABILIFY
is very rare (
12 g/ dl (
- 150 30 -
ABILIFY ,
West
risk factors
KG Kuhloweg 37
autologous
84
in
( 6.2 mmol/ l
gynaecological , 23
tablet
Patients should
5.1 ) .
clinical
)
the dose selector returns
placebo-controlled
.
could be
IT
.
doctor
each
epoetin
Co KG Kuhloweg
Centre (
e. g. ,
Aclasta
see section 4.5
cerevisiae )
daily insulin requirement
1 month after
) ,
of NMS are hyperpyrexia
of
on the pharmacokinetics
Peripheral neuropathy
and
In these
alfa .
on
of the ingredients
Although there is
wide .
waist circumference
or lithium
contains
defined
BMD
.
THE WEEK
)
3x/ week
.
species ,
lung , 22 prostate
clinical trials that
approximately 425 mg
: a maximum volume
per week
potassium in
ABILIFY
4.8
after opening
REGARDING
ABILIFY
,
rare cases
its 1-adrenergic receptor
cyclosporin ,
protein
.
the incidence of
The pharmacokinetic characteristics of
If
with
with or
with
to the baby
in
CNS medicinal products
medicine containing
had had a stroke
with aripiprazole ,
a meal
6.8 mmol/ l )
Contrada
liver cirrhosis
and drink the
during lactation
your doctor immediately
range of
alfa
,
complications
with consideration for
with aripiprazole and 3.2
haloperidol
, serotonin
are round and
international units (
is usually maximal within
the reach
that
g/ dl
.
180-minute infusions of
Centre ( Europe
adequate and
vial contains 10
5000 IU/ 0.5
you are pregnant ,
MEDICINAL PRODUCT MUST
, diabetes mellitus
insomnia
)
these
is
0.62 mmol/ l )
ABILIFY is used
OF THE MEDICINAL
to 15 minutes caused
,
.
Following initiation of
forms of
used with caution
Epoetin alfa and
- decreased locoregional control
local
if you
bound to plasma protein
placebo-controlled studies
per 100
the potential risk
)
anaemia
solution for injection
Interaction with receptors
solution for injection
Die maximale Tagesdosis
significant
e.
therapy .
a potent inhibitor
or less duration ,
no
is therefore recommended
4 or more units
rare (
In clinical
-
: +
epoetin alfa
physical
hypersensitivity reactions ,
3 ml
above baseline
% CI :
(
with osteoporosis
Special
At 24 months
In
be used .
symptomatic
in
±
carbohydrate chains are
swallowing .
If
( see section 5.1
No other erythropoietic therapy
reduction in new
lacrimation , blurred vision
the abdominal wall
.
found to be
FINLAND ) AB
4.8
reactions
) .
for injections
epoetin alfa ,
12 g/ dl (
45
monoamine oxidase inhibitors (
see section 4.4
of progression of diabetic
in paediatric and
therapeutic
5.2 ) .
for
32 2
risk for
first 24 hours
1HU
lesser amount
% and 47
Thrombocytosis has been
digoxin , warfarin ,
( see
& Co
% of
(
MUST BE STORED
than placebo , or
ABILIFY tablets
and
Novo
risk for thromboembolic events
restricted
is
method of
all cancer patients
Iserlohn
SQUIBB NORWAY LTD Tlf
, blood
been observed .
local requirements .
with
2.47 in favour of
clinical trials of aripiprazole
.
2 units .
the blood pressure is
and
: + 32 2
if
is
, pruritus , or
+
period
in two studies was
and water
Storbritannien Tlf : +
sections 4.3 and
: +44 ( 0)20
. They include thirst
45 %
patient
Functional
by
dose is 600
also be necessary
paracetamol
of angioedema
done
weight decreased , anorexia
syringe
between
in
Breastfeeding must be discontinued
safety of
placebo-controlled
Abseamed
of excipients , see
)
H1 receptors
.
the
elevated creatine phosphokinase
be
in
reached
in a
,
.
with
Patients should
aripiprazole treatment
of
indicated for
weight
.
such as sedation
, salivary hypersecretion
In most
psychosis
of a
see
not
times per
%
Common :
Kingdom
.
with
and Cmax
be necessary
the desired range
clinical trials
monkeys after
cases of
.
are not
, nausea
The inter- and
Approximately half of the
For a full list
epoetin alfa
children
coma
dose
renal failure
CONDITIONS OR
taken in combination
Centre
human .
each ml of suspension
.
Global R &
of transfusion requirements in
be at risk of
sedation
.
166 Danmark
, itching , hives
ready to use
)
the intravenous route .
-
should be considered on
measures in
the medicinal product
be
with insufficient glycaemic
before
aripiprazole
therefore
5.1
hypertension ,
Patients
the
occur .
.
Centre (
per
.
approximately
ABILIFY may increase the
section 4.5
What
,
( see
carefully weighed
vs. placebo ) was
with chronic renal failure
200
: in clinical
-
likely
(
treatment in this
, headache , dysgeusia
CYP2D6
measures are being
2 times per week
epoetin alfa
warning symptoms of hypoglycaemia
4.2 )
vivo
and go
( see section
The
the
and
patients ,
your dose of
IU (
are breast-feeding .
no
(
.
The syringes
immediately
% dissolved insulin and
of the excipients
concomitant
and 802 with
is used
In two
mg
section 5.2 )
mmol/ l )
OF UNUSED MEDICINAL PRODUCTS
used
g/ dl (
the medicinal product
(
Tlf
9
to store ABILIFY 6.
or coma ,
since 1993.
Tel
pioglitazone
compared with those
nervousness
( e. g.
)
dose
Hyperglycaemia and
of nerve cells
haloperidol-controlled trial
In most cases ,
a
or more units of
the patient
Additionally ,
%
.
PRODUCT
patient above and
and patients with
-
patients
%
Hunton
ABILIFY .
on
survival
) , if
section 5.2 )
patients
, Storbritannien
Try to take the
( see section 4.2
(
vomiting and
150
,
.
) .
whose manic symptoms
1,000 ,
done in
When
,
aripiprazole
( produced by
Eye disorders
21
Concomitant
anaemia in
were
.
if
alcohol or other
1.5-2.5
- metformin
aripiprazole
of
(
Driving and
Each tablet contains
patients
, serotonin 5HT1a
should be
37 , D-58638 Iserlohn
Water
g/ dl (
( 1.25
dogs and rats
recommended dose
Actraphane NovoLet is
IU/ kg 3 times
sterile
should be
that
.
Lilly
adolescents under
pregnancy
1800 ml
Dyslipidämie eingeschlossen
4.5 ) .
than
and inter-individual variation
epoetin alfa
Middlesex UB8 1HU -
or
If you
.
time to disease progression
this medicinal product must
of
Rimonabant has been detected
indication
United
GmbH &
If blood pressure
patients with or
of overdose should
( bilirubin
.
insulin and
patients )
potassium and
stabbing migraine-like
x
221 multiple
Additional supportive
cases
clinical trials , rare
section 4.4
have
programme ,
negative impact on
.
of 30 mg
the mouth is difficult
,
Uxbridge -
patients
3 patients
and yellow
Development Centre (
had
.
.
dosage may
4.4 -
efficacy or
and
aripiprazole
.
in whom the
in post-menopausal women
rhabdomyolysis
PRODUCTS , IF
.
mania
package leaflet before use
Global
Potential for
treatment
ABILIFY
contains 7000 international
Tel
Abraxane
of epoetin
with
After a single treatment
.
,
unused product
in adult patients
and
mg pioglitazone (
of erythrocytes
elective orthopaedic surgery
.
see section 5.1 )
For
.
(
31 In
.
,
patients with
)
aripiprazole
45 93 05 06
ml
syringes contain
Because these
.
to patients when indicated
see section 6.1 .
)
between 10
in
procedure for reconstitution
and dose regimens
trials of
Potential for other medicinal
patients with
see section 6.1
.
above indications
.
ABILIFY
Because these
, restlessness ,
BRISTOL-MYERS SQUIBB
,
Tell your
Owing to the
the
your
If
2-78 units
recent
SPECIAL WARNING
week
However , in
lead to hypoglycaemia
, 56
the
be
hypoglycaemia , hyponatraemia
(
you
may
14 and 7 )
VOLUME OR
3
( see section
or
epoetin
until hyperkalaemia has been
Abseamed may be
(
Glycine Polysorbate 80 Water
see section 4.5
controlled
a pre-filled syringe The
stroke
development
10
week by the intravenous
patients
myoglobinuria
.
A specific overdose of
12 g/ dl
cartridges x 3
alcohol or other
only
weight gain ,
aripiprazole
of transfusion requirements
)
( see section
,
10 cartridges
is
patients
) of EPS
the frequency
pioglitazone in all
of medicines used
unit dose blisters
, than
increased
If psychiatric illness
population ,
Actraphane 50
may
with
injection under
, and suicidal ideation
- Middlesex
the
the
known
of epoetin alfa*
.
x
anaemia
to protect
and 47
aripiprazole
ischaemic
aripiprazole has
and Cancer Linear
:
nausea
or
mmol/ l
is
% for
cancer
risk
or
by 32
(
complications
incidence of vertebral fractures
the levels remain the
placebo over three
aripiprazole
if they
forms of interaction
ml contains 5000
of
( 6.2 - 7.5
BY UNIT
.
not been carried out
Aclasta
7.5 mmol/ l
of anaemia
may
)
In patients with
,
elective orthopaedic surgery
.
" 30 " on
in paediatric patients
pioglitazone in all
, myoglobinuria (
" on
active substance is
( warfarin
be used
per
and
section
an
Latvij Tel :
per
4.4 )
, diabetic hyperosmolar
per month
possibility of multiple medicinal
IU/ kg
, the
The dosing pipette has
)
Authorisation Holder .
, headache
this
of aripiprazole .
12 g/ dl (
ml solution for injection
30 % )
vomiting ,
.
People with
before taking ABILIFY
cells/ µl
oedema
carbamazepine
%
,
( see section 5.2
insulin cannot be
less than 1
IU
pharmacokinetic
not
has not been established
45
or combination therapy (
patients
years )
events
corresponding to 67.2
0)20 3116 8954
epoetin
, 22
In addition ,
these characteristics
and
If the
Authorisation
( GGT )
between
) .
a dose of 600
the dose
Treatment of symptomatic anaemia
100 , less
with
trial in healthy
THE REACH
or
% )
,
and
The AUC and
to 30 mg/ day
patient population
or pharmacist
and
sedation ,
( omeprazole )
1
between
receptors on
haematocrit of
agitation
alfa and other erythropoiesis-stimulating
Road
% )
SQUIBB
with
Omission of a meal
causes of deaths were
primarily
intravenous
6.2 months
50
or
in type
0.035 mg of anhydrous
and
cerebrovascular adverse
erythropoiesis-stimulating agents
The
.
mean age
When
with
The terminal
see section 4.5 )
at the desired level
epoetin alfa
see
including ABILIFY ,
Actos 30mg
with
( see section
of
clinical
result of hypoglycaemia .
doctor
a
The decision to administer
peripheral
( MAOI )
and hypoaesthesia (
, anaemia
with chronic renal failure
more units
corresponding to 50.4 micrograms
If
.
less than
1 g/ dl
but not clinically
anxiety Uncommon : depression*
65 to 200
12
part
anaemia
observed
orthopaedic surgery
occurred
, nausea ,
of Cmax and AUC
In
The AUC and Cmax
skin
Aclasta
.
since cyclosporin
that epoetin
incidence (
the geometric means of
condition
doctor
- If you are
other clinical effects
or insufficient
Be sure to tell
4.5 ) .
colourless solution
obesity ) and
Glycine Polysorbate 80 Water
mg/ m2
the
and
including parkinsonism ,
on the
Lilly Holdings
your
and
for a year or
alfa is
% and AUC
Therabel Lucien Pharma Tél
retinopathy
consists of 20 %
they
In
in
:
+
how
your doctor or pharmacist
biological efficacy
this condition may
Thrombocytosis
not been
Hypertensive crisis with
and
glucose control
Puh/ Tel :
and "
of
mg
,
epoetin alfa
survival
In three
Global R & D
dissolved insulin
R & D
with
the
hepatic metabolism and
Arzneimittel Pütter GmbH
Aclasta should not be
otherwise decided by
deep vein thrombosis
elective
coma
in adult patients with
SpA Tel :
SQUIBB
for smokers .
Benommenheit
studies
arrhythmias , sudden
, both via
cardiac failure or
The syringes
by multiple
,
.
.
-
( 2°C
AUC
of aripiprazole .
to
monitoring
times the mean steady-state
43 1 60 14
If you accidentally
) AB Puh/ Tel
After injection
tell your
2 g/ dl
)
patients
treatment with aripiprazole
When
per
,
,
associated with Abilify ?
entire
greater than 12
( 0)20
pregnancy
is very
The therapeutic margin
be added to
maximum of 30
704
E218 ,
50 IU/ kg 3
antipsychotics
Suicidal thoughts and
Aripiprazole
In
insulin products ,
per
This
and 11
.
aripiprazole
contain
survival
.
,
Zoledronic acid is not
alfa
,
is the risk
with Actos
declined
.
a
, especially in
ml
the active substance
There is an
Treatment of
facilitate the
of
section 4.4
of angioedema
see section
sulphonamides .
of
but not in
SPC )
If you
10
of CYP3A4 (
Eli Lilly Holdings
the
.
marked
extreme and associated
,
clinical
chest pain , peripheral
shortened overall survival and
100
44-20
mmol/ l
than 1
KG ,
House Highbridge Business
observed ( see sections
Cancer Therapy- Anaemia
Peripheral neuropathy
with
,
a
)
The
patients
of
study included only 3
dizziness , neuropathic pain
1
increased Aspartate Aminotransferase (
cartridge ( 3
patients
approximately 60
Each tablet
pioglitazone
of
of controls
healthy subjects
infections and
of EPS was
is 15
( 0)20
30
55 53 50
Erythropoietins are growth factors
.
pioglitazone
a specialised genetic
The daily dose
trials , rare
Uncommon
8 704 71
)
BY WEIGHT
and
( GGT ) ,
wastewater or household waste
% CI
below the
glucose fluctuation ,
.
and
large controlled studies
and
or 2 )
mmol/
after
patients
injection , intermediate-acting
haemoglobin (
in haemoglobin ( 1
)
of
section 5.1 )
: +
by your doctor
12
other
.
each ml of suspension
but
orthostatic
.
SQUIBB BV Tel :
aripiprazole in
The following maintenance doses
treatment with aripiprazole alone
the levels
) 524 40 64
serotonin
60
12
These effects were
with severe renal
be monitored and
It could be
should not be
.
smaller
should be
may vary with age
vial provides 9.75 mg
Aripiprazole should be
Eye disorders Very
times
1
trials , rare
infarction , cerebrovascular accidents
small amount of
essentially sodium- free
( normal and
,
, joint swelling ,
and
SQUIBB
loss of efficacy or
sodium chloride , glycine
change in their usual
4.4 Special
Sensory
Park , Oxford Road
or
may
in the
.
When seen , it
events cannot be excluded
patients with
should
.
aripiprazole
an increased risk
( see
is
%
eská
not
or 5 or more
with
subjects
be followed .
events
MAOI
unused product
pioglitazone and its
weakness
4.4 )
Erythropoietin is
a pre-filled syringe
) general scale
t½ 0.24
aripiprazole in
a
( 1 800 )
73 % )
)
of
agents
Survival [ 95
( see section
not
of manufacture ( recombinant
)
for thromboembolic
Abseamed
)
.
Polysorbate 80 Water
should be advised accordingly
Abraxane
treatment with
mg
they
of
with
or intentional
mmol/ l
260
no
that
reduction
more than
was
5
sealed in a
treatment with
The
g/ dl (
of zoledronic acid in
In two
and was rapidly reversible
3
.
maximum of 30 mg
of
In
to
normal and anaemic rats
increased
very rapid or
neutropenia
be necessary when
no
30
t½ 1.87
version
potent
about this medicine
closely .
blister
myocardial infarction
the
,
any
of epoetin alfa
your dog
10 Penfill 100
active substance is
.
approximately
PACKAGING UNITS
should be
erythropoietin
irregular
hyponatraemia
drive
sizes may
of agitation ,
significant changes
thigh or
.
In paediatric
aripiprazole
with Actos
aripiprazole has not been
Tel : +
ABILIFY
with
Takeda
10 000 IU
aripiprazole
,
three
in a pre-filled syringe
The
12 g/ dl
ml
antagonist properties in
patients
doctor
the
dextromethorphan/ 3-methoxymorphinan ratio
Uncommon - Peripheral
be used in
in
effect of the
alfa
(
A lower dose of
( see section
pathways involving the
19 %
see section 4.8
After administration of
The
olanzapine-treated patients
speech disorder ,
)
male patients
lung ,
based
to
by
- Refraction disorders
with ABILIFY
be paid to sudden
intervals
(
In
with aripiprazole ,
, anorexia , hyponatremia
Abseamed .
section 5.1 ) .
with epoetin
84 00
chest pain
mice
still
-
1/
diabetic hyperosmolar
or
,
aripiprazole
Treatment of adult
patients should seek
of
whose first
58.8 micrograms
In
- In
01
treated patients
anxious or
of EPS including
D Centre (
than 2 g/ dl
injection ,
the treatment of
after subcutaneous administration
carefully weighed
normal
clinical
Insulin
In
especially infections
.
Specific
dose
distal radius
8167
aripiprazole
administration .
and
carbohydrate chains
section 4.4 )
In
contains 6000
CHMP requests the inclusion
,
to 12 g/ dl
baseline on the
and
the Package Leaflet (
haemoglobin is
THE REACH
%
increased incidence of
SAFE AND
whilst the
receptor , and
to
with
diabetes mellitus ,
open-label study there was
insufficiency
In patients with
itching , hives ,
or
see section
in
(
of epoetin
1,000 , less
of
.
defined .
the treatment of
Abseamed
Starting dose of 50
for pH-adjustment )
pharmacist
occurred in
The potentially
(
reduction
: orthostatic hypotension*
injections
, inform
is necessary .
of children
diarrhoea .
Use
, pulmonary
rather than of the
% and
third
aspartame ( E951 )
) .
14 and 7
for
a
IU/ kg/ day .
in pregnant women .
.
per se of insulin
1.5-2.5
If you
is needed .
with
( 57.3
prostate
two years
including PANSS and the
Polyneuropathy ,
is
the
+ 358
section 4.4
please contact
.
Abraxane
erythropoiesis-stimulating
units in increments
Takeda UK
g/ dl (
stools
BOX )
output from the liver
of
stroke who
Actraphane
the administration of
( 5.9 - 6.8
-
by
treatment
dizziness , somnolence ,
mg
) ,
the patient
.
( see section
The pharmacokinetic
significant
for
Intensified control in
they
age
of the
.
contains 10 000
including
-
and no
insulin in
.
and Cmax of dehydro-aripiprazole
and
4 or more units
treatment
and
standard
four carbohydrate chains
epoetin alfa
with
NovoLet is
three
the
,
nausea ,
cartridges
pioglitazone
erythropoiesis stimulating agents (
effect of
been
site conditions Uncommon -
for ABILIFY
and
years ; the average
enzymes and
cases fatal outcome has
0.3
isolated cases of
dose
weeks prior to
severe
Interactions
Actraphane 30 consists of
or
% CI
units ( IU )
)
hepatic impairment : no
nausea
Eesti filiaal
also be used
to a
with metformin and/ or
-
,
ABILIFY
an
0)1628 537
or diuretics
Following intravenous
was
The possibility of
medicines known to
1 tablets
identified metabolites are
3116 8953
6.2
Oxford Road Uxbridge
.
ge reported with
PHARMACEUTICALS
14
, Storbritannien Tlf :
Paget s disease ,
administration .
it may also be
and
the
ABILIFY
iron stores .
in
of recombinant human erythropoietin
also prevents
with aripiprazole
should be considered on
all medicines
: in clinical
( two studies
on the
,
( see section
the
% )
administration of
been
aggravation of existing hypertension
Park , Oxford Road
usually
The peak is always
There is no accumulation
, 49 x 1
for a longer
- Do not use
with
contains 2000 international units
0.035 mg of anhydrous
cell volume
4 hours in
is eliminated by renal
of
µ :
i. e.
delay recovery
overall survival and
autologous
recombinant DNA technology
or
IU/ kg
reversible and
6000 IU/
open-label studies
)
Phlebotomy may be
OR WASTE MATERIALS
tablets are white
SQUIBB GESMBH Tel
In
, insomnia ,
4.10 Overdose (
risk factors such as
active
( see section
, uncommon cases of
recent low-trauma
a half-life of a
Special warnings
24 hours after
your doctor or
251
( 2°C - 8°C
, increased
93 05
Patients were treated
during
some
in
higher
versus
of efficacy or
3116 8950
THE
reported in children .
DISPOSAL
R & D Centre
THE
mmol/ l )
AND
, sodium hydroxide
) .
amino acids .
of CYP3A4 (
with
Weight gain :
Effects on
alcohol
below 30°C ) .
.
the skin (
A gastric
controlled
valproate
g/ dl (
pain and/ or
Kingdom BRISTOL-MYERS
.
treatment
.
a
, 14 and
CYP3A4 inducer
- Peripheral neuropathy
important differences .
Aclasta
a
: in
the
or mixed episode
on
hyperosmolar
or
a sulphonylurea .
.
danazol
male and female
%
the
In paediatric
signs
experience in children
( see
5.2 ) .
)
or
g/ dl
less
Occlusion of
may
pioglitazone (
, or
should
to sudden stabbing migraine-
.
Actraphane 30
67 55
efficacy
effectiveness of Abseamed
Starting dose
receptors on
water for injections
observed
The metabolism
to maintain haemoglobin values
should be
use
Iserlohn
A-007 and 5 on
including
ON BLISTERS OR STRIPS
working ,
in patients
disposed of via
injection site
increased
, and
)
dosing
.
patients
when
: +
THAT THE
The therapeutic margin of
meal or unplanned ,
Eli
6.1 .
use in this
Continuous rotation
less
Nausea ,
washed and
site conditions
12
Patients
(
,
first
a
between 10
x 1
be considered
contains 5 mg
15 mg has not
symptomatic
or
of
, accidental or intentional
.
with
Component
use in dogs with
37 D-58638 Iserlohn
of
of thrombotic
The initial dose is
In the long-term studies
Within 60 days of
938 ;
or
have
2 (
no relevant effect on
SQUIBB BELGIUM
suppress
should
Eye disorders Common
section
.
section 5.3
.
,
with medicinal products
,
.
during
blister .
aripiprazole
Pioglitazone is also
is
Iron status
fast-acting
the
section 4.8
patients
see section
% ) .
recommended
1
be
reported
significant effects
information
Hyperglycaemia and
of
( see section 4.5
, metformin )
-
no
and/ or non-healing sores
accepted
the effect
1HU -
also
ALT )
HORIZON
) Dyslipidämie eingeschlossen
doctor or pharmacist .
is thought to
if
e. g.
34 857 42 22
and
Mildly anaemic
should only be
:
102 avoided ; guidance
RESTRICTIONS WITH
glucose
patients
are
general scale
of
be monitored closely
.
0)21
with bipolar disorder
in humans and may
active ( M-II
when
the injection
patient
.
- 6.8
Treatment
Centre
overdose
medicinal products .
of
4.4 )
6.1
pain
thrombosis
in
manic episodes
the
with repeated infusions
been studied .
)
of
see section
overdose with aripiprazole
of aripiprazole
(
,
Finland OY
human ) .
weeks
These measures will help
characteristics of aripiprazole and
manufacturer of the
6.2 - 7.5
other
and
ml contains 2000 international
aripiprazole and 3.0
a
treatment ,
Aripiprazole exhibited
without psychotic features
37
3
)
The recommended dosing regimen
.
when stored between
toxicity
Uxbridge -
symptoms
IT
see
days following
or previous
treatment
three
the risk of
%
additional
post-dose symptoms occurring within
on in
dissolved insulin and 60
In
headache
pharmacist
a dose of
( injection
Gamma Glutamyl Transferase
800
90 and 98
.
The
mortality was
duration
and
Syringes
your pharmacist
be discontinued immediately
537 900
,
seriousness
7000 IU/ 0.7 ml
Any unused product
0.4 ml contains 4000
a cardiovascular
more information
planning to become pregnant
hydroxylated metabolites is catalysed
the patient should
What benefit
following
is therefore
by
information
units ( IU
to tell your doctor
are pregnant
see section 4.5
with chronic renal failure
% in
blurred vision
Aripiprazol sollte
There is
Usual maintenance dose
dose
with Abseamed
( as hydrochloride )
be adjusted
patients
5.3 )
272 16 00
after administration of Aclasta
on the pharmacokinetics
to tell
corresponding
investigated .
2AQ United Kingdom
long-acting insulin
women
and haloperidol
progression of diabetic
information on
drive and
therapy
rare cases
,
medically important
before
0.5 %
)
and dehydro-aripiprazole , but
the
E216 ) Sodium hydroxide
of adult
between 17 and
somnolence , sedation
events in
to 2 g/ dl
of greater than
to maintain urea
Uncommon -
68
change in
,
clinical trials and
with
these
for three
administered
signs and
.
no influence
,
recommended
by the intravenous route
lung , 22
retinopathy Long-term improved glycaemic
pioglitazone
A specific overdose of
subjects with
g/ dl ( 6.2
ohne Adipositas
see section
disorder , akathisia
NMS
dosing
years .
in
most of these patients
you
metabolised
2 g/ dl
of dehydro-aripiprazole
There have been
+33 (
increased risk of
vascular events ,
( 0
,
with
:
section
aripiprazole
, especially
: + 40 (
method
with aripiprazole
%
" and
to
should be
by pinching the
x
Centre ( Europe
hyperosmolar coma or death
.
.
under
2000 IU/ 1 ml
administered
6.2
with these
the
The terminal half-life
53 % ) .
Common :
is concomitantly administered
and blurred vision .
SQUIBB
headache
3000 IU ) of
4.4 ) .
of hands
Centre
Abseamed 6000 IU/
or
Patients
That
4.5 Interaction with
Your doctor will
. It can
tablets 49 x 1
hydrolysis ) sites on
)
When a
800
were treated without
: a
,
pancreatitis , dysphagia
+ 44 ( 0800
Middlesex UB8 1HU -
, the suspension
A
hydrolysis ) sites on
AUC and Cmax of
30
or
than placebo
58.8
:
encephalopathy-like symptoms (
in
various
unable
aripiprazole
not
fast-acting
after
, sedation , headache
,
Cancer Therapy- Anaemia (
to
+ 45
anaemia (
diarrhoea .
the
insulin ( human
blood tests
0)810 410
tablets
( see section
contraeptives ,
When a dose adjustment
be
: in clinical
company
60
exhibit complications (
Abseamed should be
the pharmacokinetic
g/ dl
HF Sími : +
years ) of
, aripiprazole
a medicine containing
cerebrovascular adverse
12 g/ dl
( 0)810 410
( 1 to
forms of
kg over 2
kg and
are round
infusion fluids .
may
.
scheduled for
( or
any remaining contents
environment .
unit dose blisters
in
.
Abseamed should be
be monitored closely
Non-clinical
see section 5.1 )
on
- Treatment of
ABILIFY
in vitro solubility .
in
caudate
see section
anxious or tense
mg
taking ABILIFY .
prior to
The
21
muscle
units (
(
with ABILIFY
an efficacy of
subjects ,
anaemia
the
.
In
BV
studies
diesen Patienten sollte
insulin and isophane
S. A.
is
and 2.47 in
of ketoconazole or other
fast-acting , insulin
6.6
Abseamed
The pharmacokinetic characteristics
House Highbridge
mmol/ l ) to
injection under the
month
mmol/ l )
2
or
If you
and
( for pH-adjustment )
hyperglycaemia , diabetes
be
Abseamed has
3XX United
section 4.2 )
anaemia
of anaemic patients .
Suomi/ Finland OY
- Treatment
a dose of 600
were 39.5
( human ) .
ABILIFY
.
(
altered mental status
section 4.8 )
of anaemia
) .
hours
improvement
patients
( 0)20
of NMS
(
adolescents has
, there were
)
in subjects with
, aripiprazole
forms of interaction
IU/ kg epoetin alfa
)
(
(
.
mortality : in
vomiting , nausea
1736
significant risk factors
the present state
residual
.
should be monitored closely
a disease in which
placebo
.
( as hydrochloride )
mitratapide versus
if you
unconsciousness
.
maximum
insulin requirements
micrograms epoetin
serious
at
for use
and
between 9.5
in
Abseamed 4000 IU/
children
have frequent
with
see section 6.1
administered alone
mg/ kg
Ireland
should be
, accidental or intentional
, Oxford
about hurting yourself
in the placebo group
:
ml contains 7000 international
8950
Eye disorders Very
1
alfa
,
- 7.5 mmol/ l
treated patients
if your
- Middlesex
and in
and sulphonamides
the treatment in this
forms of interaction
%
see
.
:
The usual dose is
impairment ,
if
As with other
at least 500
instructions given to
animals ,
.
-
headache , tiredness
a
the intravenous
following undesirable effects occurred
and
symptoms can occur .
(
inhibitors of
The recommended
been performed
hyperglycaemia ,
a few days to
or 98 tablets
Injection
hypotension
Arzneimittel Pütter GmbH
to placebo
sensitivity to a
-
with
Eesti filiaal
Limited
infants , Abraxane is
,
chronic renal failure patients
mmol/ l
REACH
In clinical trials of
drink the
[
aripiprazole
of
t½ ) is
see section 5.2 )
)
West Sussex , RH12
under the skin
Although there is
chronic renal failure patients
Aripiprazole and other
increasing
, placebo-controlled trial
, nausea
read
.
with
Although there is no
.
%
.
4.8 - General )
after
see section
usual dose is 5
per month
ketoconazole )
IU/ kg
pioglitazone vs.
use in
.
insulin products ,
see section 4.4 -
in the
be a moderate
.
Kingdom BRISTOL-MYERS SQUIBB
or
solution for injection is
with chronic renal failure
monotherapy
respected
or severe sensory
vomiting , an
the
Aldwych London
OR RESTRICTIONS
pharmacokinetics of
.
Bipolar I Disorder
1.25 mmol/ l
be administered intravenously
jaundice , hepatitis
metabolites
risk of
% with
information on
) .
and
risk for thromboembolic events
+ 43
Highbridge Business
dose is 15 mg
Upon discontinuation
the solution
be impaired as a
x 1 tablets
If the
is 32,000 to
to
NPH )
E951 )
whom the
micrograms epoetin alfa
.
2-78
smoking
.
orodispersible tablet contains
of hands
+ 44
extrapyramidal symptoms .
and dyskinesia
This
12
information on
with
2 g/ dl
g/ dl :
and dehydro-aripiprazole ,
symptoms
respected .
instability ( irregular pulse
of insulin
treatment
aripiprazole has not been
to protect the
)
observed for
mmol/ l )
effects of
were not evaluated
other indications .
taken in combination
Usual maintenance dose
alfa
In the past ,
, including PANSS and
pharmacist how
One IU
study included
colourless , aqueous solution
,
91 ) 663 50
Abseamed
000
Eli Lilly
paediatric
reduction
Eli Lilly Finland
nausea ,
AND ROUTE(S ) OF
constipation
exhibited
WC2B
maximum dose
a mean total
not
mg has not
,
in section 4.2
solution for injection
physical
allergic reaction (
bei der die
, Wielka Brytania
with haematological malignancies .
in
may
Syringes
: + 45
patients with diabetes
ml
to
production .
Adult
of the
of agitation
enzymes .
itching
mg )
Haemoglobin variability
of mitratapide
may
year
symptoms
treatment with
,
,
:
meal on the pharmacokinetics
D (
(
anaemia associated with chronic
in the
diarrhoea
of anaemia associated
aripiprazole
cannot
ADMINISTRATION
condition
) .
approximately 25
substitution of
M-III
half-life of
2 hours after administration
, marked with
maximum
contains 7000 international
of
All
(
42 trials and
section
)
Treatment of anaemia associated
, restlessness ,
approximately 18
denen Midazolam
epoetin
bernsteinfarbene Glasflaschen mit 55
.
:
kg
tablets 56
to
patients with haematological malignancies
emission tomography .
anaemia associated
range
insufficient safety information
and
should be
between
Special populations (
section
,
Treatment of adult
,
and transport refrigerated (
Park
previous stroke who
+ 358 9 251
medicinal products .
.
solution .
are never to
.
absorption of
75 - 150
these patients
-
including
a sulphonylurea
is achieved
haloperidol 73
ketoacidosis ,
and your
approximately 86 %
patients scheduled for major
153 MINIMUM PARTICULARS TO
but more frequently
vision Gastrointestinal disorders
Patients
1
tablets
pathways involving the CYP2D6
731
human ,
.
women treated with pioglitazone
Maintenance dose between
patients with
+ 44 (
10
IU/ kg 3 times
7.5
cellulose Aspartame ( E951
injection :
family history of
Slovenská republika Eli
37 Adjustment
in
53.3 % for
of substances
nursing
4.5 ) .
will ask you
of
1.25 and 2.47 in
and vitamin D supplementation
at doses of 5.25
before you
and safety
when taking ABILIFY
insulin
included only
7
and
6.2 - 7.5
testosterone suppression was
The
)
receptors on muscle
patients
warfarin )
meal
of multiple medicinal
begins
epoetin alfa
you
.
unused product
)
patients
10
)
EPS was 19 %
international units (
patients
section 4.2
urticaria
Eli Lilly
valproate
symptoms of heart failure
rats after
glucocorticoids , thyroid hormones
maintaining the clinical
12
Octreotide/ lanreotide may
section 4.2
of
one year
should
insufficiency not yet
% )
50 IU/ kg 2
coma
few
, constipation ,
especially
unconsciousness
The
children
renal failure
controlled clinical studies ,
VOLUME OR BY UNIT
Water
the
a full
(
insulin products ,
dalton .
only
Effect on height
In
rare
Cmax
*frequency is based only
In addition , cases
to treat
you
a
not exceed
is
see sections
of
Abseamed
, D-58638
Attention should be paid
levels
1.25 mmol/ l )
five years .
:
with epoetin
and
of zoledronic acid
den
( with a baseline
.
human
with
or hepatic impairment
effect of pioglitazone (
alfa
7.5 mmol/ l )
6.6 Special
Adjustments of daily dosage
measures will help
Do not
28 x 1
05 06
% CI ]
recommended starting dose for
Abseamed
.
death in utero
accumulation
After administration of
is especially
indication increasing
,
treatment schedule .
)
angioedema
on
Special warnings and precautions
circumstances
:
(
trials ,
2
)
6.2
for thromboembolic events
(
ABILIFY
diabetic
Erythropoietins are growth factors
and
tumour due to
% of
Bipolar I Disorder and
, the patient
white and
aripiprazole (
( CLAS )
in
61 Aldwych London
severe manic episodes
episodes
per 8
)
Subcutaneous injection
x 3
section
aripiprazole
after
and anaemic
in patients
Kuhloweg 37 D-58638
patients with
glucose control
, which
15
-
of
a
, each ml
Pre-filled pen (
development
, the gluteal region
United Kingdom
disorder
150
per day .
13
In
are
one of
drug reactions from
SQUIBB NORWAY
+ 31 34
may be a moderate
Hb between 10 and
bone and therefore makes
) .
osteoclast-mediated bone resorption .
-
of
a dose adjustment
) and 802
00
placebo to
Abilify
patients ,
% )
epoetin
used in humans .
The pre-filled syringes
is controlled
6.2 mmol/ l )
and
hour
both fast-acting
, uncommon cases of
,
few minutes .
Sími : +
blood glucose
52 As with any
Tardive Dyskinesia : in
placebo , or were
failure in patients
treatment
. no
2°C -
may require discontinuation of
AND EFFECTIVE USE OF
g/ dl
4.4 ) .
LTD Tel
and isophane (
with solid tumours (
treatment
see section 4.4 )
section 4.4 ) .
For any information
wurden.
and
, take
DISPOSAL OF UNUSED MEDICINAL
may
or less duration ,
Cmax
increased risk for thromboembolic
clinical trial in healthy
molecule
UB8 1HU -
stroke or
.
als
use in
chest pain
.
use
- 6.8 mmol/ l
1
and vitamin
Tel : +
you have
on the PANSS Excitement
particularly overweight
.
of
reduction
the patient
reaction
23 hours .
Nederland BRISTOL-MYERS SQUIBB
4.8
with insulin syringes
events
side effects (
)
(
.
more
1
rare
( see section 5.1
day
mg tablets are
Patients should
.
34
6 weeks
been established
, a
interaction
has been
Croscarmellose sodium Crospovidone
.
few minutes )
,
well-controlled trials of
such patients
) in
6600
from
glycine ,
Neutropenia was
15 mg or
Fe2+/ day is
The following side effects
ABILIFY is used
medically important signs
the
, dysgeusia
This
symptoms
) .
incoherent speech
6.1
Nederland BRISTOL-MYERS SQUIBB BV
and
no medically
clinical trials
)
disease
CYP3A4 (
doctor or pharmacist
the reach
) Ltd 61
may
to
concentrations , aripiprazole and
D
glucocorticoids
Nederland
dose
47
In
administration of
pulse or
In the indication
be observed .
monitored
you
Survival
and
abdominal discomfort
ABILIFY is effective in
.
and inflammation
solution for injection
and
is contraindicated ,
fed
and
.
adjustment
severe
hypersensitivity occurs
diabetic retinopathy .
Lilly
events have been
micrograms epoetin alfa
other
Injection
129
Kingdom BRISTOL-MYERS
by
compared to baseline
.
wünschen
272 16
Laboratory tests did
OR WASTE
activity
.
) ,
diabetes mellitus ,
except in paediatric patients
is therefore
blurred
or
should be closely monitored
between 17 and 33
and its
or Hb increase 1
t½ of
( see
renal anaemia
or
&
(
Moreover , monitoring of
some
15.7 ,
incidence of EPS
The potential
( 2°C -
of
-
Not all pack
caudate
the incidence of
erythropoiesis stimulating agents
%
1.9
products
( 8.1 mmol/ l
, growth hormone
other atypical
ESAs ) have shown
given subcutaneously 3
501 76 03
leaflet
12 g/ dl (
CYP3A4 inducer
the levels
12 g/ dl (
:
SQUIBB BELGIUM S. A.
used
, an
pregnant
should
8 kg
the
patients with diabetes mellitus
%
(
2.47 in
children over 30 kg
anticancer medicinal product
studies ,
if the
receiving chemotherapy ,
given 2
been reported
&
Park
infections and
insulin
Novartis Norge
on mg/ m2
antipsychotic
and diarrhoea .
section 4.4 ) .
61 Aldwych
increased Aspartate Aminotransferase (
type 1
minutes
of efficacy
34 [
or
1
, whilst the relative
30 kg
.
increased
ml
and women
Road Uxbridge - Middlesex
section 4.8 ) .
aripiprazole
.
30 mg
type or brand of
ACTRAPHANE 20
the placebo group
)
and Cancer
,
The
and blurred vision
dose
haemoglobin
other
haemoglobin of greater than
cerevisiae ) .
is therefore
Non-specific skin
nicht
.
route .
Road Uxbridge - Middlesex
537 900
more units
revealed no
section 5.1
and 3.0 %
, a
two large
: + 354
)
vitro
.
inhibitors of CYP3A4 ,
, glycine ,
,
Read all of
-
Iserlohn
gastro-intestinal
71
rimonabant
your doctor
50 tablets
solution .
patients
and
the maximum recommended
hepatic impairment : no
insulin human
Abseamed should be
4.6 ) .
vorgenommen werden
situations
ischaemic
controlled
per
studies
study
The
the product
vomiting
( mean age
1
hepatic impairment
.
sudden unexplained
should be
children
see section
and
hypoglycaemia whilst driving
will help to
section 4.4 -
+49 911 273
anaphylactic reaction
be
(
no influence
.
( see sections
, thyroid hormones and
than
- Middlesex UB8
%
products to affect ABILIFY
some
3 sites
cases of stroke
)
efficacy
;
obesity ) and
patients with type 2
1 ml
the
self
A single-dose study in
micrograms epoetin alfa
increase 40,000/ µl or
of
with
of the
, hepatitis ,
not take ABILIFY
men
female rats
(
reactions are
hypoactivity
contains 15 mg of
: + 43
.
,
Tel :
with
meal or unplanned
( see
and "
The syringes contain 1
see section
a
of these
of
can be
ON BLISTERS OR STRIPS
45
Read all of
by a decrease
Tlf : + 44
with
Maintenance dose between 25
802 with
in
g/ dl (
in man .
and
, and
2
.
12 g/ dl
whilst
5.3 ) .
Based on
(
, Royaume-Uni Tél/ Tel
not
15 mg and 30
bone tissue )
In patients with
and/ or ongoing antidepressive
month )
.
( see section
aripiprazole and dehydro-aripiprazole
4 or more
Cmax of
ml
hours after the
the patient
IU/ kg given subcutaneously
.
insufficiency not yet
Patients
the intravenous
potent CYP3A4
conditions for the
of 1
AND SULPHONYLUREA
normal
Tel :
Ask your
273 0
rats , dogs ,
.
Die
mitratapide versus
BV
haloperidol .
patients with
administration
vitamin D supplementation ,
a
and dehydro-aripiprazole did
for pH-adjustment )
blood clotting (
.
6.1 .
.
store in a refrigerator
44 (
with
by
of 200 mg
renal failure
methods
of 0.45
of
inflammation .
women
patients
per
vary with
45 45 93 05
Oxford Road Uxbridge
.
contains
In two large
and anaemic rats
of
, thiazides , glucocorticoids
clinical studies ,
7.5 mmol/ l
with oral
who have difficulty
other handling
.
analogues for
hypoglycaemia )
toxicity
a potent inhibitor
not exceed 30 mg
After
and
)
.
below 100
may be needed .
subcutaneous tissue
for
In most of these
.
, IF APPROPRIATE
safety
anaemia
aripiprazole
activity , concentrations and
1
marked
pioglitazone
, cerebrovascular
may be necessary
and
BRISTOL-MYERS SQUIBB
pH adjustment )
,
chemotherapy
)
more
- 39
medicine
has
trial
211 patients in the
cell line by
.
but not in
less
section 4.8 )
episodes of hypoglycaemia .
.
increased risk of
in
attention should be paid
The efficacy
,
international units
3A4
: + 32 2
,
see section
( normal and anaemic
administration
: + 44
- 150 30 -
aripiprazole concentrations
and beta-sympathomimetics ,
not been established .
of the
baseline
reduction
, glucose-galactose malabsorption or
metformin
Common side effects (
8°C
hypoglycaemia whilst driving .
changes in routine
Del Ceraso I-03012
the
7000 international units
.
and
)
+ 358 9 251
EPS including parkinsonism
tablets 30
LTD
with
8000
,
controlled
( 1.3
see section
.
)
to patients with
of insulin resistance
see section 4.2 Treatment
warnings and
Common :
4.8
.
The recommended starting dose
mediated by a
73
patients with or
precautions for
1st-line
.
intravenous administration of
Interactions with
mmol/ l )
about operating hazardous machines
in
no
undergoing dialysis
when
:
( 1 )
solid tumours (
.
of the
( 30 % )
patients with
the bioavailability of mitratapide
contains 10 000 IU
not to
ABILIFY
clinical trials
carton contains
bone .
1.35 , 2.06 ,
for haloperidol (
blurred vision
mg
to the baby
symptoms
important
the suspension should
.
without treatment in between
with ABILIFY
is therefore
under
, the
:
the pack
bound to plasma protein
% in
recommended
patients
total hip
and paranoia .
and
- 39
Hb between
24 hours
and
Very rare
.
aripiprazole
, serum levels
Dose adjustment in order
- Middlesex UB8 1HU
% with placebo .
indicated
you
This is the diabetes
with
taking ACOMPLIA with
.
section 5.2
9.5 and 11
dissolved
:
of anaemia
65 to 200
treatment
haloperidol-treated patients
.
these patients should
,
- if
Hb
of the other
less
human tumour samples ,
If
of
studies ,
er Die
Abseamed
3A4 ( dextromethorphan
statins , fibrates )
causes of anaemia (
may
hepatic impairment
to
and 98 tablets .
with epoetin alfa
diabetes , ketoacidosis
Patients with hepatic impairment
(
and swelling of hands
of recombinant human
100 ml ready-to-infuse solution
genotoxicity ,
should be
2 times per
patients with
, increased risk
,
,
epoetin alfa Abseamed
not
clinical studies ,
30
(
,
dose reduction
In patients
is given 3
usual
a
stored at
If
5
In
per
of EPS including parkinsonism
repeated
rats
The effect of pioglitazone
to treat
last updated in 10-2007
to
, increased risk of
14 g/ dl (
after
+ 45
seriousness .
aripiprazole
section
mg
- if
information on
AND SIGHT OF
placebo-controlled trial
by
.
or
erythropoiesis stimulating agents (
- This
and
placebo-controlled
: in clinical
, vitamin B12 or
alfa
recommended total weekly dose
between 9.5
Italia Farmaceutici SpA Tel
increase in haemoglobin
valproate or
whom
( human ) .
If
) or the
cannot be excluded
potassium in
APPEAR
mg orodispersible tablets are
contents of the pack
.
pain , itching ,
manic episodes in
The unopened bottle does
pregnancy
Patients
have been
1
( PFT )
%
, Oxford Road
including dose reduction
rDNA
and symptoms
each patient
your dog
BY UNIT
with aripiprazole
Business Park ,
)
range of
adjustment
1 to
the dose should
needle
haematocrit
aripiprazole Intramuscular
you
and
+33
,
is
been observed .
Pioglitazone
95
no relevant
)
United
6.2 mmol/ l
n =
.
on
15
aripiprazole (
( for a
in
The safety
% CI
In
+ 353
2.47 in
clinical studies ,
in
other medicinal products :
g/ dl (
,
- if the
)
of the
of children .
is
dose of
haloperidol 73
The pharmacokinetic
solution
.
)
prescribed for you .
hypovolemia
98 x 1
tachycardia ,
how your anaemia
, the
Patients
well-controlled trials of aripiprazole
factor and differentiating hormone
unlikely to reduce
hypertension .
of anaemia and
and Cmax
cancer
.
healthy subjects
doses
+
for injection ( 7.5
any of the
A few
avoided
creatinine and
please inform
about this medicine
PRCA
see section 4.5 )
oral administration of
regard to meals .
ABILIFY Each ml of
Tel :
agitation and disturbed behaviours
clinical trials
site conditions Uncommon -
g/ dl (
associated
or
somnolence , sedation
Bone biopsy results
Hypoglycaemia
section 5.2
.
and 8167 patients )
hypoalbuminaemia
%
between 1.25 and
(
human
-
both
occlusive
The
When the
5.2 ) .
It
treatment with
g/ dl
or
The frequency of hypocalcaemia
8 704 71
dose
route .
Oral contraeptives ,
of
1
section
( IU
.
taken
( 0)1628 537 900
Kuhloweg
substances ( solvents
patients
were
ml
in schizophrenic
is
Within each
, and
pregnancy , lactation
in patients
.
( 7.5 mmol/ l
haemoglobin
haematological malignancies
( see sections 4.4
, rDNA
of diabetes was
, which showed
.
thrombosis
5-hydroxytryptamine
.
11
25 and 50
treatment
g/ dl (
.
There
) per ml 0.2
The
pioglitazone
.
should
aripiprazole during
overdose with aripiprazole
been reported while taking
(
your
%
alfa
33 -
or
to
5-hydroxytryptamine
There are
( MAOI ) ,
studies
% CI :
ABILIFY
see section 4.4
5.1
1,000 ,
were
. It
Limited p rst
( particularly
units (
diabetic retinopathy
orodispersible tablets 28
6.2 mmol/ l
reported after months
the
immediately if you
Park , Oxford
solution for injection
and -3A4 respectively
%
may be a moderate
) .
2°C
.
recommended total weekly dose
During
Co KG Kuhloweg 37
or pharmacist .
make sure the
two large
adult patients on
: extrapyramidal
one side .
or
paediatric
What
mitratapide
Abseamed 1000 IU/ 0.5
most frequent adverse reaction
men
(
After
g/ dl (
13 g/ dl
8.4
is 32,000 to
.
large
When activity , concentrations
see
a lesser amount
6.1 .
.
significant changes
g/ dl ( 7.5
mmol/ l
or
an interaction between epoetin
( heartburn
especially in patients
BRISTOL-MYERS SQUIBB
that
, compared
If the haemoglobin is
OUT OF
adult patients
and
Actraphane 50 NovoLet
Aclasta
severe sensory neuropathy
of
plasma concentration of
solution for injection
injection
but not
1.3
epoetin
of 600 IU/ kg
placebo group .
or overweight
and
46
in
during
see section
IU ) of solution
g. diminished
Patienten ist keine
.
enzymes .
contains 30
.
if the
experiencing potentially clinically
interaction
.
monitored
on
and
Name and
73 %
of
diabetic
of the
AND
in
units (
, open-label studies ,
after
administered by intravenous infusion
CYP3A4 (
hepatic impairment
mg
pioglitazone .
ABILIFY
comparable to placebo
The
) .
,
60
and
)
and
type 2
)
,
patients , receiving
cardiovascular therapy
Die
( IU )
18
When weak
of
.
1.25 mmol/ l
.
see
any remaining contents
:
erythrocytes from precursors
kg for the 120
Latvij Tel :
completed suicide ( see
was considered non-genotoxic
Wimblehurst Road Horsham
in
DK-2880 Bagsværd
years ) of
of controls
37 D-58638
The active substance
manic or
) .
8ºC .
,
)
are
may be observed .
speech disorder
for major
(
and mediastinal disorders :
.
and clinically
of
( i.
gp-60
in
.
)
and well-controlled
pioglitazone
included only 3 patients
.
.
aripiprazole
UB8 1HU -
an increased
not
or
The following adverse
and
6 weeks
( see
Adjustments of daily dosage
are
mellitus , diabetic ketoacidosis
section
and
Eli Lilly Holdings
is effective in
only 3
the most frequently
mg
Starting dose
vomiting ,
, Royaume-Uni
change in
times
( see
12 g/ dl (
exactly as your doctor
SpA Tel
four weeks
of effect of
4.5
medicine :
Cmax
transient ischaemic attacks
There
PRODUCT
schizophrenia patients
,
transitory and
24 and
.
%
,
should
Business Park , Oxford
the disposition of paclitaxel
study included only
and
you
tend
of epoetin
and blurred
reports are based
Units
and
, ventricular arrhythmias
Hydrochloric acid
adult patients
both decrease and increase
United Kingdom
no
elderly and
to sudden stabbing migraine-like
you
lithium
in
complications
1 , 5
hypoglycaemia
Therefore
during treatment
4000 IU/
sulphonamides
compromise or
alfa
15
initial treatment response
potent
has not been established
Montgomery-Asberg
or
events
your doctor or your
undesirable effects occurred
and
HbA1c ,
( see section 6.1
epoetin alfa .
In clinical
in bipolar patients
has no influence
in
chemotherapy induced anaemia
increased linearly
days prior to
.
or hepatic impairment may
an autologous predonation programme
of a full
.
as measured
This medicinal
carefully weighed against the
Frequencies of adverse
month
20 : soluble insulin
be followed
It can be
humans
This medicinal product
and
cell
stomach discomfort
The
or
receiving radiotherapy
side effects ,
Insulin treatment of the
Usual warning symptoms may
QT prolongation ,
or
pathways involving the
2000 IU/ 1 ml
Tlf : +
( this
nursing
reactions
of
see section 5.1
paclitaxel .
of
:
over
g/ dl (
pre-filled pen
25
with
metabolites 6 -hydroxypaclitaxel and
.
the
Hypersensitivity to
3
aripiprazole
local requirements
32 avoided ; guidance
6000 IU/
times per
the
the
2
haemodialysis and adult patients
migraine-like headaches as a
.
by hepatic metabolism
No other erythropoietic therapy
weight gain ,
your doctor
Middlesex
headache , tiredness
Tel : +
see the Package Leaflet
.
UB8 1HU -
8°C
30
of
observed
and
ABILIFY is 15
2.5
Uncommon
antipsychotic drug
children
angioedema including swollen tongue
(
on in vitro
)
speech disorder
) , contact
re- suspension .
( see
- Diabetic
.
Co KG
and
below
.
untreated
of your
blockage
pre-filled pens
mg
at the desired level
syringes contain
effects
second
7
- United Kingdom
notice any
pancreatitis ,
: + 33 (
contains
Europe ) ,
extrapyramidal symptoms .
The usual
RESTRICTIONS WITH
( PFT ,
The pharmacokinetics of
other
consists of
per
been reported in patients
by the intravenous
oedema
and M-IV
reconstituted medicinal product contains
lithium
, but not
a
, rDNA (
reported in 79 %
receiving non-platinum
hydrolysis ) sites
, Wielka Brytania Tel
- 7.5 mmol/ l
aripiprazole and 3.0
increased risk
If
)
) per month
ventricular
möglicherweise nicht alle
and Cancer
inhibitors of
the
The
In
[
Actual scores
Aclasta ( 5
+ 47 67
your dose
25 800
patients
mit
inhibitors
or other CNS
infection or
4.5 ) .
on the
in pregnant
.
and
prior to
when
It could be
und
haloperidol
meal on the pharmacokinetics
section 4.8 )
used
)
suicidal ideation ,
.
angina
patients with these
DISPOSAL OF UNUSED MEDICINAL
( 7.5
In
baseline on
181 MINIMUM
In schizophrenia
5.1 %
unused product
of vertebral fractures
Some patients may
ml
one of these
2.47 in favour of
)
, close medical
your doctor
The
mitratapide ( parent
(
As for
or pharmacist .
SUPPLY
long-lasting effect is needed
; suicide attempt ,
output from the liver
significant
3 times per week
not appropriate
+
studies ,
over 30 kg and
evaluated .
concomitant
and paediatric haemodialysis patients
55
BRISTOL-MYERS SQUIBB (
mg
this leaflet carefully
(
no clinically
In
should be
reactions
signs and
30 mg
, the
reported
(
ABILIFY orodispersible
reduction of transfusion requirements
situations
44-20
month
dose
% with
was 12.1
not clinically
- Peripheral neuropathy
anti-fungal medicines
Novo
risk of
Authorisation Holder .
but not
Kuhloweg
.
daily insulin requirement
or unplanned ,
headache in
subcutaneous administration
6.1 .
the pharmacokinetics of aripiprazole
)
in the pioglitazone
to be compatible
with
or even death .
alfa ,
epoetin
:
.
section
) .
even several weeks
the levels
: +
in
difficult
doctor
sugar
1
)
In
,
ABILIFY contains
sections
of increased
should
,
other medicinal products .
or
)
9000
higher
treatment
Store in a refrigerator
6.6
1HU - United Kingdom
( e.
men )
of
with
erythropoietin
, 64 gynaecological
l )
of 0.5 ml 6
treatment with the product
contains 15 mg of
) , increased
a
Pack size one vial
section 5.1
patients with or without
4.6 ) .
.
SAWP .
The
and Bipolar I Disorder
44-20 ) 74
Allé DK-2880 Bagsværd
individual insulin requirement is
aripiprazole
a combination
and 98 tablets .
ability
.
section 5.2
affects you .
)
evident ischaemic heart
may feel dizzy
features and with
)
( 6.2
and
e. g.
mg
of 84
other handling
) .
.
serotonin 5HT1a
patients
Dose adjustment
of mitratapide (
of osteoclast-mediated bone resorption
forms of interaction
adverse
124 PARTICULARS
aripiprazole
of 1
the intravenous
tumours ( 683 breast
treated with aripiprazole
, anorexia , hyponatremia
( e. g. stenoses
.
g/ dl ( 7.5
(
For osteoporosis
- 12
section 4.4 )
)
+
Hyperglycaemia
two
) .
) Blister
rats ,
of agitation than
% with
clinical studies
) per month
2°C - 8°C .
decision
.
placebo-controlled
( GGT )
contains 7000 international units
two main
transient
and
injection
Treatment of anaemia and
antidiabetic medicines
nurse
increased to the level
but
) .
, chest pain ,
brain
of epoetin alfa on
In
for
, sedation , headache
Amounts to be
flatulence , glossodynia
medicinal product contains
sse Der Anteil
( see section
when
medicine
pollakiuria , haematuria
dyslipidemia
( see
trials and
caudate
see section 4.8
and 5HT2a receptors and
7.5 mmol/
IU ) of solution
of greater than 12
month , or if
10 % and
dihydrogen phosphate
ml calibrated dropper
When weak inhibitors
4.8 ) .
are
scheduled for major
Sodium
of 45
flatulence ,
DATE
17 and 33
with
mania
At therapeutic concentrations
in
in patients
orodispersible tablets
only
the
Aldwych London
than 2 g/ dl
.
to placebo
.
inhibitors of CYP3A4 (
60
of aripiprazole
21 412
When the
international units ( IU
of EPS including
The
(
control group
PRODUCTS
300
Elevations of
UK Ltd Tel :
administration
to
result
arrhythmias
3116 8951
and
and protein intake
mmol/ l ) .
.
of clinical fractures
Limited Eesti filiaal
, Neuroleptic Malignant Syndrome
and approximately 60 %
Hypersensitivity to
( 1.25
that
+46 8 732
.
of
from light .
The symptoms are
15
a
50 :
be
vomiting , nausea
A sustained haemoglobin level
It
glycaemic control is associated
of death
the
is 32,000 to
and 500 film-coated tablets
In pregnant or
haloperidol
epoetin alfa ,
cartridge
of the
)
of
.
should
CHMP recommendations
This
rDNA ( produced by
increased
+ 43
than
33
62 Elimination The
aripiprazole tablets ,
residual
be avoided
pharmacist how
entire dose
during pregnancy and
, insulin requirements
tell your doctor
is
( and
recommended .
for
pH adjustment )
dosage
and sulphonamides .
7.5 mmol/ l
(
Any unused product
BRISTOL-MYERS SQUIBB
24 hours .
,
Treatment
:
The
or
.
oral
of whom
angioedema including swollen tongue
fatigue Psychiatric disorders Common
In cases where there
While on treatment ,
3 times per
Common
surgeon
pioglitazone
household waste .
receiving chemotherapy
if they
used in humans
two studies
occur in men .
be of 25
2 times per week
ABILIFY
compartment
those receiving placebo (
lifestyle
the incidence of
45 45 93
2
( dextromethorphan/ 3-methoxymorphinan ratio
cells/ µl
.
and
as white
to sudden stabbing
every 3 weeks .
published literature
( see also
no relevant
after
ketoacidosis
( 7.5
( see section 5.1
the pharmacokinetic
dose ,
solution for injection contains
of the
of administration
, D-58638 Iserlohn ,
Physicians should
The recommended starting dose
pharmacist .
4.2
tablet contains 45
some of
and
in
patients
:
as
contains
) .
a
mmol/ l
is 15 mg
taking
should be given
testing did not
precautions
ml contains 1000
was 9.5 years .
3
30 minutes , every
insulin and
Omission of a meal
see section 4.3 )
the
on ability
117 150 IU/ kg
What Actos contains The
%
a benefit-risk assessment with
dehydro-aripiprazole the
.
at 12 ,
and whose
with
is also indicated
pre-filled syringe of 0.9
ACOMPLIA is
g/ dl ( 7.5
and insulin
and anaphylactic reaction
4
,
hours
patients
were
forms of interaction
Erythropoietin is
Lilly
(
in a
of
) Sodium hydroxide
or
Allé
doctor or pharmacist
primarily
of
including
Insulins
adult patients
,
4.4
BRISTOL-MYERS
patients with normal
insulin in
Farmacêuticos
( see section 5.1
If epoetin
or mixed episode
SQUIBB SARL Tél :
in plasma
be monitored closely
THE
jaundice is observed ,
- 7.5
Treatment
tablets
in
.
you
)
the
solution
blood donation procedure
other
mmol/ l
none
Dosage Dosage
be
)
.
per week
)
combined with fast-acting
a risk
, sensory
)
mmol/ l ) in
nausea , constipation ,
elective orthopaedic surgery
in strength ,
femoral neck
a
3 times per week
greater than
for injections
2 g/ dl (
beta-sympathomimetics , growth hormone
Malignant Syndrome
Manufacturer
4.8 and 4.9
treatment
general scale
) after
new information is received
recommendations
hypoactivity
loss of consciousness and
route
to 12
solid tumours
malformations
,
with a maintenance dose
.
mg
(
than
% with placebo .
pharmacist .
with
has been proposed
4.2
Kuhloweg 37
( see section 4.5
action .
either with
be monitored closely
with aripiprazole
and well-controlled trials
Novo Allé DK-2880 Bagsværd
effect
,
recommended ( see
chemotherapy
( E216 )
contributes about 58
14 x
epoetin alfa may
very rapid
recommended starting dose for
11.6 63.8
mg
trial in healthy
store them in
metformin and a sulphonylurea
Tel : +
and female
.
.
5.3
be discontinued immediately .
pre-filled syringes are
34 857 42 22
ise
is
age group
) ,
.
than for haloperidol
resolved .
urticaria
% of
and safety
352 74
site conditions
, teardrop- shaped tablets
mg
.
SQUIBB PHARMACEUTICALS
rare cases of NMS
should be considered .
Close
usual
adverse events
doctor or pharmacist .
humans and
is
meal or unplanned
+ 40 (
, may
and
or
clinical studies
section
other medicines Please
absorb orally administered
and sometimes severe irritability
a
( 0)810 410 500
.
between 17 and
(
in paediatric patients
dose
for pH-adjustment )
+
Frequencies of adverse
( 0)20 3116 8951
irregular heart beat .
dose reductions should therefore
:
chemotherapy induced anaemia
ABILIFY
maintain haemoglobin values
treatment with aripiprazole
The
4.8 - General )
blood donation procedure .
analogues for injection ,
1 ml contains
dogs and
danazol .
an autologous predonation programme
section 5.2 ) .
)
The
whose
: fatigue Psychiatric disorders
risk
%
revealed
.
,
26.5 [ 18.98 ,
Studies
recommendations
i. e.
IU/ kg 3 times
General
15 mg once a
4.9 )
RESTRICTIONS
Abseamed
50
Actraphane is
polycythaemic mice ) .
be at risk of
by 107 %
dose
recovered in the urine
with aripiprazole
hours
use of
in haemoglobin ( 1
Special precautions
vorgenommen werden
(
, or
of 200 mg
a
12
5 vials x
.
TO APPEAR ON BLISTERS
%
67 55 53
not exceed 30 mg
( see section 4.4
use
than 2
ml contains
.
.
a
No information is
5 " on
weeks
treatment of
based
Each orodispersible tablet contains
those
( 30 %
Common : extrapyramidal
especially
be necessary
of ketoconazole
%
APPEAR ON THE
Since the
12
of
with aripiprazole
present in
g/ dl
orodispersible tablets
, for
15
of
doctor can recommend
which were
938 ;
Sodium chloride
have
glycine ,
,
( 0)21 272 16
other
Pack size one vial
or 5 or more
300
)
erythropoiesis stimulating agents (
less than 65 years
see section
reported
.
After opening the
,
times per week
The
some or all
Lilly Holdings Limited Eesti
significant change in
with
( 57.3 %
rhabdomyolysis ) ,
of
clinical
pulmonary embolism )
(
patients with
Glycine Polysorbate 80
rare
6.1 )
.
The following
including
anaemia ,
other
.
another
engraved with "
1.25 mmol/ l
.
factor and
and
or
between
5
) .
410
Road Uxbridge -
0)20 3116 8954
g/ dl
fibrates
placebo group .
Finland OY BRISTOL-MYERS
scheduled
0.8 ml
about hurting yourself
ml .
, Oxford
reported
with
keine ausreichenden Daten am
regard to meals .
)
22 PARTICULARS
.
In
In a
in
of 1.0
4.8 ) .
may
of
cooling element
incidence of
60 %
of epoetin
PRODUCT
be added to
mmol/ l
section 5.2 ) .
, feeling anxious
SQUIBB
orodispersible tablet
means
patients
150
-
serum proteins
225
In
should be
of anaemia with
.
Therefore
Actraphane
refers to
.
section 5.1
is presented
In patients with
Actos 15
,
.
sections
of ketoconazole or other
four carbohydrate chains
or
pioglitazone
(
than you
, both
)
rapidly
round and
patients
therefore be applied .
stopper .
you have any further
count has increased
.
Abseamed
( see section
growth factors
In another
the abdominal wall
contains 3
with
the intravenous route
, in patients
)
and
2°C -
blisters .
mmol/ l )
and
.
.
having a high
treatment of
should
N-dealkylation
shortened
and
controlled
-
patients
standard
abdominal and stomach discomfort
BW 210 ml
( two
if the
AUC
is
CHILDREN
) .
VOLUME
or
( 6 %
severe
( days 21 ,
conducted in 375 anaemic
forms of interaction
terminal half-life (
-
may
as
000 IU
.
times per week )
and what it is
risk of death and
( approximately 1/ 20th
sulphonamides
SPECIAL PRECAUTIONS FOR DISPOSAL
pancreatitis ,
by the intravenous route
were not
cancer
before
times per week
than children over 30
g/ dl
or peripheral
aripiprazole in pregnant
The
injected by medical staff
have been proposed
patients
.
) 524 40 64
thus not
in Saccharomyces
receiving chemotherapy
A-009
stomach discomfort ,
to 3 X
corresponding to 0.05330
carton in order
schizophrenia
when stored between
IU/ kg/ day
,
but
vomiting
not
anaphylactic reaction
.
IU
Highbridge
of
) .
family history of diabetes
a few weeks .
not
38 When either valproate
controlled
11.6
& D
smoking
the
1
no
(
treated patients
If you have
to
,
your doctor may
rate
with a manic or
and anaphylactic reaction
interaction
Fe2+/ day is
ABILIFY is used
dose
reach room temperature
of anaemic patients
of 12
7.5 mmol/ l )
recommended dosing regimen is
two weeks
of death and
proliferation of
.
11
pregnant women .
.
clinical fractures following
exposure
with
in
in a pre-filled syringe
.
.
exclude potential
Vascular disorders Uncommon :
cerebrovascular adverse events in
reported
increased risk of
IU/ kg 3
some or all
ml
catalysed by CYP3A4 .
pregnant women .
Adult patients with
unit dose blisters
Nordisk A/ S Novo
patients with
patients participating in
the frequency
is usually reversible
mmol/ l )
patients and 42
,
patients may
including ABILIFY ,
)
If you
study
CYP3A4 and
CNS medicinal products with
not
clinical trials ,
stopper
( 2
% ) .
10 Patients
to 12
vials are for
Medice Arzneimittel Pütter GmbH
,
What ABILIFY contains
( 0)20
,
)
Within 60 days
the aripiprazole dose
another
analogues for injection ,
61
see section 4.4 )
or
0.6
KG
, use
blurred
Aripiprazole also demonstrated
50 International Units
use
As with other antipsychotics
In cases where there
hypoglycaemic agents ( OHA
with
Package leaflet
mg
pancreas
hypoglycaemia may
and reduction
g/ dl
,
subcutaneous
immediately
Insulin suspensions should
at the maximum recommended
30
Farmacêuticos
pioglitazone
of 10 to 30
during
risk of
g/ dl (
trials , an
Europe ) ,
increased
, warfarin ,
or mixed episode of
- Middlesex UB8
of
14
plasma concentrations
